17,20-lyase deficiency, isolated	202110	CYP17A1	609300	10q24.32
17,20-lyase deficiency, isolated	202110	CYP17	609300	10q24.32
17,20-lyase deficiency, isolated	202110	P450C17	609300	10q24.32
17-alpha-hydroxylase/17,20-lyase deficiency	202110	CYP17A1	609300	10q24.32
17-alpha-hydroxylase/17,20-lyase deficiency	202110	CYP17	609300	10q24.32
17-alpha-hydroxylase/17,20-lyase deficiency	202110	P450C17	609300	10q24.32
17-beta-hydroxysteroid dehydrogenase X deficiency	300438	HSD17B10	300256	Xp11.22
17-beta-hydroxysteroid dehydrogenase X deficiency	300438	HADH2	300256	Xp11.22
17-beta-hydroxysteroid dehydrogenase X deficiency	300438	ERAB	300256	Xp11.22
17-beta-hydroxysteroid dehydrogenase X deficiency	300438	MRXS10	300256	Xp11.22
17-beta-hydroxysteroid dehydrogenase X deficiency	300438	MRX17	300256	Xp11.22
17-beta-hydroxysteroid dehydrogenase X deficiency	300438	MRX31	300256	Xp11.22
17-beta-hydroxysteroid dehydrogenase X deficiency	300438	DUPXp11.22	300256	Xp11.22
2-aminoadipic 2-oxoadipic aciduria	204750	DHTKD1	614984	10p14
2-aminoadipic 2-oxoadipic aciduria	204750	KIAA1630	614984	10p14
2-aminoadipic 2-oxoadipic aciduria	204750	AMOXAD	614984	10p14
2-aminoadipic 2-oxoadipic aciduria	204750	CMT2Q	614984	10p14
2-methylbutyrylglycinuria	610006	ACADSB	600301	10q26.13
2-methylbutyrylglycinuria	610006	SBCAD	600301	10q26.13
3-M syndrome 1	273750	CUL7	609577	6p21.1
3-M syndrome 2	612921	OBSL1	610991	2q35
3-M syndrome 2	612921	KIAA0657	610991	2q35
3-M syndrome 2	612921	3M2	610991	2q35
3-Methylcrotonyl-CoA carboxylase 1 deficiency	210200	MCCC1	609010	3q27.1
3-Methylcrotonyl-CoA carboxylase 1 deficiency	210200	MCCA	609010	3q27.1
3-Methylcrotonyl-CoA carboxylase 2 deficiency	210210	MCCC2	609014	5q13.2
3-Methylcrotonyl-CoA carboxylase 2 deficiency	210210	MCCB	609014	5q13.2
3-beta-hydroxysteroid dehydrogenase, type II, deficiency	201810	HSD3B2	613890	1p12
3-hydroxyacyl-CoA dehydrogenase deficiency	231530	HADHSC	601609	4q25
3-hydroxyacyl-CoA dehydrogenase deficiency	231530	SCHAD	601609	4q25
3-hydroxyacyl-CoA dehydrogenase deficiency	231530	HHF4	601609	4q25
3-hydroxyisobutryl-CoA hydrolase deficiency	250620	HIBCH	610690	2q32.2
3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	614739	SERAC1	614725	6q25.3
3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome	614739	MEGDEL	614725	6q25.3
3-methylglutaconic aciduria, type I	250950	AUH	600529	9q22.31
3-methylglutaconic aciduria, type III	258501	OPA3	606580	19q13.32
3-methylglutaconic aciduria, type III	258501	MGA3	606580	19q13.32
3-methylglutaconic aciduria, type V	610198	DNAJC19	608977	3q26.33
3-methylglutaconic aciduria, type V	610198	TIM14	608977	3q26.33
3MC syndrome 1	257920	MASP1	600521	3q27.3
3MC syndrome 1	257920	CRARF	600521	3q27.3
3MC syndrome 1	257920	3MC1	600521	3q27.3
3MC syndrome 2	265050	COLEC11	612502	2p25.3
3MC syndrome 2	265050	CLK1	612502	2p25.3
3MC syndrome 2	265050	3MC2	612502	2p25.3
3p- syndrome	613792	DEL3pterp25		3pter-p25
3p- syndrome	613792	C3DELpterp25		3pter-p25
3q21q26 syndrome		MECOM	165215	3q26.2
3q21q26 syndrome		EVI1	165215	3q26.2
46XX sex reversal 1	400045	SRY	480000	Yp11.31
46XX sex reversal 1	400045	TDF	480000	Yp11.31
46XX sex reversal 1	400045	TDY	480000	Yp11.31
46XX sex reversal 1	400045	SRXX1	480000	Yp11.31
46XX sex reversal 1	400045	SRXY1	480000	Yp11.31
46XX sex reversal 2	278850	SRXX2		17q24.3-q25.1
46XX sex reversal 2	278850	DUP17q24.3		17q24.3-q25.1
46XX sex reversal 2	278850	DEL17q24.3		17q24.3-q25.1
46XX sex reversal 3	300833	SRXX3		Xq26.3
46XY partial gonadal dysgenesis, with minifascicular neuropathy	607080	DHH	605423	12q13.12
46XY partial gonadal dysgenesis, with minifascicular neuropathy	607080	SRXY7	605423	12q13.12
46XY partial gonadal dysgenesis, with minifascicular neuropathy	607080	GDXYM	605423	12q13.12
46XY sex reversal 1	400044	SRY	480000	Yp11.31
46XY sex reversal 1	400044	TDF	480000	Yp11.31
46XY sex reversal 1	400044	TDY	480000	Yp11.31
46XY sex reversal 1	400044	SRXX1	480000	Yp11.31
46XY sex reversal 1	400044	SRXY1	480000	Yp11.31
46XY sex reversal 2, dosage-sensitive	300018	DAX1	300473	Xp21.2
46XY sex reversal 2, dosage-sensitive	300018	AHC	300473	Xp21.2
46XY sex reversal 2, dosage-sensitive	300018	AHX	300473	Xp21.2
46XY sex reversal 2, dosage-sensitive	300018	NR0B1	300473	Xp21.2
46XY sex reversal 2, dosage-sensitive	300018	SRXY2	300473	Xp21.2
46XY sex reversal 3	612965	NR5A1	184757	9q33.3
46XY sex reversal 3	612965	FTZF1	184757	9q33.3
46XY sex reversal 3	612965	FTZ1	184757	9q33.3
46XY sex reversal 3	612965	SF1	184757	9q33.3
46XY sex reversal 3	612965	AD4BP	184757	9q33.3
46XY sex reversal 3	612965	POF7	184757	9q33.3
46XY sex reversal 3	612965	SRXY3	184757	9q33.3
46XY sex reversal 3	612965	SPGF8	184757	9q33.3
46XY sex reversal 4	154230	DEL9p24.3		9p24.3
46XY sex reversal 4	154230	C9DELp24.3		9p24.3
46XY sex reversal 4	154230	SRXY4		9p24.3
46XY sex reversal 5	613080	CBX2	602770	17q25.3
46XY sex reversal 5	613080	M33	602770	17q25.3
46XY sex reversal 5	613080	SRXY5	602770	17q25.3
46XY sex reversal 6	613762	MAP3K1	600982	5q11.2
46XY sex reversal 6	613762	MEKK1	600982	5q11.2
46XY sex reversal 6	613762	MEKK	600982	5q11.2
46XY sex reversal 6	613762	SRXY6	600982	5q11.2
46XY sex reversal 7	233420	DHH	605423	12q13.12
46XY sex reversal 7	233420	SRXY7	605423	12q13.12
46XY sex reversal 7	233420	GDXYM	605423	12q13.12
46XY sex reversal 8	614279	AKR1C2	600450	10p15.1
46XY sex reversal 8	614279	DDH2	600450	10p15.1
46XY sex reversal 8	614279	DD2	600450	10p15.1
46XY sex reversal 8	614279	HAKRD	600450	10p15.1
46XY sex reversal 8	614279	SRXY8	600450	10p15.1
5-fluorouracil toxicity	274270	DPYD	612779	1p21.3
5-fluorouracil toxicity	274270	DPD	612779	1p21.3
5-oxoprolinase deficiency	260005	OPLAH	614243	8q24.3
5-oxoprolinase deficiency	260005	OPLAHD	614243	8q24.3
6-mercaptopurine sensitivity	610460	TPMT	187680	6p22.3
?ACAT2 deficiency	614055	ACAT2	100678	6q25.3
?Abruzzo-Erickson syndrome	302905	TBX22	300307	Xq21.1
?Abruzzo-Erickson syndrome	302905	CPX	300307	Xq21.1
?Abruzzo-Erickson syndrome	302905	ABERS	300307	Xq21.1
?Amelogenesis imperfecta-3, hypoplastic type	301201	AIH3		Xq22-q28
?Anal canal carcinoma		ANC	105580	11q22-qter
?Anemia, hypochromic microcytic, with iron overload 2	615234	STEAP3	609671	2q14.2
?Anemia, hypochromic microcytic, with iron overload 2	615234	TSAP6	609671	2q14.2
?Anemia, hypochromic microcytic, with iron overload 2	615234	AHMIO2	609671	2q14.2
?Antiphospholipid syndrome, familial		ATPLS	107320	6p21.3
?Arrhythmogenic right ventricular dysplasia 5	604400	LAMR1	150370	3p22.1
?Arrhythmogenic right ventricular dysplasia 5	604400	LAMBR	150370	3p22.1
?Arthrogryposis, mental retardation, and seizures	615553	SLC35A3	605632	1p21.2
?Arthrogryposis, mental retardation, and seizures	615553	AMRS	605632	1p21.2
?Breast cancer, type 3	605365	BRCA3		13q21
?Breast cancer, type 3	605365	BRCAX		13q21
?Candidiasis, familial, 8	615527	TRAF3IP2	607043	6q21
?Candidiasis, familial, 8	615527	C6orf5	607043	6q21
?Candidiasis, familial, 8	615527	ACT1	607043	6q21
?Candidiasis, familial, 8	615527	CIKS	607043	6q21
?Candidiasis, familial, 8	615527	C6orf4	607043	6q21
?Candidiasis, familial, 8	615527	C6orf6	607043	6q21
?Candidiasis, familial, 8	615527	PSORS13	607043	6q21
?Candidiasis, familial, 8	615527	CANDF8	607043	6q21
?Cardiomyopathy, dilated, 1AA	612158	ACTN2	102573	1q43
?Cardiomyopathy, dilated, 1AA	612158	CMD1AA	102573	1q43
?Carnitine acetyltransferase deficiency		CRAT	600184	9q34.11
?Carnitine acetyltransferase deficiency		CAT1	600184	9q34.11
?Cataract 41	116400	WFS1	606201	4p16.1
?Cataract 41	116400	WFRS	606201	4p16.1
?Cataract 41	116400	WFS	606201	4p16.1
?Cataract 41	116400	DFNA6	606201	4p16.1
?Cataract 41	116400	DFNA14	606201	4p16.1
?Cataract 41	116400	DFNA38	606201	4p16.1
?Cataract 41	116400	WFSL	606201	4p16.1
?Cataract 41	116400	CTRCT41	606201	4p16.1
?Cataract, congenital		SORD	182500	15q21.1
?Cataract, congenital		SORD1	182500	15q21.1
?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	615268	ATP8A2	605870	13q12.13
?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	615268	ATPIB	605870	13q12.13
?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4	615268	CAMRQ4	605870	13q12.13
?Ceroid lipofuscinosis, neuronal, 12	606693	ATP13A2	610513	1p36.13
?Ceroid lipofuscinosis, neuronal, 12	606693	PARK9	610513	1p36.13
?Ceroid lipofuscinosis, neuronal, 12	606693	KRPPD	610513	1p36.13
?Ceroid lipofuscinosis, neuronal, 12	606693	CLN12	610513	1p36.13
?Charcot-Marie-Tooth disease, X-linked dominant, 6	300905	PDK3	300906	Xp22.11
?Charcot-Marie-Tooth disease, X-linked dominant, 6	300905	CMTX6	300906	Xp22.11
?Charcot-Marie-Tooth disease, type 2R	615490	TRIM2	614141	4q31.3
?Charcot-Marie-Tooth disease, type 2R	615490	KIAA0517	614141	4q31.3
?Charcot-Marie-Tooth disease, type 2R	615490	CMT2R	614141	4q31.3
?Charcot-Marie-Tooth disease, type 4B3	615284	SBF1	603560	22q13.33
?Charcot-Marie-Tooth disease, type 4B3	615284	MTMR5	603560	22q13.33
?Charcot-Marie-Tooth disease, type 4B3	615284	CMT4B3	603560	22q13.33
?Coffin-Siris syndrome	135900	CSS		7q32-q34
?Colon cancer		SLC26A3	126650	7q31.1
?Colon cancer		DRA	126650	7q31.1
?Colon cancer		CLD	126650	7q31.1
?Combined oxidative phosphorylation deficiency 16	615395	MRPL44	611849	2q36.1
?Combined oxidative phosphorylation deficiency 16	615395	COXPD16	611849	2q36.1
?Combined oxidative phosphorylation deficiency 19	615595	LYRM4	613311	6p25.1
?Combined oxidative phosphorylation deficiency 19	615595	ISD11	613311	6p25.1
?Combined oxidative phosphorylation deficiency 19	615595	C6orf149	613311	6p25.1
?Combined oxidative phosphorylation deficiency 19	615595	COXPD19	613311	6p25.1
?Complement factor B deficiency	615561	CFB	138470	6p21.33
?Complement factor B deficiency	615561	BF	138470	6p21.33
?Complement factor B deficiency	615561	GBG	138470	6p21.33
?Complement factor B deficiency	615561	AHUS4	138470	6p21.33
?Complement factor B deficiency	615561	ARMD14	138470	6p21.33
?Complement factor B deficiency	615561	CFBD	138470	6p21.33
?Cone-rod dystrophy	604011	UNC119		17q11.2
?Cone-rod dystrophy	604011	HRG4		17q11.2
?Cone-rod dystrophy	604011	IMD13		17q11.2
?Congenital disorder of glycosylation, type Iv	615273	NGLY1	610661	3p24.2
?Congenital disorder of glycosylation, type Iv	615273	PNG1	610661	3p24.2
?Congenital disorder of glycosylation, type Iv	615273	CDG1V	610661	3p24.2
?Congenital disorder of glycosylation, type Iw	615596	STT3A	601134	11q24.2
?Congenital disorder of glycosylation, type Iw	615596	ITM1	601134	11q24.2
?Congenital disorder of glycosylation, type Iw	615596	TMC	601134	11q24.2
?Congenital disorder of glycosylation, type Ix	615597	STT3B	608605	3p23
?Congenital disorder of glycosylation, type Ix	615597	SIMP	608605	3p23
?Congenital disorder of glycosylation, type Ix	615597	CDG1X	608605	3p23
?Corneal intraepithelial dyskeratosis and ectodermal dysplasia	615225	NLRP1	606636	17p13.2
?Corneal intraepithelial dyskeratosis and ectodermal dysplasia	615225	NALP1	606636	17p13.2
?Corneal intraepithelial dyskeratosis and ectodermal dysplasia	615225	KIAA0926	606636	17p13.2
?Corneal intraepithelial dyskeratosis and ectodermal dysplasia	615225	DEFCAP	606636	17p13.2
?Corneal intraepithelial dyskeratosis and ectodermal dysplasia	615225	CARD7	606636	17p13.2
?Corneal intraepithelial dyskeratosis and ectodermal dysplasia	615225	SLEV1	606636	17p13.2
?Corneal intraepithelial dyskeratosis and ectodermal dysplasia	615225	VAMAS1	606636	17p13.2
?Corneal intraepithelial dyskeratosis and ectodermal dysplasia	615225	CIDED	606636	17p13.2
?Cortical dysplasia, complex, with other brain malformations 2	615282	KIF5C	604593	2q23.1
?Cortical dysplasia, complex, with other brain malformations 2	615282	NKHC2	604593	2q23.1
?Cortical dysplasia, complex, with other brain malformations 2	615282	CDCBM2	604593	2q23.1
?Craniofacioskeletal syndrome	300712	CFSS		Xq26-q27
?Cytochrome c oxidase deficiency	220110	COX6B1	124089	19q13.12
?DECR deficiency	222745	DECR1		8q21.3
?Deafness, X-linked 6	300914	COL4A6	303631	Xq22.3
?Deafness, X-linked 6	300914	DELXq22.3	303631	Xq22.3
?Deafness, X-linked 6	300914	CXDELq22.3	303631	Xq22.3
?Deafness, X-linked 6	300914	DFNX6	303631	Xq22.3
?Deafness, autosomal recessive 88	615429	ELMOD3	615427	2p11.2
?Deafness, autosomal recessive 88	615429	RBED1	615427	2p11.2
?Deafness, autosomal recessive 88	615429	DFNB88	615427	2p11.2
?Deafness, nonsyndromic		KIAA1199	608366	15q25.1
?Diabetes mellitus, insulin-dependent, neonatal		PBCA	600089	6p21.3
?Diamond-Blackfan anemia 11	614900	RPL26	603704	17p13.1
?Diamond-Blackfan anemia 11	614900	DBA11	603704	17p13.1
?Diamond-Blackfan anemia 12	615550	RPL15	604174	3p24.2
?Diamond-Blackfan anemia 12	615550	DBA12	604174	3p24.2
?Dystonia 23	614860	DYT23		9q34
?EEC syndrome-1	129900	EEC1		7q11.2-q21.3
?Ehlers-Danlos syndrome, musculocontractural type 2	615539	DSE	605942	6q22.1
?Ehlers-Danlos syndrome, musculocontractural type 2	615539	SART2	605942	6q22.1
?Ehlers-Danlos syndrome, musculocontractural type 2	615539	EDSMC2	605942	6q22.1
?Epilepsy, familial adult myoclonic, 5	615400	CNTN2	190197	1q32.1
?Epilepsy, familial adult myoclonic, 5	615400	TAX	190197	1q32.1
?Epilepsy, familial adult myoclonic, 5	615400	TAX1	190197	1q32.1
?Epilepsy, familial adult myoclonic, 5	615400	FAME5	190197	1q32.1
?Fanconi renotubular syndrome 3	615605	EHHADH	607037	3q27.2
?Fanconi renotubular syndrome 3	615605	PBFE	607037	3q27.2
?Fanconi renotubular syndrome 3	615605	LBFP	607037	3q27.2
?Fanconi renotubular syndrome 3	615605	FRTS3	607037	3q27.2
?Fetal hydantoin syndrome	132810	EPHX1		1q42.12
?Globozoospermia	102530	GOPC	606845	6q22.1
?Globozoospermia	102530	PIST	606845	6q22.1
?Globozoospermia	102530	FIG	606845	6q22.1
?Globozoospermia	102530	CAL	606845	6q22.1
?Glycoprotein Ia deficiency	614200	ITGA2	192974	5q11.2
?Glycoprotein Ia deficiency	614200	CD49B	192974	5q11.2
?Glycoprotein Ia deficiency	614200	BR	192974	5q11.2
?Glycoprotein Ia deficiency	614200	BDPLT9	192974	5q11.2
?Hairy ears, Y-linked		HEY	425500	Yq
?Hemochromatosis, type 5	615517	FTH1	134770	11q12.3
?Hemochromatosis, type 5	615517	FTHL6	134770	11q12.3
?Hemochromatosis, type 5	615517	HFE5	134770	11q12.3
?Hepatocellular carcinoma		LCO	165320	2q14-q21
?Heterotaxy, visceral, 3, autosomal	606325	HTX3		6q21
?Hydrocephalus, autosomal dominant	123155	HDCPH1		8q12.2-q21.2
?Hyperimmunoglobulin G1 syndrome		IGHR	144120	14q32.33
?Hyperleucinemia-isoleucinemia or hypervalinemia		BCAT1	113520	12p12.1
?Hyperleucinemia-isoleucinemia or hypervalinemia		BCT1	113520	12p12.1
?Hyperprolactinemia	615555	PRLR	176761	5p13.2
?Hyperprolactinemia	615555	MFAB	176761	5p13.2
?Hyperprolactinemia	615555	HPRL	176761	5p13.2
?Hypertension, essential	145500	PNMT	171190	17q12
?Hypertension, essential	145500	PENT	171190	17q12
?Hypertension, salt-resistant		NPR3	108962	5p13.3
?Hypertension, salt-resistant		ANPRC	108962	5p13.3
?Hypertrichosis universalis congenita, Ambras type	145701	ITC1		8q22
?Hypervalinemia or hyperleucine-isoleucinemia		BCAT2	113530	19q13.33
?Hypervalinemia or hyperleucine-isoleucinemia		BCT2	113530	19q13.33
?Immunodeficiency 12	615468	MALT1	604860	18q21.32
?Immunodeficiency 12	615468	MLT	604860	18q21.32
?Immunodeficiency 12	615468	IMD12	604860	18q21.32
?Immunodeficiency 13	615518	UNC119	604011	17q11.2
?Immunodeficiency 13	615518	HRG4	604011	17q11.2
?Immunodeficiency 13	615518	IMD13	604011	17q11.2
?Immunodeficiency 16	615593	TNFRSF4	600315	1p36.33
?Immunodeficiency 16	615593	TXGP1L	600315	1p36.33
?Immunodeficiency 16	615593	OX40	600315	1p36.33
?Immunodeficiency 16	615593	ACT35	600315	1p36.33
?Immunodeficiency 16	615593	IMD16	600315	1p36.33
?Immunodeficiency, common variable, 9	615559	PRKCD	176977	3p21.1
?Immunodeficiency, common variable, 9	615559	CVID9	176977	3p21.1
?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	615422	HNRPA2B1	600124	7p15.2
?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2	615422	IBMPFD2	600124	7p15.2
?Inclusion body myopathy wtih early-onset Paget disease without frontotemporal dementia 3	615424	HNRNPA1	164017	12q13.13
?Inclusion body myopathy wtih early-onset Paget disease without frontotemporal dementia 3	615424	IBMPFD3	164017	12q13.13
?Inclusion body myopathy wtih early-onset Paget disease without frontotemporal dementia 3	615424	ALS20	164017	12q13.13
?Infantile liver failure syndrome 2	615486	MARS	156560	12q13.3
?Infantile liver failure syndrome 2	615486	MTRNS	156560	12q13.3
?Infantile liver failure syndrome 2	615486	METRS	156560	12q13.3
?Isolated growth hormone deficiency due to defect in GHRF		GHRH	139190	20q11.23
?Isolated growth hormone deficiency due to defect in GHRF		GHRF	139190	20q11.23
?Keratoderma, palmoplantar, punctate type 3	101850	PPKP3		2p25-p12
?Klippel-Feil syndrome 2, autosomal recessive	214300	KFS2		5q11.2
?Klippel-Feil syndrome 2, autosomal recessive	214300	KFM		5q11.2
?Laryngeal adductor paralysis	150270	LAP		6p21.3-p21.2
?Lipodystrophy, familial partial, type 5	615238	CIDEC	612120	3p25.3
?Lipodystrophy, familial partial, type 5	615238	FSP27	612120	3p25.3
?Lipodystrophy, familial partial, type 5	615238	CIDE3	612120	3p25.3
?Lipodystrophy, familial partial, type 5	615238	FPLD5	612120	3p25.3
?Liver failure, infantile, syndromic	615438	LARS	151350	5q32
?Liver failure, infantile, syndromic	615438	LFIS	151350	5q32
?Lysosomal acid phosphatase deficiency	200950	ACP2	171650	11p11.2
?Male infertility		UBE2B	179095	5q31.1
?Male infertility		RAD6B	179095	5q31.1
?Male infertility due to acrosin deficiency		ACR	102480	22q13.33
?Male pseudohermaphroditism due to defective LH	152780	LHB		19q13.33
?Megalencephaly, autosomal recessive	248000	TBC1D7	612655	6p24.1
?Megalencephaly, autosomal recessive	248000	PIG51	612655	6p24.1
?Megalencephaly, autosomal recessive	248000	TBC7	612655	6p24.1
?Megalencephaly, autosomal recessive	248000	MGCPH	612655	6p24.1
?Melkersson-Rosenthal syndrome	155900	MROS		9p11
?Mental retardation, X-linked, syndromic 12	309545	MRXS12		Xp11
?Mental retardation, X-linked, syndromic, Hedera type	300423	ATP6AP2	300556	Xp11.4
?Mental retardation, X-linked, syndromic, Hedera type	300423	ATP6M8-9	300556	Xp11.4
?Mental retardation, X-linked, syndromic, Hedera type	300423	XMRE	300556	Xp11.4
?Mental retardation, X-linked, syndromic, Hedera type	300423	MRXSH	300556	Xp11.4
?Mental retardation, X-linked, syndromic, Hedera type	300423	XPDS	300556	Xp11.4
?Mental retardation, autosomal dominant 22	612337	ZBTB18	608433	1q44
?Mental retardation, autosomal dominant 22	612337	ZNF238	608433	1q44
?Mental retardation, autosomal dominant 22	612337	RP58	608433	1q44
?Mental retardation, autosomal dominant 22	612337	MRD22	608433	1q44
?Mental retardation, autosomal recessive, 37	615493	ANK3	600465	10q21.2
?Mental retardation, autosomal recessive, 37	615493	MRT37	600465	10q21.2
?Microcephaly 11, primary, autosomal recessive	615414	PHC1	602978	12p13.31
?Microcephaly 11, primary, autosomal recessive	615414	EDR1	602978	12p13.31
?Microcephaly 11, primary, autosomal recessive	615414	HPH1	602978	12p13.31
?Microcephaly 11, primary, autosomal recessive	615414	RAE28	602978	12p13.31
?Microcephaly 11, primary, autosomal recessive	615414	MCPH11	602978	12p13.31
?Microphthalmia, syndrome 1	309800	NAA10	300013	Xq28
?Microphthalmia, syndrome 1	309800	ARD1A	300013	Xq28
?Microphthalmia, syndrome 1	309800	ARD1	300013	Xq28
?Microphthalmia, syndrome 1	309800	TE2	300013	Xq28
?Microphthalmia, syndrome 1	309800	NATD	300013	Xq28
?Microphthalmia, syndrome 1	309800	MCOPS1	300013	Xq28
?Microphthalmia, syndromic 4	301590	MCOPS4		Xq27-q28
?Microphthalmia, syndromic 4	301590	ANOP1		Xq27-q28
?Microtia with or without hearing impairment (AD)	612290	HOXA2	604685	7p15.2
?Microtia with or without hearing impairment (AD)	612290	MCOHI	604685	7p15.2
?Microtia, hearing impairment, and cleft palate (AR)	612290	HOXA2	604685	7p15.2
?Microtia, hearing impairment, and cleft palate (AR)	612290	MCOHI	604685	7p15.2
?Mitochondrial complex (ATP synthase) deficiency, nuclear type 4	615228	ATP5A1	164360	18q21.1
?Mitochondrial complex (ATP synthase) deficiency, nuclear type 4	615228	ATPM	164360	18q21.1
?Mitochondrial complex (ATP synthase) deficiency, nuclear type 4	615228	ATP5A	164360	18q21.1
?Mitochondrial complex (ATP synthase) deficiency, nuclear type 4	615228	ORM	164360	18q21.1
?Mitochondrial complex (ATP synthase) deficiency, nuclear type 4	615228	MC5DN4	164360	18q21.1
?Mitochondrial complex I deficiency	252010	NDUFB9	601445	8q24.13
?Mitochondrial complex I deficiency	252010	UQOR22	601445	8q24.13
?Mitochondrial complex IV deficiency	220110	FASTKD2	612322	2q33.3
?Mitochondrial complex IV deficiency	220110	KIAA0971	612322	2q33.3
?Moebius syndrome	157900	MBS		13q12.2-q13
?Moebius syndrome	157900	MBS1		13q12.2-q13
?Multiple congenital anomalies-hypotonia-seizures syndrome 3	615398	PIGT	610272	20q13.12
?Multiple congenital anomalies-hypotonia-seizures syndrome 3	615398	NDAP	610272	20q13.12
?Multiple congenital anomalies-hypotonia-seizures syndrome 3	615398	PNH2	610272	20q13.12
?Multiple congenital anomalies-hypotonia-seizures syndrome 3	615398	MCAHS3	610272	20q13.12
?Multiple mitochondrial dysfunctions syndrome 3	615330	IBA57	615316	1q42.13
?Multiple mitochondrial dysfunctions syndrome 3	615330	C1orf69	615316	1q42.13
?Multiple mitochondrial dysfunctions syndrome 3	615330	MMDS3	615316	1q42.13
?Multiple mitochondrial dysfunctions syndrome 3	615330	VTI1A	614316	10q25.2
?Multiple mitochondrial dysfunctions syndrome 3	615330	VTI1RP2	614316	10q25.2
?Multiple mitochondrial dysfunctions syndrome 3	615330	MMDS3	614316	10q25.2
?Muscular dystrophy, limb-girdle, type 2R	615325	DES	125660	2q35
?Muscular dystrophy, limb-girdle, type 2R	615325	CMD1I	125660	2q35
?Muscular dystrophy, limb-girdle, type 2R	615325	MFM1	125660	2q35
?Muscular dystrophy, limb-girdle, type 2R	615325	SCPNK	125660	2q35
?Muscular dystrophy, limb-girdle, type 2R	615325	ARVD7	125660	2q35
?Muscular dystrophy, limb-girdle, type 2R	615325	ARVC7	125660	2q35
?Muscular dystrophy, limb-girdle, type 2R	615325	LGMD2R	125660	2q35
?Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12	615249	SGK196	615247	8p11.21
?Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12	615249	MDDGA12	615247	8p11.21
?Myofibromatosis, infantile 2	615293	NOTCH3	600276	19p13.12
?Myofibromatosis, infantile 2	615293	CADASIL	600276	19p13.12
?Myofibromatosis, infantile 2	615293	CASIL	600276	19p13.12
?Myofibromatosis, infantile 2	615293	IMF2	600276	19p13.12
?N syndrome	310465	POLA1	312040	Xp22.1-p21.3
?N-acetylaspartate deficiency	614063	NAT8L	610647	4p16.3
?N-acetylaspartate deficiency	614063	CML3	610647	4p16.3
?N-acetylaspartate deficiency	614063	NACED	610647	4p16.3
?Nephronophthisis 9	613824	NEK8	609799	17q11.2
?Nephronophthisis 9	613824	JCK	609799	17q11.2
?Nephronophthisis 9	613824	NPHP9	609799	17q11.2
?Nephronophthisis 9	613824	RHPD2	609799	17q11.2
?Nephrotic syndrome, type 8	615244	ARHGDIA	601925	17q25.3
?Nephrotic syndrome, type 8	615244	GDIA1	601925	17q25.3
?Nephrotic syndrome, type 8	615244	NPHS8	601925	17q25.3
?Neuroblastoma		TP73	601990	1p36.32
?Neurodegeneration with optic atrophy, childhood onset	615491	UCHL1	191342	4p13
?Neurodegeneration with optic atrophy, childhood onset	615491	PARK5	191342	4p13
?Neurodegeneration with optic atrophy, childhood onset	615491	NDGOA	191342	4p13
?Neutrophil chemotactic repsonse, abnormal	162820	NM		7q22-qter
?Neutrophil chemotactic repsonse, abnormal	162820	NCR		7q22-qter
?Osteoporosis, involutional	166710	VDR	601769	12q13.11
?Otofaciocervical syndrome 2	615560	PAX1	167411	20p11.22
?Otofaciocervical syndrome 2	615560	OFC2	167411	20p11.22
?Otofaciocervical syndrome	166780	EYA1	601653	8q13.3
?Otofaciocervical syndrome	166780	BOR	601653	8q13.3
?Otofaciocervical syndrome	166780	BOS1	601653	8q13.3
?Otofaciocervical syndrome	166780	OFC1	601653	8q13.3
?Paget disease of bone		PDB	167250	6p21.3
?Pancreatic endocrine tumors		ST11	602011	3p25
?Pancreatic endocrine tumors		PETS1	602011	3p25
?Parkinsonism with spasticity, X-linked	300911	ATP6AP2	300556	Xp11.4
?Parkinsonism with spasticity, X-linked	300911	ATP6M8-9	300556	Xp11.4
?Parkinsonism with spasticity, X-linked	300911	XMRE	300556	Xp11.4
?Parkinsonism with spasticity, X-linked	300911	MRXSH	300556	Xp11.4
?Parkinsonism with spasticity, X-linked	300911	XPDS	300556	Xp11.4
?Paroxysmal nocturnal hemoglobinuria 2	615399	PIGT	610272	20q13.12
?Paroxysmal nocturnal hemoglobinuria 2	615399	NDAP	610272	20q13.12
?Paroxysmal nocturnal hemoglobinuria 2	615399	PNH2	610272	20q13.12
?Paroxysmal nocturnal hemoglobinuria 2	615399	MCAHS3	610272	20q13.12
?Periventricular nodular heterotopia 6	615544	ERMARD	615532	6q27
?Periventricular nodular heterotopia 6	615544	C6orf70	615532	6q27
?Periventricular nodular heterotopia 6	615544	PVNH6	615532	6q27
?Phosphoenolpyruvate carboxykinase-1, cytosolic, deficiency	261680	PCK1	614168	20q13.31
?Polydactyly, postaxial, type A6	615226	ZNF141	194648	4p16.3
?Polydactyly, postaxial, type A6	615226	D4S90	194648	4p16.3
?Polydactyly, postaxial, type A6	615226	PAPA6	194648	4p16.3
?Preauricular fistulae, congenital	128700	PAFC		8q11.1-q13.3
?Prinzmetal angina		KCNJ8	600935	12p12.1
?Progesterone resistance	264080	PGR	607311	11q22.1
?Ptosis, congenital	178300	ZFHX4	606940	8q21.11
?Ptosis, congenital	178300	ZFH4	606940	8q21.11
?Ragweed sensitivity		RWS	179450	6p21.3
?Renal-hepatic-pancreatic dysplasia 2	615415	NEK8	609799	17q11.2
?Renal-hepatic-pancreatic dysplasia 2	615415	JCK	609799	17q11.2
?Renal-hepatic-pancreatic dysplasia 2	615415	NPHP9	609799	17q11.2
?Renal-hepatic-pancreatic dysplasia 2	615415	RHPD2	609799	17q11.2
?Retinal cone dystrophy-1	180020	RCD1		6q25-q26
?Retinitis pigmentosa 66	615233	RBP3	180290	10q11.22
?Retinitis pigmentosa 66	615233	RP66	180290	10q11.22
?Retinitis pigmentosa 67	615565	NEK2	604043	1q32.3
?Retinitis pigmentosa 67	615565	RP67	604043	1q32.3
?Retinitis pigmentosa, X-linked recessive, 6	312612	RP6		Xp21.3-p21.2
?Rienhoff syndrome	615582	TGFB3	190230	14q24.3
?Rienhoff syndrome	615582	ARVD1	190230	14q24.3
?Rienhoff syndrome	615582	RNHF	190230	14q24.3
?Roifman-Chitayat syndrome		RCHTS	613328	15q11-q21.1
?Sarcoma, synovial	300813	SSX1	312820	Xp11.23
?Sarcoma, synovial	300813	SSRC	312820	Xp11.23
?Sarcoma, synovial	300813	SSX2	300192	Xp11.22
?Sertoli-cell-only syndrome		DAZ	400003	Yq11.223
?Spastic paraplegia 41, autosomal dominant	613364	SPG41		11p14.1-p11.2
?Spastic paraplegia 43, autosomal recessive	615043	C19orf12	614297	19q12
?Spastic paraplegia 43, autosomal recessive	615043	NBIA4	614297	19q12
?Spastic paraplegia 43, autosomal recessive	615043	SPG43	614297	19q12
?Spastic paraplegia 72, autosomal dominant	615625	REEP2	609347	5q31.2
?Spastic paraplegia 72, autosomal dominant	615625	C5orf19	609347	5q31.2
?Spastic paraplegia 72, autosomal dominant	615625	SPG72	609347	5q31.2
?Spastic paraplegia 72, autosomal recessive	615625	REEP2	609347	5q31.2
?Spastic paraplegia 72, autosomal recessive	615625	C5orf19	609347	5q31.2
?Spastic paraplegia 72, autosomal recessive	615625	SPG72	609347	5q31.2
?Spinocerebellar ataxia 26	609306	EEF2	130610	19p13.3
?Spinocerebellar ataxia 26	609306	EF2	130610	19p13.3
?Spinocerebellar ataxia 26	609306	SCA26	130610	19p13.3
?Spinocerebellar ataxia 30	613371	SCA30		4q34.3-q35.1
?Spinocerebellar ataxia, X-linked 1	302500	ATP2B3	300014	Xq28
?Spinocerebellar ataxia, X-linked 1	302500	PMCA3	300014	Xq28
?Spinocerebellar ataxia, X-linked 1	302500	SCAX1	300014	Xq28
?Split-hand/foot malformation 1 with sensorineural hearing loss	220600	DLX5	600028	7q21.3
?Split-hand/foot malformation 1 with sensorineural hearing loss	220600	SHFM1D	600028	7q21.3
?Stomatocytosis I	185000	EPB72	133090	9q33.2
?Systemic lupus erythematosus, susceptibility to or protection against}	152700	C4A	120810	6p21.33
?Systemic lupus erythematosus, susceptibility to or protection against}	152700	C4S	120810	6p21.33
?Systemic lupus erythematosus, susceptibility to or protection against}	152700	C4AD	120810	6p21.33
?Testicular anomalies with or without congenital heart disease	615542	GATA4	600576	8p23.1
?Testicular anomalies with or without congenital heart disease	615542	ASD2	600576	8p23.1
?Testicular anomalies with or without congenital heart disease	615542	VSD1	600576	8p23.1
?Testicular anomalies with or without congenital heart disease	615542	TACHD	600576	8p23.1
?Testicular microlithiasis	610441	SLC34A2	604217	4p15.2
?Tetramelic mirror-image polydactyly	135750	TMIP		14q13
?Thrombocytopenia, Paris-Trousseau type	188025	TCPT		11q23
?Thrombophilia due to decreased release of tissue plasminogen	612348	THPH9		8p12
?Thromboxane synthase deficiency	614158	TBXAS1	274180	7q34
?Thromboxane synthase deficiency	614158	GHOSAL	274180	7q34
?Thromboxane synthase deficiency	614158	CYP5	274180	7q34
?Thromboxane synthase deficiency	614158	BDPLT14	274180	7q34
?Tibial hemimelia		THM	275220	8q24.1
?Winchester syndrome	277950	MMP14	600754	14q11.2
?Winchester syndrome	277950	WNCHRS	600754	14q11.2
?Zimmermann-Laband syndrome	135500	ZLS		3p14.3
?{Autism susceptibility 16}	613410	SLC9A9	608396	3q24
?{Autism susceptibility 16}	613410	AUTS16	608396	3q24
?{Parkinson disease 5, susceptibility to}	613643	UCHL1	191342	4p13
?{Parkinson disease 5, susceptibility to}	613643	PARK5	191342	4p13
?{Parkinson disease 5, susceptibility to}	613643	NDGOA	191342	4p13
ABCD syndrome	600501	EDNRB	131244	13q22.3
ABCD syndrome	600501	HSCR2	131244	13q22.3
ABCD syndrome	600501	ABCDS	131244	13q22.3
ABCD syndrome	600501	WS4A	131244	13q22.3
ACAD9 deficiency	611126	ACAD9	611103	3q21.3
ACTH-independent macronodular adrenal hyperplasia	219080	GNAS	139320	20q13.32
ACTH-independent macronodular adrenal hyperplasia	219080	GNAS1	139320	20q13.32
ACTH-independent macronodular adrenal hyperplasia	219080	GPSA	139320	20q13.32
ACTH-independent macronodular adrenal hyperplasia	219080	POH	139320	20q13.32
ACTH-independent macronodular adrenal hyperplasia	219080	PHP1B	139320	20q13.32
ACTH-independent macronodular adrenal hyperplasia	219080	PHP1A	139320	20q13.32
ACTH-independent macronodular adrenal hyperplasia	219080	AHO	139320	20q13.32
ACTH-independent macronodular adrenal hyperplasia	219080	PHP1C	139320	20q13.32
ADULT syndrome	103285	TP63	603273	3q28
ADULT syndrome	103285	TP73L	603273	3q28
ADULT syndrome	103285	KET	603273	3q28
ADULT syndrome	103285	EEC3	603273	3q28
ADULT syndrome	103285	SHFM4	603273	3q28
ADULT syndrome	103285	LMS	603273	3q28
ADULT syndrome	103285	RHS	603273	3q28
ADULT syndrome	103285	OFC8	603273	3q28
AICA-ribosiduria due to ATIC deficiency	608688	ATIC	601731	2q35
AICA-ribosiduria due to ATIC deficiency	608688	PURH	601731	2q35
AICA-ribosiduria due to ATIC deficiency	608688	AICAR	601731	2q35
Aarskog-Scott syndrome	305400	FGD1	300546	Xp11.22
Aarskog-Scott syndrome	305400	FGDY	300546	Xp11.22
Aarskog-Scott syndrome	305400	AAS	300546	Xp11.22
Aarskog-Scott syndrome	305400	MRXS16	300546	Xp11.22
Abdominal obesity-metabolic syndrome	605552	AOMS1		3q27
Abdominal obesity-metabolic syndrome	605552	SYNX		3q27
Abdominal obesity-metabolic syndrome	605572	AOMS2		17p12
Abetalipoproteinemia	200100	MTP	157147	4q23
Acampomelic campomelic dysplasia	114290	SOX9	608160	17q24.3
Acampomelic campomelic dysplasia	114290	CMD1	608160	17q24.3
Acampomelic campomelic dysplasia	114290	SRA1	608160	17q24.3
Acatalasemia	614097	CAT	115500	11p13
Acetyl-CoA carboxylase deficiency	613933	ACACA	200350	17q12
Acetyl-CoA carboxylase deficiency	613933	ACAC	200350	17q12
Acetyl-CoA carboxylase deficiency	613933	ACC1	200350	17q12
Acetyl-CoA carboxylase deficiency	613933	ACACAD	200350	17q12
Achalasia-addisonianism-alacrimia syndrome	231550	AAAS	605378	12q13.13
Achalasia-addisonianism-alacrimia syndrome	231550	AAA	605378	12q13.13
Acheiropody	200500	LMBR1	605522	7q36.3
Acheiropody	200500	ACHP	605522	7q36.3
Acheiropody	200500	C7orf2	605522	7q36.3
Acheiropody	200500	PPD2	605522	7q36.3
Achondrogenesis Ib	600972	SLC26A2	606718	5q32
Achondrogenesis Ib	600972	DTD	606718	5q32
Achondrogenesis Ib	600972	DTDST	606718	5q32
Achondrogenesis Ib	600972	D5S1708	606718	5q32
Achondrogenesis Ib	600972	EDM4	606718	5q32
Achondrogenesis, type IA	200600	TRIP11	604505	14q32.12
Achondrogenesis, type IA	200600	TRIP230	604505	14q32.12
Achondrogenesis, type IA	200600	CEV14	604505	14q32.12
Achondrogenesis, type IA	200600	ACG1A	604505	14q32.12
Achondrogenesis, type II or hypochondrogenesis	200610	COL2A1	120140	12q13.11
Achondroplasia	100800	FGFR3	134934	4p16.3
Achondroplasia	100800	ACH	134934	4p16.3
Achromatopsia 6	610024	PDE6H	601190	12p12.3
Achromatopsia 6	610024	RCD3	601190	12p12.3
Achromatopsia 6	610024	ACHM6	601190	12p12.3
Achromatopsia-2	216900	CNGA3	600053	2q11.2
Achromatopsia-2	216900	CNG3	600053	2q11.2
Achromatopsia-2	216900	ACHM2	600053	2q11.2
Achromatopsia-3	262300	CNGB3	605080	8q21.3
Achromatopsia-3	262300	ACHM3	605080	8q21.3
Achromatopsia-3	262300	ACHM1	605080	8q21.3
Achromatopsia-4	613856	GNAT2	139340	1p13.3
Achromatopsia-4	613856	ACHM4	139340	1p13.3
Acid-labile subunit, deficiency of	601489	IGFALS		16p13.3
Acid-labile subunit, deficiency of	601489	ALS		16p13.3
Acne inversa, familial, 1	142690	NCSTN	605254	1q23.2
Acne inversa, familial, 2	613736	PSENEN	607632	19q13.12
Acne inversa, familial, 2	613736	PEN2	607632	19q13.12
Acne inversa, familial, 3	613737	PSEN1	104311	14q24.2
Acne inversa, familial, 3	613737	AD3	104311	14q24.2
Acrocallosal syndrome	200990	KIF7	611254	15q26.1
Acrocallosal syndrome	200990	HLS2	611254	15q26.1
Acrocallosal syndrome	200990	ACLS	611254	15q26.1
Acrocallosal syndrome	200990	JBTS12	611254	15q26.1
Acrocapitofemoral dysplasia	607778	IHH	600726	2q35
Acrocapitofemoral dysplasia	607778	BDA1	600726	2q35
Acrodermatitis enteropathica	201100	SLC39A4	607059	8q24.3
Acrodermatitis enteropathica	201100	ZIP4	607059	8q24.3
Acrodysostosis 1, with or without hormone resistance	101800	PRKAR1A	188830	17q24.2
Acrodysostosis 1, with or without hormone resistance	101800	TSE1	188830	17q24.2
Acrodysostosis 1, with or without hormone resistance	101800	CNC1	188830	17q24.2
Acrodysostosis 1, with or without hormone resistance	101800	CAR	188830	17q24.2
Acrodysostosis 1, with or without hormone resistance	101800	PPNAD1	188830	17q24.2
Acrodysostosis 1, with or without hormone resistance	101800	ACRDYS1	188830	17q24.2
Acrodysostosis 2, with or without hormone resistance	614613	PDE4D	600129	5q11.2-q12.1
Acrodysostosis 2, with or without hormone resistance	614613	DPDE3	600129	5q11.2-q12.1
Acrodysostosis 2, with or without hormone resistance	614613	STRK1	600129	5q11.2-q12.1
Acrodysostosis 2, with or without hormone resistance	614613	ACRDYS2	600129	5q11.2-q12.1
Acrofacial dysostosis 1, Nager type	154400	SF3B4	605593	1q21.2
Acrofacial dysostosis 1, Nager type	154400	SF3B49	605593	1q21.2
Acrofacial dysostosis 1, Nager type	154400	SAP49	605593	1q21.2
Acrofacial dysostosis 1, Nager type	154400	AFD1	605593	1q21.2
Acrokeratosis verruciformis	101900	ATP2A2	108740	12q24.11
Acrokeratosis verruciformis	101900	ATP2B	108740	12q24.11
Acrokeratosis verruciformis	101900	DAR	108740	12q24.11
Acromegaloid features, overgrowth, cleft palate, and hernia	606049	AOCH		Chr.11
Acromegaly	102200	GNAS	139320	20q13.32
Acromegaly	102200	GNAS1	139320	20q13.32
Acromegaly	102200	GPSA	139320	20q13.32
Acromegaly	102200	POH	139320	20q13.32
Acromegaly	102200	PHP1B	139320	20q13.32
Acromegaly	102200	PHP1A	139320	20q13.32
Acromegaly	102200	AHO	139320	20q13.32
Acromegaly	102200	PHP1C	139320	20q13.32
Acromesomelic dysplasia, Hunter-Thompson type	201250	GDF5	601146	20q11.22
Acromesomelic dysplasia, Hunter-Thompson type	201250	CDMP1	601146	20q11.22
Acromesomelic dysplasia, Hunter-Thompson type	201250	SYNS2	601146	20q11.22
Acromesomelic dysplasia, Hunter-Thompson type	201250	OS5	601146	20q11.22
Acromesomelic dysplasia, Hunter-Thompson type	201250	BDA1C	601146	20q11.22
Acromesomelic dysplasia, Hunter-Thompson type	201250	SYM1B	601146	20q11.22
Acromesomelic dysplasia, Maroteaux type	602875	NPR2	108961	9p13.3
Acromesomelic dysplasia, Maroteaux type	602875	ANPRB	108961	9p13.3
Acromesomelic dysplasia, Maroteaux type	602875	AMDM	108961	9p13.3
Acromicric dysplasia	102370	FBN1	134797	15q21.1
Acromicric dysplasia	102370	MFS1	134797	15q21.1
Acromicric dysplasia	102370	WMS2	134797	15q21.1
Acromicric dysplasia	102370	SSKS	134797	15q21.1
Acromicric dysplasia	102370	GPHYSD2	134797	15q21.1
Acromicric dysplasia	102370	ACMICD	134797	15q21.1
Acromicric dysplasia	102370	ECTOL1	134797	15q21.1
Acropectoral syndrome	605967	ACRPS		7q36
Acropectorovertebral dysplasia	102510	ACRPV		2q36
Activated PI3K-delta immunodeficiency syndrome	615513	PIK3CD	602839	1p36.22
Activated PI3K-delta immunodeficiency syndrome	615513	APDS	602839	1p36.22
Activated PI3K-delta immunodeficiency syndrome	615513	IMD14	602839	1p36.22
Acute insulin response	601676	AIR		1p31
Acyl-CoA dehydrogenase, medium chain, deficiency of	201450	ACADM	607008	1p31.1
Acyl-CoA dehydrogenase, medium chain, deficiency of	201450	MCAD	607008	1p31.1
Acyl-CoA dehydrogenase, short-chain, deficiency of	201470	ACADS	606885	12q24.31
Acyl-CoA dehydrogenase, short-chain, deficiency of	201470	SCAD	606885	12q24.31
Adams-Oliver syndrome 1	100300	ARHGAP31	610911	3q13.33
Adams-Oliver syndrome 1	100300	CDGAP	610911	3q13.33
Adams-Oliver syndrome 1	100300	KIAA1204	610911	3q13.33
Adams-Oliver syndrome 1	100300	AOS1	610911	3q13.33
Adams-Oliver syndrome 2	614219	DOCK6	614194	19p13.2
Adams-Oliver syndrome 2	614219	KIAA1395	614194	19p13.2
Adams-Oliver syndrome 2	614219	AOS2	614194	19p13.2
Adams-Oliver syndrome 3	614814	RBPJ	147183	4p15.2
Adams-Oliver syndrome 3	614814	RBPSUH	147183	4p15.2
Adams-Oliver syndrome 3	614814	IGKJRB1	147183	4p15.2
Adams-Oliver syndrome 3	614814	AOS3	147183	4p15.2
Adams-Oliver syndrome 4	615297	EOGT	614789	3p14.1
Adams-Oliver syndrome 4	615297	EOGT1	614789	3p14.1
Adams-Oliver syndrome 4	615297	C3orf64	614789	3p14.1
Adams-Oliver syndrome 4	615297	AOS4	614789	3p14.1
Adenine phosphoribosyltransferase deficiency	614723	APRT	102600	16q24.3
Adenine phosphoribosyltransferase deficiency	614723	APRTD	102600	16q24.3
Adenocarcinoma of lung, response to tyrosine kinase inhibitor in	211980	EGFR	131550	7p11.2
Adenocarcinoma of lung, somatic	211980	BRAF	164757	7q34
Adenocarcinoma of lung, somatic	211980	NS7	164757	7q34
Adenocarcinoma of lung, somatic	211980	ERBB2	164870	17q12
Adenocarcinoma of lung, somatic	211980	NGL	164870	17q12
Adenocarcinoma of lung, somatic	211980	NEU	164870	17q12
Adenocarcinoma of lung, somatic	211980	HER2	164870	17q12
Adenocarcinoma of lung, somatic	211980	PRKN	602544	6q26
Adenocarcinoma of lung, somatic	211980	PARK2	602544	6q26
Adenocarcinoma of lung, somatic	211980	PDJ	602544	6q26
Adenocarcinoma of lung, somatic	211980	LPRS2	602544	6q26
Adenocarcinoma, colonic, somatic		RAD54L	603615	1p34.1
Adenocarcinoma, colonic, somatic		HR54	603615	1p34.1
Adenocarcinoma, colonic, somatic		HRAD54	603615	1p34.1
Adenocarcinoma, ovarian, somatic	167000	PRKN	602544	6q26
Adenocarcinoma, ovarian, somatic	167000	PARK2	602544	6q26
Adenocarcinoma, ovarian, somatic	167000	PDJ	602544	6q26
Adenocarcinoma, ovarian, somatic	167000	LPRS2	602544	6q26
Adenoma, periampullary, somatic		APC	611731	5q22.2
Adenoma, periampullary, somatic		GS	611731	5q22.2
Adenoma, periampullary, somatic		FPC	611731	5q22.2
Adenoma, periampullary, somatic		BTPS2	611731	5q22.2
Adenomas, multiple colorectal	608456	MUTYH	604933	1p34.1
Adenomas, multiple colorectal	608456	MYH	604933	1p34.1
Adenomas, salivary gland pleomorphic	181030	PLAG1	603026	8q12.1
Adenomas, salivary gland pleomorphic	181030	SGPA	603026	8q12.1
Adenomas, salivary gland pleomorphic	181030	PSA	603026	8q12.1
Adenomatous polyposis coli	175100	APC	611731	5q22.2
Adenomatous polyposis coli	175100	GS	611731	5q22.2
Adenomatous polyposis coli	175100	FPC	611731	5q22.2
Adenomatous polyposis coli	175100	BTPS2	611731	5q22.2
Adenosine deaminase deficiency, partial	102700	ADA	608958	20q13.12
Adenosine triphosphate, elevated, of erythrocytes	102900	PKLR	609712	1q22
Adenosine triphosphate, elevated, of erythrocytes	102900	PK1	609712	1q22
Adenylosuccinase deficiency	103050	ADSL	608222	22q13.1
Adermatoglyphia	136000	SMARCAD1	612761	4q22.3
Adermatoglyphia	136000	KIAA1122	612761	4q22.3
Adermatoglyphia	136000	ETL1	612761	4q22.3
Adermatoglyphia	136000	HEL1	612761	4q22.3
Adermatoglyphia	136000	ADERM	612761	4q22.3
Adiponectin deficiency	612556	ADIPOQ	605441	3q27.3
Adiponectin deficiency	612556	APM1	605441	3q27.3
Adiponectin deficiency	612556	GBP28	605441	3q27.3
Adiponectin deficiency	612556	ADIPQTL1	605441	3q27.3
Adrenal adenoma, somatic		MEN1	613733	11q13.1
Adrenal cortical carcinoma	202300	TP53	191170	17p13.1
Adrenal cortical carcinoma	202300	P53	191170	17p13.1
Adrenal cortical carcinoma	202300	LFS1 	191170	17p13.1
Adrenal cortical carcinoma	202300	BCC7	191170	17p13.1
Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	202010	CYP11B1	610613	8q24.3
Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	202010	P450C11	610613	8q24.3
Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase deficiency	202010	FHI	610613	8q24.3
Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency	201910	CYP21A2	613815	6p21.33
Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency	201910	CYP21	613815	6p21.33
Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency	201910	CA21H	613815	6p21.33
Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism	300200	DAX1	300473	Xp21.2
Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism	300200	AHC	300473	Xp21.2
Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism	300200	AHX	300473	Xp21.2
Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism	300200	NR0B1	300473	Xp21.2
Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism	300200	SRXY2	300473	Xp21.2
Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	613743	CYP11A1	118485	15q24.1
Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete	613743	P450SCC	118485	15q24.1
Adrenocortical insufficiency	184757	NR5A1		9q33.3
Adrenocortical insufficiency	184757	FTZF1		9q33.3
Adrenocortical insufficiency	184757	FTZ1		9q33.3
Adrenocortical insufficiency	184757	SF1		9q33.3
Adrenocortical insufficiency	184757	AD4BP		9q33.3
Adrenocortical insufficiency	184757	POF7		9q33.3
Adrenocortical insufficiency	184757	SRXY3		9q33.3
Adrenocortical insufficiency	184757	SPGF8		9q33.3
Adrenocortical tumor, somatic,		PRKAR1A	188830	17q24.2
Adrenocortical tumor, somatic,		TSE1	188830	17q24.2
Adrenocortical tumor, somatic,		CNC1	188830	17q24.2
Adrenocortical tumor, somatic,		CAR	188830	17q24.2
Adrenocortical tumor, somatic,		PPNAD1	188830	17q24.2
Adrenocortical tumor, somatic,		ACRDYS1	188830	17q24.2
Adrenocorticotropic hormone deficiency	201400	TBX19	604614	1q24.2
Adrenoleukodystrophy	300100	ABCD1	300371	Xq28
Adrenoleukodystrophy	300100	ALD	300371	Xq28
Adrenoleukodystrophy	300100	AMN	300371	Xq28
Adrenomyeloneuropathy, adult	300100	ABCD1	300371	Xq28
Adrenomyeloneuropathy, adult	300100	ALD	300371	Xq28
Adrenomyeloneuropathy, adult	300100	AMN	300371	Xq28
Adult i phenotype without cataract	110800	GCNT2	600429	6p24.3-p24.2
Adult i phenotype without cataract	110800	Ii	600429	6p24.3-p24.2
Adult i phenotype without cataract	110800	CTRCT13	600429	6p24.3-p24.2
Advanced sleep phase syndrome, familial, 1	604348	PER2	603426	2q37.3
Advanced sleep phase syndrome, familial, 1	604348	FASPS1	603426	2q37.3
Advanced sleep phase syndrome, familial, 1	604348	KIAA0347	603426	2q37.3
Advanced sleep-phase syndrome, familial, 2	615224	CSNK1D	600864	17q25.3
Advanced sleep-phase syndrome, familial, 2	615224	ASPS	600864	17q25.3
Advanced sleep-phase syndrome, familial, 2	615224	FASPS2	600864	17q25.3
Afibrinogenemia, congenital	202400	FGA	134820	4q31.3
Afibrinogenemia, congenital	202400	FGB	134830	4q31.3
Agammaglobulinemia 1	601495	IGHM	147020	14q32.33
Agammaglobulinemia 1	601495	MU	147020	14q32.33
Agammaglobulinemia 1	601495	AGM1	147020	14q32.33
Agammaglobulinemia 2	613500	IGLL1	146770	22q11.23
Agammaglobulinemia 2	613500	IGO	146770	22q11.23
Agammaglobulinemia 2	613500	IGL5	146770	22q11.23
Agammaglobulinemia 2	613500	VPREB2	146770	22q11.23
Agammaglobulinemia 2	613500	AGM2	146770	22q11.23
Agammaglobulinemia 3	613501	CD79A	112205	19q13.2
Agammaglobulinemia 3	613501	IGA	112205	19q13.2
Agammaglobulinemia 4	613502	BLNK	604515	10q24.1
Agammaglobulinemia 4	613502	SLP65	604515	10q24.1
Agammaglobulinemia 4	613502	AGM4	604515	10q24.1
Agammaglobulinemia 5	613506	LRRC8A	608360	9q34.11
Agammaglobulinemia 5	613506	KIAA1437	608360	9q34.11
Agammaglobulinemia 5	613506	AGM5	608360	9q34.11
Agammaglobulinemia 6	612692	CD79B	147245	17q23.3
Agammaglobulinemia 6	612692	IGB	147245	17q23.3
Agammaglobulinemia 6	612692	B29	147245	17q23.3
Agammaglobulinemia 6	612692	AGM6	147245	17q23.3
Agammaglobulinemia 7, autosomal recessive	615214	PIK3R1	171833	5q13.1
Agammaglobulinemia 7, autosomal recessive	615214	GRB1	171833	5q13.1
Agammaglobulinemia 7, autosomal recessive	615214	AGM7	171833	5q13.1
Agammaglobulinemia 7, autosomal recessive	615214	SHORT	171833	5q13.1
Agammaglobulinemia and isolated hormone deficiency	307200	BTK	300300	Xq22.1
Agammaglobulinemia and isolated hormone deficiency	307200	AGMX1	300300	Xq22.1
Agammaglobulinemia and isolated hormone deficiency	307200	IMD1	300300	Xq22.1
Agammaglobulinemia and isolated hormone deficiency	307200	XLA	300300	Xq22.1
Agammaglobulinemia and isolated hormone deficiency	307200	AT	300300	Xq22.1
Agammaglobulinemia, X-linked 1	300755	BTK	300300	Xq22.1
Agammaglobulinemia, X-linked 1	300755	AGMX1	300300	Xq22.1
Agammaglobulinemia, X-linked 1	300755	IMD1	300300	Xq22.1
Agammaglobulinemia, X-linked 1	300755	XLA	300300	Xq22.1
Agammaglobulinemia, X-linked 1	300755	AT	300300	Xq22.1
Agammaglobulinemia, X-linked 2	300310	AGMX2		Xp22
Agammaglobulinemia, X-linked 2	300310	XLA2		Xp22
Agammaglobulinemia, X-linked 2	300310	IMD6		Xp22
Agenesis of the corpus callosum with peripheral neuropathy	218000	SLC12A6	604878	15q14
Agenesis of the corpus callosum with peripheral neuropathy	218000	KCC3A	604878	15q14
Agenesis of the corpus callosum with peripheral neuropathy	218000	KCC3B	604878	15q14
Agenesis of the corpus callosum with peripheral neuropathy	218000	KCC3	604878	15q14
Agenesis of the corpus callosum with peripheral neuropathy	218000	ACCPN	604878	15q14
Agnathia-otocephaly complex	202650	PRRX1	167420	1q24.2
Agnathia-otocephaly complex	202650	PMX1	167420	1q24.2
Agnathia-otocephaly complex	202650	PHOX1	167420	1q24.2
Agnathia-otocephaly complex	202650	AGOTC	167420	1q24.2
Aicardi syndrome	304050	AIC		Xp22
Aicardi-Goutieres syndrome 1, dominant and recessive	225750	TREX1	606609	3p21.31
Aicardi-Goutieres syndrome 1, dominant and recessive	225750	AGS1	606609	3p21.31
Aicardi-Goutieres syndrome 1, dominant and recessive	225750	CRV	606609	3p21.31
Aicardi-Goutieres syndrome 1, dominant and recessive	225750	HERNS	606609	3p21.31
Aicardi-Goutieres syndrome 2	610181	RNASEH2B	610326	13q14.3
Aicardi-Goutieres syndrome 2	610181	DLEU8	610326	13q14.3
Aicardi-Goutieres syndrome 2	610181	FLJ11712	610326	13q14.3
Aicardi-Goutieres syndrome 2	610181	AGS2	610326	13q14.3
Aicardi-Goutieres syndrome 3	610329	RNASEH2C	610330	11q13.1
Aicardi-Goutieres syndrome 3	610329	AYP1	610330	11q13.1
Aicardi-Goutieres syndrome 3	610329	FLJ20974	610330	11q13.1
Aicardi-Goutieres syndrome 3	610329	AGS3	610330	11q13.1
Aicardi-Goutieres syndrome 4	610333	RNASEH2A	606034	19p13.2
Aicardi-Goutieres syndrome 4	610333	RNHIA	606034	19p13.2
Aicardi-Goutieres syndrome 4	610333	AGS4	606034	19p13.2
Aicardi-Goutieres syndrome 5	612952	SAMHD1	606754	20q11.23
Aicardi-Goutieres syndrome 5	612952	AGS5	606754	20q11.23
Aicardi-Goutieres syndrome 5	612952	DCIP	606754	20q11.23
Aicardi-Goutieres syndrome 5	612952	CHBL2	606754	20q11.23
Aicardi-Goutieres syndrome 6	615010	ADAR	146920	1q21.3
Aicardi-Goutieres syndrome 6	615010	DRADA	146920	1q21.3
Aicardi-Goutieres syndrome 6	615010	DSH	146920	1q21.3
Aicardi-Goutieres syndrome 6	615010	DSRAD	146920	1q21.3
Aicardi-Goutieres syndrome 6	615010	IFI4	146920	1q21.3
Aicardi-Goutieres syndrome 6	615010	G1P1	146920	1q21.3
Aicardi-Goutieres syndrome 6	615010	AGS6	146920	1q21.3
Alacrima, achalasia, and mental retardation syndrome	615510	GMPPA	615495	2q35
Alacrima, achalasia, and mental retardation syndrome	615510	AAMR	615495	2q35
Alagille syndrome 2	610205	NOTCH2	600275	1p12-p11
Alagille syndrome 2	610205	AGS2	600275	1p12-p11
Alagille syndrome 2	610205	HJCYS	600275	1p12-p11
Alagille syndrome	118450	JAG1	601920	20p12.2
Alagille syndrome	118450	AGS	601920	20p12.2
Alagille syndrome	118450	AHD	601920	20p12.2
Aland Island eye disease	300600	CACNA1F	300110	Xp11.23
Aland Island eye disease	300600	CSNB2	300110	Xp11.23
Aland Island eye disease	300600	CORDX3	300110	Xp11.23
Aland Island eye disease	300600	CSNB2A	300110	Xp11.23
Aland Island eye disease	300600	AIED	300110	Xp11.23
Aland Island eye disease	300600	OA2	300110	Xp11.23
Alazami syndrome	615071	LARP7	612026	4q25
Alazami syndrome	615071	PIP7S	612026	4q25
Alazami syndrome	615071	ALAZS	612026	4q25
Albinism, brown oculocutaneous	203200	OCA2	611409	15q12-q13
Albinism, brown oculocutaneous	203200	P	611409	15q12-q13
Albinism, brown oculocutaneous	203200	PED	611409	15q12-q13
Albinism, brown oculocutaneous	203200	D15S12	611409	15q12-q13
Albinism, brown oculocutaneous	203200	BOCA	611409	15q12-q13
Albinism, brown oculocutaneous	203200	EYCL3	611409	15q12-q13
Albinism, brown oculocutaneous	203200	HCL3	611409	15q12-q13
Albinism, brown oculocutaneous	203200	SHEP1	611409	15q12-q13
Albinism, oculocutaneous, type IA	203100	TYR	606933	11q14.3
Albinism, oculocutaneous, type IA	203100	SHEP3	606933	11q14.3
Albinism, oculocutaneous, type IA	203100	CMM8	606933	11q14.3
Albinism, oculocutaneous, type IA	203100	OCA1A	606933	11q14.3
Albinism, oculocutaneous, type IA	203100	ATN	606933	11q14.3
Albinism, oculocutaneous, type IB	606952	TYR	606933	11q14.3
Albinism, oculocutaneous, type IB	606952	SHEP3	606933	11q14.3
Albinism, oculocutaneous, type IB	606952	CMM8	606933	11q14.3
Albinism, oculocutaneous, type IB	606952	OCA1A	606933	11q14.3
Albinism, oculocutaneous, type IB	606952	ATN	606933	11q14.3
Albinism, oculocutaneous, type II	203200	OCA2	611409	15q12-q13
Albinism, oculocutaneous, type II	203200	P	611409	15q12-q13
Albinism, oculocutaneous, type II	203200	PED	611409	15q12-q13
Albinism, oculocutaneous, type II	203200	D15S12	611409	15q12-q13
Albinism, oculocutaneous, type II	203200	BOCA	611409	15q12-q13
Albinism, oculocutaneous, type II	203200	EYCL3	611409	15q12-q13
Albinism, oculocutaneous, type II	203200	HCL3	611409	15q12-q13
Albinism, oculocutaneous, type II	203200	SHEP1	611409	15q12-q13
Albinism, oculocutaneous, type III	203290	TYRP1	115501	9p23
Albinism, oculocutaneous, type III	203290	CAS2	115501	9p23
Albinism, oculocutaneous, type III	203290	GP75	115501	9p23
Albinism, oculocutaneous, type III	203290	SHEP11	115501	9p23
Albinism, oculocutaneous, type IV	606574	SLC45A2	606202	5p13.2
Albinism, oculocutaneous, type IV	606574	MATP	606202	5p13.2
Albinism, oculocutaneous, type IV	606574	AIM1	606202	5p13.2
Albinism, oculocutaneous, type IV	606574	SHEP5	606202	5p13.2
Albinism, oculocutaneous, type IV	606574	OCA4	606202	5p13.2
Albinism, oculocutaneous, type V	615312	OCA5		4q24
Albinism, oculocutaneous, type VI	113750	SLC24A5	609802	15q21.1
Albinism, oculocutaneous, type VI	113750	NCKX5	609802	15q21.1
Albinism, oculocutaneous, type VI	113750	SHEP4	609802	15q21.1
Albinism, oculocutaneous, type VI	113750	OCA6	609802	15q21.1
Albinism, oculocutaneous, type VII	615179	C10orf11	614537	10q22.2-q22.3
Albinism, oculocutaneous, type VII	615179	OCA7	614537	10q22.2-q22.3
Albinism-deafness syndrome	300700	ADFN		Xq24-q26
Albinism-deafness syndrome	300700	ALDS		Xq24-q26
Alcohol sensitivity, acute	610251	ALDH2	100650	12q24.12
Aldosterone to renin ratio raised		CYP11B2	124080	8q24.3
Aldosteronism, glucocorticoid-remediable	103900	CYP11B1	610613	8q24.3
Aldosteronism, glucocorticoid-remediable	103900	P450C11	610613	8q24.3
Aldosteronism, glucocorticoid-remediable	103900	FHI	610613	8q24.3
Alexander disease	203450	GFAP	137780	17q21.31
Alkaptonuria	203500	HGD	607474	3q13.33
Alkaptonuria	203500	AKU	607474	3q13.33
Allan-Herndon-Dudley syndrome	300523	SLC16A2	300095	Xq13.2
Allan-Herndon-Dudley syndrome	300523	DXS128	300095	Xq13.2
Allan-Herndon-Dudley syndrome	300523	XPCT	300095	Xq13.2
Alopecia areata 1	104000	AA1		18p11.3-p11.2
Alopecia areata 2	610753	AA2		16q11-q22
Alopecia universalis	203655	HR	602302	8p21.3
Alopecia universalis	203655	AU	602302	8p21.3
Alopecia universalis	203655	MUHH1	602302	8p21.3
Alopecia, androgenetic, 1	109200	AFA1		3q26
Alopecia, androgenetic, 1	109200	MPB		3q26
Alopecia, androgenetic, 2	300710	AGA2		Xq11-q12
Alopecia, androgenetic, 3	612421	AGA3		20p11.22
Alopecia, neurologic defects, and endocrinopathy syndrome	612079	RBM28	612074	7q32.1
Alopecia-mental retardation syndrome 1	203650	APMR1		3q26.3-q27.3
Alopecia-mental retardation syndrome 2	610422	APMR2		3q26.2-q26.31
Alopecia-mental retardation syndrome 3	613930	APMR3		18q11.2-q12.2
Alpha-1-antichymotrypsin deficiency		SERPINA3	107280	14q32.13
Alpha-1-antichymotrypsin deficiency		AACT	107280	14q32.13
Alpha-1-antichymotrypsin deficiency		ACT	107280	14q32.13
Alpha-2-macroglobulin deficiency	614036	A2M 	103950	12p13.31
Alpha-2-macroglobulin deficiency	614036	A2MD	103950	12p13.31
Alpha-2-plasmin inhibitor deficiency	262850	PLI	613168	17p13.3
Alpha-2-plasmin inhibitor deficiency	262850	SERPINF2	613168	17p13.3
Alpha-ketoglutarate dehydrogenase deficiency	203740	OGDH	613022	7p13
Alpha-methylacetoacetic aciduria	203750	ACAT1	607809	11q22.3
Alpha-methylacyl-CoA racemase deficiency	614307	AMACR	604489	5p13.2
Alpha-methylacyl-CoA racemase deficiency	614307	CBAS4	604489	5p13.2
Alpha-methylacyl-CoA racemase deficiency	614307	AMACRD	604489	5p13.2
Alpha-thalassemia myelodysplasia syndrome, somatic	300448	ATRX	300032	Xq21.1
Alpha-thalassemia myelodysplasia syndrome, somatic	300448	XH2	300032	Xq21.1
Alpha-thalassemia myelodysplasia syndrome, somatic	300448	XNP	300032	Xq21.1
Alpha-thalassemia myelodysplasia syndrome, somatic	300448	SHS	300032	Xq21.1
Alpha-thalassemia myelodysplasia syndrome, somatic	300448	SFM1	300032	Xq21.1
Alpha-thalassemia myelodysplasia syndrome, somatic	300448	MRXHF1	300032	Xq21.1
Alpha-thalassemia/mental retardation syndrome	301040	ATRX	300032	Xq21.1
Alpha-thalassemia/mental retardation syndrome	301040	XH2	300032	Xq21.1
Alpha-thalassemia/mental retardation syndrome	301040	XNP	300032	Xq21.1
Alpha-thalassemia/mental retardation syndrome	301040	SHS	300032	Xq21.1
Alpha-thalassemia/mental retardation syndrome	301040	SFM1	300032	Xq21.1
Alpha-thalassemia/mental retardation syndrome	301040	MRXHF1	300032	Xq21.1
Alpha-thalassemia/mental retardation syndrome, type 1	141750	HBHR		16pter-p13.3
Alpha-thalassemia/mental retardation syndrome, type 1	141750	ATR1		16pter-p13.3
Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity	609889	RAG1	179615	11p12
Alport syndrome	301050	COL4A5	303630	Xq22.3
Alport syndrome	301050	ATS	303630	Xq22.3
Alport syndrome	301050	ASLN	303630	Xq22.3
Alport syndrome, autosomal dominant	104200	COL4A3	120070	2q36.3
Alport syndrome, autosomal recessive	203780	COL4A3	120070	2q36.3
Alport syndrome, autosomal recessive	203780	COL4A4	120131	2q36.3
Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis	300194	AMMEC		Xq22.3
Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis	300194	DELXq22.3		Xq22.3
Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis	300194	CXDELq22.3		Xq22.3
Alstrom syndrome	203800	ALMS1	606844	2p13.1
Alstrom syndrome	203800	ALSS	606844	2p13.1
Alstrom syndrome	203800	KIAA0328	606844	2p13.1
Alternating hemiplegia of childhood 2	614820	ATP1A3	182350	19q13.2
Alternating hemiplegia of childhood 2	614820	DYT12	182350	19q13.2
Alternating hemiplegia of childhood 2	614820	RDP	182350	19q13.2
Alternating hemiplegia of childhood 2	614820	AHC2	182350	19q13.2
Alternating hemiplegia of childhood	104290	ATP1A2	182340	1q23.2
Alternating hemiplegia of childhood	104290	FHM2	182340	1q23.2
Alternating hemiplegia of childhood	104290	MHP2	182340	1q23.2
Alveolar capillary dysplasia with misalignment of pulmonary veins	265380	FOXF1	601089	16q24.1
Alveolar capillary dysplasia with misalignment of pulmonary veins	265380	FKHL5	601089	16q24.1
Alveolar capillary dysplasia with misalignment of pulmonary veins	265380	ACDMPV	601089	16q24.1
Alveolar soft-part sarcoma	606243	ASPSCR1	606236	17q25.3
Alveolar soft-part sarcoma	606243	RCC17	606236	17q25.3
Alveolar soft-part sarcoma	606243	ASPL	606236	17q25.3
Alveolar soft-part sarcoma	606243	ASPS	606236	17q25.3
Alzheimer disease 1, familial	104300	APP	104760	21q21.3
Alzheimer disease 1, familial	104300	AAA	104760	21q21.3
Alzheimer disease 1, familial	104300	CVAP	104760	21q21.3
Alzheimer disease 1, familial	104300	AD1	104760	21q21.3
Alzheimer disease 17	615080	AD17		6p21.2
Alzheimer disease 6	104300	AD6	605526	10q24
Alzheimer disease 8	104300	AD8	607116	20p
Alzheimer disease, type 3	607822	PSEN1	104311	14q24.2
Alzheimer disease, type 3	607822	AD3	104311	14q24.2
Alzheimer disease, type 3, with spastic paraparesis and apraxia	607822	PSEN1	104311	14q24.2
Alzheimer disease, type 3, with spastic paraparesis and apraxia	607822	AD3	104311	14q24.2
Alzheimer disease, type 3, with spastic paraparesis and unusual plaques	607822	PSEN1	104311	14q24.2
Alzheimer disease, type 3, with spastic paraparesis and unusual plaques	607822	AD3	104311	14q24.2
Alzheimer disease-10	104300	AD10	609636	7q36
Alzheimer disease-11	609790	AD11		9p22.1
Alzheimer disease-2	104310	APOE	107741	19q13.32
Alzheimer disease-2	104310	AD2	107741	19q13.32
Alzheimer disease-2	104310	LPG	107741	19q13.32
Alzheimer disease-2	104310	LDLCQ5	107741	19q13.32
Alzheimer disease-4	606889	PSEN2	600759	1q42.13
Alzheimer disease-4	606889	AD4	600759	1q42.13
Alzheimer disease-4	606889	STM2	600759	1q42.13
Alzheimer disease-4	606889	CMD1V	600759	1q42.13
Alzheimer disease-5	104300	AD5	602096	12p11.23-q13.12
Alzheimer disease-7	606187	AD7		10p13
Amelogenesis imperfecta and gingival fibromatosis syndrome	614253	FAM20A	611062	17q24.2
Amelogenesis imperfecta and gingival fibromatosis syndrome	614253	AIGFS	611062	17q24.2
Amelogenesis imperfecta, hypomaturation type, IIA3	613211	WDR72	613214	15q21.3
Amelogenesis imperfecta, hypomaturation type, IIA3	613211	AI2A3	613214	15q21.3
Amelogenesis imperfecta, hypomaturation type, IIA4	614832	C4orf26	614829	4q21.1
Amelogenesis imperfecta, hypomaturation-hypoplastic type, with taurodontism	104510	DLX3	600525	17q21.33
Amelogenesis imperfecta, hypomaturation-hypoplastic type, with taurodontism	104510	TDO	600525	17q21.33
Amelogenesis imperfecta, hypomaturation-hypoplastic type, with taurodontism	104510	AI4	600525	17q21.33
Amelogenesis imperfecta, hypoplastic/hypomaturation type 1E	301200	AMELX	300391	Xp22.2
Amelogenesis imperfecta, hypoplastic/hypomaturation type 1E	301200	AMG	300391	Xp22.2
Amelogenesis imperfecta, hypoplastic/hypomaturation type 1E	301200	AIH1	300391	Xp22.2
Amelogenesis imperfecta, hypoplastic/hypomaturation type 1E	301200	AMGX	300391	Xp22.2
Amelogenesis imperfecta, hypoplastic/hypomaturation type 1E	301200	AI1E	300391	Xp22.2
Amelogenesis imperfecta, type 3	130900	FAM83H	611927	8q24.3
Amelogenesis imperfecta, type 3	130900	AI3	611927	8q24.3
Amelogenesis imperfecta, type IB	104500	ENAM	606585	4q13.3
Amelogenesis imperfecta, type IB	104500	AIH2	606585	4q13.3
Amelogenesis imperfecta, type IB	104500	AI1C	606585	4q13.3
Amelogenesis imperfecta, type IC	204650	ENAM	606585	4q13.3
Amelogenesis imperfecta, type IC	204650	AIH2	606585	4q13.3
Amelogenesis imperfecta, type IC	204650	AI1C	606585	4q13.3
Amelogenesis imperfecta, type IIA1	204700	KLK4	603767	19q13.41
Amelogenesis imperfecta, type IIA1	204700	EMSP1	603767	19q13.41
Amelogenesis imperfecta, type IIA1	204700	PRSS17	603767	19q13.41
Amelogenesis imperfecta, type IIA1	204700	AI2A1	603767	19q13.41
Amelogenesis imperfecta, type IIA2	612529	MMP20	604629	11q22.2
Amelogenesis imperfecta, type IIA2	612529	AI2A2	604629	11q22.2
Aminoacylase 1 deficiency	609924	ACY1	104620	3p21.2
Aminoacylase 1 deficiency	609924	ACY1D	104620	3p21.2
Amish infantile epilepsy syndrome	609056	SIAT9	604402	2p11.2
Amish infantile epilepsy syndrome	609056	ST3GALV	604402	2p11.2
Amyloidosis, 3 or more types	105200	APOA1	107680	11q23.3
Amyloidosis, Finnish type	105120	GSN	137350	9q33.2
Amyloidosis, hereditary renal	105200	FGA	134820	4q31.3
Amyloidosis, hereditary, transthyretin-related	105210	TTR	176300	18q12.1
Amyloidosis, hereditary, transthyretin-related	105210	PALB	176300	18q12.1
Amyloidosis, primary localized cutaneous, 1	105250	OSMR	601743	5p13.1
Amyloidosis, primary localized cutaneous, 1	105250	OSMRB	601743	5p13.1
Amyloidosis, primary localized cutaneous, 1	105250	PLCA1	601743	5p13.1
Amyloidosis, primary localized cutaneous, 2	613955	IL31RA	609510	5q11.2
Amyloidosis, primary localized cutaneous, 2	613955	GLMR	609510	5q11.2
Amyloidosis, primary localized cutaneous, 2	613955	GPL	609510	5q11.2
Amyloidosis, primary localized cutaneous, 2	613955	PLCA2	609510	5q11.2
Amyloidosis, renal	105200	LYZ	153450	12q15
Amyotrophic lateral sclerosis 1	105400	SOD1	147450	21q22.11
Amyotrophic lateral sclerosis 1	105400	ALS1	147450	21q22.11
Amyotrophic lateral sclerosis 10, with or without FTD	612069	TARDBP	605078	1p36.22
Amyotrophic lateral sclerosis 10, with or without FTD	612069	TDP43	605078	1p36.22
Amyotrophic lateral sclerosis 10, with or without FTD	612069	ALS10	605078	1p36.22
Amyotrophic lateral sclerosis 11	612577	FIG4	609390	6q21
Amyotrophic lateral sclerosis 11	612577	KIAA0274	609390	6q21
Amyotrophic lateral sclerosis 11	612577	SAC3	609390	6q21
Amyotrophic lateral sclerosis 11	612577	ALS11	609390	6q21
Amyotrophic lateral sclerosis 11	612577	YVS	609390	6q21
Amyotrophic lateral sclerosis 12	613435	OPTN	602432	10p13
Amyotrophic lateral sclerosis 12	613435	GLC1E	602432	10p13
Amyotrophic lateral sclerosis 12	613435	FIP2	602432	10p13
Amyotrophic lateral sclerosis 12	613435	HYPL	602432	10p13
Amyotrophic lateral sclerosis 12	613435	NRP	602432	10p13
Amyotrophic lateral sclerosis 12	613435	ALS12	602432	10p13
Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	613954	VCP	601023	9p13.3
Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	613954	IBMPFD1	601023	9p13.3
Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia	613954	ALS14	601023	9p13.3
Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	300857	UBQLN2	300264	Xp11.21
Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	300857	PLIC2	300264	Xp11.21
Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	300857	CHAP1	300264	Xp11.21
Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia	300857	ALS15	300264	Xp11.21
Amyotrophic lateral sclerosis 16, juvenile	614373	SIGMAR1	601978	9p13.3
Amyotrophic lateral sclerosis 16, juvenile	614373	SRBP	601978	9p13.3
Amyotrophic lateral sclerosis 16, juvenile	614373	ALS16	601978	9p13.3
Amyotrophic lateral sclerosis 17	614696	CHMP2B	609512	3p11.2
Amyotrophic lateral sclerosis 17	614696	DMT1	609512	3p11.2
Amyotrophic lateral sclerosis 17	614696	VPS2B	609512	3p11.2
Amyotrophic lateral sclerosis 17	614696	ALS17	609512	3p11.2
Amyotrophic lateral sclerosis 18	614808	PFN1	176610	17p13.2
Amyotrophic lateral sclerosis 18	614808	ALS18	176610	17p13.2
Amyotrophic lateral sclerosis 19	615515	ERBB4	600543	2q34
Amyotrophic lateral sclerosis 19	615515	HER4	600543	2q34
Amyotrophic lateral sclerosis 19	615515	ALS19	600543	2q34
Amyotrophic lateral sclerosis 2, juvenile	205100	ALS2	606352	2q33.1
Amyotrophic lateral sclerosis 2, juvenile	205100	ALSJ	606352	2q33.1
Amyotrophic lateral sclerosis 2, juvenile	205100	PLSJ	606352	2q33.1
Amyotrophic lateral sclerosis 2, juvenile	205100	IAHSP	606352	2q33.1
Amyotrophic lateral sclerosis 20	615426	HNRNPA1	164017	12q13.13
Amyotrophic lateral sclerosis 20	615426	IBMPFD3	164017	12q13.13
Amyotrophic lateral sclerosis 20	615426	ALS20	164017	12q13.13
Amyotrophic lateral sclerosis 3	606640	ALS3		18q21
Amyotrophic lateral sclerosis 4, juvenile	602433	SETX	608465	9q34.13
Amyotrophic lateral sclerosis 4, juvenile	602433	SCAR1	608465	9q34.13
Amyotrophic lateral sclerosis 4, juvenile	602433	AOA2	608465	9q34.13
Amyotrophic lateral sclerosis 4, juvenile	602433	ALS4	608465	9q34.13
Amyotrophic lateral sclerosis 5, juvenile recessive	602099	ALS5		15q15.1-q21.1
Amyotrophic lateral sclerosis 6, autosomal recessive, with or without frontotemporal dementia	608030	FUS	137070	16p11.2
Amyotrophic lateral sclerosis 6, autosomal recessive, with or without frontotemporal dementia	608030	TLS	137070	16p11.2
Amyotrophic lateral sclerosis 6, autosomal recessive, with or without frontotemporal dementia	608030	ALS6	137070	16p11.2
Amyotrophic lateral sclerosis 6, autosomal recessive, with or without frontotemporal dementia	608030	ETM4	137070	16p11.2
Amyotrophic lateral sclerosis 7	608031	ALS7		20p13
Amyotrophic lateral sclerosis 8	608627	VAPB	605704	20q13.32
Amyotrophic lateral sclerosis 8	608627	VAPC	605704	20q13.32
Amyotrophic lateral sclerosis 8	608627	ALS8	605704	20q13.32
Amyotrophic lateral sclerosis 9	611895	ANG	105850	14q11.2
Amyotrophic lateral sclerosis 9	611895	RNASE5	105850	14q11.2
Amyotrophic lateral sclerosis 9	611895	ALS9	105850	14q11.2
Amyotrophic lateral sclerosis and/or frontotemporal dementia	105550	C9orf72	614260	9p21.2
Amyotrophic lateral sclerosis and/or frontotemporal dementia	105550	FTDALS	614260	9p21.2
Amyotrophic lateral sclerosis and/or frontotemporal dementia	105550	ALSFTD	614260	9p21.2
Amyotrophy, hereditary neuralgic	162100	SEPT9	604061	17q25.2-q25.3
Amyotrophy, hereditary neuralgic	162100	MSF	604061	17q25.2-q25.3
Amyotrophy, hereditary neuralgic	162100	MSF1	604061	17q25.2-q25.3
Amyotrophy, hereditary neuralgic	162100	NAPB	604061	17q25.2-q25.3
Analbuminemia	103600	ALB		4q13.3
Anauxetic dysplasia	607095	RMRP	157660	9p13.3
Anauxetic dysplasia	607095	RMRPR	157660	9p13.3
Anauxetic dysplasia	607095	CHH	157660	9p13.3
Andersen syndrome	170390	KCNJ2	600681	17q24.3
Andersen syndrome	170390	HHIRK1	600681	17q24.3
Andersen syndrome	170390	KIR2.1	600681	17q24.3
Andersen syndrome	170390	IRK1	600681	17q24.3
Andersen syndrome	170390	LQT7	600681	17q24.3
Andersen syndrome	170390	SQT3	600681	17q24.3
Andersen syndrome	170390	ATFB9	600681	17q24.3
Androgen insensitivity	300068	AR	313700	Xq12
Androgen insensitivity	300068	DHTR	313700	Xq12
Androgen insensitivity	300068	TFM	313700	Xq12
Androgen insensitivity	300068	SBMA	313700	Xq12
Androgen insensitivity	300068	KD	313700	Xq12
Androgen insensitivity	300068	SMAX1	313700	Xq12
Androgen insensitivity	300068	HYSP1	313700	Xq12
Androgen insensitivity, partial, with or without breast cancer	312300	AR	313700	Xq12
Androgen insensitivity, partial, with or without breast cancer	312300	DHTR	313700	Xq12
Androgen insensitivity, partial, with or without breast cancer	312300	TFM	313700	Xq12
Androgen insensitivity, partial, with or without breast cancer	312300	SBMA	313700	Xq12
Androgen insensitivity, partial, with or without breast cancer	312300	KD	313700	Xq12
Androgen insensitivity, partial, with or without breast cancer	312300	SMAX1	313700	Xq12
Androgen insensitivity, partial, with or without breast cancer	312300	HYSP1	313700	Xq12
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	GATA1	305371	Xp11.23
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	GF1	305371	Xp11.23
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	ERYF1	305371	Xp11.23
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	NFE1	305371	Xp11.23
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	XLTDA	305371	Xp11.23
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	XLTT	305371	Xp11.23
Anemia, X-linked, with/without neutropenia and/or platelet abnormalities	300835	XLANP	305371	Xp11.23
Anemia, hemolytic, Rh-null, regulator type	268150	RHAG	180297	6p12.3
Anemia, hemolytic, Rh-null, regulator type	268150	RH50A	180297	6p12.3
Anemia, hemolytic, due to UMPH1 deficiency	266120	NT5C3A	606224	7p14.3
Anemia, hemolytic, due to UMPH1 deficiency	266120	NT5C3	606224	7p14.3
Anemia, hemolytic, due to UMPH1 deficiency	266120	UMPH1	606224	7p14.3
Anemia, hemolytic, due to UMPH1 deficiency	266120	PSN1	606224	7p14.3
Anemia, hypochromic microcytic	206100	NRAMP2	600523	12q13.12
Anemia, neonatal hemolytic, fatal and near-fatal	182870	SPTB		14q23.3
Anemia, neonatal hemolytic, fatal and near-fatal	182870	SPH2		14q23.3
Anemia, neonatal hemolytic, fatal and near-fatal	182870	EL3		14q23.3
Anemia, neonatal hemolytic, fatal and near-fatal	182870	HS2		14q23.3
Anemia, sideroblastic, X-linked	300751	ALAS2	301300	Xp11.21
Anemia, sideroblastic, X-linked	300751	ANH1	301300	Xp11.21
Anemia, sideroblastic, X-linked	300751	ASB	301300	Xp11.21
Anemia, sideroblastic, X-linked	300751	XLEPP	301300	Xp11.21
Anemia, sideroblastic, X-linked	300751	XLSA	301300	Xp11.21
Anemia, sideroblastic, X-linked	300751	ANH1	301300	Xp11.21
Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive	205950	GLRX5	609588	14q32.13
Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive	205950	C14orf87	609588	14q32.13
Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive	205950	PRO1238	609588	14q32.13
Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive	205950	FLB4739	609588	14q32.13
Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive	205950	SLC25A38	610819	3p22.1
Anemia, sideroblastic, with ataxia	301310	ABCB7	300135	Xq13.3
Anemia, sideroblastic, with ataxia	301310	ABC7	300135	Xq13.3
Anemia, sideroblastic, with ataxia	301310	ASAT	300135	Xq13.3
Aneurysm, intracranial berry, 1	105800	ANIB1		7q11.2
Aneurysm, intracranial berry, 11	614252	ANIB11		8p22
Aneurysm, intracranial berry, 2	608542	ANIB2		19q13
Aneurysm, intracranial berry, 3	609122	ANIB3		1p36.13-p34.3
Aneurysm, intracranial berry, 4	610213	ANIB4		5p15.2-p14.3
Aneurysm, intracranial berry, 5	300870	ANIB5		Xp22
Aneurysm, intracranial berry, 5		ANIB5	610402	2p15-q14
Aneurysm, intracranial berry, 7	612161	ANIB7		11q24-q25
Aneurysm, intracranial berry, 8	612162	ANIB8		14q23
Aneurysmal bone cysts		ANBC	606179	16q22
Angelman syndrome	105830	MECP2	300005	Xq28
Angelman syndrome	105830	RTT	300005	Xq28
Angelman syndrome	105830	PPMX	300005	Xq28
Angelman syndrome	105830	MRX16	300005	Xq28
Angelman syndrome	105830	MRX79	300005	Xq28
Angelman syndrome	105830	AUTSX3	300005	Xq28
Angelman syndrome	105830	MRXSL	300005	Xq28
Angelman syndrome	105830	MRXS13	300005	Xq28
Angelman syndrome	105830	MRX79	300005	Xq28
Angelman syndrome	105830	MRX16	300005	Xq28
Angelman syndrome	105830	UBE3A	601623	15q11.2
Angelman syndrome	105830	ANCR	601623	15q11.2
Angelman syndrome-like	105830	CDKL5	300203	Xp22.13
Angelman syndrome-like	105830	STK9	300203	Xp22.13
Angelman syndrome-like	105830	ISSX	300203	Xp22.13
Angelman syndrome-like	105830	EIEE2	300203	Xp22.13
Angio serpiginosum	300652	AGSPX		Xp11.3-q12
Angioedema, hereditary, type III	610618	F12	610619	5q35.3
Angioedema, hereditary, type III	610618	HAF	610619	5q35.3
Angioedema, hereditary, type III	610618	HAE3	610619	5q35.3
Angioedema, hereditary, types I and II	106100	C1NH	606860	11q12.1
Angioedema, hereditary, types I and II	106100	HAE1	606860	11q12.1
Angioedema, hereditary, types I and II	106100	HAE2	606860	11q12.1
Angioedema, hereditary, types I and II	106100	SERPING1	606860	11q12.1
Angiofibroma, somatic		MEN1	613733	11q13.1
Angiopathy, hereditary, with nephropathy, aneurysms, and muscle	611773	COL4A1	120130	13q34
Angiopathy, hereditary, with nephropathy, aneurysms, and muscle	611773	POREN1	120130	13q34
Angiopathy, hereditary, with nephropathy, aneurysms, and muscle	611773	HANAC	120130	13q34
Angiopathy, hereditary, with nephropathy, aneurysms, and muscle	611773	ICH	120130	13q34
Aniridia	106210	PAX6	607108	11p13
Aniridia	106210	AN2	607108	11p13
Aniridia	106210	MGDA	607108	11p13
Anisomastia	605746	ANMA		16q13-q21
Anonychia congenita	206800	RSPO4	610573	20p13
Anonychia congenita	206800	CRISTIN4	610573	20p13
Anosmia, isolated congenital	107200	ANIC		18p11.23-q12.2
Anterior segment anomalies with or without cataract	113650	EYA1	601653	8q13.3
Anterior segment anomalies with or without cataract	113650	BOR	601653	8q13.3
Anterior segment anomalies with or without cataract	113650	BOS1	601653	8q13.3
Anterior segment anomalies with or without cataract	113650	OFC1	601653	8q13.3
Anterior segment mesenchymal dysgenesis	107250	FOXE3	601094	1p33
Anterior segment mesenchymal dysgenesis	107250	FKHL12	601094	1p33
Anterior segment mesenchymal dysgenesis	107250	ASMD	601094	1p33
Anterior segment mesenchymal dysgenesis	107250	PITX3	602669	10q24.32
Anterior segment mesenchymal dysgenesis	107250	CTPP4	602669	10q24.32
Anterior segment mesenchymal dysgenesis	107250	CTRCT11	602669	10q24.32
Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis	201750	POR	124015	7q11.23
Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	FGFR2	176943	10q26.13
Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	BEK	176943	10q26.13
Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	CFD1	176943	10q26.13
Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	JWS	176943	10q26.13
Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	TK14	176943	10q26.13
Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis	207410	BBDS	176943	10q26.13
Aortic aneurysm, ascending, and dissection		FBN1	134797	15q21.1
Aortic aneurysm, ascending, and dissection		MFS1	134797	15q21.1
Aortic aneurysm, ascending, and dissection		WMS2	134797	15q21.1
Aortic aneurysm, ascending, and dissection		SSKS	134797	15q21.1
Aortic aneurysm, ascending, and dissection		GPHYSD2	134797	15q21.1
Aortic aneurysm, ascending, and dissection		ACMICD	134797	15q21.1
Aortic aneurysm, ascending, and dissection		ECTOL1	134797	15q21.1
Aortic aneurysm, familial abdominal 1	100070	AAA1		19q13
Aortic aneurysm, familial abdominal 1	100070	AAA		19q13
Aortic aneurysm, familial abdominal 2	609782	AAA2		4q31
Aortic aneurysm, familial abdominal, 4	614375	AAA4		12q13.3
Aortic aneurysm, familial thoracic 1	607086	AAT1		11q23.3-q24
Aortic aneurysm, familial thoracic 1	607086	FAA1		11q23.3-q24
Aortic aneurysm, familial thoracic 2	607087	AAT2		5q13-q14
Aortic aneurysm, familial thoracic 2	607087	FAA2		5q13-q14
Aortic aneurysm, familial thoracic 4	132900	MYH11	160745	16p13.11
Aortic aneurysm, familial thoracic 4	132900	AAT4	160745	16p13.11
Aortic aneurysm, familial thoracic 4	132900	FAA4	160745	16p13.11
Aortic aneurysm, familial thoracic 6	611788	ACTA2	102620	10q23.31
Aortic aneurysm, familial thoracic 6	611788	ACTSA	102620	10q23.31
Aortic aneurysm, familial thoracic 6	611788	AAT6	102620	10q23.31
Aortic aneurysm, familial thoracic 6	611788	MYMY5	102620	10q23.31
Aortic aneurysm, familial thoracic 7	613780	MYLK	600922	3q21.1
Aortic aneurysm, familial thoracic 7	613780	MLCK	600922	3q21.1
Aortic aneurysm, familial thoracic 7	613780	AAT7	600922	3q21.1
Aortic aneurysm, familial thoracic 8	615436	PRKG1	176894	10q11.2-q21.1
Aortic aneurysm, familial thoracic 8	615436	PRKG1B	176894	10q11.2-q21.1
Aortic aneurysm, familial thoracic 8	615436	PRKGR1B	176894	10q11.2-q21.1
Aortic aneurysm, familial thoracic 8	615436	AAT8	176894	10q11.2-q21.1
Aortic valve disease 2	614823	SMAD6	602931	15q22.31
Aortic valve disease 2	614823	MADH6	602931	15q22.31
Aortic valve disease 2	614823	AOVD2	602931	15q22.31
Aortic valve disease	109730	NOTCH1	190198	9q34.3
Aortic valve disease	109730	TAN1	190198	9q34.3
Apert syndrome	101200	FGFR2	176943	10q26.13
Apert syndrome	101200	BEK	176943	10q26.13
Apert syndrome	101200	CFD1	176943	10q26.13
Apert syndrome	101200	JWS	176943	10q26.13
Apert syndrome	101200	TK14	176943	10q26.13
Apert syndrome	101200	BBDS	176943	10q26.13
Aphakia, congenital primary	610256	FOXE3	601094	1p33
Aphakia, congenital primary	610256	FKHL12	601094	1p33
Aphakia, congenital primary	610256	ASMD	601094	1p33
Aphasia, primary progressive	607485	GRN	138945	17q21.31
Aphasia, primary progressive	607485	CLN11	138945	17q21.31
Aplasia cutis congenita, reticulolinear, with mmicrocephaly, facial dysmorphism and other congenital anomalies	300887	COX7B	300885	Xq21.1
Aplasia cutis congenita, reticulolinear, with mmicrocephaly, facial dysmorphism and other congenital anomalies	300887	APLCC	300885	Xq21.1
Aplasia of lacrimal and salivary glands	180920	FGF10	602115	5p12
Aplastic anemia	609135	NBS1	602667	8q21.3
Aplastic anemia	609135	NBS	602667	8q21.3
Apnea, postanesthetic	177400	BCHE		3q26.1
Apnea, postanesthetic	177400	CHE1		3q26.1
ApoA-I and apoC-III deficiency, combined	107680	APOA1		11q23.3
Apolipoprotein A-II deficiency	107670	APOA2		1q23.3
Apparent mineralocorticoid excess	218030	HSD11B2	614232	16q22.1
Apparent mineralocorticoid excess	218030	HSD11K	614232	16q22.1
Apparent mineralocorticoid excess	218030	AME	614232	16q22.1
Argininemia	207800	ARG1	608313	6q23.2
Argininosuccinic aciduria	207900	ASL	608310	7q11.21
Aromatase deficiency	613546	CYP19A1	107910	15q21.2
Aromatase deficiency	613546	CYP19	107910	15q21.2
Aromatase deficiency	613546	ARO	107910	15q21.2
Aromatase excess syndrome	139300	CYP19A1	107910	15q21.2
Aromatase excess syndrome	139300	CYP19	107910	15q21.2
Aromatase excess syndrome	139300	ARO	107910	15q21.2
Aromatic L-amino acid decarboxylase deficiency	608643	DDC	107930	7p12.1
Arrhythmogenic right ventricular dysplasia 1	107970	TGFB3	190230	14q24.3
Arrhythmogenic right ventricular dysplasia 1	107970	ARVD1	190230	14q24.3
Arrhythmogenic right ventricular dysplasia 1	107970	RNHF	190230	14q24.3
Arrhythmogenic right ventricular dysplasia 10	610193	DSG2	125671	18q12.1
Arrhythmogenic right ventricular dysplasia 10	610193	ARVD10	125671	18q12.1
Arrhythmogenic right ventricular dysplasia 10	610193	ARVC10	125671	18q12.1
Arrhythmogenic right ventricular dysplasia 10	610193	CMD1BB	125671	18q12.1
Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair	610476	DSC2	125645	18q12.1
Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair	610476	DSC3	125645	18q12.1
Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratoderma and woolly hair	610476	ARVD11	125645	18q12.1
Arrhythmogenic right ventricular dysplasia 11	610476	DSC2	125645	18q12.1
Arrhythmogenic right ventricular dysplasia 11	610476	DSC3	125645	18q12.1
Arrhythmogenic right ventricular dysplasia 11	610476	ARVD11	125645	18q12.1
Arrhythmogenic right ventricular dysplasia 12	611528	JUP	173325	17q21.2
Arrhythmogenic right ventricular dysplasia 12	611528	DP3	173325	17q21.2
Arrhythmogenic right ventricular dysplasia 12	611528	PDGB	173325	17q21.2
Arrhythmogenic right ventricular dysplasia 12	611528	ARVD12	173325	17q21.2
Arrhythmogenic right ventricular dysplasia 2	600996	RYR2	180902	1q43
Arrhythmogenic right ventricular dysplasia 2	600996	VTSIP	180902	1q43
Arrhythmogenic right ventricular dysplasia 2	600996	ARVD2	180902	1q43
Arrhythmogenic right ventricular dysplasia 2	600996	ARVC2	180902	1q43
Arrhythmogenic right ventricular dysplasia 3	602086	ARVD3		14q12-q22
Arrhythmogenic right ventricular dysplasia 4	602087	ARVD4		2q32.1-q32.3
Arrhythmogenic right ventricular dysplasia 5	604400	TMEM43	612048	3p25.1
Arrhythmogenic right ventricular dysplasia 5	604400	ARVD5	612048	3p25.1
Arrhythmogenic right ventricular dysplasia 5	604400	ARVC5	612048	3p25.1
Arrhythmogenic right ventricular dysplasia 5	604400	EDMD7	612048	3p25.1
Arrhythmogenic right ventricular dysplasia 6	604401	ARVD6		10p14-p12
Arrhythmogenic right ventricular dysplasia 8	607450	DSP	125647	6p24.3
Arrhythmogenic right ventricular dysplasia 8	607450	KPPS2	125647	6p24.3
Arrhythmogenic right ventricular dysplasia 8	607450	PPKS2	125647	6p24.3
Arrhythmogenic right ventricular dysplasia 9	609040	PKP2	602861	12p11.21
Arrhythmogenic right ventricular dysplasia 9	609040	ARVD9	602861	12p11.21
Arrhythmogenic right ventricular dysplasia, familial, 13	615616	CTNNA3	607667	10q21.3
Arrhythmogenic right ventricular dysplasia, familial, 13	615616	ARVD13	607667	10q21.3
Arterial calcification, generalized, of infancy, 1	208000	ENPP1	173335	6q23.2
Arterial calcification, generalized, of infancy, 1	208000	PDNP1	173335	6q23.2
Arterial calcification, generalized, of infancy, 1	208000	NPPS	173335	6q23.2
Arterial calcification, generalized, of infancy, 1	208000	M6S1	173335	6q23.2
Arterial calcification, generalized, of infancy, 1	208000	PCA1	173335	6q23.2
Arterial calcification, generalized, of infancy, 1	208000	ARHR2	173335	6q23.2
Arterial calcification, generalized, of infancy, 1	208000	COLED	173335	6q23.2
Arterial calcification, generalized, of infancy, 2	614473	ABCC6	603234	16p13.11
Arterial calcification, generalized, of infancy, 2	614473	ARA	603234	16p13.11
Arterial calcification, generalized, of infancy, 2	614473	ABC34	603234	16p13.11
Arterial calcification, generalized, of infancy, 2	614473	MLP1	603234	16p13.11
Arterial calcification, generalized, of infancy, 2	614473	PXE	603234	16p13.11
Arterial calcification, generalized, of infancy, 2	614473	GACI2	603234	16p13.11
Arterial tortuosity syndrome	208050	SLC2A10	606145	20q13.12
Arterial tortuosity syndrome	208050	GLUT10	606145	20q13.12
Arterial tortuosity syndrome	208050	ATS	606145	20q13.12
Arthrogryposis multiplex congenita, distal, type 1	108120	TPM2	190990	9p13.3
Arthrogryposis multiplex congenita, distal, type 1	108120	TMSB	190990	9p13.3
Arthrogryposis multiplex congenita, distal, type 1	108120	AMCD1	190990	9p13.3
Arthrogryposis multiplex congenita, distal, type 1	108120	DA1	190990	9p13.3
Arthrogryposis multiplex congenita, distal, type 1	108120	DA2B	190990	9p13.3
Arthrogryposis multiplex congenita, distal, type 1	108120	NEM4	190990	9p13.3
Arthrogryposis multiplex congenita, distal, type 2B	601680	TNNI2	191043	11p15.5
Arthrogryposis multiplex congenita, distal, type 2B	601680	AMCD2B	191043	11p15.5
Arthrogryposis multiplex congenita, distal, type 2B	601680	DA2B	191043	11p15.5
Arthrogryposis multiplex congenita, distal, type 2B	601680	FSSV	191043	11p15.5
Arthrogryposis multiplex congenita, neurogenic	208100	AMCN		5q35
Arthrogryposis multiplex congenita, neurogenic	208100	AMCN1		5q35
Arthrogryposis, distal, type 10	187370	DA10		2q31.3-q32.1
Arthrogryposis, distal, type 1B	614335	MYBPC1	160794	12q23.2
Arthrogryposis, distal, type 1B	614335	LCCS4	160794	12q23.2
Arthrogryposis, distal, type 2A	193700	MYH3	160720	17p13.1
Arthrogryposis, distal, type 2B	601680	MYH3	160720	17p13.1
Arthrogryposis, distal, type 2B	601680	TPM2	190990	9p13.3
Arthrogryposis, distal, type 2B	601680	TMSB	190990	9p13.3
Arthrogryposis, distal, type 2B	601680	AMCD1	190990	9p13.3
Arthrogryposis, distal, type 2B	601680	DA1	190990	9p13.3
Arthrogryposis, distal, type 2B	601680	DA2B	190990	9p13.3
Arthrogryposis, distal, type 2B	601680	NEM4	190990	9p13.3
Arthrogryposis, distal, type 5	108145	PIEZO2	613629	18p11.22-p11.21
Arthrogryposis, distal, type 5	108145	FAM38B	613629	18p11.22-p11.21
Arthrogryposis, distal, type 5	108145	DA5	613629	18p11.22-p11.21
Arthrogryposis, distal, type 5D	615065	ECEL1	605896	2q37.1
Arthrogryposis, distal, type 5D	615065	XCE	605896	2q37.1
Arthrogryposis, distal, type 5D	615065	DA5D	605896	2q37.1
Arthrogryposis, lethal, with anterior horn cell disease	611890	GLE1	603371	9q34.11
Arthrogryposis, lethal, with anterior horn cell disease	611890	GLE1L	603371	9q34.11
Arthrogryposis, lethal, with anterior horn cell disease	611890	LCCS	603371	9q34.11
Arthrogryposis, lethal, with anterior horn cell disease	611890	LCCS1	603371	9q34.11
Arthrogryposis, renal dysfunction, and cholestasis 1	208085	VPS33B	608552	15q26.1
Arthrogryposis, renal dysfunction, and cholestasis 2	613404	VIPAS39	613401	14q24.3
Arthrogryposis, renal dysfunction, and cholestasis 2	613404	VIPAR	613401	14q24.3
Arthrogryposis, renal dysfunction, and cholestasis 2	613404	SPE39	613401	14q24.3
Arthrogryposis, renal dysfunction, and cholestasis 2	613404	C14orf133	613401	14q24.3
Arthropathy, progressive pseudorheumatoid, of childhood	208230	WISP3	603400	6q21
Arthropathy, progressive pseudorheumatoid, of childhood	208230	PPAC	603400	6q21
Arthropathy, progressive pseudorheumatoid, of childhood	208230	PPD	603400	6q21
Arthyrgryposis, distal, type 2B	601680	TNNT3	600692	11p15.5
Arthyrgryposis, distal, type 2B	601680	AMCD2B	600692	11p15.5
Arthyrgryposis, distal, type 2B	601680	DA2B	600692	11p15.5
Arthyrgryposis, distal, type 2B	601680	FSSV	600692	11p15.5
Arts syndrome	301835	PRPS1	311850	Xq22.3
Arts syndrome	301835	CMTX5	311850	Xq22.3
Arts syndrome	301835	DFNX1	311850	Xq22.3
Arts syndrome	301835	DFN2	311850	Xq22.3
Asparagine synthetase deficiency	615574	ASNS	108370	7q21.3
Asparagine synthetase deficiency	615574	ASNSD	108370	7q21.3
Aspartate aminotransferase, serum level of, QTL1	614419	GOT1	138180	10q24.2
Aspartate aminotransferase, serum level of, QTL1	614419	ASTQTL1	138180	10q24.2
Aspartylglucosaminuria	208400	AGA	613228	4q34.3
Asthma and nasal polyps	208550	TBX21	604895	17q21.32
Asthma and nasal polyps	208550	TBET	604895	17q21.32
Ataxia with isolated vitamin E deficiency	277460	TTPA	600415	8q12.3
Ataxia with isolated vitamin E deficiency	277460	TTP1	600415	8q12.3
Ataxia with isolated vitamin E deficiency	277460	AVED	600415	8q12.3
Ataxia, cerebellar, Cayman type	601238	ATCAY	608179	19p13.3
Ataxia, cerebellar, Cayman type	601238	CLAC	608179	19p13.3
Ataxia, cerebellar, Cayman type	601238	KIAA1872	608179	19p13.3
Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	208920	APTX	606350	9p21.1
Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	208920	AOA	606350	9p21.1
Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia	208920	AOA1	606350	9p21.1
Ataxia, posterior column, with retinitis pigmentosa	609033	FLVCR1	609144	1q32.3
Ataxia, posterior column, with retinitis pigmentosa	609033	AXPC1	609144	1q32.3
Ataxia, posterior column, with retinitis pigmentosa	609033	PCARP	609144	1q32.3
Ataxia, sensory, 1, autosomal dominant	608984	RNF170	614649	8p11.21
Ataxia, sensory, 1, autosomal dominant	608984	SNAX1	614649	8p11.21
Ataxia, spastic, 4	613672	MTPAP	613669	10p11.23
Ataxia, spastic, 4	613672	PAPD1	613669	10p11.23
Ataxia, spastic, 4	613672	SPAX4	613669	10p11.23
Ataxia, spastic, 5, autosomal recessive	614487	AFG3L2	604581	18p11.21
Ataxia, spastic, 5, autosomal recessive	614487	SCA28	604581	18p11.21
Ataxia, spastic, 5, autosomal recessive	614487	SPAX5	604581	18p11.21
Ataxia-ocular apraxia-2	606002	SETX	608465	9q34.13
Ataxia-ocular apraxia-2	606002	SCAR1	608465	9q34.13
Ataxia-ocular apraxia-2	606002	AOA2	608465	9q34.13
Ataxia-ocular apraxia-2	606002	ALS4	608465	9q34.13
Ataxia-oculomotor apraxia 3	615217	PIK3R5	611317	17p13.1
Ataxia-oculomotor apraxia 3	615217	p101	611317	17p13.1
Ataxia-telangiectasia	208900	ATM	607585	11q22.3
Ataxia-telangiectasia	208900	ATA	607585	11q22.3
Ataxia-telangiectasia	208900	AT1	607585	11q22.3
Ataxia-telangiectasia-like disorder	604391	MRE11A	600814	11q21
Ataxia-telangiectasia-like disorder	604391	MRE11	600814	11q21
Ataxia-telangiectasia-like disorder	604391	ATLD	600814	11q21
Atelosteogenesis II	256050	SLC26A2	606718	5q32
Atelosteogenesis II	256050	DTD	606718	5q32
Atelosteogenesis II	256050	DTDST	606718	5q32
Atelosteogenesis II	256050	D5S1708	606718	5q32
Atelosteogenesis II	256050	EDM4	606718	5q32
Atelosteogenesis, type I	108720	FLNB	603381	3p14.3
Atelosteogenesis, type I	108720	SCT	603381	3p14.3
Atelosteogenesis, type I	108720	AOI	603381	3p14.3
Atelosteogenesis, type I	108720	LRS1	603381	3p14.3
Atelosteogenesis, type III	108721	FLNB	603381	3p14.3
Atelosteogenesis, type III	108721	SCT	603381	3p14.3
Atelosteogenesis, type III	108721	AOI	603381	3p14.3
Atelosteogenesis, type III	108721	LRS1	603381	3p14.3
Athabaskan brainstem dysgenesis syndrome	601536	HOXA1	142955	7p15.2
Athabaskan brainstem dysgenesis syndrome	601536	HOX1F	142955	7p15.2
Athabaskan brainstem dysgenesis syndrome	601536	BSAS	142955	7p15.2
Atopy	147050	SPINK5	605010	5q32
Atopy	147050	LEKTI	605010	5q32
Atransferrinemia	209300	TF	190000	3q22.1
Atransferrinemia	209300	TFQTL1	190000	3q22.1
Atrial fibrillation, familial, 1	608583	ATFB1		10q22-q24
Atrial fibrillation, familial, 10	614022	SCN5A	600163	3p22.2
Atrial fibrillation, familial, 10	614022	LQT3	600163	3p22.2
Atrial fibrillation, familial, 10	614022	VF1	600163	3p22.2
Atrial fibrillation, familial, 10	614022	HB1	600163	3p22.2
Atrial fibrillation, familial, 10	614022	SSS1	600163	3p22.2
Atrial fibrillation, familial, 10	614022	CMD1E	600163	3p22.2
Atrial fibrillation, familial, 10	614022	CDCD2	600163	3p22.2
Atrial fibrillation, familial, 11	614049	GJA5	121013	1q21.2
Atrial fibrillation, familial, 11	614049	CX40	121013	1q21.2
Atrial fibrillation, familial, 11	614049	ATFB11	121013	1q21.2
Atrial fibrillation, familial, 12	614050	ABCC9	601439	12p12.1
Atrial fibrillation, familial, 12	614050	SUR2	601439	12p12.1
Atrial fibrillation, familial, 12	614050	CMD1O	601439	12p12.1
Atrial fibrillation, familial, 12	614050	ATFB12	601439	12p12.1
Atrial fibrillation, familial, 12	614050	CANTU	601439	12p12.1
Atrial fibrillation, familial, 13	615377	SCN1B	600235	19q13.12
Atrial fibrillation, familial, 13	615377	GEFSP1	600235	19q13.12
Atrial fibrillation, familial, 13	615377	BRGDA5	600235	19q13.12
Atrial fibrillation, familial, 13	615377	ATFB13	600235	19q13.12
Atrial fibrillation, familial, 14	615378	SCN2B	601327	11q23.3
Atrial fibrillation, familial, 14	615378	ATFB14	601327	11q23.3
Atrial fibrillation, familial, 2	608988	ATFB2		6q14-q16
Atrial fibrillation, familial, 3	607554	KCNQ1	607542	11p15.5-p15.4
Atrial fibrillation, familial, 3	607554	KCNA9	607542	11p15.5-p15.4
Atrial fibrillation, familial, 3	607554	LQT1	607542	11p15.5-p15.4
Atrial fibrillation, familial, 3	607554	KVLQT1	607542	11p15.5-p15.4
Atrial fibrillation, familial, 3	607554	ATFB3	607542	11p15.5-p15.4
Atrial fibrillation, familial, 3	607554	SQT2	607542	11p15.5-p15.4
Atrial fibrillation, familial, 4	611493	KCNE2	603796	21q22.11
Atrial fibrillation, familial, 4	611493	MIRP1	603796	21q22.11
Atrial fibrillation, familial, 4	611493	LQT6	603796	21q22.11
Atrial fibrillation, familial, 4	611493	ATFB4	603796	21q22.11
Atrial fibrillation, familial, 6	612201	NPPA	108780	1p36.22
Atrial fibrillation, familial, 6	612201	PND	108780	1p36.22
Atrial fibrillation, familial, 6	612201	ANP	108780	1p36.22
Atrial fibrillation, familial, 6	612201	ATFB6	108780	1p36.22
Atrial fibrillation, familial, 7	612240	KCNA5	176267	12p13.32
Atrial fibrillation, familial, 7	612240	ATFB7	176267	12p13.32
Atrial fibrillation, familial, 8	613055	ATFB8		16q22
Atrial fibrillation, familial, 9	613980	KCNJ2	600681	17q24.3
Atrial fibrillation, familial, 9	613980	HHIRK1	600681	17q24.3
Atrial fibrillation, familial, 9	613980	KIR2.1	600681	17q24.3
Atrial fibrillation, familial, 9	613980	IRK1	600681	17q24.3
Atrial fibrillation, familial, 9	613980	LQT7	600681	17q24.3
Atrial fibrillation, familial, 9	613980	SQT3	600681	17q24.3
Atrial fibrillation, familial, 9	613980	ATFB9	600681	17q24.3
Atrial septal defect 1	108800	ASD1		5p
Atrial septal defect 2	607941	GATA4	600576	8p23.1
Atrial septal defect 2	607941	ASD2	600576	8p23.1
Atrial septal defect 2	607941	VSD1	600576	8p23.1
Atrial septal defect 2	607941	TACHD	600576	8p23.1
Atrial septal defect 3	614089	MYH6	160710	14q11.2
Atrial septal defect 3	614089	ASD3	160710	14q11.2
Atrial septal defect 3	614089	MYHCA	160710	14q11.2
Atrial septal defect 3	614089	CMD1EE	160710	14q11.2
Atrial septal defect 3	614089	CMH14	160710	14q11.2
Atrial septal defect 3	614089	SSS3	160710	14q11.2
Atrial septal defect 4	611363	TBX20	606061	7p14.2
Atrial septal defect 4	611363	ASD4	606061	7p14.2
Atrial septal defect 5	612794	ACTC1	102540	15q14
Atrial septal defect 5	612794	CMD1R	102540	15q14
Atrial septal defect 5	612794	CMH11	102540	15q14
Atrial septal defect 5	612794	ASD5	102540	15q14
Atrial septal defect 5	612794	LVNC4	102540	15q14
Atrial septal defect 6	613087	TLL1	606742	4q32.3
Atrial septal defect 6	613087	TLL	606742	4q32.3
Atrial septal defect 6	613087	ASD6	606742	4q32.3
Atrial septal defect 7, with or without AV conduction defects	108900	NKX2-5	600584	5q35.1
Atrial septal defect 7, with or without AV conduction defects	108900	NKX2E	600584	5q35.1
Atrial septal defect 7, with or without AV conduction defects	108900	CSX	600584	5q35.1
Atrial septal defect 7, with or without AV conduction defects	108900	CHNG5	600584	5q35.1
Atrial septal defect 7, with or without AV conduction defects	108900	VSD3	600584	5q35.1
Atrial septal defect 7, with or without AV conduction defects	108900	HLHS2	600584	5q35.1
Atrial septal defect 8	614433	CITED2	602937	6q24.1
Atrial septal defect 8	614433	MRG1	602937	6q24.1
Atrial septal defect 8	614433	P35SRJ	602937	6q24.1
Atrial septal defect 8	614433	VSD2	602937	6q24.1
Atrial septal defect 8	614433	ASD8	602937	6q24.1
Atrial septal defect 9	614475	GATA6	601656	18q11.2
Atrial septal defect 9	614475	AVSD5	601656	18q11.2
Atrial septal defect 9	614475	ASD9	601656	18q11.2
Atrial septal defect 9	614475	AVSD5	601656	18q11.2
Atrial septal defect 9	614475	PACHD	601656	18q11.2
Atrial standstill, digenic	108770	GJA5	121013	1q21.2
Atrial standstill, digenic	108770	CX40	121013	1q21.2
Atrial standstill, digenic	108770	ATFB11	121013	1q21.2
Atrichia with papular lesions	209500	HR	602302	8p21.3
Atrichia with papular lesions	209500	AU	602302	8p21.3
Atrichia with papular lesions	209500	MUHH1	602302	8p21.3
Atrioventricular septal defect 3	600309	GJA1	121014	6q22.31
Atrioventricular septal defect 3	600309	CX43	121014	6q22.31
Atrioventricular septal defect 3	600309	ODDD	121014	6q22.31
Atrioventricular septal defect 3	600309	SDTY3	121014	6q22.31
Atrioventricular septal defect 3	600309	ODOD	121014	6q22.31
Atrioventricular septal defect 3	600309	HSS	121014	6q22.31
Atrioventricular septal defect 3	600309	AVSD3	121014	6q22.31
Atrioventricular septal defect 3	600309	HLHS1	121014	6q22.31
Atrioventricular septal defect 3	600309	CMDR	121014	6q22.31
Atrioventricular septal defect 4	614430	GATA4	600576	8p23.1
Atrioventricular septal defect 4	614430	ASD2	600576	8p23.1
Atrioventricular septal defect 4	614430	VSD1	600576	8p23.1
Atrioventricular septal defect 4	614430	TACHD	600576	8p23.1
Atrioventricular septal defect 5	614474	GATA6	601656	18q11.2
Atrioventricular septal defect 5	614474	AVSD5	601656	18q11.2
Atrioventricular septal defect 5	614474	ASD9	601656	18q11.2
Atrioventricular septal defect 5	614474	AVSD5	601656	18q11.2
Atrioventricular septal defect 5	614474	PACHD	601656	18q11.2
Atrioventricular septal defect, partial, with heterotaxy syndrome	606217	CRELD1	607170	3p25.3
Atrioventricular septal defect, partial, with heterotaxy syndrome	606217	AVSD2	607170	3p25.3
Atypical mycobacteriosis, familial, X-linked 2	300645	CYBB	300481	Xp11.4
Atypical mycobacteriosis, familial, X-linked 2	300645	CGD	300481	Xp11.4
Atypical mycobacteriosis, familial, X-linked 2	300645	AMCBX2	300481	Xp11.4
Auditory neuropathy, autosomal dominant, 1	609129	DIAPH3	614567	13q21.2
Auditory neuropathy, autosomal dominant, 1	609129	DIA2	614567	13q21.2
Auditory neuropathy, autosomal dominant, 1	609129	DRF3	614567	13q21.2
Auditory neuropathy, autosomal dominant, 1	609129	AUNA1	614567	13q21.2
Auditory neuropathy, autosomal dominant, 1	609129	NSDAN	614567	13q21.2
Auditory neuropathy, autosomal recessive, 1	601071	OTOF	603681	2p23.3
Auditory neuropathy, autosomal recessive, 1	601071	DFNB9	603681	2p23.3
Auditory neuropathy, autosomal recessive, 1	601071	NSRD9	603681	2p23.3
Auditory neuropathy, autosomal recessive, 1	601071	AUNB1	603681	2p23.3
Aural atresia, congenital	607842	CAA		18q22.3-q23
Aural atresia, congenital	607842	TSHZ1	614427	18q22.3
Aural atresia, congenital	607842	TSH1	614427	18q22.3
Aural atresia, congenital	607842	CAA	614427	18q22.3
Auriculocondylar syndrome 1	602483	GNAI3	139370	1p13.3
Auriculocondylar syndrome 1	602483	ARCND1	139370	1p13.3
Auriculocondylar syndrome 2	614669	PLCB4	600810	20p12.3-p12.2
Auriculocondylar syndrome 2	614669	ARCND2	600810	20p12.3-p12.2
Autoimmune disease, syndromic multisystem	613385	ITCH	606409	20q11.22
Autoimmune disease, syndromic multisystem	613385	AIP4	606409	20q11.22
Autoimmune disease, syndromic multisystem	613385	NAPP1	606409	20q11.22
Autoimmune lymphoproliferative syndrome type IV	614470	NRAS	164790	1p13.2
Autoimmune lymphoproliferative syndrome type IV	614470	ALPS4	164790	1p13.2
Autoimmune lymphoproliferative syndrome type IV	614470	NS6	164790	1p13.2
Autoimmune lymphoproliferative syndrome, type IA	601859	TNFRSF6	134637	10q23.31
Autoimmune lymphoproliferative syndrome, type IA	601859	APT1	134637	10q23.31
Autoimmune lymphoproliferative syndrome, type IA	601859	FAS	134637	10q23.31
Autoimmune lymphoproliferative syndrome, type IA	601859	CD95	134637	10q23.31
Autoimmune lymphoproliferative syndrome, type IA	601859	ALPS1A	134637	10q23.31
Autoimmune lymphoproliferative syndrome, type IB	601859	TNFSF6	134638	1q24.3
Autoimmune lymphoproliferative syndrome, type IB	601859	APT1LG1	134638	1q24.3
Autoimmune lymphoproliferative syndrome, type IB	601859	FASL	134638	1q24.3
Autoimmune lymphoproliferative syndrome, type IB	601859	ALPS1B	134638	1q24.3
Autoimmune lymphoproliferative syndrome, type II	603909	CASP10	601762	2q33.1
Autoimmune lymphoproliferative syndrome, type II	603909	MCH4	601762	2q33.1
Autoimmune lymphoproliferative syndrome, type II	603909	ALPS2	601762	2q33.1
Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	240300	AIRE	607358	21q22.3
Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	240300	APECED	607358	21q22.3
Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia	240300	APS1	607358	21q22.3
Autoinflammation, antibody deficiency, and immune dysregulation syndrome	614878	PLCG2	600220	16q23.3
Autoinflammation, antibody deficiency, and immune dysregulation syndrome	614878	FCAS3	600220	16q23.3
Autoinflammation, antibody deficiency, and immune dysregulation syndrome	614878	APLAID	600220	16q23.3
Autoinflammation, lipodystrophy, and dermatosis syndrome	256040	PSMB8	177046	6p21.32
Autoinflammation, lipodystrophy, and dermatosis syndrome	256040	LMP7	177046	6p21.32
Autoinflammation, lipodystrophy, and dermatosis syndrome	256040	RING10	177046	6p21.32
Autoinflammation, lipodystrophy, and dermatosis syndrome	256040	JMP	177046	6p21.32
Autoinflammation, lipodystrophy, and dermatosis syndrome	256040	NKJO	177046	6p21.32
Autoinflammation, lipodystrophy, and dermatosis syndrome	256040	ALDD	177046	6p21.32
Autonomic nervous system dysfunction		DRD4	126452	11p15.5
Avascular necrosis of the femoral head	608805	COL2A1	120140	12q13.11
Axenfeld-Rieger syndrome, type 1	180500	PITX2	601542	4q25
Axenfeld-Rieger syndrome, type 1	180500	IDG2	601542	4q25
Axenfeld-Rieger syndrome, type 1	180500	RIEG1	601542	4q25
Axenfeld-Rieger syndrome, type 1	180500	RGS	601542	4q25
Axenfeld-Rieger syndrome, type 1	180500	IGDS2	601542	4q25
Axenfeld-Rieger syndrome, type 3	602482	FOXC1	601090	6p25.3
Axenfeld-Rieger syndrome, type 3	602482	FKHL7	601090	6p25.3
Axenfeld-Rieger syndrome, type 3	602482	FREAC3	601090	6p25.3
Axenfeld-Rieger syndrome, type 3	602482	IRID1	601090	6p25.3
Axenfeld-Rieger syndrome, type 3	602482	RIEG3	601090	6p25.3
B-cell non-Hodgkin lymphoma, high-grade		BCL7A	601406	12q24.31
B-cell non-Hodgkin lymphoma, high-grade		BCL7	601406	12q24.31
BCG and salmonella infection, disseminated	209950	IL12B	161561	5q33.3
BCG and salmonella infection, disseminated	209950	NKSF2	161561	5q33.3
BCG infection, generalized familial	209950	IFNGR1	107470	6q23.3
Bainbridge-Ropers syndrome	615485	ASXL3	615115	18q12.1
Bainbridge-Ropers syndrome	615485	KIAA1713	615115	18q12.1
Bainbridge-Ropers syndrome	615485	BRPS	615115	18q12.1
Baller-Gerold syndrome	218600	RECQL4	603780	8q24.3
Baller-Gerold syndrome	218600	RTS	603780	8q24.3
Baller-Gerold syndrome	218600	RECQ4	603780	8q24.3
Bamforth-Lazarus syndrome	241850	FOXE1	602617	9q22.33
Bamforth-Lazarus syndrome	241850	FKHL15	602617	9q22.33
Bamforth-Lazarus syndrome	241850	TITF2	602617	9q22.33
Bamforth-Lazarus syndrome	241850	TTF2	602617	9q22.33
Band-like calcification with simplified gyration and polymicrogyria	251290	OCLN	602876	5q13.2
Band-like calcification with simplified gyration and polymicrogyria	251290	BLCPMG	602876	5q13.2
Bannayan-Riley-Ruvalcaba syndrome	153480	PTEN	601728	10q23.31
Bannayan-Riley-Ruvalcaba syndrome	153480	MMAC1	601728	10q23.31
Bannayan-Riley-Ruvalcaba syndrome	153480	GLM2	601728	10q23.31
Bannayan-Riley-Ruvalcaba syndrome	153480	CWS1	601728	10q23.31
Baraitser-Winter syndrome 1	243310	ACTB	102630	7p22.1
Baraitser-Winter syndrome 1	243310	BRWS1	102630	7p22.1
Baraitser-Winter syndrome 2	614583	ACTG1	102560	17q25.3
Baraitser-Winter syndrome 2	614583	DFNA20	102560	17q25.3
Baraitser-Winter syndrome 2	614583	DFNA26	102560	17q25.3
Baraitser-Winter syndrome 2	614583	BRWS2	102560	17q25.3
Bardet-Biedl syndrome 1	209900	BBS1	209901	11q13.2
Bardet-Biedl syndrome 10	209900	BBS10	610148	12q21.2
Bardet-Biedl syndrome 10	209900	C12orf58	610148	12q21.2
Bardet-Biedl syndrome 10	209900	FLJ23560	610148	12q21.2
Bardet-Biedl syndrome 11	209900	TRIM32	602290	9q33.1
Bardet-Biedl syndrome 11	209900	HT2A	602290	9q33.1
Bardet-Biedl syndrome 11	209900	LGMD2H	602290	9q33.1
Bardet-Biedl syndrome 11	209900	BBS11	602290	9q33.1
Bardet-Biedl syndrome 12	209900	BBS12	610683	4q27
Bardet-Biedl syndrome 12	209900	FLJ35630	610683	4q27
Bardet-Biedl syndrome 12	209900	C4orf24	610683	4q27
Bardet-Biedl syndrome 13	209900	MKS1	609883	17q22
Bardet-Biedl syndrome 13	209900	MKS	609883	17q22
Bardet-Biedl syndrome 13	209900	BBS13	609883	17q22
Bardet-Biedl syndrome 14	209900	CEP290	610142	12q21.32
Bardet-Biedl syndrome 14	209900	KIAA0373	610142	12q21.32
Bardet-Biedl syndrome 14	209900	3H11AG	610142	12q21.32
Bardet-Biedl syndrome 14	209900	JBTS5	610142	12q21.32
Bardet-Biedl syndrome 14	209900	SLSN6	610142	12q21.32
Bardet-Biedl syndrome 14	209900	LCA10	610142	12q21.32
Bardet-Biedl syndrome 14	209900	BBS14	610142	12q21.32
Bardet-Biedl syndrome 15	209900	C2orf86	613580	2p15
Bardet-Biedl syndrome 15	209900	BBS15	613580	2p15
Bardet-Biedl syndrome 2	209900	BBS2	606151	16q12.2
Bardet-Biedl syndrome 3	209900	ARL6	608845	3q11.2
Bardet-Biedl syndrome 3	209900	BBS3	608845	3q11.2
Bardet-Biedl syndrome 3	209900	RP55	608845	3q11.2
Bardet-Biedl syndrome 4	209900	BBS4	600374	15q24.1
Bardet-Biedl syndrome 5	209900	BBS5	603650	2q31.1
Bardet-Biedl syndrome 6	209900	MKKS	604896	20p12.2
Bardet-Biedl syndrome 6	209900	HMCS	604896	20p12.2
Bardet-Biedl syndrome 6	209900	KMS	604896	20p12.2
Bardet-Biedl syndrome 6	209900	MKS	604896	20p12.2
Bardet-Biedl syndrome 6	209900	BBS6	604896	20p12.2
Bardet-Biedl syndrome 7	209900	BBS7	607590	4q27
Bardet-Biedl syndrome 8	209900	TTC8	608132	14q31.3
Bardet-Biedl syndrome 8	209900	BBS8	608132	14q31.3
Bardet-Biedl syndrome 8	209900	RP51	608132	14q31.3
Bardet-Biedl syndrome 9	209900	PTHB1	607968	7p14.3
Bardet-Biedl syndrome 9	209900	BBS9	607968	7p14.3
Bare lymphocyte syndrome, type I	604571	TAP1	170260	6p21.32
Bare lymphocyte syndrome, type I	604571	ABCB2	170260	6p21.32
Bare lymphocyte syndrome, type I	604571	TAP1	170260	6p21.32
Bare lymphocyte syndrome, type I	604571	RING4	170260	6p21.32
Bare lymphocyte syndrome, type I	604571	PSF1	170260	6p21.32
Bare lymphocyte syndrome, type I	604571	TAPBP	601962	6p21.32
Bare lymphocyte syndrome, type I	604571	TPSN	601962	6p21.32
Bare lymphocyte syndrome, type I, due to TAP2 deficiency	604571	TAP2	170261	6p21.32
Bare lymphocyte syndrome, type I, due to TAP2 deficiency	604571	ABCB3	170261	6p21.32
Bare lymphocyte syndrome, type I, due to TAP2 deficiency	604571	PSF2	170261	6p21.32
Bare lymphocyte syndrome, type I, due to TAP2 deficiency	604571	RING11	170261	6p21.32
Bare lymphocyte syndrome, type II, complementation group A	209920	MHC2TA	600005	16p13.13
Bare lymphocyte syndrome, type II, complementation group A	209920	C2TA	600005	16p13.13
Bare lymphocyte syndrome, type II, complementation group C	209920	RFX5	601863	1q21.3
Bare lymphocyte syndrome, type II, complementation group D	209920	RFXAP	601861	13q13.3
Bare lymphocyte syndrome, type II, complementation group E	209920	RFX5	601863	1q21.3
Barrett esophagus/esophageal adenocarcinoma	614266	ASCC1	614215	10q22.1
Barrett esophagus/esophageal adenocarcinoma	614266	p50	614215	10q22.1
Barrett esophagus/esophageal adenocarcinoma	614266	CTHRC1	610635	8q22.3
Barrett esophagus/esophageal adenocarcinoma	614266	MSR1	153622	8p22
Barrett esophagus/esophageal adenocarcinoma	614266	SCARA1	153622	8p22
Barrett esophagus/esophageal adenocarcinoma	614266	SRA	153622	8p22
Bart-Pumphrey syndrome	149200	GJB2	121011	13q12.11
Bart-Pumphrey syndrome	149200	CX26	121011	13q12.11
Bart-Pumphrey syndrome	149200	DFNB1A	121011	13q12.11
Bart-Pumphrey syndrome	149200	PPK	121011	13q12.11
Bart-Pumphrey syndrome	149200	DFNA3A	121011	13q12.11
Bart-Pumphrey syndrome	149200	KID	121011	13q12.11
Bart-Pumphrey syndrome	149200	HID	121011	13q12.11
Barth syndrome	302060	TAZ	300394	Xq28
Barth syndrome	302060	EFE2	300394	Xq28
Barth syndrome	302060	BTHS	300394	Xq28
Barth syndrome	302060	CMD3A	300394	Xq28
Barth syndrome	302060	LVNCX	300394	Xq28
Bartter syndrome, type 1	601678	SLC12A1	600839	15q21.1
Bartter syndrome, type 1	601678	NKCC2	600839	15q21.1
Bartter syndrome, type 2	241200	KCNJ1	600359	11q24.3
Bartter syndrome, type 2	241200	ROMK1	600359	11q24.3
Bartter syndrome, type 3	607364	CLCNKB	602023	1p36.13
Bartter syndrome, type 4a	602522	BSND	606412	1p32.3
Bartter syndrome, type 4b, digenic	613090	CLCNKA	602024	1p36.13
Bartter syndrome, type 4b, digenic	613090	CLCNKB	602023	1p36.13
Basal cell carcinoma, somatic		SMOH	601500	7q32.1
Basal cell carcinoma, somatic		SMO	601500	7q32.1
Basal cell carcinoma, somatic	605462	PTCH1	601309	9q22.32
Basal cell carcinoma, somatic	605462	NBCCS	601309	9q22.32
Basal cell carcinoma, somatic	605462	BCNS	601309	9q22.32
Basal cell carcinoma, somatic	605462	HPE7	601309	9q22.32
Basal cell carcinoma, somatic	605462	PTCH2	603673	1p34.1
Basal cell carcinoma, somatic	605462	RASA1	139150	5q14.3
Basal cell carcinoma, somatic	605462	GAP	139150	5q14.3
Basal cell carcinoma, somatic	605462	CMAVM	139150	5q14.3
Basal cell carcinoma, somatic	605462	PKWS	139150	5q14.3
Basal cell nevus syndrome	109400	PTCH1	601309	9q22.32
Basal cell nevus syndrome	109400	NBCCS	601309	9q22.32
Basal cell nevus syndrome	109400	BCNS	601309	9q22.32
Basal cell nevus syndrome	109400	HPE7	601309	9q22.32
Basal ganglia calcification, idiopathic, 2	606656	IBGC2		2q37
Basal ganglia calcification, idiopathic, 4	615007	PDGFRB	173410	5q32
Basal ganglia calcification, idiopathic, 4	615007	PDGFR	173410	5q32
Basal ganglia calcification, idiopathic, 4	615007	IBGC4	173410	5q32
Basal ganglia calcification, idiopathic, 4	615007	IMF1	173410	5q32
Basal ganglia calcification, idiopathic, 5	615483	PDGFB	190040	22q13.1
Basal ganglia calcification, idiopathic, 5	615483	SIS	190040	22q13.1
Basal ganglia calcification, idiopathic, 5	615483	IBGC5	190040	22q13.1
Basal ganglia cancification, idiopathic, 1	213600	SLC20A2	158378	8p11.21
Basal ganglia cancification, idiopathic, 1	213600	MLVAR	158378	8p11.21
Basal ganglia cancification, idiopathic, 1	213600	GLVR2	158378	8p11.21
Basal ganglia cancification, idiopathic, 1	213600	IBGC1	158378	8p11.21
Basal laminar drusen	126700	HF1	134370	1q31.3
Basal laminar drusen	126700	CFH	134370	1q31.3
Basal laminar drusen	126700	HUS	134370	1q31.3
Basal laminar drusen	126700	ARMD4	134370	1q31.3
Basal laminar drusen	126700	AHUS1	134370	1q31.3
Bazex syndrome	301845	BZX		Xq24-q27
Beare-Stevenson cutis gyrata syndrome	123790	FGFR2	176943	10q26.13
Beare-Stevenson cutis gyrata syndrome	123790	BEK	176943	10q26.13
Beare-Stevenson cutis gyrata syndrome	123790	CFD1	176943	10q26.13
Beare-Stevenson cutis gyrata syndrome	123790	JWS	176943	10q26.13
Beare-Stevenson cutis gyrata syndrome	123790	TK14	176943	10q26.13
Beare-Stevenson cutis gyrata syndrome	123790	BBDS	176943	10q26.13
Beaulieu-Boycott-Innes syndrome	613680	THOC6	615403	16p13.3
Beaulieu-Boycott-Innes syndrome	613680	FSAP35	615403	16p13.3
Beaulieu-Boycott-Innes syndrome	613680	BBIS	615403	16p13.3
Becker muscular dystrophy	300376	DMD	300377	Xp21.2-p21.1
Becker muscular dystrophy	300376	BMD	300377	Xp21.2-p21.1
Becker muscular dystrophy	300376	CMD3B	300377	Xp21.2-p21.1
Beckwith-Wiedemann syndrome	130650	CDKN1C	600856	11p15.4
Beckwith-Wiedemann syndrome	130650	KIP2	600856	11p15.4
Beckwith-Wiedemann syndrome	130650	BWS	600856	11p15.4
Beckwith-Wiedemann syndrome	130650	IMAGE	600856	11p15.4
Beckwith-Wiedemann syndrome	130650	H19	103280	11p15.5
Beckwith-Wiedemann syndrome	130650	D11S813E	103280	11p15.5
Beckwith-Wiedemann syndrome	130650	ASM1	103280	11p15.5
Beckwith-Wiedemann syndrome	130650	BWS	103280	11p15.5
Beckwith-Wiedemann syndrome	130650	WT2	103280	11p15.5
Beckwith-Wiedemann syndrome	130650	KCNQ1OT1	604115	11p15.5
Beckwith-Wiedemann syndrome	130650	LIT1	604115	11p15.5
Beckwith-Wiedemann syndrome	130650	NSD1	606681	5q35.2-q35.3
Beckwith-Wiedemann syndrome	130650	ARA267	606681	5q35.2-q35.3
Beckwith-Wiedemann syndrome	130650	STO	606681	5q35.2-q35.3
Beckwith-Wiedemann syndrome	130650	SOTOS1	606681	5q35.2-q35.3
Bent bone dysplasia syndrome	614592	FGFR2	176943	10q26.13
Bent bone dysplasia syndrome	614592	BEK	176943	10q26.13
Bent bone dysplasia syndrome	614592	CFD1	176943	10q26.13
Bent bone dysplasia syndrome	614592	JWS	176943	10q26.13
Bent bone dysplasia syndrome	614592	TK14	176943	10q26.13
Bent bone dysplasia syndrome	614592	BBDS	176943	10q26.13
Bernard-Soulier syndrome, type A1 (recessive)	231200	GP1BA	606672	17p13.2
Bernard-Soulier syndrome, type A1 (recessive)	231200	BSS	606672	17p13.2
Bernard-Soulier syndrome, type A1 (recessive)	231200	BDPLT1	606672	17p13.2
Bernard-Soulier syndrome, type A1 (recessive)	231200	VWDP	606672	17p13.2
Bernard-Soulier syndrome, type A1 (recessive)	231200	BDPLT3	606672	17p13.2
Bernard-Soulier syndrome, type A2 (dominant)	153670	GP1BA	606672	17p13.2
Bernard-Soulier syndrome, type A2 (dominant)	153670	BSS	606672	17p13.2
Bernard-Soulier syndrome, type A2 (dominant)	153670	BDPLT1	606672	17p13.2
Bernard-Soulier syndrome, type A2 (dominant)	153670	VWDP	606672	17p13.2
Bernard-Soulier syndrome, type A2 (dominant)	153670	BDPLT3	606672	17p13.2
Bernard-Soulier syndrome, type B	231200	GP1BB	138720	22q11.21
Bernard-Soulier syndrome, type B	231200	BS	138720	22q11.21
Bernard-Soulier syndrome, type B	231200	BDPLT1	138720	22q11.21
Bernard-Soulier syndrome, type C	231200	GP9	173515	3q21.3
Best macular dystrophy	153700	BEST1	607854	11q12.3
Best macular dystrophy	153700	VMD2	607854	11q12.3
Best macular dystrophy	153700	ARB	607854	11q12.3
Best macular dystrophy	153700	RP50	607854	11q12.3
Bestrophinopathy	611809	BEST1	607854	11q12.3
Bestrophinopathy	611809	VMD2	607854	11q12.3
Bestrophinopathy	611809	ARB	607854	11q12.3
Bestrophinopathy	611809	RP50	607854	11q12.3
Beta-2-adrenoreceptor agonist, reduced response to	109690	ADRB2		5q32
Beta-ureidopropionase deficiency	613161	UPB1	606673	22q11.23
Beta-ureidopropionase deficiency	613161	BUP1	606673	22q11.23
Bethlem myopathy	158810	COL6A1	120220	21q22.3
Bethlem myopathy	158810	OPLL	120220	21q22.3
Bethlem myopathy	158810	COL6A2	120240	21q22.3
Bethlem myopathy	158810	COL6A3	120250	2q37.3
Bietti crystalline corneoretinal dystrophy	210370	CYP4V2	608614	4q35.2
Bietti crystalline corneoretinal dystrophy	210370	BCD	608614	4q35.2
Bifid nose with or without anorectal and renal anomalies	608980	FREM1	608944	9p22.3
Bifid nose with or without anorectal and renal anomalies	608980	C9orf154	608944	9p22.3
Bifid nose with or without anorectal and renal anomalies	608980	BNAR	608944	9p22.3
Bifid nose with or without anorectal and renal anomalies	608980	MOTA	608944	9p22.3
Bifid nose with or without anorectal and renal anomalies	608980	TRIGNO2	608944	9p22.3
Bile acid malabsorption, primary	613291	SLC10A2	601295	13q33.1
Bile acid malabsorption, primary	613291	NTCP2	601295	13q33.1
Bile acid malabsorption, primary	613291	PBAM	601295	13q33.1
Bile acid synthesis defect, congenital, 1	607765	HSD3B7	607764	16p11.2
Bile acid synthesis defect, congenital, 1	607765	CBAS1	607764	16p11.2
Bile acid synthesis defect, congenital, 2	235555	AKR1D1	604741	7q33
Bile acid synthesis defect, congenital, 2	235555	SRD5B1	604741	7q33
Bile acid synthesis defect, congenital, 2	235555	CBAS2	604741	7q33
Bile acid synthesis defect, congenital, 3	613812	CYP7B1	603711	8q12.3
Bile acid synthesis defect, congenital, 3	613812	CBAS3	603711	8q12.3
Bile acid synthesis defect, congenital, 3	613812	SPG5A	603711	8q12.3
Bile acid synthesis defect, congenital, 4	214950	AMACR	604489	5p13.2
Bile acid synthesis defect, congenital, 4	214950	CBAS4	604489	5p13.2
Bile acid synthesis defect, congenital, 4	214950	AMACRD	604489	5p13.2
Biliary cirrhosis, primary, 1	109720	PBC1		3p12-q13.2
Biliary cirrhosis, primary, 4	614220	PBC4		7q32
Biliary cirrhosis, primary, 5	614221	PBC5		17q12
Biotinidase deficiency	253260	BTD	609019	3p25.1
Birk-Barel mental retardation dysmorphism syndrome	612292	KCNK9	605874	8q24.3
Birk-Barel mental retardation dysmorphism syndrome	612292	TASK3	605874	8q24.3
Birt-Hogg-Dube syndrome	135150	FLCN	607273	17p11.2
Birt-Hogg-Dube syndrome	135150	BHD	607273	17p11.2
Bjornstad syndrome	262000	BCS1L	603647	2q35
Bjornstad syndrome	262000	FLNMS	603647	2q35
Bjornstad syndrome	262000	GRACILE	603647	2q35
Bjornstad syndrome	262000	BJS	603647	2q35
Bjornstad syndrome	262000	PTD	603647	2q35
Bjornstad syndrome	262000	MC3DN1	603647	2q35
Bladder cancer, somatic	109800	FGFR3	134934	4p16.3
Bladder cancer, somatic	109800	ACH	134934	4p16.3
Bladder cancer, somatic	109800	KRAS	190070	12p12.1
Bladder cancer, somatic	109800	KRAS2	190070	12p12.1
Bladder cancer, somatic	109800	RASK2	190070	12p12.1
Bladder cancer, somatic	109800	NS	190070	12p12.1
Bladder cancer, somatic	109800	CFC2	190070	12p12.1
Bladder cancer, somatic	109800	RB1	614041	13q14.2
Blau syndrome	186580	NOD2	605956	16q12.1
Blau syndrome	186580	CARD15	605956	16q12.1
Blau syndrome	186580	IBD1	605956	16q12.1
Blau syndrome	186580	CD	605956	16q12.1
Blau syndrome	186580	ACUG	605956	16q12.1
Blau syndrome	186580	PSORAS1	605956	16q12.1
Bleeding disorder due to P2RX1 defect		P2RX1	600845	17p13.2
Bleeding disorder due to P2RX1 defect		P2X1	600845	17p13.2
Bleeding disorder, east Texas type	605913	BDET		1q23
Bleeding disorder, platelet-type, 11	614201	GP6	605546	19q13.42
Bleeding disorder, platelet-type, 11	614201	GPIV	605546	19q13.42
Bleeding disorder, platelet-type, 11	614201	BDPLT11	605546	19q13.42
Bleeding disorder, platelet-type, 15	615193	ACTN1	102575	14q24.1
Bleeding disorder, platelet-type, 15	615193	BDPLT15	102575	14q24.1
Bleeding disorder, platelet-type, 16, autosomal dominant	187800	ITGA2B	607759	17q21.31
Bleeding disorder, platelet-type, 16, autosomal dominant	187800	GP2B	607759	17q21.31
Bleeding disorder, platelet-type, 16, autosomal dominant	187800	CD41B	607759	17q21.31
Bleeding disorder, platelet-type, 16, autosomal dominant	187800	GT	607759	17q21.31
Bleeding disorder, platelet-type, 16, autosomal dominant	187800	BDPLT2	607759	17q21.31
Bleeding disorder, platelet-type, 16, autosomal dominant	187800	BDPLT16	607759	17q21.31
Bleeding disorder, platelet-type, 16, autosomal dominant	187800	ITGB3	173470	17q21.32
Bleeding disorder, platelet-type, 16, autosomal dominant	187800	GP3A	173470	17q21.32
Bleeding disorder, platelet-type, 16, autosomal dominant	187800	GT	173470	17q21.32
Bleeding disorder, platelet-type, 16, autosomal dominant	187800	BDPLT2	173470	17q21.32
Bleeding disorder, platelet-type, 16, autosomal dominant	187800	BDPLT16	173470	17q21.32
Bleeding disorder, platelet-type, 17	187900	GFI1B	604383	9q34.13
Bleeding disorder, platelet-type, 17	187900	BDPLT17	604383	9q34.13
Bleeding disorder, platelet-type, 8	609821	P2RY12	600515	3q25.1
Bleeding disorder, platelet-type, 8	609821	P2Y12	600515	3q25.1
Bleeding disorder, platelet-type, 8	609821	BDPLT8	600515	3q25.1
Blepharophimosis, epicanthus inversus, and ptosis, type 1	110100	FOXL2	605597	3q22.3
Blepharophimosis, epicanthus inversus, and ptosis, type 1	110100	BPES	605597	3q22.3
Blepharophimosis, epicanthus inversus, and ptosis, type 1	110100	BPES1	605597	3q22.3
Blepharophimosis, epicanthus inversus, and ptosis, type 1	110100	PFRK	605597	3q22.3
Blepharophimosis, epicanthus inversus, and ptosis, type 1	110100	POF3	605597	3q22.3
Blepharophimosis, epicanthus inversus, and ptosis, type 2	110100	FOXL2	605597	3q22.3
Blepharophimosis, epicanthus inversus, and ptosis, type 2	110100	BPES	605597	3q22.3
Blepharophimosis, epicanthus inversus, and ptosis, type 2	110100	BPES1	605597	3q22.3
Blepharophimosis, epicanthus inversus, and ptosis, type 2	110100	PFRK	605597	3q22.3
Blepharophimosis, epicanthus inversus, and ptosis, type 2	110100	POF3	605597	3q22.3
Blepharophimosis-ptosis-intellectual disability syndrome	615057	UBE3B	608047	12q24.11
Blepharophimosis-ptosis-intellectual disability syndrome	615057	BPIDS	608047	12q24.11
Blood group--Lutheran inhibitor	111150	KLF1	600599	19p13.2
Blood group--Lutheran inhibitor	111150	EKLF	600599	19p13.2
Blood group--Lutheran inhibitor	111150	INLU	600599	19p13.2
Blood group--Lutheran inhibitor	111150	HBFQTL6	600599	19p13.2
Blood group--Lutheran inhibitor	111150	CDAN4	600599	19p13.2
Bloom syndrome	210900	RECQL3	604610	15q26.1
Bloom syndrome	210900	RECQ2	604610	15q26.1
Bloom syndrome	210900	BLM	604610	15q26.1
Bloom syndrome	210900	BS	604610	15q26.1
Blue cone monochromacy	303700	OPN1LW	300822	Xq28
Blue cone monochromacy	303700	RCP	300822	Xq28
Blue cone monochromacy	303700	CBP	300822	Xq28
Blue cone monochromacy	303700	CBBM	300822	Xq28
Blue cone monochromacy	303700	OPN1MW	300821	Xq28
Blue cone monochromacy	303700	GCP	300821	Xq28
Blue cone monochromacy	303700	CBD	300821	Xq28
Blue cone monochromacy	303700	CBBM	300821	Xq28
Bohring-Opitz syndrome	605039	ASXL1	612990	20q11.21
Bohring-Opitz syndrome	605039	KIAA0978	612990	20q11.21
Bohring-Opitz syndrome	605039	BOPS	612990	20q11.21
Bohring-Opitz syndrome	605039	MDS	612990	20q11.21
Bone marrow failure, familial	614675	SRP72	602122	4q12
Bone marrow failure, familial	614675	BMFF	602122	4q12
Bone mineral density QTL18, osteoporosis	300910	PLS3	300131	Xq23
Bone mineral density QTL18, osteoporosis	300910	BMND18	300131	Xq23
Boomerang dysplasia	112310	FLNB	603381	3p14.3
Boomerang dysplasia	112310	SCT	603381	3p14.3
Boomerang dysplasia	112310	AOI	603381	3p14.3
Boomerang dysplasia	112310	LRS1	603381	3p14.3
Bor-Duane hydrocephalus contiguous gene syndrome	600257	DEL8q12q21		8q12.2-q21.2
Bor-Duane hydrocephalus contiguous gene syndrome	600257	C8DELq12q21		8q12.2-q21.2
Borjeson-Forssman-Lehmann syndrome	301900	PHF6	300414	Xq26.2
Borjeson-Forssman-Lehmann syndrome	301900	BFLS	300414	Xq26.2
Bornholm eye disease	300843	BED		Xq28
Bosley-Salih-Alorainy syndrome	601536	HOXA1	142955	7p15.2
Bosley-Salih-Alorainy syndrome	601536	HOX1F	142955	7p15.2
Bosley-Salih-Alorainy syndrome	601536	BSAS	142955	7p15.2
Bothnia retinal dystrophy	607475	RLBP1	180090	15q26.1
Bowen-Conradi syndrome	211180	EMG1	611531	12p13.31
Bowen-Conradi syndrome	211180	NEP1	611531	12p13.31
Bowen-Conradi syndrome	211180	C2F	611531	12p13.31
Bowen-Conradi syndrome	211180	BWCNS	611531	12p13.31
Brachiootic syndrome 3	608389	SIX1	601205	14q23.1
Brachiootic syndrome 3	608389	BOS3	601205	14q23.1
Brachiootic syndrome 3	608389	DFNA23	601205	14q23.1
Brachydactyly, type A1	112500	BDA1B	607004	5p13.3-p13.2
Brachydactyly, type A1	112500	IHH	600726	2q35
Brachydactyly, type A1	112500	BDA1	600726	2q35
Brachydactyly, type A1, C	615072	GDF5	601146	20q11.22
Brachydactyly, type A1, C	615072	CDMP1	601146	20q11.22
Brachydactyly, type A1, C	615072	SYNS2	601146	20q11.22
Brachydactyly, type A1, C	615072	OS5	601146	20q11.22
Brachydactyly, type A1, C	615072	BDA1C	601146	20q11.22
Brachydactyly, type A1, C	615072	SYM1B	601146	20q11.22
Brachydactyly, type A2	112600	BMP2	112261	20p12.3
Brachydactyly, type A2	112600	BMP2A	112261	20p12.3
Brachydactyly, type A2	112600	BDA2	112261	20p12.3
Brachydactyly, type A2	112600	BMPR1B	603248	4q22.3
Brachydactyly, type A2	112600	ALK6	603248	4q22.3
Brachydactyly, type A2	112600	GDF5	601146	20q11.22
Brachydactyly, type A2	112600	CDMP1	601146	20q11.22
Brachydactyly, type A2	112600	SYNS2	601146	20q11.22
Brachydactyly, type A2	112600	OS5	601146	20q11.22
Brachydactyly, type A2	112600	BDA1C	601146	20q11.22
Brachydactyly, type A2	112600	SYM1B	601146	20q11.22
Brachydactyly, type B1	113000	ROR2	602337	9q22.31
Brachydactyly, type B1	113000	BDB1	602337	9q22.31
Brachydactyly, type B1	113000	BDB	602337	9q22.31
Brachydactyly, type B1	113000	NTRKR2	602337	9q22.31
Brachydactyly, type B2	611377	NOG	602991	17q22
Brachydactyly, type B2	611377	SYM1	602991	17q22
Brachydactyly, type B2	611377	SYNS1	602991	17q22
Brachydactyly, type C	113100	GDF5	601146	20q11.22
Brachydactyly, type C	113100	CDMP1	601146	20q11.22
Brachydactyly, type C	113100	SYNS2	601146	20q11.22
Brachydactyly, type C	113100	OS5	601146	20q11.22
Brachydactyly, type C	113100	BDA1C	601146	20q11.22
Brachydactyly, type C	113100	SYM1B	601146	20q11.22
Brachydactyly, type D	113200	HOXD13	142989	2q31.1
Brachydactyly, type D	113200	HOX4I	142989	2q31.1
Brachydactyly, type D	113200	SPD	142989	2q31.1
Brachydactyly, type D	113200	BDSD	142989	2q31.1
Brachydactyly, type E	113300	HOXD13	142989	2q31.1
Brachydactyly, type E	113300	HOX4I	142989	2q31.1
Brachydactyly, type E	113300	SPD	142989	2q31.1
Brachydactyly, type E	113300	BDSD	142989	2q31.1
Brachydactyly, type E2	613382	PTHLH	168470	12p11.22
Brachydactyly, type E2	613382	BDE2	168470	12p11.22
Brachydactyly-mental retardation syndrome	600430	HDAC4	605314	2q37.3
Brachydactyly-mental retardation syndrome	600430	HDACA	605314	2q37.3
Brachydactyly-mental retardation syndrome	600430	BDMR	605314	2q37.3
Brachydactyly-mental retardation syndrome	600430	AHO3	605314	2q37.3
Brachydactyly-syndactyly syndrome	610713	HOXD13	142989	2q31.1
Brachydactyly-syndactyly syndrome	610713	HOX4I	142989	2q31.1
Brachydactyly-syndactyly syndrome	610713	SPD	142989	2q31.1
Brachydactyly-syndactyly syndrome	610713	BDSD	142989	2q31.1
Brachyolmia 4 with mild epiphyseal and metaphyseal changes	612847	PAPSS2	603005	10q23.2-q23.3
Brachyolmia 4 with mild epiphyseal and metaphyseal changes	612847	ATPSK2	603005	10q23.2-q23.3
Brachyolmia 4 with mild epiphyseal and metaphyseal changes	612847	BCYM4	603005	10q23.2-q23.3
Brachyolmia type 3	113500	TRPV4	605427	12q24.11
Brachyolmia type 3	113500	VROAC	605427	12q24.11
Brachyolmia type 3	113500	HMSN2C	605427	12q24.11
Brachyolmia type 3	113500	CMT2C	605427	12q24.11
Brachyolmia type 3	113500	SPSMA	605427	12q24.11
Brachyolmia type 3	113500	SSQTL1	605427	12q24.11
Brachyolmia type 3	113500	SMAL	605427	12q24.11
Bradyopsia	608415	RGS9	604067	17q24.1
Bradyopsia	608415	PERRS	604067	17q24.1
Bradyopsia	608415	RGS9BP	607814	19q13.11
Bradyopsia	608415	R9AP	607814	19q13.11
Bradyopsia	608415	RGS9	607814	19q13.11
Bradyopsia	608415	PERRS	607814	19q13.11
Brain small vessel disease with Axenfeld-Rieger anomaly	607595	COL4A1	120130	13q34
Brain small vessel disease with Axenfeld-Rieger anomaly	607595	POREN1	120130	13q34
Brain small vessel disease with Axenfeld-Rieger anomaly	607595	HANAC	120130	13q34
Brain small vessel disease with Axenfeld-Rieger anomaly	607595	ICH	120130	13q34
Brain small vessel disease with hemorrhage	607595	COL4A1	120130	13q34
Brain small vessel disease with hemorrhage	607595	POREN1	120130	13q34
Brain small vessel disease with hemorrhage	607595	HANAC	120130	13q34
Brain small vessel disease with hemorrhage	607595	ICH	120130	13q34
Brain tumor-polyposis syndrome 2	175100	APC	611731	5q22.2
Brain tumor-polyposis syndrome 2	175100	GS	611731	5q22.2
Brain tumor-polyposis syndrome 2	175100	FPC	611731	5q22.2
Brain tumor-polyposis syndrome 2	175100	BTPS2	611731	5q22.2
Branched-chain ketoacid dehydrogenase kinase deficiency	614923	BCKDK	614901	16p11.2
Branched-chain ketoacid dehydrogenase kinase deficiency	614923	BDK	614901	16p11.2
Branched-chain ketoacid dehydrogenase kinase deficiency	614923	BCKDKD	614901	16p11.2
Branchiooculofacial syndrome	113620	TFAP2A	107580	6p24.3
Branchiooculofacial syndrome	113620	AP2TF	107580	6p24.3
Branchiooculofacial syndrome	113620	BOFS	107580	6p24.3
Branchiootic syndrome 1	602588	EYA1	601653	8q13.3
Branchiootic syndrome 1	602588	BOR	601653	8q13.3
Branchiootic syndrome 1	602588	BOS1	601653	8q13.3
Branchiootic syndrome 1	602588	OFC1	601653	8q13.3
Branchiootic syndrome 2	120502	BOS2		1q31
Branchiootorenal syndrome 1, with or without cataracts	113650	EYA1	601653	8q13.3
Branchiootorenal syndrome 1, with or without cataracts	113650	BOR	601653	8q13.3
Branchiootorenal syndrome 1, with or without cataracts	113650	BOS1	601653	8q13.3
Branchiootorenal syndrome 1, with or without cataracts	113650	OFC1	601653	8q13.3
Branchiootorenal syndrome 2	610896	SIX5	600963	19q13.32
Branchiootorenal syndrome 2	610896	DMAHP	600963	19q13.32
Branchiootorenal syndrome 2	610896	BOR2	600963	19q13.32
Breast cancer		BCPR	113721	17p13.3
Breast cancer	114480	PPM1D	605100	17q23.2
Breast cancer	114480	WIP1	605100	17q23.2
Breast cancer	114480	TP53	191170	17p13.1
Breast cancer	114480	P53	191170	17p13.1
Breast cancer	114480	LFS1 	191170	17p13.1
Breast cancer	114480	BCC7	191170	17p13.1
Breast cancer, 11:22 translocation associated	600048	BRCATA		11q23
Breast cancer, early-onset	114480	BRIP1	605882	17q23.2
Breast cancer, early-onset	114480	BACH1	605882	17q23.2
Breast cancer, early-onset	114480	FANCJ	605882	17q23.2
Breast cancer, somatic	114480	AKT1	164730	14q32.33
Breast cancer, somatic	114480	CWS6	164730	14q32.33
Breast cancer, somatic	114480	KRAS	190070	12p12.1
Breast cancer, somatic	114480	KRAS2	190070	12p12.1
Breast cancer, somatic	114480	RASK2	190070	12p12.1
Breast cancer, somatic	114480	NS	190070	12p12.1
Breast cancer, somatic	114480	CFC2	190070	12p12.1
Breast cancer, somatic	114480	PIK3CA	171834	3q26.32
Breast cancer, somatic	114480	CLOVE	171834	3q26.32
Breast cancer, somatic	114480	MCAP	171834	3q26.32
Breast cancer, somatic	114480	MCM	171834	3q26.32
Breast cancer, somatic	114480	MCMTC	171834	3q26.32
Breast cancer, somatic	114480	CWS5	171834	3q26.32
Breast cancer, somatic	114480	RB1CC1	606837	8q11.23
Breast cancer, somatic	114480	CC1	606837	8q11.23
Breast cancer, somatic	114480	KIAA0203	606837	8q11.23
Breast cancer, somatic	114480	SLC22A1L	602631	11p15.4
Breast cancer, somatic	114480	BWSCR1A	602631	11p15.4
Breast cancer, somatic	114480	IMPT1	602631	11p15.4
Breast cancer, somatic	114480	TSG101	601387	11p15.1
Brittle cornea syndrome 2	614170	PRDM5	614161	4q27
Brittle cornea syndrome 2	614170	BCS2	614161	4q27
Brittle cornea syndrome	229200	ZNF469	612078	16q24.2
Brittle cornea syndrome	229200	KIAA1858	612078	16q24.2
Brittle cornea syndrome	229200	BCS	612078	16q24.2
Brody myopathy	601003	ATP2A1	108730	16p11.2
Brody myopathy	601003	SERCA1	108730	16p11.2
Bronchiectasis with or without elevated sweat chloride 1	211400	SCNN1B	600760	16p12.2
Bronchiectasis with or without elevated sweat chloride 1	211400	BESC1	600760	16p12.2
Bronchiectasis with or without elevated sweat chloride 2	613021	SCNN1A	600228	12p13.31
Bronchiectasis with or without elevated sweat chloride 2	613021	BESC2	600228	12p13.31
Bronchiectasis with or without elevated sweat chloride 3	613071	SCNN1G	600761	16p12.2
Bronchiectasis with or without elevated sweat chloride 3	613071	PHA1	600761	16p12.2
Bronchiectasis with or without elevated sweat chloride 3	613071	BESC3	600761	16p12.2
Brooke-Spiegler syndrome	605041	CYLD	605018	16q12.1
Brooke-Spiegler syndrome	605041	CDMT	605018	16q12.1
Brooke-Spiegler syndrome	605041	EAC	605018	16q12.1
Brooke-Spiegler syndrome	605041	MFT1	605018	16q12.1
Brooke-Spiegler syndrome	605041	KIAA0849	605018	16q12.1
Brooke-Spiegler syndrome	605041	BRSS	605018	16q12.1
Brown-Vialetto-Van Laere syndrome 1	211530	SLC52A3	613350	20p13
Brown-Vialetto-Van Laere syndrome 1	211530	C20orf54	613350	20p13
Brown-Vialetto-Van Laere syndrome 1	211530	RFT2	613350	20p13
Brown-Vialetto-Van Laere syndrome 1	211530	BVVLS1	613350	20p13
Brown-Vialetto-Van Laere syndrome 2	614707	SLC52A2	607882	8q24.3
Brown-Vialetto-Van Laere syndrome 2	614707	GPR172A	607882	8q24.3
Brown-Vialetto-Van Laere syndrome 2	614707	GPCR41	607882	8q24.3
Brown-Vialetto-Van Laere syndrome 2	614707	PAR1	607882	8q24.3
Brown-Vialetto-Van Laere syndrome 2	614707	FLJ11856	607882	8q24.3
Brown-Vialetto-Van Laere syndrome 2	614707	BVVLS2	607882	8q24.3
Bruck syndrome 1	259450	BRKS1		17p12
Bruck syndrome 2	609220	PLOD2	601865	3q24
Bruck syndrome 2	609220	LH2	601865	3q24
Bruck syndrome 2	609220	TLH	601865	3q24
Brugada syndrome 1	601144	SCN5A	600163	3p22.2
Brugada syndrome 1	601144	LQT3	600163	3p22.2
Brugada syndrome 1	601144	VF1	600163	3p22.2
Brugada syndrome 1	601144	HB1	600163	3p22.2
Brugada syndrome 1	601144	SSS1	600163	3p22.2
Brugada syndrome 1	601144	CMD1E	600163	3p22.2
Brugada syndrome 1	601144	CDCD2	600163	3p22.2
Brugada syndrome 2	611777	GPD1L	611778	3p22.3
Brugada syndrome 2	611777	KIAA0089	611778	3p22.3
Brugada syndrome 3	611875	CACNA1C	114205	12p13.33
Brugada syndrome 3	611875	CACNL1A1	114205	12p13.33
Brugada syndrome 3	611875	CCHL1A1	114205	12p13.33
Brugada syndrome 3	611875	TS	114205	12p13.33
Brugada syndrome 4	611876	CACNB2	600003	10p12.33-p12.31
Brugada syndrome 5	612838	SCN1B	600235	19q13.12
Brugada syndrome 5	612838	GEFSP1	600235	19q13.12
Brugada syndrome 5	612838	BRGDA5	600235	19q13.12
Brugada syndrome 5	612838	ATFB13	600235	19q13.12
Brugada syndrome 6	613119	KCNE3	604433	11q13.4
Brugada syndrome 6	613119	HOKPP	604433	11q13.4
Brugada syndrome 6	613119	HYPP	604433	11q13.4
Brugada syndrome 7	613120	SCN3B	608214	11q24.1
Brugada syndrome 7	613120	SCNB3	608214	11q24.1
Brugada syndrome 8	613123	HCN4	605206	15q24.1
Brugada syndrome 8	613123	SSS2	605206	15q24.1
Brunner syndrome	300615	MAOA	309850	Xp11.3
Burkitt lymphoma	113970	MYC	190080	8q24.21
Buschke-Ollendorff syndrome	166700	LEMD3	607844	12q14.3
Buschke-Ollendorff syndrome	166700	MAN1	607844	12q14.3
C syndrome	211750	CD96	606037	3q13.1-q13.2
C syndrome	211750	TACTILE	606037	3q13.1-q13.2
C1q deficiency	613652	C1QA	120550	1p36.12
C1q deficiency	613652	C1QB	120570	1p36.12
C1q deficiency	613652	C1QC	120575	1p36.12
C1q deficiency	613652	C1QG	120575	1p36.12
C1r/C1s deficiency, combined	216950	C1R	613785	12p13.31
C1s deficiency	613783	C1S	120580	12p13.31
C2 deficiency	217000	C2	613927	6p21.33
C2 deficiency	217000	ARMD14	613927	6p21.33
C3 deficiency	613779	C3	120700	19p13.3
C3 deficiency	613779	ARMD9	120700	19p13.3
C3 deficiency	613779	AHUS5	120700	19p13.3
C4B deficiency	614379	C4B	120820	6p21.33
C4B deficiency	614379	C4F	120820	6p21.33
C4B deficiency	614379	C4BD	120820	6p21.33
C4a deficiency	614380	C4A	120810	6p21.33
C4a deficiency	614380	C4S	120810	6p21.33
C4a deficiency	614380	C4AD	120810	6p21.33
C5 deficiency	609536	C5	120900	9q33.2
C6 deficiency	612446	C6	217050	5p13.1
C7 deficiency	610102	C7	217070	5p13.1
C8 deficiency, type I	613790	C8A	120950	1p32.2
C8 deficiency, type II	613789	C8B	120960	1p32.2
C9 deficiency	613825	C9	120940	5p13.1
C9 deficiency	613825	C9D	120940	5p13.1
C9 deficiency	613825	ARMD15	120940	5p13.1
CAP myopathy 1	609284	TPM3	191030	1q21.3
CAP myopathy 1	609284	NEM1	191030	1q21.3
CAP myopathy 1	609284	CFTD	191030	1q21.3
CAP myopathy 1	609284	CAPM1	191030	1q21.3
CAP myopathy 2	609285	TPM2	190990	9p13.3
CAP myopathy 2	609285	TMSB	190990	9p13.3
CAP myopathy 2	609285	AMCD1	190990	9p13.3
CAP myopathy 2	609285	DA1	190990	9p13.3
CAP myopathy 2	609285	DA2B	190990	9p13.3
CAP myopathy 2	609285	NEM4	190990	9p13.3
CARASIL syndrome	600142	HTRA1	602194	10q26.13
CARASIL syndrome	600142	PRSS11	602194	10q26.13
CARASIL syndrome	600142	ARMD7	602194	10q26.13
CARASIL syndrome	600142	CARASIL	602194	10q26.13
CATSHL syndrome	610474	FGFR3	134934	4p16.3
CATSHL syndrome	610474	ACH	134934	4p16.3
CD11C+/CD1C+ dendritic cell deficiency, dominant	614893	IRF8	601565	16q24.1
CD11C+/CD1C+ dendritic cell deficiency, dominant	614893	ICSBP1	601565	16q24.1
CD8 deficiency, familial	608957	CD8A	186910	2p11.2
CDAGS syndrome	603116	CDAGS		22q12-q13
CHARGE syndrome	214800	CHD7	608892	8q12.1-q12.2
CHARGE syndrome	214800	IS3	608892	8q12.1-q12.2
CHARGE syndrome	214800	HH5	608892	8q12.1-q12.2
CHARGE syndrome	214800	SEMA3E	608166	7q21.11
CHARGE syndrome	214800	SEMAH	608166	7q21.11
CHARGE syndrome	214800	KIAA0331	608166	7q21.11
CHILD syndrome	308050	NSDHL	300275	Xq28
CHIME syndrome	280000	PIGL	605947	17p11.2
CHIME syndrome	280000	CHIME	605947	17p11.2
CINCA syndrome	607115	NLRP3	606416	1q44
CINCA syndrome	607115	CIAS1	606416	1q44
CINCA syndrome	607115	FCU	606416	1q44
CINCA syndrome	607115	FCAS	606416	1q44
CINCA syndrome	607115	NALP3	606416	1q44
CINCA syndrome	607115	PYPAF1	606416	1q44
CK syndrome	300831	NSDHL	300275	Xq28
CLOVE syndrome, somatic	612918	PIK3CA	171834	3q26.32
CLOVE syndrome, somatic	612918	CLOVE	171834	3q26.32
CLOVE syndrome, somatic	612918	MCAP	171834	3q26.32
CLOVE syndrome, somatic	612918	MCM	171834	3q26.32
CLOVE syndrome, somatic	612918	MCMTC	171834	3q26.32
CLOVE syndrome, somatic	612918	CWS5	171834	3q26.32
COACH syndrome	216360	CC2D2A	612013	4p15.32
COACH syndrome	216360	KIAA1345	612013	4p15.32
COACH syndrome	216360	MKS6	612013	4p15.32
COACH syndrome	216360	RPGRIP1L	610937	16q12.2
COACH syndrome	216360	KIAA1005	610937	16q12.2
COACH syndrome	216360	JBTS7	610937	16q12.2
COACH syndrome	216360	MKS5	610937	16q12.2
COACH syndrome	216360	TMEM67	609884	8q22.1
COACH syndrome	216360	MKS3	609884	8q22.1
COACH syndrome	216360	JBTS6	609884	8q22.1
COACH syndrome	216360	NPHP11	609884	8q22.1
COPD, rate of decline of lung function in	606963	MMP1	120353	11q22.2
COPD, rate of decline of lung function in	606963	CLG	120353	11q22.2
CPT II deficiency, lethal neonatal	608836	CPT2	600650	1p32.3
CPT II deficiency, lethal neonatal	608836	IIAE4	600650	1p32.3
CPT deficiency, hepatic, type IA	255120	CPT1A	600528	11q13.3
CPT deficiency, hepatic, type II	600649	CPT2	600650	1p32.3
CPT deficiency, hepatic, type II	600649	IIAE4	600650	1p32.3
CR1 deficiency		CR1	120620	1q32.2
CR1 deficiency		C3BR	120620	1q32.2
CRASH syndrome	303350	L1CAM	308840	Xq28
CRASH syndrome	303350	CAML1	308840	Xq28
CRASH syndrome	303350	HSAS1	308840	Xq28
CRASH syndrome	303350	MASA	308840	Xq28
CRASH syndrome	303350	SPG1	308840	Xq28
Caffey disease	114000	COL1A1	120150	17q21.33
Calcification of joints and arteries	211800	NT5E	129190	6q14.3
Calcification of joints and arteries	211800	NT5	129190	6q14.3
Campomelic dysplasia with autosomal sex reversal	114290	SOX9	608160	17q24.3
Campomelic dysplasia with autosomal sex reversal	114290	CMD1	608160	17q24.3
Campomelic dysplasia with autosomal sex reversal	114290	SRA1	608160	17q24.3
Campomelic dysplasia	114290	SOX9	608160	17q24.3
Campomelic dysplasia	114290	CMD1	608160	17q24.3
Campomelic dysplasia	114290	SRA1	608160	17q24.3
Camptodactyly 1	114200	CAMPD1		3q11.2-q13.12
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	208250	PRG4	604283	1q31.1
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	208250	CACP	604283	1q31.1
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	208250	MSF	604283	1q31.1
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	208250	SZP	604283	1q31.1
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome	208250	HAPO	604283	1q31.1
Camurati-Engelmann disease	131300	TGFB1	190180	19q13.2
Camurati-Engelmann disease	131300	DPD1	190180	19q13.2
Camurati-Engelmann disease	131300	CED	190180	19q13.2
Canavan disease	271900	ASPA	608034	17p13.2
Candidiasis, familial, 1, autosomal dominant	114580	CANDF1		2p22.3-p21
Candidiasis, familial, 1, autosomal dominant	114580	CMCT		2p22.3-p21
Candidiasis, familial, 2, autosomal recessive	212050	CARD9	607212	9q34.3
Candidiasis, familial, 2, autosomal recessive	212050	CANDF2	607212	9q34.3
Candidiasis, familial, 3	607644	CANDF3		11p13-q12
Candidiasis, familial, 3	607644	CANDN1		11p13-q12
Candidiasis, familial, 3	607644	FCNC		11p13-q12
Candidiasis, familial, 4, autosomal recessive	613108	CLEC7A	606264	12p13.2
Candidiasis, familial, 4, autosomal recessive	613108	CLECSF12	606264	12p13.2
Candidiasis, familial, 4, autosomal recessive	613108	DECTIN1	606264	12p13.2
Candidiasis, familial, 4, autosomal recessive	613108	CANDF4	606264	12p13.2
Candidiasis, familial, 5, autosomal recessive	613953	IL17RA	605461	22q11.1
Candidiasis, familial, 5, autosomal recessive	613953	IL17R	605461	22q11.1
Candidiasis, familial, 5, autosomal recessive	613953	CANDF5	605461	22q11.1
Candidiasis, familial, 6, autosomal dominant	613956	IL17F	606496	6p12.2
Candidiasis, familial, 6, autosomal dominant	613956	ML1	606496	6p12.2
Candidiasis, familial, 6, autosomal dominant	613956	CANDF6	606496	6p12.2
Candidiasis, familial, 7	614162	STAT1	600555	2q32.2
Candidiasis, familial, 7	614162	CANDF7	600555	2q32.2
Capillary malformation-arteriovenous malformation	608354	RASA1	139150	5q14.3
Capillary malformation-arteriovenous malformation	608354	GAP	139150	5q14.3
Capillary malformation-arteriovenous malformation	608354	CMAVM	139150	5q14.3
Capillary malformation-arteriovenous malformation	608354	PKWS	139150	5q14.3
Capillary malformations, congenital, 1, somatic, mosaic	163000	GNAQ	600998	9q21.2
Capillary malformations, congenital, 1, somatic, mosaic	163000	SWS	600998	9q21.2
Capillary malformations, congenital, 1, somatic, mosaic	163000	CMC1	600998	9q21.2
Capillary malformations, hereditary	163000	CMAL		5q13-q22
Carbamoylphosphate synthetase I deficiency	237300	CPS1	608307	2q34
Carbamoylphosphate synthetase I deficiency	237300	PHN	608307	2q34
Carboxylesterase 1 deficiency	114835	CES1		16q12.2
Carboxylesterase 1 deficiency	114835	SES1		16q12.2
Carboxypeptidase N deficiency	212070	CPN1	603103	10q24.2
Carboxypeptidase N deficiency	212070	SCPN	603103	10q24.2
Carboxypeptidase N deficiency	212070	CPN	603103	10q24.2
Carcinoid tumor of lung		MEN1	613733	11q13.1
Carcinoid tumors, intestinal	114900	SDHD	602690	11q23.1
Carcinoid tumors, intestinal	114900	PGL1	602690	11q23.1
Carcinoid tumors, intestinal	114900	CWS3	602690	11q23.1
Cardiac arrhythmia, ankyrin-B-related	600919	ANK2	106410	4q25-q26
Cardiac arrhythmia, ankyrin-B-related	600919	LQT4	106410	4q25-q26
Cardiac conduction defect, nonspecific	612838	SCN1B	600235	19q13.12
Cardiac conduction defect, nonspecific	612838	GEFSP1	600235	19q13.12
Cardiac conduction defect, nonspecific	612838	BRGDA5	600235	19q13.12
Cardiac conduction defect, nonspecific	612838	ATFB13	600235	19q13.12
Cardiac valvular dysplasia, X-linked	314400	FLNA	300017	Xq28
Cardiac valvular dysplasia, X-linked	314400	FLN1	300017	Xq28
Cardiac valvular dysplasia, X-linked	314400	NHBP	300017	Xq28
Cardiac valvular dysplasia, X-linked	314400	OPD1	300017	Xq28
Cardiac valvular dysplasia, X-linked	314400	OPD2	300017	Xq28
Cardiac valvular dysplasia, X-linked	314400	FMD	300017	Xq28
Cardiac valvular dysplasia, X-linked	314400	MNS	300017	Xq28
Cardiac valvular dysplasia, X-linked	314400	CVD1	300017	Xq28
Cardiac valvular dysplasia, X-linked	314400	CSBS	300017	Xq28
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1	604377	SCO2	604272	22q13.33
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1	604377	CEMCOX1	604272	22q13.33
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1	604377	MYP6	604272	22q13.33
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2	615119	COX15	603646	10q24.2
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2	615119	CEMCOX2	603646	10q24.2
Cardiofaciocutaneous syndrome 2	615278	KRAS	190070	12p12.1
Cardiofaciocutaneous syndrome 2	615278	KRAS2	190070	12p12.1
Cardiofaciocutaneous syndrome 2	615278	RASK2	190070	12p12.1
Cardiofaciocutaneous syndrome 2	615278	NS	190070	12p12.1
Cardiofaciocutaneous syndrome 2	615278	CFC2	190070	12p12.1
Cardiofaciocutaneous syndrome 3	615279	MAP2K1	176872	15q22.31
Cardiofaciocutaneous syndrome 3	615279	PRKMK1	176872	15q22.31
Cardiofaciocutaneous syndrome 3	615279	MKK1	176872	15q22.31
Cardiofaciocutaneous syndrome 3	615279	MEK1	176872	15q22.31
Cardiofaciocutaneous syndrome 3	615279	CFC3	176872	15q22.31
Cardiofaciocutaneous syndrome 4	615280	MAP2K2	601263	19p13.3
Cardiofaciocutaneous syndrome 4	615280	PRKMK2	601263	19p13.3
Cardiofaciocutaneous syndrome 4	615280	MEK2	601263	19p13.3
Cardiofaciocutaneous syndrome 4	615280	MKK2	601263	19p13.3
Cardiofaciocutaneous syndrome 4	615280	CFC4	601263	19p13.3
Cardiofaciocutaneous syndrome	115150	BRAF	164757	7q34
Cardiofaciocutaneous syndrome	115150	NS7	164757	7q34
Cardiomyopathy, dilated 1B	600884	CMD1B		9q13
Cardiomyopathy, dilated 1B	600884	CMPD1		9q13
Cardiomyopathy, dilated 1B	600884	FDC		9q13
Cardiomyopathy, dilated 1C	601493	LDB3	605906	10q23.2
Cardiomyopathy, dilated 1C	601493	ZASP	605906	10q23.2
Cardiomyopathy, dilated 1C	601493	CYPHER	605906	10q23.2
Cardiomyopathy, dilated 1C	601493	KIAA01613	605906	10q23.2
Cardiomyopathy, dilated 1C	601493	CMD1C	605906	10q23.2
Cardiomyopathy, dilated 1C	601493	LVNC3	605906	10q23.2
Cardiomyopathy, dilated 1C	601493	MFM4	605906	10q23.2
Cardiomyopathy, dilated, 1A	115200	LMNA	150330	1q22
Cardiomyopathy, dilated, 1A	115200	LMN1	150330	1q22
Cardiomyopathy, dilated, 1A	115200	EMD2	150330	1q22
Cardiomyopathy, dilated, 1A	115200	FPLD2	150330	1q22
Cardiomyopathy, dilated, 1A	115200	CMD1A	150330	1q22
Cardiomyopathy, dilated, 1A	115200	HGPS	150330	1q22
Cardiomyopathy, dilated, 1A	115200	LGMD1B	150330	1q22
Cardiomyopathy, dilated, 1BB	612877	DSG2	125671	18q12.1
Cardiomyopathy, dilated, 1BB	612877	ARVD10	125671	18q12.1
Cardiomyopathy, dilated, 1BB	612877	ARVC10	125671	18q12.1
Cardiomyopathy, dilated, 1BB	612877	CMD1BB	125671	18q12.1
Cardiomyopathy, dilated, 1CC	613122	NEXN	613121	1p31.1
Cardiomyopathy, dilated, 1CC	613122	NELIN	613121	1p31.1
Cardiomyopathy, dilated, 1CC	613122	CMD1CC	613121	1p31.1
Cardiomyopathy, dilated, 1CC	613122	CMH20	613121	1p31.1
Cardiomyopathy, dilated, 1D	601494	TNNT2	191045	1q32.1
Cardiomyopathy, dilated, 1D	601494	CMH2	191045	1q32.1
Cardiomyopathy, dilated, 1D	601494	CMD1D	191045	1q32.1
Cardiomyopathy, dilated, 1D	601494	RCM3	191045	1q32.1
Cardiomyopathy, dilated, 1D	601494	LVNC6	191045	1q32.1
Cardiomyopathy, dilated, 1DD	613172	RBM20	613171	10q25.2
Cardiomyopathy, dilated, 1E	601154	SCN5A	600163	3p22.2
Cardiomyopathy, dilated, 1E	601154	LQT3	600163	3p22.2
Cardiomyopathy, dilated, 1E	601154	VF1	600163	3p22.2
Cardiomyopathy, dilated, 1E	601154	HB1	600163	3p22.2
Cardiomyopathy, dilated, 1E	601154	SSS1	600163	3p22.2
Cardiomyopathy, dilated, 1E	601154	CMD1E	600163	3p22.2
Cardiomyopathy, dilated, 1E	601154	CDCD2	600163	3p22.2
Cardiomyopathy, dilated, 1EE	613252	MYH6	160710	14q11.2
Cardiomyopathy, dilated, 1EE	613252	ASD3	160710	14q11.2
Cardiomyopathy, dilated, 1EE	613252	MYHCA	160710	14q11.2
Cardiomyopathy, dilated, 1EE	613252	CMD1EE	160710	14q11.2
Cardiomyopathy, dilated, 1EE	613252	CMH14	160710	14q11.2
Cardiomyopathy, dilated, 1EE	613252	SSS3	160710	14q11.2
Cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy type 1D		CMD1F	602067	6q23
Cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy type 1D		CDCD3	602067	6q23
Cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy type 1D		LGMD1D	602067	6q23
Cardiomyopathy, dilated, 1FF	613286	TNNI3	191044	19q13.42
Cardiomyopathy, dilated, 1FF	613286	CMH7	191044	19q13.42
Cardiomyopathy, dilated, 1FF	613286	CMD2A	191044	19q13.42
Cardiomyopathy, dilated, 1FF	613286	RCM1	191044	19q13.42
Cardiomyopathy, dilated, 1FF	613286	CMD1FF	191044	19q13.42
Cardiomyopathy, dilated, 1G	604145	TTN	188840	2q31.2
Cardiomyopathy, dilated, 1G	604145	CMD1G	188840	2q31.2
Cardiomyopathy, dilated, 1G	604145	TMD	188840	2q31.2
Cardiomyopathy, dilated, 1G	604145	LGMD2J	188840	2q31.2
Cardiomyopathy, dilated, 1G	604145	MPRM	188840	2q31.2
Cardiomyopathy, dilated, 1G	604145	HMERF	188840	2q31.2
Cardiomyopathy, dilated, 1G	604145	EOMFC	188840	2q31.2
Cardiomyopathy, dilated, 1GG	613642	SDHA	600857	5p15.33
Cardiomyopathy, dilated, 1GG	613642	SDH1	600857	5p15.33
Cardiomyopathy, dilated, 1GG	613642	SDHF	600857	5p15.33
Cardiomyopathy, dilated, 1GG	613642	CMD1GG	600857	5p15.33
Cardiomyopathy, dilated, 1GG	613642	PGL5	600857	5p15.33
Cardiomyopathy, dilated, 1H	604288	CMD1H		2q14-q22
Cardiomyopathy, dilated, 1HH	613881	BAG3	603883	10q26.11
Cardiomyopathy, dilated, 1HH	613881	MFM6	603883	10q26.11
Cardiomyopathy, dilated, 1I	604765	DES	125660	2q35
Cardiomyopathy, dilated, 1I	604765	CMD1I	125660	2q35
Cardiomyopathy, dilated, 1I	604765	MFM1	125660	2q35
Cardiomyopathy, dilated, 1I	604765	SCPNK	125660	2q35
Cardiomyopathy, dilated, 1I	604765	ARVD7	125660	2q35
Cardiomyopathy, dilated, 1I	604765	ARVC7	125660	2q35
Cardiomyopathy, dilated, 1I	604765	LGMD2R	125660	2q35
Cardiomyopathy, dilated, 1II	615184	CRYAB	123590	11q23.1
Cardiomyopathy, dilated, 1II	615184	CRYA2	123590	11q23.1
Cardiomyopathy, dilated, 1II	615184	CTPP2	123590	11q23.1
Cardiomyopathy, dilated, 1II	615184	CMD1II	123590	11q23.1
Cardiomyopathy, dilated, 1II	615184	CTRCT16	123590	11q23.1
Cardiomyopathy, dilated, 1II	615184	MFM2	123590	11q23.1
Cardiomyopathy, dilated, 1J	605362	EYA4	603550	6q23.2
Cardiomyopathy, dilated, 1J	605362	DFNA10	603550	6q23.2
Cardiomyopathy, dilated, 1J	605362	CMD1J	603550	6q23.2
Cardiomyopathy, dilated, 1JJ	615235	LAMA4	600133	6q21
Cardiomyopathy, dilated, 1JJ	615235	LAMA3	600133	6q21
Cardiomyopathy, dilated, 1JJ	615235	CMD1JJ	600133	6q21
Cardiomyopathy, dilated, 1K	605582	CMD1K		6q12-q16
Cardiomyopathy, dilated, 1KK	615248	MYPN	608517	10q21.3
Cardiomyopathy, dilated, 1KK	615248	CMD1DD	608517	10q21.3
Cardiomyopathy, dilated, 1KK	615248	CMH22	608517	10q21.3
Cardiomyopathy, dilated, 1KK	615248	RCM4	608517	10q21.3
Cardiomyopathy, dilated, 1L	606685	SGCD	601411	5q33.2-q33.3
Cardiomyopathy, dilated, 1L	606685	SGD	601411	5q33.2-q33.3
Cardiomyopathy, dilated, 1L	606685	LGMD2F	601411	5q33.2-q33.3
Cardiomyopathy, dilated, 1L	606685	CMD1L	601411	5q33.2-q33.3
Cardiomyopathy, dilated, 1LL	615373	PRDM16	605557	1p36.32
Cardiomyopathy, dilated, 1LL	615373	MEL1	605557	1p36.32
Cardiomyopathy, dilated, 1LL	615373	LVNC8	605557	1p36.32
Cardiomyopathy, dilated, 1LL	615373	CMD1LL	605557	1p36.32
Cardiomyopathy, dilated, 1M	607482	CSRP3	600824	11p15.1
Cardiomyopathy, dilated, 1M	607482	CRP3	600824	11p15.1
Cardiomyopathy, dilated, 1M	607482	CLP	600824	11p15.1
Cardiomyopathy, dilated, 1M	607482	CMD1M	600824	11p15.1
Cardiomyopathy, dilated, 1M	607482	CMH12	600824	11p15.1
Cardiomyopathy, dilated, 1MM	615396	MYBPC3	600958	11p11.2
Cardiomyopathy, dilated, 1MM	615396	CMH4	600958	11p11.2
Cardiomyopathy, dilated, 1MM	615396	CMD1MM	600958	11p11.2
Cardiomyopathy, dilated, 1MM	615396	LVNC10	600958	11p11.2
Cardiomyopathy, dilated, 1N	607487	TCAP	604488	17q12
Cardiomyopathy, dilated, 1N	607487	LGMD2G	604488	17q12
Cardiomyopathy, dilated, 1N	607487	CMD1N	604488	17q12
Cardiomyopathy, dilated, 1O	608569	ABCC9	601439	12p12.1
Cardiomyopathy, dilated, 1O	608569	SUR2	601439	12p12.1
Cardiomyopathy, dilated, 1O	608569	CMD1O	601439	12p12.1
Cardiomyopathy, dilated, 1O	608569	ATFB12	601439	12p12.1
Cardiomyopathy, dilated, 1O	608569	CANTU	601439	12p12.1
Cardiomyopathy, dilated, 1P	609909	PLN	172405	6q22.31
Cardiomyopathy, dilated, 1P	609909	PLB	172405	6q22.31
Cardiomyopathy, dilated, 1P	609909	CMD1P	172405	6q22.31
Cardiomyopathy, dilated, 1P	609909	CMH18	172405	6q22.31
Cardiomyopathy, dilated, 1Q	609915	CMD1Q		7q22.3-q31.1
Cardiomyopathy, dilated, 1R	613424	ACTC1	102540	15q14
Cardiomyopathy, dilated, 1R	613424	CMD1R	102540	15q14
Cardiomyopathy, dilated, 1R	613424	CMH11	102540	15q14
Cardiomyopathy, dilated, 1R	613424	ASD5	102540	15q14
Cardiomyopathy, dilated, 1R	613424	LVNC4	102540	15q14
Cardiomyopathy, dilated, 1S	613426	MYH7	160760	14q11.2
Cardiomyopathy, dilated, 1S	613426	CMH1	160760	14q11.2
Cardiomyopathy, dilated, 1S	613426	MPD1	160760	14q11.2
Cardiomyopathy, dilated, 1S	613426	CMD1S	160760	14q11.2
Cardiomyopathy, dilated, 1S	613426	SPMM	160760	14q11.2
Cardiomyopathy, dilated, 1S	613426	SPMD	160760	14q11.2
Cardiomyopathy, dilated, 1T	613740	TMPO	188380	12q23.1
Cardiomyopathy, dilated, 1T	613740	LAP2	188380	12q23.1
Cardiomyopathy, dilated, 1T	613740	CMD1T	188380	12q23.1
Cardiomyopathy, dilated, 1U	613694	PSEN1	104311	14q24.2
Cardiomyopathy, dilated, 1U	613694	AD3	104311	14q24.2
Cardiomyopathy, dilated, 1V	613697	PSEN2	600759	1q42.13
Cardiomyopathy, dilated, 1V	613697	AD4	600759	1q42.13
Cardiomyopathy, dilated, 1V	613697	STM2	600759	1q42.13
Cardiomyopathy, dilated, 1V	613697	CMD1V	600759	1q42.13
Cardiomyopathy, dilated, 1W	611407	VCL	193065	10q22.2
Cardiomyopathy, dilated, 1W	611407	CMD1W	193065	10q22.2
Cardiomyopathy, dilated, 1W	611407	CMH15	193065	10q22.2
Cardiomyopathy, dilated, 1X	611615	FKTN	607440	9q31.2
Cardiomyopathy, dilated, 1X	611615	FCMD	607440	9q31.2
Cardiomyopathy, dilated, 1X	611615	CMD1X	607440	9q31.2
Cardiomyopathy, dilated, 1X	611615	LGMD2M	607440	9q31.2
Cardiomyopathy, dilated, 1X	611615	MDDGA4	607440	9q31.2
Cardiomyopathy, dilated, 1X	611615	MDDGB4	607440	9q31.2
Cardiomyopathy, dilated, 1X	611615	MDDGC4	607440	9q31.2
Cardiomyopathy, dilated, 1Y	611878	TPM1	191010	15q22.2
Cardiomyopathy, dilated, 1Y	611878	CMH3	191010	15q22.2
Cardiomyopathy, dilated, 1Y	611878	CMD1Y 	191010	15q22.2
Cardiomyopathy, dilated, 1Y	611878	LVNC9	191010	15q22.2
Cardiomyopathy, dilated, 1Z	611879	TNNC1	191040	3p21.1
Cardiomyopathy, dilated, 1Z	611879	CMD1Z	191040	3p21.1
Cardiomyopathy, dilated, 1Z	611879	CMH13	191040	3p21.1
Cardiomyopathy, dilated, 2A	611880	TNNI3	191044	19q13.42
Cardiomyopathy, dilated, 2A	611880	CMH7	191044	19q13.42
Cardiomyopathy, dilated, 2A	611880	CMD2A	191044	19q13.42
Cardiomyopathy, dilated, 2A	611880	RCM1	191044	19q13.42
Cardiomyopathy, dilated, 2A	611880	CMD1FF	191044	19q13.42
Cardiomyopathy, dilated, 2B	614672	GATAD1	614518	7q21.2
Cardiomyopathy, dilated, 2B	614672	ODAG	614518	7q21.2
Cardiomyopathy, dilated, 2B	614672	CMD2B	614518	7q21.2
Cardiomyopathy, dilated, 3B	302045	DMD	300377	Xp21.2-p21.1
Cardiomyopathy, dilated, 3B	302045	BMD	300377	Xp21.2-p21.1
Cardiomyopathy, dilated, 3B	302045	CMD3B	300377	Xp21.2-p21.1
Cardiomyopathy, familial hypertrophic 17	613873	JPH2	605267	20q13.12
Cardiomyopathy, familial hypertrophic 17	613873	JP2	605267	20q13.12
Cardiomyopathy, familial hypertrophic 17	613873	CMH17	605267	20q13.12
Cardiomyopathy, familial hypertrophic 6	600858	PRKAG2	602743	7q36.1
Cardiomyopathy, familial hypertrophic 6	600858	WPWS	602743	7q36.1
Cardiomyopathy, familial hypertrophic 6	600858	CMH6	602743	7q36.1
Cardiomyopathy, familial hypertrophic, 1	192600	MYH7	160760	14q11.2
Cardiomyopathy, familial hypertrophic, 1	192600	CMH1	160760	14q11.2
Cardiomyopathy, familial hypertrophic, 1	192600	MPD1	160760	14q11.2
Cardiomyopathy, familial hypertrophic, 1	192600	CMD1S	160760	14q11.2
Cardiomyopathy, familial hypertrophic, 1	192600	SPMM	160760	14q11.2
Cardiomyopathy, familial hypertrophic, 1	192600	SPMD	160760	14q11.2
Cardiomyopathy, familial hypertrophic, 10	608758	MYL2	160781	12q24.11
Cardiomyopathy, familial hypertrophic, 10	608758	CMH10	160781	12q24.11
Cardiomyopathy, familial hypertrophic, 11	612098	ACTC1	102540	15q14
Cardiomyopathy, familial hypertrophic, 11	612098	CMD1R	102540	15q14
Cardiomyopathy, familial hypertrophic, 11	612098	CMH11	102540	15q14
Cardiomyopathy, familial hypertrophic, 11	612098	ASD5	102540	15q14
Cardiomyopathy, familial hypertrophic, 11	612098	LVNC4	102540	15q14
Cardiomyopathy, familial hypertrophic, 12	612124	CSRP3	600824	11p15.1
Cardiomyopathy, familial hypertrophic, 12	612124	CRP3	600824	11p15.1
Cardiomyopathy, familial hypertrophic, 12	612124	CLP	600824	11p15.1
Cardiomyopathy, familial hypertrophic, 12	612124	CMD1M	600824	11p15.1
Cardiomyopathy, familial hypertrophic, 12	612124	CMH12	600824	11p15.1
Cardiomyopathy, familial hypertrophic, 13	613243	TNNC1	191040	3p21.1
Cardiomyopathy, familial hypertrophic, 13	613243	CMD1Z	191040	3p21.1
Cardiomyopathy, familial hypertrophic, 13	613243	CMH13	191040	3p21.1
Cardiomyopathy, familial hypertrophic, 14	613251	MYH6	160710	14q11.2
Cardiomyopathy, familial hypertrophic, 14	613251	ASD3	160710	14q11.2
Cardiomyopathy, familial hypertrophic, 14	613251	MYHCA	160710	14q11.2
Cardiomyopathy, familial hypertrophic, 14	613251	CMD1EE	160710	14q11.2
Cardiomyopathy, familial hypertrophic, 14	613251	CMH14	160710	14q11.2
Cardiomyopathy, familial hypertrophic, 14	613251	SSS3	160710	14q11.2
Cardiomyopathy, familial hypertrophic, 15	613255	VCL	193065	10q22.2
Cardiomyopathy, familial hypertrophic, 15	613255	CMD1W	193065	10q22.2
Cardiomyopathy, familial hypertrophic, 15	613255	CMH15	193065	10q22.2
Cardiomyopathy, familial hypertrophic, 16	613838	MYOZ2	605602	4q26
Cardiomyopathy, familial hypertrophic, 16	613838	CMH16	605602	4q26
Cardiomyopathy, familial hypertrophic, 18	613874	PLN	172405	6q22.31
Cardiomyopathy, familial hypertrophic, 18	613874	PLB	172405	6q22.31
Cardiomyopathy, familial hypertrophic, 18	613874	CMD1P	172405	6q22.31
Cardiomyopathy, familial hypertrophic, 18	613874	CMH18	172405	6q22.31
Cardiomyopathy, familial hypertrophic, 19	613875	CALR3	611414	19p13.11
Cardiomyopathy, familial hypertrophic, 19	613875	CRT2	611414	19p13.11
Cardiomyopathy, familial hypertrophic, 19	613875	CMH19	611414	19p13.11
Cardiomyopathy, familial hypertrophic	192600	CAV3	601253	3p25.3
Cardiomyopathy, familial hypertrophic	192600	LGMD1C	601253	3p25.3
Cardiomyopathy, familial hypertrophic	192600	LQT9	601253	3p25.3
Cardiomyopathy, familial hypertrophic, 2	115195	TNNT2	191045	1q32.1
Cardiomyopathy, familial hypertrophic, 2	115195	CMH2	191045	1q32.1
Cardiomyopathy, familial hypertrophic, 2	115195	CMD1D	191045	1q32.1
Cardiomyopathy, familial hypertrophic, 2	115195	RCM3	191045	1q32.1
Cardiomyopathy, familial hypertrophic, 2	115195	LVNC6	191045	1q32.1
Cardiomyopathy, familial hypertrophic, 20	613876	NEXN	613121	1p31.1
Cardiomyopathy, familial hypertrophic, 20	613876	NELIN	613121	1p31.1
Cardiomyopathy, familial hypertrophic, 20	613876	CMD1CC	613121	1p31.1
Cardiomyopathy, familial hypertrophic, 20	613876	CMH20	613121	1p31.1
Cardiomyopathy, familial hypertrophic, 21	614676	CMH21		7p12.1-q21
Cardiomyopathy, familial hypertrophic, 3	115196	TPM1	191010	15q22.2
Cardiomyopathy, familial hypertrophic, 3	115196	CMH3	191010	15q22.2
Cardiomyopathy, familial hypertrophic, 3	115196	CMD1Y 	191010	15q22.2
Cardiomyopathy, familial hypertrophic, 3	115196	LVNC9	191010	15q22.2
Cardiomyopathy, familial hypertrophic, 4	115197	MYBPC3	600958	11p11.2
Cardiomyopathy, familial hypertrophic, 4	115197	CMH4	600958	11p11.2
Cardiomyopathy, familial hypertrophic, 4	115197	CMD1MM	600958	11p11.2
Cardiomyopathy, familial hypertrophic, 4	115197	LVNC10	600958	11p11.2
Cardiomyopathy, familial hypertrophic, 7	613690	TNNI3	191044	19q13.42
Cardiomyopathy, familial hypertrophic, 7	613690	CMH7	191044	19q13.42
Cardiomyopathy, familial hypertrophic, 7	613690	CMD2A	191044	19q13.42
Cardiomyopathy, familial hypertrophic, 7	613690	RCM1	191044	19q13.42
Cardiomyopathy, familial hypertrophic, 7	613690	CMD1FF	191044	19q13.42
Cardiomyopathy, familial hypertrophic, 8	608751	MYL3	160790	3p21.31
Cardiomyopathy, familial hypertrophic, 8	608751	CMH8	160790	3p21.31
Cardiomyopathy, familial hypertrophic, 9	613765	TTN	188840	2q31.2
Cardiomyopathy, familial hypertrophic, 9	613765	CMD1G	188840	2q31.2
Cardiomyopathy, familial hypertrophic, 9	613765	TMD	188840	2q31.2
Cardiomyopathy, familial hypertrophic, 9	613765	LGMD2J	188840	2q31.2
Cardiomyopathy, familial hypertrophic, 9	613765	MPRM	188840	2q31.2
Cardiomyopathy, familial hypertrophic, 9	613765	HMERF	188840	2q31.2
Cardiomyopathy, familial hypertrophic, 9	613765	EOMFC	188840	2q31.2
Cardiomyopathy, familial restrictive	115210	TNNI3	191044	19q13.42
Cardiomyopathy, familial restrictive	115210	CMH7	191044	19q13.42
Cardiomyopathy, familial restrictive	115210	CMD2A	191044	19q13.42
Cardiomyopathy, familial restrictive	115210	RCM1	191044	19q13.42
Cardiomyopathy, familial restrictive	115210	CMD1FF	191044	19q13.42
Cardiomyopathy, familial restrictive, 2	609578	RCM2		10q23.3
Cardiomyopathy, familial restrictive, 3	612422	TNNT2	191045	1q32.1
Cardiomyopathy, familial restrictive, 3	612422	CMH2	191045	1q32.1
Cardiomyopathy, familial restrictive, 3	612422	CMD1D	191045	1q32.1
Cardiomyopathy, familial restrictive, 3	612422	RCM3	191045	1q32.1
Cardiomyopathy, familial restrictive, 3	612422	LVNC6	191045	1q32.1
Cardiomyopathy, hypertrophic, midventricular, digenic	192600	MYLK2	606566	20q11.21
Cardiomyopathy, hypertrophic, midventricular, digenic	192600	MLCK	606566	20q11.21
Cardiomyopaty, familial restrictive 4	615248	MYPN	608517	10q21.3
Cardiomyopaty, familial restrictive 4	615248	CMD1DD	608517	10q21.3
Cardiomyopaty, familial restrictive 4	615248	CMH22	608517	10q21.3
Cardiomyopaty, familial restrictive 4	615248	RCM4	608517	10q21.3
Cardiomypathy, familial hypertrophic, 22	615248	MYPN	608517	10q21.3
Cardiomypathy, familial hypertrophic, 22	615248	CMD1DD	608517	10q21.3
Cardiomypathy, familial hypertrophic, 22	615248	CMH22	608517	10q21.3
Cardiomypathy, familial hypertrophic, 22	615248	RCM4	608517	10q21.3
Carney complex variant	608837	MYH8	160741	17p13.1
Carney complex, type 1	160980	PRKAR1A	188830	17q24.2
Carney complex, type 1	160980	TSE1	188830	17q24.2
Carney complex, type 1	160980	CNC1	188830	17q24.2
Carney complex, type 1	160980	CAR	188830	17q24.2
Carney complex, type 1	160980	PPNAD1	188830	17q24.2
Carney complex, type 1	160980	ACRDYS1	188830	17q24.2
Carney complex, type II	605244	CNC2		2p16
Carnitine deficiency, systemic primary	212140	SLC22A5	603377	5q31.1
Carnitine deficiency, systemic primary	212140	OCTN2	603377	5q31.1
Carnitine deficiency, systemic primary	212140	CDSP	603377	5q31.1
Carnitine deficiency, systemic primary	212140	SCD	603377	5q31.1
Carnitine-acylcarnitine translocase deficiency	212138	SLC25A20	613698	3p21.31
Carnitine-acylcarnitine translocase deficiency	212138	CACT	613698	3p21.31
Carnitine-acylcarnitine translocase deficiency	212138	CAC	613698	3p21.31
Carnosinemia	212200	CNSN		18q21.3
Carotid intimal medial thickness	608447	CIMT		12q24
Carotid intimal medial thickness 1	609338	PPARG	601487	3p25.2
Carotid intimal medial thickness 1	609338	PPARG1	601487	3p25.2
Carotid intimal medial thickness 1	609338	PPARG2	601487	3p25.2
Carotid intimal medial thickness 1	609338	CIMT1	601487	3p25.2
Carotid intimal medial thickness 1	609338	GLM1	601487	3p25.2
Carpal tunnel syndrome, familial	115430	TTR	176300	18q12.1
Carpal tunnel syndrome, familial	115430	PALB	176300	18q12.1
Carpenter syndrome 2	614976	MEGF8	604267	19q13.2
Carpenter syndrome 2	614976	EGFL4	604267	19q13.2
Carpenter syndrome 2	614976	CRPT2	604267	19q13.2
Carpenter syndrome	201000	RAB23	606144	6p11.2
Cartilage-hair hypoplasia	250250	RMRP	157660	9p13.3
Cartilage-hair hypoplasia	250250	RMRPR	157660	9p13.3
Cartilage-hair hypoplasia	250250	CHH	157660	9p13.3
Cat eye syndrome	115470	CECR		22q11
Cat eye syndrome	115470	CES		22q11
Cataract 1, multiple types	116200	GJA8	600897	1q21.2
Cataract 1, multiple types	116200	CX50	600897	1q21.2
Cataract 1, multiple types	116200	CTRCT1	600897	1q21.2
Cataract 1, multiple types	116200	CZP1	600897	1q21.2
Cataract 1, multiple types	116200	CAE1	600897	1q21.2
Cataract 10, multiple types	600881	CRYBA1	123610	17q11.2
Cataract 10, multiple types	600881	CRYB1	123610	17q11.2
Cataract 10, multiple types	600881	CTRCT10	123610	17q11.2
Cataract 11, multiple types	610623	PITX3	602669	10q24.32
Cataract 11, multiple types	610623	CTPP4	602669	10q24.32
Cataract 11, multiple types	610623	CTRCT11	602669	10q24.32
Cataract 11, syndromic	610623	PITX3	602669	10q24.32
Cataract 11, syndromic	610623	CTPP4	602669	10q24.32
Cataract 11, syndromic	610623	CTRCT11	602669	10q24.32
Cataract 12, multiple types	611597	BFSP2	603212	3q22.1
Cataract 12, multiple types	611597	CP49	603212	3q22.1
Cataract 12, multiple types	611597	CP47	603212	3q22.1
Cataract 12, multiple types	611597	CTRCT12	603212	3q22.1
Cataract 13 with adult i phenotype	110800	GCNT2	600429	6p24.3-p24.2
Cataract 13 with adult i phenotype	110800	Ii	600429	6p24.3-p24.2
Cataract 13 with adult i phenotype	110800	CTRCT13	600429	6p24.3-p24.2
Cataract 14, multiple types	601885	GJA3	121015	13q12.11
Cataract 14, multiple types	601885	CX46	121015	13q12.11
Cataract 14, multiple types	601885	CZP3	121015	13q12.11
Cataract 14, multiple types	601885	CAE3	121015	13q12.11
Cataract 14, multiple types	601885	CTRCT14	121015	13q12.11
Cataract 15, multiple types	615274	MIP	154050	12q13.3
Cataract 15, multiple types	615274	AQP0	154050	12q13.3
Cataract 15, multiple types	615274	CTRCT15	154050	12q13.3
Cataract 16, multiple types	613763	CRYAB	123590	11q23.1
Cataract 16, multiple types	613763	CRYA2	123590	11q23.1
Cataract 16, multiple types	613763	CTPP2	123590	11q23.1
Cataract 16, multiple types	613763	CMD1II	123590	11q23.1
Cataract 16, multiple types	613763	CTRCT16	123590	11q23.1
Cataract 16, multiple types	613763	MFM2	123590	11q23.1
Cataract 17, multiple types	611544	CRYBB1	600929	22q12.1
Cataract 17, multiple types	611544	CATCN3	600929	22q12.1
Cataract 17, multiple types	611544	CTRCT17	600929	22q12.1
Cataract 18, autosomal recessive	610019	FYCO1	607182	3p21.31
Cataract 18, autosomal recessive	610019	CATC2	607182	3p21.31
Cataract 18, autosomal recessive	610019	CTRCT18	607182	3p21.31
Cataract 19	615277	LIM2	154045	19q13.41
Cataract 19	615277	MP19	154045	19q13.41
Cataract 19	615277	CTRCT19	154045	19q13.41
Cataract 2, multiple types	604307	CRYGC	123680	2q33.3
Cataract 2, multiple types	604307	CRYG3	123680	2q33.3
Cataract 2, multiple types	604307	CTRCT2	123680	2q33.3
Cataract 2, multiple types	604307	CCL	123680	2q33.3
Cataract 20, multiple types	116100	CRYGS	123730	3q27.3
Cataract 20, multiple types	116100	CRYG8	123730	3q27.3
Cataract 20, multiple types	116100	CTRCT20	123730	3q27.3
Cataract 22, autosomal recessive	609741	CRYBB3	123630	22q11.23
Cataract 22, autosomal recessive	609741	CRYB3	123630	22q11.23
Cataract 22, autosomal recessive	609741	CATCN2	123630	22q11.23
Cataract 22, autosomal recessive	609741	CTRCT22	123630	22q11.23
Cataract 23	610425	CRYBA4	123631	22q12.1
Cataract 23	610425	CTRCT23	123631	22q12.1
Cataract 24, anterior polar	601202	CTRCT24		17p13
Cataract 24, anterior polar	601202	CTAA2		17p13
Cataract 25	605728	CTRCT25		15q21-q22
Cataract 25	605728	CCSSO		15q21-q22
Cataract 26, multiple types	605749	CTRCT26		9q13-q22
Cataract 26, multiple types	605749	CAAR		9q13-q22
Cataract 27, nuclear progressive	607304	CTRCT27		2p12
Cataract 27, nuclear progressive	607304	CCNP		2p12
Cataract 29, coralliform	115800	CTRCT29		2pter-p24
Cataract 3, multiple types	601547	CRYBB2	123620	22q11.23
Cataract 3, multiple types	601547	CRYB2	123620	22q11.23
Cataract 3, multiple types	601547	CTRCT3	123620	22q11.23
Cataract 3, multiple types	601547	CCA2	123620	22q11.23
Cataract 30, pulverulent	116300	VIM	193060	10p13
Cataract 30, pulverulent	116300	CTRCT30	193060	10p13
Cataract 31, multiple types	605387	CHMP4B	610897	20q11.22
Cataract 31, multiple types	605387	SNF7	610897	20q11.22
Cataract 31, multiple types	605387	CTPP3	610897	20q11.22
Cataract 31, multiple types	605387	CTRCT31	610897	20q11.22
Cataract 32, multiple types	115650	CTRCT32		14q22-q23
Cataract 32, multiple types	115650	CTAA1		14q22-q23
Cataract 32, multiple types	115650	CAP		14q22-q23
Cataract 32, multiple types	115650	CTPP5		14q22-q23
Cataract 33	611391	BFSP1	603307	20p12.1
Cataract 33	611391	CP115	603307	20p12.1
Cataract 33	611391	CTRCT33	603307	20p12.1
Cataract 34, multiple types	612968	CTRCT34		1p34.3-p32.2
Cataract 34, multiple types	612968	CATC3		1p34.3-p32.2
Cataract 35, congenital nuclear	609376	CTRCT35		19q13
Cataract 35, congenital nuclear	609376	CATCN1		19q13
Cataract 36	613887	TDRD7	611258	9q22.33
Cataract 36	613887	KIAA1529	611258	9q22.33
Cataract 36	613887	TRAP	611258	9q22.33
Cataract 36	613887	CATC4	611258	9q22.33
Cataract 36	613887	CTRCT36	611258	9q22.33
Cataract 37, autosomal dominant	614422	CTRCT37		12q24.2-q24.3
Cataract 37, autosomal dominant	614422	CCA5		12q24.2-q24.3
Cataract 38, autosomal recessive	614691	AGK	610345	7q34
Cataract 38, autosomal recessive	614691	MULK	610345	7q34
Cataract 38, autosomal recessive	614691	MTDPS10	610345	7q34
Cataract 38, autosomal recessive	614691	CATC5	610345	7q34
Cataract 38, autosomal recessive	614691	CTRCT38	610345	7q34
Cataract 39, multiple types, autosomal dominant	615188	CRYGB	123670	2q34
Cataract 39, multiple types, autosomal dominant	615188	CRYG2	123670	2q34
Cataract 39, multiple types, autosomal dominant	615188	CTRCT39	123670	2q34
Cataract 4, multiple types	115700	CRYGD	123690	2q33.3
Cataract 4, multiple types	115700	CRYG4	123690	2q33.3
Cataract 4, multiple types	115700	CTRCT4	123690	2q33.3
Cataract 4, multiple types	115700	CACA	123690	2q33.3
Cataract 4, multiple types	115700	CCA3	123690	2q33.3
Cataract 4, multiple types	115700	PCC	123690	2q33.3
Cataract 40, X-linked	302200	NHS	300457	Xp22.13
Cataract 40, X-linked	302200	CXN	300457	Xp22.13
Cataract 40, X-linked	302200	CTRCT40	300457	Xp22.13
Cataract 5, multiple types	116800	HSF4	602438	16q22.1
Cataract 5, multiple types	116800	CTM	602438	16q22.1
Cataract 5, multiple types	116800	CTRCT5	602438	16q22.1
Cataract 6, multiple types	116600	EPHA2	176946	1p36.13
Cataract 6, multiple types	116600	ECK	176946	1p36.13
Cataract 6, multiple types	116600	ARCC2	176946	1p36.13
Cataract 6, multiple types	116600	CTPP1	176946	1p36.13
Cataract 6, multiple types	116600	CTPA	176946	1p36.13
Cataract 6, multiple types	116600	ARCC2	176946	1p36.13
Cataract 6, multiple types	116600	CTRCT6	176946	1p36.13
Cataract 7	115660	CTRCT7		17q24
Cataract 7	115660	CCA1		17q24
Cataract 8, multiple types	115665	CTRCT8		1pter-p36.13
Cataract 8, multiple types	115665	CCV		1pter-p36.13
Cataract 9, multiple types	604219	CRYAA	123580	21q22.3
Cataract 9, multiple types	604219	CRYA1	123580	21q22.3
Cataract 9, multiple types	604219	CTRCT9	123580	21q22.3
Cataract with late-onset corneal dystrophy	106210	PAX6	607108	11p13
Cataract with late-onset corneal dystrophy	106210	AN2	607108	11p13
Cataract with late-onset corneal dystrophy	106210	MGDA	607108	11p13
Cataract, juvenile, with microcornea and glucosuria	612018	SLC16A12	611910	10q23.31
Cataract, juvenile, with microcornea and glucosuria	612018	MCT12	611910	10q23.31
Cataract, juvenile, with microcornea and glucosuria	612018	CJMG	611910	10q23.31
Cataract, pulverulent or cerulean, with or without microcornea	610202	MAF	177075	16q23.2
Cataract, pulverulent or cerulean, with or without microcornea	610202	CCA4	177075	16q23.2
Catel-Manzke syndrome	302380	CATMANS		Chr.X
Caudal duplication anomaly	607864	AXIN1	603816	16p13.3
Caudal duplication anomaly	607864	AXIN	603816	16p13.3
Caudal regression syndrome	600145	VANGL1	610132	1p13.1
Caudal regression syndrome	600145	STBM2	610132	1p13.1
Cavernous malformations of CNS and retina	116860	CCM1	604214	7q21.2
Cavernous malformations of CNS and retina	116860	CAM	604214	7q21.2
Cavernous malformations of CNS and retina	116860	KRIT1	604214	7q21.2
Cavitary optic disc anomalies	611543	CODA		12q
Cayler cardiofacial syndrome	125520	ACF		22q11
Cenani-Lenz syndactyly syndrome	212780	LRP4	604270	11p11.2
Cenani-Lenz syndactyly syndrome	212780	MEGF7	604270	11p11.2
Cenani-Lenz syndactyly syndrome	212780	CLSS	604270	11p11.2
Cenani-Lenz syndactyly syndrome	212780	SOST2	604270	11p11.2
Central core disease	117000	RYR1	180901	19q13.2
Central core disease	117000	MHS	180901	19q13.2
Central core disease	117000	CCO	180901	19q13.2
Central hypoventilation syndrome	209880	GDNF	600837	5p13.2
Central hypoventilation syndrome	209880	HSCR3	600837	5p13.2
Central hypoventilation syndrome, congenital	209880	ASCL1	100790	12q23.2
Central hypoventilation syndrome, congenital	209880	ASH1	100790	12q23.2
Central hypoventilation syndrome, congenital	209880	BDNF	113505	11p14.1
Central hypoventilation syndrome, congenital	209880	BULN2	113505	11p14.1
Central hypoventilation syndrome, congenital	209880	ANON2	113505	11p14.1
Central hypoventilation syndrome, congenital	209880	EDN3	131242	20q13.32
Central hypoventilation syndrome, congenital	209880	WS4B	131242	20q13.32
Central hypoventilation syndrome, congenital	209880	HSCR4	131242	20q13.32
Central hypoventilation syndrome, congenital	209880	RET	164761	10q11.21
Central hypoventilation syndrome, congenital	209880	MEN2A	164761	10q11.21
Central hypoventilation syndrome, congenital	209880	HSCR1	164761	10q11.21
Central hypoventilation syndrome, congenital, with or without Hirschsprung disease	209880	PMX2B	603851	4p13
Central hypoventilation syndrome, congenital, with or without Hirschsprung disease	209880	NBPHOX	603851	4p13
Central hypoventilation syndrome, congenital, with or without Hirschsprung disease	209880	PHOX2B	603851	4p13
Central hypoventilation syndrome, congenital, with or without Hirschsprung disease	209880	NBLST2	603851	4p13
Centrotemporal epilepsy	117100	ECT		11p13
Centrotemporal epilepsy	117100	BECTS		11p13
Cerebellar ataxia and hypogonadotropic hypogonadism	212840	RNF216	609948	7p22.1
Cerebellar ataxia and hypogonadotropic hypogonadism	212840	TRIAD3	609948	7p22.1
Cerebellar ataxia and hypogonadotropic hypogonadism	212840	ZIN	609948	7p22.1
Cerebellar ataxia and hypogonadotropic hypogonadism	212840	CAHH	609948	7p22.1
Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3	613227	CA8	114815	8q12.1
Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3	613227	CALS	114815	8q12.1
Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3	613227	CARP	114815	8q12.1
Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3	613227	CAMRQ3	114815	8q12.1
Cerebellar ataxia	604290	CP	117700	3q24-q25
Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	604121	DNMT1	126375	19p13.2
Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	604121	MCMT	126375	19p13.2
Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	604121	HSN1E	126375	19p13.2
Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant	604121	ADCADN	126375	19p13.2
Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	610185	WDR81	614218	17p13.3
Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2	610185	CAMRQ2	614218	17p13.3
Cerebellar ataxia, nonprogressive, with mental retardation	614756	CAMTA1	611501	1p36.31-p36.23
Cerebellar ataxia, nonprogressive, with mental retardation	614756	KIAA0833	611501	1p36.31-p36.23
Cerebellar ataxia, nonprogressive, with mental retardation	614756	CANPMR	611501	1p36.31-p36.23
Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1	224050	VLDLR	192977	9p24.2
Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1	224050	CARMQ1	192977	9p24.2
Cerebral amyloid angiopathy	105150	CST3	604312	20p11.21
Cerebral amyloid angiopathy	105150	ARMD11	604312	20p11.21
Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	605714	APP	104760	21q21.3
Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	605714	AAA	104760	21q21.3
Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	605714	CVAP	104760	21q21.3
Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants	605714	AD1	104760	21q21.3
Cerebral amyloid angiopathy, PRNP-related	137440	PRNP	176640	20p13
Cerebral amyloid angiopathy, PRNP-related	137440	PRIP	176640	20p13
Cerebral amyloid angiopathy, PRNP-related	137440	KURU	176640	20p13
Cerebral amyloid angiopathy, PRNP-related	137440	CJD	176640	20p13
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	125310	NOTCH3	600276	19p13.12
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	125310	CADASIL	600276	19p13.12
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	125310	CASIL	600276	19p13.12
Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy	125310	IMF2	600276	19p13.12
Cerebral cavernous malformations 3	603285	PDCD10	609118	3q26.1
Cerebral cavernous malformations 3	603285	TFAR15	609118	3q26.1
Cerebral cavernous malformations 3	603285	CCM3	609118	3q26.1
Cerebral cavernous malformations-1	116860	CCM1	604214	7q21.2
Cerebral cavernous malformations-1	116860	CAM	604214	7q21.2
Cerebral cavernous malformations-1	116860	KRIT1	604214	7q21.2
Cerebral cavernous malformations-2	603284	C7orf22	607929	7p13
Cerebral cavernous malformations-2	603284	CCM2	607929	7p13
Cerebral cavernous malformations-2	603284	MGC4067	607929	7p13
Cerebral creatine deficiency syndrome 1	300352	SLC6A8	300036	Xq28
Cerebral creatine deficiency syndrome 1	300352	CRTR	300036	Xq28
Cerebral creatine deficiency syndrome 1	300352	CCDS1	300036	Xq28
Cerebral creatine deficiency syndrome 2	612736	GAMT	601240	19p13.3
Cerebral creatine deficiency syndrome 2	612736	CCDS2	601240	19p13.3
Cerebral creatine deficiency syndrome 3	612718	GATM	602360	15q21.1
Cerebral creatine deficiency syndrome 3	612718	AGAT	602360	15q21.1
Cerebral creatine deficiency syndrome 3	612718	CCDS3	602360	15q21.1
Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	609528	SNAP29	604202	22q11.21
Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome	609528	CEDNIK	604202	22q11.21
Cerebral palsy, ataxic, autosomal recessive	605388	ACP		9p12-q12
Cerebral palsy, spastic quadriplegic, 1	603513	GAD1	605363	2q31.1
Cerebral palsy, spastic quadriplegic, 1	603513	SCP	605363	2q31.1
Cerebral palsy, spastic quadriplegic, 1	603513	CPSQ1	605363	2q31.1
Cerebral palsy, spastic quadriplegic, 2	612900	KANK1	607704	9p24.3
Cerebral palsy, spastic quadriplegic, 2	612900	KANK	607704	9p24.3
Cerebral palsy, spastic quadriplegic, 2	612900	ANKRD15	607704	9p24.3
Cerebral palsy, spastic quadriplegic, 2	612900	KIAA0172	607704	9p24.3
Cerebral palsy, spastic quadriplegic, 2	612900	CPSQ2	607704	9p24.3
Cerebral-cerebellar-coloboma syndrome, X-linked		CCCSX	300864	Chr.X
Cerebrooculofacioskeletal syndrome 1	214150	ERCC6	609413	10q11.23
Cerebrooculofacioskeletal syndrome 1	214150	CKN2	609413	10q11.23
Cerebrooculofacioskeletal syndrome 1	214150	COFS1	609413	10q11.23
Cerebrooculofacioskeletal syndrome 1	214150	CSB	609413	10q11.23
Cerebrooculofacioskeletal syndrome 1	214150	ARMD5	609413	10q11.23
Cerebrooculofacioskeletal syndrome 1	214150	UVSS1	609413	10q11.23
Cerebrooculofacioskeletal syndrome 2	610756	ERCC2	126340	19q13.32
Cerebrooculofacioskeletal syndrome 2	610756	EM9	126340	19q13.32
Cerebrooculofacioskeletal syndrome 2	610756	XPD	126340	19q13.32
Cerebrooculofacioskeletal syndrome 2	610756	COFS2	126340	19q13.32
Cerebrooculofacioskeletal syndrome 4	610758	ERCC1	126380	19q13.32
Cerebrooculofacioskeletal syndrome 4	610758	UV20	126380	19q13.32
Cerebrooculofacioskeletal syndrome 4	610758	COFS4	126380	19q13.32
Cerebroretinal microangiopathy with calcifications and cysts	612199	CTC1	613129	17p13.1
Cerebroretinal microangiopathy with calcifications and cysts	612199	CRMCC	613129	17p13.1
Cerebroretinal microangiopathy with calcifications and cysts	612199	C17orf68	613129	17p13.1
Cerebroretinal microangiopathy with calcifications and cysts	612199	AAF132	613129	17p13.1
Cerebrotendinous xanthomatosis	213700	CYP27A1	606530	2q35
Cerebrotendinous xanthomatosis	213700	CYP27	606530	2q35
Cerebrotendinous xanthomatosis	213700	CTX	606530	2q35
Cerebrovascular disease, occlusive		SERPINA3	107280	14q32.13
Cerebrovascular disease, occlusive		AACT	107280	14q32.13
Cerebrovascular disease, occlusive		ACT	107280	14q32.13
Ceroid lipofuscinosis, neuronal, 1	256730	PPT1	600722	1p34.2
Ceroid lipofuscinosis, neuronal, 1	256730	CLN1	600722	1p34.2
Ceroid lipofuscinosis, neuronal, 10	610127	CTSD	116840	11p15.5
Ceroid lipofuscinosis, neuronal, 10	610127	CPSD	116840	11p15.5
Ceroid lipofuscinosis, neuronal, 10	610127	CLN10	116840	11p15.5
Ceroid lipofuscinosis, neuronal, 11	614706	GRN	138945	17q21.31
Ceroid lipofuscinosis, neuronal, 11	614706	CLN11	138945	17q21.31
Ceroid lipofuscinosis, neuronal, 13, Kufs type	615362	CTSF	603539	11q13.2
Ceroid lipofuscinosis, neuronal, 13, Kufs type	615362	CLN13	603539	11q13.2
Ceroid lipofuscinosis, neuronal, 2	204500	TPP1	607998	11p15.4
Ceroid lipofuscinosis, neuronal, 2	204500	CLN2	607998	11p15.4
Ceroid lipofuscinosis, neuronal, 2	204500	SCAR7	607998	11p15.4
Ceroid lipofuscinosis, neuronal, 3	204200	CLN3	607042	16p11.2
Ceroid lipofuscinosis, neuronal, 3	204200	BTS	607042	16p11.2
Ceroid lipofuscinosis, neuronal, 4, Parry type	162350	DNAJC5	611203	20q13.33
Ceroid lipofuscinosis, neuronal, 4, Parry type	162350	DNAJC5A	611203	20q13.33
Ceroid lipofuscinosis, neuronal, 4, Parry type	162350	CSP	611203	20q13.33
Ceroid lipofuscinosis, neuronal, 4, Parry type	162350	CLN4B	611203	20q13.33
Ceroid lipofuscinosis, neuronal, 5	256731	CLN5	608102	13q22.3
Ceroid lipofuscinosis, neuronal, 6	601780	CLN6	606725	15q23
Ceroid lipofuscinosis, neuronal, 6	601780	CLN4A	606725	15q23
Ceroid lipofuscinosis, neuronal, 7	610951	MFSD8	611124	4q28.2
Ceroid lipofuscinosis, neuronal, 7	610951	MGC33302	611124	4q28.2
Ceroid lipofuscinosis, neuronal, 7	610951	CLN7	611124	4q28.2
Ceroid lipofuscinosis, neuronal, 8	600143	CLN8	607837	8p23.3
Ceroid lipofuscinosis, neuronal, 8	600143	EPMR	607837	8p23.3
Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant	610003	CLN8	607837	8p23.3
Ceroid lipofuscinosis, neuronal, 8, Northern epilepsy variant	610003	EPMR	607837	8p23.3
Ceroid lipofuscinosis, neuronal, Kufs type, adult onset	204300	CLN6	606725	15q23
Ceroid lipofuscinosis, neuronal, Kufs type, adult onset	204300	CLN4A	606725	15q23
Cervical cancer, somatic	603956	FGFR3	134934	4p16.3
Cervical cancer, somatic	603956	ACH	134934	4p16.3
Cervical carcinoma	191181	ST3		11q13
Chanarin-Dorfman syndrome	275630	ABHD5	604780	3p21.33
Chanarin-Dorfman syndrome	275630	CGI58	604780	3p21.33
Chanarin-Dorfman syndrome	275630	IECN2	604780	3p21.33
Chanarin-Dorfman syndrome	275630	NCIE2	604780	3p21.33
Char syndrome	169100	TFAP2B	601601	6p12.3
Char syndrome	169100	CHAR	601601	6p12.3
Charcot-Marie-Tooth disease, X-linked recessive, 5	311070	PRPS1	311850	Xq22.3
Charcot-Marie-Tooth disease, X-linked recessive, 5	311070	CMTX5	311850	Xq22.3
Charcot-Marie-Tooth disease, X-linked recessive, 5	311070	DFNX1	311850	Xq22.3
Charcot-Marie-Tooth disease, X-linked recessive, 5	311070	DFN2	311850	Xq22.3
Charcot-Marie-Tooth disease, axonal, type 20	614228	DYNC1H1	600112	14q32.31
Charcot-Marie-Tooth disease, axonal, type 20	614228	DNCL	600112	14q32.31
Charcot-Marie-Tooth disease, axonal, type 20	614228	DNECL	600112	14q32.31
Charcot-Marie-Tooth disease, axonal, type 20	614228	CMT20	600112	14q32.31
Charcot-Marie-Tooth disease, axonal, type 20	614228	MRD13	600112	14q32.31
Charcot-Marie-Tooth disease, axonal, type 20	614228	SMALED1	600112	14q32.31
Charcot-Marie-Tooth disease, axonal, type 2F	606595	HSPB1	602195	7q11.23
Charcot-Marie-Tooth disease, axonal, type 2F	606595	HSP27	602195	7q11.23
Charcot-Marie-Tooth disease, axonal, type 2F	606595	CMT2F	602195	7q11.23
Charcot-Marie-Tooth disease, axonal, type 2F	606595	HMN2B	602195	7q11.23
Charcot-Marie-Tooth disease, axonal, type 2G	608591	CMT2G		12q12-q13.3
Charcot-Marie-Tooth disease, axonal, type 2K	607831	GDAP1	606598	8q21.11
Charcot-Marie-Tooth disease, axonal, type 2K	607831	CMT4A	606598	8q21.11
Charcot-Marie-Tooth disease, axonal, type 2K	607831	CMT2K	606598	8q21.11
Charcot-Marie-Tooth disease, axonal, type 2K	607831	CMTRIA	606598	8q21.11
Charcot-Marie-Tooth disease, axonal, type 2L	608673	HSPB8	608014	12q24.23
Charcot-Marie-Tooth disease, axonal, type 2L	608673	H11	608014	12q24.23
Charcot-Marie-Tooth disease, axonal, type 2L	608673	E2IG1	608014	12q24.23
Charcot-Marie-Tooth disease, axonal, type 2L	608673	DHMN2	608014	12q24.23
Charcot-Marie-Tooth disease, axonal, type 2L	608673	CMT2L	608014	12q24.23
Charcot-Marie-Tooth disease, axonal, type 2L	608673	HMN2A	608014	12q24.23
Charcot-Marie-Tooth disease, axonal, type 2M	606482	DNM2	602378	19p13.2
Charcot-Marie-Tooth disease, axonal, type 2M	606482	CMTDIB	602378	19p13.2
Charcot-Marie-Tooth disease, axonal, type 2M	606482	CMTDI1	602378	19p13.2
Charcot-Marie-Tooth disease, axonal, type 2M	606482	CMT2M	602378	19p13.2
Charcot-Marie-Tooth disease, axonal, type 2M	606482	LCCS5	602378	19p13.2
Charcot-Marie-Tooth disease, axonal, type 2N	613287	AARS	601065	16q22.1
Charcot-Marie-Tooth disease, axonal, type 2N	613287	CMT2N	601065	16q22.1
Charcot-Marie-Tooth disease, axonal, type 2Q	615025	DHTKD1	614984	10p14
Charcot-Marie-Tooth disease, axonal, type 2Q	615025	KIAA1630	614984	10p14
Charcot-Marie-Tooth disease, axonal, type 2Q	615025	AMOXAD	614984	10p14
Charcot-Marie-Tooth disease, axonal, type 2Q	615025	CMT2Q	614984	10p14
Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	607706	GDAP1	606598	8q21.11
Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	607706	CMT4A	606598	8q21.11
Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	607706	CMT2K	606598	8q21.11
Charcot-Marie-Tooth disease, axonal, with vocal cord paresis	607706	CMTRIA	606598	8q21.11
Charcot-Marie-Tooth disease, dominant intermediate A	606483	CMTDIA		10q24.1-q25.1
Charcot-Marie-Tooth disease, dominant intermediate B	606482	DNM2	602378	19p13.2
Charcot-Marie-Tooth disease, dominant intermediate B	606482	CMTDIB	602378	19p13.2
Charcot-Marie-Tooth disease, dominant intermediate B	606482	CMTDI1	602378	19p13.2
Charcot-Marie-Tooth disease, dominant intermediate B	606482	CMT2M	602378	19p13.2
Charcot-Marie-Tooth disease, dominant intermediate B	606482	LCCS5	602378	19p13.2
Charcot-Marie-Tooth disease, dominant intermediate C	608323	YARS	603623	1p35.1
Charcot-Marie-Tooth disease, dominant intermediate C	608323	CMTDIC	603623	1p35.1
Charcot-Marie-Tooth disease, dominant intermediate C	608323	TYRRS	603623	1p35.1
Charcot-Marie-Tooth disease, dominant intermediate C	608323	YTS	603623	1p35.1
Charcot-Marie-Tooth disease, dominant intermediate C	608323	YRS	603623	1p35.1
Charcot-Marie-Tooth disease, dominant intermediate D	607791	MPZ	159440	1q23.3
Charcot-Marie-Tooth disease, dominant intermediate D	607791	CMT1B	159440	1q23.3
Charcot-Marie-Tooth disease, dominant intermediate D	607791	CMTDID	159440	1q23.3
Charcot-Marie-Tooth disease, dominant intermediate D	607791	CHM	159440	1q23.3
Charcot-Marie-Tooth disease, dominant intermediate D	607791	DSS	159440	1q23.3
Charcot-Marie-Tooth disease, dominant intermediate E	614455	INF2	610982	14q32.33
Charcot-Marie-Tooth disease, dominant intermediate E	614455	FSGS5	610982	14q32.33
Charcot-Marie-Tooth disease, dominant intermediate E	614455	C14orf173	610982	14q32.33
Charcot-Marie-Tooth disease, dominant intermediate E	614455	CMTDIE	610982	14q32.33
Charcot-Marie-Tooth disease, dominant intermediate F	615185	GNB4	610863	3q26.33
Charcot-Marie-Tooth disease, dominant intermediate F	615185	CMTD1F	610863	3q26.33
Charcot-Marie-Tooth disease, foot deformity of	192950	HOXD10	142984	2q31.1
Charcot-Marie-Tooth disease, foot deformity of	192950	HOX4D	142984	2q31.1
Charcot-Marie-Tooth disease, recessive intermediate C	615376	PLEKHG5	611101	1p36.31
Charcot-Marie-Tooth disease, recessive intermediate C	615376	KIAA0720	611101	1p36.31
Charcot-Marie-Tooth disease, recessive intermediate C	615376	DSMA4	611101	1p36.31
Charcot-Marie-Tooth disease, recessive intermediate C	615376	CMTRIC	611101	1p36.31
Charcot-Marie-Tooth disease, recessive intermediate, A	608340	GDAP1	606598	8q21.11
Charcot-Marie-Tooth disease, recessive intermediate, A	608340	CMT4A	606598	8q21.11
Charcot-Marie-Tooth disease, recessive intermediate, A	608340	CMT2K	606598	8q21.11
Charcot-Marie-Tooth disease, recessive intermediate, A	608340	CMTRIA	606598	8q21.11
Charcot-Marie-Tooth disease, recessive intermediate, B	613641	KARS	601421	16q23.1
Charcot-Marie-Tooth disease, recessive intermediate, B	613641	CMTRIB	601421	16q23.1
Charcot-Marie-Tooth disease, recessive intermediate, B	613641	DFNB89	601421	16q23.1
Charcot-Marie-Tooth disease, type 1A	118220	PMP22	601097	17p12
Charcot-Marie-Tooth disease, type 1A	118220	CMT1A	601097	17p12
Charcot-Marie-Tooth disease, type 1A	118220	CMT1E	601097	17p12
Charcot-Marie-Tooth disease, type 1A	118220	DSS	601097	17p12
Charcot-Marie-Tooth disease, type 1B	118200	MPZ	159440	1q23.3
Charcot-Marie-Tooth disease, type 1B	118200	CMT1B	159440	1q23.3
Charcot-Marie-Tooth disease, type 1B	118200	CMTDID	159440	1q23.3
Charcot-Marie-Tooth disease, type 1B	118200	CHM	159440	1q23.3
Charcot-Marie-Tooth disease, type 1B	118200	DSS	159440	1q23.3
Charcot-Marie-Tooth disease, type 1C	601098	LITAF	603795	16p13.13
Charcot-Marie-Tooth disease, type 1C	601098	CMT1C	603795	16p13.13
Charcot-Marie-Tooth disease, type 1D	607678	EGR2	129010	10q21.3
Charcot-Marie-Tooth disease, type 1D	607678	KROX20	129010	10q21.3
Charcot-Marie-Tooth disease, type 1E	118300	PMP22	601097	17p12
Charcot-Marie-Tooth disease, type 1E	118300	CMT1A	601097	17p12
Charcot-Marie-Tooth disease, type 1E	118300	CMT1E	601097	17p12
Charcot-Marie-Tooth disease, type 1E	118300	DSS	601097	17p12
Charcot-Marie-Tooth disease, type 1F	607734	NEFL	162280	8p21.2
Charcot-Marie-Tooth disease, type 1F	607734	CMT2E	162280	8p21.2
Charcot-Marie-Tooth disease, type 1F	607734	CMT1F	162280	8p21.2
Charcot-Marie-Tooth disease, type 2A1	118210	KIF1B	605995	1p36.22
Charcot-Marie-Tooth disease, type 2A1	118210	CMT2A	605995	1p36.22
Charcot-Marie-Tooth disease, type 2A1	118210	CMT2A1	605995	1p36.22
Charcot-Marie-Tooth disease, type 2A1	118210	NBLST1	605995	1p36.22
Charcot-Marie-Tooth disease, type 2A2	609260	MFN2	608507	1p36.22
Charcot-Marie-Tooth disease, type 2A2	609260	KIAA0214	608507	1p36.22
Charcot-Marie-Tooth disease, type 2A2	609260	CMT2A2	608507	1p36.22
Charcot-Marie-Tooth disease, type 2B	600882	RAB7	602298	3q21.3
Charcot-Marie-Tooth disease, type 2B	600882	CMT2B	602298	3q21.3
Charcot-Marie-Tooth disease, type 2B	600882	PSN	602298	3q21.3
Charcot-Marie-Tooth disease, type 2B1	605588	LMNA	150330	1q22
Charcot-Marie-Tooth disease, type 2B1	605588	LMN1	150330	1q22
Charcot-Marie-Tooth disease, type 2B1	605588	EMD2	150330	1q22
Charcot-Marie-Tooth disease, type 2B1	605588	FPLD2	150330	1q22
Charcot-Marie-Tooth disease, type 2B1	605588	CMD1A	150330	1q22
Charcot-Marie-Tooth disease, type 2B1	605588	HGPS	150330	1q22
Charcot-Marie-Tooth disease, type 2B1	605588	LGMD1B	150330	1q22
Charcot-Marie-Tooth disease, type 2B2	605589	MED25	610197	19q13.33
Charcot-Marie-Tooth disease, type 2B2	605589	PTOV2	610197	19q13.33
Charcot-Marie-Tooth disease, type 2B2	605589	ARC92	610197	19q13.33
Charcot-Marie-Tooth disease, type 2B2	605589	CMT2B2	610197	19q13.33
Charcot-Marie-Tooth disease, type 2D	601472	GARS	600287	7p14.3
Charcot-Marie-Tooth disease, type 2D	601472	SMAD1	600287	7p14.3
Charcot-Marie-Tooth disease, type 2D	601472	CMT2D	600287	7p14.3
Charcot-Marie-Tooth disease, type 2D	601472	HMN5	600287	7p14.3
Charcot-Marie-Tooth disease, type 2E	607684	NEFL	162280	8p21.2
Charcot-Marie-Tooth disease, type 2E	607684	CMT2E	162280	8p21.2
Charcot-Marie-Tooth disease, type 2E	607684	CMT1F	162280	8p21.2
Charcot-Marie-Tooth disease, type 2I	607677	MPZ	159440	1q23.3
Charcot-Marie-Tooth disease, type 2I	607677	CMT1B	159440	1q23.3
Charcot-Marie-Tooth disease, type 2I	607677	CMTDID	159440	1q23.3
Charcot-Marie-Tooth disease, type 2I	607677	CHM	159440	1q23.3
Charcot-Marie-Tooth disease, type 2I	607677	DSS	159440	1q23.3
Charcot-Marie-Tooth disease, type 2J	607736	MPZ	159440	1q23.3
Charcot-Marie-Tooth disease, type 2J	607736	CMT1B	159440	1q23.3
Charcot-Marie-Tooth disease, type 2J	607736	CMTDID	159440	1q23.3
Charcot-Marie-Tooth disease, type 2J	607736	CHM	159440	1q23.3
Charcot-Marie-Tooth disease, type 2J	607736	DSS	159440	1q23.3
Charcot-Marie-Tooth disease, type 4A	214400	GDAP1	606598	8q21.11
Charcot-Marie-Tooth disease, type 4A	214400	CMT4A	606598	8q21.11
Charcot-Marie-Tooth disease, type 4A	214400	CMT2K	606598	8q21.11
Charcot-Marie-Tooth disease, type 4A	214400	CMTRIA	606598	8q21.11
Charcot-Marie-Tooth disease, type 4B1	601382	MTMR2	603557	11q21
Charcot-Marie-Tooth disease, type 4B1	601382	CMT4B1	603557	11q21
Charcot-Marie-Tooth disease, type 4B2	604563	SBF2	607697	11p15.4
Charcot-Marie-Tooth disease, type 4B2	604563	MTMR13	607697	11p15.4
Charcot-Marie-Tooth disease, type 4B2	604563	CMT4B2	607697	11p15.4
Charcot-Marie-Tooth disease, type 4C	601596	SH3TC2	608206	5q32
Charcot-Marie-Tooth disease, type 4C	601596	KIAA1985	608206	5q32
Charcot-Marie-Tooth disease, type 4C	601596	MNMN	608206	5q32
Charcot-Marie-Tooth disease, type 4D	601455	NDRG1	605262	8q24.22
Charcot-Marie-Tooth disease, type 4D	601455	HMSNL	605262	8q24.22
Charcot-Marie-Tooth disease, type 4D	601455	CMT4D	605262	8q24.22
Charcot-Marie-Tooth disease, type 4F	614895	PRX	605725	19q13.2
Charcot-Marie-Tooth disease, type 4F	614895	CMT4F	605725	19q13.2
Charcot-Marie-Tooth disease, type 4H	609311	FGD4	611104	12p11.21
Charcot-Marie-Tooth disease, type 4H	609311	FRABIN	611104	12p11.21
Charcot-Marie-Tooth disease, type 4H	609311	CMT4H	611104	12p11.21
Charcot-Marie-Tooth disease, type 4J	611228	FIG4	609390	6q21
Charcot-Marie-Tooth disease, type 4J	611228	KIAA0274	609390	6q21
Charcot-Marie-Tooth disease, type 4J	611228	SAC3	609390	6q21
Charcot-Marie-Tooth disease, type 4J	611228	ALS11	609390	6q21
Charcot-Marie-Tooth disease, type 4J	611228	YVS	609390	6q21
Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	302800	GJB1	304040	Xq13.1
Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	302800	CX32	304040	Xq13.1
Charcot-Marie-Tooth neuropathy, X-linked dominant, 1	302800	CMTX1	304040	Xq13.1
Charcot-Marie-Tooth neuropathy, X-linked recessive, 2	302801	CMTX2		Xp22.2
Charcot-Marie-Tooth neuropathy, X-linked recessive, 3	302802	CMTX3		Xq26
Charcot-Marie-Toothe disease, axonal, type 2P	614436	LRSAM1	610933	9q33.3
Charcot-Marie-Toothe disease, axonal, type 2P	614436	TAL	610933	9q33.3
Charcot-Marie-Toothe disease, axonal, type 2P	614436	RIFLE	610933	9q33.3
Charcot-Marie-Toothe disease, axonal, type 2P	614436	CMT2P	610933	9q33.3
Chediak-Higashi syndrome	214500	CHS1	606897	1q42.3
Chediak-Higashi syndrome	214500	LYST	606897	1q42.3
Cherubism	118400	SH3BP2	602104	4p16.3
Cherubism	118400	CRPM	602104	4p16.3
Chilblain lupus 2	614415	SAMHD1	606754	20q11.23
Chilblain lupus 2	614415	AGS5	606754	20q11.23
Chilblain lupus 2	614415	DCIP	606754	20q11.23
Chilblain lupus 2	614415	CHBL2	606754	20q11.23
Chilblain lupus	610448	TREX1	606609	3p21.31
Chilblain lupus	610448	AGS1	606609	3p21.31
Chilblain lupus	610448	CRV	606609	3p21.31
Chilblain lupus	610448	HERNS	606609	3p21.31
Chloride diarrhea, congenital, Finnish type	214700	SLC26A3	126650	7q31.1
Chloride diarrhea, congenital, Finnish type	214700	DRA	126650	7q31.1
Chloride diarrhea, congenital, Finnish type	214700	CLD	126650	7q31.1
Choanal atresia and lymphedema	613611	PTPN14	603155	1q41
Choanal atresia and lymphedema	613611	PEZ	603155	1q41
Cholangitis, primary sclerosing	613806	PSC		3p21
Cholestasis, benign recurrent intrahepatic, 2	605479	ABCB11	603201	2q31.1
Cholestasis, benign recurrent intrahepatic, 2	605479	BSEP	603201	2q31.1
Cholestasis, benign recurrent intrahepatic, 2	605479	SPGP	603201	2q31.1
Cholestasis, benign recurrent intrahepatic, 2	605479	PFIC2	603201	2q31.1
Cholestasis, benign recurrent intrahepatic, 2	605479	BRIC2	603201	2q31.1
Cholestasis, benign recurrent intrahepatic	243300	ATP8B1	602397	18q21.31
Cholestasis, benign recurrent intrahepatic	243300	FIC1	602397	18q21.31
Cholestasis, benign recurrent intrahepatic	243300	BRIC	602397	18q21.31
Cholestasis, benign recurrent intrahepatic	243300	PFIC1	602397	18q21.31
Cholestasis, benign recurrent intrahepatic	243300	ICP1	602397	18q21.31
Cholestasis, intrahepatic, of pregnancy, 1	147480	ATP8B1	602397	18q21.31
Cholestasis, intrahepatic, of pregnancy, 1	147480	FIC1	602397	18q21.31
Cholestasis, intrahepatic, of pregnancy, 1	147480	BRIC	602397	18q21.31
Cholestasis, intrahepatic, of pregnancy, 1	147480	PFIC1	602397	18q21.31
Cholestasis, intrahepatic, of pregnancy, 1	147480	ICP1	602397	18q21.31
Cholestasis, intrahepatic, of pregnancy, 3	614972	ABCB4	171060	7q21.12
Cholestasis, intrahepatic, of pregnancy, 3	614972	PGY3	171060	7q21.12
Cholestasis, intrahepatic, of pregnancy, 3	614972	MDR3	171060	7q21.12
Cholestasis, intrahepatic, of pregnancy, 3	614972	ICP3	171060	7q21.12
Cholestasis, progressive canalicular		VIL1	193040	2q35
Cholestasis, progressive familial intrahepatic 1	211600	ATP8B1	602397	18q21.31
Cholestasis, progressive familial intrahepatic 1	211600	FIC1	602397	18q21.31
Cholestasis, progressive familial intrahepatic 1	211600	BRIC	602397	18q21.31
Cholestasis, progressive familial intrahepatic 1	211600	PFIC1	602397	18q21.31
Cholestasis, progressive familial intrahepatic 1	211600	ICP1	602397	18q21.31
Cholestasis, progressive familial intrahepatic 2	601847	ABCB11	603201	2q31.1
Cholestasis, progressive familial intrahepatic 2	601847	BSEP	603201	2q31.1
Cholestasis, progressive familial intrahepatic 2	601847	SPGP	603201	2q31.1
Cholestasis, progressive familial intrahepatic 2	601847	PFIC2	603201	2q31.1
Cholestasis, progressive familial intrahepatic 2	601847	BRIC2	603201	2q31.1
Cholestasis, progressive familial intrahepatic 3	602347	ABCB4	171060	7q21.12
Cholestasis, progressive familial intrahepatic 3	602347	PGY3	171060	7q21.12
Cholestasis, progressive familial intrahepatic 3	602347	MDR3	171060	7q21.12
Cholestasis, progressive familial intrahepatic 3	602347	ICP3	171060	7q21.12
Cholestasis-lymphedema syndrome	214900	LCS1		15q
Cholestasis-lymphedema syndrome	214900	CHLS		15q
Cholesteryl ester storage disease	278000	LIPA	613497	10q23.31
Cholesteryl ester storage disease	278000	CESD	613497	10q23.31
Chondrocalcinosis 2	118600	ANKH	605145	5p15.2
Chondrocalcinosis 2	118600	HANK	605145	5p15.2
Chondrocalcinosis 2	118600	ANK	605145	5p15.2
Chondrocalcinosis 2	118600	CMDJ	605145	5p15.2
Chondrocalcinosis 2	118600	CCAL2	605145	5p15.2
Chondrocalcinosis 2	118600	CPPDD	605145	5p15.2
Chondrocalcinosis with early-onset osteoarthritis	600668	CCAL1		8q
Chondrodysplasia punctata, X-linked dominant	302960	EBP	300205	Xp11.23
Chondrodysplasia punctata, X-linked dominant	302960	CDPX2	300205	Xp11.23
Chondrodysplasia punctata, X-linked dominant	302960	CPXD	300205	Xp11.23
Chondrodysplasia punctata, X-linked dominant	302960	CPX	300205	Xp11.23
Chondrodysplasia punctata, X-linked recessive	302950	ARSE	300180	Xp22.33
Chondrodysplasia punctata, X-linked recessive	302950	CDPX1	300180	Xp22.33
Chondrodysplasia punctata, X-linked recessive	302950	CDPXR	300180	Xp22.33
Chondrodysplasia punctata, rhizomelic, type 2	222765	GNPAT	602744	1q42.2
Chondrodysplasia punctata, rhizomelic, type 2	222765	DHAPAT	602744	1q42.2
Chondrodysplasia with joint dislocations, GRAPP type	614078	IMPAD1	614010	8q12.1
Chondrodysplasia with joint dislocations, GRAPP type	614078	GPAPP	614010	8q12.1
Chondrodysplasia with joint dislocations, GRAPP type	614078	IMPA3	614010	8q12.1
Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia	300863	HDAC6	300272	Xp11.23
Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia	300863	CPBHM	300272	Xp11.23
Chondrodysplasia, Blomstrand type	215045	PTHR1	168468	3p21.31
Chondrodysplasia, Blomstrand type	215045	PTHR	168468	3p21.31
Chondrodysplasia, Blomstrand type	215045	PFE	168468	3p21.31
Chondrodysplasia, Grebe type	200700	GDF5	601146	20q11.22
Chondrodysplasia, Grebe type	200700	CDMP1	601146	20q11.22
Chondrodysplasia, Grebe type	200700	SYNS2	601146	20q11.22
Chondrodysplasia, Grebe type	200700	OS5	601146	20q11.22
Chondrodysplasia, Grebe type	200700	BDA1C	601146	20q11.22
Chondrodysplasia, Grebe type	200700	SYM1B	601146	20q11.22
Chondrosarcoma	215300	EXT1	608177	8q24.11
Chondrosarcoma, extraskeletal myxoid	612237	TAF15	601574	17q12
Chondrosarcoma, extraskeletal myxoid	612237	TAF2N	601574	17q12
Chondrosarcoma, extraskeletal myxoid	612237	RBP56	601574	17q12
Chondrosarcoma, extraskeletal myxoid	612237	TFG	602498	3q12.2
Chondrosarcoma, extraskeletal myxoid	612237	HMSNP	602498	3q12.2
Chondrosarcoma, extraskeletal myxoid	612237	CSMF	600542	9q22.3-q31.1
Chorea, hereditary benign	118700	NKX2-1	600635	14q13.3
Chorea, hereditary benign	118700	TITF1	600635	14q13.3
Chorea, hereditary benign	118700	NKX2A	600635	14q13.3
Chorea, hereditary benign	118700	TTF1	600635	14q13.3
Choreoacanthocytosis	200150	VPS13A	605978	9q21.2
Choreoacanthocytosis	200150	CHAC	605978	9q21.2
Choreoathetosis, hypothyroidism, and neonatal respiratory distress	610978	NKX2-1	600635	14q13.3
Choreoathetosis, hypothyroidism, and neonatal respiratory distress	610978	TITF1	600635	14q13.3
Choreoathetosis, hypothyroidism, and neonatal respiratory distress	610978	NKX2A	600635	14q13.3
Choreoathetosis, hypothyroidism, and neonatal respiratory distress	610978	TTF1	600635	14q13.3
Choreoathetosis/spasticity, episodic	601042	CSE		1p
Choreoathetosis/spasticity, episodic	601042	DYT9		1p
Choriodal dystrophy, central areolar 2	613105	PRPH2	179605	6p21.1
Choriodal dystrophy, central areolar 2	613105	DS	179605	6p21.1
Choriodal dystrophy, central areolar 2	613105	RP7	179605	6p21.1
Choriodal dystrophy, central areolar 2	613105	PRPH	179605	6p21.1
Choriodal dystrophy, central areolar 2	613105	AVMD	179605	6p21.1
Choriodal dystrophy, central areolar 2	613105	AOFMD	179605	6p21.1
Choriodal dystrophy, central areolar 2	613105	CACD2	179605	6p21.1
Chorioretinal atrophy, progressive bifocal	600790	PBCRA		6q14-q16.2
Chorioretinal atrophy, progressive bifocal	600790	CRAPB		6q14-q16.2
Choroid plexus papilloma	260500	TP53	191170	17p13.1
Choroid plexus papilloma	260500	P53	191170	17p13.1
Choroid plexus papilloma	260500	LFS1 	191170	17p13.1
Choroid plexus papilloma	260500	BCC7	191170	17p13.1
Choroidal dystrophy, central areolar 1	215500	CACD1		17p
Choroideremia	303100	CHM	300390	Xq21.2
Choroideremia	303100	TCD	300390	Xq21.2
Choroideremia, deafness, and mental retardation	303110	DELXq21		Xq21
Choroideremia, deafness, and mental retardation	303110	CXDELq21		Xq21
Chromosome 10q23 deletion syndrome	612242	DEL10q23		10q23
Chromosome 10q23 deletion syndrome	612242	C10DELq23		10q23
Chromosome 10q26 deletion syndrome	609625	DEL10q26		10q26
Chromosome 10q26 deletion syndrome	609625	C10q26DEL		10q26
Chromosome 11p15-p14 deletion syndrome	606528	DEL11p15p14		11p15-p14
Chromosome 11p15-p14 deletion syndrome	606528	C11DELp15p14		11p15-p14
Chromosome 13q14 deletion syndrome	613884	DEL13q14		13q14
Chromosome 13q14 deletion syndrome	613884	C13DELq14		13q14
Chromosome 14q11-q22 deletion syndrome	613457	DEL14q11q22		14q11-q22
Chromosome 14q11-q22 deletion syndrome	613457	C14DELq11q22		14q11-q22
Chromosome 15q13.3 microdeletion syndrome	612001	DEL15q13.3		15q13.3
Chromosome 15q13.3 microdeletion syndrome	612001	MICRODEL15q13.3		15q13.3
Chromosome 15q24 deletion syndrome	613406	DEL15q24		15q24
Chromosome 15q24 deletion syndrome	613406	CHR15DELq24		15q24
Chromosome 15q25 deletion syndrome	614294	DEL15q25		15q25
Chromosome 15q25 deletion syndrome	614294	C15DELq25		15q25
Chromosome 15q26-qter deletion syndrome	612626	DEL15q26qter		15q26-qter
Chromosome 15q26-qter deletion syndrome	612626	C15DELq26qter		15q26-qter
Chromosome 16p11.2 deletion syndrome, 220kb	613444	BMIQ16		16p11.2
Chromosome 16p11.2 deletion syndrome, 220kb	613444	DEL16p.11.2		16p11.2
Chromosome 16p11.2 deletion syndrome, 220kb	613444	C16DELp11.2		16p11.2
Chromosome 16p11.2 deletion syndrome, 593kb	611913	DEL16p11.2		16p11.2
Chromosome 16p11.2 deletion syndrome, 593kb	611913	C16DELp11.2		16p11.2
Chromosome 16p11.2 deletion syndrome, 593kb	611913	AUTS14A		16p11.2
Chromosome 16p11.2 duplication syndrome	614671	DUP16p11.2		16p11.2
Chromosome 16p11.2 duplication syndrome	614671	C16DUPp11.2		16p11.2
Chromosome 16p11.2 duplication syndrome	614671	AUTS14B		16p11.2
Chromosome 16p12.1 deletion syndrome, 520kb	136570	DEL16p12.1		16p12
Chromosome 16p12.1 deletion syndrome, 520kb	136570	C16DELp12.1		16p12
Chromosome 16p12.2-p11.2 deletion syndrome	613604	DEL16p12.1p11.2		16p12.2-p11.2
Chromosome 16p12.2-p11.2 deletion syndrome	613604	C16DELp12.1p11.2		16p12.2-p11.2
Chromosome 16p13.3 deletion syndrome	610543	DEL16p13.3		16p13.3
Chromosome 16p13.3 deletion syndrome	610543	RSTSS		16p13.3
Chromosome 16p13.3 duplication syndrome	613458	DUP16p13.3		16p13.3
Chromosome 16p13.3 duplication syndrome	613458	C16DUPq13.3		16p13.3
Chromosome 16q22 deletion syndrome	614541	C16DELq22		16q22
Chromosome 16q22 deletion syndrome	614541	DEL16q22		16q22
Chromosome 17p13.1 deletion syndrome	613776	DEL17p13.1		17p13.1
Chromosome 17p13.1 deletion syndrome	613776	C17DELp13.1		17p13.1
Chromosome 17p13.3 duplication syndrome	613215	DUP17p13.3		17p13.3
Chromosome 17p13.3 duplication syndrome	613215	C17DUPp13.3		17p13.3
Chromosome 17q11.2 deletion syndrome, 1.4Mb	613675	DEL17q11.2		17q11.2
Chromosome 17q11.2 deletion syndrome, 1.4Mb	613675	C17DELq11.2		17q11.2
Chromosome 17q12 deletion syndrome	614527	DEL17q12		17q12
Chromosome 17q12 deletion syndrome	614527	C17DELq12		17q12
Chromosome 17q12 duplication syndrome	614526	DUP17q12		17q12
Chromosome 17q12 duplication syndrome	614526	C17DUPq12		17q12
Chromosome 17q21.31 duplication syndrome	613533	DUP17q21.31		17q21.31
Chromosome 17q21.31 duplication syndrome	613533	C17DUPq21.31		17q21.31
Chromosome 17q23.1-q23.2 deletion syndrome	613355	DEL17q23.1q23.2		17q23.1-q23.2
Chromosome 17q23.1-q23.2 deletion syndrome	613355	C17DELq23.1q23.2		17q23.1-q23.2
Chromosome 17q23.1-q23.2 duplication syndrome	613618	DUP17q23.1q23.2		17q23.1-q23.2
Chromosome 17q23.1-q23.2 duplication syndrome	613618	C17DUPq23.1q23.2		17q23.1-q23.2
Chromosome 18 pericentric inversion	609334	DUP18pDEL18q		18q22
Chromosome 18 pericentric inversion	609334	DUP81qDEL18p		18q22
Chromosome 18p deletion syndrome	146390	DEL18p		18p
Chromosome 18p deletion syndrome	146390	C18DELp		18p
Chromosome 18q deletion syndrome	601808	DEL18q		18q
Chromosome 19p13.13 deletion syndrome	613638	DEL19p13.13		19p13.13
Chromosome 19p13.13 deletion syndrome	613638	C19DELp13.13		19p13.13
Chromosome 19p13.13 deletion syndrome	613638	DUP19p13.13		19p13.13
Chromosome 19p13.13 deletion syndrome	613638	C19DUPp13.13		19p13.13
Chromosome 19p13.13 duplication syndrome	613638	DEL19p13.13		19p13.13
Chromosome 19p13.13 duplication syndrome	613638	C19DELp13.13		19p13.13
Chromosome 19p13.13 duplication syndrome	613638	DUP19p13.13		19p13.13
Chromosome 19p13.13 duplication syndrome	613638	C19DUPp13.13		19p13.13
Chromosome 19q13.11 deletion syndrome	613026	DEL19q13.11		19q13.11
Chromosome 19q13.11 deletion syndrome	613026	C19DELq13.11		19q13.11
Chromosome 1p32-p31 deletion syndrome	613735	DEL1p32p31		1p32-p31
Chromosome 1p32-p31 deletion syndrome	613735	C1DELp32p31		1p32-p31
Chromosome 1p36 deletion syndrome	607872	DEL1p36		1p36
Chromosome 1p36 deletion syndrome	607872	C1DELp36		1p36
Chromosome 1q21.1 deletion syndrome	612474	DEL1q21		1q21.1
Chromosome 1q21.1 deletion syndrome	612474	C1DELq21		1q21.1
Chromosome 1q21.1 duplication syndrome	612475	DUP1q21		1q21.1
Chromosome 1q21.1 duplication syndrome	612475	C1DUPq21		1q21.1
Chromosome 1q41-q42 deletion syndrome	612530	DEL1q41q42		1q41-q42
Chromosome 1q41-q42 deletion syndrome	612530	C1DELq41q42		1q41-q42
Chromosome 1q43-q44 deletion syndrome	612337	DEL1q43q44		1q43-q44
Chromosome 1q43-q44 deletion syndrome	612337	C1DELq43q44		1q43-q44
Chromosome 22q11.2 deletion syndrome, distal	611867	DEL22q11.2		22q11.2
Chromosome 22q11.2 deletion syndrome, distal	611867	C22DELq11.2		22q11.2
Chromosome 22q11.2 microduplication syndrome	608363	DUP22q11.2		22q11.2
Chromosome 22q13 duplication syndrome	615538	DUP22q13		22q13
Chromosome 22q13 duplication syndrome	615538	C22DUPq13		22q13
Chromosome 2p12-p11.2 deletion syndrome	613564	DEL2p12p11.2		2p12-p11.2
Chromosome 2p12-p11.2 deletion syndrome	613564	C2DELp12p11.2		2p12-p11.2
Chromosome 2p16.1-p15 deletion syndrome	612513	DEL2p16.1-p15		2p16.1-p15
Chromosome 2p16.1-p15 deletion syndrome	612513	C2DELp161-p15		2p16.1-p15
Chromosome 2q31.1 duplication syndrome	613681	DUP2q31.1		2q31.1
Chromosome 2q31.1 duplication syndrome	613681	C2DUPq31.1		2q31.1
Chromosome 2q31.2 deletion syndrome	612345	DEL2q31		2q31.2
Chromosome 3q13.31 deletion syndrome	615433	DEL3q13.31		3q13.31
Chromosome 3q13.31 deletion syndrome	615433	C13DELq13.31		3q13.31
Chromosome 3q29 microdeletion syndrome	609425	DEL3q29		3q29
Chromosome 3q29 microdeletion syndrome	609425	MICRODEL3q29		3q29
Chromosome 3q29 microduplication syndrome	611936	DUP3q29		3q29
Chromosome 3q29 microduplication syndrome	611936	MICRODUP3q29		3q29
Chromosome 4q21 deletion syndrome	613509	DEL4q21		4q21
Chromosome 4q21 deletion syndrome	613509	C4DELq21		4q21
Chromosome 4q32.1-q32.2 triplication syndrome	613603	TRIP4q32.1q32.2		4q32.1-q32.2
Chromosome 4q32.1-q32.2 triplication syndrome	613603	C4TRIPq32.1q32.2		4q32.1-q32.2
Chromosome 5p13 duplication syndrome	613174	DUP5p13		5p13
Chromosome 5p13 duplication syndrome	613174	C5DUPp13		5p13
Chromosome 5q14.3 deletion syndrome	613443	MEF2C	600662	5q14.3
Chromosome 5q14.3 deletion syndrome	613443	C5DELq14.3	600662	5q14.3
Chromosome 5q14.3 deletion syndrome	613443	DEL5q14.3	600662	5q14.3
Chromosome 6pter-p24 deletion syndrome	612582	DEL6pter		6pter-p24
Chromosome 6pter-p24 deletion syndrome	612582	C6DELpter		6pter-p24
Chromosome 6q11-q14 deletion syndrome	613544	DEL6q11q14		6q11-q14
Chromosome 6q11-q14 deletion syndrome	613544	C6DELq11q14		6q11-q14
Chromosome 6q25-q25 deletion syndrome	612863	DEL6q24q25		6q24-q25
Chromosome 6q25-q25 deletion syndrome	612863	C6DELq25q25		6q24-q25
Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb	613729	DEL7q11.23		7q11.23
Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb	613729	C7DELq11.23		7q11.23
Chromosome 7q11.23 duplication syndrome	609757	DUP7q11.23		7q11.23
Chromosome 7q11.23 duplication syndrome	609757	C7DUPq11.23		7q11.23
Chromosome 8p11 myeloproliferative syndrome	613523	SCLL		8p11
Chromosome 8q21.11 deletion syndrome	614230	DEL8q21.11		8q21.11
Chromosome 8q21.11 deletion syndrome	614230	C8DELq21.11		8q21.11
Chromosome 9p deletion syndrome	158170	DEL9p		9p
Chromosome 9p deletion syndrome	158170	C9DELp		9p
Chromosome Xp11.23-p11.22 duplication syndrome	300801	DUPXp11.23p11.22		Xp11.23-p11.22
Chromosome Xp11.23-p11.22 duplication syndrome	300801	CXDUPp11.23p11.22		Xp11.23-p11.22
Chromosome Xp11.3 deletion syndrome	300578	DELXp11.3		Xp11.3
Chromosome Xp11.3 deletion syndrome	300578	CXDELp11.3		Xp11.3
Chromosome Xp21 deletion syndrome	300679	DELXp21		Xp21
Chromosome Xp21 deletion syndrome	300679	CXDELp21		Xp21
Chromosome Xq27.3-q28 duplication syndrome	300869	DUPXq27.3q28		Xq27.3-q28
Chromosome Xq27.3-q28 duplication syndrome	300869	CXDUPq27.3q28		Xq27.3-q28
Chromosome Xq28 duplication syndrome	300815	DUPXq28		Xq28
Chromosome Xq28 duplication syndrome	300815	CXq28		Xq28
Chrondrodysplasia, acromesomelic, with genital anomalies	609441	BMPR1B	603248	4q22.3
Chrondrodysplasia, acromesomelic, with genital anomalies	609441	ALK6	603248	4q22.3
Chronic granulomatous disease due to deficiency of NCF-1	233700	NCF1	608512	7q11.23
Chronic granulomatous disease due to deficiency of NCF-2	233710	NCF2	608515	1q25.3
Chronic granulomatous disease, X-linked	306400	CYBB	300481	Xp11.4
Chronic granulomatous disease, X-linked	306400	CGD	300481	Xp11.4
Chronic granulomatous disease, X-linked	306400	AMCBX2	300481	Xp11.4
Chronic granulomatous disease, autosomal, due to deficiency of CYBA	233690	CYBA	608508	16q24.3
Chudley-McCullough syndrome	604213	GPSM2	609245	1p13.3
Chudley-McCullough syndrome	604213	LGN	609245	1p13.3
Chudley-McCullough syndrome	604213	PINS	609245	1p13.3
Chudley-McCullough syndrome	604213	DFNB82	609245	1p13.3
Chudley-McCullough syndrome	604213	CMCS	609245	1p13.3
Chylomicron retention disease	246700	SAR1B	607690	5q31.1
Chylomicron retention disease	246700	CMRD	607690	5q31.1
Chylomicron retention disease	246700	SARA2	607690	5q31.1
Chylomicron retention disease	246700	ANDD	607690	5q31.1
Ciliary dyskinesia, primary, 1, with or without situs inversus	244400	DNAI1	604366	9p13.3
Ciliary dyskinesia, primary, 1, with or without situs inversus	244400	CILD1	604366	9p13.3
Ciliary dyskinesia, primary, 1, with or without situs inversus	244400	ICS	604366	9p13.3
Ciliary dyskinesia, primary, 1, with or without situs inversus	244400	PCD	604366	9p13.3
Ciliary dyskinesia, primary, 10	612518	KTU	612517	14q21.3
Ciliary dyskinesia, primary, 10	612518	C14orf104	612517	14q21.3
Ciliary dyskinesia, primary, 10	612518	CILD10	612517	14q21.3
Ciliary dyskinesia, primary, 11	612649	RSPH4A	612647	6q22.1
Ciliary dyskinesia, primary, 11	612649	CILD11	612647	6q22.1
Ciliary dyskinesia, primary, 12	612650	RSPH9	612648	6p21.1
Ciliary dyskinesia, primary, 12	612650	CILD12	612648	6p21.1
Ciliary dyskinesia, primary, 13	613193	LRRC50	613190	16q23.3-q24.1
Ciliary dyskinesia, primary, 13	613193	ODA7	613190	16q23.3-q24.1
Ciliary dyskinesia, primary, 13	613193	CILD13	613190	16q23.3-q24.1
Ciliary dyskinesia, primary, 14	613807	CCDC39	613798	3q26.33
Ciliary dyskinesia, primary, 15	613808	CCDC40	613799	17q25.3
Ciliary dyskinesia, primary, 15	613808	KIAA1640	613799	17q25.3
Ciliary dyskinesia, primary, 16	614017	DNAL1	610062	14q24.3
Ciliary dyskinesia, primary, 16	614017	C14orf168	610062	14q24.3
Ciliary dyskinesia, primary, 16	614017	CILD16	610062	14q24.3
Ciliary dyskinesia, primary, 17	614679	CCDC103	614677	17q21.31
Ciliary dyskinesia, primary, 17	614679	SMH	614677	17q21.31
Ciliary dyskinesia, primary, 17	614679	PR46B	614677	17q21.31
Ciliary dyskinesia, primary, 17	614679	CILD17	614677	17q21.31
Ciliary dyskinesia, primary, 18	614874	HEATR2	614864	7p22.3
Ciliary dyskinesia, primary, 18	614874	CILD18	614864	7p22.3
Ciliary dyskinesia, primary, 19	614935	LRRC6	614930	8q24.22
Ciliary dyskinesia, primary, 19	614935	LRTP	614930	8q24.22
Ciliary dyskinesia, primary, 19	614935	CILD19	614930	8q24.22
Ciliary dyskinesia, primary, 2	606763	DNAAF3	614566	19q13.42
Ciliary dyskinesia, primary, 2	606763	PF22	614566	19q13.42
Ciliary dyskinesia, primary, 2	606763	DAB1	614566	19q13.42
Ciliary dyskinesia, primary, 2	606763	CILD2	614566	19q13.42
Ciliary dyskinesia, primary, 20	615067	CCDC114	615038	19q13.33
Ciliary dyskinesia, primary, 20	615067	CILD20	615038	19q13.33
Ciliary dyskinesia, primary, 21	615294	DRC1	615288	2p23.3
Ciliary dyskinesia, primary, 21	615294	CCDC164	615288	2p23.3
Ciliary dyskinesia, primary, 21	615294	C2orf39	615288	2p23.3
Ciliary dyskinesia, primary, 21	615294	CILD21	615288	2p23.3
Ciliary dyskinesia, primary, 22	615444	ZMYND10	607070	3p21.31
Ciliary dyskinesia, primary, 22	615444	BLU	607070	3p21.31
Ciliary dyskinesia, primary, 23	615451	ARMC4	615408	10p12.1
Ciliary dyskinesia, primary, 23	615451	CILD23	615408	10p12.1
Ciliary dyskinesia, primary, 24	615481	RSPH1	609314	21q22.3
Ciliary dyskinesia, primary, 24	615481	TSGA2	609314	21q22.3
Ciliary dyskinesia, primary, 24	615481	TSA2	609314	21q22.3
Ciliary dyskinesia, primary, 24	615481	CILD24	609314	21q22.3
Ciliary dyskinesia, primary, 25	615482	DYX1C1	608706	15q21.3
Ciliary dyskinesia, primary, 25	615482	DYXC1	608706	15q21.3
Ciliary dyskinesia, primary, 25	615482	DYX1	608706	15q21.3
Ciliary dyskinesia, primary, 25	615482	CILD25	608706	15q21.3
Ciliary dyskinesia, primary, 26	615500	C21ORF59	615494	21q22.11
Ciliary dyskinesia, primary, 26	615500	CILD26	615494	21q22.11
Ciliary dyskinesia, primary, 27	615504	CCDC65	611088	12q13.12
Ciliary dyskinesia, primary, 27	615504	CILD27	611088	12q13.12
Ciliary dyskinesia, primary, 28	615505	SPAG1	603395	8q22.2
Ciliary dyskinesia, primary, 28	615505	CILD28	603395	8q22.2
Ciliary dyskinesia, primary, 3, with or without situs inversus	608644	DNAH5	603335	5p15.2
Ciliary dyskinesia, primary, 3, with or without situs inversus	608644	HL1	603335	5p15.2
Ciliary dyskinesia, primary, 3, with or without situs inversus	608644	PCD	603335	5p15.2
Ciliary dyskinesia, primary, 3, with or without situs inversus	608644	CILD3	603335	5p15.2
Ciliary dyskinesia, primary, 4	608646	CILD4		15q13.1-q15.1
Ciliary dyskinesia, primary, 5	608647	HYDIN	610812	16q22.2
Ciliary dyskinesia, primary, 5	608647	HYDIN1	610812	16q22.2
Ciliary dyskinesia, primary, 5	608647	CILD5	610812	16q22.2
Ciliary dyskinesia, primary, 6	610852	NME8	607421	7p14.1
Ciliary dyskinesia, primary, 6	610852	TXNDC3	607421	7p14.1
Ciliary dyskinesia, primary, 6	610852	SPTRX2	607421	7p14.1
Ciliary dyskinesia, primary, 6	610852	CILD6	607421	7p14.1
Ciliary dyskinesia, primary, 7, with or without situs inversus	611884	DNAH11	603339	7p15.3
Ciliary dyskinesia, primary, 7, with or without situs inversus	611884	DNAHC11	603339	7p15.3
Ciliary dyskinesia, primary, 7, with or without situs inversus	611884	CILD7	603339	7p15.3
Ciliary dyskinesia, primary, 7, with or without situs inversus	611884	DNAHBL	603339	7p15.3
Ciliary dyskinesia, primary, 8	612274	CILD8		15q24-q25
Ciliary dyskinesia, primary, 9, with or without situs inversus	612444	DNAI2	605483	17q25.1
Ciliary dyskinesia, primary, 9, with or without situs inversus	612444	CILD9	605483	17q25.1
Cirrhosis due to liver phosphorylase kinase deficiency		PHKG2	172471	16p11.2
Cirrhosis due to liver phosphorylase kinase deficiency		GSD9C	172471	16p11.2
Cirrhosis, North American Indian childhood type	604901	CIRH1A	607456	16q22.1
Cirrhosis, North American Indian childhood type	604901	NAIC	607456	16q22.1
Cirrhosis, North American Indian childhood type	604901	TEX292	607456	16q22.1
Cirrhosis, North American Indian childhood type	604901	KIAA1988	607456	16q22.1
Cirrhosis, cryptogenic	215600	KRT18	148070	12q13.13
Cirrhosis, cryptogenic	215600	KRT8	148060	12q13.13
Citrullinemia	215700	ASS1	603470	9q34.11
Citrullinemia	215700	ASS	603470	9q34.11
Citrullinemia, adult-onset type II	603471	SLC25A13	603859	7q21.3
Citrullinemia, adult-onset type II	603471	CTLN2	603859	7q21.3
Citrullinemia, type II, neonatal-onset	605814	SLC25A13	603859	7q21.3
Citrullinemia, type II, neonatal-onset	605814	CTLN2	603859	7q21.3
Cleft lip/palate-ectodermal dysplasia syndrome	225060	HVEC	600644	11q23.3
Cleft lip/palate-ectodermal dysplasia syndrome	225060	PVRL1	600644	11q23.3
Cleft lip/palate-ectodermal dysplasia syndrome	225060	PVRR1	600644	11q23.3
Cleft lip/palate-ectodermal dysplasia syndrome	225060	PRR1	600644	11q23.3
Cleft lip/palate-ectodermal dysplasia syndrome	225060	ED4	600644	11q23.3
Cleft lip/palate-ectodermal dysplasia syndrome	225060	OFC7	600644	11q23.3
Cleft lip/palate-ectodermal dysplasia syndrome	225060	CLPED1	600644	11q23.3
Cleft palate with ankyloglossia	303400	TBX22	300307	Xq21.1
Cleft palate with ankyloglossia	303400	CPX	300307	Xq21.1
Cleft palate with ankyloglossia	303400	ABERS	300307	Xq21.1
Cleft palate, isolated	119540	UBB	191339	17p11.2
Cleidocranial dysplasia	119600	RUNX2	600211	6p21.1
Cleidocranial dysplasia	119600	CBFA1	600211	6p21.1
Cleidocranial dysplasia	119600	PEBP2A1	600211	6p21.1
Cleidocranial dysplasia	119600	AML3	600211	6p21.1
Cleidocranial dysplasia	119600	CCD	600211	6p21.1
Cleidocranial dysplasia	119600	CLCD	600211	6p21.1
Cleidocranial dysplasia, forme fruste, dental anomalies only	119600	RUNX2	600211	6p21.1
Cleidocranial dysplasia, forme fruste, dental anomalies only	119600	CBFA1	600211	6p21.1
Cleidocranial dysplasia, forme fruste, dental anomalies only	119600	PEBP2A1	600211	6p21.1
Cleidocranial dysplasia, forme fruste, dental anomalies only	119600	AML3	600211	6p21.1
Cleidocranial dysplasia, forme fruste, dental anomalies only	119600	CCD	600211	6p21.1
Cleidocranial dysplasia, forme fruste, dental anomalies only	119600	CLCD	600211	6p21.1
Cleidocranial dysplasia, forme fruste, with brachydactyly	119600	RUNX2	600211	6p21.1
Cleidocranial dysplasia, forme fruste, with brachydactyly	119600	CBFA1	600211	6p21.1
Cleidocranial dysplasia, forme fruste, with brachydactyly	119600	PEBP2A1	600211	6p21.1
Cleidocranial dysplasia, forme fruste, with brachydactyly	119600	AML3	600211	6p21.1
Cleidocranial dysplasia, forme fruste, with brachydactyly	119600	CCD	600211	6p21.1
Cleidocranial dysplasia, forme fruste, with brachydactyly	119600	CLCD	600211	6p21.1
Clopidogrel, impaired responsiveness to	609535	CYP2C	124020	10q23.33
Clopidogrel, impaired responsiveness to	609535	CYP2C19	124020	10q23.33
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800	PITX1	602149	5q31.1
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800	PTX1	602149	5q31.1
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800	BFT	602149	5q31.1
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800	POTX	602149	5q31.1
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800	CCF	602149	5q31.1
Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	119800	LBNBG	602149	5q31.1
Cockayne syndrome, type A	216400	ERCC8	609412	5q12.1
Cockayne syndrome, type A	216400	CKN1	609412	5q12.1
Cockayne syndrome, type A	216400	CSA	609412	5q12.1
Cockayne syndrome, type A	216400	UVSS2	609412	5q12.1
Cockayne syndrome, type B	133540	ERCC6	609413	10q11.23
Cockayne syndrome, type B	133540	CKN2	609413	10q11.23
Cockayne syndrome, type B	133540	COFS1	609413	10q11.23
Cockayne syndrome, type B	133540	CSB	609413	10q11.23
Cockayne syndrome, type B	133540	ARMD5	609413	10q11.23
Cockayne syndrome, type B	133540	UVSS1	609413	10q11.23
Cocoon syndrome	613630	CHUK	600664	10q24.31
Cocoon syndrome	613630	IKBKA	600664	10q24.31
Cocoon syndrome	613630	NFKBIKA	600664	10q24.31
Cocoon syndrome	613630	IKKA	600664	10q24.31
Cocoon syndrome	613630	IKK1	600664	10q24.31
Coenzyme Q10 deficiency, primary, 1	607426	COQ2	609825	4q21.23
Coenzyme Q10 deficiency, primary, 1	607426	COQ10D1	609825	4q21.23
Coenzyme Q10 deficiency, primary, 1	607426	MSA1	609825	4q21.23
Coenzyme Q10 deficiency, primary, 2	614651	PDSS1	607429	10p12.1
Coenzyme Q10 deficiency, primary, 2	614651	TPT	607429	10p12.1
Coenzyme Q10 deficiency, primary, 2	614651	COQ1	607429	10p12.1
Coenzyme Q10 deficiency, primary, 2	614651	COQ10D2	607429	10p12.1
Coenzyme Q10 deficiency, primary, 3	614652	PDSS2	610564	6q21
Coenzyme Q10 deficiency, primary, 3	614652	DLP1	610564	6q21
Coenzyme Q10 deficiency, primary, 3	614652	C6orf210	610564	6q21
Coenzyme Q10 deficiency, primary, 3	614652	COQ10D3	610564	6q21
Coenzyme Q10 deficiency, primary, 4	612016	CABC1	606980	1q42.13
Coenzyme Q10 deficiency, primary, 4	612016	COQ8	606980	1q42.13
Coenzyme Q10 deficiency, primary, 4	612016	ADCK3	606980	1q42.13
Coenzyme Q10 deficiency, primary, 4	612016	SCAR9	606980	1q42.13
Coenzyme Q10 deficiency, primary, 4	612016	ARCA2	606980	1q42.13
Coenzyme Q10 deficiency, primary, 4	612016	COQ10D4	606980	1q42.13
Coenzyme Q10 deficiency, primary, 5	614654	COQ9	612837	16q21
Coenzyme Q10 deficiency, primary, 5	614654	C16orf49	612837	16q21
Coenzyme Q10 deficiency, primary, 5	614654	COQ10D5	612837	16q21
Coenzyme Q10 deficiency, primary, 6	614650	COQ6	614647	14q24.3
Coenzyme Q10 deficiency, primary, 6	614650	CGI10	614647	14q24.3
Coenzyme Q10 deficiency, primary, 6	614650	COQ10D6	614647	14q24.3
Coffin-Lowry syndrome	303600	RPS6KA3	300075	Xp22.12
Coffin-Lowry syndrome	303600	RSK2	300075	Xp22.12
Coffin-Lowry syndrome	303600	MRX19	300075	Xp22.12
Cognitive impairment with or without cerebellar ataxia	614306	SCN8A	600702	12q13.13
Cognitive impairment with or without cerebellar ataxia	614306	CIAT	600702	12q13.13
Cognitive impairment with or without cerebellar ataxia	614306	EIEE13	600702	12q13.13
Cohen syndrome	216550	VPS13B	607817	8q22.2
Cohen syndrome	216550	KIAA0532	607817	8q22.2
Cohen syndrome	216550	COH1	607817	8q22.2
Cold-induced autoinflammatory syndrome, familial	120100	NLRP3	606416	1q44
Cold-induced autoinflammatory syndrome, familial	120100	CIAS1	606416	1q44
Cold-induced autoinflammatory syndrome, familial	120100	FCU	606416	1q44
Cold-induced autoinflammatory syndrome, familial	120100	FCAS	606416	1q44
Cold-induced autoinflammatory syndrome, familial	120100	NALP3	606416	1q44
Cold-induced autoinflammatory syndrome, familial	120100	PYPAF1	606416	1q44
Cold-induced sweating syndrome 1	610313	CLCF1	607672	11q13.2
Cold-induced sweating syndrome 1	610313	BSF3	607672	11q13.2
Cold-induced sweating syndrome 1	610313	CLC	607672	11q13.2
Cold-induced sweating syndrome	272430	CRLF1	604237	19p13.11
Cold-induced sweating syndrome	272430	CISS	604237	19p13.11
Cole disease	615522	ENPP1	173335	6q23.2
Cole disease	615522	PDNP1	173335	6q23.2
Cole disease	615522	NPPS	173335	6q23.2
Cole disease	615522	M6S1	173335	6q23.2
Cole disease	615522	PCA1	173335	6q23.2
Cole disease	615522	ARHR2	173335	6q23.2
Cole disease	615522	COLED	173335	6q23.2
Coloboma of optic nerve	120430	PAX6	607108	11p13
Coloboma of optic nerve	120430	AN2	607108	11p13
Coloboma of optic nerve	120430	MGDA	607108	11p13
Coloboma, ocular	120200	PAX6	607108	11p13
Coloboma, ocular	120200	AN2	607108	11p13
Coloboma, ocular	120200	MGDA	607108	11p13
Colon cancer, advanced		SRC	190090	20q11.23
Colon cancer, advanced		ASV	190090	20q11.23
Colon cancer, advanced		SRC1	190090	20q11.23
Colon cancer, somatic	114500	PTPN12	600079	7q11.23
Colon cancer, somatic	114500	PTPG1	600079	7q11.23
Colon cancer, somatic	114500	PTPRJ	600925	11p11.2
Colon cancer, somatic	114500	DEP1	600925	11p11.2
Colon cancer, somatic	114500	RAD54B	604289	8q22.1
Colorblindness, deutan	303800	OPN1MW	300821	Xq28
Colorblindness, deutan	303800	GCP	300821	Xq28
Colorblindness, deutan	303800	CBD	300821	Xq28
Colorblindness, deutan	303800	CBBM	300821	Xq28
Colorblindness, protan	303900	OPN1LW	300822	Xq28
Colorblindness, protan	303900	RCP	300822	Xq28
Colorblindness, protan	303900	CBP	300822	Xq28
Colorblindness, protan	303900	CBBM	300822	Xq28
Colorblindness, tritan	190900	OPN1SW	613522	7q32.1
Colorblindness, tritan	190900	BCP	613522	7q32.1
Colorblindness, tritan	190900	CBT	613522	7q32.1
Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas	132600	MUTYH	604933	1p34.1
Colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas	132600	MYH	604933	1p34.1
Colorectal cancer with chromosomal instability		BUB1	602452	2q13
Colorectal cancer	114500	BAX	600040	19q13.33
Colorectal cancer	114500	MCC	159350	5q22.2
Colorectal cancer	114500	TP53	191170	17p13.1
Colorectal cancer	114500	P53	191170	17p13.1
Colorectal cancer	114500	LFS1 	191170	17p13.1
Colorectal cancer	114500	BCC7	191170	17p13.1
Colorectal cancer, hereditary nonpolyposis, type 1	120435	MSH2	609309	2p21
Colorectal cancer, hereditary nonpolyposis, type 1	120435	COCA1	609309	2p21
Colorectal cancer, hereditary nonpolyposis, type 1	120435	FCC1	609309	2p21
Colorectal cancer, hereditary nonpolyposis, type 1	120435	HNPCC1	609309	2p21
Colorectal cancer, hereditary nonpolyposis, type 2	609310	MLH1	120436	3p22.2
Colorectal cancer, hereditary nonpolyposis, type 2	609310	COCA2	120436	3p22.2
Colorectal cancer, hereditary nonpolyposis, type 2	609310	HNPCC2	120436	3p22.2
Colorectal cancer, hereditary nonpolyposis, type 4	614337	PMS2	600259	7p22.1
Colorectal cancer, hereditary nonpolyposis, type 4	614337	PMSL2	600259	7p22.1
Colorectal cancer, hereditary nonpolyposis, type 4	614337	HNPCC4	600259	7p22.1
Colorectal cancer, hereditary nonpolyposis, type 5	614350	MSH6	600678	2p16.3
Colorectal cancer, hereditary nonpolyposis, type 5	614350	GTBP	600678	2p16.3
Colorectal cancer, hereditary nonpolyposis, type 5	614350	HNPCC5	600678	2p16.3
Colorectal cancer, hereditary nonpolyposis, type 6	614331	TGFBR2	190182	3p24.1
Colorectal cancer, hereditary nonpolyposis, type 6	614331	HNPCC6	190182	3p24.1
Colorectal cancer, hereditary nonpolyposis, type 6	614331	AAT3	190182	3p24.1
Colorectal cancer, hereditary nonpolyposis, type 6	614331	MFS2	190182	3p24.1
Colorectal cancer, hereditary nonpolyposis, type 6	614331	LDS1B	190182	3p24.1
Colorectal cancer, hereditary nonpolyposis, type 6	614331	LDS2B	190182	3p24.1
Colorectal cancer, hereditary nonpolyposis, type 7	614385	MLH3	604395	14q24.3
Colorectal cancer, hereditary nonpolyposis, type 7	614385	HNPCC7	604395	14q24.3
Colorectal cancer, hereditary nonpolyposis, type 8	613244	EPCAM	185535	2p21
Colorectal cancer, hereditary nonpolyposis, type 8	613244	ACSTD1	185535	2p21
Colorectal cancer, hereditary nonpolyposis, type 8	613244	TROP1	185535	2p21
Colorectal cancer, hereditary nonpolyposis, type 8	613244	M4S1	185535	2p21
Colorectal cancer, hereditary nonpolyposis, type 8	613244	MIC18	185535	2p21
Colorectal cancer, hereditary nonpolyposis, type 8	613244	DIAR5	185535	2p21
Colorectal cancer, hereditary nonpolyposis, type 8	613244	HNPCC8	185535	2p21
Colorectal cancer, somatic		BRAF	164757	7q34
Colorectal cancer, somatic		NS7	164757	7q34
Colorectal cancer, somatic		DLC1	604258	8p22
Colorectal cancer, somatic	114500	AKT1	164730	14q32.33
Colorectal cancer, somatic	114500	CWS6	164730	14q32.33
Colorectal cancer, somatic	114500	APC	611731	5q22.2
Colorectal cancer, somatic	114500	GS	611731	5q22.2
Colorectal cancer, somatic	114500	FPC	611731	5q22.2
Colorectal cancer, somatic	114500	BTPS2	611731	5q22.2
Colorectal cancer, somatic	114500	AXIN2	604025	17q24.1
Colorectal cancer, somatic	114500	ODCRCS	604025	17q24.1
Colorectal cancer, somatic	114500	BUB1B	602860	15q15.1
Colorectal cancer, somatic	114500	BUBR1	602860	15q15.1
Colorectal cancer, somatic	114500	MVA1	602860	15q15.1
Colorectal cancer, somatic	114500	CTNNB1	116806	3p22.1
Colorectal cancer, somatic	114500	MRD19	116806	3p22.1
Colorectal cancer, somatic	114500	DCC	120470	18q21.2
Colorectal cancer, somatic	114500	MRMV1	120470	18q21.2
Colorectal cancer, somatic	114500	EP300	602700	22q13.2
Colorectal cancer, somatic	114500	RSTS2	602700	22q13.2
Colorectal cancer, somatic	114500	FGFR3	134934	4p16.3
Colorectal cancer, somatic	114500	ACH	134934	4p16.3
Colorectal cancer, somatic	114500	FLCN	607273	17p11.2
Colorectal cancer, somatic	114500	BHD	607273	17p11.2
Colorectal cancer, somatic	114500	MLH3	604395	14q24.3
Colorectal cancer, somatic	114500	HNPCC7	604395	14q24.3
Colorectal cancer, somatic	114500	NRAS	164790	1p13.2
Colorectal cancer, somatic	114500	ALPS4	164790	1p13.2
Colorectal cancer, somatic	114500	NS6	164790	1p13.2
Colorectal cancer, somatic	114500	PDGFRL	604584	8p22
Colorectal cancer, somatic	114500	PDGRL	604584	8p22
Colorectal cancer, somatic	114500	PRLTS	604584	8p22
Colorectal cancer, somatic	114500	PIK3CA	171834	3q26.32
Colorectal cancer, somatic	114500	CLOVE	171834	3q26.32
Colorectal cancer, somatic	114500	MCAP	171834	3q26.32
Colorectal cancer, somatic	114500	MCM	171834	3q26.32
Colorectal cancer, somatic	114500	MCMTC	171834	3q26.32
Colorectal cancer, somatic	114500	CWS5	171834	3q26.32
Combined C6/C7 deficiency		C6	217050	5p13.1
Combined D-2- and L-2-hydroxyglutaric aciduria	615182	SLC25A1	190315	22q11.21
Combined D-2- and L-2-hydroxyglutaric aciduria	615182	SLC20A3	190315	22q11.21
Combined D-2- and L-2-hydroxyglutaric aciduria	615182	CTP	190315	22q11.21
Combined D-2- and L-2-hydroxyglutaric aciduria	615182	D2L2AD	190315	22q11.21
Combined SAP deficiency	611721	PSAP	176801	10q22.1
Combined SAP deficiency	611721	SAP1	176801	10q22.1
Combined cellular and humoral immune defects with granulomas	233650	RAG1	179615	11p12
Combined cellular and humoral immune defects with granulomas	233650	RAG2	179616	11p12
Combined factor V and VIII deficiency	227300	LMAN1	601567	18q21.32
Combined factor V and VIII deficiency	227300	ERGIC53	601567	18q21.32
Combined factor V and VIII deficiency	227300	F5F8D	601567	18q21.32
Combined factor V and VIII deficiency	227300	MCFD1	601567	18q21.32
Combined hyperlipidemia, familial	144250	LPL	609708	8p21.3
Combined hyperlipidemia, familial	144250	LIPD	609708	8p21.3
Combined hyperlipidemia, familial	144250	HDLCQ11	609708	8p21.3
Combined immunodeficiency, X-linked, moderate	312863	IL2RG	308380	Xq13.1
Combined immunodeficiency, X-linked, moderate	312863	SCIDX1	308380	Xq13.1
Combined immunodeficiency, X-linked, moderate	312863	SCIDX	308380	Xq13.1
Combined immunodeficiency, X-linked, moderate	312863	IMD4	308380	Xq13.1
Combined malonic and methylmalonic aciduria	614265	ACSF3	614245	16q24.3
Combined oxidative phosphorylation deficiency 1	609060	GFM1	606639	3q25.32
Combined oxidative phosphorylation deficiency 1	609060	EFG1	606639	3q25.32
Combined oxidative phosphorylation deficiency 1	609060	GFM	606639	3q25.32
Combined oxidative phosphorylation deficiency 1	609060	COXPD1	606639	3q25.32
Combined oxidative phosphorylation deficiency 10	614702	MTO1	614667	6q13
Combined oxidative phosphorylation deficiency 10	614702	COXPD10	614667	6q13
Combined oxidative phosphorylation deficiency 11	614922	RMND1	614917	6q25.1
Combined oxidative phosphorylation deficiency 11	614922	COXPD11	614917	6q25.1
Combined oxidative phosphorylation deficiency 12	614924	EARS2	612799	16p12.2
Combined oxidative phosphorylation deficiency 12	614924	KIAA1970	612799	16p12.2
Combined oxidative phosphorylation deficiency 12	614924	COXPD12	612799	16p12.2
Combined oxidative phosphorylation deficiency 13	614932	PNPT1	610316	2p16.1
Combined oxidative phosphorylation deficiency 13	614932	OLD35	610316	2p16.1
Combined oxidative phosphorylation deficiency 13	614932	COXPD13	610316	2p16.1
Combined oxidative phosphorylation deficiency 13	614932	DFNB70	610316	2p16.1
Combined oxidative phosphorylation deficiency 14	614946	FARS2	611592	6p25.1
Combined oxidative phosphorylation deficiency 14	614946	FARS1	611592	6p25.1
Combined oxidative phosphorylation deficiency 14	614946	COXPD14	611592	6p25.1
Combined oxidative phosphorylation deficiency 15	614947	MTFMT	611766	15q22.31
Combined oxidative phosphorylation deficiency 15	614947	COXPD15	611766	15q22.31
Combined oxidative phosphorylation deficiency 17	615440	ELAC2	605367	17p12
Combined oxidative phosphorylation deficiency 17	615440	HPC2	605367	17p12
Combined oxidative phosphorylation deficiency 17	615440	COXPD17	605367	17p12
Combined oxidative phosphorylation deficiency 18	615578	SFXN4	615564	10q26.11
Combined oxidative phosphorylation deficiency 18	615578	COXPD18	615564	10q26.11
Combined oxidative phosphorylation deficiency 2	610498	MRPS16	609204	10q22.2
Combined oxidative phosphorylation deficiency 2	610498	COXPD2	609204	10q22.2
Combined oxidative phosphorylation deficiency 3	610505	TSFM	604723	12q14.1
Combined oxidative phosphorylation deficiency 3	610505	COXPD3	604723	12q14.1
Combined oxidative phosphorylation deficiency 4	610678	TUFM	602389	16p11.2
Combined oxidative phosphorylation deficiency 4	610678	EFTU	602389	16p11.2
Combined oxidative phosphorylation deficiency 4	610678	COXPD4	602389	16p11.2
Combined oxidative phosphorylation deficiency 5	611719	MRPS22	605810	3q23
Combined oxidative phosphorylation deficiency 5	611719	C3orf5	605810	3q23
Combined oxidative phosphorylation deficiency 5	611719	COXPD5	605810	3q23
Combined oxidative phosphorylation deficiency 6	300816	AIFM1	300169	Xq26.1
Combined oxidative phosphorylation deficiency 6	300816	PDCD8	300169	Xq26.1
Combined oxidative phosphorylation deficiency 6	300816	AIF	300169	Xq26.1
Combined oxidative phosphorylation deficiency 6	300816	COXPD6	300169	Xq26.1
Combined oxidative phosphorylation deficiency 6	300816	COWCK	300169	Xq26.1
Combined oxidative phosphorylation deficiency 6	300816	CMTX4	300169	Xq26.1
Combined oxidative phosphorylation deficiency 7	613559	C12orf65	613541	12q24.31
Combined oxidative phosphorylation deficiency 7	613559	COXPD7	613541	12q24.31
Combined oxidative phosphorylation deficiency 7	613559	SPG55	613541	12q24.31
Combined oxidative phosphorylation deficiency 8	614096	AARS2	612035	6p21.1
Combined oxidative phosphorylation deficiency 8	614096	KIAA1270	612035	6p21.1
Combined oxidative phosphorylation deficiency 8	614096	MTALARS	612035	6p21.1
Combined oxidative phosphorylation deficiency 8	614096	COXPD8	612035	6p21.1
Combined oxidative phosphorylation deficiency 9	614582	MRPL3	607118	3q22.1
Combined oxidative phosphorylation deficiency 9	614582	MRL3	607118	3q22.1
Combined oxidative phosphorylation deficiency 9	614582	COXPD9	607118	3q22.1
Complement component 4, partial deficiency of	120790	C1NH	606860	11q12.1
Complement component 4, partial deficiency of	120790	HAE1	606860	11q12.1
Complement component 4, partial deficiency of	120790	HAE2	606860	11q12.1
Complement component 4, partial deficiency of	120790	SERPING1	606860	11q12.1
Complement factor D deficiency	613912	CFD	134350	19p13.3
Complement factor D deficiency	613912	ADN	134350	19p13.3
Complement factor H deficiency	609814	HF1	134370	1q31.3
Complement factor H deficiency	609814	CFH	134370	1q31.3
Complement factor H deficiency	609814	HUS	134370	1q31.3
Complement factor H deficiency	609814	ARMD4	134370	1q31.3
Complement factor H deficiency	609814	AHUS1	134370	1q31.3
Complement factor I deficiency	610984	CFI	217030	4q25
Complement factor I deficiency	610984	FI	217030	4q25
Complement factor I deficiency	610984	AHUS3	217030	4q25
Complement factor I deficiency	610984	ARMD13	217030	4q25
Complex I, mitochondrial respiratory chain, deficiency of	252010	NDUFS6	603848	5p15.33
Cone dystrophy 4	613093	PDE6C	600827	10q23.33
Cone dystrophy 4	613093	PDEA2	600827	10q23.33
Cone dystrophy 4	613093	COD4	600827	10q23.33
Cone dystrophy, progressive X-linked, 2	300085	COD2		Xq27
Cone dystrophy-3	602093	GUCA1A	600364	6p21.1
Cone dystrophy-3	602093	GCAP	600364	6p21.1
Cone dystrophy-3	602093	COD3	600364	6p21.1
Cone dystrophy-3	602093	CORD14	600364	6p21.1
Cone-rod dystrophy 10	610283	SEMA4A	607292	1q22
Cone-rod dystrophy 10	610283	SEMB	607292	1q22
Cone-rod dystrophy 10	610283	RP35	607292	1q22
Cone-rod dystrophy 10	610283	CORD10	607292	1q22
Cone-rod dystrophy 11	610381	RAXL1	610362	19p13.3
Cone-rod dystrophy 11	610381	QRX	610362	19p13.3
Cone-rod dystrophy 11	610381	CORD11	610362	19p13.3
Cone-rod dystrophy 11	610381	ARMD6	610362	19p13.3
Cone-rod dystrophy 12	612657	PROM1	604365	4p15.32
Cone-rod dystrophy 12	612657	PROML1	604365	4p15.32
Cone-rod dystrophy 12	612657	AC133	604365	4p15.32
Cone-rod dystrophy 12	612657	RP41	604365	4p15.32
Cone-rod dystrophy 12	612657	CORD12	604365	4p15.32
Cone-rod dystrophy 12	612657	CD133	604365	4p15.32
Cone-rod dystrophy 12	612657	MCDR2	604365	4p15.32
Cone-rod dystrophy 12	612657	STGD4	604365	4p15.32
Cone-rod dystrophy 13	608194	RPGRIP1	605446	14q11.2
Cone-rod dystrophy 13	608194	LCA6	605446	14q11.2
Cone-rod dystrophy 13	608194	CORD13	605446	14q11.2
Cone-rod dystrophy 14	602093	GUCA1A	600364	6p21.1
Cone-rod dystrophy 14	602093	GCAP	600364	6p21.1
Cone-rod dystrophy 14	602093	COD3	600364	6p21.1
Cone-rod dystrophy 14	602093	CORD14	600364	6p21.1
Cone-rod dystrophy 15	613660	CDHR1	609502	10q23.1
Cone-rod dystrophy 15	613660	PCDH21	609502	10q23.1
Cone-rod dystrophy 15	613660	PRCAD	609502	10q23.1
Cone-rod dystrophy 15	613660	CORD15	609502	10q23.1
Cone-rod dystrophy 15	613660	RP65	609502	10q23.1
Cone-rod dystrophy 16	614500	C8orf37	614477	8q22.1
Cone-rod dystrophy 16	614500	CORD16	614477	8q22.1
Cone-rod dystrophy 16	614500	RP64	614477	8q22.1
Cone-rod dystrophy 17	615163	CORD17		10q26
Cone-rod dystrophy 18	615374	RAB28	612994	4p15.33
Cone-rod dystrophy 18	615374	CORD18	612994	4p15.33
Cone-rod dystrophy 3	604116	ABCA4	601691	1p22.1
Cone-rod dystrophy 3	604116	ABCR	601691	1p22.1
Cone-rod dystrophy 3	604116	STGD1	601691	1p22.1
Cone-rod dystrophy 3	604116	FFM	601691	1p22.1
Cone-rod dystrophy 3	604116	RP19	601691	1p22.1
Cone-rod dystrophy 3	604116	CORD3	601691	1p22.1
Cone-rod dystrophy 3	604116	ARMD2	601691	1p22.1
Cone-rod dystrophy 5	600977	PITPNM3	608921	17p13.2
Cone-rod dystrophy 5	600977	NIR1	608921	17p13.2
Cone-rod dystrophy 5	600977	CORD5	608921	17p13.2
Cone-rod dystrophy 6	601777	GUCY2D	600179	17p13.1
Cone-rod dystrophy 6	601777	GUC2D	600179	17p13.1
Cone-rod dystrophy 6	601777	LCA1	600179	17p13.1
Cone-rod dystrophy 6	601777	CORD6	600179	17p13.1
Cone-rod dystrophy 6	601777	RCD2	600179	17p13.1
Cone-rod dystrophy 7	603649	RIMS1	606629	6q13
Cone-rod dystrophy 7	603649	RIM1	606629	6q13
Cone-rod dystrophy 7	603649	RIM	606629	6q13
Cone-rod dystrophy 7	603649	KIAA0340	606629	6q13
Cone-rod dystrophy 7	603649	CORD7	606629	6q13
Cone-rod dystrophy 8	605549	CORD8		1q12-q24
Cone-rod dystrophy 9	612775	ADAM9	602713	8p11.22
Cone-rod dystrophy 9	612775	MDC9	602713	8p11.22
Cone-rod dystrophy 9	612775	MCMP	602713	8p11.22
Cone-rod dystrophy 9	612775	CORD9	602713	8p11.22
Cone-rod dystrophy	604393	AIPL1	604392	17p13.2
Cone-rod dystrophy	604393	LCA4	604392	17p13.2
Cone-rod dystrophy, X-linked, 1	304020	RPGR	312610	Xp11.4
Cone-rod dystrophy, X-linked, 1	304020	RP3	312610	Xp11.4
Cone-rod dystrophy, X-linked, 1	304020	CRD	312610	Xp11.4
Cone-rod dystrophy, X-linked, 1	304020	RP15	312610	Xp11.4
Cone-rod dystrophy, X-linked, 1	304020	COD1	312610	Xp11.4
Cone-rod dystrophy, X-linked, 1	304020	CORDX1	312610	Xp11.4
Cone-rod dystropy, X-linked, 3	300476	CACNA1F	300110	Xp11.23
Cone-rod dystropy, X-linked, 3	300476	CSNB2	300110	Xp11.23
Cone-rod dystropy, X-linked, 3	300476	CORDX3	300110	Xp11.23
Cone-rod dystropy, X-linked, 3	300476	CSNB2A	300110	Xp11.23
Cone-rod dystropy, X-linked, 3	300476	AIED	300110	Xp11.23
Cone-rod dystropy, X-linked, 3	300476	OA2	300110	Xp11.23
Cone-rod retinal dystrophy-1	600624	CORD1		18q21.1-q21.3
Cone-rod retinal dystrophy-1	600624	CRD1		18q21.1-q21.3
Cone-rod retinal dystrophy-2	120970	CRX	602225	19q13.33
Cone-rod retinal dystrophy-2	120970	CORD2	602225	19q13.33
Cone-rod retinal dystrophy-2	120970	CRD	602225	19q13.33
Cone-rod retinal dystrophy-2	120970	LCA7	602225	19q13.33
Congenital bilateral absence of vas deferens	277180	CFTR	602421	7q31.2
Congenital bilateral absence of vas deferens	277180	ABCC7	602421	7q31.2
Congenital bilateral absence of vas deferens	277180	CF	602421	7q31.2
Congenital bilateral absence of vas deferens	277180	MRP7	602421	7q31.2
Congenital cataracts, facial dysmorphism, and neuropathy	604168	CTDP1	604927	18q23
Congenital cataracts, facial dysmorphism, and neuropathy	604168	FCP1	604927	18q23
Congenital cataracts, facial dysmorphism, and neuropathy	604168	CCFDN	604927	18q23
Congenital cataracts, hearing loss, and neurodegeneration	614482	SLC33A1	603690	3q25.31
Congenital cataracts, hearing loss, and neurodegeneration	614482	ACATN	603690	3q25.31
Congenital cataracts, hearing loss, and neurodegeneration	614482	AT1	603690	3q25.31
Congenital cataracts, hearing loss, and neurodegeneration	614482	SPG42	603690	3q25.31
Congenital cataracts, hearing loss, and neurodegeneration	614482	CCHLND	603690	3q25.31
Congenital disorder of glycosylation, type IIa	212066	MGAT2	602616	14q21.3
Congenital disorder of glycosylation, type IIa	212066	CDGS2	602616	14q21.3
Congenital disorder of glycosylation, type IIa	212066	CDG2A	602616	14q21.3
Congenital disorder of glycosylation, type IIb	606056	GCS1	601336	2p13.1
Congenital disorder of glycosylation, type IIb	606056	CDG2B	601336	2p13.1
Congenital disorder of glycosylation, type IIc	266265	SLC35C1	605881	11p11.2
Congenital disorder of glycosylation, type IIc	266265	FUCT1	605881	11p11.2
Congenital disorder of glycosylation, type IIc	266265	CDG2C	605881	11p11.2
Congenital disorder of glycosylation, type IId	607091	B4GALT1	137060	9p21.1
Congenital disorder of glycosylation, type IId	607091	GGTB2	137060	9p21.1
Congenital disorder of glycosylation, type IId	607091	GT1	137060	9p21.1
Congenital disorder of glycosylation, type IId	607091	GTB	137060	9p21.1
Congenital disorder of glycosylation, type IId	607091	CDG2D	137060	9p21.1
Congenital disorder of glycosylation, type IIe	608779	COG7	606978	16p12.2
Congenital disorder of glycosylation, type IIe	608779	CDG2E	606978	16p12.2
Congenital disorder of glycosylation, type IIf	603585	SLC35A1	605634	6q15
Congenital disorder of glycosylation, type IIf	603585	CST	605634	6q15
Congenital disorder of glycosylation, type IIf	603585	CDG2F	605634	6q15
Congenital disorder of glycosylation, type IIg	611209	COG1	606973	17q25.1
Congenital disorder of glycosylation, type IIg	611209	LDLB	606973	17q25.1
Congenital disorder of glycosylation, type IIg	611209	KIAA1381	606973	17q25.1
Congenital disorder of glycosylation, type IIg	611209	CDG2G	606973	17q25.1
Congenital disorder of glycosylation, type IIh	611182	COG8	606979	16q22.1
Congenital disorder of glycosylation, type IIh	611182	DOR1	606979	16q22.1
Congenital disorder of glycosylation, type IIh	611182	CDG2H	606979	16q22.1
Congenital disorder of glycosylation, type IIi	613612	COG5	606821	7q22.3
Congenital disorder of glycosylation, type IIi	613612	GOLTC1	606821	7q22.3
Congenital disorder of glycosylation, type IIi	613612	GTC90	606821	7q22.3
Congenital disorder of glycosylation, type IIi	613612	CDG2I	606821	7q22.3
Congenital disorder of glycosylation, type IIj	613489	COG4	606976	16q22.1
Congenital disorder of glycosylation, type IIj	613489	COD1	606976	16q22.1
Congenital disorder of glycosylation, type IIj	613489	CDG2J	606976	16q22.1
Congenital disorder of glycosylation, type IIk	614727	TMEM165	614726	4q12
Congenital disorder of glycosylation, type IIk	614727	FT27	614726	4q12
Congenital disorder of glycosylation, type IIk	614727	CDG2K	614726	4q12
Congenital disorder of glycosylation, type IIl	614576	COG6	606977	13q14.11
Congenital disorder of glycosylation, type IIl	614576	COD2	606977	13q14.11
Congenital disorder of glycosylation, type IIl	614576	KIAA1134	606977	13q14.11
Congenital disorder of glycosylation, type IIl	614576	CDG2L	606977	13q14.11
Congenital disorder of glycosylation, type IIl	614576	SHNS	606977	13q14.11
Congenital disorder of glycosylation, type IIm	300896	SLC35A2	314375	Xp11.23
Congenital disorder of glycosylation, type IIm	300896	UGALT	314375	Xp11.23
Congenital disorder of glycosylation, type IIm	300896	UGTL	314375	Xp11.23
Congenital disorder of glycosylation, type IIm	300896	UGT2	314375	Xp11.23
Congenital disorder of glycosylation, type IIm	300896	CDGX	314375	Xp11.23
Congenital disorder of glycosylation, type IIm	300896	CDG2M	314375	Xp11.23
Congenital disorder of glycosylation, type Ia	212065	PMM2	601785	16p13.2
Congenital disorder of glycosylation, type Ia	212065	CDG1A	601785	16p13.2
Congenital disorder of glycosylation, type Ib	602579	MPI	154550	15q24.1
Congenital disorder of glycosylation, type Ib	602579	PMI1	154550	15q24.1
Congenital disorder of glycosylation, type Ib	602579	CDG1B	154550	15q24.1
Congenital disorder of glycosylation, type Ic	603147	ALG6	604566	1p31.3
Congenital disorder of glycosylation, type Ic	603147	CDG1C	604566	1p31.3
Congenital disorder of glycosylation, type Id	601110	ALG3	608750	3q27.1
Congenital disorder of glycosylation, type Id	601110	NOT56L	608750	3q27.1
Congenital disorder of glycosylation, type Id	601110	CDGS4	608750	3q27.1
Congenital disorder of glycosylation, type Id	601110	CDG1D	608750	3q27.1
Congenital disorder of glycosylation, type Ie	608799	DPM1	603503	20q13.13
Congenital disorder of glycosylation, type Ie	608799	MPDS	603503	20q13.13
Congenital disorder of glycosylation, type Ie	608799	CDGIE	603503	20q13.13
Congenital disorder of glycosylation, type If	609180	MPDU1	604041	17p13.1
Congenital disorder of glycosylation, type If	609180	SL15	604041	17p13.1
Congenital disorder of glycosylation, type If	609180	CDGIF	604041	17p13.1
Congenital disorder of glycosylation, type Ig	607143	ALG12	607144	22q13.33
Congenital disorder of glycosylation, type Ig	607143	CDG1G	607144	22q13.33
Congenital disorder of glycosylation, type Ih	608104	ALG8	608103	11q14.1
Congenital disorder of glycosylation, type Ih	608104	CDG1H	608103	11q14.1
Congenital disorder of glycosylation, type Ii	607906	ALG2	607905	9q22.33
Congenital disorder of glycosylation, type Ii	607906	CDGII	607905	9q22.33
Congenital disorder of glycosylation, type Ij	608093	DPAGT1	191350	11q23.3
Congenital disorder of glycosylation, type Ij	608093	DPAGT2	191350	11q23.3
Congenital disorder of glycosylation, type Ij	608093	DGPT	191350	11q23.3
Congenital disorder of glycosylation, type Ij	608093	CDG1J	191350	11q23.3
Congenital disorder of glycosylation, type Ij	608093	CMSTA2	191350	11q23.3
Congenital disorder of glycosylation, type Ik	608540	ALG1	605907	16p13.3
Congenital disorder of glycosylation, type Ik	608540	HMAT1	605907	16p13.3
Congenital disorder of glycosylation, type Ik	608540	HMT1	605907	16p13.3
Congenital disorder of glycosylation, type Ik	608540	CDG1K	605907	16p13.3
Congenital disorder of glycosylation, type Il	608776	ALG9	606941	11q23.1
Congenital disorder of glycosylation, type Il	608776	DIBD1	606941	11q23.1
Congenital disorder of glycosylation, type Il	608776	CDG1L	606941	11q23.1
Congenital disorder of glycosylation, type Im	610768	TMEM15	610746	9q34.11
Congenital disorder of glycosylation, type Im	610768	DK1	610746	9q34.11
Congenital disorder of glycosylation, type Im	610768	SEC59	610746	9q34.11
Congenital disorder of glycosylation, type Im	610768	KIAA1094	610746	9q34.11
Congenital disorder of glycosylation, type Im	610768	CDG1M	610746	9q34.11
Congenital disorder of glycosylation, type In	612015	RFT1	611908	3p21.1
Congenital disorder of glycosylation, type In	612015	CDG1N	611908	3p21.1
Congenital disorder of glycosylation, type Io	612937	DPM3	605951	1q22
Congenital disorder of glycosylation, type Io	612937	CDG1O	605951	1q22
Congenital disorder of glycosylation, type Ip	613661	ALG11	613666	13q14.3
Congenital disorder of glycosylation, type Ip	613661	KIAA1266	613666	13q14.3
Congenital disorder of glycosylation, type Ip	613661	CDG1P	613666	13q14.3
Congenital disorder of glycosylation, type Iq	612379	SRD5A3	611715	4q12
Congenital disorder of glycosylation, type Iq	612379	SRD5A2L	611715	4q12
Congenital disorder of glycosylation, type Iq	612379	CDG1Q	611715	4q12
Congenital disorder of glycosylation, type Iq	612379	KRIZI	611715	4q12
Congenital disorder of glycosylation, type Ir	614507	DDOST	602202	1p36.12
Congenital disorder of glycosylation, type Ir	614507	OST	602202	1p36.12
Congenital disorder of glycosylation, type Ir	614507	OST48	602202	1p36.12
Congenital disorder of glycosylation, type Ir	614507	CDG1R	602202	1p36.12
Congenital disorder of glycosylation, type Is	300884	ALG13	300776	Xq23
Congenital disorder of glycosylation, type Is	300884	GLT28D1	300776	Xq23
Congenital disorder of glycosylation, type Is	300884	CDG1S	300776	Xq23
Congenital disorder of glycosylation, type It	614921	PGM1	171900	1p31.3
Congenital disorder of glycosylation, type It	614921	GSD14	171900	1p31.3
Congenital disorder of glycosylation, type It	614921	GSD14	171900	1p31.3
Congenital disorder of glycosylation, type It	614921	CDG1T	171900	1p31.3
Congenital disorder of glycosylation, type Iu	615042	DPM2	603564	9q34.11
Congenital disorder of glycosylation, type Iu	615042	CDG1U	603564	9q34.11
Congenital heart defects, multiple types, 3	614954	CHDT3		9q31.1
Congenital heart defects, nonsyndromic, 1, X-linked	306955	ZIC3	300265	Xq26.3
Congenital heart defects, nonsyndromic, 1, X-linked	306955	HTX1	300265	Xq26.3
Congenital heart defects, nonsyndromic, 1, X-linked	306955	HTX	300265	Xq26.3
Congenital heart defects, nonsyndromic, 1, X-linked	306955	VACTERLX	300265	Xq26.3
Congenital heart defects, nonsyndromic, 2	614980	TAB2	605101	6q25.1
Congenital heart defects, nonsyndromic, 2	614980	MAP3K7IP2	605101	6q25.1
Congenital heart defects, nonsyndromic, 2	614980	KIAA0733	605101	6q25.1
Congenital heart defects, nonsyndromic, 2	614980	CHTD2	605101	6q25.1
Congenital myopathy with excess of muscle spindles	218040	HRAS	190020	11p15.5
Congenital short bowel syndrome	300048	FLNA	300017	Xq28
Congenital short bowel syndrome	300048	FLN1	300017	Xq28
Congenital short bowel syndrome	300048	NHBP	300017	Xq28
Congenital short bowel syndrome	300048	OPD1	300017	Xq28
Congenital short bowel syndrome	300048	OPD2	300017	Xq28
Congenital short bowel syndrome	300048	FMD	300017	Xq28
Congenital short bowel syndrome	300048	MNS	300017	Xq28
Congenital short bowel syndrome	300048	CVD1	300017	Xq28
Congenital short bowel syndrome	300048	CSBS	300017	Xq28
Congenital short bowel syndrome	615237	CLMP	611693	11q24.1
Congenital short bowel syndrome	615237	ASAM	611693	11q24.1
Congenital short bowel syndrome	615237	ACAM	611693	11q24.1
Congenital short bowel syndrome	615237	CSBS	611693	11q24.1
Conjunctivitis, ligneous	217090	PLG	173350	6q26
Conotruncal anomaly face syndrome	217095	TBX1	602054	22q11.21
Conotruncal anomaly face syndrome	217095	DGS	602054	22q11.21
Conotruncal anomaly face syndrome	217095	CTHM	602054	22q11.21
Conotruncal anomaly face syndrome	217095	CAFS	602054	22q11.21
Conotruncal anomaly face syndrome	217095	TGA	602054	22q11.21
Conotruncal anomaly face syndrome	217095	DORV	602054	22q11.21
Conotruncal anomaly face syndrome	217095	VCFS	602054	22q11.21
Conotruncal anomaly face syndrome	217095	DGCR	602054	22q11.21
Conotruncal heart malformations, variable	217095	NKX2-5	600584	5q35.1
Conotruncal heart malformations, variable	217095	NKX2E	600584	5q35.1
Conotruncal heart malformations, variable	217095	CSX	600584	5q35.1
Conotruncal heart malformations, variable	217095	CHNG5	600584	5q35.1
Conotruncal heart malformations, variable	217095	VSD3	600584	5q35.1
Conotruncal heart malformations, variable	217095	HLHS2	600584	5q35.1
Contractural arachnodactyly, congenital	121050	FBN2	612570	5q23.3
Contractural arachnodactyly, congenital	121050	CCA	612570	5q23.3
Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	PRRT2	614386	16p11.2
Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	PKC	614386	16p11.2
Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	DYT10	614386	16p11.2
Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	EKD1	614386	16p11.2
Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	BFIS2	614386	16p11.2
Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	BFIC2	614386	16p11.2
Convulsions, familial infantile, with paroxysmal choreoathetosis	602066	ICCA	614386	16p11.2
Coproporphyria	121300	CPOX	612732	3q11.2-q12.1
Cornea plana congenita, recessive	217300	KERA	603288	12q21.33
Cornea plana congenita, recessive	217300	CNA2	603288	12q21.33
Corneal clouding, autosomal recessive	107680	APOA1		11q23.3
Corneal dystrophy polymorphous posterior, 2	609140	COL8A2	120252	1p34.3
Corneal dystrophy polymorphous posterior, 2	609140	FECD1	120252	1p34.3
Corneal dystrophy polymorphous posterior, 2	609140	PPCD2	120252	1p34.3
Corneal dystrophy, Avellino type	607541	TGFBI	601692	5q31.1
Corneal dystrophy, Avellino type	607541	CSD2	601692	5q31.1
Corneal dystrophy, Avellino type	607541	CDGG1	601692	5q31.1
Corneal dystrophy, Avellino type	607541	CSD	601692	5q31.1
Corneal dystrophy, Avellino type	607541	BIGH3	601692	5q31.1
Corneal dystrophy, Avellino type	607541	CDG2	601692	5q31.1
Corneal dystrophy, Avellino type	607541	EBMD	601692	5q31.1
Corneal dystrophy, Fuchs endothelial, 1	136800	COL8A2	120252	1p34.3
Corneal dystrophy, Fuchs endothelial, 1	136800	FECD1	120252	1p34.3
Corneal dystrophy, Fuchs endothelial, 1	136800	PPCD2	120252	1p34.3
Corneal dystrophy, Fuchs endothelial, 2	610158	FECD2		13pter-q12.13
Corneal dystrophy, Fuchs endothelial, 2	610158	FCD1		13pter-q12.13
Corneal dystrophy, Fuchs endothelial, 3	613267	FECD3		18q21.2-q21.3
Corneal dystrophy, Fuchs endothelial, 3	613267	FCD2		18q21.2-q21.3
Corneal dystrophy, Fuchs endothelial, 4	613268	SLC4A11	610206	20p13
Corneal dystrophy, Fuchs endothelial, 4	613268	BTR1	610206	20p13
Corneal dystrophy, Fuchs endothelial, 4	613268	NABC1	610206	20p13
Corneal dystrophy, Fuchs endothelial, 4	613268	CHED2	610206	20p13
Corneal dystrophy, Fuchs endothelial, 4	613268	CDPD	610206	20p13
Corneal dystrophy, Fuchs endothelial, 4	613268	FECD4	610206	20p13
Corneal dystrophy, Fuchs endothelial, 5	613269	FECD5		5q33.1-q35.2
Corneal dystrophy, Fuchs endothelial, 5	613269	FCD3		5q33.1-q35.2
Corneal dystrophy, Fuchs endothelial, 6	613270	ZEB1	189909	10p11.22
Corneal dystrophy, Fuchs endothelial, 6	613270	TCF8	189909	10p11.22
Corneal dystrophy, Fuchs endothelial, 6	613270	NIL2A	189909	10p11.22
Corneal dystrophy, Fuchs endothelial, 6	613270	PPCD3	189909	10p11.22
Corneal dystrophy, Fuchs endothelial, 6	613270	FECD6	189909	10p11.22
Corneal dystrophy, Fuchs endothelial, 7	613271	FECD7		9p24.1-p22.1
Corneal dystrophy, Fuchs endothelial, 7	613271	FCD4		9p24.1-p22.1
Corneal dystrophy, Fuchs endothelial, 8	615523	AGBL1	615496	15q25.3
Corneal dystrophy, Fuchs endothelial, 8	615523	CCP4	615496	15q25.3
Corneal dystrophy, Fuchs endothelial, 8	615523	FECD8	615496	15q25.3
Corneal dystrophy, Groenouw type I	121900	TGFBI	601692	5q31.1
Corneal dystrophy, Groenouw type I	121900	CSD2	601692	5q31.1
Corneal dystrophy, Groenouw type I	121900	CDGG1	601692	5q31.1
Corneal dystrophy, Groenouw type I	121900	CSD	601692	5q31.1
Corneal dystrophy, Groenouw type I	121900	BIGH3	601692	5q31.1
Corneal dystrophy, Groenouw type I	121900	CDG2	601692	5q31.1
Corneal dystrophy, Groenouw type I	121900	EBMD	601692	5q31.1
Corneal dystrophy, Lisch epithelial	300778	LECD		Xp22.3
Corneal dystrophy, Reis-Bucklers type	608470	TGFBI	601692	5q31.1
Corneal dystrophy, Reis-Bucklers type	608470	CSD2	601692	5q31.1
Corneal dystrophy, Reis-Bucklers type	608470	CDGG1	601692	5q31.1
Corneal dystrophy, Reis-Bucklers type	608470	CSD	601692	5q31.1
Corneal dystrophy, Reis-Bucklers type	608470	BIGH3	601692	5q31.1
Corneal dystrophy, Reis-Bucklers type	608470	CDG2	601692	5q31.1
Corneal dystrophy, Reis-Bucklers type	608470	EBMD	601692	5q31.1
Corneal dystrophy, Schnyder type	121800	UBIAD1	611632	1p36.22
Corneal dystrophy, Schnyder type	121800	TERE1	611632	1p36.22
Corneal dystrophy, Schnyder type	121800	SCCD	611632	1p36.22
Corneal dystrophy, Thiel-Behnke type	602082	CDB2		10q24
Corneal dystrophy, Thiel-Behnke type	602082	CDTB		10q24
Corneal dystrophy, Thiel-Behnke type	602082	TGFBI	601692	5q31.1
Corneal dystrophy, Thiel-Behnke type	602082	CSD2	601692	5q31.1
Corneal dystrophy, Thiel-Behnke type	602082	CDGG1	601692	5q31.1
Corneal dystrophy, Thiel-Behnke type	602082	CSD	601692	5q31.1
Corneal dystrophy, Thiel-Behnke type	602082	BIGH3	601692	5q31.1
Corneal dystrophy, Thiel-Behnke type	602082	CDG2	601692	5q31.1
Corneal dystrophy, Thiel-Behnke type	602082	EBMD	601692	5q31.1
Corneal dystrophy, congenital stromal	610048	DCN	125255	12q21.33
Corneal dystrophy, congenital stromal	610048	CSCD	125255	12q21.33
Corneal dystrophy, endothelial, X-linked	300779	XECD		Xq25
Corneal dystrophy, epithelial basement membrane	121820	TGFBI	601692	5q31.1
Corneal dystrophy, epithelial basement membrane	121820	CSD2	601692	5q31.1
Corneal dystrophy, epithelial basement membrane	121820	CDGG1	601692	5q31.1
Corneal dystrophy, epithelial basement membrane	121820	CSD	601692	5q31.1
Corneal dystrophy, epithelial basement membrane	121820	BIGH3	601692	5q31.1
Corneal dystrophy, epithelial basement membrane	121820	CDG2	601692	5q31.1
Corneal dystrophy, epithelial basement membrane	121820	EBMD	601692	5q31.1
Corneal dystrophy, gelatinous drop-like	204870	TACSTD2	137290	1p32.1
Corneal dystrophy, gelatinous drop-like	204870	TROP2	137290	1p32.1
Corneal dystrophy, gelatinous drop-like	204870	M1S1	137290	1p32.1
Corneal dystrophy, hereditary polymorphous posterior	122000	VSX1	605020	20p11.21
Corneal dystrophy, hereditary polymorphous posterior	122000	RINX	605020	20p11.21
Corneal dystrophy, hereditary polymorphous posterior	122000	PPCD	605020	20p11.21
Corneal dystrophy, hereditary polymorphous posterior	122000	PPD	605020	20p11.21
Corneal dystrophy, hereditary polymorphous posterior	122000	KTCN1	605020	20p11.21
Corneal dystrophy, hereditary polymorphous posterior	122000	CAASDS	605020	20p11.21
Corneal dystrophy, lattice type I	122200	TGFBI	601692	5q31.1
Corneal dystrophy, lattice type I	122200	CSD2	601692	5q31.1
Corneal dystrophy, lattice type I	122200	CDGG1	601692	5q31.1
Corneal dystrophy, lattice type I	122200	CSD	601692	5q31.1
Corneal dystrophy, lattice type I	122200	BIGH3	601692	5q31.1
Corneal dystrophy, lattice type I	122200	CDG2	601692	5q31.1
Corneal dystrophy, lattice type I	122200	EBMD	601692	5q31.1
Corneal dystrophy, lattice type IIIA	608471	TGFBI	601692	5q31.1
Corneal dystrophy, lattice type IIIA	608471	CSD2	601692	5q31.1
Corneal dystrophy, lattice type IIIA	608471	CDGG1	601692	5q31.1
Corneal dystrophy, lattice type IIIA	608471	CSD	601692	5q31.1
Corneal dystrophy, lattice type IIIA	608471	BIGH3	601692	5q31.1
Corneal dystrophy, lattice type IIIA	608471	CDG2	601692	5q31.1
Corneal dystrophy, lattice type IIIA	608471	EBMD	601692	5q31.1
Corneal dystrophy, posterior polymorphous, 3	609141	ZEB1	189909	10p11.22
Corneal dystrophy, posterior polymorphous, 3	609141	TCF8	189909	10p11.22
Corneal dystrophy, posterior polymorphous, 3	609141	NIL2A	189909	10p11.22
Corneal dystrophy, posterior polymorphous, 3	609141	PPCD3	189909	10p11.22
Corneal dystrophy, posterior polymorphous, 3	609141	FECD6	189909	10p11.22
Corneal endothelial dystrophy 1, autosomal dominant	121700	CHED1		20p11.2-q11.2
Corneal endothelial dystrophy 1, autosomal dominant	121700	CHED		20p11.2-q11.2
Corneal endothelial dystrophy 2, autosomal recessive	217700	SLC4A11	610206	20p13
Corneal endothelial dystrophy 2, autosomal recessive	217700	BTR1	610206	20p13
Corneal endothelial dystrophy 2, autosomal recessive	217700	NABC1	610206	20p13
Corneal endothelial dystrophy 2, autosomal recessive	217700	CHED2	610206	20p13
Corneal endothelial dystrophy 2, autosomal recessive	217700	CDPD	610206	20p13
Corneal endothelial dystrophy 2, autosomal recessive	217700	FECD4	610206	20p13
Corneal endothelial dystrophy and perceptive deafness	217400	SLC4A11	610206	20p13
Corneal endothelial dystrophy and perceptive deafness	217400	BTR1	610206	20p13
Corneal endothelial dystrophy and perceptive deafness	217400	NABC1	610206	20p13
Corneal endothelial dystrophy and perceptive deafness	217400	CHED2	610206	20p13
Corneal endothelial dystrophy and perceptive deafness	217400	CDPD	610206	20p13
Corneal endothelial dystrophy and perceptive deafness	217400	FECD4	610206	20p13
Corneal fleck dystrophy	121850	PIKFYVE	609414	2q34
Corneal fleck dystrophy	121850	PIP5K3	609414	2q34
Cornelia de Lange syndrome 1	122470	NIPBL	608667	5p13.2
Cornelia de Lange syndrome 1	122470	CDLS1	608667	5p13.2
Cornelia de Lange syndrome 2	300590	DXS423E	300040	Xp11.22
Cornelia de Lange syndrome 2	300590	SMC1	300040	Xp11.22
Cornelia de Lange syndrome 2	300590	CDLS2	300040	Xp11.22
Cornelia de Lange syndrome 3	610759	CSPG6	606062	10q25.2
Cornelia de Lange syndrome 3	610759	SMC3	606062	10q25.2
Cornelia de Lange syndrome 3	610759	HCAP	606062	10q25.2
Cornelia de Lange syndrome 3	610759	BAM	606062	10q25.2
Cornelia de Lange syndrome 3	610759	CDLS3	606062	10q25.2
Cornelia de Lange syndrome 4	614701	RAD21	606462	8q24.11
Cornelia de Lange syndrome 4	614701	SCC1	606462	8q24.11
Cornelia de Lange syndrome 4	614701	NXP1	606462	8q24.11
Cornelia de Lange syndrome 4	614701	KIAA0078	606462	8q24.11
Cornelia de Lange syndrome 4	614701	CDLS4	606462	8q24.11
Cornelia de Lange syndrome 5	300882	HDAC8	300269	Xq13.1
Cornelia de Lange syndrome 5	300882	WTS	300269	Xq13.1
Cornelia de Lange syndrome 5	300882	MRXS6	300269	Xq13.1
Cornelia de Lange syndrome 5	300882	CDLS5	300269	Xq13.1
Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia	300472	IGBP1	300139	Xq13.1
Corpus callosum, partial agenesis of	304100	L1CAM	308840	Xq28
Corpus callosum, partial agenesis of	304100	CAML1	308840	Xq28
Corpus callosum, partial agenesis of	304100	HSAS1	308840	Xq28
Corpus callosum, partial agenesis of	304100	MASA	308840	Xq28
Corpus callosum, partial agenesis of	304100	SPG1	308840	Xq28
Cortical dysplasia, complex, with other brain malformations 1	614039	TUBB3	602661	16q24.3
Cortical dysplasia, complex, with other brain malformations 1	614039	TUBB4	602661	16q24.3
Cortical dysplasia, complex, with other brain malformations 1	614039	CFEOM3A	602661	16q24.3
Cortical dysplasia, complex, with other brain malformations 1	614039	CDCBM1	602661	16q24.3
Cortical dysplasia, complex, with other brain malformations 3	615411	KIF2A	602591	5q12.1
Cortical dysplasia, complex, with other brain malformations 3	615411	CDCBM3	602591	5q12.1
Cortical dysplasia, complex, with other brain malformations 4	615412	TUBG1	191135	17q21.2
Cortical dysplasia, complex, with other brain malformations 4	615412	CDCBM4	191135	17q21.2
Cortical dysplasia-focal epilepsy syndrome	610042	CNTNAP2	604569	7q35-q36
Cortical dysplasia-focal epilepsy syndrome	610042	CASPR2	604569	7q35-q36
Cortical dysplasia-focal epilepsy syndrome	610042	NRXN4	604569	7q35-q36
Cortical dysplasia-focal epilepsy syndrome	610042	CDFE	604569	7q35-q36
Cortical dysplasia-focal epilepsy syndrome	610042	AUTS15	604569	7q35-q36
Cortical dysplasia-focal epilepsy syndrome	610042	PTHSL1	604569	7q35-q36
Cortical malformations, occipital	614115	LAMC3	604349	9q34.12
Cortical malformations, occipital	614115	OCCM	604349	9q34.12
Corticosteroid-binding globulin deficiency	611489	CBG	122500	14q32.13
Corticosteroid-binding globulin deficiency	611489	SERPINA6	122500	14q32.13
Cortisol resistance	138040	NR3C1		5q31.3
Cortisol resistance	138040	GCR		5q31.3
Cortisol resistance	138040	GRL		5q31.3
Cortisone reductase deficiency 1	604931	H6PD	138090	1p36.22
Cortisone reductase deficiency 1	604931	GDH	138090	1p36.22
Cortisone reductase deficiency 1	604931	G6PDH	138090	1p36.22
Cortisone reductase deficiency 1	604931	CORTRD1	138090	1p36.22
Cortisone reductase deficiency 2	614662	HSD11B1	600713	1q32.2
Cortisone reductase deficiency 2	614662	HSD11	600713	1q32.2
Cortisone reductase deficiency 2	614662	HSD11L	600713	1q32.2
Cortisone reductase deficiency 2	614662	CORTRD2	600713	1q32.2
Costello syndrome	218040	HRAS	190020	11p15.5
Coumarin resistance	122700	CYP2A6	122720	19q13.2
Coumarin resistance	122700	CYP2A3	122720	19q13.2
Coumarin resistance	122700	CYP2A	122720	19q13.2
Coumarin resistance	122700	P450C2A	122720	19q13.2
Cousin syndrome	260660	TBX15	604127	1p12
Cowchock syndrome	310490	NAMSD		Xq24-q26.1
Cowchock syndrome	310490	NADMR		Xq24-q26.1
Cowchock syndrome	310490	AIFM1	300169	Xq26.1
Cowchock syndrome	310490	PDCD8	300169	Xq26.1
Cowchock syndrome	310490	AIF	300169	Xq26.1
Cowchock syndrome	310490	COXPD6	300169	Xq26.1
Cowchock syndrome	310490	COWCK	300169	Xq26.1
Cowchock syndrome	310490	CMTX4	300169	Xq26.1
Cowden syndrome 1	158350	PTEN	601728	10q23.31
Cowden syndrome 1	158350	MMAC1	601728	10q23.31
Cowden syndrome 1	158350	GLM2	601728	10q23.31
Cowden syndrome 1	158350	CWS1	601728	10q23.31
Cowden syndrome 2	612359	SDHB	185470	1p36.13
Cowden syndrome 2	612359	SDH2	185470	1p36.13
Cowden syndrome 2	612359	SDHIP	185470	1p36.13
Cowden syndrome 2	612359	PGL4	185470	1p36.13
Cowden syndrome 2	612359	CWS2	185470	1p36.13
Cowden syndrome 3	615106	SDHD	602690	11q23.1
Cowden syndrome 3	615106	PGL1	602690	11q23.1
Cowden syndrome 3	615106	CWS3	602690	11q23.1
Cowden syndrome 4	615107	KLLN	612105	10q23.31
Cowden syndrome 4	615107	CWS4	612105	10q23.31
Cowden syndrome 5	615108	PIK3CA	171834	3q26.32
Cowden syndrome 5	615108	CLOVE	171834	3q26.32
Cowden syndrome 5	615108	MCAP	171834	3q26.32
Cowden syndrome 5	615108	MCM	171834	3q26.32
Cowden syndrome 5	615108	MCMTC	171834	3q26.32
Cowden syndrome 5	615108	CWS5	171834	3q26.32
Cowden syndrome 6	615109	AKT1	164730	14q32.33
Cowden syndrome 6	615109	CWS6	164730	14q32.33
Craniodiaphyseal dysplasia, autosomal dominant	122860	SOST	605740	17q21.31
Craniodiaphyseal dysplasia, autosomal dominant	122860	VBCH	605740	17q21.31
Craniodiaphyseal dysplasia, autosomal dominant	122860	CDD	605740	17q21.31
Cranioectodermal dysplasia 1	218330	IFT122	606045	3q21.3-q22.1
Cranioectodermal dysplasia 1	218330	WDR10	606045	3q21.3-q22.1
Cranioectodermal dysplasia 1	218330	CED1	606045	3q21.3-q22.1
Cranioectodermal dysplasia 2	613610	WDR35	613602	2p24.1
Cranioectodermal dysplasia 2	613610	NAOFEN	613602	2p24.1
Cranioectodermal dysplasia 2	613610	KIAA1336	613602	2p24.1
Cranioectodermal dysplasia 2	613610	CED2	613602	2p24.1
Cranioectodermal dysplasia 2	613610	SRTD7	613602	2p24.1
Cranioectodermal dysplasia 3	614099	IFT43	614068	14q24.3
Cranioectodermal dysplasia 3	614099	C14orf179	614068	14q24.3
Cranioectodermal dysplasia 3	614099	CED3	614068	14q24.3
Cranioectodermal dysplasia 4	614378	WDR19	608151	4p14
Cranioectodermal dysplasia 4	614378	SRTD5	608151	4p14
Cranioectodermal dysplasia 4	614378	ATD5	608151	4p14
Cranioectodermal dysplasia 4	614378	NPHP13	608151	4p14
Cranioectodermal dysplasia 4	614378	CED4	608151	4p14
Craniofacial anomalies and anterior segment dysgenesis syndrome	614195	VSX1	605020	20p11.21
Craniofacial anomalies and anterior segment dysgenesis syndrome	614195	RINX	605020	20p11.21
Craniofacial anomalies and anterior segment dysgenesis syndrome	614195	PPCD	605020	20p11.21
Craniofacial anomalies and anterior segment dysgenesis syndrome	614195	PPD	605020	20p11.21
Craniofacial anomalies and anterior segment dysgenesis syndrome	614195	KTCN1	605020	20p11.21
Craniofacial anomalies and anterior segment dysgenesis syndrome	614195	CAASDS	605020	20p11.21
Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	614132	TMCO1	614123	1q24.1
Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome	614132	CFSMR	614123	1q24.1
Craniofacial-deafness-hand syndrome	122880	PAX3	606597	2q36.1
Craniofacial-deafness-hand syndrome	122880	WS1	606597	2q36.1
Craniofacial-deafness-hand syndrome	122880	HUP2	606597	2q36.1
Craniofacial-deafness-hand syndrome	122880	CDHS	606597	2q36.1
Craniofacial-deafness-hand syndrome	122880	WS3	606597	2q36.1
Craniofacial-skeletal-dermatologic dysplasia	101600	FGFR2	176943	10q26.13
Craniofacial-skeletal-dermatologic dysplasia	101600	BEK	176943	10q26.13
Craniofacial-skeletal-dermatologic dysplasia	101600	CFD1	176943	10q26.13
Craniofacial-skeletal-dermatologic dysplasia	101600	JWS	176943	10q26.13
Craniofacial-skeletal-dermatologic dysplasia	101600	TK14	176943	10q26.13
Craniofacial-skeletal-dermatologic dysplasia	101600	BBDS	176943	10q26.13
Craniofrontonasal dysplasia	304110	EFNB1	300035	Xq13.1
Craniofrontonasal dysplasia	304110	EPLG2	300035	Xq13.1
Craniofrontonasal dysplasia	304110	CFNS	300035	Xq13.1
Craniofrontonasal dysplasia	304110	CFND	300035	Xq13.1
Craniolenticulosutural dysplasia	607812	SEC23A	610511	14q21.1
Craniolenticulosutural dysplasia	607812	CLSD	610511	14q21.1
Craniometaphyseal dysplasia	123000	ANKH	605145	5p15.2
Craniometaphyseal dysplasia	123000	HANK	605145	5p15.2
Craniometaphyseal dysplasia	123000	ANK	605145	5p15.2
Craniometaphyseal dysplasia	123000	CMDJ	605145	5p15.2
Craniometaphyseal dysplasia	123000	CCAL2	605145	5p15.2
Craniometaphyseal dysplasia	123000	CPPDD	605145	5p15.2
Craniometaphyseal dysplasia, autosomal recessive	218400	CMDR		6q21-q22
Craniometaphyseal dysplasia, autosomal recessive	218400	GJA1	121014	6q22.31
Craniometaphyseal dysplasia, autosomal recessive	218400	CX43	121014	6q22.31
Craniometaphyseal dysplasia, autosomal recessive	218400	ODDD	121014	6q22.31
Craniometaphyseal dysplasia, autosomal recessive	218400	SDTY3	121014	6q22.31
Craniometaphyseal dysplasia, autosomal recessive	218400	ODOD	121014	6q22.31
Craniometaphyseal dysplasia, autosomal recessive	218400	HSS	121014	6q22.31
Craniometaphyseal dysplasia, autosomal recessive	218400	AVSD3	121014	6q22.31
Craniometaphyseal dysplasia, autosomal recessive	218400	HLHS1	121014	6q22.31
Craniometaphyseal dysplasia, autosomal recessive	218400	CMDR	121014	6q22.31
Cranioosteoarthropathy	259100	HPGD	601688	4q34.1
Cranioosteoarthropathy	259100	PGDH1	601688	4q34.1
Cranioosteoarthropathy	259100	PHOAR1	601688	4q34.1
Craniosynostosis 3	615314	TCF12	600480	15q21.3
Craniosynostosis 3	615314	HTF4	600480	15q21.3
Craniosynostosis 3	615314	CRS3	600480	15q21.3
Craniosynostosis 4	600775	ERF	611888	19q13.2
Craniosynostosis 4	600775	PE2	611888	19q13.2
Craniosynostosis 4	600775	CRS4	611888	19q13.2
Craniosynostosis and dental anomalies	614188	IL11RA	600939	9p13.3
Craniosynostosis and dental anomalies	614188	CRSDA	600939	9p13.3
Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies	614416	CYP26B1	605207	2p13.2
Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies	614416	CYP26A2	605207	2p13.2
Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies	614416	P450RAI2	605207	2p13.2
Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies	614416	RHFCA	605207	2p13.2
Craniosynostosis, Adelaide type	600593	CRSA		4p16
Craniosynostosis, Adelaide type	600593	CRS3		4p16
Craniosynostosis, Philadelphia type	185900	CUP2q35		2q34-q36
Craniosynostosis, Philadelphia type	185900	C2DUPq35		2q34-q36
Craniosynostosis, Philadelphia type	185900	SDTY1		2q34-q36
Craniosynostosis, Philadelphia type	185900	SD1		2q34-q36
Craniosynostosis, nonspecific		FGFR2	176943	10q26.13
Craniosynostosis, nonspecific		BEK	176943	10q26.13
Craniosynostosis, nonspecific		CFD1	176943	10q26.13
Craniosynostosis, nonspecific		JWS	176943	10q26.13
Craniosynostosis, nonspecific		TK14	176943	10q26.13
Craniosynostosis, nonspecific		BBDS	176943	10q26.13
Craniosynostosis, type 1	123100	TWIST1	601622	7p21.1
Craniosynostosis, type 1	123100	ACS3	601622	7p21.1
Craniosynostosis, type 1	123100	SCS	601622	7p21.1
Craniosynostosis, type 1	123100	CRS1	601622	7p21.1
Craniosynostosis, type 2	604757	MSX2	123101	5q35.2
Craniosynostosis, type 2	604757	CRS2	123101	5q35.2
Craniosynostosis, type 2	604757	HOX8	123101	5q35.2
Creatine phosphokinase, elevated serum	123320	CAV3	601253	3p25.3
Creatine phosphokinase, elevated serum	123320	LGMD1C	601253	3p25.3
Creatine phosphokinase, elevated serum	123320	LQT9	601253	3p25.3
Creatinine clearance QTL	607135	CRCL		3p
Creutzfeldt-Jakob disease	123400	PRNP	176640	20p13
Creutzfeldt-Jakob disease	123400	PRIP	176640	20p13
Creutzfeldt-Jakob disease	123400	KURU	176640	20p13
Creutzfeldt-Jakob disease	123400	CJD	176640	20p13
Crigler-Najjar syndrome, type I	218800	UGT1A1	191740	2q37.1
Crigler-Najjar syndrome, type I	218800	UGT1	191740	2q37.1
Crigler-Najjar syndrome, type I	218800	GNT1	191740	2q37.1
Crigler-Najjar syndrome, type I	218800	BILIQTL1	191740	2q37.1
Crigler-Najjar syndrome, type II	606785	UGT1A1	191740	2q37.1
Crigler-Najjar syndrome, type II	606785	UGT1	191740	2q37.1
Crigler-Najjar syndrome, type II	606785	GNT1	191740	2q37.1
Crigler-Najjar syndrome, type II	606785	BILIQTL1	191740	2q37.1
Crouzon syndrome with acanthosis nigricans	612247	FGFR3	134934	4p16.3
Crouzon syndrome with acanthosis nigricans	612247	ACH	134934	4p16.3
Crouzon syndrome	123500	FGFR2	176943	10q26.13
Crouzon syndrome	123500	BEK	176943	10q26.13
Crouzon syndrome	123500	CFD1	176943	10q26.13
Crouzon syndrome	123500	JWS	176943	10q26.13
Crouzon syndrome	123500	TK14	176943	10q26.13
Crouzon syndrome	123500	BBDS	176943	10q26.13
Cryptorchidism	219050	INSL3	146738	19p13.11
Cryptorchidism	219050	LGR8	606655	13q13.1
Cryptorchidism	219050	GREAT	606655	13q13.1
Cubitus valgus with mental retardation and unusual facies	300471	CVMRF		Chr.X
Currarino syndrome	176450	MNX1	142994	7q36.3
Currarino syndrome	176450	HLXB9	142994	7q36.3
Currarino syndrome	176450	HOXHB9	142994	7q36.3
Currarino syndrome	176450	SCRA1	142994	7q36.3
Cutaneous telangiectasia and cancer syndrome, familial	614564	ATR	601215	3q23
Cutaneous telangiectasia and cancer syndrome, familial	614564	FRP1	601215	3q23
Cutaneous telangiectasia and cancer syndrome, familial	614564	SCKL1	601215	3q23
Cutaneous telangiectasia and cancer syndrome, familial	614564	FCTCS	601215	3q23
Cutis laxa, AD	123700	ELN	130160	7q11.23
Cutis laxa, autosomal dominant 2	614434	FBLN5	604580	14q32.12
Cutis laxa, autosomal dominant 2	614434	ARMD3	604580	14q32.12
Cutis laxa, autosomal dominant 2	614434	ADCL2	604580	14q32.12
Cutis laxa, autosomal dominant 2	614434	ARCL1A	604580	14q32.12
Cutis laxa, autosomal recessive, type IA	219100	FBLN5	604580	14q32.12
Cutis laxa, autosomal recessive, type IA	219100	ARMD3	604580	14q32.12
Cutis laxa, autosomal recessive, type IA	219100	ADCL2	604580	14q32.12
Cutis laxa, autosomal recessive, type IA	219100	ARCL1A	604580	14q32.12
Cutis laxa, autosomal recessive, type IB	614437	EFEMP2	604633	11q13.1
Cutis laxa, autosomal recessive, type IB	614437	FBLN4	604633	11q13.1
Cutis laxa, autosomal recessive, type IB	614437	UPH1	604633	11q13.1
Cutis laxa, autosomal recessive, type IB	614437	ARCL1B	604633	11q13.1
Cutis laxa, autosomal recessive, type IC	613177	LTBP4	604710	19q13.2
Cutis laxa, autosomal recessive, type IC	613177	LTBP4S	604710	19q13.2
Cutis laxa, autosomal recessive, type IC	613177	LTBP4L	604710	19q13.2
Cutis laxa, autosomal recessive, type IC	613177	ARCL1C	604710	19q13.2
Cutis laxa, autosomal recessive, type IIA	219200	ATP6V0A2	611716	12q24.31
Cutis laxa, autosomal recessive, type IIA	219200	WSS	611716	12q24.31
Cutis laxa, autosomal recessive, type IIA	219200	ARCL2A	611716	12q24.31
Cutis laxa, autosomal recessive, type IIB	612940	PYCR1	179035	17q25.3
Cutis laxa, autosomal recessive, type IIB	612940	PRO3	179035	17q25.3
Cutis laxa, autosomal recessive, type IIB	612940	ARCL2B	179035	17q25.3
Cutis laxa, autosomal recessive, type IIB	612940	ARCL3B	179035	17q25.3
Cutis laxa, autosomal recessive, type IIIA	219150	ALDH18A1	138250	10q24.1
Cutis laxa, autosomal recessive, type IIIA	219150	PYCS	138250	10q24.1
Cutis laxa, autosomal recessive, type IIIA	219150	GSAS	138250	10q24.1
Cutis laxa, autosomal recessive, type IIIA	219150	ARCL3A	138250	10q24.1
Cutis laxa, autosomal recessive, type IIIB	614438	PYCR1	179035	17q25.3
Cutis laxa, autosomal recessive, type IIIB	614438	PRO3	179035	17q25.3
Cutis laxa, autosomal recessive, type IIIB	614438	ARCL2B	179035	17q25.3
Cutis laxa, autosomal recessive, type IIIB	614438	ARCL3B	179035	17q25.3
Cyanosis, transient neonatal	613977	HBG2	142250	11p15.4
Cyanosis, transient neonatal	613977	TNCY	142250	11p15.4
Cylindromatosis, familial	132700	CYLD	605018	16q12.1
Cylindromatosis, familial	132700	CDMT	605018	16q12.1
Cylindromatosis, familial	132700	EAC	605018	16q12.1
Cylindromatosis, familial	132700	MFT1	605018	16q12.1
Cylindromatosis, familial	132700	KIAA0849	605018	16q12.1
Cylindromatosis, familial	132700	BRSS	605018	16q12.1
Cystathioninuria	219500	CTH	607657	1p31.1
Cystic fibrosis	219700	CFTR	602421	7q31.2
Cystic fibrosis	219700	ABCC7	602421	7q31.2
Cystic fibrosis	219700	CF	602421	7q31.2
Cystic fibrosis	219700	MRP7	602421	7q31.2
Cystinosis, atypical nephropathic	219800	CTNS	606272	17p13.2
Cystinosis, late-onset juvenile or adolescent nephropathic	219900	CTNS	606272	17p13.2
Cystinosis, nephropathic	219800	CTNS	606272	17p13.2
Cystinosis, ocular nonnephropathic	219750	CTNS	606272	17p13.2
Cystinuria	220100	SLC3A1	104614	2p21
Cystinuria	220100	ATR1	104614	2p21
Cystinuria	220100	D2H	104614	2p21
Cystinuria	220100	NBAT	104614	2p21
Cystinuria	220100	SLC7A9	604144	19q13.11
Cystinuria	220100	CSNU3	604144	19q13.11
Czech dysplasia	609162	COL2A1	120140	12q13.11
D-2-hydroxyglutaric aciduria 2	613657	IDH2	147650	15q26.1
D-2-hydroxyglutaric aciduria 2	613657	IDPM	147650	15q26.1
D-2-hydroxyglutaric aciduria 2	613657	D2HGA2	147650	15q26.1
D-2-hydroxyglutaric aciduria	600721	D2HGDH	609186	2q37.3
D-2-hydroxyglutaric aciduria	600721	D2HGD	609186	2q37.3
D-bifunctional protein deficiency	261515	HSD17B4	601860	5q23.1
D-bifunctional protein deficiency	261515	PRLTS1	601860	5q23.1
D-glyceric aciduria	220120	GLYCTK	610516	3p21.1
D-glyceric aciduria	220120	GLYCTK1	610516	3p21.1
DNA ligase I deficiency		LIG1	126391	19q13.33
DNA topoisomerase I, camptothecin-resistant		TOP1	126420	20q12
DNA topoisomerase II, resistance to inhibition of, by amsacrine		TOP2A	126430	17q21.2
DNA topoisomerase II, resistance to inhibition of, by amsacrine		TOP2	126430	17q21.2
DOOR syndrome	220500	TBC1D24	613577	16p13.3
DOOR syndrome	220500	KIAA1171	613577	16p13.3
DOOR syndrome	220500	FIME	613577	16p13.3
DOOR syndrome	220500	EIEE16	613577	16p13.3
DOOR syndrome	220500	DOORS	613577	16p13.3
Dandy-Walker syndrome	220200	DWS		3q22-q24
Dandy-Walker syndrome	220200	C3DELq22q24		3q22-q24
Dandy-Walker syndrome	220200	DEL3q22q24		3q22-q24
Danon disease	300257	LAMP2	309060	Xq24
Danon disease	300257	LAMPB	309060	Xq24
Danon disease	300257	LGP110	309060	Xq24
Darier disease	124200	ATP2A2	108740	12q24.11
Darier disease	124200	ATP2B	108740	12q24.11
Darier disease	124200	DAR	108740	12q24.11
De Sanctis-Cacchione syndrome	278800	ERCC6	609413	10q11.23
De Sanctis-Cacchione syndrome	278800	CKN2	609413	10q11.23
De Sanctis-Cacchione syndrome	278800	COFS1	609413	10q11.23
De Sanctis-Cacchione syndrome	278800	CSB	609413	10q11.23
De Sanctis-Cacchione syndrome	278800	ARMD5	609413	10q11.23
De Sanctis-Cacchione syndrome	278800	UVSS1	609413	10q11.23
De la Chapelle dysplasia	256050	SLC26A2	606718	5q32
De la Chapelle dysplasia	256050	DTD	606718	5q32
De la Chapelle dysplasia	256050	DTDST	606718	5q32
De la Chapelle dysplasia	256050	D5S1708	606718	5q32
De la Chapelle dysplasia	256050	EDM4	606718	5q32
Deafness and male infertility	611102	DEL15q15.3		15q15.3
Deafness and male infertility	611102	C15DELq15.3		15q15.3
Deafness and myopia	221200	SLITRK6	609681	13q31.1
Deafness and myopia	221200	DFNMYP	609681	13q31.1
Deafness, X-linked 1	304500	PRPS1	311850	Xq22.3
Deafness, X-linked 1	304500	CMTX5	311850	Xq22.3
Deafness, X-linked 1	304500	DFNX1	311850	Xq22.3
Deafness, X-linked 1	304500	DFN2	311850	Xq22.3
Deafness, X-linked 1, progressive		TIMM8A	300356	Xq22.1
Deafness, X-linked 1, progressive		DFN1	300356	Xq22.1
Deafness, X-linked 1, progressive		DDP	300356	Xq22.1
Deafness, X-linked 1, progressive		MTS	300356	Xq22.1
Deafness, X-linked 1, progressive		DDP1	300356	Xq22.1
Deafness, X-linked 2	304400	POU3F4	300039	Xq21.1
Deafness, X-linked 2	304400	DFN3	300039	Xq21.1
Deafness, X-linked 2	304400	DFNX2	300039	Xq21.1
Deafness, X-linked 3	300030	DFNX3		Xp21.2
Deafness, X-linked 3	300030	DFN4		Xp21.2
Deafness, X-linked 4	300066	SMPX	300226	Xp22.12
Deafness, X-linked 4	300066	DFNX4	300226	Xp22.12
Deafness, X-linked 5	300614	DFNX5		Xq23-q27.3
Deafness, X-linked 5	300614	AUNX1		Xq23-q27.3
Deafness, Y-linked 1	400043	DFNY1		Chr.Y
Deafness, autosomal dominant 1	124900	DIAPH1	602121	5q31.3
Deafness, autosomal dominant 1	124900	DFNA1	602121	5q31.3
Deafness, autosomal dominant 1	124900	LFHL1	602121	5q31.3
Deafness, autosomal dominant 10	601316	EYA4	603550	6q23.2
Deafness, autosomal dominant 10	601316	DFNA10	603550	6q23.2
Deafness, autosomal dominant 10	601316	CMD1J	603550	6q23.2
Deafness, autosomal dominant 11	601317	MYO7A	276903	11q13.5
Deafness, autosomal dominant 11	601317	USH1B	276903	11q13.5
Deafness, autosomal dominant 11	601317	DFNB2	276903	11q13.5
Deafness, autosomal dominant 11	601317	DFNA11	276903	11q13.5
Deafness, autosomal dominant 13	601868	COL11A2	120290	6p21.32
Deafness, autosomal dominant 13	601868	STL3	120290	6p21.32
Deafness, autosomal dominant 13	601868	DFNA13	120290	6p21.32
Deafness, autosomal dominant 13	601868	DFNB53	120290	6p21.32
Deafness, autosomal dominant 13	601868	FBCG2	120290	6p21.32
Deafness, autosomal dominant 15	602459	POU4F3	602460	5q32
Deafness, autosomal dominant 15	602459	BRN3C	602460	5q32
Deafness, autosomal dominant 16	603964	DFNA16		2q23-q24.3
Deafness, autosomal dominant 17	603622	MYH9	160775	22q12.3
Deafness, autosomal dominant 17	603622	MHA	160775	22q12.3
Deafness, autosomal dominant 17	603622	FTNS	160775	22q12.3
Deafness, autosomal dominant 17	603622	DFNA17	160775	22q12.3
Deafness, autosomal dominant 17	603622	BDPLT6	160775	22q12.3
Deafness, autosomal dominant 18	606012	DFNA18		3q22
Deafness, autosomal dominant 20/26	604717	ACTG1	102560	17q25.3
Deafness, autosomal dominant 20/26	604717	DFNA20	102560	17q25.3
Deafness, autosomal dominant 20/26	604717	DFNA26	102560	17q25.3
Deafness, autosomal dominant 20/26	604717	BRWS2	102560	17q25.3
Deafness, autosomal dominant 21	607017	DFNA21		6p24.1-p22.3
Deafness, autosomal dominant 22	606346	MYO6	600970	6q14.1
Deafness, autosomal dominant 22	606346	DFNA22	600970	6q14.1
Deafness, autosomal dominant 22	606346	DFNB37	600970	6q14.1
Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy	606346	MYO6	600970	6q14.1
Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy	606346	DFNA22	600970	6q14.1
Deafness, autosomal dominant 22, with hypertrophic cardiomyopathy	606346	DFNB37	600970	6q14.1
Deafness, autosomal dominant 23	605192	SIX1	601205	14q23.1
Deafness, autosomal dominant 23	605192	BOS3	601205	14q23.1
Deafness, autosomal dominant 23	605192	DFNA23	601205	14q23.1
Deafness, autosomal dominant 24	606282	DFNA24		4q35-qter
Deafness, autosomal dominant 25	605583	SLC17A8	607557	12q23.1
Deafness, autosomal dominant 25	605583	VGLUT3	607557	12q23.1
Deafness, autosomal dominant 25	605583	DFNA25	607557	12q23.1
Deafness, autosomal dominant 27	612431	DFNA27		4q12-q13.1
Deafness, autosomal dominant 28	608641	GRHL2	608576	8q22.3
Deafness, autosomal dominant 28	608641	TFCP2L3	608576	8q22.3
Deafness, autosomal dominant 28	608641	DFNA28	608576	8q22.3
Deafness, autosomal dominant 2A	600101	KCNQ4	603537	1p34.2
Deafness, autosomal dominant 2A	600101	DFNA2A	603537	1p34.2
Deafness, autosomal dominant 2B	612644	GJB3	603324	1p34.3
Deafness, autosomal dominant 2B	612644	CX31	603324	1p34.3
Deafness, autosomal dominant 2B	612644	DFNA2B	603324	1p34.3
Deafness, autosomal dominant 30	606451	DFNA30		15q25-q26
Deafness, autosomal dominant 31	608645	DFNA31		6p21.3
Deafness, autosomal dominant 33	614211	DFNA33		13q34
Deafness, autosomal dominant 36	606705	TMC1	606706	9q21.13
Deafness, autosomal dominant 36	606705	DFNB7	606706	9q21.13
Deafness, autosomal dominant 36	606705	DFNB11	606706	9q21.13
Deafness, autosomal dominant 36	606705	DFNA36	606706	9q21.13
Deafness, autosomal dominant 36, with dentinogenesis	605594	DSPP	125485	4q22.1
Deafness, autosomal dominant 36, with dentinogenesis	605594	DPP	125485	4q22.1
Deafness, autosomal dominant 36, with dentinogenesis	605594	DGI1	125485	4q22.1
Deafness, autosomal dominant 36, with dentinogenesis	605594	DFNA39	125485	4q22.1
Deafness, autosomal dominant 36, with dentinogenesis	605594	DTDP2	125485	4q22.1
Deafness, autosomal dominant 3A	601544	GJB2	121011	13q12.11
Deafness, autosomal dominant 3A	601544	CX26	121011	13q12.11
Deafness, autosomal dominant 3A	601544	DFNB1A	121011	13q12.11
Deafness, autosomal dominant 3A	601544	PPK	121011	13q12.11
Deafness, autosomal dominant 3A	601544	DFNA3A	121011	13q12.11
Deafness, autosomal dominant 3A	601544	KID	121011	13q12.11
Deafness, autosomal dominant 3A	601544	HID	121011	13q12.11
Deafness, autosomal dominant 3B	612643	GJB6	604418	13q12.11
Deafness, autosomal dominant 3B	612643	CX30	604418	13q12.11
Deafness, autosomal dominant 3B	612643	DFNA3B	604418	13q12.11
Deafness, autosomal dominant 3B	612643	DFNB1B	604418	13q12.11
Deafness, autosomal dominant 3B	612643	ECTD2	604418	13q12.11
Deafness, autosomal dominant 3B	612643	HED2	604418	13q12.11
Deafness, autosomal dominant 40		CRYM	123740	16p12.2
Deafness, autosomal dominant 40		DFNA40	123740	16p12.2
Deafness, autosomal dominant 41	608224	P2RX2	600844	12q24.33
Deafness, autosomal dominant 41	608224	P2X2	600844	12q24.33
Deafness, autosomal dominant 41	608224	DFNA41	600844	12q24.33
Deafness, autosomal dominant 43	608394	DFNA43		2p12
Deafness, autosomal dominant 44	607453	CCDC50	611051	3q28
Deafness, autosomal dominant 44	607453	C3orf6	611051	3q28
Deafness, autosomal dominant 44	607453	DFNA44	611051	3q28
Deafness, autosomal dominant 47	608652	DFNA47		9p22-p21
Deafness, autosomal dominant 47	608652	DFNB83		9p22-p21
Deafness, autosomal dominant 48	607841	MYO1A	601478	12q13.3
Deafness, autosomal dominant 48	607841	DFNA48	601478	12q13.3
Deafness, autosomal dominant 49	608372	DFNA49		1q21-q23
Deafness, autosomal dominant 4A	600652	MYH14	608568	19q13.33
Deafness, autosomal dominant 4A	600652	KIAA2034	608568	19q13.33
Deafness, autosomal dominant 4A	600652	DFNA4A	608568	19q13.33
Deafness, autosomal dominant 4A	600652	PNMHH	608568	19q13.33
Deafness, autosomal dominant 4B	614614	CEACAM16	614591	19q13.32
Deafness, autosomal dominant 4B	614614	CEAL2	614591	19q13.32
Deafness, autosomal dominant 4B	614614	DFNA4B	614591	19q13.32
Deafness, autosomal dominant 5	600994	DFNA5	608798	7p15.3
Deafness, autosomal dominant 50	613074	MIR96	611606	7q32.2
Deafness, autosomal dominant 50	613074	MIRN96	611606	7q32.2
Deafness, autosomal dominant 50	613074	DFNA50	611606	7q32.2
Deafness, autosomal dominant 51	613558	DFNA51		9q21.11
Deafness, autosomal dominant 51	613558	C9DUPq21.11		9q21.11
Deafness, autosomal dominant 51	613558	DUP9q21.11		9q21.11
Deafness, autosomal dominant 52	607683	DFNA52		5q31.1-q32
Deafness, autosomal dominant 52	607683	DFNA42		5q31.1-q32
Deafness, autosomal dominant 53	609965	DFNA53		14q11.2-q12
Deafness, autosomal dominant 56	615629	TNC	187380	9q33.1
Deafness, autosomal dominant 56	615629	HXB	187380	9q33.1
Deafness, autosomal dominant 56	615629	DFNA56	187380	9q33.1
Deafness, autosomal dominant 59	612642	DFNA59		11p14.2-q12.3
Deafness, autosomal dominant 6/14/38	600965	WFS1	606201	4p16.1
Deafness, autosomal dominant 6/14/38	600965	WFRS	606201	4p16.1
Deafness, autosomal dominant 6/14/38	600965	WFS	606201	4p16.1
Deafness, autosomal dominant 6/14/38	600965	DFNA6	606201	4p16.1
Deafness, autosomal dominant 6/14/38	600965	DFNA14	606201	4p16.1
Deafness, autosomal dominant 6/14/38	600965	DFNA38	606201	4p16.1
Deafness, autosomal dominant 6/14/38	600965	WFSL	606201	4p16.1
Deafness, autosomal dominant 6/14/38	600965	CTRCT41	606201	4p16.1
Deafness, autosomal dominant 64	614152	SMAC	605219	12q24.31
Deafness, autosomal dominant 64	614152	DIABLO	605219	12q24.31
Deafness, autosomal dominant 64	614152	DFNA64	605219	12q24.31
Deafness, autosomal dominant 7	601412	DFNA7		1q21-q23
Deafness, autosomal dominant 8/12	601543	TECTA	602574	11q23.3
Deafness, autosomal dominant 8/12	601543	DFNA8	602574	11q23.3
Deafness, autosomal dominant 8/12	601543	DFNA12	602574	11q23.3
Deafness, autosomal dominant 8/12	601543	DFNB21	602574	11q23.3
Deafness, autosomal dominant 9	601369	COCH	603196	14q12
Deafness, autosomal dominant 9	601369	DFNA9	603196	14q12
Deafness, autosomal dominant, with peripheral neuropathy	603324	GJB3		1p34.3
Deafness, autosomal dominant, with peripheral neuropathy	603324	CX31		1p34.3
Deafness, autosomal dominant, with peripheral neuropathy	603324	DFNA2B		1p34.3
Deafness, autosomal recessive	603324	GJB3		1p34.3
Deafness, autosomal recessive	603324	CX31		1p34.3
Deafness, autosomal recessive	603324	DFNA2B		1p34.3
Deafness, autosomal recessive 12	601386	CDH23	605516	10q22.1
Deafness, autosomal recessive 12	601386	USH1D	605516	10q22.1
Deafness, autosomal recessive 13	603098	DFNB13		7q34-q36
Deafness, autosomal recessive 14	603678	DFNB14		7q31
Deafness, autosomal recessive 15	601869	GIPC3	608792	19p13.3
Deafness, autosomal recessive 15	601869	DFNB15	608792	19p13.3
Deafness, autosomal recessive 15	601869	DFNB72	608792	19p13.3
Deafness, autosomal recessive 15	601869	DFNB95	608792	19p13.3
Deafness, autosomal recessive 16	603720	STRC	606440	15q15.3
Deafness, autosomal recessive 16	603720	DFNB16	606440	15q15.3
Deafness, autosomal recessive 17	603010	DFNB17		7q31
Deafness, autosomal recessive 18A	602092	USH1C	605242	11p15.1
Deafness, autosomal recessive 18A	602092	DFNB18A	605242	11p15.1
Deafness, autosomal recessive 18B	614945	OTOG	604487	11p15.1
Deafness, autosomal recessive 18B	614945	OTGN	604487	11p15.1
Deafness, autosomal recessive 18B	614945	DFNB18B	604487	11p15.1
Deafness, autosomal recessive 1A	220290	GJB2	121011	13q12.11
Deafness, autosomal recessive 1A	220290	CX26	121011	13q12.11
Deafness, autosomal recessive 1A	220290	DFNB1A	121011	13q12.11
Deafness, autosomal recessive 1A	220290	PPK	121011	13q12.11
Deafness, autosomal recessive 1A	220290	DFNA3A	121011	13q12.11
Deafness, autosomal recessive 1A	220290	KID	121011	13q12.11
Deafness, autosomal recessive 1A	220290	HID	121011	13q12.11
Deafness, autosomal recessive 1B	612645	GJB6	604418	13q12.11
Deafness, autosomal recessive 1B	612645	CX30	604418	13q12.11
Deafness, autosomal recessive 1B	612645	DFNA3B	604418	13q12.11
Deafness, autosomal recessive 1B	612645	DFNB1B	604418	13q12.11
Deafness, autosomal recessive 1B	612645	ECTD2	604418	13q12.11
Deafness, autosomal recessive 1B	612645	HED2	604418	13q12.11
Deafness, autosomal recessive 2	600060	MYO7A	276903	11q13.5
Deafness, autosomal recessive 2	600060	USH1B	276903	11q13.5
Deafness, autosomal recessive 2	600060	DFNB2	276903	11q13.5
Deafness, autosomal recessive 2	600060	DFNA11	276903	11q13.5
Deafness, autosomal recessive 20	604060	DFNB20		11q25-qter
Deafness, autosomal recessive 21	603629	TECTA	602574	11q23.3
Deafness, autosomal recessive 21	603629	DFNA8	602574	11q23.3
Deafness, autosomal recessive 21	603629	DFNA12	602574	11q23.3
Deafness, autosomal recessive 21	603629	DFNB21	602574	11q23.3
Deafness, autosomal recessive 22	607039	OTOA	607038	16p12.2
Deafness, autosomal recessive 22	607039	DFNB22	607038	16p12.2
Deafness, autosomal recessive 23	609533	PCDH15	605514	10q21.1
Deafness, autosomal recessive 23	609533	DFNB23	605514	10q21.1
Deafness, autosomal recessive 23	609533	USH1F	605514	10q21.1
Deafness, autosomal recessive 24	611022	RDX	179410	11q22.3
Deafness, autosomal recessive 24	611022	DFNB24	179410	11q22.3
Deafness, autosomal recessive 25	613285	GRXCR1	613283	4p13
Deafness, autosomal recessive 26	605428	DFNB26		4q31
Deafness, autosomal recessive 27	605818	DFNB27		2q23-q31
Deafness, autosomal recessive 28	609823	TRIOBP	609761	22q13.1
Deafness, autosomal recessive 28	609823	KIAA1662	609761	22q13.1
Deafness, autosomal recessive 29	614035	CLDN14	605608	21q22.13
Deafness, autosomal recessive 29	614035	DFNB29	605608	21q22.13
Deafness, autosomal recessive 3	600316	MYO15A	602666	17p11.2
Deafness, autosomal recessive 3	600316	DFNB3	602666	17p11.2
Deafness, autosomal recessive 30	607101	MYO3A	606808	10p12.1
Deafness, autosomal recessive 30	607101	DFNB30	606808	10p12.1
Deafness, autosomal recessive 31	607084	WHRN	607928	9q32
Deafness, autosomal recessive 31	607084	CIP98	607928	9q32
Deafness, autosomal recessive 31	607084	KIAA1526	607928	9q32
Deafness, autosomal recessive 31	607084	DFNB31	607928	9q32
Deafness, autosomal recessive 31	607084	USH2D	607928	9q32
Deafness, autosomal recessive 32	608653	DFNB32		1p22.1-p13.3
Deafness, autosomal recessive 33	607239	DFNB33		10p11.23-q21.1
Deafness, autosomal recessive 35	608565	ESRRB	602167	14q24.3
Deafness, autosomal recessive 35	608565	ESRL2	602167	14q24.3
Deafness, autosomal recessive 35	608565	DFNB35	602167	14q24.3
Deafness, autosomal recessive 36	609006	ESPN	606351	1p36.31
Deafness, autosomal recessive 37	607821	MYO6	600970	6q14.1
Deafness, autosomal recessive 37	607821	DFNA22	600970	6q14.1
Deafness, autosomal recessive 37	607821	DFNB37	600970	6q14.1
Deafness, autosomal recessive 38	608219	DFNB38		6q26-q27
Deafness, autosomal recessive 39	608265	HGF	142409	7q21.11
Deafness, autosomal recessive 39	608265	DFNB39	142409	7q21.11
Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	600791	SLC26A4	605646	7q22.3
Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	600791	PDS	605646	7q22.3
Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	600791	DFNB4	605646	7q22.3
Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	600791	EVA	605646	7q22.3
Deafness, autosomal recessive 4, with enlarged vestibular aqueduct	600791	TDH2B	605646	7q22.3
Deafness, autosomal recessive 40	608264	DFNB40		22q11.21-q12.1
Deafness, autosomal recessive 42	609646	ILDR1	609739	3q13.33
Deafness, autosomal recessive 42	609646	DFNB42	609739	3q13.33
Deafness, autosomal recessive 44	610154	DFNB44		7p14.1-q11.22
Deafness, autosomal recessive 45	612433	DFNB45		1q43-q44
Deafness, autosomal recessive 46	609647	DFNB46		18p11.32-p11.31
Deafness, autosomal recessive 48	609439	CIB2	605564	15q25.1
Deafness, autosomal recessive 48	609439	KIP2	605564	15q25.1
Deafness, autosomal recessive 49	610153	MARVELD2	610572	5q13.2
Deafness, autosomal recessive 49	610153	MARVD2	610572	5q13.2
Deafness, autosomal recessive 49	610153	TRIC	610572	5q13.2
Deafness, autosomal recessive 49	610153	DFNB49	610572	5q13.2
Deafness, autosomal recessive 5	600792	DFNB5		14q12
Deafness, autosomal recessive 51	609941	DFNB51		11p13-p12
Deafness, autosomal recessive 53	609706	COL11A2	120290	6p21.32
Deafness, autosomal recessive 53	609706	STL3	120290	6p21.32
Deafness, autosomal recessive 53	609706	DFNA13	120290	6p21.32
Deafness, autosomal recessive 53	609706	DFNB53	120290	6p21.32
Deafness, autosomal recessive 53	609706	FBCG2	120290	6p21.32
Deafness, autosomal recessive 55	609952	DFNB55		4q12-q13.2
Deafness, autosomal recessive 59	610220	PJVK	610219	2q31.2
Deafness, autosomal recessive 59	610220	DFNB59	610219	2q31.2
Deafness, autosomal recessive 6	600971	TMIE	607237	3p21.31
Deafness, autosomal recessive 6	600971	DFNB6	607237	3p21.31
Deafness, autosomal recessive 61	613865	SLC26A5	604943	7q22.1
Deafness, autosomal recessive 61	613865	PRES	604943	7q22.1
Deafness, autosomal recessive 62	610143	DFNB62		12p13.2-p11.23
Deafness, autosomal recessive 63	611451	LRTOMT	612414	11q13.4
Deafness, autosomal recessive 63	611451	LRTOMT1	612414	11q13.4
Deafness, autosomal recessive 63	611451	LRTOMT2	612414	11q13.4
Deafness, autosomal recessive 63	611451	DFNB63	612414	11q13.4
Deafness, autosomal recessive 65	610248	DFNB65		20q13.2-q13.3
Deafness, autosomal recessive 66	610212	DFNB66		6p22.3-p21.2
Deafness, autosomal recessive 67	610265	LHFPL5	609427	6p21.31
Deafness, autosomal recessive 67	610265	TMHS	609427	6p21.31
Deafness, autosomal recessive 67	610265	DFNB67	609427	6p21.31
Deafness, autosomal recessive 68	610419	DFNB68		19p13.2
Deafness, autosomal recessive 7	600974	TMC1	606706	9q21.13
Deafness, autosomal recessive 7	600974	DFNB7	606706	9q21.13
Deafness, autosomal recessive 7	600974	DFNB11	606706	9q21.13
Deafness, autosomal recessive 7	600974	DFNA36	606706	9q21.13
Deafness, autosomal recessive 70	614934	PNPT1	610316	2p16.1
Deafness, autosomal recessive 70	614934	OLD35	610316	2p16.1
Deafness, autosomal recessive 70	614934	COXPD13	610316	2p16.1
Deafness, autosomal recessive 70	614934	DFNB70	610316	2p16.1
Deafness, autosomal recessive 71	612789	DFNB71		8p22-p21.3
Deafness, autosomal recessive 74	613718	MSRB3	613719	12q14.3
Deafness, autosomal recessive 74	613718	DFNB74	613719	12q14.3
Deafness, autosomal recessive 76	615540	SYNE4	615535	19q13.12
Deafness, autosomal recessive 76	615540	NESP4	615535	19q13.12
Deafness, autosomal recessive 76	615540	C19orf46	615535	19q13.12
Deafness, autosomal recessive 76	615540	DFNB76	615535	19q13.12
Deafness, autosomal recessive 77	613079	LOXHD1	613072	18q21.1
Deafness, autosomal recessive 77	613079	DFNB77	613072	18q21.1
Deafness, autosomal recessive 79	613307	TPRN	613354	9q34.3
Deafness, autosomal recessive 79	613307	C9orf75	613354	9q34.3
Deafness, autosomal recessive 79	613307	DFNB79	613354	9q34.3
Deafness, autosomal recessive 8/10	601072	TMPRSS3	605511	21q22.3
Deafness, autosomal recessive 8/10	601072	ECHOS1	605511	21q22.3
Deafness, autosomal recessive 8/10	601072	DFNB8	605511	21q22.3
Deafness, autosomal recessive 8/10	601072	DFNB10	605511	21q22.3
Deafness, autosomal recessive 81	614129	DFNB81		19p13
Deafness, autosomal recessive 83	613685	DFNB83		9p23-p21.2
Deafness, autosomal recessive 84A	613391	PTPRQ	603317	12q21.31
Deafness, autosomal recessive 84A	613391	PTPGMC1	603317	12q21.31
Deafness, autosomal recessive 84A	613391	DFNB84A	603317	12q21.31
Deafness, autosomal recessive 84B	614944	OTOGL	614925	12q21.31
Deafness, autosomal recessive 84B	614944	C12orf64	614925	12q21.31
Deafness, autosomal recessive 84B	614944	DFNB84B	614925	12q21.31
Deafness, autosomal recessive 85	613392	DFNB85		17p12-q11.2
Deafness, autosomal recessive 86	614617	DFNB86		16p13.3
Deafness, autosomal recessive 89	613916	KARS	601421	16q23.1
Deafness, autosomal recessive 89	613916	CMTRIB	601421	16q23.1
Deafness, autosomal recessive 89	613916	DFNB89	601421	16q23.1
Deafness, autosomal recessive 9	601071	OTOF	603681	2p23.3
Deafness, autosomal recessive 9	601071	DFNB9	603681	2p23.3
Deafness, autosomal recessive 9	601071	NSRD9	603681	2p23.3
Deafness, autosomal recessive 9	601071	AUNB1	603681	2p23.3
Deafness, autosomal recessive 91	613453	SERPINB6	173321	6p25.2
Deafness, autosomal recessive 91	613453	PI6	173321	6p25.2
Deafness, autosomal recessive 91	613453	PTI	173321	6p25.2
Deafness, autosomal recessive 91	613453	SPI3	173321	6p25.2
Deafness, autosomal recessive 91	613453	DFNB91	173321	6p25.2
Deafness, autosomal recessive 93	614899	CABP2	607314	11q13.2
Deafness, autosomal recessive 93	614899	DFNB93	607314	11q13.2
Deafness, autosomal recessive 96	614414	DFNB96		1p36.31-p36.13
Deafness, autosomal recessive 98	614861	TSPEAR	612920	21q22.3
Deafness, autosomal recessive 98	614861	C21orf29	612920	21q22.3
Deafness, autosomal recessive 98	614861	DFNB98	612920	21q22.3
Deafness, cataract, retinitis pigmentosa, and sperm abnormalities	300719	DFCTRPS		Chr.X
Deafness, congenital heart defects, and posterior embryotoxon	601920	JAG1		20p12.2
Deafness, congenital heart defects, and posterior embryotoxon	601920	AGS		20p12.2
Deafness, congenital heart defects, and posterior embryotoxon	601920	AHD		20p12.2
Deafness, congenital with inner ear agenesis, microtia, and microdontia	610706	FGF3	164950	11q13.3
Deafness, congenital with inner ear agenesis, microtia, and microdontia	610706	INT2	164950	11q13.3
Deafness, digenic GJB2/GJB6	220290	GJB6	604418	13q12.11
Deafness, digenic GJB2/GJB6	220290	CX30	604418	13q12.11
Deafness, digenic GJB2/GJB6	220290	DFNA3B	604418	13q12.11
Deafness, digenic GJB2/GJB6	220290	DFNB1B	604418	13q12.11
Deafness, digenic GJB2/GJB6	220290	ECTD2	604418	13q12.11
Deafness, digenic GJB2/GJB6	220290	HED2	604418	13q12.11
Deafness, digenic, GJB2/GJB3	220290	GJB3	603324	1p34.3
Deafness, digenic, GJB2/GJB3	220290	CX31	603324	1p34.3
Deafness, digenic, GJB2/GJB3	220290	DFNA2B	603324	1p34.3
Deafness, dystonia, and cerebral hypomyelination	300475	BCAP31	300398	Xq28
Deafness, dystonia, and cerebral hypomyelination	300475	BAP31	300398	Xq28
Deafness, dystonia, and cerebral hypomyelination	300475	DXS1357E	300398	Xq28
Deafness, dystonia, and cerebral hypomyelination	300475	DDCH	300398	Xq28
Deafness, neurosensory, autosomal recessive 47	609946	DFNB47		2p25.1-p24.3
Deafness, neurosensory, without vestibular involvement, autosomal dominant		ESPN	606351	1p36.31
Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380	PIEZO1	611184	16q24.3
Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380	FAM38A	611184	16q24.3
Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380	MIB	611184	16q24.3
Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema	194380	DHS	611184	16q24.3
Dejerine-Sottas disease	145900	EGR2	129010	10q21.3
Dejerine-Sottas disease	145900	KROX20	129010	10q21.3
Dejerine-Sottas disease	145900	MPZ	159440	1q23.3
Dejerine-Sottas disease	145900	CMT1B	159440	1q23.3
Dejerine-Sottas disease	145900	CMTDID	159440	1q23.3
Dejerine-Sottas disease	145900	CHM	159440	1q23.3
Dejerine-Sottas disease	145900	DSS	159440	1q23.3
Dejerine-Sottas disease	145900	PMP22	601097	17p12
Dejerine-Sottas disease	145900	CMT1A	601097	17p12
Dejerine-Sottas disease	145900	CMT1E	601097	17p12
Dejerine-Sottas disease	145900	DSS	601097	17p12
Dejerine-Sottas disease, autosomal recessive	145900	PRX	605725	19q13.2
Dejerine-Sottas disease, autosomal recessive	145900	CMT4F	605725	19q13.2
Delta-beta thalassemia	141749	HBB	141900	11p15.4
Dementia, Lewy body	127750	SNCA	163890	4q22.1
Dementia, Lewy body	127750	NACP	163890	4q22.1
Dementia, Lewy body	127750	PARK1	163890	4q22.1
Dementia, Lewy body	127750	PARK4	163890	4q22.1
Dementia, Lewy body	127750	SNCB	602569	5q35.2
Dementia, familial British	176500	ITM2B	603904	13q14.2
Dementia, familial British	176500	BRI	603904	13q14.2
Dementia, familial British	176500	ABRI	603904	13q14.2
Dementia, familial British	176500	FBD	603904	13q14.2
Dementia, familial Danish	117300	ITM2B	603904	13q14.2
Dementia, familial Danish	117300	BRI	603904	13q14.2
Dementia, familial Danish	117300	ABRI	603904	13q14.2
Dementia, familial Danish	117300	FBD	603904	13q14.2
Dementia, familial, nonspecific	600795	CHMP2B	609512	3p11.2
Dementia, familial, nonspecific	600795	DMT1	609512	3p11.2
Dementia, familial, nonspecific	600795	VPS2B	609512	3p11.2
Dementia, familial, nonspecific	600795	ALS17	609512	3p11.2
Dementia, frontotemporal	600274	PSEN1	104311	14q24.2
Dementia, frontotemporal	600274	AD3	104311	14q24.2
Dementia, frontotemporal, with or without parkinsonism	600274	MAPT	157140	17q21.31
Dementia, frontotemporal, with or without parkinsonism	600274	MTBT1	157140	17q21.31
Dementia, frontotemporal, with or without parkinsonism	600274	DDPAC	157140	17q21.31
Dementia, frontotemporal, with or without parkinsonism	600274	MSTD	157140	17q21.31
Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency	614172	GATA2	137295	3q21.3
Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency	614172	DCML	137295	3q21.3
Dendritic cell, monocyte, B lymphocyte, and natural killer lymphocyte deficiency	614172	MONOMAC	137295	3q21.3
Dent disease 2	300555	OCRL	300535	Xq25-q26
Dent disease 2	300555	LOCR	300535	Xq25-q26
Dent disease 2	300555	OCRL1	300535	Xq25-q26
Dent disease 2	300555	NPHL2	300535	Xq25-q26
Dent disease	300009	CLCN5	300008	Xp11.23-p11.22
Dent disease	300009	CLCK2	300008	Xp11.23-p11.22
Dent disease	300009	NPHL2	300008	Xp11.23-p11.22
Dent disease	300009	DENTS	300008	Xp11.23-p11.22
Dent disease	300009	NPHL1	300008	Xp11.23-p11.22
Dentatorubro-pallidoluysian atrophy	125370	ATN1	607462	12p13.31
Dentatorubro-pallidoluysian atrophy	125370	DRPLA	607462	12p13.31
Dentatorubro-pallidoluysian atrophy	125370	HRS	607462	12p13.31
Dentatorubro-pallidoluysian atrophy	125370	NOD	607462	12p13.31
Dentin dysplasia, type I, with microdontia and misshapen teeth	125400	SMOC2	607223	6q27
Dentin dysplasia, type I, with microdontia and misshapen teeth	125400	SMAP2	607223	6q27
Dentin dysplasia, type I, with microdontia and misshapen teeth	125400	DTDP1	607223	6q27
Dentin dysplasia, type II	125420	DSPP	125485	4q22.1
Dentin dysplasia, type II	125420	DPP	125485	4q22.1
Dentin dysplasia, type II	125420	DGI1	125485	4q22.1
Dentin dysplasia, type II	125420	DFNA39	125485	4q22.1
Dentin dysplasia, type II	125420	DTDP2	125485	4q22.1
Dentinogenesis imperfecta, Shields type II	125490	DSPP	125485	4q22.1
Dentinogenesis imperfecta, Shields type II	125490	DPP	125485	4q22.1
Dentinogenesis imperfecta, Shields type II	125490	DGI1	125485	4q22.1
Dentinogenesis imperfecta, Shields type II	125490	DFNA39	125485	4q22.1
Dentinogenesis imperfecta, Shields type II	125490	DTDP2	125485	4q22.1
Dentinogenesis imperfecta, Shields type III	125500	DSPP	125485	4q22.1
Dentinogenesis imperfecta, Shields type III	125500	DPP	125485	4q22.1
Dentinogenesis imperfecta, Shields type III	125500	DGI1	125485	4q22.1
Dentinogenesis imperfecta, Shields type III	125500	DFNA39	125485	4q22.1
Dentinogenesis imperfecta, Shields type III	125500	DTDP2	125485	4q22.1
Denys-Drash syndrome	194080	WT1	607102	11p13
Denys-Drash syndrome	194080	NPHS4	607102	11p13
Dermatofibrosarcoma protuberans	607907	PDGFB	190040	22q13.1
Dermatofibrosarcoma protuberans	607907	SIS	190040	22q13.1
Dermatofibrosarcoma protuberans	607907	IBGC5	190040	22q13.1
Dermatopathia pigmentosa reticularis	125595	KRT14	148066	17q21.2
Dermoids of cornea	304730	CND		Xq24-qter
Desbuquois dysplasia	251450	CANT1	613165	17q25.3
Desbuquois dysplasia	251450	SCAN1	613165	17q25.3
Desbuquois dysplasia	251450	DBQD	613165	17q25.3
Desmoid disease, hereditary	135290	APC	611731	5q22.2
Desmoid disease, hereditary	135290	GS	611731	5q22.2
Desmoid disease, hereditary	135290	FPC	611731	5q22.2
Desmoid disease, hereditary	135290	BTPS2	611731	5q22.2
Desmosterolosis	602398	DHCR24	606418	1p32.3
Desmosterolosis	602398	KIAA0018	606418	1p32.3
Developmental dysplasia of the hip 1	142700	DDH1		13q22
Developmental dysplasia of the hip 2	615612	DDH2		3p22.2
DiGeorge syndrome	188400	TBX1	602054	22q11.21
DiGeorge syndrome	188400	DGS	602054	22q11.21
DiGeorge syndrome	188400	CTHM	602054	22q11.21
DiGeorge syndrome	188400	CAFS	602054	22q11.21
DiGeorge syndrome	188400	TGA	602054	22q11.21
DiGeorge syndrome	188400	DORV	602054	22q11.21
DiGeorge syndrome	188400	VCFS	602054	22q11.21
DiGeorge syndrome	188400	DGCR	602054	22q11.21
DiGeorge syndrome/velocardiofacial syndrome complex-2	601362	DGCR2		10p14-p13
DiGeorge syndrome/velocardiofacial syndrome complex-2	601362	DGS2		10p14-p13
Diabetes insipidus, nephrogenic	125800	AQP2	107777	12q13.12
Diabetes insipidus, nephrogenic	304800	AVPR2	300538	Xq28
Diabetes insipidus, nephrogenic	304800	DIR	300538	Xq28
Diabetes insipidus, nephrogenic	304800	DI1	300538	Xq28
Diabetes insipidus, nephrogenic	304800	ADHR	300538	Xq28
Diabetes insipidus, neurohypophyseal	125700	AVP	192340	20p13
Diabetes insipidus, neurohypophyseal	125700	AVRP	192340	20p13
Diabetes insipidus, neurohypophyseal	125700	VP	192340	20p13
Diabetes mellitus, gestational	125851	GCK	138079	7p13
Diabetes mellitus, gestational	125851	HHF3	138079	7p13
Diabetes mellitus, insulin-dependent, 2	125852	INS	176730	11p15.5
Diabetes mellitus, insulin-dependent, 2	125852	MODY10	176730	11p15.5
Diabetes mellitus, insulin-dependent, 2	125852	IDDM2	176730	11p15.5
Diabetes mellitus, insulin-dependent, 20	612520	HNF1A	142410	12q24.31
Diabetes mellitus, insulin-dependent, 20	612520	TCF1	142410	12q24.31
Diabetes mellitus, insulin-dependent, 20	612520	MODY3	142410	12q24.31
Diabetes mellitus, insulin-dependent, 20	612520	IDDM20	142410	12q24.31
Diabetes mellitus, insulin-resistant, with acanthosis nigricans	610549	INSR	147670	19p13.2
Diabetes mellitus, insulin-resistant, with acanthosis nigricans	610549	HHF5	147670	19p13.2
Diabetes mellitus, ketosis-prone	612227	PAX4	167413	7q32.1
Diabetes mellitus, ketosis-prone	612227	MODY9	167413	7q32.1
Diabetes mellitus, ketosis-prone	612227	KPD	167413	7q32.1
Diabetes mellitus, neonatal, with congenital hypothyroidism	610199	GLIS3	610192	9p24.2
Diabetes mellitus, neonatal, with congenital hypothyroidism	610199	ZNF515	610192	9p24.2
Diabetes mellitus, noninsulin-dependent	125853	ABCC8	600509	11p15.1
Diabetes mellitus, noninsulin-dependent	125853	SUR	600509	11p15.1
Diabetes mellitus, noninsulin-dependent	125853	PHHI	600509	11p15.1
Diabetes mellitus, noninsulin-dependent	125853	SUR1	600509	11p15.1
Diabetes mellitus, noninsulin-dependent	125853	HHF1	600509	11p15.1
Diabetes mellitus, noninsulin-dependent	125853	TNDM2	600509	11p15.1
Diabetes mellitus, noninsulin-dependent	125853	HNF1B	189907	17q12
Diabetes mellitus, noninsulin-dependent	125853	TCF2	189907	17q12
Diabetes mellitus, noninsulin-dependent	125853	HNF2	189907	17q12
Diabetes mellitus, noninsulin-dependent	125853	MODY5	189907	17q12
Diabetes mellitus, noninsulin-dependent	125853	FJHN	189907	17q12
Diabetes mellitus, noninsulin-dependent	125853	HPC11	189907	17q12
Diabetes mellitus, noninsulin-dependent, 2	601407	NIDDM2		12q24.2
Diabetes mellitus, noninsulin-dependent, late onset	125853	GCK	138079	7p13
Diabetes mellitus, noninsulin-dependent, late onset	125853	HHF3	138079	7p13
Diabetes mellitus, permanent neonatal	606176	ABCC8	600509	11p15.1
Diabetes mellitus, permanent neonatal	606176	SUR	600509	11p15.1
Diabetes mellitus, permanent neonatal	606176	PHHI	600509	11p15.1
Diabetes mellitus, permanent neonatal	606176	SUR1	600509	11p15.1
Diabetes mellitus, permanent neonatal	606176	HHF1	600509	11p15.1
Diabetes mellitus, permanent neonatal	606176	TNDM2	600509	11p15.1
Diabetes mellitus, permanent neonatal	606176	GCK	138079	7p13
Diabetes mellitus, permanent neonatal	606176	HHF3	138079	7p13
Diabetes mellitus, permanent neonatal	606176	INS	176730	11p15.5
Diabetes mellitus, permanent neonatal	606176	MODY10	176730	11p15.5
Diabetes mellitus, permanent neonatal	606176	IDDM2	176730	11p15.5
Diabetes mellitus, permanent neonatal, with cerebellar agenesis	609069	PTF1A	607194	10p12.2
Diabetes mellitus, permanent neonatal, with neurologic features	606176	KCNJ11	600937	11p15.1
Diabetes mellitus, permanent neonatal, with neurologic features	606176	BIR	600937	11p15.1
Diabetes mellitus, permanent neonatal, with neurologic features	606176	PHHI	600937	11p15.1
Diabetes mellitus, permanent neonatal, with neurologic features	606176	HHF2	600937	11p15.1
Diabetes mellitus, permanent neonatal, with neurologic features	606176	TNDM3	600937	11p15.1
Diabetes mellitus, transient neonatal 2	610374	ABCC8	600509	11p15.1
Diabetes mellitus, transient neonatal 2	610374	SUR	600509	11p15.1
Diabetes mellitus, transient neonatal 2	610374	PHHI	600509	11p15.1
Diabetes mellitus, transient neonatal 2	610374	SUR1	600509	11p15.1
Diabetes mellitus, transient neonatal 2	610374	HHF1	600509	11p15.1
Diabetes mellitus, transient neonatal 2	610374	TNDM2	600509	11p15.1
Diabetes mellitus, transient neonatal, 1	601410	ZFP57	612192	6p22.1
Diabetes mellitus, transient neonatal, 1	601410	TNDM1	612192	6p22.1
Diabetes mellitus, transient neonatal, 3	610582	KCNJ11	600937	11p15.1
Diabetes mellitus, transient neonatal, 3	610582	BIR	600937	11p15.1
Diabetes mellitus, transient neonatal, 3	610582	PHHI	600937	11p15.1
Diabetes mellitus, transient neonatal, 3	610582	HHF2	600937	11p15.1
Diabetes mellitus, transient neonatal, 3	610582	TNDM3	600937	11p15.1
Diabetes mellitus, type 1	125852	INS	176730	11p15.5
Diabetes mellitus, type 1	125852	MODY10	176730	11p15.5
Diabetes mellitus, type 1	125852	IDDM2	176730	11p15.5
Diabetes mellitus, type 2	125853	PAX4	167413	7q32.1
Diabetes mellitus, type 2	125853	MODY9	167413	7q32.1
Diabetes mellitus, type 2	125853	KPD	167413	7q32.1
Diabetes mellitus, type II	125853	AKT2	164731	19q13.2
Diabetes mellitus, type II	125853	HIHGHH	164731	19q13.2
Diabetes, permanent neonatal	606176	KCNJ11	600937	11p15.1
Diabetes, permanent neonatal	606176	BIR	600937	11p15.1
Diabetes, permanent neonatal	606176	PHHI	600937	11p15.1
Diabetes, permanent neonatal	606176	HHF2	600937	11p15.1
Diabetes, permanent neonatal	606176	TNDM3	600937	11p15.1
Diamond-Blackfan anemia 1	105650	RPS19	603474	19q13.2
Diamond-Blackfan anemia 1	105650	DBA	603474	19q13.2
Diamond-Blackfan anemia 1	105650	DBA1	603474	19q13.2
Diamond-Blackfan anemia 10	613309	RPS26	603701	12q13.2
Diamond-Blackfan anemia 10	613309	DBA10	603701	12q13.2
Diamond-Blackfan anemia 2	606129	DBA2		8p23.3-p22
Diamond-Blackfan anemia 4	612527	RPS17	180472	15q25.2
Diamond-Blackfan anemia 4	612527	RPS17L1	180472	15q25.2
Diamond-Blackfan anemia 4	612527	RPS17L2	180472	15q25.2
Diamond-Blackfan anemia 4	612527	DBA4	180472	15q25.2
Diamond-Blackfan anemia 5	612528	RPL35A	180468	3q29
Diamond-Blackfan anemia 5	612528	DBA5	180468	3q29
Diamond-Blackfan anemia 6	612561	RPL5	603634	1p22.1
Diamond-Blackfan anemia 6	612561	DBA6	603634	1p22.1
Diamond-Blackfan anemia 7	612562	RPL11	604175	1p36.11
Diamond-Blackfan anemia 7	612562	DBA7	604175	1p36.11
Diamond-Blackfan anemia 8	612563	RPS7	603658	2p25.3
Diamond-Blackfan anemia 8	612563	DBA8	603658	2p25.3
Diamond-Blackfan anemia 9	613308	RPS10	603632	6p21.31
Diamond-Blackfan anemia 9	613308	DBA9	603632	6p21.31
Diamond-blackfan anemia 3	610629	RPS24	602412	10q22.3
Diamond-blackfan anemia 3	610629	DBA3	602412	10q22.3
Diaphanospondylodysostosis	608022	BMPER	608699	7p14.3
Diaphanospondylodysostosis	608022	CV2	608699	7p14.3
Diaphragmatic hernia 3	610187	ZFPM2	603693	8q23.1
Diaphragmatic hernia 3	610187	FOG2	603693	8q23.1
Diaphragmatic hernia 3	610187	DIH3	603693	8q23.1
Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250	DMSMFH		9p22-p21
Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250	BDMF		9p22-p21
Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250	MTAP	156540	9p21.3
Diaphyseal medullary stenosis with malignant fibrous histiocytoma	112250	DMSMFH	156540	9p21.3
Diarrhea 3, secretory sodium, congenital, syndromic	270420	SPINT2	605124	19q13.2
Diarrhea 3, secretory sodium, congenital, syndromic	270420	HAI2	605124	19q13.2
Diarrhea 3, secretory sodium, congenital, syndromic	270420	DIAR3	605124	19q13.2
Diarrhea 4, malabsorptive, congenital	610370	NEUROG3	604882	10q22.1
Diarrhea 4, malabsorptive, congenital	610370	NGN3	604882	10q22.1
Diarrhea 4, malabsorptive, congenital	610370	ATOH5	604882	10q22.1
Diarrhea 5, with tufting enteropathy, congenital	613217	EPCAM	185535	2p21
Diarrhea 5, with tufting enteropathy, congenital	613217	ACSTD1	185535	2p21
Diarrhea 5, with tufting enteropathy, congenital	613217	TROP1	185535	2p21
Diarrhea 5, with tufting enteropathy, congenital	613217	M4S1	185535	2p21
Diarrhea 5, with tufting enteropathy, congenital	613217	MIC18	185535	2p21
Diarrhea 5, with tufting enteropathy, congenital	613217	DIAR5	185535	2p21
Diarrhea 5, with tufting enteropathy, congenital	613217	HNPCC8	185535	2p21
Diarrhea 6	614616	GUCY2C	601330	12p13.1-p12.3
Diarrhea 6	614616	GUC2C	601330	12p13.1-p12.3
Diarrhea 6	614616	DIAR6	601330	12p13.1-p12.3
Diarrhea 6	614616	MECIL	601330	12p13.1-p12.3
Diastrophic dysplasia	222600	SLC26A2	606718	5q32
Diastrophic dysplasia	222600	DTD	606718	5q32
Diastrophic dysplasia	222600	DTDST	606718	5q32
Diastrophic dysplasia	222600	D5S1708	606718	5q32
Diastrophic dysplasia	222600	EDM4	606718	5q32
Diastrophic dysplasia, broad bone-platyspondylic variant	222600	SLC26A2	606718	5q32
Diastrophic dysplasia, broad bone-platyspondylic variant	222600	DTD	606718	5q32
Diastrophic dysplasia, broad bone-platyspondylic variant	222600	DTDST	606718	5q32
Diastrophic dysplasia, broad bone-platyspondylic variant	222600	D5S1708	606718	5q32
Diastrophic dysplasia, broad bone-platyspondylic variant	222600	EDM4	606718	5q32
Digital arthropathy-brachydactyly, familial	606835	TRPV4	605427	12q24.11
Digital arthropathy-brachydactyly, familial	606835	VROAC	605427	12q24.11
Digital arthropathy-brachydactyly, familial	606835	HMSN2C	605427	12q24.11
Digital arthropathy-brachydactyly, familial	606835	CMT2C	605427	12q24.11
Digital arthropathy-brachydactyly, familial	606835	SPSMA	605427	12q24.11
Digital arthropathy-brachydactyly, familial	606835	SSQTL1	605427	12q24.11
Digital arthropathy-brachydactyly, familial	606835	SMAL	605427	12q24.11
Digital clubbing, isolated congenital	119900	HPGD	601688	4q34.1
Digital clubbing, isolated congenital	119900	PGDH1	601688	4q34.1
Digital clubbing, isolated congenital	119900	PHOAR1	601688	4q34.1
Dihydrolipoamide dehydrogenase deficiency	246900	DLD	238331	7q31.1
Dihydrolipoamide dehydrogenase deficiency	246900	LAD	238331	7q31.1
Dihydrolipoamide dehydrogenase deficiency	246900	PHE3	238331	7q31.1
Dihydrolipoamide dehydrogenase deficiency	246900	DLDD	238331	7q31.1
Dihydropyrimidine dehydrogenase deficiency	274270	DPYD	612779	1p21.3
Dihydropyrimidine dehydrogenase deficiency	274270	DPD	612779	1p21.3
Dihydropyrimidinuria	222748	DPYS	613326	8q22.3
Dihydropyrimidinuria	222748	DHP	613326	8q22.3
Dilated cardiomyopathy with woolly hair and keratoderma	605676	DSP	125647	6p24.3
Dilated cardiomyopathy with woolly hair and keratoderma	605676	KPPS2	125647	6p24.3
Dilated cardiomyopathy with woolly hair and keratoderma	605676	PPKS2	125647	6p24.3
Dimethylglycine dehydrogenase deficiency	605850	DMGDH	605849	5q14.1
Dimethylglycine dehydrogenase deficiency	605850	DMGDHD	605849	5q14.1
Diphenylhydantoin toxicity	132810	EPHX1		1q42.12
Disordered steroidogenesis due to cytochrome P450 oxidoreductase	613571	POR	124015	7q11.23
Donnai-Barrow syndrome	222448	LRP2	600073	2q31.1
Donnai-Barrow syndrome	222448	DBS	600073	2q31.1
Dopamine beta-hydroxylase deficiency	223360	DBH	609312	9q34.2
Dopamine receptor D2, reduced brain density of	608774	ANKK1		11q23.2
Double-outlet right ventricle	217095	CFC1	605194	2q21.1
Double-outlet right ventricle	217095	CRYPTIC	605194	2q21.1
Double-outlet right ventricle	217095	HTX2	605194	2q21.1
Double-outlet right ventricle	217095	DTGA2	605194	2q21.1
Double-outlet right ventricle	217095	GDF1	602880	19p13.11
Double-outlet right ventricle	217095	DTGA3	602880	19p13.11
Double-outlet right ventricle	217095	DORV	602880	19p13.11
Double-outlet right ventricle	217095	RAI	602880	19p13.11
Dowling-Degos disease 1	179850	KRT5	148040	12q13.13
Dowling-Degos disease 1	179850	DDD1	148040	12q13.13
Dowling-Degos disease 2	615327	POFUT1	607491	20q11.21
Dowling-Degos disease 2	615327	OFUCT1	607491	20q11.21
Dowling-Degos disease 2	615327	KIAA0180	607491	20q11.21
Dowling-Degos disease 2	615327	DDD2	607491	20q11.21
Down syndrome	190685	DCR		21q22.3
Down syndrome	190685	DSCR		21q22.3
Doyne honeycomb degeneration of retina	126600	EFEMP1	601548	2p16.1
Doyne honeycomb degeneration of retina	126600	FBNL	601548	2p16.1
Doyne honeycomb degeneration of retina	126600	DHRD	601548	2p16.1
Dravet syndrome	607208	SCN1A	182389	2q24.3
Dravet syndrome	607208	GEFSP2	182389	2q24.3
Dravet syndrome	607208	SMEI	182389	2q24.3
Dravet syndrome	607208	FEB3A	182389	2q24.3
Dravet syndrome	607208	EIEE6	182389	2q24.3
Dravet syndrome	607208	FHM3	182389	2q24.3
Du Pan syndrome	228900	GDF5	601146	20q11.22
Du Pan syndrome	228900	CDMP1	601146	20q11.22
Du Pan syndrome	228900	SYNS2	601146	20q11.22
Du Pan syndrome	228900	OS5	601146	20q11.22
Du Pan syndrome	228900	BDA1C	601146	20q11.22
Du Pan syndrome	228900	SYM1B	601146	20q11.22
Duane retraction syndrome 1	126800	DURS1		8q13
Duane retraction syndrome 1	126800	DUS		8q13
Duane retraction syndrome 2	604356	CHN1	118423	2q31.1
Duane retraction syndrome 2	604356	CHN	118423	2q31.1
Duane retraction syndrome 2	604356	ARHGAP2	118423	2q31.1
Duane retraction syndrome 2	604356	RHOGAP2	118423	2q31.1
Duane retraction syndrome 2	604356	DURS2	118423	2q31.1
Duane-radial ray syndrome	607323	SALL4	607343	20q13.2
Duane-radial ray syndrome	607323	HSAL4	607343	20q13.2
Dubin-Johnson syndrome	237500	ABCC2	601107	10q24.2
Dubin-Johnson syndrome	237500	CMOAT	601107	10q24.2
Duchenne muscular dystrophy	310200	DMD	300377	Xp21.2-p21.1
Duchenne muscular dystrophy	310200	BMD	300377	Xp21.2-p21.1
Duchenne muscular dystrophy	310200	CMD3B	300377	Xp21.2-p21.1
Dupuytren contracture 1	126900	DUPC1		16q11.1-q22
Dursun syndrome	612541	G6PC3	611045	17q21.31
Dursun syndrome	612541	UGRP	611045	17q21.31
Dursun syndrome	612541	SCN4	611045	17q21.31
Dyggve-Melchior-Clausen disease	223800	DYM	607461	18q21.1
Dyggve-Melchior-Clausen disease	223800	FLJ90130	607461	18q21.1
Dyggve-Melchior-Clausen disease	223800	DMC	607461	18q21.1
Dyggve-Melchior-Clausen disease	223800	SMC	607461	18q21.1
Dysautonomia, familial	223900	IKBKAP	603722	9q31.3
Dysautonomia, familial	223900	IKAP	603722	9q31.3
Dyschromatosis symmetrica hereditaria	127400	ADAR	146920	1q21.3
Dyschromatosis symmetrica hereditaria	127400	DRADA	146920	1q21.3
Dyschromatosis symmetrica hereditaria	127400	DSH	146920	1q21.3
Dyschromatosis symmetrica hereditaria	127400	DSRAD	146920	1q21.3
Dyschromatosis symmetrica hereditaria	127400	IFI4	146920	1q21.3
Dyschromatosis symmetrica hereditaria	127400	G1P1	146920	1q21.3
Dyschromatosis symmetrica hereditaria	127400	AGS6	146920	1q21.3
Dyschromatosis universalis hereditaria 1	127500	DUH1		6q24.2-q25.2
Dyschromatosis universalis hereditaria 1	127500	DUH		6q24.2-q25.2
Dyschromatosis universalis hereditaria 2	612715	DUH2		12q21-q23
Dyschromatosis universalis hereditaria 3	615402	ABCB6	605452	2q35
Dyschromatosis universalis hereditaria 3	615402	MTABC3	605452	2q35
Dyschromatosis universalis hereditaria 3	615402	MCOPCB7	605452	2q35
Dyschromatosis universalis hereditaria 3	615402	LAN	605452	2q35
Dyschromatosis universalis hereditaria 3	615402	DUH3	605452	2q35
Dyserythropoietic anemia, congenital, type II	224100	SEC23B	610512	20p11.23
Dyserythropoietic anemia, congenital, type II	224100	CDAN2	610512	20p11.23
Dyserythropoietic anemia, congenital, type II	224100	HEMPAS	610512	20p11.23
Dyserythropoietic anemia, congenital, type III	105600	CDAN3		15q21
Dyserythropoietic anemia, congenital, type III	105600	CDA3		15q21
Dyserythropoietic anemia, congenital, type IV	613673	KLF1	600599	19p13.2
Dyserythropoietic anemia, congenital, type IV	613673	EKLF	600599	19p13.2
Dyserythropoietic anemia, congenital, type IV	613673	INLU	600599	19p13.2
Dyserythropoietic anemia, congenital, type IV	613673	HBFQTL6	600599	19p13.2
Dyserythropoietic anemia, congenital, type IV	613673	CDAN4	600599	19p13.2
Dyserythropoietic anemia, congenital, type Ia	224120	CDAN1	607465	15q15.2
Dyserythropoietic anemia, congenital, type Ia	224120	CDA1	607465	15q15.2
Dyserythropoietic anemia, congenital, type Ia	224120	CDAN1A	607465	15q15.2
Dyserythropoietic anemia, congenital, type Ib	615631	C15orf41	615626	15q14
Dysfibrinogenemia, alpha type, causing bleeding diathesis	134820	FGA		4q31.3
Dysfibrinogenemia, alpha type, causing recurrent thrombosis	134820	FGA		4q31.3
Dysfibrinogenemia, beta type		FGB	134830	4q31.3
Dysfibrinogenemia, gamma type		FGG	134850	4q31.3
Dyskeratosis congenita, X-linked	305000	DKC1	300126	Xq28
Dyskeratosis congenita, X-linked	305000	DKCX	300126	Xq28
Dyskeratosis congenita, autosomal dominant 1	127550	TERC	602322	3q26.2
Dyskeratosis congenita, autosomal dominant 1	127550	TRC3	602322	3q26.2
Dyskeratosis congenita, autosomal dominant 1	127550	TR	602322	3q26.2
Dyskeratosis congenita, autosomal dominant 1	127550	DKCA1	602322	3q26.2
Dyskeratosis congenita, autosomal dominant 1	127550	PFBMFT2	602322	3q26.2
Dyskeratosis congenita, autosomal dominant 3	613990	TINF2	604319	14q12
Dyskeratosis congenita, autosomal dominant 3	613990	TIN2	604319	14q12
Dyskeratosis congenita, autosomal dominant 3	613990	DKCA3	604319	14q12
Dyskeratosis congenita, autosomal dominant 4	615190	RTEL1	608833	20q13.33
Dyskeratosis congenita, autosomal dominant 4	615190	C20orf41	608833	20q13.33
Dyskeratosis congenita, autosomal dominant 4	615190	NHL	608833	20q13.33
Dyskeratosis congenita, autosomal dominant 4	615190	KIAA1088	608833	20q13.33
Dyskeratosis congenita, autosomal dominant 4	615190	DKCB5	608833	20q13.33
Dyskeratosis congenita, autosomal dominant 4	615190	DKCA4	608833	20q13.33
Dyskeratosis congenita, autosomal recessive 1	224230	NOLA3	606471	15q14
Dyskeratosis congenita, autosomal recessive 1	224230	NOP10	606471	15q14
Dyskeratosis congenita, autosomal recessive 1	224230	DKCB1	606471	15q14
Dyskeratosis congenita, autosomal recessive 2	613987	NOLA2	606470	5q35.3
Dyskeratosis congenita, autosomal recessive 2	613987	NHP2	606470	5q35.3
Dyskeratosis congenita, autosomal recessive 2	613987	DKCB2	606470	5q35.3
Dyskeratosis congenita, autosomal recessive 3	613988	WRAP53	612661	17p13.1
Dyskeratosis congenita, autosomal recessive 3	613988	TCAB1	612661	17p13.1
Dyskeratosis congenita, autosomal recessive 3	613988	WDR79	612661	17p13.1
Dyskeratosis congenita, autosomal recessive 3	613988	DKCB3	612661	17p13.1
Dyskeratosis congenita, autosomal recessive 5	615190	RTEL1	608833	20q13.33
Dyskeratosis congenita, autosomal recessive 5	615190	C20orf41	608833	20q13.33
Dyskeratosis congenita, autosomal recessive 5	615190	NHL	608833	20q13.33
Dyskeratosis congenita, autosomal recessive 5	615190	KIAA1088	608833	20q13.33
Dyskeratosis congenita, autosomal recessive 5	615190	DKCB5	608833	20q13.33
Dyskeratosis congenita, autosomal recessive 5	615190	DKCA4	608833	20q13.33
Dyskeratosis, hereditary benign intraepithelial	127600	DKBI		4q35
Dyskinesia, familial, with facial myokymia	606703	ADCY5	600293	3q21.1
Dyskinesia, familial, with facial myokymia	606703	FDFM	600293	3q21.1
Dysprothrombinemia	613679	F2	176930	11p11.2
Dysprothrombinemia	613679	THPH1	176930	11p11.2
Dysprothrombinemia	613679	RPRGL2	176930	11p11.2
Dyssegmental dysplasia, Silverman-Handmaker type	224410	HSPG2	142461	1p36.12
Dyssegmental dysplasia, Silverman-Handmaker type	224410	PLC	142461	1p36.12
Dyssegmental dysplasia, Silverman-Handmaker type	224410	SJS	142461	1p36.12
Dyssegmental dysplasia, Silverman-Handmaker type	224410	SJA	142461	1p36.12
Dyssegmental dysplasia, Silverman-Handmaker type	224410	SJS1	142461	1p36.12
Dystonia 13, torsion	607671	DYT13		1p36.32-p36.13
Dystonia 16	612067	PRKRA	603424	2q31.2
Dystonia 16	612067	PACT	603424	2q31.2
Dystonia 16	612067	RAX	603424	2q31.2
Dystonia 16	612067	DYT16	603424	2q31.2
Dystonia 21	614588	DYT21		2q14.3-q21.3
Dystonia 24	615034	ANO3	610110	11p14.2
Dystonia 24	615034	TMEM16C	610110	11p14.2
Dystonia 24	615034	C11orf25	610110	11p14.2
Dystonia 24	615034	DYT24	610110	11p14.2
Dystonia 25	615073	GNAL	139312	18p11.21
Dystonia 25	615073	DYT25	139312	18p11.21
Dystonia 4, torsion, autosomal dominant	128101	TUBB4A	602662	19p13.3
Dystonia 4, torsion, autosomal dominant	128101	TUBB4	602662	19p13.3
Dystonia 4, torsion, autosomal dominant	128101	TUBB5	602662	19p13.3
Dystonia 4, torsion, autosomal dominant	128101	DYT4	602662	19p13.3
Dystonia 4, torsion, autosomal dominant	128101	HLD6	602662	19p13.3
Dystonia 6, torsion	602629	THAP1	609520	8p11.21
Dystonia 6, torsion	602629	DYT6	609520	8p11.21
Dystonia 9	601042	SLC2A1	138140	1p34.2
Dystonia 9	601042	GLUT1	138140	1p34.2
Dystonia 9	601042	DYT18	138140	1p34.2
Dystonia 9	601042	PED	138140	1p34.2
Dystonia 9	601042	GLUT1DS	138140	1p34.2
Dystonia 9	601042	EIG12	138140	1p34.2
Dystonia 9	601042	DYT9	138140	1p34.2
Dystonia, DOPA-responsive, with or without hyperphenylalaninemia	128230	GCH1	600225	14q22.2
Dystonia, DOPA-responsive, with or without hyperphenylalaninemia	128230	DYT5	600225	14q22.2
Dystonia, DOPA-responsive, with or without hyperphenylalaninemia	128230	HPABH4B	600225	14q22.2
Dystonia, dopa-responsive, due to sepiapterin reductase deficiency	612716	SPR	182125	2p13.2
Dystonia, early-onset atypical, with myoclonic features		DYT1	605204	9q34.11
Dystonia, early-onset atypical, with myoclonic features		TOR1A	605204	9q34.11
Dystonia, juvenile-onset	607371	ACTB	102630	7p22.1
Dystonia, juvenile-onset	607371	BRWS1	102630	7p22.1
Dystonia, myoclonic	159900	DRD2	126450	11q23.2
Dystonia, primary cervical	126453	DRD5		4p16.1
Dystonia, primary cervical	126453	DRD1B		4p16.1
Dystonia, primary cervical	126453	DRD1L2		4p16.1
Dystonia-1, torsion	128100	DYT1	605204	9q34.11
Dystonia-1, torsion	128100	TOR1A	605204	9q34.11
Dystonia-11, myoclonic	159900	SGCE	604149	7q21.3
Dystonia-11, myoclonic	159900	DYT11	604149	7q21.3
Dystonia-12	128235	ATP1A3	182350	19q13.2
Dystonia-12	128235	DYT12	182350	19q13.2
Dystonia-12	128235	RDP	182350	19q13.2
Dystonia-12	128235	AHC2	182350	19q13.2
Dystonia-15, myoclonic	607488	DYT15		18p11
Dystonia-17, primary torsion	612406	DYT17		20p11.2-q13.12
Dystonia-7, torsion	602124	DYT7		18p
Dystonia-Parkinsonism, X-linked	314250	TAF1	313650	Xq13.1
Dystonia-Parkinsonism, X-linked	314250	TAF2A	313650	Xq13.1
Dystonia-Parkinsonism, X-linked	314250	CCG1	313650	Xq13.1
Dystonia-Parkinsonism, X-linked	314250	BA2R	313650	Xq13.1
Dystonia-Parkinsonism, X-linked	314250	DYT3	313650	Xq13.1
EBD inversa	226600	COL7A1	120120	3p21.31
EBD, Bart type	132000	COL7A1	120120	3p21.31
EBD, localisata variant		COL7A1	120120	3p21.31
EDICT syndrome	614303	MIR184	613146	15q25.1
EDICT syndrome	614303	MIRN184	613146	15q25.1
EDICT syndrome	614303	KTCNCT	613146	15q25.1
EDICT syndrome	614303	EDICT	613146	15q25.1
Eagle-Barrett syndrome	100100	CHRM3	118494	1q43
Eagle-Barrett syndrome	100100	EGBRS	118494	1q43
Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	ED1	300451	Xq13.1
Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	EDA	300451	Xq13.1
Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	ECTD1	300451	Xq13.1
Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	EDA	300451	Xq13.1
Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	HED1	300451	Xq13.1
Ectodermal dysplasia 1, hypohidrotic, X-linked	305100	STHAGX1	300451	Xq13.1
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	EDAR	604095	2q12.3
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	DL	604095	2q12.3
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	ED3	604095	2q12.3
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	EDA3	604095	2q12.3
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	HRM1	604095	2q12.3
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	ECTD10A	604095	2q12.3
Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant	129490	ECTD10B	604095	2q12.3
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	EDAR	604095	2q12.3
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	DL	604095	2q12.3
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	ED3	604095	2q12.3
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	EDA3	604095	2q12.3
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	HRM1	604095	2q12.3
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	ECTD10A	604095	2q12.3
Ectodermal dysplasia 10B, hypohidrotic/hair/tooth type, autosomal recessive	224900	ECTD10B	604095	2q12.3
Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type	614940	EDARADD	606603	1q42-q43
Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type	614940	ED3	606603	1q42-q43
Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type	614940	EDA3	606603	1q42-q43
Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type	614940	ECTD11B	606603	1q42-q43
Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type	614940	ECTD11A	606603	1q42-q43
Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	614941	EDARADD	606603	1q42-q43
Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	614941	ED3	606603	1q42-q43
Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	614941	EDA3	606603	1q42-q43
Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	614941	ECTD11B	606603	1q42-q43
Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive	614941	ECTD11A	606603	1q42-q43
Ectodermal dysplasia 2, Clouston type	129500	GJB6	604418	13q12.11
Ectodermal dysplasia 2, Clouston type	129500	CX30	604418	13q12.11
Ectodermal dysplasia 2, Clouston type	129500	DFNA3B	604418	13q12.11
Ectodermal dysplasia 2, Clouston type	129500	DFNB1B	604418	13q12.11
Ectodermal dysplasia 2, Clouston type	129500	ECTD2	604418	13q12.11
Ectodermal dysplasia 2, Clouston type	129500	HED2	604418	13q12.11
Ectodermal dysplasia 3, Witkop type	189500	MSX1	142983	4p16.2
Ectodermal dysplasia 3, Witkop type	189500	HOX7	142983	4p16.2
Ectodermal dysplasia 3, Witkop type	189500	HYD1	142983	4p16.2
Ectodermal dysplasia 3, Witkop type	189500	OFC5	142983	4p16.2
Ectodermal dysplasia 3, Witkop type	189500	STHAG1	142983	4p16.2
Ectodermal dysplasia 3, Witkop type	189500	ECTD3	142983	4p16.2
Ectodermal dysplasia 4, hair/nail type	602032	KRT85	602767	12q13.13
Ectodermal dysplasia 4, hair/nail type	602032	KRTHB5	602767	12q13.13
Ectodermal dysplasia 4, hair/nail type	602032	HB5	602767	12q13.13
Ectodermal dysplasia 4, hair/nail type	602032	ECTD4	602767	12q13.13
Ectodermal dysplasia 5, hair/nail type	614927	ECTD5		10q24.32-q25.1
Ectodermal dysplasia 6, hair/nail type	614928	ECTD6		17p12-q21.2
Ectodermal dysplasia 7, hair/nail type	614929	ECTD7		12p11.1-q21.1
Ectodermal dysplasia 8, hair/tooth/nail type	602401	ECTD8		18q22.1-q22.3
Ectodermal dysplasia 9, hair/nail type	614931	HOXC13	142976	12q13.13
Ectodermal dysplasia 9, hair/nail type	614931	HOX3G	142976	12q13.13
Ectodermal dysplasia 9, hair/nail type	614931	ECTD9	142976	12q13.13
Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency	612132	NFKBIA	164008	14q13.2
Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency	612132	IKBA	164008	14q13.2
Ectodermal dysplasia, ectrodactyly, and macular dystrophy	225280	CDH3	114021	16q22.1
Ectodermal dysplasia, ectrodactyly, and macular dystrophy	225280	CDHP	114021	16q22.1
Ectodermal dysplasia, ectrodactyly, and macular dystrophy	225280	PCAD	114021	16q22.1
Ectodermal dysplasia, ectrodactyly, and macular dystrophy	225280	HJMD	114021	16q22.1
Ectodermal dysplasia, hypohidrotic, with immune deficiency	300291	IKBKG	300248	Xq28
Ectodermal dysplasia, hypohidrotic, with immune deficiency	300291	NEMO	300248	Xq28
Ectodermal dysplasia, hypohidrotic, with immune deficiency	300291	FIP3	300248	Xq28
Ectodermal dysplasia, hypohidrotic, with immune deficiency	300291	IP2	300248	Xq28
Ectodermal dysplasia, hypohidrotic, with immune deficiency	300291	IPD2	300248	Xq28
Ectodermal dysplasia, hypohidrotic, with immune deficiency	300291	AMCBX1	300248	Xq28
Ectodermal dysplasia-syndactyly syndrome 1	613573	PVRL4	609607	1q23.3
Ectodermal dysplasia-syndactyly syndrome 1	613573	PRR4	609607	1q23.3
Ectodermal dysplasia-syndactyly syndrome 1	613573	EDSS1	609607	1q23.3
Ectodermal dysplasia-syndactyly syndrome 2	613576	EDSS2		7p21.2-p14.3
Ectodermal dysplasia/skin fragility syndrome	604536	PKP1	601975	1q32.1
Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency	300301	IKBKG	300248	Xq28
Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency	300301	NEMO	300248	Xq28
Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency	300301	FIP3	300248	Xq28
Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency	300301	IP2	300248	Xq28
Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency	300301	IPD2	300248	Xq28
Ectodermal, dysplasia, anhidrotic, lymphedema and immunodeficiency	300301	AMCBX1	300248	Xq28
Ectopia lentis et pupillae	225200	ADAMTSL4	610113	1q21.3
Ectopia lentis et pupillae	225200	TSRC1	610113	1q21.3
Ectopia lentis et pupillae	225200	ECTOL2	610113	1q21.3
Ectopia lentis, familial	129600	FBN1	134797	15q21.1
Ectopia lentis, familial	129600	MFS1	134797	15q21.1
Ectopia lentis, familial	129600	WMS2	134797	15q21.1
Ectopia lentis, familial	129600	SSKS	134797	15q21.1
Ectopia lentis, familial	129600	GPHYSD2	134797	15q21.1
Ectopia lentis, familial	129600	ACMICD	134797	15q21.1
Ectopia lentis, familial	129600	ECTOL1	134797	15q21.1
Ectopia lentis, isolated, autosomal recessive	225100	ADAMTSL4	610113	1q21.3
Ectopia lentis, isolated, autosomal recessive	225100	TSRC1	610113	1q21.3
Ectopia lentis, isolated, autosomal recessive	225100	ECTOL2	610113	1q21.3
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	TP63	603273	3q28
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	TP73L	603273	3q28
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	KET	603273	3q28
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	EEC3	603273	3q28
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	SHFM4	603273	3q28
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	LMS	603273	3q28
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	RHS	603273	3q28
Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3	604292	OFC8	603273	3q28
Efavirenz, poor metabolism of	614546	CYP2B6	123930	19q13.2
Efavirenz, poor metabolism of	614546	CYP2B	123930	19q13.2
Efavirenz, poor metabolism of	614546	EFVM	123930	19q13.2
Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss	614557	FKBP14	614505	7p14.3
Ehlers-Danlos syndrome with progressive kyphoscoliosis, myopathy, and hearing loss	614557	EDSKMH	614505	7p14.3
Ehlers-Danlos syndrome, autosomal dominant, hypermobility type	130020	TNXB	600985	6p21.33
Ehlers-Danlos syndrome, autosomal dominant, hypermobility type	130020	TNX	600985	6p21.33
Ehlers-Danlos syndrome, autosomal dominant, hypermobility type	130020	TNXB1	600985	6p21.33
Ehlers-Danlos syndrome, autosomal dominant, hypermobility type	130020	TNXBS	600985	6p21.33
Ehlers-Danlos syndrome, autosomal dominant, hypermobility type	130020	TNXB2	600985	6p21.33
Ehlers-Danlos syndrome, autosomal dominant, hypermobility type	130020	EDS3	600985	6p21.33
Ehlers-Danlos syndrome, autosomal recessive, due to tenascin X deficiency	606408	TNXB	600985	6p21.33
Ehlers-Danlos syndrome, autosomal recessive, due to tenascin X deficiency	606408	TNX	600985	6p21.33
Ehlers-Danlos syndrome, autosomal recessive, due to tenascin X deficiency	606408	TNXB1	600985	6p21.33
Ehlers-Danlos syndrome, autosomal recessive, due to tenascin X deficiency	606408	TNXBS	600985	6p21.33
Ehlers-Danlos syndrome, autosomal recessive, due to tenascin X deficiency	606408	TNXB2	600985	6p21.33
Ehlers-Danlos syndrome, autosomal recessive, due to tenascin X deficiency	606408	EDS3	600985	6p21.33
Ehlers-Danlos syndrome, cardiac valvular form	225320	COL1A2	120160	7q21.3
Ehlers-Danlos syndrome, musculocontractural type 1	601776	CHST14	608429	15q15.1
Ehlers-Danlos syndrome, musculocontractural type 1	601776	D4ST1	608429	15q15.1
Ehlers-Danlos syndrome, musculocontractural type 1	601776	ATCS	608429	15q15.1
Ehlers-Danlos syndrome, musculocontractural type 1	601776	EDSMC1	608429	15q15.1
Ehlers-Danlos syndrome, progeroid type, 1	130070	B4GALT7	604327	5q35.3
Ehlers-Danlos syndrome, progeroid type, 1	130070	XGALT1	604327	5q35.3
Ehlers-Danlos syndrome, progeroid type, 1	130070	XGPT1	604327	5q35.3
Ehlers-Danlos syndrome, progeroid type, 1	130070	EDSP1	604327	5q35.3
Ehlers-Danlos syndrome, progeroid type, 2	615349	B3GALT6	615291	1p36.33
Ehlers-Danlos syndrome, progeroid type, 2	615349	SEMDJL1	615291	1p36.33
Ehlers-Danlos syndrome, progeroid type, 2	615349	EDSP2	615291	1p36.33
Ehlers-Danlos syndrome, type I	130000	COL1A1	120150	17q21.33
Ehlers-Danlos syndrome, type I	130000	COL5A1	120215	9q34.3
Ehlers-Danlos syndrome, type I	130000	COL5A2	120190	2q32.2
Ehlers-Danlos syndrome, type II	130010	COL5A1	120215	9q34.3
Ehlers-Danlos syndrome, type III	130020	COL3A1	120180	2q32.2
Ehlers-Danlos syndrome, type IV	130050	COL3A1	120180	2q32.2
Ehlers-Danlos syndrome, type VI	225400	PLOD1	153454	1p36.22
Ehlers-Danlos syndrome, type VI	225400	LH1	153454	1p36.22
Ehlers-Danlos syndrome, type VI	225400	LLH	153454	1p36.22
Ehlers-Danlos syndrome, type VI	225400	EDS6	153454	1p36.22
Ehlers-Danlos syndrome, type VIIA	130060	COL1A1	120150	17q21.33
Ehlers-Danlos syndrome, type VIIB	130060	COL1A2	120160	7q21.3
Ehlers-Danlos syndrome, type VIIC	225410	ADAMTS2	604539	5q35.3
Ehlers-Danlos syndrome, type VIIC	225410	NPI	604539	5q35.3
Ehlers-Danlos syndrome, type VIII	130080	EDS8		12p13
Eiken syndrome	600002	PTHR1	168468	3p21.31
Eiken syndrome	600002	PTHR	168468	3p21.31
Eiken syndrome	600002	PFE	168468	3p21.31
Elliptocytosis-1	611804	EPB41	130500	1p35.3
Elliptocytosis-1	611804	EL1	130500	1p35.3
Elliptocytosis-2	130600	SPTA1	182860	1q23.1
Elliptocytosis-2	130600	EL2	182860	1q23.1
Elliptocytosis-2	130600	SPH3	182860	1q23.1
Elliptocytosis-2	130600	HS3	182860	1q23.1
Elliptocytosis-2	130600	HPP	182860	1q23.1
Elliptocytosis-3	182870	SPTB		14q23.3
Elliptocytosis-3	182870	SPH2		14q23.3
Elliptocytosis-3	182870	EL3		14q23.3
Elliptocytosis-3	182870	HS2		14q23.3
Ellis-van Creveld syndrome	225500	EVC	604831	4p16.2
Ellis-van Creveld syndrome	225500	LBN	607261	4p16.2
Ellis-van Creveld syndrome	225500	EVC2	607261	4p16.2
Emanuel syndrome	609029	DER22t11-22		22q11.2
Emberger syndrome	614038	GATA2	137295	3q21.3
Emberger syndrome	614038	DCML	137295	3q21.3
Emberger syndrome	614038	MONOMAC	137295	3q21.3
Emery-Dreifuss muscular dystrophy 1, X-linked	310300	EMD	300384	Xq28
Emery-Dreifuss muscular dystrophy 1, X-linked	310300	EDMD	300384	Xq28
Emery-Dreifuss muscular dystrophy 1, X-linked	310300	STA	300384	Xq28
Emery-Dreifuss muscular dystrophy 2, AD	181350	LMNA	150330	1q22
Emery-Dreifuss muscular dystrophy 2, AD	181350	LMN1	150330	1q22
Emery-Dreifuss muscular dystrophy 2, AD	181350	EMD2	150330	1q22
Emery-Dreifuss muscular dystrophy 2, AD	181350	FPLD2	150330	1q22
Emery-Dreifuss muscular dystrophy 2, AD	181350	CMD1A	150330	1q22
Emery-Dreifuss muscular dystrophy 2, AD	181350	HGPS	150330	1q22
Emery-Dreifuss muscular dystrophy 2, AD	181350	LGMD1B	150330	1q22
Emery-Dreifuss muscular dystrophy 3, AR	181350	LMNA	150330	1q22
Emery-Dreifuss muscular dystrophy 3, AR	181350	LMN1	150330	1q22
Emery-Dreifuss muscular dystrophy 3, AR	181350	EMD2	150330	1q22
Emery-Dreifuss muscular dystrophy 3, AR	181350	FPLD2	150330	1q22
Emery-Dreifuss muscular dystrophy 3, AR	181350	CMD1A	150330	1q22
Emery-Dreifuss muscular dystrophy 3, AR	181350	HGPS	150330	1q22
Emery-Dreifuss muscular dystrophy 3, AR	181350	LGMD1B	150330	1q22
Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998	SYNE1	608441	6q25.1-q25.2
Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998	KIAA0796	608441	6q25.1-q25.2
Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998	KIAA1756	608441	6q25.1-q25.2
Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998	KIAA1262	608441	6q25.1-q25.2
Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998	SCAR8	608441	6q25.1-q25.2
Emery-Dreifuss muscular dystrophy 4, autosomal dominant	612998	EDMD4	608441	6q25.1-q25.2
Emery-Dreifuss muscular dystrophy 5, autosomal dominant	612999	SYNE2	608442	14q23.2
Emery-Dreifuss muscular dystrophy 5, autosomal dominant	612999	NUANCE	608442	14q23.2
Emery-Dreifuss muscular dystrophy 5, autosomal dominant	612999	KIAA1011	608442	14q23.2
Emery-Dreifuss muscular dystrophy 5, autosomal dominant	612999	EDMD5	608442	14q23.2
Emery-Dreifuss muscular dystrophy 6, X-linked	300696	FHL1	300163	Xq26.3
Emery-Dreifuss muscular dystrophy 6, X-linked	300696	SLIM1	300163	Xq26.3
Emery-Dreifuss muscular dystrophy 6, X-linked	300696	XMPMA	300163	Xq26.3
Emery-Dreifuss muscular dystrophy 6, X-linked	300696	KYOT	300163	Xq26.3
Emery-Dreifuss muscular dystrophy 6, X-linked	300696	FHL1A	300163	Xq26.3
Emery-Dreifuss muscular dystrophy 6, X-linked	300696	FHL1B	300163	Xq26.3
Emery-Dreifuss muscular dystrophy 7, AD	614302	TMEM43	612048	3p25.1
Emery-Dreifuss muscular dystrophy 7, AD	614302	ARVD5	612048	3p25.1
Emery-Dreifuss muscular dystrophy 7, AD	614302	ARVC5	612048	3p25.1
Emery-Dreifuss muscular dystrophy 7, AD	614302	EDMD7	612048	3p25.1
Emphysema due to AAT deficiency	613490	SERPINA1	107400	14q32.13
Emphysema due to AAT deficiency	613490	PI	107400	14q32.13
Emphysema due to AAT deficiency	613490	AAT	107400	14q32.13
Emphysema-cirrhosis, due to AAT deficiency	613490	SERPINA1	107400	14q32.13
Emphysema-cirrhosis, due to AAT deficiency	613490	PI	107400	14q32.13
Emphysema-cirrhosis, due to AAT deficiency	613490	AAT	107400	14q32.13
Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission	614388	DNM1L	603850	12p11.21
Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission	614388	DRP1	603850	12p11.21
Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission	614388	DVLP	603850	12p11.21
Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission	614388	DYMPLE	603850	12p11.21
Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission	614388	EMPF	603850	12p11.21
Encephalopathy, familial, with neuroserpin inclusion bodies	604218	SERPINI1	602445	3q26.1
Encephalopathy, familial, with neuroserpin inclusion bodies	604218	PI12	602445	3q26.1
Encephalopathy, neonatal severe	300673	MECP2	300005	Xq28
Encephalopathy, neonatal severe	300673	RTT	300005	Xq28
Encephalopathy, neonatal severe	300673	PPMX	300005	Xq28
Encephalopathy, neonatal severe	300673	MRX16	300005	Xq28
Encephalopathy, neonatal severe	300673	MRX79	300005	Xq28
Encephalopathy, neonatal severe	300673	AUTSX3	300005	Xq28
Encephalopathy, neonatal severe	300673	MRXSL	300005	Xq28
Encephalopathy, neonatal severe	300673	MRXS13	300005	Xq28
Encephalopathy, neonatal severe	300673	MRX79	300005	Xq28
Encephalopathy, neonatal severe	300673	MRX16	300005	Xq28
Encephalopathy, progressive mitochondrial, with proximal renal tubulopathy due to cytochrome c oxidase deficiency		COX10	602125	17p12
Endocrine-cerebroosteodysplasia	612651	ICK	612325	6p12.2-p12.1
Endocrine-cerebroosteodysplasia	612651	MRK	612325	6p12.2-p12.1
Endocrine-cerebroosteodysplasia	612651	KIAA0936	612325	6p12.2-p12.1
Endocrine-cerebroosteodysplasia	612651	ECO	612325	6p12.2-p12.1
Endometrial cancer	608089	MLH3	604395	14q24.3
Endometrial cancer	608089	HNPCC7	604395	14q24.3
Endometrial cancer, familial	608089	MSH6	600678	2p16.3
Endometrial cancer, familial	608089	GTBP	600678	2p16.3
Endometrial cancer, familial	608089	HNPCC5	600678	2p16.3
Endometrial carcinoma		MSH3	600887	5q14.1
Endometrial carcinoma, somatic	608089	CDH1	192090	16q22.1
Endometrial carcinoma, somatic	608089	UVO	192090	16q22.1
Endometrial carcinoma, somatic	608089	LCAM	192090	16q22.1
Endometrial carcinoma, somatic	608089	ECAD	192090	16q22.1
Endometrial carcinoma, somatic	608089	PTEN	601728	10q23.31
Endometrial carcinoma, somatic	608089	MMAC1	601728	10q23.31
Endometrial carcinoma, somatic	608089	GLM2	601728	10q23.31
Endometrial carcinoma, somatic	608089	CWS1	601728	10q23.31
Endometrial stromal tumors		JAZF1	606246	7p15.2-p15.1
Endometrial stromal tumors		TIP27	606246	7p15.2-p15.1
Endometrial stromal tumors		JJAZ1	606245	17q11.2
Endometrial stromal tumors		KIAA0160	606245	17q11.2
Endotoxin hyporesponsiveness	603030	TLR4		9q33.1
Endotoxin hyporesponsiveness	603030	ARMD10		9q33.1
Endplate acetylcholinesterase deficiency	603034	COLQ	603033	3p25.1
Endplate acetylcholinesterase deficiency	603034	EAD	603033	3p25.1
Enhanced S-cone syndrome	268100	NR2E3	604485	15q23
Enhanced S-cone syndrome	268100	PNR	604485	15q23
Enhanced S-cone syndrome	268100	ESCS	604485	15q23
Enhanced S-cone syndrome	268100	RP37	604485	15q23
Enlarged vestibular aqueduct	600791	FOXI1	601093	5q35.1
Enlarged vestibular aqueduct	600791	FKHL10	601093	5q35.1
Enlarged vestibular aqueduct	600791	FREAC6	601093	5q35.1
Enlarged vestibular aqueduct, digenic	600791	KCNJ10	602208	1q23.2
Enlarged vestibular aqueduct, digenic	600791	SESAME	602208	1q23.2
Enolase deficiency		ENO1	172430	1p36.23
Enolase deficiency		PPH	172430	1p36.23
Enolase deficiency		MPB1	172430	1p36.23
Enterokinase deficiency	226200	PRSS7	606635	21q21.1
Enterokinase deficiency	226200	ENTK	606635	21q21.1
Enuresis, nocturnal, 1	600631	ENUR1		13q13-q14.3
Enuresis, nocturnal, 2	600808	ENUR2		12q13-q21
Eosinophil peroxidase deficiency	261500	EPX	131399	17q22
Eosinophilia, familial	131400	EOS		5q31-q33
Epidermal nevus, somatic	162900	NRAS	164790	1p13.2
Epidermal nevus, somatic	162900	ALPS4	164790	1p13.2
Epidermal nevus, somatic	162900	NS6	164790	1p13.2
Epidermodysplasia verruciformis	226400	TMC6	605828	17q25.3
Epidermodysplasia verruciformis	226400	EVER1	605828	17q25.3
Epidermodysplasia verruciformis	226400	EV1	605828	17q25.3
Epidermodysplasia verruciformis	226400	TMC8	605829	17q25.3
Epidermodysplasia verruciformis	226400	EVER2	605829	17q25.3
Epidermodysplasia verruciformis	226400	EV2	605829	17q25.3
Epidermolysis bullosa dystrophica, AD	131750	COL7A1	120120	3p21.31
Epidermolysis bullosa dystrophica, AR	226600	COL7A1	120120	3p21.31
Epidermolysis bullosa of hands and feet	131800	ITGB4	147557	17q25.1
Epidermolysis bullosa pruriginosa	604129	COL7A1	120120	3p21.31
Epidermolysis bullosa simplex with pyloric atresia	612138	PLEC1	601282	8q24.3
Epidermolysis bullosa simplex with pyloric atresia	612138	PLEC	601282	8q24.3
Epidermolysis bullosa simplex with pyloric atresia	612138	PLTN	601282	8q24.3
Epidermolysis bullosa simplex with pyloric atresia	612138	EBS1	601282	8q24.3
Epidermolysis bullosa simplex with pyloric atresia	612138	LGMD2Q	601282	8q24.3
Epidermolysis bullosa simplex, Dowling-Meara type	131760	KRT14	148066	17q21.2
Epidermolysis bullosa simplex, Dowling-Meara type	131760	KRT5	148040	12q13.13
Epidermolysis bullosa simplex, Dowling-Meara type	131760	DDD1	148040	12q13.13
Epidermolysis bullosa simplex, Koebner type	131900	KRT14	148066	17q21.2
Epidermolysis bullosa simplex, Koebner type	131900	KRT5	148040	12q13.13
Epidermolysis bullosa simplex, Koebner type	131900	DDD1	148040	12q13.13
Epidermolysis bullosa simplex, Ogna type	131950	PLEC1	601282	8q24.3
Epidermolysis bullosa simplex, Ogna type	131950	PLEC	601282	8q24.3
Epidermolysis bullosa simplex, Ogna type	131950	PLTN	601282	8q24.3
Epidermolysis bullosa simplex, Ogna type	131950	EBS1	601282	8q24.3
Epidermolysis bullosa simplex, Ogna type	131950	LGMD2Q	601282	8q24.3
Epidermolysis bullosa simplex, Weber-Cockayne type	131800	KRT14	148066	17q21.2
Epidermolysis bullosa simplex, Weber-Cockayne type	131800	KRT5	148040	12q13.13
Epidermolysis bullosa simplex, Weber-Cockayne type	131800	DDD1	148040	12q13.13
Epidermolysis bullosa simplex, recessive 1	601001	KRT14	148066	17q21.2
Epidermolysis bullosa simplex, recessive 1	601001	KRT5	148040	12q13.13
Epidermolysis bullosa simplex, recessive 1	601001	DDD1	148040	12q13.13
Epidermolysis bullosa simplex, sutosomal recessive 2	615425	DST	113810	6p12.1
Epidermolysis bullosa simplex, sutosomal recessive 2	615425	BPAG1	113810	6p12.1
Epidermolysis bullosa simplex, sutosomal recessive 2	615425	DMH	113810	6p12.1
Epidermolysis bullosa simplex, sutosomal recessive 2	615425	D6S1101	113810	6p12.1
Epidermolysis bullosa simplex, sutosomal recessive 2	615425	HSAN6	113810	6p12.1
Epidermolysis bullosa simplex, sutosomal recessive 2	615425	EBSB2	113810	6p12.1
Epidermolysis bullosa simplex-MP	131960	KRT5	148040	12q13.13
Epidermolysis bullosa simplex-MP	131960	DDD1	148040	12q13.13
Epidermolysis bullosa, generalized atrophic benign	226650	LAMA3	600805	18q11.2
Epidermolysis bullosa, generalized atrophic benign	226650	LOCS	600805	18q11.2
Epidermolysis bullosa, junctional, Herlitz type	226700	LAMA3	600805	18q11.2
Epidermolysis bullosa, junctional, Herlitz type	226700	LOCS	600805	18q11.2
Epidermolysis bullosa, junctional, Herlitz type	226700	LAMB3	150310	1q32.2
Epidermolysis bullosa, junctional, Herlitz type	226700	LAMC2	150292	1q25.3
Epidermolysis bullosa, junctional, Herlitz type	226700	LAMNB2	150292	1q25.3
Epidermolysis bullosa, junctional, Herlitz type	226700	LAMB2T	150292	1q25.3
Epidermolysis bullosa, junctional, non-Herlitz type	226650	COL17A1	113811	10q24.3-q25.1
Epidermolysis bullosa, junctional, non-Herlitz type	226650	BPAG2	113811	10q24.3-q25.1
Epidermolysis bullosa, junctional, non-Herlitz type	226650	ITGB4	147557	17q25.1
Epidermolysis bullosa, junctional, non-Herlitz type	226650	LAMB3	150310	1q32.2
Epidermolysis bullosa, junctional, non-Herlitz type	226650	LAMC2	150292	1q25.3
Epidermolysis bullosa, junctional, non-Herlitz type	226650	LAMNB2	150292	1q25.3
Epidermolysis bullosa, junctional, non-Herlitz type	226650	LAMB2T	150292	1q25.3
Epidermolysis bullosa, junctional, with pyloric atresia	226730	ITGB4	147557	17q25.1
Epidermolysis bullosa, junctional, with pyloric stenosis	226730	ITGA6	147556	2q31.1
Epidermolysis bullosa, lethal acantholytic	609638	DSP	125647	6p24.3
Epidermolysis bullosa, lethal acantholytic	609638	KPPS2	125647	6p24.3
Epidermolysis bullosa, lethal acantholytic	609638	PPKS2	125647	6p24.3
Epidermolysis bullosa, nonspecific, autosomal recessive	615028	EXPH5	612878	11q22.3
Epidermolysis bullosa, nonspecific, autosomal recessive	615028	SLAC2B	612878	11q22.3
Epidermolysis bullosa, nonspecific, autosomal recessive	615028	KIAA0624	612878	11q22.3
Epidermolysis bullosa, pretibial	131850	COL7A1	120120	3p21.31
Epidermolytic hyperkeratosis	113800	KRT1	139350	12q13.13
Epidermolytic hyperkeratosis	113800	EPPK	139350	12q13.13
Epidermolytic hyperkeratosis	113800	NEPPK	139350	12q13.13
Epidermolytic hyperkeratosis	113800	EHK	139350	12q13.13
Epidermolytic hyperkeratosis	113800	KRT10	148080	17q21.2
Epidermolytic hyperkeratosis	113800	EHK	148080	17q21.2
Epidermolytic hyperkeratosis	113800	BCIE	148080	17q21.2
Epidermolytic hyperkeratosis	113800	BIE	148080	17q21.2
Epidermylysis bullosa simplex-MCR	609352	KRT5	148040	12q13.13
Epidermylysis bullosa simplex-MCR	609352	DDD1	148040	12q13.13
Epilepsy, X-linked, with variable learning disabilities and behavior disorders	300491	SYN1	313440	Xp11.23
Epilepsy, childhood absence, 1	600131	ECA1		8q24
Epilepsy, familial adult myoclonic, 4	615127	FAME4		3q26.32-q28
Epilepsy, familial adult myoclonic, 4	615127	FCMTE4		3q26.32-q28
Epilepsy, familial focal, with variable foci	604364	DEPDC5	614191	22q12.2-q12.3
Epilepsy, familial focal, with variable foci	604364	KIAA0645	614191	22q12.2-q12.3
Epilepsy, familial focal, with variable foci	604364	FFEVF	614191	22q12.2-q12.3
Epilepsy, familial mesial temporal lobe	611630	FMTLE		4q13.2-q21.3
Epilepsy, familial mesial temporal lobe	611630	ETL3		4q13.2-q21.3
Epilepsy, familial temporal lobe, 1	600512	LGI1	604619	10q23.33
Epilepsy, familial temporal lobe, 1	600512	EPT	604619	10q23.33
Epilepsy, familial temporal lobe, 1	600512	ETL1	604619	10q23.33
Epilepsy, familial temporal lobe, 1	600512	ADLTE	604619	10q23.33
Epilepsy, familial temporal lobe, 1	600512	ADPEAF	604619	10q23.33
Epilepsy, familial temporal lobe, 2	608096	ETL2		12q22-q23.3
Epilepsy, familial temporal lobe, 2	608096	FTLE		12q22-q23.3
Epilepsy, familial temporal lobe, 4	611631	ETL4		9q21-q22
Epilepsy, familial temporal lobe, 4	611631	ETOLM		9q21-q22
Epilepsy, familial temporal lobe, 5	614417	CPA6	609562	8q13.2
Epilepsy, familial temporal lobe, 5	614417	CPAH	609562	8q13.2
Epilepsy, familial temporal lobe, 5	614417	ETL5	609562	8q13.2
Epilepsy, familial temporal lobe, 5	614417	FEB11	609562	8q13.2
Epilepsy, focal, with speech disorder and with or without mental retardation	245570	GRIN2A	138253	16p13.2
Epilepsy, focal, with speech disorder and with or without mental retardation	245570	NMDAR2A	138253	16p13.2
Epilepsy, focal, with speech disorder and with or without mental retardation	245570	FESD	138253	16p13.2
Epilepsy, focal, with speech disorder and with or without mental retardation	245570	LKS	138253	16p13.2
Epilepsy, generalized, with febrile seizures plus, type 1	604233	SCN1B	600235	19q13.12
Epilepsy, generalized, with febrile seizures plus, type 1	604233	GEFSP1	600235	19q13.12
Epilepsy, generalized, with febrile seizures plus, type 1	604233	BRGDA5	600235	19q13.12
Epilepsy, generalized, with febrile seizures plus, type 1	604233	ATFB13	600235	19q13.12
Epilepsy, generalized, with febrile seizures plus, type 2	604403	SCN1A	182389	2q24.3
Epilepsy, generalized, with febrile seizures plus, type 2	604403	GEFSP2	182389	2q24.3
Epilepsy, generalized, with febrile seizures plus, type 2	604403	SMEI	182389	2q24.3
Epilepsy, generalized, with febrile seizures plus, type 2	604403	FEB3A	182389	2q24.3
Epilepsy, generalized, with febrile seizures plus, type 2	604403	EIEE6	182389	2q24.3
Epilepsy, generalized, with febrile seizures plus, type 2	604403	FHM3	182389	2q24.3
Epilepsy, generalized, with febrile seizures plus, type 3	611277	GABRG2	137164	5q34
Epilepsy, generalized, with febrile seizures plus, type 3	611277	GEFSP3	137164	5q34
Epilepsy, generalized, with febrile seizures plus, type 3	611277	CAE2	137164	5q34
Epilepsy, generalized, with febrile seizures plus, type 3	611277	ECA2	137164	5q34
Epilepsy, generalized, with febrile seizures plus, type 4	609800	GEFSP4		2p24
Epilepsy, generalized, with febrile seizures plus, type 6	612279	GEFSP6		8p23-p21
Epilepsy, generalized, with febrile seizures plus, type 7	613863	SCN9A	603415	2q24.3
Epilepsy, generalized, with febrile seizures plus, type 7	613863	NENA	603415	2q24.3
Epilepsy, generalized, with febrile seizures plus, type 7	613863	PN1	603415	2q24.3
Epilepsy, generalized, with febrile seizures plus, type 7	613863	FEB3B	603415	2q24.3
Epilepsy, generalized, with febrile seizures plus, type 7	613863	GEFSP7	603415	2q24.3
Epilepsy, generalized, with febrile seizures plus, type 7	613863	SFNP	603415	2q24.3
Epilepsy, hot water, 1	613339	HWE1		10q21.3-q22.3
Epilepsy, hot water, 2	613340	HWE2		4q24-q28
Epilepsy, idiopathic generalized, susceptibility to 4	609750	EIG4		10q25-q26
Epilepsy, idiopathic generalized, susceptibility to, 5	611934	EIG5		10p11.22
Epilepsy, juvenile myoclonic	604827	EIG7		15q14
Epilepsy, juvenile myoclonic	604827	EJM2		15q14
Epilepsy, juvenile myoclonic 3	608816	EJM3		6p21
Epilepsy, myoclonic, adult familial, 1	601068	FAME1		8q24
Epilepsy, myoclonic, adult familial, 1	601068	BAFME1		8q24
Epilepsy, myoclonic, adult familial, 1	601068	MEBA		8q24
Epilepsy, myoclonic, adult familial, 2	607876	FAME2		2p11.1-q12.2
Epilepsy, myoclonic, adult familial, 2	607876	BAFME2		2p11.1-q12.2
Epilepsy, myoclonic, adult familial, 2	607876	ADCME		2p11.1-q12.2
Epilepsy, myoclonic, familial adult, 3	613608	FAME3		5p15.31-p15.1
Epilepsy, myoclonic, familial adult, 3	613608	FCMTE3		5p15.31-p15.1
Epilepsy, nocturnal frontal lobe, 1	600513	CHRNA4	118504	20q13.33
Epilepsy, nocturnal frontal lobe, 1	600513	ENFL1	118504	20q13.33
Epilepsy, nocturnal frontal lobe, 3	605375	CHRNB2	118507	1q21.3
Epilepsy, nocturnal frontal lobe, 3	605375	EFNL3	118507	1q21.3
Epilepsy, nocturnal frontal lobe, 5	615005	KCNT1	608167	9q34.3
Epilepsy, nocturnal frontal lobe, 5	615005	KIAA1422	608167	9q34.3
Epilepsy, nocturnal frontal lobe, 5	615005	EIEE14	608167	9q34.3
Epilepsy, nocturnal frontal lobe, 5	615005	ENFL5	608167	9q34.3
Epilepsy, nocturnal frontal lobe, type 2	603204	ENFL2		15q24
Epilepsy, nocturnal frontal lobe, type 4	610353	CHRNA2	118502	8p21.2
Epilepsy, partial, with pericentral spikes	607221	EPPS		4p15
Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	CSTB	601145	21q22.3
Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	STFB	601145	21q22.3
Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	EPM1	601145	21q22.3
Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	PME	601145	21q22.3
Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	EPM1A	601145	21q22.3
Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg)	254800	ULD	601145	21q22.3
Epilepsy, progressive myoclonic 1B	612437	PRICKLE1	608500	12q12
Epilepsy, progressive myoclonic 1B	612437	RILP	608500	12q12
Epilepsy, progressive myoclonic 1B	612437	EPM1B	608500	12q12
Epilepsy, progressive myoclonic 2A (Lafora)	254780	EPM2A	607566	6q24.3
Epilepsy, progressive myoclonic 2A (Lafora)	254780	MELF	607566	6q24.3
Epilepsy, progressive myoclonic 2A (Lafora)	254780	EPM2	607566	6q24.3
Epilepsy, progressive myoclonic 2B (Lafora)	254780	NHLRC1	608072	6p22.3
Epilepsy, progressive myoclonic 2B (Lafora)	254780	EPM2A	608072	6p22.3
Epilepsy, progressive myoclonic 2B (Lafora)	254780	EPM2B	608072	6p22.3
Epilepsy, progressive myoclonic 3, with or without intracellular inclusions	611726	KCTD7	611725	7q11.21
Epilepsy, progressive myoclonic 3, with or without intracellular inclusions	611726	EPM3	611725	7q11.21
Epilepsy, progressive myoclonic 3, with or without intracellular inclusions	611726	CLN14	611725	7q11.21
Epilepsy, progressive myoclonic 4, with or without renal failure	254900	SCARB2	602257	4q21.1
Epilepsy, progressive myoclonic 4, with or without renal failure	254900	CD36L2	602257	4q21.1
Epilepsy, progressive myoclonic 4, with or without renal failure	254900	LIMPII	602257	4q21.1
Epilepsy, progressive myoclonic 4, with or without renal failure	254900	AMRF	602257	4q21.1
Epilepsy, progressive myoclonic 4, with or without renal failure	254900	EPM4	602257	4q21.1
Epilepsy, progressive myoclonic 5	613832	PRICKLE2	608501	3p14.1
Epilepsy, progressive myoclonic 5	613832	EPM5	608501	3p14.1
Epilepsy, progressive myoclonic 6	614018	GOSR2	604027	17q21.32
Epilepsy, progressive myoclonic 6	614018	GS27	604027	17q21.32
Epilepsy, progressive myoclonic 6	614018	EPM6	604027	17q21.32
Epilepsy, pyridoxine-dependent	266100	ALDH7A1	107323	5q23.2
Epilepsy, pyridoxine-dependent	266100	ATQ1	107323	5q23.2
Epilepsy, pyridoxine-dependent	266100	EPD	107323	5q23.2
Epilepsy, pyridoxine-dependent	266100	PDE	107323	5q23.2
Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and writer's cramp	608105	EPRPDC		16p12-p11.2
Epileptic encephalopathy, childhood-onset	615369	CHD2	602119	15q26.1
Epileptic encephalopathy, childhood-onset	615369	EEOC	602119	15q26.1
Epileptic encephalopathy, early infantile, 1	308350	ARX	300382	Xp21.3
Epileptic encephalopathy, early infantile, 1	308350	ISSX	300382	Xp21.3
Epileptic encephalopathy, early infantile, 1	308350	PRTS	300382	Xp21.3
Epileptic encephalopathy, early infantile, 1	308350	MRXS1	300382	Xp21.3
Epileptic encephalopathy, early infantile, 1	308350	MRX36	300382	Xp21.3
Epileptic encephalopathy, early infantile, 1	308350	MRX54	300382	Xp21.3
Epileptic encephalopathy, early infantile, 1	308350	MRX43	300382	Xp21.3
Epileptic encephalopathy, early infantile, 1	308350	MRX87	300382	Xp21.3
Epileptic encephalopathy, early infantile, 1	308350	MRX29	300382	Xp21.3
Epileptic encephalopathy, early infantile, 1	308350	MRX32	300382	Xp21.3
Epileptic encephalopathy, early infantile, 10	613402	PNKP	605610	19q13.33
Epileptic encephalopathy, early infantile, 10	613402	PNK	605610	19q13.33
Epileptic encephalopathy, early infantile, 10	613402	MCSZ	605610	19q13.33
Epileptic encephalopathy, early infantile, 10	613402	EIEE10	605610	19q13.33
Epileptic encephalopathy, early infantile, 11	613721	SCN2A	182390	2q24.3
Epileptic encephalopathy, early infantile, 11	613721	SCN2A1	182390	2q24.3
Epileptic encephalopathy, early infantile, 11	613721	BFIC3	182390	2q24.3
Epileptic encephalopathy, early infantile, 11	613721	EIEE11	182390	2q24.3
Epileptic encephalopathy, early infantile, 11	613721	BFIS3	182390	2q24.3
Epileptic encephalopathy, early infantile, 11	613721	BFNIS	182390	2q24.3
Epileptic encephalopathy, early infantile, 12	613722	PLCB1	607120	20p12.3
Epileptic encephalopathy, early infantile, 12	613722	KIAA0581	607120	20p12.3
Epileptic encephalopathy, early infantile, 12	613722	PLCB1A	607120	20p12.3
Epileptic encephalopathy, early infantile, 12	613722	PLCB1B	607120	20p12.3
Epileptic encephalopathy, early infantile, 12	613722	EIEE12	607120	20p12.3
Epileptic encephalopathy, early infantile, 13	614558	SCN8A	600702	12q13.13
Epileptic encephalopathy, early infantile, 13	614558	CIAT	600702	12q13.13
Epileptic encephalopathy, early infantile, 13	614558	EIEE13	600702	12q13.13
Epileptic encephalopathy, early infantile, 14	614959	KCNT1	608167	9q34.3
Epileptic encephalopathy, early infantile, 14	614959	KIAA1422	608167	9q34.3
Epileptic encephalopathy, early infantile, 14	614959	EIEE14	608167	9q34.3
Epileptic encephalopathy, early infantile, 14	614959	ENFL5	608167	9q34.3
Epileptic encephalopathy, early infantile, 15	615006	ST3GAL3	606494	1p34.1
Epileptic encephalopathy, early infantile, 15	615006	SIAT6	606494	1p34.1
Epileptic encephalopathy, early infantile, 15	615006	ST3GALII	606494	1p34.1
Epileptic encephalopathy, early infantile, 15	615006	MRT12	606494	1p34.1
Epileptic encephalopathy, early infantile, 15	615006	EIEE15	606494	1p34.1
Epileptic encephalopathy, early infantile, 16	615338	TBC1D24	613577	16p13.3
Epileptic encephalopathy, early infantile, 16	615338	KIAA1171	613577	16p13.3
Epileptic encephalopathy, early infantile, 16	615338	FIME	613577	16p13.3
Epileptic encephalopathy, early infantile, 16	615338	EIEE16	613577	16p13.3
Epileptic encephalopathy, early infantile, 16	615338	DOORS	613577	16p13.3
Epileptic encephalopathy, early infantile, 17	615473	GNAO1	139311	16q12.2
Epileptic encephalopathy, early infantile, 17	615473	EIEE17	139311	16q12.2
Epileptic encephalopathy, early infantile, 18	615476	SZT2	615463	1p34.2
Epileptic encephalopathy, early infantile, 18	615476	KIAA0467	615463	1p34.2
Epileptic encephalopathy, early infantile, 18	615476	EIEE18	615463	1p34.2
Epileptic encephalopathy, early infantile, 2	300672	CDKL5	300203	Xp22.13
Epileptic encephalopathy, early infantile, 2	300672	STK9	300203	Xp22.13
Epileptic encephalopathy, early infantile, 2	300672	ISSX	300203	Xp22.13
Epileptic encephalopathy, early infantile, 2	300672	EIEE2	300203	Xp22.13
Epileptic encephalopathy, early infantile, 3	609304	SLC25A22	609302	11p15.5
Epileptic encephalopathy, early infantile, 3	609304	GC1	609302	11p15.5
Epileptic encephalopathy, early infantile, 3	609304	EIEE3	609302	11p15.5
Epileptic encephalopathy, early infantile, 4	612164	STXBP1	602926	9q34.11
Epileptic encephalopathy, early infantile, 4	612164	UNC18	602926	9q34.11
Epileptic encephalopathy, early infantile, 4	612164	EIEE4	602926	9q34.11
Epileptic encephalopathy, early infantile, 5	613477	SPTAN1	182810	9q34.11
Epileptic encephalopathy, early infantile, 5	613477	NEAS	182810	9q34.11
Epileptic encephalopathy, early infantile, 5	613477	EIEE5	182810	9q34.11
Epileptic encephalopathy, early infantile, 7	613720	KCNQ2	602235	20q13.33
Epileptic encephalopathy, early infantile, 7	613720	EBN1	602235	20q13.33
Epileptic encephalopathy, early infantile, 7	613720	EIEE7	602235	20q13.33
Epileptic encephalopathy, early infantile, 7	613720	BFNS1	602235	20q13.33
Epileptic encephalopathy, early infantile, 8	300607	ARHGEF9	300429	Xq11.1-q11.2
Epileptic encephalopathy, early infantile, 8	300607	PEM2	300429	Xq11.1-q11.2
Epileptic encephalopathy, early infantile, 8	300607	KIAA0424	300429	Xq11.1-q11.2
Epileptic encephalopathy, early infantile, 8	300607	EIEE8	300429	Xq11.1-q11.2
Epileptic encephalopathy, early infantile, 9	300088	PCDH19	300460	Xq22.1
Epileptic encephalopathy, early infantile, 9	300088	KIAA1313	300460	Xq22.1
Epileptic encephalopathy, early infantile, 9	300088	EFMR	300460	Xq22.1
Epileptic encephalopathy, early infantile, 9	300088	EIEE9	300460	Xq22.1
Epilespy, generalized, with febrile seizures plus, type 8	613828	GEFSP8		6q16.3-q22.31
Epiphyseal dysplasia, multiple 1	132400	COMP	600310	19p13.11
Epiphyseal dysplasia, multiple 1	132400	EDM1	600310	19p13.11
Epiphyseal dysplasia, multiple 1	132400	MED	600310	19p13.11
Epiphyseal dysplasia, multiple 1	132400	PSACH	600310	19p13.11
Epiphyseal dysplasia, multiple, 2	600204	COL9A2	120260	1p34.2
Epiphyseal dysplasia, multiple, 2	600204	EDM2	120260	1p34.2
Epiphyseal dysplasia, multiple, 2	600204	STL5	120260	1p34.2
Epiphyseal dysplasia, multiple, 3	600969	COL9A3	120270	20q13.33
Epiphyseal dysplasia, multiple, 3	600969	EDM3	120270	20q13.33
Epiphyseal dysplasia, multiple, 3	600969	IDD	120270	20q13.33
Epiphyseal dysplasia, multiple, 4	226900	SLC26A2	606718	5q32
Epiphyseal dysplasia, multiple, 4	226900	DTD	606718	5q32
Epiphyseal dysplasia, multiple, 4	226900	DTDST	606718	5q32
Epiphyseal dysplasia, multiple, 4	226900	D5S1708	606718	5q32
Epiphyseal dysplasia, multiple, 4	226900	EDM4	606718	5q32
Epiphyseal dysplasia, multiple, 5	607078	MATN3	602109	2p24.1
Epiphyseal dysplasia, multiple, 5	607078	EDM5	602109	2p24.1
Epiphyseal dysplasia, multiple, 5	607078	HOA	602109	2p24.1
Epiphyseal dysplasia, multiple, 5	607078	OS2	602109	2p24.1
Epiphyseal dysplasia, multiple, 6	614135	COL9A1	120210	6q13
Epiphyseal dysplasia, multiple, 6	614135	EDM6	120210	6q13
Epiphyseal dysplasia, multiple, 6	614135	STL4	120210	6q13
Epiphyseal dysplasia, multiple, with myopathy		COL9A3	120270	20q13.33
Epiphyseal dysplasia, multiple, with myopathy		EDM3	120270	20q13.33
Epiphyseal dysplasia, multiple, with myopathy		IDD	120270	20q13.33
Epiphyseal dysplasia, multiple, with myopia and deafness	132450	COL2A1	120140	12q13.11
Episodic ataxia, type 2	108500	CACNA1A	601011	19p13.2
Episodic ataxia, type 2	108500	CACNL1A4	601011	19p13.2
Episodic ataxia, type 2	108500	SCA6	601011	19p13.2
Episodic ataxia, type 3	606554	EA3		1q42
Episodic ataxia, type 5	613855	CACNB4	601949	2q23.3
Episodic ataxia, type 5	613855	EJM6	601949	2q23.3
Episodic ataxia, type 5	613855	EA5	601949	2q23.3
Episodic ataxia, type 5	613855	EIG9	601949	2q23.3
Episodic ataxia, type 6	612656	SLC1A3	600111	5p13.2
Episodic ataxia, type 6	612656	EAAT1	600111	5p13.2
Episodic ataxia, type 6	612656	EA6	600111	5p13.2
Episodic ataxia, type 7	611907	EA7		19q13
Episodic ataxia/myokymia syndrome	160120	KCNA1	176260	12p13.32
Episodic ataxia/myokymia syndrome	160120	AEMK	176260	12p13.32
Episodic ataxia/myokymia syndrome	160120	EA1	176260	12p13.32
Episodic kinesigenic dyskinesia 1	128200	PRRT2	614386	16p11.2
Episodic kinesigenic dyskinesia 1	128200	PKC	614386	16p11.2
Episodic kinesigenic dyskinesia 1	128200	DYT10	614386	16p11.2
Episodic kinesigenic dyskinesia 1	128200	EKD1	614386	16p11.2
Episodic kinesigenic dyskinesia 1	128200	BFIS2	614386	16p11.2
Episodic kinesigenic dyskinesia 1	128200	BFIC2	614386	16p11.2
Episodic kinesigenic dyskinesia 1	128200	ICCA	614386	16p11.2
Episodic kinesigenic dyskinesia 2	611031	EKD2		16q13-q22.1
Episodic muscle weakness, X-linked	300211	EMWX		Xp22.3
Episodic pain syndrome, familial, 2	615551	SCN10A	604427	3p22.2
Episodic pain syndrome, familial, 2	615551	FEPS2	604427	3p22.2
Episodic pain syndrome, familial, 3	615552	SCN11A	604385	3p22.2
Episodic pain syndrome, familial, 3	615552	HSAN7	604385	3p22.2
Episodic pain syndrome, familial, 3	615552	FEPS3	604385	3p22.2
Episodic pain syndrome, familial	615040	TRPA1	604775	8q13.3
Episodic pain syndrome, familial	615040	ANKTM1	604775	8q13.3
Episodic pain syndrome, familial	615040	FEPS	604775	8q13.3
Epsilon-trimethyllysine hydroxylase deficiency	300872	TMLHE	300777	Xq28
Epsilon-trimethyllysine hydroxylase deficiency	300872	BBOX2	300777	Xq28
Epsilon-trimethyllysine hydroxylase deficiency	300872	TMLH	300777	Xq28
Epsilon-trimethyllysine hydroxylase deficiency	300872	TMLHED	300777	Xq28
Epsilon-trimethyllysine hydroxylase deficiency	300872	AUTSX6	300777	Xq28
Epstein syndrome	153650	MYH9	160775	22q12.3
Epstein syndrome	153650	MHA	160775	22q12.3
Epstein syndrome	153650	FTNS	160775	22q12.3
Epstein syndrome	153650	DFNA17	160775	22q12.3
Epstein syndrome	153650	BDPLT6	160775	22q12.3
Erythermalgia, primary	133020	SCN9A	603415	2q24.3
Erythermalgia, primary	133020	NENA	603415	2q24.3
Erythermalgia, primary	133020	PN1	603415	2q24.3
Erythermalgia, primary	133020	FEB3B	603415	2q24.3
Erythermalgia, primary	133020	GEFSP7	603415	2q24.3
Erythermalgia, primary	133020	SFNP	603415	2q24.3
Erythremias, alpha-	141800	HBA1		16p13.3
Erythremias, alpha-	141800	HBH		16p13.3
Erythremias, beta-	141900	HBB		11p15.4
Erythrocyte lactate transporter defect	245340	SLC16A1	600682	1p13.2
Erythrocyte lactate transporter defect	245340	MCT1	600682	1p13.2
Erythrocyte lactate transporter defect	245340	HHF7	600682	1p13.2
Erythrocytosis		HBA2	141850	16p13.3
Erythrocytosis		HBH	141850	16p13.3
Erythrocytosis due to bisphosphoglycerate mutase deficiency	222800	BPGM	613896	7q33
Erythrocytosis, familial, 2	263400	VHL	608537	3p25.3
Erythrocytosis, familial, 3	609820	EGLN1	606425	1q42.2
Erythrocytosis, familial, 3	609820	PHD2	606425	1q42.2
Erythrocytosis, familial, 3	609820	HIFPH2	606425	1q42.2
Erythrocytosis, familial, 3	609820	C1orf12	606425	1q42.2
Erythrocytosis, familial, 3	609820	ZMYND6	606425	1q42.2
Erythrocytosis, familial, 3	609820	SM20	606425	1q42.2
Erythrocytosis, familial, 3	609820	ECYT3	606425	1q42.2
Erythrocytosis, familial, 4	611783	EPAS1	603349	2p21
Erythrocytosis, familial, 4	611783	MOP2	603349	2p21
Erythrocytosis, familial, 4	611783	HIF2A	603349	2p21
Erythrocytosis, familial, 4	611783	ECYT4	603349	2p21
Erythrocytosis, somatic	133100	JAK2	147796	9p24.1
Erythrocytosis, somatic	133100	THCYT3	147796	9p24.1
Erythrocytosis, somatic	133100	SH2B3	605093	12q24.12
Erythrocytosis, somatic	133100	LNK	605093	12q24.12
Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	615508	DSG1	125670	18q12.1
Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	615508	PPKS1	125670	18q12.1
Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	615508	SPPK1	125670	18q12.1
Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE	615508	EPKHE	125670	18q12.1
Erythrokeratodermia variabilis et progressiva	133200	GJB3	603324	1p34.3
Erythrokeratodermia variabilis et progressiva	133200	CX31	603324	1p34.3
Erythrokeratodermia variabilis et progressiva	133200	DFNA2B	603324	1p34.3
Erythrokeratodermia variabilis with erythema gyratum repens	133200	GJB4	605425	1p34.3
Erythrokeratodermia variabilis with erythema gyratum repens	133200	CX30.3	605425	1p34.3
Escobar syndrome	265000	CHRNG	100730	2q37.1
Escobar syndrome	265000	ACHRG	100730	2q37.1
Esophageal cancer	133239	DLEC1	604050	3p22.2
Esophageal cancer	133239	DLC1	604050	3p22.2
Esophageal cancer, somatic	133239	TGFBR2	190182	3p24.1
Esophageal cancer, somatic	133239	HNPCC6	190182	3p24.1
Esophageal cancer, somatic	133239	AAT3	190182	3p24.1
Esophageal cancer, somatic	133239	MFS2	190182	3p24.1
Esophageal cancer, somatic	133239	LDS1B	190182	3p24.1
Esophageal cancer, somatic	133239	LDS2B	190182	3p24.1
Esophageal carcinoma, somatic 133239		DCC	120470	18q21.2
Esophageal carcinoma, somatic 133239		MRMV1	120470	18q21.2
Esophageal carcinoma, somatic	133239	RNF6	604242	13q12.13
Esophageal squamous cell carcinoma	133239	DEC1	604767	9q33.1
Esophageal squamous cell carcinoma	133239	LZTS1	606551	8p21.3
Esophageal squamous cell carcinoma	133239	F37	606551	8p21.3
Esophageal squamous cell carcinoma	133239	FEZ1	606551	8p21.3
Esophageal squamous cell carcinoma	133239	WWOX	605131	16q23.1-q23.2
Esophageal squamous cell carcinoma	133239	FOR	605131	16q23.1-q23.2
Estrogen resistance	615363	ESR1	133430	6q25.1
Estrogen resistance	615363	ESR	133430	6q25.1
Estrogen resistance	615363	ESTRR	133430	6q25.1
Ethylmalonic encephalopathy	602473	ETHE1	608451	19q13.31
Ethylmalonic encephalopathy	602473	HSCO	608451	19q13.31
Ethylmalonic encephalopathy	602473	D83198	608451	19q13.31
Ewing sarcoma	612219	EWSR1	133450	22q12.2
Ewing sarcoma	612219	EWS	133450	22q12.2
Exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of Siemens-like	607936	CSTA	184600	3q21.1
Exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of Siemens-like	607936	STFA	184600	3q21.1
Exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of Siemens-like	607936	STF1	184600	3q21.1
Exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of Siemens-like	607936	AREI	184600	3q21.1
Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis	612714	COX4I2	607976	20q11.21
Exostoses, multiple, type 1	133700	EXT1	608177	8q24.11
Exostoses, multiple, type 2	133701	EXT2	608210	11p11.2
Exostoses, multiple, type 3	600209	EXT3		19p
Exudative vitreoretinopathy 4	601813	LRP5	603506	11q13.2
Exudative vitreoretinopathy 4	601813	BMND1	603506	11q13.2
Exudative vitreoretinopathy 4	601813	LRP7	603506	11q13.2
Exudative vitreoretinopathy 4	601813	LR3	603506	11q13.2
Exudative vitreoretinopathy 4	601813	OPPG	603506	11q13.2
Exudative vitreoretinopathy 4	601813	VBCH2	603506	11q13.2
Exudative vitreoretinopathy 4	601813	OPTA1	603506	11q13.2
Exudative vitreoretinopathy 4	601813	EVR4	603506	11q13.2
Exudative vitreoretinopathy 5	613310	TSPAN12	613138	7q31.31
Exudative vitreoretinopathy 5	613310	NET2	613138	7q31.31
Exudative vitreoretinopathy 5	613310	EVR5	613138	7q31.31
Exudative vitreoretinopathy	133780	FZD4	604579	11q14.2
Exudative vitreoretinopathy	133780	EVR1	604579	11q14.2
Exudative vitreoretinopathy, X-linked	305390	NDP	300658	Xp11.3
Exudative vitreoretinopathy, X-linked	305390	ND	300658	Xp11.3
Exudative vitreoretinopathy-3	605750	EVR3		11p13-p12
FG syndrome 2	300321	FLNA	300017	Xq28
FG syndrome 2	300321	FLN1	300017	Xq28
FG syndrome 2	300321	NHBP	300017	Xq28
FG syndrome 2	300321	OPD1	300017	Xq28
FG syndrome 2	300321	OPD2	300017	Xq28
FG syndrome 2	300321	FMD	300017	Xq28
FG syndrome 2	300321	MNS	300017	Xq28
FG syndrome 2	300321	CVD1	300017	Xq28
FG syndrome 2	300321	CSBS	300017	Xq28
FG syndrome 3	300406	FGS3		Xp22.3
FG syndrome 4	300422	CASK	300172	Xp11.4
FG syndrome 4	300422	MICPCH	300172	Xp11.4
FG syndrome 4	300422	FGS4	300172	Xp11.4
FG syndrome 4	300422	CMG	300172	Xp11.4
FG syndrome 4	300422	MRXSNA	300172	Xp11.4
FG syndrome 5	300581	FGS5		Xq22.3
FILS syndrome	615139	POLE1	174762	12q24.33
FILS syndrome	615139	CRCS12	174762	12q24.33
FILS syndrome	615139	FILS	174762	12q24.33
Fabry disease	301500	GLA	300644	Xq22.1
Fabry disease, cardiac variant	301500	GLA	300644	Xq22.1
Facial clefting, oblique, 1	600251	SPECC1L	614140	22q11.23
Facial clefting, oblique, 1	600251	KIAA0376	614140	22q11.23
Facial clefting, oblique, 1	600251	OBLFC1	614140	22q11.23
Facial paresis, hereditary congenital, 1	601471	HCFP1		3q21-q22
Facial paresis, hereditary congenital, 1	601471	MBS2		3q21-q22
Facial paresis, hereditary congenital, 3	614744	HOXB1	142968	17q21.32
Facial paresis, hereditary congenital, 3	614744	HOX2I	142968	17q21.32
Facial paresis, hereditary congenital, 3	614744	HCFP3	142968	17q21.32
Facioscapulohumeral muscular dystrophy 1	158900	FSHD1		4q35
Facioscapulohumeral muscular dystrophy 1	158900	FSHD1A		4q35
Factor V and factor VIII, combined deficiency of	613625	MCFD2	607788	2p21
Factor V and factor VIII, combined deficiency of	613625	F5F8D2	607788	2p21
Factor V deficiency	227400	F5	612309	1q24.2
Factor V deficiency	227400	THPH2	612309	1q24.2
Factor V deficiency	227400	RPRGL1	612309	1q24.2
Factor VII deficiency	227500	F7	613878	13q34
Factor X deficiency	227600	F10	613872	13q34
Factor XI deficiency, autosomal dominant	612416	F11	264900	4q35.2
Factor XI deficiency, autosomal recessive	612416	F11	264900	4q35.2
Factor XII deficiency	234000	F12	610619	5q35.3
Factor XII deficiency	234000	HAF	610619	5q35.3
Factor XII deficiency	234000	HAE3	610619	5q35.3
Factor XIIIA deficiency	613225	F13A1	134570	6p25.1
Factor XIIIA deficiency	613225	F13A	134570	6p25.1
Factor XIIIB deficiency	613235	F13B	134580	1q31.3
Failure of tooth eruption, primary	125350	PTHR1	168468	3p21.31
Failure of tooth eruption, primary	125350	PTHR	168468	3p21.31
Failure of tooth eruption, primary	125350	PFE	168468	3p21.31
Familial Mediterranean fever, AD	134610	MEFV	608107	16p13.3
Familial Mediterranean fever, AD	134610	MEF	608107	16p13.3
Familial Mediterranean fever, AD	134610	FMF	608107	16p13.3
Familial Mediterranean fever, AR	249100	MEFV	608107	16p13.3
Familial Mediterranean fever, AR	249100	MEF	608107	16p13.3
Familial Mediterranean fever, AR	249100	FMF	608107	16p13.3
Familial cold autoinflammatory syndrome 2	611762	NLRP12	609648	19q13.42
Familial cold autoinflammatory syndrome 2	611762	NALP12	609648	19q13.42
Familial cold autoinflammatory syndrome 2	611762	PYPAF7	609648	19q13.42
Familial cold autoinflammatory syndrome 2	611762	RNO	609648	19q13.42
Familial cold autoinflammatory syndrome 2	611762	FCAS2	609648	19q13.42
Familial cold autoinflammatory syndrome 3	614468	PLCG2	600220	16q23.3
Familial cold autoinflammatory syndrome 3	614468	FCAS3	600220	16q23.3
Familial cold autoinflammatory syndrome 3	614468	APLAID	600220	16q23.3
Fanconi anemia, complementation group A	227650	FANCA	607139	16q24.3
Fanconi anemia, complementation group A	227650	FACA	607139	16q24.3
Fanconi anemia, complementation group A	227650	FA1	607139	16q24.3
Fanconi anemia, complementation group A	227650	FA	607139	16q24.3
Fanconi anemia, complementation group A	227650	FAA	607139	16q24.3
Fanconi anemia, complementation group B	300514	FAAP95	300515	Xp22.2
Fanconi anemia, complementation group B	300514	FAAP90	300515	Xp22.2
Fanconi anemia, complementation group B	300514	FLJ34064	300515	Xp22.2
Fanconi anemia, complementation group B	300514	FANCB	300515	Xp22.2
Fanconi anemia, complementation group C	227645	FANCC	613899	9q22.32
Fanconi anemia, complementation group C	227645	FACC	613899	9q22.32
Fanconi anemia, complementation group D1	605724	BRCA2	600185	13q13.1
Fanconi anemia, complementation group D1	605724	FANCD1	600185	13q13.1
Fanconi anemia, complementation group D1	605724	BROVCA2	600185	13q13.1
Fanconi anemia, complementation group D1	605724	GLM3	600185	13q13.1
Fanconi anemia, complementation group D1	605724	PNCA2	600185	13q13.1
Fanconi anemia, complementation group D2	227646	FANCD2	613984	3p25.3
Fanconi anemia, complementation group D2	227646	FANCD	613984	3p25.3
Fanconi anemia, complementation group D2	227646	FACD	613984	3p25.3
Fanconi anemia, complementation group D2	227646	FAD	613984	3p25.3
Fanconi anemia, complementation group E	600901	FANCE	613976	6p21.31
Fanconi anemia, complementation group E	600901	FACE	613976	6p21.31
Fanconi anemia, complementation group F	603467	FANCF	613897	11p14.3
Fanconi anemia, complementation group G	614082	XRCC9	602956	9p13.3
Fanconi anemia, complementation group G	614082	FANCG	602956	9p13.3
Fanconi anemia, complementation group I	609053	FANCI	611360	15q26.1
Fanconi anemia, complementation group I	609053	KIAA1794	611360	15q26.1
Fanconi anemia, complementation group J	609054	BRIP1	605882	17q23.2
Fanconi anemia, complementation group J	609054	BACH1	605882	17q23.2
Fanconi anemia, complementation group J	609054	FANCJ	605882	17q23.2
Fanconi anemia, complementation group L	614083	PHF9	608111	2p16.1
Fanconi anemia, complementation group L	614083	FANCL	608111	2p16.1
Fanconi anemia, complementation group M	614087	FANCM	609644	14q21.2
Fanconi anemia, complementation group M	614087	KIAA1596	609644	14q21.2
Fanconi anemia, complementation group N	610832	PALB2	610355	16p12.2
Fanconi anemia, complementation group N	610832	FANCN	610355	16p12.2
Fanconi anemia, complementation group N	610832	PNCA3	610355	16p12.2
Fanconi anemia, complementation group O	613390	RAD51C	602774	17q22
Fanconi anemia, complementation group O	613390	FANCO	602774	17q22
Fanconi anemia, complementation group O	613390	BROVCA3	602774	17q22
Fanconi anemia, complementation group P	613951	SLX4	613278	16p13.3
Fanconi anemia, complementation group P	613951	BTBD12	613278	16p13.3
Fanconi anemia, complementation group P	613951	MUS312	613278	16p13.3
Fanconi anemia, complementation group P	613951	KIAA1784	613278	16p13.3
Fanconi anemia, complementation group P	613951	KIAA1987	613278	16p13.3
Fanconi anemia, complementation group P	613951	FANCP	613278	16p13.3
Fanconi anemia, complementation group Q	615272	ERCC4	133520	16p13.12
Fanconi anemia, complementation group Q	615272	XPF	133520	16p13.12
Fanconi anemia, complementation group Q	615272	FANCQ	133520	16p13.12
Fanconi renotubular syndrome 1	134600	FRTS1		15q15.3
Fanconi renotubular syndrome 1	134600	FRTS		15q15.3
Fanconi renotubular syndrome 1	134600	RFS		15q15.3
Fanconi renotubular syndrome 2	613388	SLC34A1	182309	5q35.3
Fanconi renotubular syndrome 2	613388	SLC17A2	182309	5q35.3
Fanconi renotubular syndrome 2	613388	NPT2	182309	5q35.3
Fanconi renotubular syndrome 2	613388	NPHLOP1	182309	5q35.3
Fanconi renotubular syndrome 2	613388	FRTS2	182309	5q35.3
Fanconi-Bickel syndrome	227810	SLC2A2	138160	3q26.2
Fanconi-Bickel syndrome	227810	GLUT2	138160	3q26.2
Farber lipogranulomatosis	228000	ASAH1	613468	8p22
Farber lipogranulomatosis	228000	AC	613468	8p22
Farber lipogranulomatosis	228000	SMAPME	613468	8p22
Fascioscapulohumeral muscular dystrophy 2, digenic	158901	SMCHD1	614982	18p11.32
Fascioscapulohumeral muscular dystrophy 2, digenic	158901	KIAA0650	614982	18p11.32
Fatty liver, acute, of pregnancy	609016	HADHA	600890	2p23.3
Fatty liver, acute, of pregnancy	609016	MTPA	600890	2p23.3
Favism	134700	G6PD	305900	Xq28
Favism	134700	G6PD1	305900	Xq28
Fazio-Londe disease	211500	SLC52A3	613350	20p13
Fazio-Londe disease	211500	C20orf54	613350	20p13
Fazio-Londe disease	211500	RFT2	613350	20p13
Fazio-Londe disease	211500	BVVLS1	613350	20p13
Febrile seizures, familial, 1	121210	FEB1		8q13-q21
Febrile seizures, familial, 10	612637	FEB10		3q26.2-q26.33
Febrile seizures, familial, 11	614418	CPA6	609562	8q13.2
Febrile seizures, familial, 11	614418	CPAH	609562	8q13.2
Febrile seizures, familial, 11	614418	ETL5	609562	8q13.2
Febrile seizures, familial, 11	614418	FEB11	609562	8q13.2
Febrile seizures, familial, 2	602477	FEB2		19p13.3
Febrile seizures, familial, 3A	604403	SCN1A	182389	2q24.3
Febrile seizures, familial, 3A	604403	GEFSP2	182389	2q24.3
Febrile seizures, familial, 3A	604403	SMEI	182389	2q24.3
Febrile seizures, familial, 3A	604403	FEB3A	182389	2q24.3
Febrile seizures, familial, 3A	604403	EIEE6	182389	2q24.3
Febrile seizures, familial, 3A	604403	FHM3	182389	2q24.3
Febrile seizures, familial, 3B	613863	SCN9A	603415	2q24.3
Febrile seizures, familial, 3B	613863	NENA	603415	2q24.3
Febrile seizures, familial, 3B	613863	PN1	603415	2q24.3
Febrile seizures, familial, 3B	613863	FEB3B	603415	2q24.3
Febrile seizures, familial, 3B	613863	GEFSP7	603415	2q24.3
Febrile seizures, familial, 3B	613863	SFNP	603415	2q24.3
Febrile seizures, familial, 4	604352	GPR98	602851	5q14.3
Febrile seizures, familial, 4	604352	MASS1	602851	5q14.3
Febrile seizures, familial, 4	604352	VLGR1	602851	5q14.3
Febrile seizures, familial, 4	604352	KIAA0686	602851	5q14.3
Febrile seizures, familial, 4	604352	FEB4	602851	5q14.3
Febrile seizures, familial, 4	604352	USH2C	602851	5q14.3
Febrile seizures, familial, 5	609255	FEB5		6q22-q24
Febrile seizures, familial, 6	609253	FEB6		18p11.2
Febrile seizures, familial, 7	611515	FEB7		21q22
Febrile seizures, familial, 8	611277	GABRG2	137164	5q34
Febrile seizures, familial, 8	611277	GEFSP3	137164	5q34
Febrile seizures, familial, 8	611277	CAE2	137164	5q34
Febrile seizures, familial, 8	611277	ECA2	137164	5q34
Febrile seizures, familial, 9	611634	FEB9		3p24.2-p23
Fechtner syndrome	153640	MYH9	160775	22q12.3
Fechtner syndrome	153640	MHA	160775	22q12.3
Fechtner syndrome	153640	FTNS	160775	22q12.3
Fechtner syndrome	153640	DFNA17	160775	22q12.3
Fechtner syndrome	153640	BDPLT6	160775	22q12.3
Feingold syndrome 2	614326	MIR17HG	609415	13q31.3
Feingold syndrome 2	614326	MIRH1	609415	13q31.3
Feingold syndrome 2	614326	MIHG1	609415	13q31.3
Feingold syndrome 2	614326	MIRHG1	609415	13q31.3
Feingold syndrome 2	614326	C13orf25	609415	13q31.3
Feingold syndrome 2	614326	FGLDS2	609415	13q31.3
Feingold syndrome	164280	MYCN	164840	2p24.3
Feingold syndrome	164280	NMYC	164840	2p24.3
Feingold syndrome	164280	ODED	164840	2p24.3
Feingold syndrome	164280	MODED	164840	2p24.3
Fertile eunuch syndrome	228300	GNRHR	138850	4q13.2
Fertile eunuch syndrome	228300	LHRHR	138850	4q13.2
Fertile eunuch syndrome	228300	HH7	138850	4q13.2
Fetal akinesia deformation sequence	208150	DOK7	610285	4p16.3
Fetal akinesia deformation sequence	208150	C4orf25	610285	4p16.3
Fetal akinesia deformation sequence	208150	CMS1B	610285	4p16.3
Fetal akinesia deformation sequence	208150	RAPSN	601592	11p11.2
Fetal akinesia deformation sequence	208150	CMS1D	601592	11p11.2
Fetal akinesia deformation sequence	208150	CMS1E	601592	11p11.2
Fetal hemoglobin quantitative trait locus 1	141749	HBG1	142200	11p15.4
Fetal hemoglobin quantitative trait locus 1	141749	HBG2	142250	11p15.4
Fetal hemoglobin quantitative trait locus 1	141749	TNCY	142250	11p15.4
Fetal hemoglobin quantitative trait locus 2	142470	HBFQTL2		6q22.3-q23.1
Fetal hemoglobin quantitative trait locus 2	142470	FCP		6q22.3-q23.1
Fetal hemoglobin quantitative trait locus 3	305435	HBFQTL3		Xp22.2
Fetal hemoglobin quantitative trait locus 3	305435	FCP1		Xp22.2
Fetal hemoglobin quantitative trait locus 3	305435	FCPX		Xp22.2
Fetal hemoglobin quantitative trait locus 3	305435	FCP		Xp22.2
Fetal hemoglobin quantitative trait locus 4	606789	HBFQTL4		8q
Fibrochondrogenesis 2	614524	COL11A2	120290	6p21.32
Fibrochondrogenesis 2	614524	STL3	120290	6p21.32
Fibrochondrogenesis 2	614524	DFNA13	120290	6p21.32
Fibrochondrogenesis 2	614524	DFNB53	120290	6p21.32
Fibrochondrogenesis 2	614524	FBCG2	120290	6p21.32
Fibrochondrogenesis	228520	COL11A1	120280	1p21.1
Fibrochondrogenesis	228520	STL2	120280	1p21.1
Fibrodysplasia ossificans progressiva	135100	ACVR1	102576	2q24.1
Fibrodysplasia ossificans progressiva	135100	ACVRLK2	102576	2q24.1
Fibrodysplasia ossificans progressiva	135100	ALK2	102576	2q24.1
Fibrodysplasia ossificans progressiva	135100	FOP	102576	2q24.1
Fibromatosis, gingival	135300	SOS1	182530	2p22.1
Fibromatosis, gingival	135300	GINGF	182530	2p22.1
Fibromatosis, gingival	135300	GF1	182530	2p22.1
Fibromatosis, gingival	135300	HGF	182530	2p22.1
Fibromatosis, gingival	135300	NS4	182530	2p22.1
Fibromatosis, gingival, 2	605544	GINGF2		5q13-q22
Fibromatosis, gingival, 2	605544	GGF2		5q13-q22
Fibromatosis, gingival, 2	605544	HGF2		5q13-q22
Fibromatosis, gingival, 3	609955	GINGF3		2p23.3-p22.3
Fibromatosis, gingival, 3	609955	HGF3		2p23.3-p22.3
Fibromatosis, gingival, 3	609955	GGF3		2p23.3-p22.3
Fibromatosis, gingival, 4	611010	GINGF4		11p15
Fibromatosis, gingival, 4	611010	HGF4		11p15
Fibromatosis, gingival, 4	611010	GGF4		11p15
Fibrosis of extraocular muscles, congenital, 1	135700	KIF21A	608283	12q12
Fibrosis of extraocular muscles, congenital, 1	135700	KIAA1708	608283	12q12
Fibrosis of extraocular muscles, congenital, 1	135700	FEOM1	608283	12q12
Fibrosis of extraocular muscles, congenital, 1	135700	CFEOM1	608283	12q12
Fibrosis of extraocular muscles, congenital, 1	135700	CFEOM3B	608283	12q12
Fibrosis of extraocular muscles, congenital, 2	602078	PHOX2A	602753	11q13.4
Fibrosis of extraocular muscles, congenital, 2	602078	ARIX	602753	11q13.4
Fibrosis of extraocular muscles, congenital, 2	602078	CFEOM2	602753	11q13.4
Fibrosis of extraocular muscles, congenital, 3A	600638	TUBB3	602661	16q24.3
Fibrosis of extraocular muscles, congenital, 3A	600638	TUBB4	602661	16q24.3
Fibrosis of extraocular muscles, congenital, 3A	600638	CFEOM3A	602661	16q24.3
Fibrosis of extraocular muscles, congenital, 3A	600638	CDCBM1	602661	16q24.3
Fibrosis of extraocular muscles, congenital, 3B	135700	KIF21A	608283	12q12
Fibrosis of extraocular muscles, congenital, 3B	135700	KIAA1708	608283	12q12
Fibrosis of extraocular muscles, congenital, 3B	135700	FEOM1	608283	12q12
Fibrosis of extraocular muscles, congenital, 3B	135700	CFEOM1	608283	12q12
Fibrosis of extraocular muscles, congenital, 3B	135700	CFEOM3B	608283	12q12
Fibrosis of extraocular muscles, congenital, 3C	609384	CFEOM3C		13q12.11
Fibrosis of extraocular muscles, congenital, 3C	609384	FEOM4		13q12.11
Fish-eye disease	136120	LCAT	606967	16q22.1
Fleck retina, familial benign	228980	PLA2G5	601192	1p36.13-p36.12
Fleck retina, familial benign	228980	FRFB	601192	1p36.13-p36.12
Fletcher factor deficiency	612423	KLKB1	229000	4q35.2
Fletcher factor deficiency	612423	KLK3	229000	4q35.2
Floating-Harbor syndrome	136140	SRCAP	611421	16p11.2
Floating-Harbor syndrome	136140	SWR1	611421	16p11.2
Floating-Harbor syndrome	136140	KIAA0309	611421	16p11.2
Floating-Harbor syndrome	136140	FLHS	611421	16p11.2
Focal cortical dysplasia, Taylor balloon cell type	607341	TSC1	605284	9q34.13
Focal cortical dysplasia, Taylor balloon cell type	607341	LAM	605284	9q34.13
Focal dermal hypoplasia	305600	PORCN	300651	Xp11.23
Focal dermal hypoplasia	305600	PORC	300651	Xp11.23
Focal dermal hypoplasia	305600	DHOF	300651	Xp11.23
Focal dermal hypoplasia	305600	FODH	300651	Xp11.23
Focal facial dermal dysplasia 3, Setleis type	227260	TWIST2	607556	2q37.3
Focal facial dermal dysplasia 3, Setleis type	227260	DERMO1	607556	2q37.3
Focal facial dermal dysplasia 3, Setleis type	227260	SETLSS	607556	2q37.3
Focal facial dermal dysplasia 3, Setleis type	227260	FFDD3	607556	2q37.3
Focal facial dermal dysplasia 4	614974	CYP26C1	608428	10q23.33
Focal facial dermal dysplasia 4	614974	FFDD4	608428	10q23.33
Folate malabsorption, hereditary	229050	SLC46A1	611672	17q11.2
Folate malabsorption, hereditary	229050	HCP1	611672	17q11.2
Folate malabsorption, hereditary	229050	PCFT	611672	17q11.2
Follicle-stimulating hormone deficiency, isolated	229070	FSHB	136530	11p14.1
Forebrain defects	187395	TDGF1		3p21.31
Forsythe-Wakeling syndrome	613606	FWS		1p33-p31.1
Foveal hyperplasia	136520	PAX6	607108	11p13
Foveal hyperplasia	136520	AN2	607108	11p13
Foveal hyperplasia	136520	MGDA	607108	11p13
Foveal hypoplasia and anterior segment dysgenesis	609218	FHASD		16q23.2-q24.2
Foveomacular dystrophy, adult-onset, with choroidal neovascularization	608161	PRPH2	179605	6p21.1
Foveomacular dystrophy, adult-onset, with choroidal neovascularization	608161	DS	179605	6p21.1
Foveomacular dystrophy, adult-onset, with choroidal neovascularization	608161	RP7	179605	6p21.1
Foveomacular dystrophy, adult-onset, with choroidal neovascularization	608161	PRPH	179605	6p21.1
Foveomacular dystrophy, adult-onset, with choroidal neovascularization	608161	AVMD	179605	6p21.1
Foveomacular dystrophy, adult-onset, with choroidal neovascularization	608161	AOFMD	179605	6p21.1
Foveomacular dystrophy, adult-onset, with choroidal neovascularization	608161	CACD2	179605	6p21.1
Fragile X syndrome	300624	FMR1	309550	Xq27.3
Fragile X syndrome	300624	FRAXA	309550	Xq27.3
Fragile X syndrome	300624	POF1	309550	Xq27.3
Fragile X tremor/ataxia syndrome	300623	FMR1	309550	Xq27.3
Fragile X tremor/ataxia syndrome	300623	FRAXA	309550	Xq27.3
Fragile X tremor/ataxia syndrome	300623	POF1	309550	Xq27.3
Frank-ter Haar syndrome	249420	SH3PXD2B	613293	5q35.1
Frank-ter Haar syndrome	249420	TKS4	613293	5q35.1
Frank-ter Haar syndrome	249420	KIAA1295	613293	5q35.1
Frank-ter Haar syndrome	249420	FTHS	613293	5q35.1
Fraser syndrome	219000	FRAS1	607830	4q21.21
Fraser syndrome	219000	FREM2	608945	13q13.3
Fraser syndrome	219000	GRIP1	604597	12q14.3
Frasier syndrome	136680	WT1	607102	11p13
Frasier syndrome	136680	NPHS4	607102	11p13
Friedreich ataxia 2	601992	FRDA2		9p23-p11
Friedreich ataxia with retained reflexes	229300	FXN	606829	9q21.11
Friedreich ataxia with retained reflexes	229300	FRDA	606829	9q21.11
Friedreich ataxia with retained reflexes	229300	FARR	606829	9q21.11
Friedreich ataxia with retained reflexes	229300	X25	606829	9q21.11
Friedreich ataxia	229300	FXN	606829	9q21.11
Friedreich ataxia	229300	FRDA	606829	9q21.11
Friedreich ataxia	229300	FARR	606829	9q21.11
Friedreich ataxia	229300	X25	606829	9q21.11
Frontometaphyseal dysplasia	305620	FLNA	300017	Xq28
Frontometaphyseal dysplasia	305620	FLN1	300017	Xq28
Frontometaphyseal dysplasia	305620	NHBP	300017	Xq28
Frontometaphyseal dysplasia	305620	OPD1	300017	Xq28
Frontometaphyseal dysplasia	305620	OPD2	300017	Xq28
Frontometaphyseal dysplasia	305620	FMD	300017	Xq28
Frontometaphyseal dysplasia	305620	MNS	300017	Xq28
Frontometaphyseal dysplasia	305620	CVD1	300017	Xq28
Frontometaphyseal dysplasia	305620	CSBS	300017	Xq28
Frontonasal dysplasia 1	136760	ALX3	606014	1p13.3
Frontonasal dysplasia 1	136760	FND1	606014	1p13.3
Frontonasal dysplasia 2	613451	ALX4	605420	11p11.2
Frontonasal dysplasia 2	613451	PFM2	605420	11p11.2
Frontonasal dysplasia 2	613451	FPP	605420	11p11.2
Frontonasal dysplasia 2	613451	FND2	605420	11p11.2
Frontonasal dysplasia 2	613451	CRS5	605420	11p11.2
Frontonasal dysplasia 3	613456	ALX1	601527	12q21.31
Frontonasal dysplasia 3	613456	CART1	601527	12q21.31
Frontonasal dysplasia 3	613456	FND3	601527	12q21.31
Frontotemporal lobar degeneration with ubiquitin-positive inclusions	607485	GRN	138945	17q21.31
Frontotemporal lobar degeneration with ubiquitin-positive inclusions	607485	CLN11	138945	17q21.31
Frontotemporal lobar degeneration, TARDBP-related	612069	TARDBP	605078	1p36.22
Frontotemporal lobar degeneration, TARDBP-related	612069	TDP43	605078	1p36.22
Frontotemporal lobar degeneration, TARDBP-related	612069	ALS10	605078	1p36.22
Fructose intolerance	229600	ALDOB	612724	9q31.1
Fructose-1,6-bidphosphatase deficiency	229700	FBP1	611570	9q22.32
Fucosidosis	230000	FUCA1	612280	1p36.11
Fucosyltransferase 6 deficiency	613852	FUT6	136836	19p13.3
Fuhrmann syndrome	228930	WNT7A	601570	3p25.1
Fumarase deficiency	606812	FH	136850	1q43
Fumarase deficiency	606812	HLRCC	136850	1q43
Fumarase deficiency	606812	MCUL1	136850	1q43
Fundus albipunctatus	136880	RDH5	601617	12q13.2
Fundus albipunctatus	136880	RLBP1	180090	15q26.1
Fundus flavimaculatus	248200	ABCA4	601691	1p22.1
Fundus flavimaculatus	248200	ABCR	601691	1p22.1
Fundus flavimaculatus	248200	STGD1	601691	1p22.1
Fundus flavimaculatus	248200	FFM	601691	1p22.1
Fundus flavimaculatus	248200	RP19	601691	1p22.1
Fundus flavimaculatus	248200	CORD3	601691	1p22.1
Fundus flavimaculatus	248200	ARMD2	601691	1p22.1
GABA-transaminase deficiency	613163	ABAT	137150	16p13.2
GABA-transaminase deficiency	613163	GABAT	137150	16p13.2
GAPO syndrome	230740	ANTXR1	606410	2p13.3
GAPO syndrome	230740	TEM8	606410	2p13.3
GAPO syndrome	230740	ATR	606410	2p13.3
GAPO syndrome	230740	GAPO	606410	2p13.3
GLUT1 deficiency syndrome 1	606777	SLC2A1	138140	1p34.2
GLUT1 deficiency syndrome 1	606777	GLUT1	138140	1p34.2
GLUT1 deficiency syndrome 1	606777	DYT18	138140	1p34.2
GLUT1 deficiency syndrome 1	606777	PED	138140	1p34.2
GLUT1 deficiency syndrome 1	606777	GLUT1DS	138140	1p34.2
GLUT1 deficiency syndrome 1	606777	EIG12	138140	1p34.2
GLUT1 deficiency syndrome 1	606777	DYT9	138140	1p34.2
GLUT1 deficiency syndrome 2	612126	SLC2A1	138140	1p34.2
GLUT1 deficiency syndrome 2	612126	GLUT1	138140	1p34.2
GLUT1 deficiency syndrome 2	612126	DYT18	138140	1p34.2
GLUT1 deficiency syndrome 2	612126	PED	138140	1p34.2
GLUT1 deficiency syndrome 2	612126	GLUT1DS	138140	1p34.2
GLUT1 deficiency syndrome 2	612126	EIG12	138140	1p34.2
GLUT1 deficiency syndrome 2	612126	DYT9	138140	1p34.2
GM1-gangliosidosis, type I	230500	GLB1	611458	3p22.3
GM1-gangliosidosis, type I	230500	MPS4B	611458	3p22.3
GM1-gangliosidosis, type II	230600	GLB1	611458	3p22.3
GM1-gangliosidosis, type II	230600	MPS4B	611458	3p22.3
GM1-gangliosidosis, type III	230650	GLB1	611458	3p22.3
GM1-gangliosidosis, type III	230650	MPS4B	611458	3p22.3
GM2-gangliosidosis, AB variant	272750	GM2A	613109	5q33.1
GM2-gangliosidosis, several forms	272800	HEXA	606869	15q23
GM2-gangliosidosis, several forms	272800	TSD	606869	15q23
GRACILE syndrome	603358	BCS1L	603647	2q35
GRACILE syndrome	603358	FLNMS	603647	2q35
GRACILE syndrome	603358	GRACILE	603647	2q35
GRACILE syndrome	603358	BJS	603647	2q35
GRACILE syndrome	603358	PTD	603647	2q35
GRACILE syndrome	603358	MC3DN1	603647	2q35
Galactokinase deficiency with cataracts	230200	GALK1	604313	17q25.1
Galactose epimerase deficiency	230350	GALE	606953	1p36.11
Galactosemia	230400	GALT	606999	9p13.3
Galactosialidosis	256540	CTSA	613111	20q13.12
Galactosialidosis	256540	PPGB	613111	20q13.12
Galactosialidosis	256540	GSL	613111	20q13.12
Galactosialidosis	256540	NGBE	613111	20q13.12
Galactosialidosis	256540	GLB2	613111	20q13.12
Gallbladder disease 1	600803	ABCB4	171060	7q21.12
Gallbladder disease 1	600803	PGY3	171060	7q21.12
Gallbladder disease 1	600803	MDR3	171060	7q21.12
Gallbladder disease 1	600803	ICP3	171060	7q21.12
Gallbladder disease 2	609918	GBD2		1p36.21
Gallbladder disease 3	609919	GBD3		1p34.3
Gallbladder disease 4	611465	ABCG8	605460	2p21
Gallbladder disease 4	611465	GBD4	605460	2p21
Gardner syndrome	175100	APC	611731	5q22.2
Gardner syndrome	175100	GS	611731	5q22.2
Gardner syndrome	175100	FPC	611731	5q22.2
Gardner syndrome	175100	BTPS2	611731	5q22.2
Gastric cancer, familial diffuse, with or without cleft lip and/or palate	137215	CDH1	192090	16q22.1
Gastric cancer, familial diffuse, with or without cleft lip and/or palate	137215	UVO	192090	16q22.1
Gastric cancer, familial diffuse, with or without cleft lip and/or palate	137215	LCAM	192090	16q22.1
Gastric cancer, familial diffuse, with or without cleft lip and/or palate	137215	ECAD	192090	16q22.1
Gastric cancer, somatic	137215	KRAS	190070	12p12.1
Gastric cancer, somatic	137215	KRAS2	190070	12p12.1
Gastric cancer, somatic	137215	RASK2	190070	12p12.1
Gastric cancer, somatic	137215	NS	190070	12p12.1
Gastric cancer, somatic	137215	CFC2	190070	12p12.1
Gastric cancer, somatic	613659	APC	611731	5q22.2
Gastric cancer, somatic	613659	GS	611731	5q22.2
Gastric cancer, somatic	613659	FPC	611731	5q22.2
Gastric cancer, somatic	613659	BTPS2	611731	5q22.2
Gastric cancer, somatic	613659	CASP10	601762	2q33.1
Gastric cancer, somatic	613659	MCH4	601762	2q33.1
Gastric cancer, somatic	613659	ALPS2	601762	2q33.1
Gastric cancer, somatic	613659	ERBB2	164870	17q12
Gastric cancer, somatic	613659	NGL	164870	17q12
Gastric cancer, somatic	613659	NEU	164870	17q12
Gastric cancer, somatic	613659	HER2	164870	17q12
Gastric cancer, somatic	613659	FGFR2	176943	10q26.13
Gastric cancer, somatic	613659	BEK	176943	10q26.13
Gastric cancer, somatic	613659	CFD1	176943	10q26.13
Gastric cancer, somatic	613659	JWS	176943	10q26.13
Gastric cancer, somatic	613659	TK14	176943	10q26.13
Gastric cancer, somatic	613659	BBDS	176943	10q26.13
Gastric cancer, somatic	613659	IRF1	147575	5q31.1
Gastric cancer, somatic	613659	MAR	147575	5q31.1
Gastric cancer, somatic	613659	KLF6	602053	10p15.1
Gastric cancer, somatic	613659	COPEB	602053	10p15.1
Gastric cancer, somatic	613659	BCD1	602053	10p15.1
Gastric cancer, somatic	613659	ZF9	602053	10p15.1
Gastric cancer, somatic	613659	MUTYH	604933	1p34.1
Gastric cancer, somatic	613659	MYH	604933	1p34.1
Gastric cancer, somatic	613659	PIK3CA	171834	3q26.32
Gastric cancer, somatic	613659	CLOVE	171834	3q26.32
Gastric cancer, somatic	613659	MCAP	171834	3q26.32
Gastric cancer, somatic	613659	MCM	171834	3q26.32
Gastric cancer, somatic	613659	MCMTC	171834	3q26.32
Gastric cancer, somatic	613659	CWS5	171834	3q26.32
Gastroesophageal reflux	109350	GER		13q14
Gastrointestinal stromal tumor	606764	SDHB	185470	1p36.13
Gastrointestinal stromal tumor	606764	SDH2	185470	1p36.13
Gastrointestinal stromal tumor	606764	SDHIP	185470	1p36.13
Gastrointestinal stromal tumor	606764	PGL4	185470	1p36.13
Gastrointestinal stromal tumor	606764	CWS2	185470	1p36.13
Gastrointestinal stromal tumor	606764	SDHC	602413	1q23.3
Gastrointestinal stromal tumor	606764	PGL3	602413	1q23.3
Gastrointestinal stromal tumor, familial	606764	KIT	164920	4q12
Gastrointestinal stromal tumor, familial	606764	PBT	164920	4q12
Gastrointestinal stromal tumor, somatic	606764	PDGFRA	173490	4q12
Gaucher disease, atypical	610539	PSAP	176801	10q22.1
Gaucher disease, atypical	610539	SAP1	176801	10q22.1
Gaucher disease, perinatal lethal	608013	GBA	606463	1q22
Gaucher disease, type I	230800	GBA	606463	1q22
Gaucher disease, type II	230900	GBA	606463	1q22
Gaucher disease, type III	231000	GBA	606463	1q22
Gaucher disease, type IIIC	231005	GBA	606463	1q22
Gaze palsy, horizontal, with progressive scoliosis	607313	ROBO3	608630	11q24.2
Gaze palsy, horizontal, with progressive scoliosis	607313	RBIG1	608630	11q24.2
Gaze palsy, horizontal, with progressive scoliosis	607313	RIG1	608630	11q24.2
Gaze palsy, horizontal, with progressive scoliosis	607313	HGPPS	608630	11q24.2
Geleophysic dysplasia 1	231050	ADAMTSL2	612277	9q34.2
Geleophysic dysplasia 1	231050	KIAA0605	612277	9q34.2
Geleophysic dysplasia 1	231050	GPHYSD1	612277	9q34.2
Geleophysic dysplasia 2	614185	FBN1	134797	15q21.1
Geleophysic dysplasia 2	614185	MFS1	134797	15q21.1
Geleophysic dysplasia 2	614185	WMS2	134797	15q21.1
Geleophysic dysplasia 2	614185	SSKS	134797	15q21.1
Geleophysic dysplasia 2	614185	GPHYSD2	134797	15q21.1
Geleophysic dysplasia 2	614185	ACMICD	134797	15q21.1
Geleophysic dysplasia 2	614185	ECTOL1	134797	15q21.1
Generalized epilepsy and paroxysmal dyskinesia	609446	KCNMA1	600150	10q22.3
Generalized epilepsy and paroxysmal dyskinesia	609446	SLO	600150	10q22.3
Geniospasm	190100	GSM1		9q13-q21
Geniospasm	190100	GSP		9q13-q21
Genitopatellar syndrome	606170	KAT6B	605880	10q22.2
Genitopatellar syndrome	606170	MYST4	605880	10q22.2
Genitopatellar syndrome	606170	MORF	605880	10q22.2
Genitopatellar syndrome	606170	GTPTS	605880	10q22.2
Germ cell tumors	273300	KIT	164920	4q12
Germ cell tumors	273300	PBT	164920	4q12
Geroderma osteodysplasticum	231070	GORAB	607983	1q24.2
Geroderma osteodysplasticum	231070	SCYL1BP1	607983	1q24.2
Geroderma osteodysplasticum	231070	NTKLBP1	607983	1q24.2
Geroderma osteodysplasticum	231070	GO	607983	1q24.2
Gerstmann-Straussler disease	137440	PRNP	176640	20p13
Gerstmann-Straussler disease	137440	PRIP	176640	20p13
Gerstmann-Straussler disease	137440	KURU	176640	20p13
Gerstmann-Straussler disease	137440	CJD	176640	20p13
Ghosal hematodiaphyseal syndrome	231095	TBXAS1	274180	7q34
Ghosal hematodiaphyseal syndrome	231095	GHOSAL	274180	7q34
Ghosal hematodiaphyseal syndrome	231095	CYP5	274180	7q34
Ghosal hematodiaphyseal syndrome	231095	BDPLT14	274180	7q34
Giant axonal neuropathy-1	256850	GAN	605379	16q23.2
Giant axonal neuropathy-1	256850	GAN1	605379	16q23.2
Giant platelet disorder, isolated	231200	GP1BB	138720	22q11.21
Giant platelet disorder, isolated	231200	BS	138720	22q11.21
Giant platelet disorder, isolated	231200	BDPLT1	138720	22q11.21
Gigantism due to GHRF hypersecretion		GHRH	139190	20q11.23
Gigantism due to GHRF hypersecretion		GHRF	139190	20q11.23
Gillespie syndrome	206700	PAX6	607108	11p13
Gillespie syndrome	206700	AN2	607108	11p13
Gillespie syndrome	206700	MGDA	607108	11p13
Gitelman syndrome	263800	SLC12A3	600968	16q13
Gitelman syndrome	263800	NCCT	600968	16q13
Gitelman syndrome	263800	TSC	600968	16q13
Glanzmann thrombasthenia	273800	ITGA2B	607759	17q21.31
Glanzmann thrombasthenia	273800	GP2B	607759	17q21.31
Glanzmann thrombasthenia	273800	CD41B	607759	17q21.31
Glanzmann thrombasthenia	273800	GT	607759	17q21.31
Glanzmann thrombasthenia	273800	BDPLT2	607759	17q21.31
Glanzmann thrombasthenia	273800	BDPLT16	607759	17q21.31
Glanzmann thrombasthenia	273800	ITGB3	173470	17q21.32
Glanzmann thrombasthenia	273800	GP3A	173470	17q21.32
Glanzmann thrombasthenia	273800	GT	173470	17q21.32
Glanzmann thrombasthenia	273800	BDPLT2	173470	17q21.32
Glanzmann thrombasthenia	273800	BDPLT16	173470	17q21.32
Glass syndrome	119540	SATB2	608148	2q33.1
Glass syndrome	119540	KIAA1034	608148	2q33.1
Glaucoma 1, open angle, 1O	613100	NTF4 	162662	19q13.33
Glaucoma 1, open angle, 1O	613100	NTF5	162662	19q13.33
Glaucoma 1, open angle, 1O	613100	NT5	162662	19q13.33
Glaucoma 1, open angle, 1O	613100	NT4	162662	19q13.33
Glaucoma 1, open angle, 1O	613100	GLC1O	162662	19q13.33
Glaucoma 1, open angle, E	137760	OPTN	602432	10p13
Glaucoma 1, open angle, E	137760	GLC1E	602432	10p13
Glaucoma 1, open angle, E	137760	FIP2	602432	10p13
Glaucoma 1, open angle, E	137760	HYPL	602432	10p13
Glaucoma 1, open angle, E	137760	NRP	602432	10p13
Glaucoma 1, open angle, E	137760	ALS12	602432	10p13
Glaucoma 1, open angle, F	603383	ASB10	615054	7q36.1
Glaucoma 1, open angle, F	603383	GLC1F	615054	7q36.1
Glaucoma 1, open angle, G	609887	WDR36	609669	5q22.1
Glaucoma 1, open angle, G	609887	TAWDRP	609669	5q22.1
Glaucoma 1, open angle, G	609887	GLC1G	609669	5q22.1
Glaucoma 1, open angle, H	611276	GLC1H		2p16-p15
Glaucoma 1, open angle, I	609745	GLC1I		15q11-q13
Glaucoma 1, open angle, M	610535	GLC1M		5q22.1-q32
Glaucoma 1, open angle, P	177700	GLC1P		12q14
Glaucoma 1A, primary open angle	137750	MYOC	601652	1q24.3
Glaucoma 1A, primary open angle	137750	TIGR	601652	1q24.3
Glaucoma 1A, primary open angle	137750	GLC1A	601652	1q24.3
Glaucoma 1A, primary open angle	137750	JOAG	601652	1q24.3
Glaucoma 1A, primary open angle	137750	GPOA	601652	1q24.3
Glaucoma 1B, primary open angle, adult onset,	606689	GLC1B		2cen-q13
Glaucoma 1C, primary open angle	601682	GLC1C		3q21-q24
Glaucoma 1D, primary open angle	602429	GLC1D		8q23
Glaucoma 1K, primary open angle, juvenile-onset	608696	GLC1K		20p12
Glaucoma 1K, primary open angle, juvenile-onset	608696	JOAG3		20p12
Glaucoma 3, primary congenital, C	613085	GLC3C		14q24.3
Glaucoma 3, primary congenital, D	613086	LTBP2	602091	14q24.3
Glaucoma 3, primary congenital, D	613086	LTBP3	602091	14q24.3
Glaucoma 3, primary congenital, D	613086	GLC3D	602091	14q24.3
Glaucoma 3, primary congenital, D	613086	MSPKA	602091	14q24.3
Glaucoma 3, primary congenital, D	613086	WMS3	602091	14q24.3
Glaucoma 3, primary infantile, B	600975	GLC3B		1p36.2-p36.1
Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	231300	CYP1B1	601771	2p22.2
Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset	231300	GLC3A	601771	2p22.2
Glaucoma, primary open angle, juvenile-onset, 2	608695	JOAG2		9q22
Glioblastoma, somatic	137800	ERBB2	164870	17q12
Glioblastoma, somatic	137800	NGL	164870	17q12
Glioblastoma, somatic	137800	NEU	164870	17q12
Glioblastoma, somatic	137800	HER2	164870	17q12
Glomerulocystic kidney disease with hyperuricemia and isosthenuria	609886	UMOD	191845	16p12.3
Glomerulocystic kidney disease with hyperuricemia and isosthenuria	609886	HNFJ1	191845	16p12.3
Glomerulocystic kidney disease with hyperuricemia and isosthenuria	609886	FJHN	191845	16p12.3
Glomerulocystic kidney disease with hyperuricemia and isosthenuria	609886	MCKD2	191845	16p12.3
Glomerulocystic kidney disease with hyperuricemia and isosthenuria	609886	ADMCKD2	191845	16p12.3
Glomerulopathy with fibronectin deposits 1	137950	GFND1		1q32
Glomerulopathy with fibronectin deposits 2	601894	FN1	135600	2q35
Glomerulopathy with fibronectin deposits 2	601894	FN	135600	2q35
Glomerulopathy with fibronectin deposits 2	601894	LETS	135600	2q35
Glomerulopathy with fibronectin deposits 2	601894	FNZ	135600	2q35
Glomerulopathy with fibronectin deposits 2	601894	GFND2	135600	2q35
Glomerulosclerosis, focal segmental, 1	603278	ACTN4	604638	19q13.2
Glomerulosclerosis, focal segmental, 1	603278	FSGS1	604638	19q13.2
Glomerulosclerosis, focal segmental, 1	603278	FSGS	604638	19q13.2
Glomerulosclerosis, focal segmental, 2	603965	TRPC6	603652	11q22.1
Glomerulosclerosis, focal segmental, 2	603965	TRP6	603652	11q22.1
Glomerulosclerosis, focal segmental, 2	603965	FSGS2	603652	11q22.1
Glomerulosclerosis, focal segmental, 3	607832	CD2AP	604241	6p12.3
Glomerulosclerosis, focal segmental, 3	607832	CMS	604241	6p12.3
Glomerulosclerosis, focal segmental, 5	613237	INF2	610982	14q32.33
Glomerulosclerosis, focal segmental, 5	613237	FSGS5	610982	14q32.33
Glomerulosclerosis, focal segmental, 5	613237	C14orf173	610982	14q32.33
Glomerulosclerosis, focal segmental, 5	613237	CMTDIE	610982	14q32.33
Glomerulosclerosis, focal segmental, 6	614131	MYO1E	601479	15q22.2
Glomerulosclerosis, focal segmental, 6	614131	MYO1C	601479	15q22.2
Glomerulosclerosis, focal segmental, 6	614131	FSGS6	601479	15q22.2
Glomuvenous malformations	138000	GLML	601749	1p22.1
Glomuvenous malformations	138000	GVM	601749	1p22.1
Glomuvenous malformations	138000	VMGLOM	601749	1p22.1
Glucocorticoid deficiency 2	607398	MRAP	609196	21q22.11
Glucocorticoid deficiency 2	607398	FALP	609196	21q22.11
Glucocorticoid deficiency 2	607398	C21orf61	609196	21q22.11
Glucocorticoid deficiency 2	607398	GCCD2	609196	21q22.11
Glucocorticoid deficiency 2	607398	FGD2	609196	21q22.11
Glucocorticoid deficiency 3	609197	GCCD3		8q11.2-q13.2
Glucocorticoid deficiency 3	609197	FGD3		8q11.2-q13.2
Glucocorticoid deficiency 3	609197	GCCD2		8q11.2-q13.2
Glucocorticoid deficiency 4	614736	NNT	607878	5p12
Glucocorticoid deficiency 4	614736	GCCD4	607878	5p12
Glucocorticoid deficiency, due to ACTH unresponsiveness	202200	MC2R	607397	18p11.21
Glucose/galactose malabsorption	606824	SLC5A1	182380	22q12.3
Glucose/galactose malabsorption	606824	SGLT1	182380	22q12.3
Glutamate formiminotransferase deficiency	229100	FTCD	606806	21q22.3
Glutamine deficiency, congenital	610015	GLUL	138290	1q25.3
Glutamine deficiency, congenital	610015	GLNS	138290	1q25.3
Glutaric acidemia IIA	231680	ETFA	608053	15q24.2-q24.3
Glutaric acidemia IIA	231680	GA2	608053	15q24.2-q24.3
Glutaric acidemia IIA	231680	MADD	608053	15q24.2-q24.3
Glutaric acidemia IIB	231680	ETFB	130410	19q13.41
Glutaric acidemia IIB	231680	MADD	130410	19q13.41
Glutaric acidemia IIC	231680	ETFDH	231675	4q32.1
Glutaric acidemia IIC	231680	MADD	231675	4q32.1
Glutaricaciduria, type I	231670	GCDH	608801	19p13.2
Glutathione synthetase deficiency	266130	GSS	601002	20q11.22
Glutathione synthetase deficiency	266130	GSHS	601002	20q11.22
Glutathioninuria		GGT1	231950	22q11.1-q11.2
Glutathioninuria		GTG	231950	22q11.1-q11.2
Glycerol kinase deficiency	307030	GK	300474	Xp21.2
Glycine N-methyltransferase deficiency	606664	GNMT	606628	6p21.1
Glycine encephalopathy	605899	AMT	238310	3p21.31
Glycine encephalopathy	605899	NKH	238310	3p21.31
Glycine encephalopathy	605899	GCE	238310	3p21.31
Glycine encephalopathy	605899	GCSH	238330	16q23.2
Glycine encephalopathy	605899	NKH	238330	16q23.2
Glycine encephalopathy	605899	GLDC	238300	9p24.1
Glycine encephalopathy	605899	HYGN1	238300	9p24.1
Glycine encephalopathy	605899	GCSP	238300	9p24.1
Glycine encephalopathy	605899	GCE	238300	9p24.1
Glycine encephalopathy	605899	NKH	238300	9p24.1
Glycogen storage disease 0, muscle	611556	GYS1	138570	19q13.33
Glycogen storage disease 0, muscle	611556	GYS	138570	19q13.33
Glycogen storage disease II	232300	GAA	606800	17q25.3
Glycogen storage disease IIIa	232400	AGL	610860	1p21.2
Glycogen storage disease IIIa	232400	GDE	610860	1p21.2
Glycogen storage disease IIIb	232400	AGL	610860	1p21.2
Glycogen storage disease IIIb	232400	GDE	610860	1p21.2
Glycogen storage disease IV	232500	GBE1	607839	3p12.2
Glycogen storage disease IV	232500	GSD4	607839	3p12.2
Glycogen storage disease IV	232500	APBD	607839	3p12.2
Glycogen storage disease IXc	613027	PHKG2	172471	16p11.2
Glycogen storage disease IXc	613027	GSD9C	172471	16p11.2
Glycogen storage disease Ia	232200	G6PC	613742	17q21.31
Glycogen storage disease Ia	232200	G6PT	613742	17q21.31
Glycogen storage disease Ib	232220	SLC37A4	602671	11q23.3
Glycogen storage disease Ib	232220	G6PT1	602671	11q23.3
Glycogen storage disease Ic	232240	SLC37A4	602671	11q23.3
Glycogen storage disease Ic	232240	G6PT1	602671	11q23.3
Glycogen storage disease VI	232700	PYGL	613741	14q22.1
Glycogen storage disease VII	232800	PFKM	610681	12q13.11
Glycogen storage disease VII	232800	GSD7	610681	12q13.11
Glycogen storage disease X	261670	PGAM2	612931	7p13
Glycogen storage disease X	261670	PGAMM	612931	7p13
Glycogen storage disease X	261670	GSD10	612931	7p13
Glycogen storage disease XI	612933	LDHA	150000	11p15.1
Glycogen storage disease XI	612933	LDH1	150000	11p15.1
Glycogen storage disease XI	612933	GSD11	150000	11p15.1
Glycogen storage disease XII	611881	ALDOA	103850	16p11.2
Glycogen storage disease XII	611881	GSD12	103850	16p11.2
Glycogen storage disease XIII	612932	ENO3	131370	17p13.2
Glycogen storage disease XIII	612932	GSD13	131370	17p13.2
Glycogen storage disease XIV	612934	PGM1	171900	1p31.3
Glycogen storage disease XIV	612934	GSD14	171900	1p31.3
Glycogen storage disease XIV	612934	GSD14	171900	1p31.3
Glycogen storage disease XIV	612934	CDG1T	171900	1p31.3
Glycogen storage disease XV	613507	GYG1	603942	3q24
Glycogen storage disease XV	613507	GSD15	603942	3q24
Glycogen storage disease of heart, lethal congenital	261740	PRKAG2	602743	7q36.1
Glycogen storage disease of heart, lethal congenital	261740	WPWS	602743	7q36.1
Glycogen storage disease of heart, lethal congenital	261740	CMH6	602743	7q36.1
Glycogen storage disease, type 0	240600	GYS2	138571	12p12.1
Glycogen storage disease, type IXa1	306000	PHKA2	300798	Xp22.13
Glycogen storage disease, type IXa1	306000	PHK	300798	Xp22.13
Glycogen storage disease, type IXa1	306000	XLG	300798	Xp22.13
Glycogen storage disease, type IXa1	306000	PHK	300798	Xp22.13
Glycogen storage disease, type IXa1	306000	PYKL	300798	Xp22.13
Glycogen storage disease, type IXa1	306000	GSD9A	300798	Xp22.13
Glycogen storage disease, type IXa2	306000	PHKA2	300798	Xp22.13
Glycogen storage disease, type IXa2	306000	PHK	300798	Xp22.13
Glycogen storage disease, type IXa2	306000	XLG	300798	Xp22.13
Glycogen storage disease, type IXa2	306000	PHK	300798	Xp22.13
Glycogen storage disease, type IXa2	306000	PYKL	300798	Xp22.13
Glycogen storage disease, type IXa2	306000	GSD9A	300798	Xp22.13
Glycosylphosphatidylinositol deficiency	610293	PIGM	610273	1q23.2
Gnathodiaphyseal dysplasia	166260	ANO5	608662	11p14.3
Gnathodiaphyseal dysplasia	166260	TMEM16E	608662	11p14.3
Gnathodiaphyseal dysplasia	166260	GDD1	608662	11p14.3
Gnathodiaphyseal dysplasia	166260	LGMD2L	608662	11p14.3
Goeminne TKCR syndrome	314300	TKCR		Xq28
Goeminne TKCR syndrome	314300	TKC		Xq28
Goiter, familial, due to TTF-1 defect		NKX2-1	600635	14q13.3
Goiter, familial, due to TTF-1 defect		TITF1	600635	14q13.3
Goiter, familial, due to TTF-1 defect		NKX2A	600635	14q13.3
Goiter, familial, due to TTF-1 defect		TTF1	600635	14q13.3
Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	138800	DICER1	606241	14q32.13
Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	138800	HERNA	606241	14q32.13
Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	138800	KIAA0928	606241	14q32.13
Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	138800	MNG1	606241	14q32.13
Goiter, multinodular 1, with or without Sertoli-Leydig cell tumors	138800	RMSE2	606241	14q32.13
Goiter, multinodular, 2	300273	MNG2		Xp22
Goiter, multinodular, 3	606082	MNG3		3q26.1-q26.3
Goldberg-Shprintzen megacolon syndrome	609460	KIAA1279	609367	10q22.1
Gonadal dysgenesis, XY female type		GDXY	306100	Xp22.11-p21.2
Gonadal dysgenesis, XY female type		TDFX	306100	Xp22.11-p21.2
Gonadal dysgenesis, XY female type		SRVX	306100	Xp22.11-p21.2
Gout, PRPS-related	300661	PRPS1	311850	Xq22.3
Gout, PRPS-related	300661	CMTX5	311850	Xq22.3
Gout, PRPS-related	300661	DFNX1	311850	Xq22.3
Gout, PRPS-related	300661	DFN2	311850	Xq22.3
Gracile bone dysplasia	602361	FAM111A	615292	11q12.1
Gracile bone dysplasia	602361	KIAA1895	615292	11q12.1
Gracile bone dysplasia	602361	KCS2	615292	11q12.1
Gracile bone dysplasia	602361	GCLEB	615292	11q12.1
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III	613960	NCF4	601488	22q12.3
Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III	613960	P40PHOX	601488	22q12.3
Gray platelet syndrome	139090	NBEAL2	614169	3p21.31
Gray platelet syndrome	139090	KIAA0540	614169	3p21.31
Gray platelet syndrome	139090	GPS	614169	3p21.31
Gray platelet syndrome	139090	BDPLT4	614169	3p21.31
Greig cephalopolysyndactyly syndrome	175700	GLI3	165240	7p14.1
Greig cephalopolysyndactyly syndrome	175700	PAPA	165240	7p14.1
Greig cephalopolysyndactyly syndrome	175700	PAPB	165240	7p14.1
Griscelli syndrome, type 1	214450	MYO5A	160777	15q21.2
Griscelli syndrome, type 1	214450	MYH12	160777	15q21.2
Griscelli syndrome, type 1	214450	GS1	160777	15q21.2
Griscelli syndrome, type 2	607624	RAB27A	603868	15q21.3
Griscelli syndrome, type 2	607624	RAM	603868	15q21.3
Griscelli syndrome, type 2	607624	GS2	603868	15q21.3
Griscelli syndrome, type 3	609227	MLPH	606526	2q37.3
Growth hormone deficiency with pituitary anomalies	182230	HESX1	601802	3p14.3
Growth hormone deficiency with pituitary anomalies	182230	RPX	601802	3p14.3
Growth hormone deficiency with pituitary anomalies	182230	CPHD5	601802	3p14.3
Growth hormone deficiency, isolated, type IA	262400	GH1	139250	17q23.3
Growth hormone deficiency, isolated, type IA	262400	GHN	139250	17q23.3
Growth hormone deficiency, isolated, type IA	262400	IGHD1B	139250	17q23.3
Growth hormone deficiency, isolated, type IB	612781	GH1	139250	17q23.3
Growth hormone deficiency, isolated, type IB	612781	GHN	139250	17q23.3
Growth hormone deficiency, isolated, type IB	612781	IGHD1B	139250	17q23.3
Growth hormone deficiency, isolated, type IB	612781	GHRHR	139191	7p14.3
Growth hormone deficiency, isolated, type IB	612781	GHRFR	139191	7p14.3
Growth hormone deficiency, isolated, type IB	612781	IGHD1B	139191	7p14.3
Growth hormone deficiency, isolated, type II	173100	GH1	139250	17q23.3
Growth hormone deficiency, isolated, type II	173100	GHN	139250	17q23.3
Growth hormone deficiency, isolated, type II	173100	IGHD1B	139250	17q23.3
Growth hormone insensitivity with immunodeficiency	245590	STAT5B	604260	17q21.2
Growth retardation with deafness and mental retardation due to IGF1 deficiency	608747	IGF1	147440	12q23.2
Growth retardation, developmental delay, coarse facies, and early death	612938	FTO	610966	16q12.2
Gustavson syndrome	309555	GUST		Xq26
Guttmacher syndrome	176305	HOXA13	142959	7p15.2
Guttmacher syndrome	176305	HOX1J	142959	7p15.2
Gyrate atrophy of choroid and retina with or without ornithinemia	258870	OAT	613349	10q26.13
Gyrate atrophy of choroid and retina with or without ornithinemia	258870	GACR	613349	10q26.13
HARP syndrome	607236	PANK2	606157	20p13
HARP syndrome	607236	NBIA1	606157	20p13
HARP syndrome	607236	PKAN	606157	20p13
HARP syndrome	607236	HARP	606157	20p13
HDL deficiency, type 2	604091	ABCA1	600046	9q31.1
HDL deficiency, type 2	604091	ABC1	600046	9q31.1
HDL deficiency, type 2	604091	HDLDT1	600046	9q31.1
HDL deficiency, type 2	604091	TGD	600046	9q31.1
HELLP syndrome, maternal, of pregnancy	609016	HADHA	600890	2p23.3
HELLP syndrome, maternal, of pregnancy	609016	MTPA	600890	2p23.3
HEM skeletal dysplasia	215140	LBR	600024	1q42.12
HEM skeletal dysplasia	215140	PHA	600024	1q42.12
HMG-CoA lyase deficiency	246450	HMGCL	613898	1p36.11
HMG-CoA synthase-2 deficiency	605911	HMGCS2	600234	1p12
HPRT-related gout	300323	HPRT1	308000	Xq26.2-q26.3
HPRT-related gout	300323	HPRT	308000	Xq26.2-q26.3
Haddad syndrome	209880	ASCL1	100790	12q23.2
Haddad syndrome	209880	ASH1	100790	12q23.2
Hailey-Hailey disease	169600	ATP2C1	604384	3q22.1
Hailey-Hailey disease	169600	BCPM	604384	3q22.1
Hailey-Hailey disease	169600	HHD	604384	3q22.1
Haim-Munk syndrome	245010	CTSC	602365	11q14.2
Haim-Munk syndrome	245010	CPPI	602365	11q14.2
Haim-Munk syndrome	245010	PALS	602365	11q14.2
Haim-Munk syndrome	245010	PLS	602365	11q14.2
Haim-Munk syndrome	245010	HMS	602365	11q14.2
Haim-Munk syndrome	245010	PDON1	602365	11q14.2
Haim-Munk syndrome	245010	JPD	602365	11q14.2
Hair, curly	139450	HRM2		1q21.3
Hajdu-Cheney syndrome	102500	NOTCH2	600275	1p12-p11
Hajdu-Cheney syndrome	102500	AGS2	600275	1p12-p11
Hajdu-Cheney syndrome	102500	HJCYS	600275	1p12-p11
Hamamy syndrome	611174	IRX5	606195	16q12.2
Hamamy syndrome	611174	HMMS	606195	16q12.2
Hand-foot-uterus syndrome	140000	HOXA13	142959	7p15.2
Hand-foot-uterus syndrome	140000	HOX1J	142959	7p15.2
Harderoporphyria	121300	CPOX	612732	3q11.2-q12.1
Hartnup disorder	234500	SLC6A19	608893	5p15.33
Hartnup disorder	234500	HND	608893	5p15.33
Hartsfield syndrome	615465	FGFR1	136350	8p11.23-p11.22
Hartsfield syndrome	615465	FLT2	136350	8p11.23-p11.22
Hartsfield syndrome	615465	OGD	136350	8p11.23-p11.22
Hartsfield syndrome	615465	KAL2	136350	8p11.23-p11.22
Hartsfield syndrome	615465	HH2	136350	8p11.23-p11.22
Hartsfield syndrome	615465	HRTFDS	136350	8p11.23-p11.22
Hashimoto thyroiditis	140300	HT		8q23-q24
Hawkinsinuria	140350	HPD	609695	12q24.31
Hay-Wells syndrome	106260	TP63	603273	3q28
Hay-Wells syndrome	106260	TP73L	603273	3q28
Hay-Wells syndrome	106260	KET	603273	3q28
Hay-Wells syndrome	106260	EEC3	603273	3q28
Hay-Wells syndrome	106260	SHFM4	603273	3q28
Hay-Wells syndrome	106260	LMS	603273	3q28
Hay-Wells syndrome	106260	RHS	603273	3q28
Hay-Wells syndrome	106260	OFC8	603273	3q28
Heart block, nonprogressive	113900	SCN5A	600163	3p22.2
Heart block, nonprogressive	113900	LQT3	600163	3p22.2
Heart block, nonprogressive	113900	VF1	600163	3p22.2
Heart block, nonprogressive	113900	HB1	600163	3p22.2
Heart block, nonprogressive	113900	SSS1	600163	3p22.2
Heart block, nonprogressive	113900	CMD1E	600163	3p22.2
Heart block, nonprogressive	113900	CDCD2	600163	3p22.2
Heart block, progressive, type IA	113900	SCN5A	600163	3p22.2
Heart block, progressive, type IA	113900	LQT3	600163	3p22.2
Heart block, progressive, type IA	113900	VF1	600163	3p22.2
Heart block, progressive, type IA	113900	HB1	600163	3p22.2
Heart block, progressive, type IA	113900	SSS1	600163	3p22.2
Heart block, progressive, type IA	113900	CMD1E	600163	3p22.2
Heart block, progressive, type IA	113900	CDCD2	600163	3p22.2
Heart-hand syndrome, Slovenian type	610140	LMNA	150330	1q22
Heart-hand syndrome, Slovenian type	610140	LMN1	150330	1q22
Heart-hand syndrome, Slovenian type	610140	EMD2	150330	1q22
Heart-hand syndrome, Slovenian type	610140	FPLD2	150330	1q22
Heart-hand syndrome, Slovenian type	610140	CMD1A	150330	1q22
Heart-hand syndrome, Slovenian type	610140	HGPS	150330	1q22
Heart-hand syndrome, Slovenian type	610140	LGMD1B	150330	1q22
Heinz body anemia	140700	HBA2	141850	16p13.3
Heinz body anemia	140700	HBH	141850	16p13.3
Heinz body anemias, alpha-	140700	HBA1	141800	16p13.3
Heinz body anemias, alpha-	140700	HBH	141800	16p13.3
Heinz body anemias, beta-	140700	HBB	141900	11p15.4
Hemangioblastoma, cerebellar, somatic		VHL	608537	3p25.3
Hemangioma, capillary infantile, somatic	602089	FLT4	136352	5q35.3
Hemangioma, capillary infantile, somatic	602089	VEGFR3	136352	5q35.3
Hemangioma, capillary infantile, somatic	602089	PCL	136352	5q35.3
Hemangioma, capillary infantile, somatic	602089	LMPH1A	136352	5q35.3
Hemangioma, capillary infantile, somatic	602089	KDR	191306	4q12
Hematuria, benign familial	141200	COL4A3	120070	2q36.3
Hematuria, familial benign		COL4A4	120131	2q36.3
Heme oxygenase-1 deficiency	614034	HMOX1	141250	22q12.3
Heme oxygenase-1 deficiency	614034	HMOX1D	141250	22q12.3
Hemifacial microsomia	164210	HFM		14q32
Hemihypertrophy	235000	IH		11p15
Hemihypertrophy	235000	HHP		11p15
Hemochromatosis	235200	HFE	613609	6p22.2
Hemochromatosis	235200	HLA-H	613609	6p22.2
Hemochromatosis	235200	HFE1	613609	6p22.2
Hemochromatosis	235200	MVCD7	613609	6p22.2
Hemochromatosis	235200	TFQTL2	613609	6p22.2
Hemochromatosis, type 2A	602390	HJV	608374	1q21.1
Hemochromatosis, type 2A	602390	HFE2A	608374	1q21.1
Hemochromatosis, type 2B	613313	HAMP	606464	19q13.12
Hemochromatosis, type 2B	613313	LEAP1	606464	19q13.12
Hemochromatosis, type 2B	613313	HEPC	606464	19q13.12
Hemochromatosis, type 2B	613313	HFE2B	606464	19q13.12
Hemochromatosis, type 3	604250	TFR2	604720	7q22.1
Hemochromatosis, type 3	604250	HFE3	604720	7q22.1
Hemochromatosis, type 4	606069	SLC40A1	604653	2q32.2
Hemochromatosis, type 4	606069	SLC11A3	604653	2q32.2
Hemochromatosis, type 4	606069	FPN1	604653	2q32.2
Hemochromatosis, type 4	606069	IREG1	604653	2q32.2
Hemochromatosis, type 4	606069	HFE4	604653	2q32.2
Hemoglobin H disease, nondeletional	613978	HBA1	141800	16p13.3
Hemoglobin H disease, nondeletional	613978	HBH	141800	16p13.3
Hemoglobin H disease, nondeletional	613978	HBA2	141850	16p13.3
Hemoglobin H disease, nondeletional	613978	HBH	141850	16p13.3
Hemolytic anemia due to G6PD deficiency	300908	G6PD	305900	Xq28
Hemolytic anemia due to G6PD deficiency	300908	G6PD1	305900	Xq28
Hemolytic anemia due to adenylate kinase deficiency	612631	AK1	103000	9q34.11
Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency	230450	GCLC	606857	6p12.1
Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency	230450	GLCLC	606857	6p12.1
Hemolytic anemia due to glutathione peroxidase deficiency	614164	GPX1	138320	3p21.31
Hemolytic anemia due to glutathione peroxidase deficiency	614164	GPXD	138320	3p21.31
Hemolytic anemia due to glutathione reductase deficiency	138300	GSR		8p12
Hemolytic anemia due to glutathione synthetase deficiency	231900	GSS	601002	20q11.22
Hemolytic anemia due to glutathione synthetase deficiency	231900	GSHS	601002	20q11.22
Hemolytic anemia due to hexokinase deficiency	235700	HK1	142600	10q22.1
Hemolytic anemia due to hexokinase deficiency	235700	HKD	142600	10q22.1
Hemolytic anemia due to hexokinase deficiency	235700	HMSNR	142600	10q22.1
Hemolytic anemia due to phosphofructokinase deficiency		PFKL	171860	21q22.3
Hemolytic anemia due to triosephosphate isomerase deficiency	615512	TPI1	190450	12p13.31
Hemolytic anemia due to triosephosphate isomerase deficiency	615512	TPID	190450	12p13.31
Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy	612300	CD59	107271	11p13
Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy	612300	MIC11	107271	11p13
Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency	613470	GPI	172400	19q13.11
Hemophagocytic lymphohistiocytosis, familial, 1	267700	FHL1		9q21.3-q22
Hemophagocytic lymphohistiocytosis, familial, 1	267700	HPLH1		9q21.3-q22
Hemophagocytic lymphohistiocytosis, familial, 1	267700	HLH1		9q21.3-q22
Hemophagocytic lymphohistiocytosis, familial, 2	603553	PRF1	170280	10q22.1
Hemophagocytic lymphohistiocytosis, familial, 2	603553	HPLH2	170280	10q22.1
Hemophagocytic lymphohistiocytosis, familial, 2	603553	FLH2	170280	10q22.1
Hemophagocytic lymphohistiocytosis, familial, 3	608898	UNC13D	608897	17q25.1
Hemophagocytic lymphohistiocytosis, familial, 3	608898	MUNC13-4	608897	17q25.1
Hemophagocytic lymphohistiocytosis, familial, 3	608898	HPLH3	608897	17q25.1
Hemophagocytic lymphohistiocytosis, familial, 3	608898	HLH3	608897	17q25.1
Hemophagocytic lymphohistiocytosis, familial, 3	608898	FHL3	608897	17q25.1
Hemophagocytic lymphohistiocytosis, familial, 4	603552	STX11	605014	6q24.2
Hemophagocytic lymphohistiocytosis, familial, 4	603552	FHL4	605014	6q24.2
Hemophagocytic lymphohistiocytosis, familial, 4	603552	HPLH4	605014	6q24.2
Hemophagocytic lymphohistiocytosis, familial, 4	603552	HLH4	605014	6q24.2
Hemophagocytic lymphohistiocytosis, familial, 5	613101	STXBP2	601717	19p13.2
Hemophagocytic lymphohistiocytosis, familial, 5	613101	UNC18B	601717	19p13.2
Hemophagocytic lymphohistiocytosis, familial, 5	613101	FHL5	601717	19p13.2
Hemophilia A	306700	F8	300841	Xq28
Hemophilia A	306700	F8C	300841	Xq28
Hemophilia A	306700	HEMA	300841	Xq28
Hemophilia B	306900	F9	300746	Xq27.1
Hemophilia B	306900	HEMB	300746	Xq27.1
Hemophilia B	306900	THPH8	300746	Xq27.1
Hemorrhagic destruction of the brain, subependymal calcification, and cataracts	613730	JAM3	606871	11q25
Hemorrhagic diathesis due to \'antithrombin\' Pittsburgh	613490	SERPINA1	107400	14q32.13
Hemorrhagic diathesis due to \'antithrombin\' Pittsburgh	613490	PI	107400	14q32.13
Hemorrhagic diathesis due to \'antithrombin\' Pittsburgh	613490	AAT	107400	14q32.13
Hemosiderosis, systemic, due to aceruloplasminemia	604290	CP	117700	3q24-q25
Hennekam lymphangiectasia-lymphedema syndrome	235510	CCBE1	612753	18q21.32
Hennekam lymphangiectasia-lymphedema syndrome	235510	KIAA1983	612753	18q21.32
Hepatic adenoma, somatic	142330	HNF1A	142410	12q24.31
Hepatic adenoma, somatic	142330	TCF1	142410	12q24.31
Hepatic adenoma, somatic	142330	MODY3	142410	12q24.31
Hepatic adenoma, somatic	142330	IDDM20	142410	12q24.31
Hepatic failure, early onset, and neurologic disorder		SCOD1	603644	17p13.1
Hepatic failure, early onset, and neurologic disorder		SCO1	603644	17p13.1
Hepatic lipase deficiency	614025	LIPC	151670	15q21.3
Hepatic lipase deficiency	614025	HL	151670	15q21.3
Hepatic lipase deficiency	614025	LIPH	151670	15q21.3
Hepatic lipase deficiency	614025	HDLCQ12	151670	15q21.3
Hepatic venoocclusive disease with immunodeficiency	235550	SP110	604457	2q37.1
Hepatic venoocclusive disease with immunodeficiency	235550	IFI41	604457	2q37.1
Hepatic venoocclusive disease with immunodeficiency	235550	IFI75	604457	2q37.1
Hepatic venoocclusive disease with immunodeficiency	235550	VODI	604457	2q37.1
Hepatoblastoma, somatic	114550	APC	611731	5q22.2
Hepatoblastoma, somatic	114550	GS	611731	5q22.2
Hepatoblastoma, somatic	114550	FPC	611731	5q22.2
Hepatoblastoma, somatic	114550	BTPS2	611731	5q22.2
Hepatocellular cancer, somatic	114550	PDGFRL	604584	8p22
Hepatocellular cancer, somatic	114550	PDGRL	604584	8p22
Hepatocellular cancer, somatic	114550	PRLTS	604584	8p22
Hepatocellular carcinoma	114550	TP53	191170	17p13.1
Hepatocellular carcinoma	114550	P53	191170	17p13.1
Hepatocellular carcinoma	114550	LFS1 	191170	17p13.1
Hepatocellular carcinoma	114550	BCC7	191170	17p13.1
Hepatocellular carcinoma, childhood type	114550	MET	164860	7q31.2
Hepatocellular carcinoma, somatic	114550	AXIN1	603816	16p13.3
Hepatocellular carcinoma, somatic	114550	AXIN	603816	16p13.3
Hepatocellular carcinoma, somatic	114550	CASP8	601763	2q33.1
Hepatocellular carcinoma, somatic	114550	MCH5	601763	2q33.1
Hepatocellular carcinoma, somatic	114550	ALPS2B	601763	2q33.1
Hepatocellular carcinoma, somatic	114550	CTNNB1	116806	3p22.1
Hepatocellular carcinoma, somatic	114550	MRD19	116806	3p22.1
Hepatocellular carcinoma, somatic	114550	IGF2R	147280	6q25.3
Hepatocellular carcinoma, somatic	114550	MPRI	147280	6q25.3
Hepatocellular carcinoma, somatic	114550	PIK3CA	171834	3q26.32
Hepatocellular carcinoma, somatic	114550	CLOVE	171834	3q26.32
Hepatocellular carcinoma, somatic	114550	MCAP	171834	3q26.32
Hepatocellular carcinoma, somatic	114550	MCM	171834	3q26.32
Hepatocellular carcinoma, somatic	114550	MCMTC	171834	3q26.32
Hepatocellular carcinoma, somatic	114550	CWS5	171834	3q26.32
Hereditary motor and sensory neuropathy V	600361	HMSN5		4q34.3-q35.2
Hereditary motor and sensory neuropathy VI	601152	MFN2	608507	1p36.22
Hereditary motor and sensory neuropathy VI	601152	KIAA0214	608507	1p36.22
Hereditary motor and sensory neuropathy VI	601152	CMT2A2	608507	1p36.22
Hereditary motor and sensory neuropathy, proximal type	604484	TFG	602498	3q12.2
Hereditary motor and sensory neuropathy, proximal type	604484	HMSNP	602498	3q12.2
Hereditary motor and sensory neuropathy, type IIc	606071	TRPV4	605427	12q24.11
Hereditary motor and sensory neuropathy, type IIc	606071	VROAC	605427	12q24.11
Hereditary motor and sensory neuropathy, type IIc	606071	HMSN2C	605427	12q24.11
Hereditary motor and sensory neuropathy, type IIc	606071	CMT2C	605427	12q24.11
Hereditary motor and sensory neuropathy, type IIc	606071	SPSMA	605427	12q24.11
Hereditary motor and sensory neuropathy, type IIc	606071	SSQTL1	605427	12q24.11
Hereditary motor and sensory neuropathy, type IIc	606071	SMAL	605427	12q24.11
Hereditary persistence of fetal hemoglobin	141749	HBB	141900	11p15.4
Hermansky-Pudlak syndrome 1	203300	HPS1	604982	10q24.2
Hermansky-Pudlak syndrome 2	608233	AP3B1	603401	5q14.1
Hermansky-Pudlak syndrome 2	608233	ADTB3A	603401	5q14.1
Hermansky-Pudlak syndrome 2	608233	HPS2	603401	5q14.1
Hermansky-Pudlak syndrome 3	614072	HPS3	606118	3q24
Hermansky-Pudlak syndrome 4	614073	HPS4	606682	22q12.1
Hermansky-Pudlak syndrome 5	614074	HPS5	607521	11p15.1
Hermansky-Pudlak syndrome 5	614074	RU2	607521	11p15.1
Hermansky-Pudlak syndrome 5	614074	KIAA1017	607521	11p15.1
Hermansky-Pudlak syndrome 6	614075	HPS6	607522	10q24.32
Hermansky-Pudlak syndrome 6	614075	RU	607522	10q24.32
Hermansky-Pudlak syndrome 7	614076	DTNBP1	607145	6p22.3
Hermansky-Pudlak syndrome 7	614076	HPS7	607145	6p22.3
Hermansky-Pudlak syndrome 8	614077	BLOC1S3	609762	19q13.32
Hermansky-Pudlak syndrome 8	614077	BLOS3	609762	19q13.32
Hermansky-Pudlak syndrome 8	614077	HPS8	609762	19q13.32
Hermansky-pudlak syndrome 9	614171	BLOC1S6	604310	15q21.1
Hermansky-pudlak syndrome 9	614171	BLOS6	604310	15q21.1
Hermansky-pudlak syndrome 9	614171	PLDN	604310	15q21.1
Hermansky-pudlak syndrome 9	614171	PA	604310	15q21.1
Hermansky-pudlak syndrome 9	614171	HPS9	604310	15q21.1
Hernia, congenital diaphragmatic 1	142340	DIH1		15q26.1
Hernia, congenital diaphragmatic 1	142340	HCD		15q26.1
Hernia, congenital diaphragmatic 2	222400	DIH2		8p23.1
Herpes simplex encephalitis, susceptibility to, 1	610551	UNC93B1	608204	11q13.2
Herpes simplex encephalitis, susceptibility to, 1	610551	IIAE1	608204	11q13.2
Heterotaxy, visceral, 1, X-linked 306955		ZIC3	300265	Xq26.3
Heterotaxy, visceral, 1, X-linked 306955		HTX1	300265	Xq26.3
Heterotaxy, visceral, 1, X-linked 306955		HTX	300265	Xq26.3
Heterotaxy, visceral, 1, X-linked 306955		VACTERLX	300265	Xq26.3
Heterotaxy, visceral, 2, autosomal	605376	CFC1	605194	2q21.1
Heterotaxy, visceral, 2, autosomal	605376	CRYPTIC	605194	2q21.1
Heterotaxy, visceral, 2, autosomal	605376	HTX2	605194	2q21.1
Heterotaxy, visceral, 2, autosomal	605376	DTGA2	605194	2q21.1
Heterotaxy, visceral, 4, autosomal	613751	ACVR2B	602730	3p22.2
Heterotaxy, visceral, 4, autosomal	613751	ACTRIIB	602730	3p22.2
Heterotaxy, visceral, 4, autosomal	613751	HTX4	602730	3p22.2
Heterotaxy, visceral, 5	270100	NODAL	601265	10q22.1
Heterotaxy, visceral, 5	270100	HTX5	601265	10q22.1
Heterotaxy, visceral, 6, autosomal recessive	614779	CCDC11	614759	18q21.1
Heterotaxy, visceral, 6, autosomal recessive	614779	HTX6	614759	18q21.1
Heterotopia, periventricular	300049	FLNA	300017	Xq28
Heterotopia, periventricular	300049	FLN1	300017	Xq28
Heterotopia, periventricular	300049	NHBP	300017	Xq28
Heterotopia, periventricular	300049	OPD1	300017	Xq28
Heterotopia, periventricular	300049	OPD2	300017	Xq28
Heterotopia, periventricular	300049	FMD	300017	Xq28
Heterotopia, periventricular	300049	MNS	300017	Xq28
Heterotopia, periventricular	300049	CVD1	300017	Xq28
Heterotopia, periventricular	300049	CSBS	300017	Xq28
Heterotopia, periventricular, ED variant	300537	FLNA	300017	Xq28
Heterotopia, periventricular, ED variant	300537	FLN1	300017	Xq28
Heterotopia, periventricular, ED variant	300537	NHBP	300017	Xq28
Heterotopia, periventricular, ED variant	300537	OPD1	300017	Xq28
Heterotopia, periventricular, ED variant	300537	OPD2	300017	Xq28
Heterotopia, periventricular, ED variant	300537	FMD	300017	Xq28
Heterotopia, periventricular, ED variant	300537	MNS	300017	Xq28
Heterotopia, periventricular, ED variant	300537	CVD1	300017	Xq28
Heterotopia, periventricular, ED variant	300537	CSBS	300017	Xq28
High density lipoprotein cholesterol level QTL14	605201	HDLCQ14		11q23.3
High density lipoprotein cholesterol level QTL14	605201	HYLAP		11q23.3
Hip dysplasia, Beukes type	142669	BHD		4q35
Hip dysplasia, Beukes type	142669	BFHD		4q35
Hirschsprung disease, cardiac defects, and autonomic dysfunction	613870	ECE1	600423	1p36.12
Histiocytoma, angiomatoid fibrous, somatic	612160	CREB1	123810	2q33.3
Histiocytosis-lymphadenopathy plus syndrome	602782	HJCD		11q25
Histiocytosis-lymphadenopathy plus syndrome	602782	HCLAP		11q25
Histiocytosis-lymphadenopathy plus syndrome	602782	SLC29A3	612373	10q22.1
Histiocytosis-lymphadenopathy plus syndrome	602782	ENT3	612373	10q22.1
Histiocytosis-lymphadenopathy plus syndrome	602782	PHID	612373	10q22.1
Histiocytosis-lymphadenopathy plus syndrome	602782	HCLAP	612373	10q22.1
Hodgkin lymphoma	236000	KLHDC8B	613169	3p21.31
Holocarboxylase synthetase deficiency	253270	HLCS	609018	21q22.13
Holocarboxylase synthetase deficiency	253270	HCS	609018	21q22.13
Holoprosencephaly 11	614226	CDON	608707	11q24.2
Holoprosencephaly 11	614226	CDO	608707	11q24.2
Holoprosencephaly 11	614226	HPE11	608707	11q24.2
Holoprosencephaly-1	236100	HPE1		21q22.3
Holoprosencephaly-2	157170	SIX3	603714	2p21
Holoprosencephaly-2	157170	HPE2	603714	2p21
Holoprosencephaly-3	142945	SHH	600725	7q36.3
Holoprosencephaly-3	142945	HPE3	600725	7q36.3
Holoprosencephaly-3	142945	HLP3	600725	7q36.3
Holoprosencephaly-3	142945	SMMCI	600725	7q36.3
Holoprosencephaly-3	142945	MCOPCB5	600725	7q36.3
Holoprosencephaly-4	142946	TGIF	602630	18p11.31
Holoprosencephaly-4	142946	HPE4	602630	18p11.31
Holoprosencephaly-5	609637	ZIC2	603073	13q32.3
Holoprosencephaly-5	609637	HPE5	603073	13q32.3
Holoprosencephaly-6	605934	HPE6		2q37.1-q37.3
Holoprosencephaly-7	610828	PTCH1	601309	9q22.32
Holoprosencephaly-7	610828	NBCCS	601309	9q22.32
Holoprosencephaly-7	610828	BCNS	601309	9q22.32
Holoprosencephaly-7	610828	HPE7	601309	9q22.32
Holoprosencephaly-8	609408	HPE8		14q13
Holoprosencephaly-9	610829	GLI2	165230	2q14.2
Holoprosencephaly-9	610829	HPE9	165230	2q14.2
Holt-Oram syndrome	142900	TBX5	601620	12q24.21
Homocysteine plasma level		NNMT	600008	11q23.2
Homocysteine, total plasma, elevated		CTH	607657	1p31.1
Homocystinuria due to MTHFR deficiency	236250	MTHFR	607093	1p36.22
Homocystinuria, B6-responsive and nonresponsive types	236200	CBS	613381	21q22.3
Homocystinuria, cblD type, variant 1	277410	C2orf25	611935	2q23.2
Homocystinuria, cblD type, variant 1	277410	MMADHC	611935	2q23.2
Homocystinuria-megaloblastic anemia, cbl E type	236270	MTRR	602568	5p15.31
Homocystinuria-megaloblastic anemia, cblG complementation type	250940	MTR	156570	1q43
Homocystinuria-megaloblastic anemia, cblG complementation type	250940	HMAG	156570	1q43
Humoral hypercalcemia of malignancy	168470	PTHLH		12p11.22
Humoral hypercalcemia of malignancy	168470	BDE2		12p11.22
Huntington disease	143100	HTT	613004	4p16.3
Huntington disease	143100	HD	613004	4p16.3
Huntington disease	143100	IT15	613004	4p16.3
Huntington disease-like 1	603218	PRNP	176640	20p13
Huntington disease-like 1	603218	PRIP	176640	20p13
Huntington disease-like 1	603218	KURU	176640	20p13
Huntington disease-like 1	603218	CJD	176640	20p13
Huntington disease-like 2	606438	JPH3	605268	16q24.2
Huntington disease-like 2	606438	JP3	605268	16q24.2
Huntington disease-like 2	606438	HDL2	605268	16q24.2
Huntington disease-like 3	604802	HDL3		4p15.3
Huntington disease-like 3	604802	HLN2		4p15.3
Huriez syndrome	181600	TYS		4q23
Huriez syndrome	181600	HRZ		4q23
Hutchinson-Gilford progeria	176670	LMNA	150330	1q22
Hutchinson-Gilford progeria	176670	LMN1	150330	1q22
Hutchinson-Gilford progeria	176670	EMD2	150330	1q22
Hutchinson-Gilford progeria	176670	FPLD2	150330	1q22
Hutchinson-Gilford progeria	176670	CMD1A	150330	1q22
Hutchinson-Gilford progeria	176670	HGPS	150330	1q22
Hutchinson-Gilford progeria	176670	LGMD1B	150330	1q22
Hyaline fibromatosis syndrome	228600	ANTXR2	608041	4q21.21
Hyaline fibromatosis syndrome	228600	CMG2	608041	4q21.21
Hyaline fibromatosis syndrome	228600	HFS	608041	4q21.21
Hydatidiform mole	231090	NALP7	609661	19q13.42
Hydatidiform mole	231090	NOD12	609661	19q13.42
Hydatidiform mole	231090	PYPAF3	609661	19q13.42
Hydatidiform mole	231090	HYDM	609661	19q13.42
Hydatidiform mole, recurrent, 2	614293	KHDC3L	611687	6q13
Hydatidiform mole, recurrent, 2	614293	C6orf221	611687	6q13
Hydatidiform mole, recurrent, 2	614293	ECAT1	611687	6q13
Hydatidiform mole, recurrent, 2	614293	HYDM2	611687	6q13
Hydranencephaly with abnormal genitalia	300215	ARX	300382	Xp21.3
Hydranencephaly with abnormal genitalia	300215	ISSX	300382	Xp21.3
Hydranencephaly with abnormal genitalia	300215	PRTS	300382	Xp21.3
Hydranencephaly with abnormal genitalia	300215	MRXS1	300382	Xp21.3
Hydranencephaly with abnormal genitalia	300215	MRX36	300382	Xp21.3
Hydranencephaly with abnormal genitalia	300215	MRX54	300382	Xp21.3
Hydranencephaly with abnormal genitalia	300215	MRX43	300382	Xp21.3
Hydranencephaly with abnormal genitalia	300215	MRX87	300382	Xp21.3
Hydranencephaly with abnormal genitalia	300215	MRX29	300382	Xp21.3
Hydranencephaly with abnormal genitalia	300215	MRX32	300382	Xp21.3
Hydrocephalus due to aqueductal stenosis	307000	L1CAM	308840	Xq28
Hydrocephalus due to aqueductal stenosis	307000	CAML1	308840	Xq28
Hydrocephalus due to aqueductal stenosis	307000	HSAS1	308840	Xq28
Hydrocephalus due to aqueductal stenosis	307000	MASA	308840	Xq28
Hydrocephalus due to aqueductal stenosis	307000	SPG1	308840	Xq28
Hydrocephalus with Hirschsprung disease	307000	L1CAM	308840	Xq28
Hydrocephalus with Hirschsprung disease	307000	CAML1	308840	Xq28
Hydrocephalus with Hirschsprung disease	307000	HSAS1	308840	Xq28
Hydrocephalus with Hirschsprung disease	307000	MASA	308840	Xq28
Hydrocephalus with Hirschsprung disease	307000	SPG1	308840	Xq28
Hydrocephalus with congenital idiopathic intestinal pseudoobstruction	307000	L1CAM	308840	Xq28
Hydrocephalus with congenital idiopathic intestinal pseudoobstruction	307000	CAML1	308840	Xq28
Hydrocephalus with congenital idiopathic intestinal pseudoobstruction	307000	HSAS1	308840	Xq28
Hydrocephalus with congenital idiopathic intestinal pseudoobstruction	307000	MASA	308840	Xq28
Hydrocephalus with congenital idiopathic intestinal pseudoobstruction	307000	SPG1	308840	Xq28
Hydrocephalus, nonsyndromic, autosomal recessive 2	615219	MPDZ	603785	9p23
Hydrocephalus, nonsyndromic, autosomal recessive 2	615219	MUPP1	603785	9p23
Hydrocephalus, nonsyndromic, autosomal recessive 2	615219	HYC2	603785	9p23
Hydrocephalus, nonsyndromic, autosomal recessive	236600	CCDC88C	611204	14q32.11
Hydrocephalus, nonsyndromic, autosomal recessive	236600	HKRP2	611204	14q32.11
Hydrocephalus, nonsyndromic, autosomal recessive	236600	DAPLE	611204	14q32.11
Hydrocephalus, nonsyndromic, autosomal recessive	236600	KIAA1509	611204	14q32.11
Hydrocephalus, nonsyndromic, autosomal recessive	236600	HYC	611204	14q32.11
Hydrolethalus syndrome 2	614120	KIF7	611254	15q26.1
Hydrolethalus syndrome 2	614120	HLS2	611254	15q26.1
Hydrolethalus syndrome 2	614120	ACLS	611254	15q26.1
Hydrolethalus syndrome 2	614120	JBTS12	611254	15q26.1
Hydrolethalus syndrome	236680	HYLS1	610693	11q24.2
Hydrolethalus syndrome	236680	FLJ32915	610693	11q24.2
Hyper-IgD syndrome	260920	MVK	251170	12q24.11
Hyper-IgD syndrome	260920	MVLK	251170	12q24.11
Hyper-IgD syndrome	260920	POROK3	251170	12q24.11
Hyper-IgE recurrent infection syndrome	147060	STAT3	102582	17q21.2
Hyper-IgE recurrent infection syndrome	147060	APRF	102582	17q21.2
Hyper-IgE recurrent infection syndrome	147060	HIES	102582	17q21.2
Hyper-IgE recurrent infection syndrome, autosomal recessive	243700	DOCK8	611432	9p24.3
Hyper-IgE recurrent infection syndrome, autosomal recessive	243700	MRD2	611432	9p24.3
Hyperaldosteronism, familial, type II	605635	FHII		7p22
Hyperaldosteronism, familial, type III	613677	KCNJ5	600734	11q24.3
Hyperaldosteronism, familial, type III	613677	GIRK4	600734	11q24.3
Hyperaldosteronism, familial, type III	613677	KATP1	600734	11q24.3
Hyperaldosteronism, familial, type III	613677	LQT13	600734	11q24.3
Hyperalphalipoproteinemia 2	614028	APOC3	107720	11q23.3
Hyperalphalipoproteinemia 2	614028	HALP2	107720	11q23.3
Hyperalphalipoproteinemia	143470	CETP	118470	16q13
Hyperalphalipoproteinemia	143470	HDLCQ10	118470	16q13
Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency	201910	CYP21A2	613815	6p21.33
Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency	201910	CYP21	613815	6p21.33
Hyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency	201910	CA21H	613815	6p21.33
Hyperbilirubinemia, Rotor type, digenic	237450	SLCO1B1	604843	12p12.2-p12.1
Hyperbilirubinemia, Rotor type, digenic	237450	LST1	604843	12p12.2-p12.1
Hyperbilirubinemia, Rotor type, digenic	237450	OATP2	604843	12p12.2-p12.1
Hyperbilirubinemia, Rotor type, digenic	237450	OATPC	604843	12p12.2-p12.1
Hyperbilirubinemia, Rotor type, digenic	237450	OATP1B1	604843	12p12.2-p12.1
Hyperbilirubinemia, Rotor type, digenic	237450	HBLRR	604843	12p12.2-p12.1
Hyperbilirubinemia, Rotor type, digenic	237450	SLCO1B3	605495	12p12.2
Hyperbilirubinemia, Rotor type, digenic	237450	OATP8	605495	12p12.2
Hyperbilirubinemia, Rotor type, digenic	237450	OATP1B3	605495	12p12.2
Hyperbilirubinemia, Rotor type, digenic	237450	SLC21A8	605495	12p12.2
Hyperbilirubinemia, Rotor type, digenic	237450	HBLRR	605495	12p12.2
Hyperbilirubinemia, familial transcient neonatal	237900	UGT1A1	191740	2q37.1
Hyperbilirubinemia, familial transcient neonatal	237900	UGT1	191740	2q37.1
Hyperbilirubinemia, familial transcient neonatal	237900	GNT1	191740	2q37.1
Hyperbilirubinemia, familial transcient neonatal	237900	BILIQTL1	191740	2q37.1
Hyperbiliverdinemia	614156	BLVRA	109750	7p13
Hypercalcemia, infantile	143880	CYP24A1	126065	20q13.2
Hypercalcemia, infantile	143880	CYP24	126065	20q13.2
Hypercalcemia, infantile	143880	HCAI	126065	20q13.2
Hypercalciuria, absorptive	607258	HCA1		4q33-qter
Hypercalciuric hypercalcemia	601199	CASR		3q21.1
Hypercalciuric hypercalcemia	601199	HHC1		3q21.1
Hypercalciuric hypercalcemia	601199	PCAR1		3q21.1
Hypercalciuric hypercalcemia	601199	FIH		3q21.1
Hypercalciuric hypercalcemia	601199	EIG8		3q21.1
Hypercalciuric hypercalcemia	601199	HYPOC1		3q21.1
Hypercarotenemia and vitamin A deficiency, autosomal dominant	115300	BCMO1	605748	16q23.2
Hypercarotenemia and vitamin A deficiency, autosomal dominant	115300	BCDO	605748	16q23.2
Hypercarotenemia and vitamin A deficiency, autosomal dominant	115300	BCO1	605748	16q23.2
Hyperchlorhidrosis, isolated	143860	CA12	603263	15q22.2
Hypercholanemia, familial	607748	BAAT	602938	9q31.1
Hypercholanemia, familial	607748	EPHX1	132810	1q42.12
Hypercholanemia, familial	607748	TJP2	607709	9q21.11
Hypercholanemia, familial	607748	ZO2	607709	9q21.11
Hypercholesterolemia, due to ligand-defective apo B	144010	APOB	107730	2p24.1
Hypercholesterolemia, due to ligand-defective apo B	144010	FLDB	107730	2p24.1
Hypercholesterolemia, due to ligand-defective apo B	144010	LDLCQ4	107730	2p24.1
Hypercholesterolemia, familial	143890	LDLR	606945	19p13.2
Hypercholesterolemia, familial	143890	FHC	606945	19p13.2
Hypercholesterolemia, familial	143890	FH	606945	19p13.2
Hypercholesterolemia, familial	143890	LDLCQ2	606945	19p13.2
Hypercholesterolemia, familial, 3	603776	PCSK9	607786	1p32.3
Hypercholesterolemia, familial, 3	603776	NARC1	607786	1p32.3
Hypercholesterolemia, familial, 3	603776	HCHOLA3	607786	1p32.3
Hypercholesterolemia, familial, 3	603776	FH3	607786	1p32.3
Hypercholesterolemia, familial, 3	603776	LDLCQ1	607786	1p32.3
Hypercholesterolemia, familial, autosomal recessive	603813	LDLRAP1	605747	1p36.11
Hypercholesterolemia, familial, autosomal recessive	603813	ARH	605747	1p36.11
Hypercholesterolemia, familial, autosomal recessive	603813	FHCB2	605747	1p36.11
Hypercholesterolemia, familial, autosomal recessive	603813	FHCB1	605747	1p36.11
Hyperchylomicronemia, late-onset	144650	APOA5	606368	11q23.3
Hyperekplexia 2, autosomal recessive	614619	GLRB	138492	4q32.1
Hyperekplexia 2, autosomal recessive	614619	HKPX2	138492	4q32.1
Hyperekplexia 3	614618	SLC6A5	604159	11p15.1
Hyperekplexia 3	614618	GLYT2	604159	11p15.1
Hyperekplexia 3	614618	HKPX3	604159	11p15.1
Hyperekplexia, hereditary 1, autosomal dominant or recessive	149400	GLRA1	138491	5q33.1
Hyperekplexia, hereditary 1, autosomal dominant or recessive	149400	STHE	138491	5q33.1
Hyperekplexia, hereditary 1, autosomal dominant or recessive	149400	HKPX1	138491	5q33.1
Hypereosinophilic syndrome, idiopathic, resistant to imatinib	607685	PDGFRA	173490	4q12
Hyperferritinemia-cataract syndrome	600886	FTL	134790	19q13.33
Hyperferritinemia-cataract syndrome	600886	NBIA3	134790	19q13.33
Hyperferritinemia-cataract syndrome	600886	LFTD	134790	19q13.33
Hyperfibrinolysis, familial, due to increased release of PLAT	612348	PLAT	173370	8p11.21
Hyperfibrinolysis, familial, due to increased release of PLAT	612348	TPA	173370	8p11.21
Hyperglycinuria	138500	SLC36A2	608331	5q33.1
Hyperglycinuria	138500	PAT2	608331	5q33.1
Hyperglycinuria	138500	SLC6A19	608893	5p15.33
Hyperglycinuria	138500	HND	608893	5p15.33
Hyperglycinuria	138500	SLC6A20	605616	3p21.31
Hyperglycinuria	138500	XT3	605616	3p21.31
Hyperhidrosis palmaris et plantaris	144110	HHPP		14q11.2-q13
Hyperinsulinemic hypoglycemia, familial, 1	256450	ABCC8	600509	11p15.1
Hyperinsulinemic hypoglycemia, familial, 1	256450	SUR	600509	11p15.1
Hyperinsulinemic hypoglycemia, familial, 1	256450	PHHI	600509	11p15.1
Hyperinsulinemic hypoglycemia, familial, 1	256450	SUR1	600509	11p15.1
Hyperinsulinemic hypoglycemia, familial, 1	256450	HHF1	600509	11p15.1
Hyperinsulinemic hypoglycemia, familial, 1	256450	TNDM2	600509	11p15.1
Hyperinsulinemic hypoglycemia, familial, 2	601820	KCNJ11	600937	11p15.1
Hyperinsulinemic hypoglycemia, familial, 2	601820	BIR	600937	11p15.1
Hyperinsulinemic hypoglycemia, familial, 2	601820	PHHI	600937	11p15.1
Hyperinsulinemic hypoglycemia, familial, 2	601820	HHF2	600937	11p15.1
Hyperinsulinemic hypoglycemia, familial, 2	601820	TNDM3	600937	11p15.1
Hyperinsulinemic hypoglycemia, familial, 3	602485	GCK	138079	7p13
Hyperinsulinemic hypoglycemia, familial, 3	602485	HHF3	138079	7p13
Hyperinsulinemic hypoglycemia, familial, 4	609975	HADHSC	601609	4q25
Hyperinsulinemic hypoglycemia, familial, 4	609975	SCHAD	601609	4q25
Hyperinsulinemic hypoglycemia, familial, 4	609975	HHF4	601609	4q25
Hyperinsulinemic hypoglycemia, familial, 5	609968	INSR	147670	19p13.2
Hyperinsulinemic hypoglycemia, familial, 5	609968	HHF5	147670	19p13.2
Hyperinsulinemic hypoglycemia, familial, 7	610021	SLC16A1	600682	1p13.2
Hyperinsulinemic hypoglycemia, familial, 7	610021	MCT1	600682	1p13.2
Hyperinsulinemic hypoglycemia, familial, 7	610021	HHF7	600682	1p13.2
Hyperinsulinism-hyperammonemia syndrome	606762	GLUD1	138130	10q23.2
Hyperkalemic periodic paralysis, type 2	170500	SCN4A	603967	17q23.3
Hyperkalemic periodic paralysis, type 2	170500	HYPP	603967	17q23.3
Hyperkalemic periodic paralysis, type 2	170500	NAC1A	603967	17q23.3
Hyperkalemic periodic paralysis, type 2	170500	HOKPP2	603967	17q23.3
Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations	116860	CCM1	604214	7q21.2
Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations	116860	CAM	604214	7q21.2
Hyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations	116860	KRIT1	604214	7q21.2
Hyperlipidemia, combined, 2	604499	HYPLIP2		11p
Hyperlipoproteinemia, type III	107741	APOE		19q13.32
Hyperlipoproteinemia, type III	107741	AD2		19q13.32
Hyperlipoproteinemia, type III	107741	LPG		19q13.32
Hyperlipoproteinemia, type III	107741	LDLCQ5		19q13.32
Hyperlipoproteinemia, type Ib	207750	APOC2	608083	19q13.32
Hyperlysinemia	238700	AASS	605113	7q31.32
Hypermanganesemia with dystonia, polycythemia, and cirrhosis	613280	SLC30A10	611146	1q41
Hypermanganesemia with dystonia, polycythemia, and cirrhosis	613280	ZNT10	611146	1q41
Hypermanganesemia with dystonia, polycythemia, and cirrhosis	613280	HMDPC	611146	1q41
Hypermethioninemia due to adenosine kinase deficiency	614300	ADK	102750	10q22.2
Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	613752	AHCY	180960	20q11.22
Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase	613752	SAHH	180960	20q11.22
Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency	250850	MAT1A	610550	10q23.1
Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency	250850	MATA1	610550	10q23.1
Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency	250850	SAMS1	610550	10q23.1
Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	238970	SLC25A15	603861	13q14.11
Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	238970	ORNT1	603861	13q14.11
Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome	238970	HHH	603861	13q14.11
Hyperostosis, endosteal	144750	LRP5	603506	11q13.2
Hyperostosis, endosteal	144750	BMND1	603506	11q13.2
Hyperostosis, endosteal	144750	LRP7	603506	11q13.2
Hyperostosis, endosteal	144750	LR3	603506	11q13.2
Hyperostosis, endosteal	144750	OPPG	603506	11q13.2
Hyperostosis, endosteal	144750	VBCH2	603506	11q13.2
Hyperostosis, endosteal	144750	OPTA1	603506	11q13.2
Hyperostosis, endosteal	144750	EVR4	603506	11q13.2
Hyperoxaluria, primary, type 1	259900	AGXT	604285	2q37.3
Hyperoxaluria, primary, type 1	259900	SPAT	604285	2q37.3
Hyperoxaluria, primary, type II	260000	GRHPR	604296	9p13.2
Hyperoxaluria, primary, type II	260000	GLXR	604296	9p13.2
Hyperoxaluria, primary, type III	613616	HOGA1	613597	10q24.2
Hyperoxaluria, primary, type III	613616	DHDPSL	613597	10q24.2
Hyperoxaluria, primary, type III	613616	HP3	613597	10q24.2
Hyperparathyroidism 3	610071	HRPT3		2p14-p13.3
Hyperparathyroidism, familial primary	145000	HRPT2	607393	1q31.2
Hyperparathyroidism, familial primary	145000	C1orf28	607393	1q31.2
Hyperparathyroidism, neonatal	239200	CASR	601199	3q21.1
Hyperparathyroidism, neonatal	239200	HHC1	601199	3q21.1
Hyperparathyroidism, neonatal	239200	PCAR1	601199	3q21.1
Hyperparathyroidism, neonatal	239200	FIH	601199	3q21.1
Hyperparathyroidism, neonatal	239200	EIG8	601199	3q21.1
Hyperparathyroidism, neonatal	239200	HYPOC1	601199	3q21.1
Hyperparathyroidism-jaw tumor syndrome	145001	HRPT2	607393	1q31.2
Hyperparathyroidism-jaw tumor syndrome	145001	C1orf28	607393	1q31.2
Hyperphenylalaninemia, BH4-deficient, A	261640	PTS	612719	11q23.1
Hyperphenylalaninemia, BH4-deficient, B	233910	GCH1	600225	14q22.2
Hyperphenylalaninemia, BH4-deficient, B	233910	DYT5	600225	14q22.2
Hyperphenylalaninemia, BH4-deficient, B	233910	HPABH4B	600225	14q22.2
Hyperphenylalaninemia, BH4-deficient, C	261630	QDPR	612676	4p15.32
Hyperphenylalaninemia, BH4-deficient, C	261630	DHPR	612676	4p15.32
Hyperphenylalaninemia, BH4-deficient, D	264070	PCBD	126090	10q22.1
Hyperphenylalaninemia, BH4-deficient, D	264070	DCOH	126090	10q22.1
Hyperphosphatasia with mental retardation syndrome 1	239300	PIGV	610274	1p36.11
Hyperphosphatasia with mental retardation syndrome 1	239300	HPMRS1	610274	1p36.11
Hyperphosphatasia with mental retardation syndrome 2	614749	PIGO	614730	9p13.3
Hyperphosphatasia with mental retardation syndrome 2	614749	HPMRS2	614730	9p13.3
Hyperphosphatasia with mental retardation syndrome 3	614207	PGAP2	615187	11p15.4
Hyperphosphatasia with mental retardation syndrome 3	614207	FRAG1	615187	11p15.4
Hyperphosphatasia with mental retardation syndrome 3	614207	HPMRS3	615187	11p15.4
Hyperphosphatasia with mental retardation syndrome 3	614207	MRT17	615187	11p15.4
Hyperphosphatasia with mental retardation syndrome 3	614207	MRT21	615187	11p15.4
Hyperpigmentation, familial progressive, 1	614233	FPH1		19pter-p13.1
Hyperpigmentation, familial progressive, 1	614233	MUH		19pter-p13.1
Hyperpigmentation, familial progressive, 1	614233	HPP		19pter-p13.1
Hyperpigmentation, familial progressive, 2	145250	KITLG	184745	12q21.32
Hyperpigmentation, familial progressive, 2	145250	MGF	184745	12q21.32
Hyperpigmentation, familial progressive, 2	145250	SF	184745	12q21.32
Hyperpigmentation, familial progressive, 2	145250	SCF	184745	12q21.32
Hyperpigmentation, familial progressive, 2	145250	SHEP7	184745	12q21.32
Hyperproinsulinemia, familial, with or without diabetes	176730	INS		11p15.5
Hyperproinsulinemia, familial, with or without diabetes	176730	MODY10		11p15.5
Hyperproinsulinemia, familial, with or without diabetes	176730	IDDM2		11p15.5
Hyperprolinemia, type I	239500	PRODH	606810	22q11.21
Hyperprolinemia, type I	239500	PRODH2	606810	22q11.21
Hyperprolinemia, type I	239500	SCZD4	606810	22q11.21
Hyperprolinemia, type II	239510	ALDH4A1	606811	1p36.13
Hyperprolinemia, type II	239510	ALDH4	606811	1p36.13
Hyperprolinemia, type II	239510	P5CDH	606811	1p36.13
Hypertelorism, preauricular sinus, punctal pits, and deafness	614187	HPPD		14q31
Hypertension with brachydactyly	112410	HTNB		12p12.2-p11.2
Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	605115	NR3C2	600983	4q31.23
Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	605115	MLR	600983	4q31.23
Hypertension, early-onset, autosomal dominant, with exacerbation in pregnancy	605115	MCR	600983	4q31.23
Hypertension, essential	145500	AGTR1	106165	3q24
Hypertension, essential	145500	AGTR1A	106165	3q24
Hypertension, essential	145500	AT2R1	106165	3q24
Hypertension, essential	145500	PTGIS	601699	20q13.13
Hypertension, essential	145500	CYP8A1	601699	20q13.13
Hypertension, essential	145500	PGIS	601699	20q13.13
Hypertension, essential	145500	CYP8	601699	20q13.13
Hypertensive nephropathy	608026	HNP1		9q31-q32
Hyperthyroidism, familial gestational	603373	TSHR	603372	14q31.1
Hyperthyroidism, familial gestational	603373	CHNG1	603372	14q31.1
Hyperthyroidism, nonautoimmune	609152	TSHR	603372	14q31.1
Hyperthyroidism, nonautoimmune	609152	CHNG1	603372	14q31.1
Hypertrichosis terminalis, generalized, with or without gingival hyperplasia	135400	HTGH		17q24.2-q24.3
Hypertrichosis terminalis, generalized, with or without gingival hyperplasia	135400	DEL17q24		17q24.2-q24.3
Hypertrichosis, congenital generalized	307150	HTC2		Xq27.1
Hypertrichosis, congenital generalized	307150	HCG		Xq27.1
Hypertrichosis, congenital generalized	307150	CGH		Xq27.1
Hypertrichosis, congenital generalized	307150	CXINSq27.1,		Xq27.1
Hypertrichotic osteochondrodysplasia	239850	ABCC9	601439	12p12.1
Hypertrichotic osteochondrodysplasia	239850	SUR2	601439	12p12.1
Hypertrichotic osteochondrodysplasia	239850	CMD1O	601439	12p12.1
Hypertrichotic osteochondrodysplasia	239850	ATFB12	601439	12p12.1
Hypertrichotic osteochondrodysplasia	239850	CANTU	601439	12p12.1
Hypertriglyceridemia, transient infantile	614480	GPD1	138420	12q13.12
Hypertriglyceridemia, transient infantile	614480	HTGTI	138420	12q13.12
Hypertrophic osteoarthropathy, primary, autosomal recessive 1	259100	HPGD	601688	4q34.1
Hypertrophic osteoarthropathy, primary, autosomal recessive 1	259100	PGDH1	601688	4q34.1
Hypertrophic osteoarthropathy, primary, autosomal recessive 1	259100	PHOAR1	601688	4q34.1
Hypertrophic osteoarthropathy, primary, autosomal recessive 2	614441	SLCO2A1	601460	3q22.1-q22.2
Hypertrophic osteoarthropathy, primary, autosomal recessive 2	614441	OATP2A1	601460	3q22.1-q22.2
Hypertrophic osteoarthropathy, primary, autosomal recessive 2	614441	PGT	601460	3q22.1-q22.2
Hypertrophic osteoarthropathy, primary, autosomal recessive 2	614441	SLC21A2	601460	3q22.1-q22.2
Hypertrophic osteoarthropathy, primary, autosomal recessive 2	614441	PHOAR2	601460	3q22.1-q22.2
Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis	613845	SARS2	612804	19q13.2
Hyperuricemic nephropathy, familial juvenile 1	162000	UMOD	191845	16p12.3
Hyperuricemic nephropathy, familial juvenile 1	162000	HNFJ1	191845	16p12.3
Hyperuricemic nephropathy, familial juvenile 1	162000	FJHN	191845	16p12.3
Hyperuricemic nephropathy, familial juvenile 1	162000	MCKD2	191845	16p12.3
Hyperuricemic nephropathy, familial juvenile 1	162000	ADMCKD2	191845	16p12.3
Hyperuricemic nephropathy, familial juvenile 2	613092	REN	179820	1q32.1
Hyperuricemic nephropathy, familial juvenile 2	613092	HNFJ2	179820	1q32.1
Hyperuricemic nephropathy, familial juvenile, 3	614227	HNFJ3		2p22.1-p21
Hypoaldosteronism, congenital, due to CMO I deficiency	203400	CYP11B2	124080	8q24.3
Hypoaldosteronism, congenital, due to CMO II deficiency	610600	CYP11B2	124080	8q24.3
Hypoalphalipoproteinemia	604091	APOA1	107680	11q23.3
Hypobetalipoproteinemia	615558	APOB	107730	2p24.1
Hypobetalipoproteinemia	615558	FLDB	107730	2p24.1
Hypobetalipoproteinemia	615558	LDLCQ4	107730	2p24.1
Hypobetalipoproteinemia, familial, 2	605019	ANGPTL3	604774	1p31.3
Hypobetalipoproteinemia, familial, 2	605019	ANGPT5	604774	1p31.3
Hypobetalipoproteinemia, familial, 2	605019	FHBL2	604774	1p31.3
Hypocalcemia, autosomal dominant 2	615361	GNA11	139313	19p13.3
Hypocalcemia, autosomal dominant 2	615361	HHC2	139313	19p13.3
Hypocalcemia, autosomal dominant 2	615361	HYPOC2	139313	19p13.3
Hypocalcemia, autosomal dominant	601198	CASR	601199	3q21.1
Hypocalcemia, autosomal dominant	601198	HHC1	601199	3q21.1
Hypocalcemia, autosomal dominant	601198	PCAR1	601199	3q21.1
Hypocalcemia, autosomal dominant	601198	FIH	601199	3q21.1
Hypocalcemia, autosomal dominant	601198	EIG8	601199	3q21.1
Hypocalcemia, autosomal dominant	601198	HYPOC1	601199	3q21.1
Hypocalcemia, autosomal dominant, with Bartter syndrome	601198	CASR	601199	3q21.1
Hypocalcemia, autosomal dominant, with Bartter syndrome	601198	HHC1	601199	3q21.1
Hypocalcemia, autosomal dominant, with Bartter syndrome	601198	PCAR1	601199	3q21.1
Hypocalcemia, autosomal dominant, with Bartter syndrome	601198	FIH	601199	3q21.1
Hypocalcemia, autosomal dominant, with Bartter syndrome	601198	EIG8	601199	3q21.1
Hypocalcemia, autosomal dominant, with Bartter syndrome	601198	HYPOC1	601199	3q21.1
Hypocalciuric hypercalcemia, familial, type III	600740	AP2S1	602242	19q13.32
Hypocalciuric hypercalcemia, familial, type III	600740	CLAPS2	602242	19q13.32
Hypocalciuric hypercalcemia, familial, type III	600740	AP17	602242	19q13.32
Hypocalciuric hypercalcemia, familial, type III	600740	HHC3	602242	19q13.32
Hypocalciuric hypercalcemia, type I	145980	CASR	601199	3q21.1
Hypocalciuric hypercalcemia, type I	145980	HHC1	601199	3q21.1
Hypocalciuric hypercalcemia, type I	145980	PCAR1	601199	3q21.1
Hypocalciuric hypercalcemia, type I	145980	FIH	601199	3q21.1
Hypocalciuric hypercalcemia, type I	145980	EIG8	601199	3q21.1
Hypocalciuric hypercalcemia, type I	145980	HYPOC1	601199	3q21.1
Hypocalciuric hypercalcemia, type II	145981	HHC2		19p13.3
Hypocalciuric hypercalcemia, type II	145981	FHH2		19p13.3
Hypocalciuric hypercalcemia, type II	145981	GNA11	139313	19p13.3
Hypocalciuric hypercalcemia, type II	145981	HHC2	139313	19p13.3
Hypocalciuric hypercalcemia, type II	145981	HYPOC2	139313	19p13.3
Hypochondroplasia	146000	FGFR3	134934	4p16.3
Hypochondroplasia	146000	ACH	134934	4p16.3
Hypochromic microcytic anemia		HBA2	141850	16p13.3
Hypochromic microcytic anemia		HBH	141850	16p13.3
Hypofibrinogenemia, gamma type		FGG	134850	4q31.3
Hypoglycemia of infancy, leucine-sensitive	240800	ABCC8	600509	11p15.1
Hypoglycemia of infancy, leucine-sensitive	240800	SUR	600509	11p15.1
Hypoglycemia of infancy, leucine-sensitive	240800	PHHI	600509	11p15.1
Hypoglycemia of infancy, leucine-sensitive	240800	SUR1	600509	11p15.1
Hypoglycemia of infancy, leucine-sensitive	240800	HHF1	600509	11p15.1
Hypoglycemia of infancy, leucine-sensitive	240800	TNDM2	600509	11p15.1
Hypogonadism, hypergonadotropic	152780	LHB		19q13.33
Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	308700	KAL1	300836	Xp22.31
Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	308700	KMS	300836	Xp22.31
Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	308700	ADMLX	300836	Xp22.31
Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1)	308700	HH1	300836	Xp22.31
Hypogonadotropic hypogonadism 10 with or without anosmia	614839	TAC3	162330	12q13.3
Hypogonadotropic hypogonadism 10 with or without anosmia	614839	NKNB	162330	12q13.3
Hypogonadotropic hypogonadism 10 with or without anosmia	614839	HH10	162330	12q13.3
Hypogonadotropic hypogonadism 11 with or without anosmia	614840	TACR3	162332	4q24
Hypogonadotropic hypogonadism 11 with or without anosmia	614840	NK3R	162332	4q24
Hypogonadotropic hypogonadism 11 with or without anosmia	614840	HH11	162332	4q24
Hypogonadotropic hypogonadism 12 with or without anosmia	614841	GNRH1	152760	8p21.2
Hypogonadotropic hypogonadism 12 with or without anosmia	614841	LNRH	152760	8p21.2
Hypogonadotropic hypogonadism 12 with or without anosmia	614841	HH12	152760	8p21.2
Hypogonadotropic hypogonadism 13 with or without anosmia	614842	KISS1	603286	1q32.1
Hypogonadotropic hypogonadism 13 with or without anosmia	614842	HH13	603286	1q32.1
Hypogonadotropic hypogonadism 14 with or without anosmia	614858	WDR11	606417	10q26.12
Hypogonadotropic hypogonadism 14 with or without anosmia	614858	DR11	606417	10q26.12
Hypogonadotropic hypogonadism 14 with or without anosmia	614858	KIAA1351	606417	10q26.12
Hypogonadotropic hypogonadism 14 with or without anosmia	614858	BRWD2	606417	10q26.12
Hypogonadotropic hypogonadism 14 with or without anosmia	614858	HH14	606417	10q26.12
Hypogonadotropic hypogonadism 17 with or without anosmia	615266	SPRY4	607984	5q31.3
Hypogonadotropic hypogonadism 17 with or without anosmia	615266	HH17	607984	5q31.3
Hypogonadotropic hypogonadism 18 with or without anosmia	615267	IL17RD	606807	3p14.3
Hypogonadotropic hypogonadism 18 with or without anosmia	615267	SEF	606807	3p14.3
Hypogonadotropic hypogonadism 18 with or without anosmia	615267	HH18	606807	3p14.3
Hypogonadotropic hypogonadism 19 with or without anosmia	615269	DUSP6	602748	12q21.33
Hypogonadotropic hypogonadism 19 with or without anosmia	615269	MKP3	602748	12q21.33
Hypogonadotropic hypogonadism 19 with or without anosmia	615269	PYST1	602748	12q21.33
Hypogonadotropic hypogonadism 19 with or without anosmia	615269	HH19	602748	12q21.33
Hypogonadotropic hypogonadism 2 with or without anosmia	147950	FGFR1	136350	8p11.23-p11.22
Hypogonadotropic hypogonadism 2 with or without anosmia	147950	FLT2	136350	8p11.23-p11.22
Hypogonadotropic hypogonadism 2 with or without anosmia	147950	OGD	136350	8p11.23-p11.22
Hypogonadotropic hypogonadism 2 with or without anosmia	147950	KAL2	136350	8p11.23-p11.22
Hypogonadotropic hypogonadism 2 with or without anosmia	147950	HH2	136350	8p11.23-p11.22
Hypogonadotropic hypogonadism 2 with or without anosmia	147950	HRTFDS	136350	8p11.23-p11.22
Hypogonadotropic hypogonadism 20 with or without anosmia	615270	FGF17	603725	8p21.3
Hypogonadotropic hypogonadism 20 with or without anosmia	615270	HH20	603725	8p21.3
Hypogonadotropic hypogonadism 21 with anosmia	615271	FLRT3	604808	20p12.1
Hypogonadotropic hypogonadism 21 with anosmia	615271	HH21	604808	20p12.1
Hypogonadotropic hypogonadism 3 with or without anosmia	244200	PROKR2	607123	20p12.3
Hypogonadotropic hypogonadism 3 with or without anosmia	244200	PKR2	607123	20p12.3
Hypogonadotropic hypogonadism 3 with or without anosmia	244200	GPR73L1	607123	20p12.3
Hypogonadotropic hypogonadism 3 with or without anosmia	244200	HH3	607123	20p12.3
Hypogonadotropic hypogonadism 4 with or without anosmia	610628	PROK2	607002	3p13
Hypogonadotropic hypogonadism 4 with or without anosmia	610628	PK2	607002	3p13
Hypogonadotropic hypogonadism 4 with or without anosmia	610628	BV8	607002	3p13
Hypogonadotropic hypogonadism 4 with or without anosmia	610628	HH4	607002	3p13
Hypogonadotropic hypogonadism 5 with or without anosmia	612370	CHD7	608892	8q12.1-q12.2
Hypogonadotropic hypogonadism 5 with or without anosmia	612370	IS3	608892	8q12.1-q12.2
Hypogonadotropic hypogonadism 5 with or without anosmia	612370	HH5	608892	8q12.1-q12.2
Hypogonadotropic hypogonadism 6 with or without anosmia	612702	FGF8	600483	10q24.32
Hypogonadotropic hypogonadism 6 with or without anosmia	612702	HH6	600483	10q24.32
Hypogonadotropic hypogonadism 7 with or without anosmia	146110	GNRHR	138850	4q13.2
Hypogonadotropic hypogonadism 7 with or without anosmia	146110	LHRHR	138850	4q13.2
Hypogonadotropic hypogonadism 7 with or without anosmia	146110	HH7	138850	4q13.2
Hypogonadotropic hypogonadism 8 with or without anosmia	614837	KISS1R	604161	19p13.3
Hypogonadotropic hypogonadism 8 with or without anosmia	614837	GPR54 	604161	19p13.3
Hypogonadotropic hypogonadism 8 with or without anosmia	614837	HH8	604161	19p13.3
Hypogonadotropic hypogonadism 8 with or without anosmia	614837	CPPB1	604161	19p13.3
Hypogonadotropic hypogonadism 9 with or without anosmia	614838	NSMF	608137	9q34.3
Hypogonadotropic hypogonadism 9 with or without anosmia	614838	NELF	608137	9q34.3
Hypogonadotropic hypogonadism 9 with or without anosmia	614838	HH9	608137	9q34.3
Hypoinsulinemic hypoglycemia with hemihypertrophy	240900	AKT2	164731	19q13.2
Hypoinsulinemic hypoglycemia with hemihypertrophy	240900	HIHGHH	164731	19q13.2
Hypokalemic periodic paralysis, type 1	170400	CACNA1S	114208	1q32.1
Hypokalemic periodic paralysis, type 1	170400	CACNL1A3	114208	1q32.1
Hypokalemic periodic paralysis, type 1	170400	CCHL1A3	114208	1q32.1
Hypokalemic periodic paralysis, type 1	170400	TTPP1	114208	1q32.1
Hypokalemic periodic paralysis, type 1	170400	HOKPP1	114208	1q32.1
Hypokalemic periodic paralysis, type 2	613345	SCN4A	603967	17q23.3
Hypokalemic periodic paralysis, type 2	613345	HYPP	603967	17q23.3
Hypokalemic periodic paralysis, type 2	613345	NAC1A	603967	17q23.3
Hypokalemic periodic paralysis, type 2	613345	HOKPP2	603967	17q23.3
Hypomagnesemia 1, intestinal	602014	TRPM6	607009	9q21.13
Hypomagnesemia 1, intestinal	602014	CHAK2	607009	9q21.13
Hypomagnesemia 1, intestinal	602014	HOMG1	607009	9q21.13
Hypomagnesemia 3, renal	248250	CLDN16	603959	3q28
Hypomagnesemia 3, renal	248250	PCLN1	603959	3q28
Hypomagnesemia 3, renal	248250	HOMG3	603959	3q28
Hypomagnesemia 4, renal	611718	EGF	131530	4q25
Hypomagnesemia 4, renal	611718	URG	131530	4q25
Hypomagnesemia 4, renal	611718	HOMG4	131530	4q25
Hypomagnesemia 5, renal, with ocular involvement	248190	CLDN19	610036	1p34.2
Hypomagnesemia 5, renal, with ocular involvement	248190	HOMG5	610036	1p34.2
Hypomagnesemia 6, renal	613882	CNNM2	607803	10q24.32
Hypomagnesemia 6, renal	613882	ACDP2	607803	10q24.32
Hypomagnesemia-2, renal	154020	FXYD2	601814	11q23.3
Hypomagnesemia-2, renal	154020	ATP1G1	601814	11q23.3
Hypomagnesemia-2, renal	154020	HOMG2	601814	11q23.3
Hypomyelination with brainstem and spinal cord involvement and leg spasticity	615281	DARS	603084	2q21.3
Hypomyelination with brainstem and spinal cord involvement and leg spasticity	615281	HBSL	603084	2q21.3
Hypomyelination, global cerebral	612949	SLC25A12	603667	2q31.1
Hypomyelination, global cerebral	612949	ARALAR	603667	2q31.1
Hypoparathyroidism, X-linked	307700	HPT		Xq26-q27
Hypoparathyroidism, X-linked	307700	HPTX		Xq26-q27
Hypoparathyroidism, X-linked	307700	HYPX		Xq26-q27
Hypoparathyroidism, autosomal dominant	146200	PTH	168450	11p15.2
Hypoparathyroidism, autosomal recessive	146200	PTH	168450	11p15.2
Hypoparathyroidism, familial isolated	146200	GCMB	603716	6p24.2
Hypoparathyroidism, sensorineural deafness, and renal dysplasia	146255	GATA3	131320	10p14
Hypoparathyroidism, sensorineural deafness, and renal dysplasia	146255	HDR	131320	10p14
Hypoparathyroidism, sensorineural deafness, and renal dysplasia	146255	HDRS	131320	10p14
Hypoparathyroidism-retardation-dysmorphism syndrome	241410	TBCE	604934	1q42.3
Hypoparathyroidism-retardation-dysmorphism syndrome	241410	KCS	604934	1q42.3
Hypoparathyroidism-retardation-dysmorphism syndrome	241410	KCS1	604934	1q42.3
Hypoparathyroidism-retardation-dysmorphism syndrome	241410	HRD	604934	1q42.3
Hypophosphatasia, adult	146300	ALPL	171760	1p36.12
Hypophosphatasia, adult	146300	HOPS	171760	1p36.12
Hypophosphatasia, adult	146300	TNSALP	171760	1p36.12
Hypophosphatasia, childhood	241510	ALPL	171760	1p36.12
Hypophosphatasia, childhood	241510	HOPS	171760	1p36.12
Hypophosphatasia, childhood	241510	TNSALP	171760	1p36.12
Hypophosphatasia, infantile	241500	ALPL	171760	1p36.12
Hypophosphatasia, infantile	241500	HOPS	171760	1p36.12
Hypophosphatasia, infantile	241500	TNSALP	171760	1p36.12
Hypophosphatemic rickets and hyperparathyroidism	612089	HPRHP		13q13.1
Hypophosphatemic rickets with hypercalciuria	241530	SLC34A3	609826	9q34.3
Hypophosphatemic rickets with hypercalciuria	241530	NPTIIC	609826	9q34.3
Hypophosphatemic rickets with hypercalciuria	241530	HHRH	609826	9q34.3
Hypophosphatemic rickets	300554	CLCN5	300008	Xp11.23-p11.22
Hypophosphatemic rickets	300554	CLCK2	300008	Xp11.23-p11.22
Hypophosphatemic rickets	300554	NPHL2	300008	Xp11.23-p11.22
Hypophosphatemic rickets	300554	DENTS	300008	Xp11.23-p11.22
Hypophosphatemic rickets	300554	NPHL1	300008	Xp11.23-p11.22
Hypophosphatemic rickets, AR	241520	DMP1	600980	4q22.1
Hypophosphatemic rickets, AR	241520	ARHR	600980	4q22.1
Hypophosphatemic rickets, AR	241520	ARHP	600980	4q22.1
Hypophosphatemic rickets, X-linked dominant	307800	PHEX	300550	Xp22.11
Hypophosphatemic rickets, X-linked dominant	307800	HYP	300550	Xp22.11
Hypophosphatemic rickets, X-linked dominant	307800	HPDR1	300550	Xp22.11
Hypophosphatemic rickets, X-linked dominant	307800	LXHR	300550	Xp22.11
Hypophosphatemic rickets, autosomal dominant	193100	FGF23	605380	12p13.32
Hypophosphatemic rickets, autosomal dominant	193100	ADHR	605380	12p13.32
Hypophosphatemic rickets, autosomal dominant	193100	HPDR2	605380	12p13.32
Hypophosphatemic rickets, autosomal dominant	193100	PHPTC	605380	12p13.32
Hypophosphatemic rickets, autosomal recessive, 2	613312	ENPP1	173335	6q23.2
Hypophosphatemic rickets, autosomal recessive, 2	613312	PDNP1	173335	6q23.2
Hypophosphatemic rickets, autosomal recessive, 2	613312	NPPS	173335	6q23.2
Hypophosphatemic rickets, autosomal recessive, 2	613312	M6S1	173335	6q23.2
Hypophosphatemic rickets, autosomal recessive, 2	613312	PCA1	173335	6q23.2
Hypophosphatemic rickets, autosomal recessive, 2	613312	ARHR2	173335	6q23.2
Hypophosphatemic rickets, autosomal recessive, 2	613312	COLED	173335	6q23.2
Hypoplastic left heart syndrome 1	241550	GJA1	121014	6q22.31
Hypoplastic left heart syndrome 1	241550	CX43	121014	6q22.31
Hypoplastic left heart syndrome 1	241550	ODDD	121014	6q22.31
Hypoplastic left heart syndrome 1	241550	SDTY3	121014	6q22.31
Hypoplastic left heart syndrome 1	241550	ODOD	121014	6q22.31
Hypoplastic left heart syndrome 1	241550	HSS	121014	6q22.31
Hypoplastic left heart syndrome 1	241550	AVSD3	121014	6q22.31
Hypoplastic left heart syndrome 1	241550	HLHS1	121014	6q22.31
Hypoplastic left heart syndrome 1	241550	CMDR	121014	6q22.31
Hypoplastic left heart syndrome 2	614435	NKX2-5	600584	5q35.1
Hypoplastic left heart syndrome 2	614435	NKX2E	600584	5q35.1
Hypoplastic left heart syndrome 2	614435	CSX	600584	5q35.1
Hypoplastic left heart syndrome 2	614435	CHNG5	600584	5q35.1
Hypoplastic left heart syndrome 2	614435	VSD3	600584	5q35.1
Hypoplastic left heart syndrome 2	614435	HLHS2	600584	5q35.1
Hypoproteinemia, hypercatabolic	241600	B2M	109700	15q21.1
Hypoprothrombinemia	613679	F2	176930	11p11.2
Hypoprothrombinemia	613679	THPH1	176930	11p11.2
Hypoprothrombinemia	613679	RPRGL2	176930	11p11.2
Hypospadias 1, X-linked	300633	AR	313700	Xq12
Hypospadias 1, X-linked	300633	DHTR	313700	Xq12
Hypospadias 1, X-linked	300633	TFM	313700	Xq12
Hypospadias 1, X-linked	300633	SBMA	313700	Xq12
Hypospadias 1, X-linked	300633	KD	313700	Xq12
Hypospadias 1, X-linked	300633	SMAX1	313700	Xq12
Hypospadias 1, X-linked	300633	HYSP1	313700	Xq12
Hypospadias 2, X-linked	300758	MAMLD1	300120	Xq28
Hypospadias 2, X-linked	300758	CXorf6	300120	Xq28
Hypospadias 2, X-linked	300758	F18	300120	Xq28
Hypospadias 2, X-linked	300758	HYSP2	300120	Xq28
Hypospadias 3, autosomal	146450	HYSP3		7q32.2-q36.1
Hypothryoidism, congenital, nongoitrous 4	275100	TSHB	188540	1p13.2
Hypothryoidism, congenital, nongoitrous 4	275100	CHNG4	188540	1p13.2
Hypothyroidism, central, and testicular enlargement	300888	IGSF1	300137	Xq26.2
Hypothyroidism, central, and testicular enlargement	300888	IGDC1	300137	Xq26.2
Hypothyroidism, central, and testicular enlargement	300888	CHTE	300137	Xq26.2
Hypothyroidism, congenital nongoitrous, 5	225250	NKX2-5	600584	5q35.1
Hypothyroidism, congenital nongoitrous, 5	225250	NKX2E	600584	5q35.1
Hypothyroidism, congenital nongoitrous, 5	225250	CSX	600584	5q35.1
Hypothyroidism, congenital nongoitrous, 5	225250	CHNG5	600584	5q35.1
Hypothyroidism, congenital nongoitrous, 5	225250	VSD3	600584	5q35.1
Hypothyroidism, congenital nongoitrous, 5	225250	HLHS2	600584	5q35.1
Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia	218700	PAX8	167415	2q13
Hypothyroidism, congenital, nongoitrous, 1 275200	603372	TSHR		14q31.1
Hypothyroidism, congenital, nongoitrous, 1 275200	603372	CHNG1		14q31.1
Hypothyroidism, congenital, nongoitrous, 3	609893	CHNG3		15q25.3-q26.1
Hypothyroidism, congenital, nongoitrous, 3	609893	RTSH		15q25.3-q26.1
Hypothyroidism, congenital, nongoitrous, 6	614450	THRA	190120	17q21.1
Hypothyroidism, congenital, nongoitrous, 6	614450	ERBA1	190120	17q21.1
Hypothyroidism, congenital, nongoitrous, 6	614450	THRA1	190120	17q21.1
Hypothyroidism, congenital, nongoitrous, 6	614450	CHNG6	190120	17q21.1
Hypotonia-cystinuria syndrome	606407	DEL2p21		2p21
Hypotonia-cystinuria syndrome	606407	C2DELp21		2p21
Hypotrichosis 10	614238	HYP10		7p22.3-p21.3
Hypotrichosis 11	615059	SNRPE	128260	1q32.1
Hypotrichosis 11	615059	HYPT11	128260	1q32.1
Hypotrichosis 8	278150	LPAR6	609239	13q14.2
Hypotrichosis 8	278150	P2RY5	609239	13q14.2
Hypotrichosis 8	278150	P2Y5	609239	13q14.2
Hypotrichosis 8	278150	LAH3	609239	13q14.2
Hypotrichosis 8	278150	ARWH1	609239	13q14.2
Hypotrichosis 9	614237	HYPT9		10q11.23-q22.3
Hypotrichosis and recurrent skin vesicles	613102	DSC3	600271	18q12.1
Hypotrichosis and recurrent skin vesicles	613102	DSC4	600271	18q12.1
Hypotrichosis simplex of scalp 1	146520	CDSN	602593	6p21.33
Hypotrichosis simplex of scalp 1	146520	HTSS1	602593	6p21.33
Hypotrichosis simplex of scalp 1	146520	PSS	602593	6p21.33
Hypotrichosis simplex of the scalp 2	613981	KRT74	608248	12q13.13
Hypotrichosis simplex of the scalp 2	613981	K6IRS4	608248	12q13.13
Hypotrichosis simplex of the scalp 2	613981	KRT6IRS4	608248	12q13.13
Hypotrichosis simplex of the scalp 2	613981	HTSS2	608248	12q13.13
Hypotrichosis simplex	605389	APCDD1	607479	18p11.22
Hypotrichosis simplex	605389	HHS	607479	18p11.22
Hypotrichosis simplex	605389	HTS	607479	18p11.22
Hypotrichosis, congenital, with juvenile macular dystrophy	601553	CDH3	114021	16q22.1
Hypotrichosis, congenital, with juvenile macular dystrophy	601553	CDHP	114021	16q22.1
Hypotrichosis, congenital, with juvenile macular dystrophy	601553	PCAD	114021	16q22.1
Hypotrichosis, congenital, with juvenile macular dystrophy	601553	HJMD	114021	16q22.1
Hypotrichosis, hereditary, Marie Unna type, 1	146550	HR	602302	8p21.3
Hypotrichosis, hereditary, Marie Unna type, 1	146550	AU	602302	8p21.3
Hypotrichosis, hereditary, Marie Unna type, 1	146550	MUHH1	602302	8p21.3
Hypotrichosis, hereditary, Marie Unna type, 2	612841	MUHH2		1p21.1-q21.3
Hypotrichosis, localized, autosomal recessive 2	604379	LIPH	607365	3q27.2
Hypotrichosis, localized, autosomal recessive 2	604379	LAH2	607365	3q27.2
Hypotrichosis, localized, autosomal recessive 2	604379	ARWH2	607365	3q27.2
Hypotrichosis, localized, autosomal recessive	607903	DSG4	607892	18q12.1
Hypotrichosis, localized, autosomal recessive	607903	LAH	607892	18q12.1
Hypotrichosis-lymphedema-telangiectasia syndrome	607823	SOX18	601618	20q13.33
Hypotrichosis-lymphedema-telangiectasia syndrome	607823	HLTS	601618	20q13.33
Hypouricemia, renal, 2	612076	SLC2A9	606142	4p16.1
Hypouricemia, renal, 2	612076	GLUT9	606142	4p16.1
Hypouricemia, renal, 2	612076	UAQTL2	606142	4p16.1
Hypouricemia, renal	220150	SLC22A12	607096	11q13.1
Hypouricemia, renal	220150	OAT4L	607096	11q13.1
Hypouricemia, renal	220150	URAT1	607096	11q13.1
Hystrix-like ichthyosis with deafness	602540	GJB2	121011	13q12.11
Hystrix-like ichthyosis with deafness	602540	CX26	121011	13q12.11
Hystrix-like ichthyosis with deafness	602540	DFNB1A	121011	13q12.11
Hystrix-like ichthyosis with deafness	602540	PPK	121011	13q12.11
Hystrix-like ichthyosis with deafness	602540	DFNA3A	121011	13q12.11
Hystrix-like ichthyosis with deafness	602540	KID	121011	13q12.11
Hystrix-like ichthyosis with deafness	602540	HID	121011	13q12.11
IFAP syndrome with or without BRESHECK syndrome	308205	MBTPS2	300294	Xp22.12-p22.11
IFAP syndrome with or without BRESHECK syndrome	308205	S2P	300294	Xp22.12-p22.11
IFAP syndrome with or without BRESHECK syndrome	308205	IFAP	300294	Xp22.12-p22.11
IFAP syndrome with or without BRESHECK syndrome	308205	KFSDX	300294	Xp22.12-p22.11
IMAGE syndrome	614732	CDKN1C	600856	11p15.4
IMAGE syndrome	614732	KIP2	600856	11p15.4
IMAGE syndrome	614732	BWS	600856	11p15.4
IMAGE syndrome	614732	IMAGE	600856	11p15.4
IRAK4 deficiency	607676	IRAK4	606883	12q12
IRAK4 deficiency	607676	REN64	606883	12q12
IRAK4 deficiency	607676	IPD1	606883	12q12
IVIC syndrome	147750	SALL4	607343	20q13.2
IVIC syndrome	147750	HSAL4	607343	20q13.2
Ichthyosis bullosa of Siemens	146800	KRT2	600194	12q13.13
Ichthyosis bullosa of Siemens	146800	KRT2A	600194	12q13.13
Ichthyosis bullosa of Siemens	146800	KRT2E	600194	12q13.13
Ichthyosis histrix, Curth-Macklin type	146590	KRT1	139350	12q13.13
Ichthyosis histrix, Curth-Macklin type	146590	EPPK	139350	12q13.13
Ichthyosis histrix, Curth-Macklin type	146590	NEPPK	139350	12q13.13
Ichthyosis histrix, Curth-Macklin type	146590	EHK	139350	12q13.13
Ichthyosis prematurity syndrome	608649	SLC27A4	604194	9q34.11
Ichthyosis prematurity syndrome	608649	FATP4	604194	9q34.11
Ichthyosis prematurity syndrome	608649	IPS	604194	9q34.11
Ichthyosis vulgaris	146700	FLG	135940	1q21.3
Ichthyosis vulgaris	146700	ATOD2	135940	1q21.3
Ichthyosis with confetti	609165	KRT10	148080	17q21.2
Ichthyosis with confetti	609165	EHK	148080	17q21.2
Ichthyosis with confetti	609165	BCIE	148080	17q21.2
Ichthyosis with confetti	609165	BIE	148080	17q21.2
Ichthyosis with hypotrichosis	610765	ST14	606797	11q24.3
Ichthyosis with hypotrichosis	610765	MTSP1	606797	11q24.3
Ichthyosis, X-linked	308100	STS	300747	Xp22.31
Ichthyosis, X-linked	308100	ARSC1	300747	Xp22.31
Ichthyosis, X-linked	308100	ARSC	300747	Xp22.31
Ichthyosis, X-linked	308100	SSDD	300747	Xp22.31
Ichthyosis, X-linked	308100	XLI	300747	Xp22.31
Ichthyosis, autosomal recessive 4B (harlequin)	242500	ABCA12	607800	2q35
Ichthyosis, autosomal recessive 4B (harlequin)	242500	ARCI4A	607800	2q35
Ichthyosis, autosomal recessive 4B (harlequin)	242500	ARCI4B	607800	2q35
Ichthyosis, autosomal recessive 4B (harlequin)	242500	ICR2B	607800	2q35
Ichthyosis, autosomal recessive 4B (harlequin)	242500	LI2	607800	2q35
Ichthyosis, congenital, autosomal recessive 1	242300	TGM1	190195	14q12
Ichthyosis, congenital, autosomal recessive 1	242300	ICR2	190195	14q12
Ichthyosis, congenital, autosomal recessive 1	242300	ARCI1	190195	14q12
Ichthyosis, congenital, autosomal recessive 10	615024	PNPLA1	612121	6p21.31
Ichthyosis, congenital, autosomal recessive 10	615024	ARCI10	612121	6p21.31
Ichthyosis, congenital, autosomal recessive 2	242100	ALOX12B	603741	17p13.1
Ichthyosis, congenital, autosomal recessive 2	242100	ARCI2	603741	17p13.1
Ichthyosis, congenital, autosomal recessive 3	606545	ALOXE3	607206	17p13.1
Ichthyosis, congenital, autosomal recessive 3	606545	ARCI3	607206	17p13.1
Ichthyosis, congenital, autosomal recessive 4A	601277	ABCA12	607800	2q35
Ichthyosis, congenital, autosomal recessive 4A	601277	ARCI4A	607800	2q35
Ichthyosis, congenital, autosomal recessive 4A	601277	ARCI4B	607800	2q35
Ichthyosis, congenital, autosomal recessive 4A	601277	ICR2B	607800	2q35
Ichthyosis, congenital, autosomal recessive 4A	601277	LI2	607800	2q35
Ichthyosis, congenital, autosomal recessive 5	604777	CYP4F22	611495	19p13.12
Ichthyosis, congenital, autosomal recessive 5	604777	ARCI5	611495	19p13.12
Ichthyosis, congenital, autosomal recessive 5	604777	LI3	611495	19p13.12
Ichthyosis, congenital, autosomal recessive 6	612281	NIPAL4	609383	5q33.3
Ichthyosis, congenital, autosomal recessive 6	612281	ICHYN	609383	5q33.3
Ichthyosis, congenital, autosomal recessive 6	612281	ARCI6	609383	5q33.3
Ichthyosis, congenital, autosomal recessive 7	615022	ARCI7		12p11.2-q13.1
Ichthyosis, congenital, autosomal recessive 8	613943	LIPN	613924	10q23.31
Ichthyosis, congenital, autosomal recessive 8	613943	LIPL4	613924	10q23.31
Ichthyosis, congenital, autosomal recessive 8	613943	ARCI8	613924	10q23.31
Ichthyosis, congenital, autosomal recessive 8	613943	LI4	613924	10q23.31
Ichthyosis, congenital, autosomal recessive 9	615023	CERS3	615276	15q26.3
Ichthyosis, congenital, autosomal recessive 9	615023	LASS3	615276	15q26.3
Ichthyosis, congenital, autosomal recessive 9	615023	ARCI9	615276	15q26.3
Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	KRT1	139350	12q13.13
Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	EPPK	139350	12q13.13
Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	NEPPK	139350	12q13.13
Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	EHK	139350	12q13.13
Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	KRT10	148080	17q21.2
Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	EHK	148080	17q21.2
Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	BCIE	148080	17q21.2
Ichthyosis, cyclic, with epidermolytic hyperkeratosis	607602	BIE	148080	17q21.2
Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	607626	CLDN1	603718	3q28
Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	607626	SEMP1	603718	3q28
Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis	607626	ILVASC	603718	3q28
Ichthyosis, spastic quadriplegia, and mental retardation	614457	ELOVL4	605512	6q14.1
Ichthyosis, spastic quadriplegia, and mental retardation	614457	ADMD	605512	6q14.1
Ichthyosis, spastic quadriplegia, and mental retardation	614457	STGD2	605512	6q14.1
Ichthyosis, spastic quadriplegia, and mental retardation	614457	STGD3	605512	6q14.1
Ichthyosis, spastic quadriplegia, and mental retardation	614457	ISQMR	605512	6q14.1
IgA nephropathy, susceptibility to, 1	161950	IGAN1		6q22-q23
IgG2 deficiency, selective		IGHG2	147110	14q32.33
Iminoglycinuria, digenic	242600	SLC36A2	608331	5q33.1
Iminoglycinuria, digenic	242600	PAT2	608331	5q33.1
Iminoglycinuria, digenic	242600	SLC6A19	608893	5p15.33
Iminoglycinuria, digenic	242600	HND	608893	5p15.33
Iminoglycinuria, digenic	242600	SLC6A20	605616	3p21.31
Iminoglycinuria, digenic	242600	XT3	605616	3p21.31
Immunodeficiency 10	612783	STIM1	605921	11p15.4
Immunodeficiency 10	612783	TAM	605921	11p15.4
Immunodeficiency 10	612783	IMD10	605921	11p15.4
Immunodeficiency 11	615206	CARD11	607210	7p22.2
Immunodeficiency 11	615206	CARMA1	607210	7p22.2
Immunodeficiency 11	615206	BIMP3	607210	7p22.2
Immunodeficiency 11	615206	PPBL	607210	7p22.2
Immunodeficiency 11	615206	BENTA	607210	7p22.2
Immunodeficiency 11	615206	IMD11	607210	7p22.2
Immunodeficiency 15	615592	IKBKB	603258	8p11.21
Immunodeficiency 15	615592	NFKBIKB	603258	8p11.21
Immunodeficiency 15	615592	IMD15	603258	8p11.21
Immunodeficiency 17, CD3 gamma deficient	615607	CD3G	186740	11q23.3
Immunodeficiency 17, CD3 gamma deficient	615607	IMD17	186740	11q23.3
Immunodeficiency 18	615615	CD3E	186830	11q23.3
Immunodeficiency 18	615615	IMD18	186830	11q23.3
Immunodeficiency 18, SCID variant	615615	CD3E	186830	11q23.3
Immunodeficiency 18, SCID variant	615615	IMD18	186830	11q23.3
Immunodeficiency 19	615617	CD3D	186790	11q23.3
Immunodeficiency 19	615617	T3D	186790	11q23.3
Immunodeficiency 19	615617	IMD19	186790	11q23.3
Immunodeficiency 7, TCR-alpha/beta deficient	615387	TRAC	186880	14q11.2
Immunodeficiency 7, TCR-alpha/beta deficient	615387	TRCA	186880	14q11.2
Immunodeficiency 7, TCR-alpha/beta deficient	615387	TRA	186880	14q11.2
Immunodeficiency 7, TCR-alpha/beta deficient	615387	IMD7	186880	14q11.2
Immunodeficiency 8	615401	CORO1A	605000	16p11.2
Immunodeficiency 8	615401	TACO	605000	16p11.2
Immunodeficiency 8	615401	CLIPINA	605000	16p11.2
Immunodeficiency 8	615401	IMD8	605000	16p11.2
Immunodeficiency 9	612782	ORAI1	610277	12q24.31
Immunodeficiency 9	612782	TMEM142A	610277	12q24.31
Immunodeficiency 9	612782	CRACM1	610277	12q24.31
Immunodeficiency 9	612782	IMD9	610277	12q24.31
Immunodeficiency due to CASP8 deficiency	607271	CASP8	601763	2q33.1
Immunodeficiency due to CASP8 deficiency	607271	MCH5	601763	2q33.1
Immunodeficiency due to CASP8 deficiency	607271	ALPS2B	601763	2q33.1
Immunodeficiency due to defect in CD3-zeta	610163	CD247	186780	1q24.2
Immunodeficiency due to defect in CD3-zeta	610163	CD3Z	186780	1q24.2
Immunodeficiency due to defect in CD3-zeta	610163	TCRZ	186780	1q24.2
Immunodeficiency due to defect in MAPBP-interacting protein	610798	LAMTOR2	610389	1q22
Immunodeficiency due to defect in MAPBP-interacting protein	610798	MAPBPIP	610389	1q22
Immunodeficiency due to defect in MAPBP-interacting protein	610798	p14	610389	1q22
Immunodeficiency due to ficolin 3 deficiency	613860	FCN3	604973	1p36.11
Immunodeficiency due to ficolin 3 deficiency	613860	HAKA1	604973	1p36.11
Immunodeficiency due to purine nucleoside phosphorylase deficiency	613179	PNP	164050	14q11.2
Immunodeficiency due to purine nucleoside phosphorylase deficiency	613179	NP	164050	14q11.2
Immunodeficiency with hyper IgM, type 5	608106	UNG	191525	12q24.11
Immunodeficiency with hyper IgM, type 5	608106	DGU	191525	12q24.11
Immunodeficiency with hyper IgM, type 5	608106	HIGM5	191525	12q24.11
Immunodeficiency with hyper-IgM, type 2	605258	AICDA	605257	12p13.31
Immunodeficiency with hyper-IgM, type 2	605258	AID	605257	12p13.31
Immunodeficiency with hyper-IgM, type 2	605258	HIGM2	605257	12p13.31
Immunodeficiency with hyper-IgM, type 3	606843	CD40	109535	20q13.12
Immunodeficiency with hyper-IgM, type 3	606843	TNFRSF5	109535	20q13.12
Immunodeficiency, X-linked, with hyper-IgM	308230	TNFSF5	300386	Xq26.3
Immunodeficiency, X-linked, with hyper-IgM	308230	CD40LG	300386	Xq26.3
Immunodeficiency, X-linked, with hyper-IgM	308230	HIGM1	300386	Xq26.3
Immunodeficiency, X-linked, with hyper-IgM	308230	IGM	300386	Xq26.3
Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	300853	MAGT1	300715	Xq21.1
Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	300853	IAP	300715	Xq21.1
Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia	300853	XMEN	300715	Xq21.1
Immunodeficiency, common variable, 1	607594	ICOS	604558	2q33.2
Immunodeficiency, common variable, 1	607594	AILIM	604558	2q33.2
Immunodeficiency, common variable, 1	607594	CVID1	604558	2q33.2
Immunodeficiency, common variable, 10	615577	NFKB2	164012	10q24.32
Immunodeficiency, common variable, 10	615577	LYT10	164012	10q24.32
Immunodeficiency, common variable, 10	615577	CVID10	164012	10q24.32
Immunodeficiency, common variable, 2	240500	TNFRSF13B	604907	17p11.2
Immunodeficiency, common variable, 2	240500	TACI	604907	17p11.2
Immunodeficiency, common variable, 2	240500	CVID2	604907	17p11.2
Immunodeficiency, common variable, 3	613493	CD19	107265	16p11.2
Immunodeficiency, common variable, 3	613493	CVID3	107265	16p11.2
Immunodeficiency, common variable, 4	613494	TNFRSF13C	606269	22q13.2
Immunodeficiency, common variable, 4	613494	BAFFR	606269	22q13.2
Immunodeficiency, common variable, 4	613494	CVID4	606269	22q13.2
Immunodeficiency, common variable, 5	613495	MS4A1	112210	11q12.2
Immunodeficiency, common variable, 5	613495	CD20	112210	11q12.2
Immunodeficiency, common variable, 5	613495	CVID5	112210	11q12.2
Immunodeficiency, common variable, 6	613496	CD81	186845	11p15.5
Immunodeficiency, common variable, 6	613496	TAPA1	186845	11p15.5
Immunodeficiency, common variable, 6	613496	CVID6	186845	11p15.5
Immunodeficiency, common variable, 7	614699	CR2	120650	1q32.2
Immunodeficiency, common variable, 7	614699	C3DR	120650	1q32.2
Immunodeficiency, common variable, 7	614699	SLEB9	120650	1q32.2
Immunodeficiency, common variable, 7	614699	CVID7	120650	1q32.2
Immunodeficiency, common variable, 8, with autoimmunity	614700	LRBA	606453	4q31.3
Immunodeficiency, common variable, 8, with autoimmunity	614700	LBA	606453	4q31.3
Immunodeficiency, common variable, 8, with autoimmunity	614700	CDC4L	606453	4q31.3
Immunodeficiency, common variable, 8, with autoimmunity	614700	CVID8	606453	4q31.3
Immunodeficiency, isolated	300584	IKBKG	300248	Xq28
Immunodeficiency, isolated	300584	NEMO	300248	Xq28
Immunodeficiency, isolated	300584	FIP3	300248	Xq28
Immunodeficiency, isolated	300584	IP2	300248	Xq28
Immunodeficiency, isolated	300584	IPD2	300248	Xq28
Immunodeficiency, isolated	300584	AMCBX1	300248	Xq28
Immunodeficiency, primary, autosomal recessive, IL21R-related	615207	IL21R	605383	16p12.1
Immunodeficiency-centromeric instability-facial anomalies syndrome 1	242860	DNMT3B	602900	20q11.21
Immunodeficiency-centromeric instability-facial anomalies syndrome 1	242860	ICF1	602900	20q11.21
Immunodeficiency-centromeric instability-facial anomalies syndrome-2	614069	ZBTB24	614064	6q21
Immunodeficiency-centromeric instability-facial anomalies syndrome-2	614069	PATZ2	614064	6q21
Immunodeficiency-centromeric instability-facial anomalies syndrome-2	614069	ZNF450	614064	6q21
Immunodeficiency-centromeric instability-facial anomalies syndrome-2	614069	KIAA0441	614064	6q21
Immunodeficiency-centromeric instability-facial anomalies syndrome-2	614069	ICF2	614064	6q21
Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790	FOXP3	300292	Xp11.23
Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790	IPEX	300292	Xp11.23
Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790	AIID	300292	Xp11.23
Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790	XPID	300292	Xp11.23
Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked	304790	PIDX	300292	Xp11.23
Immunoglobulin A deficiency	137100	IGAD1		6p21.3
Immunoglobulin A deficiency 2	609529	TNFRSF13B	604907	17p11.2
Immunoglobulin A deficiency 2	609529	TACI	604907	17p11.2
Immunoglobulin A deficiency 2	609529	CVID2	604907	17p11.2
Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	167320	VCP	601023	9p13.3
Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	167320	IBMPFD1	601023	9p13.3
Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1	167320	ALS14	601023	9p13.3
Inclusion body myopathy, autosomal recessive	600737	GNE	603824	9p13.3
Inclusion body myopathy, autosomal recessive	600737	GLCNE	603824	9p13.3
Inclusion body myopathy, autosomal recessive	600737	IBM2	603824	9p13.3
Inclusion body myopathy, autosomal recessive	600737	DMRV	603824	9p13.3
Inclusion body myopathy, autosomal recessive	600737	NM	603824	9p13.3
Inclusion body myopathy-3	605637	MYH2	160740	17p13.1
Incontinentia pigmenti, type II	308300	IKBKG	300248	Xq28
Incontinentia pigmenti, type II	308300	NEMO	300248	Xq28
Incontinentia pigmenti, type II	308300	FIP3	300248	Xq28
Incontinentia pigmenti, type II	308300	IP2	300248	Xq28
Incontinentia pigmenti, type II	308300	IPD2	300248	Xq28
Incontinentia pigmenti, type II	308300	AMCBX1	300248	Xq28
Increased responsiveness to growth hormone		GHR	600946	5p13-p12
Infantile cerebellar-retinal degeneration	614559	ACO2	100850	22q13.2
Infantile cerebellar-retinal degeneration	614559	ICRD	100850	22q13.2
Infantile neuroaxonal dystrophy 1	256600	PLA2G6	603604	22q13.1
Infantile neuroaxonal dystrophy 1	256600	IPLA2	603604	22q13.1
Infantile neuroaxonal dystrophy 1	256600	INAD1	603604	22q13.1
Infantile neuroaxonal dystrophy 1	256600	NBIA2B	603604	22q13.1
Infantile neuroaxonal dystrophy 1	256600	NBIA2A	603604	22q13.1
Infantile neuroaxonal dystrophy 1	256600	PARK14	603604	22q13.1
Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malformations	613759	FADD	602457	11q13.3
Inflammatory bowel disease 19	612278	IRGM	608212	5q33.1
Inflammatory bowel disease 19	612278	LRG47	608212	5q33.1
Inflammatory bowel disease 19	612278	IFI1	608212	5q33.1
Inflammatory bowel disease 19	612278	IBD19	608212	5q33.1
Inflammatory bowel disease 25, early onset, autosomal recessive	612567	CRFB4	123889	21q22.11
Inflammatory bowel disease 25, early onset, autosomal recessive	612567	IBD25	123889	21q22.11
Inflammatory bowel disease 28, early onset, autosomal recessive	613148	IL10RA	146933	11q23.3
Inflammatory bowel disease 28, early onset, autosomal recessive	613148	IL10R	146933	11q23.3
Inflammatory bowel disease 28, early onset, autosomal recessive	613148	IBD28	146933	11q23.3
Inflammatory skin and bowel disease, neonatal	614328	ADAM17	603639	2p25.1
Inflammatory skin and bowel disease, neonatal	614328	TACE	603639	2p25.1
Inflammatory skin and bowel disease, neonatal	614328	NISBD	603639	2p25.1
Insensitivity to pain, channelopathy-associated	243000	SCN9A	603415	2q24.3
Insensitivity to pain, channelopathy-associated	243000	NENA	603415	2q24.3
Insensitivity to pain, channelopathy-associated	243000	PN1	603415	2q24.3
Insensitivity to pain, channelopathy-associated	243000	FEB3B	603415	2q24.3
Insensitivity to pain, channelopathy-associated	243000	GEFSP7	603415	2q24.3
Insensitivity to pain, channelopathy-associated	243000	SFNP	603415	2q24.3
Insensitivity to pain, congenital, with anhidrosis	256800	NTRK1	191315	1q23.1
Insensitivity to pain, congenital, with anhidrosis	256800	TRKA	191315	1q23.1
Insensitivity to pain, congenital, with anhidrosis	256800	MTC	191315	1q23.1
Insomnia	137192	GABRB3		15q12
Insomnia	137192	ECA5		15q12
Insomnia, fatal familial	600072	PRNP	176640	20p13
Insomnia, fatal familial	600072	PRIP	176640	20p13
Insomnia, fatal familial	600072	KURU	176640	20p13
Insomnia, fatal familial	600072	CJD	176640	20p13
Insulin resistance, severe, digenic	604367	PPARG	601487	3p25.2
Insulin resistance, severe, digenic	604367	PPARG1	601487	3p25.2
Insulin resistance, severe, digenic	604367	PPARG2	601487	3p25.2
Insulin resistance, severe, digenic	604367	CIMT1	601487	3p25.2
Insulin resistance, severe, digenic	604367	GLM1	601487	3p25.2
Insulin resistance, severe, digenic	604367	PPP1R3A	600917	7q31.1
Insulin resistance, severe, digenic	604367	PPP1R3	600917	7q31.1
Insulin-like growth factor I, resistance to	270450	IGF1R	147370	15q26.3
Insulinoma	606960	ITS		22q12.1-q12.2
Interferon, alpha, deficiency		IFNA1	147660	9p21.3
Interferon, alpha, deficiency		IFNA@	147660	9p21.3
Interleukin 1 receptor antagonist deficiency	612852	IL1RN	147679	2q13
Interleukin 1 receptor antagonist deficiency	612852	MVCD4	147679	2q13
Interleukin 1 receptor antagonist deficiency	612852	DIRA	147679	2q13
Interleukin-2 receptor, alpha chain, deficiency of	606367	IL2RA	147730	10p15.1
Interleukin-2 receptor, alpha chain, deficiency of	606367	IL2R	147730	10p15.1
Interleukin-2 receptor, alpha chain, deficiency of	606367	IDDM10	147730	10p15.1
Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	614748	ITGA3	605025	17q21.33
Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	614748	CD49C	605025	17q21.33
Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	614748	GAPB3	605025	17q21.33
Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital	614748	ILNEB	605025	17q21.33
Interstitial nephritis, karyomegalic	614817	FAN1	613534	15q13.2-q13.3
Interstitial nephritis, karyomegalic	614817	MTMR15	613534	15q13.2-q13.3
Interstitial nephritis, karyomegalic	614817	KIAA1018	613534	15q13.2-q13.3
Interstitial nephritis, karyomegalic	614817	KMIN	613534	15q13.2-q13.3
Intestinal atresia, multiple	243150	TTC7A	609332	2p21
Intestinal atresia, multiple	243150	TTC7	609332	2p21
Intestinal atresia, multiple	243150	KIAA1140	609332	2p21
Intestinal atresia, multiple	243150	MINAT	609332	2p21
Intestinal pseudoobstruction, neuronal	300048	FLNA	300017	Xq28
Intestinal pseudoobstruction, neuronal	300048	FLN1	300017	Xq28
Intestinal pseudoobstruction, neuronal	300048	NHBP	300017	Xq28
Intestinal pseudoobstruction, neuronal	300048	OPD1	300017	Xq28
Intestinal pseudoobstruction, neuronal	300048	OPD2	300017	Xq28
Intestinal pseudoobstruction, neuronal	300048	FMD	300017	Xq28
Intestinal pseudoobstruction, neuronal	300048	MNS	300017	Xq28
Intestinal pseudoobstruction, neuronal	300048	CVD1	300017	Xq28
Intestinal pseudoobstruction, neuronal	300048	CSBS	300017	Xq28
Intrinsic factor deficiency	261000	GIF	609342	11q12.1
Intrinsic factor deficiency	261000	IF	609342	11q12.1
Invasive pneumococcal disease, recurrent isolated, 1	610799	IRAK4	606883	12q12
Invasive pneumococcal disease, recurrent isolated, 1	610799	REN64	606883	12q12
Invasive pneumococcal disease, recurrent isolated, 1	610799	IPD1	606883	12q12
Invasive pneumococcal disease, recurrent isolated, 2	300640	IKBKG	300248	Xq28
Invasive pneumococcal disease, recurrent isolated, 2	300640	NEMO	300248	Xq28
Invasive pneumococcal disease, recurrent isolated, 2	300640	FIP3	300248	Xq28
Invasive pneumococcal disease, recurrent isolated, 2	300640	IP2	300248	Xq28
Invasive pneumococcal disease, recurrent isolated, 2	300640	IPD2	300248	Xq28
Invasive pneumococcal disease, recurrent isolated, 2	300640	AMCBX1	300248	Xq28
Iridogoniodysgenesis, type 1	601631	FOXC1	601090	6p25.3
Iridogoniodysgenesis, type 1	601631	FKHL7	601090	6p25.3
Iridogoniodysgenesis, type 1	601631	FREAC3	601090	6p25.3
Iridogoniodysgenesis, type 1	601631	IRID1	601090	6p25.3
Iridogoniodysgenesis, type 1	601631	RIEG3	601090	6p25.3
Iridogoniodysgenesis, type 2	137600	PITX2	601542	4q25
Iridogoniodysgenesis, type 2	137600	IDG2	601542	4q25
Iridogoniodysgenesis, type 2	137600	RIEG1	601542	4q25
Iridogoniodysgenesis, type 2	137600	RGS	601542	4q25
Iridogoniodysgenesis, type 2	137600	IGDS2	601542	4q25
Iris hypoplasia and glaucoma	601631	FOXC1	601090	6p25.3
Iris hypoplasia and glaucoma	601631	FKHL7	601090	6p25.3
Iris hypoplasia and glaucoma	601631	FREAC3	601090	6p25.3
Iris hypoplasia and glaucoma	601631	IRID1	601090	6p25.3
Iris hypoplasia and glaucoma	601631	RIEG3	601090	6p25.3
Iron-refractory iron deficiency anemia	206200	TMPRSS6	609862	22q12.3
Iron-refractory iron deficiency anemia	206200	IRIDA	609862	22q12.3
Isobutyryl-CoA dehydrogenase deficiency	611283	ACAD8	604773	11q25
Isovaleric acidemia	243500	IVD	607036	15q15.1
Jackson-Weiss syndrome	123150	FGFR1	136350	8p11.23-p11.22
Jackson-Weiss syndrome	123150	FLT2	136350	8p11.23-p11.22
Jackson-Weiss syndrome	123150	OGD	136350	8p11.23-p11.22
Jackson-Weiss syndrome	123150	KAL2	136350	8p11.23-p11.22
Jackson-Weiss syndrome	123150	HH2	136350	8p11.23-p11.22
Jackson-Weiss syndrome	123150	HRTFDS	136350	8p11.23-p11.22
Jackson-Weiss syndrome	123150	FGFR2	176943	10q26.13
Jackson-Weiss syndrome	123150	BEK	176943	10q26.13
Jackson-Weiss syndrome	123150	CFD1	176943	10q26.13
Jackson-Weiss syndrome	123150	JWS	176943	10q26.13
Jackson-Weiss syndrome	123150	TK14	176943	10q26.13
Jackson-Weiss syndrome	123150	BBDS	176943	10q26.13
Jacobsen syndrome	147791	JBS		11q23
Jalili syndrome	217080	CNNM4	607805	2q11.2
Jalili syndrome	217080	ACDP4	607805	2q11.2
Jawad syndrome	251255	RBBP8	604124	18q11.2
Jawad syndrome	251255	RIM	604124	18q11.2
Jawad syndrome	251255	SCKL2	604124	18q11.2
Jawad syndrome	251255	JWDS	604124	18q11.2
Jensen syndrome	311150	TIMM8A	300356	Xq22.1
Jensen syndrome	311150	DFN1	300356	Xq22.1
Jensen syndrome	311150	DDP	300356	Xq22.1
Jensen syndrome	311150	MTS	300356	Xq22.1
Jensen syndrome	311150	DDP1	300356	Xq22.1
Jervell and Lange-Nielsen syndrome 2	612347	KCNE1	176261	21q22.11-q22.12
Jervell and Lange-Nielsen syndrome 2	612347	JLNS	176261	21q22.11-q22.12
Jervell and Lange-Nielsen syndrome 2	612347	LQT5	176261	21q22.11-q22.12
Jervell and Lange-Nielsen syndrome 2	612347	JLNS2	176261	21q22.11-q22.12
Jervell and Lange-Nielsen syndrome	220400	KCNQ1	607542	11p15.5-p15.4
Jervell and Lange-Nielsen syndrome	220400	KCNA9	607542	11p15.5-p15.4
Jervell and Lange-Nielsen syndrome	220400	LQT1	607542	11p15.5-p15.4
Jervell and Lange-Nielsen syndrome	220400	KVLQT1	607542	11p15.5-p15.4
Jervell and Lange-Nielsen syndrome	220400	ATFB3	607542	11p15.5-p15.4
Jervell and Lange-Nielsen syndrome	220400	SQT2	607542	11p15.5-p15.4
Johanson-Blizzard syndrome	243800	UBR1	605981	15q15.2
Johanson-Blizzard syndrome	243800	JBS	605981	15q15.2
Joubert syndrome 1	213300	INPP5E	613037	9q34.3
Joubert syndrome 1	213300	MORMS	613037	9q34.3
Joubert syndrome 1	213300	JBTS1	613037	9q34.3
Joubert syndrome 1	213300	CORS1	613037	9q34.3
Joubert syndrome 10	300804	OFD1	300170	Xp22.2
Joubert syndrome 10	300804	CXorf5	300170	Xp22.2
Joubert syndrome 10	300804	SGBS2	300170	Xp22.2
Joubert syndrome 10	300804	JBTS10	300170	Xp22.2
Joubert syndrome 12	200990	KIF7	611254	15q26.1
Joubert syndrome 12	200990	HLS2	611254	15q26.1
Joubert syndrome 12	200990	ACLS	611254	15q26.1
Joubert syndrome 12	200990	JBTS12	611254	15q26.1
Joubert syndrome 13	614173	TECT1	609863	12q24.11
Joubert syndrome 13	614173	JBTS13	609863	12q24.11
Joubert syndrome 14	614424	TMEM237	614423	2q33.1
Joubert syndrome 14	614424	ALS2CR4	614423	2q33.1
Joubert syndrome 14	614424	JBTS14	614423	2q33.1
Joubert syndrome 15	614464	CEP41	610523	7q32.2
Joubert syndrome 15	614464	TSGA14	610523	7q32.2
Joubert syndrome 15	614464	JBTS15	610523	7q32.2
Joubert syndrome 16	614465	TMEM138	614459	11q12.2
Joubert syndrome 16	614465	JBTS16	614459	11q12.2
Joubert syndrome 17	614615	C5orf42	614571	5p13.2
Joubert syndrome 17	614615	JBTS17	614571	5p13.2
Joubert syndrome 18	614815	TCTN3	613847	10q24.1
Joubert syndrome 18	614815	TECT3	613847	10q24.1
Joubert syndrome 18	614815	C10orf61	613847	10q24.1
Joubert syndrome 18	614815	OFD4	613847	10q24.1
Joubert syndrome 18	614815	JBTS18	613847	10q24.1
Joubert syndrome 19	614844	ZNF423	604557	16q12.1
Joubert syndrome 19	614844	ZFP423	604557	16q12.1
Joubert syndrome 19	614844	OAZ	604557	16q12.1
Joubert syndrome 19	614844	KIAA0760	604557	16q12.1
Joubert syndrome 19	614844	NPHP14	604557	16q12.1
Joubert syndrome 19	614844	JBTS19	604557	16q12.1
Joubert syndrome 2	608091	TMEM216	613277	11q12.2
Joubert syndrome 2	608091	JBTS2	613277	11q12.2
Joubert syndrome 2	608091	CORS2	613277	11q12.2
Joubert syndrome 2	608091	MKS2	613277	11q12.2
Joubert syndrome 20	614970	TMEM231	614949	16q23.1
Joubert syndrome 20	614970	JBTS20	614949	16q23.1
Joubert syndrome 20	614970	MKS11	614949	16q23.1
Joubert syndrome 4	609583	NPHP1	607100	2q13
Joubert syndrome 4	609583	NPH1	607100	2q13
Joubert syndrome 4	609583	SLSN1	607100	2q13
Joubert syndrome 4	609583	JBTS4	607100	2q13
Joubert syndrome 5	610188	CEP290	610142	12q21.32
Joubert syndrome 5	610188	KIAA0373	610142	12q21.32
Joubert syndrome 5	610188	3H11AG	610142	12q21.32
Joubert syndrome 5	610188	JBTS5	610142	12q21.32
Joubert syndrome 5	610188	SLSN6	610142	12q21.32
Joubert syndrome 5	610188	LCA10	610142	12q21.32
Joubert syndrome 5	610188	BBS14	610142	12q21.32
Joubert syndrome 6	610688	TMEM67	609884	8q22.1
Joubert syndrome 6	610688	MKS3	609884	8q22.1
Joubert syndrome 6	610688	JBTS6	609884	8q22.1
Joubert syndrome 6	610688	NPHP11	609884	8q22.1
Joubert syndrome 7	611560	RPGRIP1L	610937	16q12.2
Joubert syndrome 7	611560	KIAA1005	610937	16q12.2
Joubert syndrome 7	611560	JBTS7	610937	16q12.2
Joubert syndrome 7	611560	MKS5	610937	16q12.2
Joubert syndrome 8	612291	ARL13B	608922	3q11.1
Joubert syndrome 8	612291	ARL2L1	608922	3q11.1
Joubert syndrome 8	612291	JBTS8	608922	3q11.1
Joubert syndrome 9	612285	CC2D2A	612013	4p15.32
Joubert syndrome 9	612285	KIAA1345	612013	4p15.32
Joubert syndrome 9	612285	MKS6	612013	4p15.32
Joubert syndrome-3	608629	AHI1	608894	6q23.3
Juvenile polyposis syndrome, infantile form	174900	BMPR1A	601299	10q23.2
Juvenile polyposis syndrome, infantile form	174900	ACVRLK3	601299	10q23.2
Juvenile polyposis syndrome, infantile form	174900	ALK3	601299	10q23.2
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050	MADH4	600993	18q21.2
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050	DPC4	600993	18q21.2
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050	SMAD4	600993	18q21.2
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050	JIP	600993	18q21.2
Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome	175050	MYHRS	600993	18q21.2
KBG syndrome	148050	ANKRD11	611192	16q24.3
KBG syndrome	148050	ANCO1	611192	16q24.3
KBG syndrome	148050	KBGS	611192	16q24.3
Kabuki syndrome 1	147920	MLL2	602113	12q13.12
Kabuki syndrome 1	147920	ALR	602113	12q13.12
Kabuki syndrome 1	147920	KABUK1	602113	12q13.12
Kabuki syndrome 2	300867	KDM6A	300128	Xp11.3
Kabuki syndrome 2	300867	UTX	300128	Xp11.3
Kabuki syndrome 2	300867	KABUK2	300128	Xp11.3
Kahrizi syndrome	612713	SRD5A3	611715	4q12
Kahrizi syndrome	612713	SRD5A2L	611715	4q12
Kahrizi syndrome	612713	CDG1Q	611715	4q12
Kahrizi syndrome	612713	KRIZI	611715	4q12
Kanzaki disease	609242	NAGA	104170	22q13.2
Kenny-Caffey syndrome, type 2	127000	FAM111A	615292	11q12.1
Kenny-Caffey syndrome, type 2	127000	KIAA1895	615292	11q12.1
Kenny-Caffey syndrome, type 2	127000	KCS2	615292	11q12.1
Kenny-Caffey syndrome, type 2	127000	GCLEB	615292	11q12.1
Kenny-Caffey syndrome-1	244460	TBCE	604934	1q42.3
Kenny-Caffey syndrome-1	244460	KCS	604934	1q42.3
Kenny-Caffey syndrome-1	244460	KCS1	604934	1q42.3
Kenny-Caffey syndrome-1	244460	HRD	604934	1q42.3
Keratitis	148190	PAX6	607108	11p13
Keratitis	148190	AN2	607108	11p13
Keratitis	148190	MGDA	607108	11p13
Keratitis-ichthyosis-deafness syndrome	148210	GJB2	121011	13q12.11
Keratitis-ichthyosis-deafness syndrome	148210	CX26	121011	13q12.11
Keratitis-ichthyosis-deafness syndrome	148210	DFNB1A	121011	13q12.11
Keratitis-ichthyosis-deafness syndrome	148210	PPK	121011	13q12.11
Keratitis-ichthyosis-deafness syndrome	148210	DFNA3A	121011	13q12.11
Keratitis-ichthyosis-deafness syndrome	148210	KID	121011	13q12.11
Keratitis-ichthyosis-deafness syndrome	148210	HID	121011	13q12.11
Keratoconus 1	148300	VSX1	605020	20p11.21
Keratoconus 1	148300	RINX	605020	20p11.21
Keratoconus 1	148300	PPCD	605020	20p11.21
Keratoconus 1	148300	PPD	605020	20p11.21
Keratoconus 1	148300	KTCN1	605020	20p11.21
Keratoconus 1	148300	CAASDS	605020	20p11.21
Keratoconus 2	608932	KTCN2		16q22.3-q23.1
Keratoconus 3	608586	KTCN3		3p14-q13
Keratoconus 4	609271	KTCN4		2p24
Keratoconus 5	614622	KTCN5		5q14.1-q21.3
Keratoconus 6	614623	KTCN6		9q34
Keratoconus 7	614629	KTCN7		13q32
Keratoconus 8	614628	KTCN8		14q24.3
Keratoderma, palmoplantar, punctate type IA	148600	AAGAB	614888	15q22-q23
Keratoderma, palmoplantar, punctate type IA	148600	p34	614888	15q22-q23
Keratoderma, palmoplantar, punctate type IA	148600	PPKP1A	614888	15q22-q23
Keratoderma, palmoplantar, punctate type IA	148600	PPKP1	614888	15q22-q23
Keratoderma, palmoplantar, punctate type IA	148600	KPPP1	614888	15q22-q23
Keratoderma, palmoplantar, punctate type IB	614936	PPKP1B		8q24.13-q24.21
Keratoderma, palmoplantar, with deafness	148350	GJB2	121011	13q12.11
Keratoderma, palmoplantar, with deafness	148350	CX26	121011	13q12.11
Keratoderma, palmoplantar, with deafness	148350	DFNB1A	121011	13q12.11
Keratoderma, palmoplantar, with deafness	148350	PPK	121011	13q12.11
Keratoderma, palmoplantar, with deafness	148350	DFNA3A	121011	13q12.11
Keratoderma, palmoplantar, with deafness	148350	KID	121011	13q12.11
Keratoderma, palmoplantar, with deafness	148350	HID	121011	13q12.11
Keratolytic winter erythema	148370	KWE		8p23-p22
Keratosis follicularis spinulosa decalvans	308800	SAT1	313020	Xp22.11
Keratosis follicularis spinulosa decalvans	308800	SSAT	313020	Xp22.11
Keratosis follicularis spinulosa decalvans	308800	KFSD	313020	Xp22.11
Keratosis follicularis spinulosa decalvans	308800	KFSDX	313020	Xp22.11
Keratosis follicularis spinulosa decalvans, X-linked	308800	MBTPS2	300294	Xp22.12-p22.11
Keratosis follicularis spinulosa decalvans, X-linked	308800	S2P	300294	Xp22.12-p22.11
Keratosis follicularis spinulosa decalvans, X-linked	308800	IFAP	300294	Xp22.12-p22.11
Keratosis follicularis spinulosa decalvans, X-linked	308800	KFSDX	300294	Xp22.12-p22.11
Keratosis linearis with ichthyosis congenita and sclerosing keratoderma	601952	POMP	613386	13q12.3
Keratosis linearis with ichthyosis congenita and sclerosing keratoderma	601952	UMP1	613386	13q12.3
Keratosis palmoplantaris striata I, AD	148700	DSG1	125670	18q12.1
Keratosis palmoplantaris striata I, AD	148700	PPKS1	125670	18q12.1
Keratosis palmoplantaris striata I, AD	148700	SPPK1	125670	18q12.1
Keratosis palmoplantaris striata I, AD	148700	EPKHE	125670	18q12.1
Keratosis palmoplantaris striata II	612908	DSP	125647	6p24.3
Keratosis palmoplantaris striata II	612908	KPPS2	125647	6p24.3
Keratosis palmoplantaris striata II	612908	PPKS2	125647	6p24.3
Keratosis palmoplantaris striata III	607654	KRT1	139350	12q13.13
Keratosis palmoplantaris striata III	607654	EPPK	139350	12q13.13
Keratosis palmoplantaris striata III	607654	NEPPK	139350	12q13.13
Keratosis palmoplantaris striata III	607654	EHK	139350	12q13.13
Keratosis, seborrheic, somatic	182000	PIK3CA	171834	3q26.32
Keratosis, seborrheic, somatic	182000	CLOVE	171834	3q26.32
Keratosis, seborrheic, somatic	182000	MCAP	171834	3q26.32
Keratosis, seborrheic, somatic	182000	MCM	171834	3q26.32
Keratosis, seborrheic, somatic	182000	MCMTC	171834	3q26.32
Keratosis, seborrheic, somatic	182000	CWS5	171834	3q26.32
Keutel syndrome	245150	MGP	154870	12p12.3
Keutel syndrome	245150	NTI	154870	12p12.3
Kindler syndrome	173650	KIND1	607900	20p12.3
Kindler syndrome	173650	URP1	607900	20p12.3
Kindler syndrome	173650	C20orf42	607900	20p12.3
King-Denborough syndrome	145600	RYR1	180901	19q13.2
King-Denborough syndrome	145600	MHS	180901	19q13.2
King-Denborough syndrome	145600	CCO	180901	19q13.2
Kleefstra syndrome	610253	EHMT1	607001	9q34.3
Kleefstra syndrome	610253	EUHMTASE1	607001	9q34.3
Kleefstra syndrome	610253	DEL9q34	607001	9q34.3
Klippel-Feil syndrome 1, autosomal dominant	118100	GDF6	601147	8q22.1
Klippel-Feil syndrome 1, autosomal dominant	118100	MCOP4	601147	8q22.1
Klippel-Feil syndrome 1, autosomal dominant	118100	KFS1	601147	8q22.1
Klippel-Feil syndrome 1, autosomal dominant	118100	MCOPCB6	601147	8q22.1
Klippel-Feil syndrome 1, autosomal dominant	118100	LCA17	601147	8q22.1
Klippel-Feil syndrome 2	214300	MEOX1	600147	17q21.31
Klippel-Feil syndrome 2	214300	MOX1	600147	17q21.31
Klippel-Feil syndrome 2	214300	KFS2	600147	17q21.31
Klippel-Feil syndrome 3, autosomal dominant	613702	GDF3	606522	12p13.31
Klippel-Feil syndrome 3, autosomal dominant	613702	KFS3	606522	12p13.31
Klippel-Feil syndrome 3, autosomal dominant	613702	MCOPCB6	606522	12p13.31
Klippel-Feil syndrome 3, autosomal dominant	613702	MCOP7	606522	12p13.31
Klippel-Trenaunay-Weber syndrome	149000	KTWS		8q22.3
Klippel-Trenaunay-Weber syndrome	149000	KTS		8q22.3
Kniest dysplasia	156550	COL2A1	120140	12q13.11
Knobloch syndrome, type 1	267750	COL18A1	120328	21q22.3
Knobloch syndrome, type 1	267750	KNO1	120328	21q22.3
Kohlschutter-Tonz syndrome	226750	ROGDI	614574	16p13.3
Kohlschutter-Tonz syndrome	226750	KTZS	614574	16p13.3
Kondoh syndrome	606242	KONDS		1p36.32-p35.3
Koolen-De Vries syndrome	610443	KANSL1	612452	17q21.31
Koolen-De Vries syndrome	610443	KIAA1267	612452	17q21.31
Koolen-De Vries syndrome	610443	MSL1V1	612452	17q21.31
Koolen-De Vries syndrome	610443	KDVS	612452	17q21.31
Kowarski syndrome	262650	GH1	139250	17q23.3
Kowarski syndrome	262650	GHN	139250	17q23.3
Kowarski syndrome	262650	IGHD1B	139250	17q23.3
Krabbe disease	245200	GALC	606890	14q31.3
Krabbe disease, atypical	611722	PSAP	176801	10q22.1
Krabbe disease, atypical	611722	SAP1	176801	10q22.1
Kufor-Rakeb syndrome	606693	ATP13A2	610513	1p36.13
Kufor-Rakeb syndrome	606693	PARK9	610513	1p36.13
Kufor-Rakeb syndrome	606693	KRPPD	610513	1p36.13
Kufor-Rakeb syndrome	606693	CLN12	610513	1p36.13
Kyphoscoliosis 1	610170	KYPSC1		5p13
L-2-hydroxyglutaric aciduria	236792	L2HGDH	609584	14q21.3
L-2-hydroxyglutaric aciduria	236792	C14orf160	609584	14q21.3
L-ferritin deficiency, dominant and recessive	615604	FTL	134790	19q13.33
L-ferritin deficiency, dominant and recessive	615604	NBIA3	134790	19q13.33
L-ferritin deficiency, dominant and recessive	615604	LFTD	134790	19q13.33
LADD syndrome	149730	FGF10	602115	5p12
LADD syndrome	149730	FGFR2	176943	10q26.13
LADD syndrome	149730	BEK	176943	10q26.13
LADD syndrome	149730	CFD1	176943	10q26.13
LADD syndrome	149730	JWS	176943	10q26.13
LADD syndrome	149730	TK14	176943	10q26.13
LADD syndrome	149730	BBDS	176943	10q26.13
LADD syndrome	149730	FGFR3	134934	4p16.3
LADD syndrome	149730	ACH	134934	4p16.3
LCHAD deficiency	609016	HADHA	600890	2p23.3
LCHAD deficiency	609016	MTPA	600890	2p23.3
LDL cholesterol level QTL2	143890	LDLR	606945	19p13.2
LDL cholesterol level QTL2	143890	FHC	606945	19p13.2
LDL cholesterol level QTL2	143890	FH	606945	19p13.2
LDL cholesterol level QTL2	143890	LDLCQ2	606945	19p13.2
LEOPARD syndrome 1	151100	PTPN11	176876	12q24.13
LEOPARD syndrome 1	151100	PTP2C	176876	12q24.13
LEOPARD syndrome 1	151100	SHP2	176876	12q24.13
LEOPARD syndrome 1	151100	NS1	176876	12q24.13
LEOPARD syndrome 2	611554	RAF1	164760	3p25.2
LEOPARD syndrome 2	611554	CRAF	164760	3p25.2
LEOPARD syndrome 2	611554	NS5	164760	3p25.2
LEOPARD syndrome 3	613707	BRAF	164757	7q34
LEOPARD syndrome 3	613707	NS7	164757	7q34
LIG4 syndrome	606593	LIG4	601837	13q33.3
Lactase deficiency, congenital	223000	LCT	603202	2q21.3
Lactase deficiency, congenital	223000	LAC	603202	2q21.3
Lactase deficiency, congenital	223000	LPH	603202	2q21.3
Lactase persistance/nonpersistance	223100	MCM6	601806	2q21.3
Lactate dehydrogenase-B deficiency	614128	LDHB	150100	12p12.1
Lactate dehydrogenase-B deficiency	614128	LDHBD	150100	12p12.1
Lacticacidemia due to PDX1 deficiency	245349	PDX1	608769	11p13
Laing distal myopathy	160500	MYH7	160760	14q11.2
Laing distal myopathy	160500	CMH1	160760	14q11.2
Laing distal myopathy	160500	MPD1	160760	14q11.2
Laing distal myopathy	160500	CMD1S	160760	14q11.2
Laing distal myopathy	160500	SPMM	160760	14q11.2
Laing distal myopathy	160500	SPMD	160760	14q11.2
Langer mesomelic dysplasia	249700	SHOX	312865	Xp22.33
Langer mesomelic dysplasia	249700	GCFX	312865	Xp22.33
Langer mesomelic dysplasia	249700	SS	312865	Xp22.33
Langer mesomelic dysplasia	249700	PHOG	312865	Xp22.33
Langer mesomelic dysplasia	249700	SHOXY	400020	Yp11.32
Laron dwarfism	262500	GHR	600946	5p13-p12
Larsen syndrome	150250	FLNB	603381	3p14.3
Larsen syndrome	150250	SCT	603381	3p14.3
Larsen syndrome	150250	AOI	603381	3p14.3
Larsen syndrome	150250	LRS1	603381	3p14.3
Larsen-like syndrome	608545	LRSL		6p25
Laryngoonychocutaneous syndrome	245660	LAMA3	600805	18q11.2
Laryngoonychocutaneous syndrome	245660	LOCS	600805	18q11.2
Lathosterolosis	607330	SC5DL	602286	11q23.3
Lathosterolosis	607330	ERG3	602286	11q23.3
Leber congenital amaurosis 1	204000	GUCY2D	600179	17p13.1
Leber congenital amaurosis 1	204000	GUC2D	600179	17p13.1
Leber congenital amaurosis 1	204000	LCA1	600179	17p13.1
Leber congenital amaurosis 1	204000	CORD6	600179	17p13.1
Leber congenital amaurosis 1	204000	RCD2	600179	17p13.1
Leber congenital amaurosis 10	611755	CEP290	610142	12q21.32
Leber congenital amaurosis 10	611755	KIAA0373	610142	12q21.32
Leber congenital amaurosis 10	611755	3H11AG	610142	12q21.32
Leber congenital amaurosis 10	611755	JBTS5	610142	12q21.32
Leber congenital amaurosis 10	611755	SLSN6	610142	12q21.32
Leber congenital amaurosis 10	611755	LCA10	610142	12q21.32
Leber congenital amaurosis 10	611755	BBS14	610142	12q21.32
Leber congenital amaurosis 11	613837	IMPDH1	146690	7q32.1
Leber congenital amaurosis 11	613837	RP10	146690	7q32.1
Leber congenital amaurosis 11	613837	LCA11	146690	7q32.1
Leber congenital amaurosis 12	610612	RD3	180040	1q32.3
Leber congenital amaurosis 12	610612	LCA12	180040	1q32.3
Leber congenital amaurosis 12	610612	C1orf36	180040	1q32.3
Leber congenital amaurosis 13	612712	RDH12	608830	14q24.1
Leber congenital amaurosis 13	612712	LCA13	608830	14q24.1
Leber congenital amaurosis 14	613341	LRAT	604863	4q32.1
Leber congenital amaurosis 14	613341	LCA14	604863	4q32.1
Leber congenital amaurosis 15	613843	TULP1	602280	6p21.31
Leber congenital amaurosis 15	613843	RP14	602280	6p21.31
Leber congenital amaurosis 15	613843	LCA15	602280	6p21.31
Leber congenital amaurosis 16	614186	KCNJ13	603208	2q37.1
Leber congenital amaurosis 16	614186	SVD	603208	2q37.1
Leber congenital amaurosis 16	614186	LCA16	603208	2q37.1
Leber congenital amaurosis 17	615360	GDF6	601147	8q22.1
Leber congenital amaurosis 17	615360	MCOP4	601147	8q22.1
Leber congenital amaurosis 17	615360	KFS1	601147	8q22.1
Leber congenital amaurosis 17	615360	MCOPCB6	601147	8q22.1
Leber congenital amaurosis 17	615360	LCA17	601147	8q22.1
Leber congenital amaurosis 2	204100	RPE65	180069	1p31.3-p31.2
Leber congenital amaurosis 2	204100	RP20	180069	1p31.3-p31.2
Leber congenital amaurosis 2	204100	LCA2	180069	1p31.3-p31.2
Leber congenital amaurosis 3	604232	SPATA7	609868	14q31.3
Leber congenital amaurosis 3	604232	HSD3	609868	14q31.3
Leber congenital amaurosis 3	604232	LCA3	609868	14q31.3
Leber congenital amaurosis 4	604393	AIPL1	604392	17p13.2
Leber congenital amaurosis 4	604393	LCA4	604392	17p13.2
Leber congenital amaurosis 5	604537	LCA5	611408	6q14.1
Leber congenital amaurosis 5	604537	C6orf152	611408	6q14.1
Leber congenital amaurosis 6	613826	RPGRIP1	605446	14q11.2
Leber congenital amaurosis 6	613826	LCA6	605446	14q11.2
Leber congenital amaurosis 6	613826	CORD13	605446	14q11.2
Leber congenital amaurosis 7	613829	CRX	602225	19q13.33
Leber congenital amaurosis 7	613829	CORD2	602225	19q13.33
Leber congenital amaurosis 7	613829	CRD	602225	19q13.33
Leber congenital amaurosis 7	613829	LCA7	602225	19q13.33
Leber congenital amaurosis 8	613835	CRB1	604210	1q31.3
Leber congenital amaurosis 8	613835	RP12	604210	1q31.3
Leber congenital amaurosis 8	613835	LCA8	604210	1q31.3
Leber congenital amaurosis 9	608553	NMNAT1	608700	1p36.22
Leber congenital amaurosis 9	608553	NMNAT	608700	1p36.22
Leber congenital amaurosis 9	608553	PNAT1	608700	1p36.22
Leber congenital amaurosis 9	608553	LCA9	608700	1p36.22
Left ventricular noncompaction 1, with or without congenital heart defects	604169	DTNA	601239	18q12.1
Left ventricular noncompaction 1, with or without congenital heart defects	604169	D18S892E	601239	18q12.1
Left ventricular noncompaction 1, with or without congenital heart defects	604169	DRP3	601239	18q12.1
Left ventricular noncompaction 1, with or without congenital heart defects	604169	LVNC1	601239	18q12.1
Left ventricular noncompaction 10	615396	MYBPC3	600958	11p11.2
Left ventricular noncompaction 10	615396	CMH4	600958	11p11.2
Left ventricular noncompaction 10	615396	CMD1MM	600958	11p11.2
Left ventricular noncompaction 10	615396	LVNC10	600958	11p11.2
Left ventricular noncompaction 2	609470	LVNC2		11p15
Left ventricular noncompaction 3, with or without dilated cardiomyopathy	601493	LDB3	605906	10q23.2
Left ventricular noncompaction 3, with or without dilated cardiomyopathy	601493	ZASP	605906	10q23.2
Left ventricular noncompaction 3, with or without dilated cardiomyopathy	601493	CYPHER	605906	10q23.2
Left ventricular noncompaction 3, with or without dilated cardiomyopathy	601493	KIAA01613	605906	10q23.2
Left ventricular noncompaction 3, with or without dilated cardiomyopathy	601493	CMD1C	605906	10q23.2
Left ventricular noncompaction 3, with or without dilated cardiomyopathy	601493	LVNC3	605906	10q23.2
Left ventricular noncompaction 3, with or without dilated cardiomyopathy	601493	MFM4	605906	10q23.2
Left ventricular noncompaction 4	613424	ACTC1	102540	15q14
Left ventricular noncompaction 4	613424	CMD1R	102540	15q14
Left ventricular noncompaction 4	613424	CMH11	102540	15q14
Left ventricular noncompaction 4	613424	ASD5	102540	15q14
Left ventricular noncompaction 4	613424	LVNC4	102540	15q14
Left ventricular noncompaction 5	613426	MYH7	160760	14q11.2
Left ventricular noncompaction 5	613426	CMH1	160760	14q11.2
Left ventricular noncompaction 5	613426	MPD1	160760	14q11.2
Left ventricular noncompaction 5	613426	CMD1S	160760	14q11.2
Left ventricular noncompaction 5	613426	SPMM	160760	14q11.2
Left ventricular noncompaction 5	613426	SPMD	160760	14q11.2
Left ventricular noncompaction 6	601494	TNNT2	191045	1q32.1
Left ventricular noncompaction 6	601494	CMH2	191045	1q32.1
Left ventricular noncompaction 6	601494	CMD1D	191045	1q32.1
Left ventricular noncompaction 6	601494	RCM3	191045	1q32.1
Left ventricular noncompaction 6	601494	LVNC6	191045	1q32.1
Left ventricular noncompaction 7	615092	MIB1	608677	18q11.2
Left ventricular noncompaction 7	615092	MIB	608677	18q11.2
Left ventricular noncompaction 7	615092	DIP1	608677	18q11.2
Left ventricular noncompaction 7	615092	KIAA1323	608677	18q11.2
Left ventricular noncompaction 7	615092	LVNC7	608677	18q11.2
Left ventricular noncompaction 8	615373	PRDM16	605557	1p36.32
Left ventricular noncompaction 8	615373	MEL1	605557	1p36.32
Left ventricular noncompaction 8	615373	LVNC8	605557	1p36.32
Left ventricular noncompaction 8	615373	CMD1LL	605557	1p36.32
Left ventricular noncompaction 9	611878	TPM1	191010	15q22.2
Left ventricular noncompaction 9	611878	CMH3	191010	15q22.2
Left ventricular noncompaction 9	611878	CMD1Y 	191010	15q22.2
Left ventricular noncompaction 9	611878	LVNC9	191010	15q22.2
Left-right axis malformations	601877	EBAF		1q42.12
Left-right axis malformations	601877	TGFB4		1q42.12
Left-right axis malformations	601877	LEFTY2		1q42.12
Left-right axis malformations	601877	LEFTA		1q42.12
Left-right axis malformations	601877	LEFTYA		1q42.12
Legg-Calve-Perthes disease	150600	COL2A1	120140	12q13.11
Legius syndrome	611431	SPRED1	609291	15q14
Legius syndrome	611431	NFLS	609291	15q14
Leigh syndrome due to cytochrome c oxidase deficiency	256000	COX15	603646	10q24.2
Leigh syndrome due to cytochrome c oxidase deficiency	256000	CEMCOX2	603646	10q24.2
Leigh syndrome due to mitochondrial complex 1 deficiency	256000	NDUFA12	614530	12q22
Leigh syndrome due to mitochondrial complex I deficiency	256000	FOXRED1	613622	11q24.2
Leigh syndrome due to mitochondrial complex I deficiency	256000	NDUFA2	602137	5q31.3
Leigh syndrome due to mitochondrial complex I deficiency	256000	NDUFA9	603834	12p13.32
Leigh syndrome due to mitochondrial complex I deficiency	256000	NDUFAF6	612392	8q22.1
Leigh syndrome due to mitochondrial complex I deficiency	256000	C8orf38	612392	8q22.1
Leigh syndrome due to mitochondrial complex I deficiency	256000	NDUFS3	603846	11p11.2
Leigh syndrome due to mitochondrial complex I deficiency	256000	NDUFS8	602141	11q13.2
Leigh syndrome	256000	BCS1L	603647	2q35
Leigh syndrome	256000	FLNMS	603647	2q35
Leigh syndrome	256000	GRACILE	603647	2q35
Leigh syndrome	256000	BJS	603647	2q35
Leigh syndrome	256000	PTD	603647	2q35
Leigh syndrome	256000	MC3DN1	603647	2q35
Leigh syndrome	256000	NDUFA10	603835	2q37.3
Leigh syndrome	256000	NDUFAF2	609653	5q12.1
Leigh syndrome	256000	NDUFA12L	609653	5q12.1
Leigh syndrome	256000	MMTN	609653	5q12.1
Leigh syndrome	256000	B17.2L	609653	5q12.1
Leigh syndrome	256000	NDUFS4	602694	5q11.2
Leigh syndrome	256000	AQDQ	602694	5q11.2
Leigh syndrome	256000	NDUFS7	601825	19p13.3
Leigh syndrome	256000	PSST	601825	19p13.3
Leigh syndrome	256000	SDHA	600857	5p15.33
Leigh syndrome	256000	SDH1	600857	5p15.33
Leigh syndrome	256000	SDHF	600857	5p15.33
Leigh syndrome	256000	CMD1GG	600857	5p15.33
Leigh syndrome	256000	PGL5	600857	5p15.33
Leigh syndrome, French-Canadian type	220111	LRPPRC	607544	2p21
Leigh syndrome, French-Canadian type	220111	LRP130	607544	2p21
Leigh syndrome, French-Canadian type	220111	LSFC	607544	2p21
Leigh syndrome, X-linked	308930	PDHA1	300502	Xp22.12
Leigh syndrome, X-linked	308930	PHE1A	300502	Xp22.12
Leigh syndrome, due to COX deficiency	256000	SURF1	185620	9q34.2
Leiomyoma, uterine, somatic	150699	HMGA2	600698	12q14.3
Leiomyoma, uterine, somatic	150699	HMGIC	600698	12q14.3
Leiomyoma, uterine, somatic	150699	BABL	600698	12q14.3
Leiomyomatosis and renal cell cancer	150800	FH	136850	1q43
Leiomyomatosis and renal cell cancer	150800	HLRCC	136850	1q43
Leiomyomatosis and renal cell cancer	150800	MCUL1	136850	1q43
Lenz-Majewski hyperostotic dwarfism	151050	PTDSS1	612792	8q22.1
Lenz-Majewski hyperostotic dwarfism	151050	PSS1	612792	8q22.1
Lenz-Majewski hyperostotic dwarfism	151050	KIAA0024	612792	8q22.1
Lenz-Majewski hyperostotic dwarfism	151050	LMHD	612792	8q22.1
Leprechaunism	246200	INSR	147670	19p13.2
Leprechaunism	246200	HHF5	147670	19p13.2
Leri-Weill dyschondrosteosis	127300	SHOX	312865	Xp22.33
Leri-Weill dyschondrosteosis	127300	GCFX	312865	Xp22.33
Leri-Weill dyschondrosteosis	127300	SS	312865	Xp22.33
Leri-Weill dyschondrosteosis	127300	PHOG	312865	Xp22.33
Leri-Weill dyschondrosteosis	127300	SHOXY	400020	Yp11.32
Lesch-Nyhan syndrome	300322	HPRT1	308000	Xq26.2-q26.3
Lesch-Nyhan syndrome	300322	HPRT	308000	Xq26.2-q26.3
Lethal congenital contractural syndrome 2	607598	ERBB3	190151	12q13.2
Lethal congenital contractural syndrome 2	607598	LCCS2	190151	12q13.2
Lethal congenital contractural syndrome 3	611369	PIP5K1C	606102	19p13.3
Lethal congenital contractural syndrome 3	611369	LCCS3	606102	19p13.3
Lethal congenital contracture syndrome 1	253310	GLE1	603371	9q34.11
Lethal congenital contracture syndrome 1	253310	GLE1L	603371	9q34.11
Lethal congenital contracture syndrome 1	253310	LCCS	603371	9q34.11
Lethal congenital contracture syndrome 1	253310	LCCS1	603371	9q34.11
Lethal congenital contracture syndrome 4	614915	MYBPC1	160794	12q23.2
Lethal congenital contracture syndrome 4	614915	LCCS4	160794	12q23.2
Lethal congenital contracture syndrome 5	615368	DNM2	602378	19p13.2
Lethal congenital contracture syndrome 5	615368	CMTDIB	602378	19p13.2
Lethal congenital contracture syndrome 5	615368	CMTDI1	602378	19p13.2
Lethal congenital contracture syndrome 5	615368	CMT2M	602378	19p13.2
Lethal congenital contracture syndrome 5	615368	LCCS5	602378	19p13.2
Leukemia, Philadelphia chromosome-positive, resistant to imatinib		ABL1	189980	9q34.12
Leukemia, T-cell acute lymphoblastic		LMO1	186921	11p15.4
Leukemia, T-cell acute lymphoblastic		RBTN1	186921	11p15.4
Leukemia, T-cell acute lymphoblastic		RHOM1	186921	11p15.4
Leukemia, T-cell acute lymphoblastic		NOTCH1	190198	9q34.3
Leukemia, T-cell acute lymphoblastic		TAN1	190198	9q34.3
Leukemia, T-cell acute lymphoblastic		NUP214	114350	9q34.13
Leukemia, T-cell acute lymphoblastic		D9S46E	114350	9q34.13
Leukemia, T-cell acute lymphoblastic		CAN	114350	9q34.13
Leukemia, T-cell acute lymphoblastic		CAIN	114350	9q34.13
Leukemia, T-cell acute lymphoblastoid		LYL1	151440	19p13.2
Leukemia, acute T-cell		LMO2	180385	11p13
Leukemia, acute T-cell		RBTNL1	180385	11p13
Leukemia, acute T-cell		RHOM2	180385	11p13
Leukemia, acute T-cell		TTG2	180385	11p13
Leukemia, acute T-cell lymphoblastic		AF10	602409	10p12.31
Leukemia, acute T-cell lymphoblastic		PICALM	603025	11q14.2
Leukemia, acute T-cell lymphoblastic		CALM	603025	11q14.2
Leukemia, acute T-cell lymphoblastic		CLTH	603025	11q14.2
Leukemia, acute T-cell lymphoblastic		LAP	603025	11q14.2
Leukemia, acute lymphoblastic		TCF3	147141	19p13.3
Leukemia, acute lymphoblastic		E2A	147141	19p13.3
Leukemia, acute lymphoblastic		LALL	247640	9p22-p21
Leukemia, acute lymphoblastic		IKZF1	603023	7p12.2
Leukemia, acute lymphoblastic		ZNFN1A1	603023	7p12.2
Leukemia, acute lymphoblastic		IK1	603023	7p12.2
Leukemia, acute lymphoblastic		LYF1	603023	7p12.2
Leukemia, acute lymphoblastic	613065	NBS1	602667	8q21.3
Leukemia, acute lymphoblastic	613065	NBS	602667	8q21.3
Leukemia, acute lymphoblastic, somatic	613065	FLT3	136351	13q12.2
Leukemia, acute lymphocytic	613065	BCR	151410	22q11.23
Leukemia, acute lymphocytic	613065	CML	151410	22q11.23
Leukemia, acute lymphocytic	613065	PHL	151410	22q11.23
Leukemia, acute lymphocytic	613065	ALL	151410	22q11.23
Leukemia, acute myeloblastic		ARNT	126110	1q21.3
Leukemia, acute myelogenous		KRAS	190070	12p12.1
Leukemia, acute myelogenous		KRAS2	190070	12p12.1
Leukemia, acute myelogenous		RASK2	190070	12p12.1
Leukemia, acute myelogenous		NS	190070	12p12.1
Leukemia, acute myelogenous		CFC2	190070	12p12.1
Leukemia, acute myelogenous	601626	GMPS	600358	3q25.31
Leukemia, acute myelogenous	601626	JAK2	147796	9p24.1
Leukemia, acute myelogenous	601626	THCYT3	147796	9p24.1
Leukemia, acute myeloid	601626	MLF1	601402	3q25.32
Leukemia, acute myeloid	601626	NSD1	606681	5q35.2-q35.3
Leukemia, acute myeloid	601626	ARA267	606681	5q35.2-q35.3
Leukemia, acute myeloid	601626	STO	606681	5q35.2-q35.3
Leukemia, acute myeloid	601626	SOTOS1	606681	5q35.2-q35.3
Leukemia, acute myeloid	601626	SH3GL1	601768	19p13.3
Leukemia, acute myeloid	601626	EEN	601768	19p13.3
Leukemia, acute myeloid	601626	AF10	602409	10p12.31
Leukemia, acute myeloid	601626	ARHGEF12	604763	11q23.3
Leukemia, acute myeloid	601626	LARG	604763	11q23.3
Leukemia, acute myeloid	601626	KIAA0382	604763	11q23.3
Leukemia, acute myeloid	601626	CEBPA	116897	19q13.11
Leukemia, acute myeloid	601626	CEBP	116897	19q13.11
Leukemia, acute myeloid	601626	FLT3	136351	13q12.2
Leukemia, acute myeloid	601626	KIT	164920	4q12
Leukemia, acute myeloid	601626	PBT	164920	4q12
Leukemia, acute myeloid	601626	LPP	600700	3q27-q28
Leukemia, acute myeloid	601626	NPM1	164040	5q35.1
Leukemia, acute myeloid	601626	NUP214	114350	9q34.13
Leukemia, acute myeloid	601626	D9S46E	114350	9q34.13
Leukemia, acute myeloid	601626	CAN	114350	9q34.13
Leukemia, acute myeloid	601626	CAIN	114350	9q34.13
Leukemia, acute myeloid	601626	PICALM	603025	11q14.2
Leukemia, acute myeloid	601626	CALM	603025	11q14.2
Leukemia, acute myeloid	601626	CLTH	603025	11q14.2
Leukemia, acute myeloid	601626	LAP	603025	11q14.2
Leukemia, acute myeloid	601626	RUNX1	151385	21q22.12
Leukemia, acute myeloid	601626	CBFA2	151385	21q22.12
Leukemia, acute myeloid	601626	AML1	151385	21q22.12
Leukemia, acute myeloid	601626	WHSC1L1	607083	8p11.23
Leukemia, acute myeloid	601626	NSD3	607083	8p11.23
Leukemia, acute myeloid, reduced survival in	601626	FLT3	136351	13q12.2
Leukemia, acute myeloid, somatic	601626	ETV6	600618	12p13.2
Leukemia, acute myeloid, somatic	601626	TEL	600618	12p13.2
Leukemia, acute myeloid, therapy-related		SEPT9	604061	17q25.2-q25.3
Leukemia, acute myeloid, therapy-related		MSF	604061	17q25.2-q25.3
Leukemia, acute myeloid, therapy-related		MSF1	604061	17q25.2-q25.3
Leukemia, acute myeloid, therapy-related		NAPB	604061	17q25.2-q25.3
Leukemia, acute myeloid, with eosinophilia		ABL2	164690	1q25.2
Leukemia, acute myeloid, with eosinophilia		ABLL	164690	1q25.2
Leukemia, acute myeloid, with eosinophilia		ARG	164690	1q25.2
Leukemia, acute myelomonocytic		MLLT11	604684	1q21.3
Leukemia, acute myelomonocytic		AF1Q	604684	1q21.3
Leukemia, acute nonlymphocytic		DEK	125264	6p22.3
Leukemia, acute nonlymphocytic		D6S231E	125264	6p22.3
Leukemia, acute pre-B-cell		PBX1	176310	1q23.3
Leukemia, acute promyelocytic	612376	RARA	180240	17q21.2
Leukemia, acute promyelocytic, NPM/RARA type		NPM1	164040	5q35.1
Leukemia, acute promyelocytic, NUMA/RARA type		NUMA1	164009	11q13.4
Leukemia, acute promyelocytic, PL2F/RARA type		ZBTB16	176797	11q23.2
Leukemia, acute promyelocytic, PL2F/RARA type		ZNF145	176797	11q23.2
Leukemia, acute promyelocytic, PL2F/RARA type		PLZF	176797	11q23.2
Leukemia, acute promyelocytic, PML/RARA type		PML	102578	15q24.1
Leukemia, acute promyelocytic, PML/RARA type		MYL	102578	15q24.1
Leukemia, acute promyelocytic, STAT5B/RARA type		STAT5B	604260	17q21.2
Leukemia, chronic myeloid	608232	BCR	151410	22q11.23
Leukemia, chronic myeloid	608232	CML	151410	22q11.23
Leukemia, chronic myeloid	608232	PHL	151410	22q11.23
Leukemia, chronic myeloid	608232	ALL	151410	22q11.23
Leukemia, juvenile myelomonocytic	607785	ARHGAP26	605370	5q31.3
Leukemia, juvenile myelomonocytic	607785	GRAF	605370	5q31.3
Leukemia, juvenile myelomonocytic	607785	NF1	613113	17q11.2
Leukemia, juvenile myelomonocytic	607785	VRNF	613113	17q11.2
Leukemia, juvenile myelomonocytic	607785	WSS	613113	17q11.2
Leukemia, juvenile myelomonocytic	607785	NFNS	613113	17q11.2
Leukemia, juvenile myelomonocytic	607785	PTPN11	176876	12q24.13
Leukemia, juvenile myelomonocytic	607785	PTP2C	176876	12q24.13
Leukemia, juvenile myelomonocytic	607785	SHP2	176876	12q24.13
Leukemia, juvenile myelomonocytic	607785	NS1	176876	12q24.13
Leukemia, megakaryoblastic, with or without Down syndrome, somatic	190685	GATA1	305371	Xp11.23
Leukemia, megakaryoblastic, with or without Down syndrome, somatic	190685	GF1	305371	Xp11.23
Leukemia, megakaryoblastic, with or without Down syndrome, somatic	190685	ERYF1	305371	Xp11.23
Leukemia, megakaryoblastic, with or without Down syndrome, somatic	190685	NFE1	305371	Xp11.23
Leukemia, megakaryoblastic, with or without Down syndrome, somatic	190685	XLTDA	305371	Xp11.23
Leukemia, megakaryoblastic, with or without Down syndrome, somatic	190685	XLTT	305371	Xp11.23
Leukemia, megakaryoblastic, with or without Down syndrome, somatic	190685	XLANP	305371	Xp11.23
Leukemia, myeloid/lymphoid or mixed-lineage	159555	MLL		11q23.3
Leukemia, myeloid/lymphoid or mixed-lineage	159555	HRX		11q23.3
Leukemia, myeloid/lymphoid or mixed-lineage	159555	HTRX1		11q23.3
Leukemia, myeloid/lymphoid or mixed-lineage	159555	WDSTS		11q23.3
Leukemia, transient, of Down syndrome	159595	TAM		21q11.2
Leukemia, transient, of Down syndrome	159595	MST		21q11.2
Leukemia-1, T-cell acute lymphocytic		TAL1	187040	1p33
Leukemia-1, T-cell acute lymphocytic		TCL5	187040	1p33
Leukemia-1, T-cell acute lymphocytic		SCL	187040	1p33
Leukemia-2, T-cell acute lymphoblastic		TAL2	186855	9q31.2
Leukemia/lymphoma, B-cell, 2	151430	BCL2		18q21.33
Leukemia/lymphoma, B-cell, 3		BCL3	109560	19q13.32
Leukemia/lymphoma, T-cell		TCL1A	186960	14q32.13
Leukemia/lymphoma, T-cell		TCL1	186960	14q32.13
Leukemia/lymphoma, T-cell		TCL1B	603769	14q32.13
Leukemia/lymphoma, T-cell		TML1	603769	14q32.13
Leukemia/lymphoma, T-cell		TCL4	186860	2q34
Leukocyte adhesion deficiency	116920	ITGB2	600065	21q22.3
Leukocyte adhesion deficiency	116920	CD18	600065	21q22.3
Leukocyte adhesion deficiency	116920	LCAMB	600065	21q22.3
Leukocyte adhesion deficiency	116920	LAD	600065	21q22.3
Leukocyte adhesion deficiency, type III	612840	KIND3	607901	11q13.1
Leukocyte adhesion deficiency, type III	612840	URP2	607901	11q13.1
Leukocyte adhesion deficiency, type III	612840	MIG2B	607901	11q13.1
Leukocyte adhesion deficiency, type III	612840	FERMT3	607901	11q13.1
Leukodystrophy, adult-onset, autosomal dominant	169500	LMNB1	150340	5q23.2
Leukodystrophy, adult-onset, autosomal dominant	169500	ADLD	150340	5q23.2
Leukodystrophy, hypomyelinating, 2	608804	GJC2	608803	1q42.13
Leukodystrophy, hypomyelinating, 2	608804	GJA12	608803	1q42.13
Leukodystrophy, hypomyelinating, 2	608804	CX47	608803	1q42.13
Leukodystrophy, hypomyelinating, 2	608804	PMLDAR	608803	1q42.13
Leukodystrophy, hypomyelinating, 2	608804	HLD2	608803	1q42.13
Leukodystrophy, hypomyelinating, 2	608804	SPG44	608803	1q42.13
Leukodystrophy, hypomyelinating, 2	608804	LMPH1C	608803	1q42.13
Leukodystrophy, hypomyelinating, 3	260600	AIMP1	603605	4q24
Leukodystrophy, hypomyelinating, 3	260600	SCYE1	603605	4q24
Leukodystrophy, hypomyelinating, 3	260600	EMAP2	603605	4q24
Leukodystrophy, hypomyelinating, 3	260600	EMAPII	603605	4q24
Leukodystrophy, hypomyelinating, 3	260600	HLD3	603605	4q24
Leukodystrophy, hypomyelinating, 4	612233	HSPD1	118190	2q33.1
Leukodystrophy, hypomyelinating, 4	612233	SPG13	118190	2q33.1
Leukodystrophy, hypomyelinating, 4	612233	HSP60	118190	2q33.1
Leukodystrophy, hypomyelinating, 4	612233	HLD4	118190	2q33.1
Leukodystrophy, hypomyelinating, 5	610532	FAM126A	610531	7p15.3
Leukodystrophy, hypomyelinating, 5	610532	DRCTNNB1A	610531	7p15.3
Leukodystrophy, hypomyelinating, 5	610532	HLD5	610531	7p15.3
Leukodystrophy, hypomyelinating, 6	612438	TUBB4A	602662	19p13.3
Leukodystrophy, hypomyelinating, 6	612438	TUBB4	602662	19p13.3
Leukodystrophy, hypomyelinating, 6	612438	TUBB5	602662	19p13.3
Leukodystrophy, hypomyelinating, 6	612438	DYT4	602662	19p13.3
Leukodystrophy, hypomyelinating, 6	612438	HLD6	602662	19p13.3
Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	607694	POLR3A	614258	10q22.3
Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	607694	RPC1	614258	10q22.3
Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	607694	RPC155	614258	10q22.3
Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	607694	ADDH	614258	10q22.3
Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism	607694	HLD7	614258	10q22.3
Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	614381	POLR3B	614366	12q23.3
Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	614381	RPC2	614366	12q23.3
Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	614381	C128	614366	12q23.3
Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism	614381	HLD8	614366	12q23.3
Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	611105	DARS2	610956	1q25.1
Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	611105	ASPRS. LBSL	610956	1q25.1
Leukoencephalopathy with dystonia and motor neuropathy	613724	SCP2	184755	1p32.3
Leukoencephalopathy with metaphyseal chondrodysplasia	300660	LKMCD		Xq25-q27
Leukoencephalopathy with vanishing white matter	603896	EIF2B1	606686	12q24.31
Leukoencephalopathy with vanishing white matter	603896	EIF2BA	606686	12q24.31
Leukoencephalopathy with vanishing white matter	603896	EIF2B2	606454	14q24.3
Leukoencephalopathy with vanishing white matter	603896	EIF2B3	606273	1p34.1
Leukoencephalopathy with vanishing white matter	603896	EIF2B5	603945	3q27.1
Leukoencephalopathy with vanishing white matter	603896	LVWM	603945	3q27.1
Leukoencephalopathy with vanishing white matter	603896	CACH	603945	3q27.1
Leukoencephalopathy with vanishing white matter	603896	CLE	603945	3q27.1
Leukoencephalopathy, cystic, without megalencephaly	612951	RNASET2	612944	6q27
Leukoencephalopathy, cystic, without megalencephaly	612951	RNASE6PL	612944	6q27
Leukoencephalopathy, diffuse hereditary, with spheroids	221820	CSF1R	164770	5q32
Leukoencephalopathy, diffuse hereditary, with spheroids	221820	FMS	164770	5q32
Leukoencephalopathy, diffuse hereditary, with spheroids	221820	HDLS	164770	5q32
Leukoencephaly with vanishing white matter	603896	EIF2B4	606687	2p23.3
Leukotriene C4 synthase deficiency	614037	LTC4S	246530	5q35.3
Levy-Shanske syndrome	614846	LVSKS		15q26-qter
Leydig cell adenoma, somatic, with precocious puberty	176410	LHCGR	152790	2p16.3
Leydig cell adenoma, somatic, with precocious puberty	176410	LHR	152790	2p16.3
Leydig cell adenoma, somatic, with precocious puberty	176410	LCGR	152790	2p16.3
Leydig cell hypoplasia with hypergonadotropic hypogonadism	238320	LHCGR	152790	2p16.3
Leydig cell hypoplasia with hypergonadotropic hypogonadism	238320	LHR	152790	2p16.3
Leydig cell hypoplasia with hypergonadotropic hypogonadism	238320	LCGR	152790	2p16.3
Leydig cell hypoplasia with pseudohermaphroditism	238320	LHCGR	152790	2p16.3
Leydig cell hypoplasia with pseudohermaphroditism	238320	LHR	152790	2p16.3
Leydig cell hypoplasia with pseudohermaphroditism	238320	LCGR	152790	2p16.3
Lhermitte-Duclos syndrome	158350	PTEN	601728	10q23.31
Lhermitte-Duclos syndrome	158350	MMAC1	601728	10q23.31
Lhermitte-Duclos syndrome	158350	GLM2	601728	10q23.31
Lhermitte-Duclos syndrome	158350	CWS1	601728	10q23.31
Li-Fraumeni syndrome 3	609266	LFS3		1q23
Li-Fraumeni syndrome	151623	TP53	191170	17p13.1
Li-Fraumeni syndrome	151623	P53	191170	17p13.1
Li-Fraumeni syndrome	151623	LFS1 	191170	17p13.1
Li-Fraumeni syndrome	151623	BCC7	191170	17p13.1
Li-Fraumeni syndrome	609265	CHEK2	604373	22q12.1
Li-Fraumeni syndrome	609265	RAD53	604373	22q12.1
Li-Fraumeni syndrome	609265	CHK2	604373	22q12.1
Li-Fraumeni syndrome	609265	CDS1	604373	22q12.1
Li-Fraumeni syndrome	609265	LFS2	604373	22q12.1
Liddle syndrome	177200	SCNN1B	600760	16p12.2
Liddle syndrome	177200	BESC1	600760	16p12.2
Liddle syndrome	177200	SCNN1G	600761	16p12.2
Liddle syndrome	177200	PHA1	600761	16p12.2
Liddle syndrome	177200	BESC3	600761	16p12.2
Liebenberg syndrome	186550	PITX1	602149	5q31.1
Liebenberg syndrome	186550	PTX1	602149	5q31.1
Liebenberg syndrome	186550	BFT	602149	5q31.1
Liebenberg syndrome	186550	POTX	602149	5q31.1
Liebenberg syndrome	186550	CCF	602149	5q31.1
Liebenberg syndrome	186550	LBNBG	602149	5q31.1
Limb-girdle muscular dystrophy, type 1G	609115	LGMD1G		4q21
Limb-mammary syndrome	603543	TP63	603273	3q28
Limb-mammary syndrome	603543	TP73L	603273	3q28
Limb-mammary syndrome	603543	KET	603273	3q28
Limb-mammary syndrome	603543	EEC3	603273	3q28
Limb-mammary syndrome	603543	SHFM4	603273	3q28
Limb-mammary syndrome	603543	LMS	603273	3q28
Limb-mammary syndrome	603543	RHS	603273	3q28
Limb-mammary syndrome	603543	OFC8	603273	3q28
Lipase deficiency, combined	246650	LMF1	611761	16p13.3
Lipase deficiency, combined	246650	TMEM112	611761	16p13.3
Lipodystrophy, congenital generalized, type 1	608594	AGPAT2	603100	9q34.3
Lipodystrophy, congenital generalized, type 1	608594	LPAAB	603100	9q34.3
Lipodystrophy, congenital generalized, type 1	608594	BSCL	603100	9q34.3
Lipodystrophy, congenital generalized, type 1	608594	BSCL1	603100	9q34.3
Lipodystrophy, congenital generalized, type 2	269700	BSCL2	606158	11q12.3
Lipodystrophy, congenital generalized, type 2	269700	SPG17	606158	11q12.3
Lipodystrophy, congenital generalized, type 2	269700	HMN5	606158	11q12.3
Lipodystrophy, congenital generalized, type 3	612526	CAV1	601047	7q31.2
Lipodystrophy, congenital generalized, type 3	612526	BSCL3	601047	7q31.2
Lipodystrophy, congenital generalized, type 3	612526	CGL3	601047	7q31.2
Lipodystrophy, congenital generalized, type 3	612526	PPH3	601047	7q31.2
Lipodystrophy, congenital generalized, type 4	613327	PTRF	603198	17q21.2
Lipodystrophy, congenital generalized, type 4	613327	CAVIN	603198	17q21.2
Lipodystrophy, congenital generalized, type 4	613327	CGL4	603198	17q21.2
Lipodystrophy, familial partial, 2	151660	LMNA	150330	1q22
Lipodystrophy, familial partial, 2	151660	LMN1	150330	1q22
Lipodystrophy, familial partial, 2	151660	EMD2	150330	1q22
Lipodystrophy, familial partial, 2	151660	FPLD2	150330	1q22
Lipodystrophy, familial partial, 2	151660	CMD1A	150330	1q22
Lipodystrophy, familial partial, 2	151660	HGPS	150330	1q22
Lipodystrophy, familial partial, 2	151660	LGMD1B	150330	1q22
Lipodystrophy, familial partial, type 3	604367	PPARG	601487	3p25.2
Lipodystrophy, familial partial, type 3	604367	PPARG1	601487	3p25.2
Lipodystrophy, familial partial, type 3	604367	PPARG2	601487	3p25.2
Lipodystrophy, familial partial, type 3	604367	CIMT1	601487	3p25.2
Lipodystrophy, familial partial, type 3	604367	GLM1	601487	3p25.2
Lipodystrophy, familial partial, type 4	613877	PLIN1	170290	15q26.1
Lipodystrophy, familial partial, type 4	613877	PLIN	170290	15q26.1
Lipodystrophy, familial partial, type 4	613877	FPLD4	170290	15q26.1
Lipoid adrenal hyperplasia	201710	STAR	600617	8p11.23
Lipoma		LPP	600700	3q27-q28
Lipoma, somatic		MEN1	613733	11q13.1
Lipoprotein glomerulopathy	611771	APOE	107741	19q13.32
Lipoprotein glomerulopathy	611771	AD2	107741	19q13.32
Lipoprotein glomerulopathy	611771	LPG	107741	19q13.32
Lipoprotein glomerulopathy	611771	LDLCQ5	107741	19q13.32
Lipoprotein lipase deficiency	238600	LPL	609708	8p21.3
Lipoprotein lipase deficiency	238600	LIPD	609708	8p21.3
Lipoprotein lipase deficiency	238600	HDLCQ11	609708	8p21.3
Liposarcoma		LPSA	164953	19p13.2-q13.3
Liposarcoma		D19S381E	164953	19p13.2-q13.3
Lissencephaly 1	607432	PAFAH1B1	601545	17p13.3
Lissencephaly 1	607432	LIS1	601545	17p13.3
Lissencephaly 2 (Norman-Roberts type)	257320	RELN	600514	7q22.1
Lissencephaly 2 (Norman-Roberts type)	257320	RL	600514	7q22.1
Lissencephaly 2 (Norman-Roberts type)	257320	LIS2	600514	7q22.1
Lissencephaly 3	611603	TUBA1A	602529	12q13.12
Lissencephaly 3	611603	TUBA3	602529	12q13.12
Lissencephaly 3	611603	LIS3	602529	12q13.12
Lissencephaly 4 (with microcephaly)	614019	NDE1	609449	16p13.11
Lissencephaly 4 (with microcephaly)	614019	NUDE	609449	16p13.11
Lissencephaly 4 (with microcephaly)	614019	LIS4	609449	16p13.11
Lissencephaly 5	615191	LAMB1	150240	7q31.1
Lissencephaly 5	615191	LIS5	150240	7q31.1
Lissencephaly, X-linked 2	300215	ARX	300382	Xp21.3
Lissencephaly, X-linked 2	300215	ISSX	300382	Xp21.3
Lissencephaly, X-linked 2	300215	PRTS	300382	Xp21.3
Lissencephaly, X-linked 2	300215	MRXS1	300382	Xp21.3
Lissencephaly, X-linked 2	300215	MRX36	300382	Xp21.3
Lissencephaly, X-linked 2	300215	MRX54	300382	Xp21.3
Lissencephaly, X-linked 2	300215	MRX43	300382	Xp21.3
Lissencephaly, X-linked 2	300215	MRX87	300382	Xp21.3
Lissencephaly, X-linked 2	300215	MRX29	300382	Xp21.3
Lissencephaly, X-linked 2	300215	MRX32	300382	Xp21.3
Lissencephaly, X-linked	300067	DCX	300121	Xq23
Lissencephaly, X-linked	300067	DBCN	300121	Xq23
Lissencephaly, X-linked	300067	LISX	300121	Xq23
Liver failure, transient infantile	613070	TRMU	610230	22q13.31
Liver failure, transient infantile	613070	MTO2	610230	22q13.31
Liver failure, transient infantile	613070	TRNT1	610230	22q13.31
Loeys-Dietz syndrome, type 1A	609192	TGFBR1	190181	9q22.33
Loeys-Dietz syndrome, type 1A	609192	ALK5	190181	9q22.33
Loeys-Dietz syndrome, type 1A	609192	AAT5	190181	9q22.33
Loeys-Dietz syndrome, type 1A	609192	LDS2A	190181	9q22.33
Loeys-Dietz syndrome, type 1A	609192	LDS1A	190181	9q22.33
Loeys-Dietz syndrome, type 1A	609192	MSSE	190181	9q22.33
Loeys-Dietz syndrome, type 1B	610168	TGFBR2	190182	3p24.1
Loeys-Dietz syndrome, type 1B	610168	HNPCC6	190182	3p24.1
Loeys-Dietz syndrome, type 1B	610168	AAT3	190182	3p24.1
Loeys-Dietz syndrome, type 1B	610168	MFS2	190182	3p24.1
Loeys-Dietz syndrome, type 1B	610168	LDS1B	190182	3p24.1
Loeys-Dietz syndrome, type 1B	610168	LDS2B	190182	3p24.1
Loeys-Dietz syndrome, type 2A	608967	TGFBR1	190181	9q22.33
Loeys-Dietz syndrome, type 2A	608967	ALK5	190181	9q22.33
Loeys-Dietz syndrome, type 2A	608967	AAT5	190181	9q22.33
Loeys-Dietz syndrome, type 2A	608967	LDS2A	190181	9q22.33
Loeys-Dietz syndrome, type 2A	608967	LDS1A	190181	9q22.33
Loeys-Dietz syndrome, type 2A	608967	MSSE	190181	9q22.33
Loeys-Dietz syndrome, type 2B	610380	TGFBR2	190182	3p24.1
Loeys-Dietz syndrome, type 2B	610380	HNPCC6	190182	3p24.1
Loeys-Dietz syndrome, type 2B	610380	AAT3	190182	3p24.1
Loeys-Dietz syndrome, type 2B	610380	MFS2	190182	3p24.1
Loeys-Dietz syndrome, type 2B	610380	LDS1B	190182	3p24.1
Loeys-Dietz syndrome, type 2B	610380	LDS2B	190182	3p24.1
Loeys-Dietz syndrome, type 3	613795	SMAD3	603109	15q22.33
Loeys-Dietz syndrome, type 3	613795	MADH3	603109	15q22.33
Loeys-Dietz syndrome, type 3	613795	LDS3	603109	15q22.33
Loeys-Dietz syndrome, type 4	614816	TGFB2	190220	1q41
Loeys-Dietz syndrome, type 4	614816	LDS4	190220	1q41
Long QT syndrome 1	192500	KCNQ1	607542	11p15.5-p15.4
Long QT syndrome 1	192500	KCNA9	607542	11p15.5-p15.4
Long QT syndrome 1	192500	LQT1	607542	11p15.5-p15.4
Long QT syndrome 1	192500	KVLQT1	607542	11p15.5-p15.4
Long QT syndrome 1	192500	ATFB3	607542	11p15.5-p15.4
Long QT syndrome 1	192500	SQT2	607542	11p15.5-p15.4
Long QT syndrome 12	612955	SNT1	601017	20q11.21
Long QT syndrome 12	612955	LQT12	601017	20q11.21
Long QT syndrome 13	613485	KCNJ5	600734	11q24.3
Long QT syndrome 13	613485	GIRK4	600734	11q24.3
Long QT syndrome 13	613485	KATP1	600734	11q24.3
Long QT syndrome 13	613485	LQT13	600734	11q24.3
Long QT syndrome 2	613688	KCNH2	152427	7q36.1
Long QT syndrome 2	613688	LQT2	152427	7q36.1
Long QT syndrome 2	613688	HERG	152427	7q36.1
Long QT syndrome 2	613688	SQT1	152427	7q36.1
Long QT syndrome 4	600919	ANK2	106410	4q25-q26
Long QT syndrome 4	600919	LQT4	106410	4q25-q26
Long QT syndrome 5	613695	KCNE1	176261	21q22.11-q22.12
Long QT syndrome 5	613695	JLNS	176261	21q22.11-q22.12
Long QT syndrome 5	613695	LQT5	176261	21q22.11-q22.12
Long QT syndrome 5	613695	JLNS2	176261	21q22.11-q22.12
Long QT syndrome 6	613693	KCNE2	603796	21q22.11
Long QT syndrome 6	613693	MIRP1	603796	21q22.11
Long QT syndrome 6	613693	LQT6	603796	21q22.11
Long QT syndrome 6	613693	ATFB4	603796	21q22.11
Long QT syndrome 9	611818	CAV3	601253	3p25.3
Long QT syndrome 9	611818	LGMD1C	601253	3p25.3
Long QT syndrome 9	611818	LQT9	601253	3p25.3
Long QT syndrome-10	611819	SCN4B	608256	11q23.3
Long QT syndrome-11	611820	AKAP9	604001	7q21.2
Long QT syndrome-11	611820	YOTIAO	604001	7q21.2
Long QT syndrome-11	611820	AKAP450	604001	7q21.2
Long QT syndrome-3	603830	SCN5A	600163	3p22.2
Long QT syndrome-3	603830	LQT3	600163	3p22.2
Long QT syndrome-3	603830	VF1	600163	3p22.2
Long QT syndrome-3	603830	HB1	600163	3p22.2
Long QT syndrome-3	603830	SSS1	600163	3p22.2
Long QT syndrome-3	603830	CMD1E	600163	3p22.2
Long QT syndrome-3	603830	CDCD2	600163	3p22.2
Lowe syndrome	309000	OCRL	300535	Xq25-q26
Lowe syndrome	309000	LOCR	300535	Xq25-q26
Lowe syndrome	309000	OCRL1	300535	Xq25-q26
Lowe syndrome	309000	NPHL2	300535	Xq25-q26
Lujan-Fryns syndrome	309520	MED12	300188	Xq13.1
Lujan-Fryns syndrome	309520	TNRC11	300188	Xq13.1
Lujan-Fryns syndrome	309520	TRAP230	300188	Xq13.1
Lujan-Fryns syndrome	309520	HOPA	300188	Xq13.1
Lujan-Fryns syndrome	309520	KIAA0192	300188	Xq13.1
Lujan-Fryns syndrome	309520	OKS	300188	Xq13.1
Lujan-Fryns syndrome	309520	FGS1	300188	Xq13.1
Lujan-Fryns syndrome	309520	OHDOX	300188	Xq13.1
Lung cancer	211980	DLEC1	604050	3p22.2
Lung cancer	211980	DLC1	604050	3p22.2
Lung cancer	211980	RASSF1	605082	3p21.31
Lung cancer	211980	PPP2R1B	603113	11q23.1
Lung cancer, somatic	211980	KRAS	190070	12p12.1
Lung cancer, somatic	211980	KRAS2	190070	12p12.1
Lung cancer, somatic	211980	RASK2	190070	12p12.1
Lung cancer, somatic	211980	NS	190070	12p12.1
Lung cancer, somatic	211980	CFC2	190070	12p12.1
Lung cancer, somatic	211980	MAP3K8	191195	10p11.23
Lung cancer, somatic	211980	COT	191195	10p11.23
Lung cancer, somatic	211980	EST	191195	10p11.23
Lung cancer, somatic	211980	TPL2	191195	10p11.23
Lung cancer, somatic	211980	SLC22A1L	602631	11p15.4
Lung cancer, somatic	211980	BWSCR1A	602631	11p15.4
Lung cancer, somatic	211980	IMPT1	602631	11p15.4
Luteinizing hormone resistance, female	238320	LHCGR	152790	2p16.3
Luteinizing hormone resistance, female	238320	LHR	152790	2p16.3
Luteinizing hormone resistance, female	238320	LCGR	152790	2p16.3
Lymphangioleiomyomatosis	606690	TSC1	605284	9q34.13
Lymphangioleiomyomatosis	606690	LAM	605284	9q34.13
Lymphangioleiomyomatosis, somatic	606690	TSC2	191092	16p13.3
Lymphangioleiomyomatosis, somatic	606690	LAM	191092	16p13.3
Lymphedema, hereditary I	153100	FLT4	136352	5q35.3
Lymphedema, hereditary I	153100	VEGFR3	136352	5q35.3
Lymphedema, hereditary I	153100	PCL	136352	5q35.3
Lymphedema, hereditary I	153100	LMPH1A	136352	5q35.3
Lymphedema, hereditary, IB	611944	LMPH1B		6q16.2-q22.1
Lymphedema, hereditary, IC	613480	GJC2	608803	1q42.13
Lymphedema, hereditary, IC	613480	GJA12	608803	1q42.13
Lymphedema, hereditary, IC	613480	CX47	608803	1q42.13
Lymphedema, hereditary, IC	613480	PMLDAR	608803	1q42.13
Lymphedema, hereditary, IC	613480	HLD2	608803	1q42.13
Lymphedema, hereditary, IC	613480	SPG44	608803	1q42.13
Lymphedema, hereditary, IC	613480	LMPH1C	608803	1q42.13
Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus	153400	FOXC2	602402	16q24.1
Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus	153400	FKHL14	602402	16q24.1
Lymphedema-distichiasis syndrome with renal disease and diabetes mellitus	153400	MFH1	602402	16q24.1
Lymphedema-distichiasis syndrome	153400	FOXC2	602402	16q24.1
Lymphedema-distichiasis syndrome	153400	FKHL14	602402	16q24.1
Lymphedema-distichiasis syndrome	153400	MFH1	602402	16q24.1
Lymphocytic leukemia, acute T-cell		RAP1GDS1	179502	4q23
Lymphoma, B-cell		BCL6	109565	3q27.3
Lymphoma, B-cell non-Hodgkin, somatic		ATM	607585	11q22.3
Lymphoma, B-cell non-Hodgkin, somatic		ATA	607585	11q22.3
Lymphoma, B-cell non-Hodgkin, somatic		AT1	607585	11q22.3
Lymphoma, MALT, somatic	137245	BCL10	603517	1p22.3
Lymphoma, diffuse large cell		NBEAP1	601889	15q11.2
Lymphoma, diffuse large cell		BCL8	601889	15q11.2
Lymphoma, mantle cell		ATM	607585	11q22.3
Lymphoma, mantle cell		ATA	607585	11q22.3
Lymphoma, mantle cell		AT1	607585	11q22.3
Lymphoma, non-Hodgkin	605027	PRF1	170280	10q22.1
Lymphoma, non-Hodgkin	605027	HPLH2	170280	10q22.1
Lymphoma, non-Hodgkin	605027	FLH2	170280	10q22.1
Lymphoma, non-Hodgkin, somatic	605027	RAD54B	604289	8q22.1
Lymphoma, non-Hodgkin, somatic	605027	RAD54L	603615	1p34.1
Lymphoma, non-Hodgkin, somatic	605027	HR54	603615	1p34.1
Lymphoma, non-Hodgkin, somatic	605027	HRAD54	603615	1p34.1
Lymphoma, somatic		MAD1L1	602686	7p22.3
Lymphoma, somatic		TXBP181	602686	7p22.3
Lymphoma/leukemia, B-cell, variant		FVT1	136440	18q21.33
Lymphoplasmacytoid lymphoma		PAX5	167414	9p13.2
Lymphoplasmacytoid lymphoma		BSAP	167414	9p13.2
Lymphoproliferative syndrome 1	613011	ITK	186973	5q33.3
Lymphoproliferative syndrome 1	613011	EMT	186973	5q33.3
Lymphoproliferative syndrome 1	613011	LPFS1	186973	5q33.3
Lymphoproliferative syndrome 2	615122	TNFRSF7	186711	12p13.31
Lymphoproliferative syndrome 2	615122	CD27	186711	12p13.31
Lymphoproliferative syndrome 2	615122	S152. LPFS2	186711	12p13.31
Lymphoproliferative syndrome, X-linked, 1	308240	SH2D1A	300490	Xq25
Lymphoproliferative syndrome, X-linked, 1	308240	LYP	300490	Xq25
Lymphoproliferative syndrome, X-linked, 1	308240	IMD5	300490	Xq25
Lymphoproliferative syndrome, X-linked, 1	308240	XLP	300490	Xq25
Lymphoproliferative syndrome, X-linked, 1	308240	XLPD1	300490	Xq25
Lymphoproliferative syndrome, X-linked, 2	300635	XIAP	300079	Xq25
Lymphoproliferative syndrome, X-linked, 2	300635	BIRC4	300079	Xq25
Lymphoproliferative syndrome, X-linked, 2	300635	API3	300079	Xq25
Lymphoproliferative syndrome, X-linked, 2	300635	XLP2	300079	Xq25
Lysinuric protein intolerance	222700	SLC7A7	603593	14q11.2
Lysinuric protein intolerance	222700	LPI	603593	14q11.2
Lysyl hydroxylase 3 deficiency	612394	PLOD3	603066	7q22.1
Lysyl hydroxylase 3 deficiency	612394	LH3	603066	7q22.1
MASA syndrome	303350	L1CAM	308840	Xq28
MASA syndrome	303350	CAML1	308840	Xq28
MASA syndrome	303350	HSAS1	308840	Xq28
MASA syndrome	303350	MASA	308840	Xq28
MASA syndrome	303350	SPG1	308840	Xq28
MASP2 deficiency	613791	MASP2	605102	1p36.22
MASS syndrome	604308	FBN1	134797	15q21.1
MASS syndrome	604308	MFS1	134797	15q21.1
MASS syndrome	604308	WMS2	134797	15q21.1
MASS syndrome	604308	SSKS	134797	15q21.1
MASS syndrome	604308	GPHYSD2	134797	15q21.1
MASS syndrome	604308	ACMICD	134797	15q21.1
MASS syndrome	604308	ECTOL1	134797	15q21.1
MEDNIK syndrome	609313	AP1S1	603531	7q22.1
MEDNIK syndrome	609313	CLAPS1	603531	7q22.1
MEDNIK syndrome	609313	AP19	603531	7q22.1
MEDNIK syndrome	609313	MEDNIK	603531	7q22.1
MEHMO syndrome	300148	MEHMO		Xp22.13-p21.1
MHC class II deficiency, complementation group B	209920	RFXANK	603200	19p13.11
MODY, type I	125850	HNF4A	600281	20q13.12
MODY, type I	125850	TCF14	600281	20q13.12
MODY, type I	125850	MODY1	600281	20q13.12
MODY, type II	125851	GCK	138079	7p13
MODY, type II	125851	HHF3	138079	7p13
MODY, type III	600496	HNF1A	142410	12q24.31
MODY, type III	600496	TCF1	142410	12q24.31
MODY, type III	600496	MODY3	142410	12q24.31
MODY, type III	600496	IDDM20	142410	12q24.31
MODY, type IV	606392	IPF1	600733	13q12.2
MODY, type IV	606392	MODY4	600733	13q12.2
Machado-Joseph disease	109150	ATXN3	607047	14q32.12
Machado-Joseph disease	109150	MJD	607047	14q32.12
Machado-Joseph disease	109150	SCA3	607047	14q32.12
Macrocephaly with multiple epiphyseal dysplasia and distinctive facies	607131	MMEDF		15q26.1
Macrocephaly, alopecia, cutis laxa, and scoliosis	613075	RIN2	610222	20p11.23
Macrocephaly, alopecia, cutis laxa, and scoliosis	613075	MACS	610222	20p11.23
Macrocephaly, macrosomia, facial dysmorphism syndrome	614192	RNF135	611358	17q11.2
Macrocephaly, macrosomia, facial dysmorphism syndrome	614192	MMFD	611358	17q11.2
Macrocephaly/autism syndrome	605309	PTEN	601728	10q23.31
Macrocephaly/autism syndrome	605309	MMAC1	601728	10q23.31
Macrocephaly/autism syndrome	605309	GLM2	601728	10q23.31
Macrocephaly/autism syndrome	605309	CWS1	601728	10q23.31
Macrocytic anemia, refractory, due to 5q deletion, somatic	153550	RPS14	130620	5q33.1
Macrocytic anemia, refractory, due to 5q deletion, somatic	153550	EMTB	130620	5q33.1
Macroglobulinemia, Waldenstrom, somatic	153600	MYD88	602170	3p22.2
Macroglobulinemia, Waldenstrom, somatic	153600	MYD88D	602170	3p22.2
Macrostomia	613545	MACST		1p34-p32
Macrothrombocytopenia and progressive sensorineural deafness	600208	MYH9	160775	22q12.3
Macrothrombocytopenia and progressive sensorineural deafness	600208	MHA	160775	22q12.3
Macrothrombocytopenia and progressive sensorineural deafness	600208	FTNS	160775	22q12.3
Macrothrombocytopenia and progressive sensorineural deafness	600208	DFNA17	160775	22q12.3
Macrothrombocytopenia and progressive sensorineural deafness	600208	BDPLT6	160775	22q12.3
Macrothrombocytopenia, autosomal dominant, TUBB1-related	613112	TUBB1	612901	20q13.32
Macular corneal dystrophy	217800	CHST6	605294	16q23.1
Macular corneal dystrophy	217800	MCDC1	605294	16q23.1
Macular degeneration, X-linked atrophic	300834	RPGR	312610	Xp11.4
Macular degeneration, X-linked atrophic	300834	RP3	312610	Xp11.4
Macular degeneration, X-linked atrophic	300834	CRD	312610	Xp11.4
Macular degeneration, X-linked atrophic	300834	RP15	312610	Xp11.4
Macular degeneration, X-linked atrophic	300834	COD1	312610	Xp11.4
Macular degeneration, X-linked atrophic	300834	CORDX1	312610	Xp11.4
Macular degeneration, age-related, 11	611953	CST3	604312	20p11.21
Macular degeneration, age-related, 11	611953	ARMD11	604312	20p11.21
Macular degeneration, age-related, 15, suscepbitility to	615591	C9	120940	5p13.1
Macular degeneration, age-related, 15, suscepbitility to	615591	C9D	120940	5p13.1
Macular degeneration, age-related, 15, suscepbitility to	615591	ARMD15	120940	5p13.1
Macular degeneration, age-related, 2	153800	ABCA4	601691	1p22.1
Macular degeneration, age-related, 2	153800	ABCR	601691	1p22.1
Macular degeneration, age-related, 2	153800	STGD1	601691	1p22.1
Macular degeneration, age-related, 2	153800	FFM	601691	1p22.1
Macular degeneration, age-related, 2	153800	RP19	601691	1p22.1
Macular degeneration, age-related, 2	153800	CORD3	601691	1p22.1
Macular degeneration, age-related, 2	153800	ARMD2	601691	1p22.1
Macular degeneration, age-related, 3	608895	FBLN5	604580	14q32.12
Macular degeneration, age-related, 3	608895	ARMD3	604580	14q32.12
Macular degeneration, age-related, 3	608895	ADCL2	604580	14q32.12
Macular degeneration, age-related, 3	608895	ARCL1A	604580	14q32.12
Macular degeneration, age-related, 6	613757	RAXL1	610362	19p13.3
Macular degeneration, age-related, 6	613757	QRX	610362	19p13.3
Macular degeneration, age-related, 6	613757	CORD11	610362	19p13.3
Macular degeneration, age-related, 6	613757	ARMD6	610362	19p13.3
Macular degeneration, juvenile	248200	CNGB3	605080	8q21.3
Macular degeneration, juvenile	248200	ACHM3	605080	8q21.3
Macular degeneration, juvenile	248200	ACHM1	605080	8q21.3
Macular dystrophy		PRPH2	179605	6p21.1
Macular dystrophy		DS	179605	6p21.1
Macular dystrophy		RP7	179605	6p21.1
Macular dystrophy		PRPH	179605	6p21.1
Macular dystrophy		AVMD	179605	6p21.1
Macular dystrophy		AOFMD	179605	6p21.1
Macular dystrophy		CACD2	179605	6p21.1
Macular dystrophy, North Carolina type	136550	MCDR1		6q14-q16.2
Macular dystrophy, autosomal dominant, chromosome 6-linked	600110	ELOVL4	605512	6q14.1
Macular dystrophy, autosomal dominant, chromosome 6-linked	600110	ADMD	605512	6q14.1
Macular dystrophy, autosomal dominant, chromosome 6-linked	600110	STGD2	605512	6q14.1
Macular dystrophy, autosomal dominant, chromosome 6-linked	600110	STGD3	605512	6q14.1
Macular dystrophy, autosomal dominant, chromosome 6-linked	600110	ISQMR	605512	6q14.1
Macular dystrophy, dominant cystoid	153880	MDDC		7p21-p15
Macular dystrophy, patterned	169150	PRPH2	179605	6p21.1
Macular dystrophy, patterned	169150	DS	179605	6p21.1
Macular dystrophy, patterned	169150	RP7	179605	6p21.1
Macular dystrophy, patterned	169150	PRPH	179605	6p21.1
Macular dystrophy, patterned	169150	AVMD	179605	6p21.1
Macular dystrophy, patterned	169150	AOFMD	179605	6p21.1
Macular dystrophy, patterned	169150	CACD2	179605	6p21.1
Macular dystrophy, retinal, 2	608051	PROM1	604365	4p15.32
Macular dystrophy, retinal, 2	608051	PROML1	604365	4p15.32
Macular dystrophy, retinal, 2	608051	AC133	604365	4p15.32
Macular dystrophy, retinal, 2	608051	RP41	604365	4p15.32
Macular dystrophy, retinal, 2	608051	CORD12	604365	4p15.32
Macular dystrophy, retinal, 2	608051	CD133	604365	4p15.32
Macular dystrophy, retinal, 2	608051	MCDR2	604365	4p15.32
Macular dystrophy, retinal, 2	608051	STGD4	604365	4p15.32
Macular dystrophy, retinal, 3	608850	MCDR3		5p15.33-p13.1
Macular dystrophy, vitelliform	608161	PRPH2	179605	6p21.1
Macular dystrophy, vitelliform	608161	DS	179605	6p21.1
Macular dystrophy, vitelliform	608161	RP7	179605	6p21.1
Macular dystrophy, vitelliform	608161	PRPH	179605	6p21.1
Macular dystrophy, vitelliform	608161	AVMD	179605	6p21.1
Macular dystrophy, vitelliform	608161	AOFMD	179605	6p21.1
Macular dystrophy, vitelliform	608161	CACD2	179605	6p21.1
Maculopathy, IMPG2-related	613581	IMPG2	607056	3q12.3
Maculopathy, IMPG2-related	613581	IPM200	607056	3q12.3
Maculopathy, IMPG2-related	613581	RP56	607056	3q12.3
Maculopathy, bull's-eye		BEST1	607854	11q12.3
Maculopathy, bull's-eye		VMD2	607854	11q12.3
Maculopathy, bull's-eye		ARB	607854	11q12.3
Maculopathy, bull's-eye		RP50	607854	11q12.3
Majeed syndrome	609628	LPIN2	605519	18p11.31
Major affective disorder 4	611247	MAFD4		16p12
Major affective disorder 4	611247	BPAD		16p12
Major depressive disorder 1	608516	MDD1	608520	12q22-q23.2
Major depressive disorder 2	608516	MDD2	608691	15q25.3-q26.2
Male germ cell tumor	273300	MGCT		12q22
Malignant fibrous histiocytoma		MFHAS1	605352	8p23.1
Malignant fibrous histiocytoma		MASL1	605352	8p23.1
Malignant melanoma, somatic	155600	PTEN	601728	10q23.31
Malignant melanoma, somatic	155600	MMAC1	601728	10q23.31
Malignant melanoma, somatic	155600	GLM2	601728	10q23.31
Malignant melanoma, somatic	155600	CWS1	601728	10q23.31
Malonyl-CoA decarboxylase deficiency	248360	MLYCD	606761	16q23.3
Malonyl-CoA decarboxylase deficiency	248360	MCD	606761	16q23.3
Malouf syndrome	212112	LMNA	150330	1q22
Malouf syndrome	212112	LMN1	150330	1q22
Malouf syndrome	212112	EMD2	150330	1q22
Malouf syndrome	212112	FPLD2	150330	1q22
Malouf syndrome	212112	CMD1A	150330	1q22
Malouf syndrome	212112	HGPS	150330	1q22
Malouf syndrome	212112	LGMD1B	150330	1q22
Mammary-digital-nail syndrome	613689	MDNS		22q12.3-q13.1
Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	615381	POLD1	174761	19q13.33
Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	615381	CRCS10	174761	19q13.33
Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome	615381	MDPL	174761	19q13.33
Mandibuloacral dysplasia with type B lipodystrophy	608612	ZMPSTE24	606480	1p34.2
Mandibuloacral dysplasia with type B lipodystrophy	608612	FACE1	606480	1p34.2
Mandibuloacral dysplasia with type B lipodystrophy	608612	STE24	606480	1p34.2
Mandibuloacral dysplasia with type B lipodystrophy	608612	MADB	606480	1p34.2
Mandibuloacral dysplasia	248370	LMNA	150330	1q22
Mandibuloacral dysplasia	248370	LMN1	150330	1q22
Mandibuloacral dysplasia	248370	EMD2	150330	1q22
Mandibuloacral dysplasia	248370	FPLD2	150330	1q22
Mandibuloacral dysplasia	248370	CMD1A	150330	1q22
Mandibuloacral dysplasia	248370	HGPS	150330	1q22
Mandibuloacral dysplasia	248370	LGMD1B	150330	1q22
Mandibulofacial dysostosis, Guion-Almeida type	610536	EFTUD2	603892	17q21.31
Mandibulofacial dysostosis, Guion-Almeida type	610536	KIAA0031	603892	17q21.31
Mandibulofacial dysostosis, Guion-Almeida type	610536	MFDGA	603892	17q21.31
Manitoba oculotrichoanal syndrome	248450	FREM1	608944	9p22.3
Manitoba oculotrichoanal syndrome	248450	C9orf154	608944	9p22.3
Manitoba oculotrichoanal syndrome	248450	BNAR	608944	9p22.3
Manitoba oculotrichoanal syndrome	248450	MOTA	608944	9p22.3
Manitoba oculotrichoanal syndrome	248450	TRIGNO2	608944	9p22.3
Mannosidosis, alpha-, types I and II	248500	MAN2B1	609458	19p13.2
Mannosidosis, alpha-, types I and II	248500	MANB	609458	19p13.2
Mannosidosis, beta	248510	MANBA	609489	4q24
Mannosidosis, beta	248510	MANB1	609489	4q24
Maple syrup urine disease, mild variant	615135	PPM1K	611065	4q22.1
Maple syrup urine disease, mild variant	615135	PP2CM	611065	4q22.1
Maple syrup urine disease, mild variant	615135	PTMP	611065	4q22.1
Maple syrup urine disease, mild variant	615135	MSUDMV	611065	4q22.1
Maple syrup urine disease, type II	248600	DBT	248610	1p21.2
Maple syrup urine disease, type II	248600	BCATE2	248610	1p21.2
Maple syrup urine disease, type Ia	248600	BCKDHA	608348	19q13.2
Maple syrup urine disease, type Ia	248600	MSUD1	608348	19q13.2
Maple syrup urine disease, type Ib	248600	BCKDHB	248611	6q14.1
Maple syrup urine disease, type Ib	248600	E1B	248611	6q14.1
Marfan syndrome	154700	FBN1	134797	15q21.1
Marfan syndrome	154700	MFS1	134797	15q21.1
Marfan syndrome	154700	WMS2	134797	15q21.1
Marfan syndrome	154700	SSKS	134797	15q21.1
Marfan syndrome	154700	GPHYSD2	134797	15q21.1
Marfan syndrome	154700	ACMICD	134797	15q21.1
Marfan syndrome	154700	ECTOL1	134797	15q21.1
Marinesco-Sjogren syndrome	248800	SIL1	608005	5q31.2
Marinesco-Sjogren syndrome	248800	BAP	608005	5q31.2
Marinesco-Sjogren syndrome	248800	MSS	608005	5q31.2
Marshall syndrome	154780	COL11A1	120280	1p21.1
Marshall syndrome	154780	STL2	120280	1p21.1
Marshall-Smith syndrome	602535	NFIX	164005	19p13.2
Marshall-Smith syndrome	602535	NF1A	164005	19p13.2
Marshall-Smith syndrome	602535	SOTOS2	164005	19p13.2
Marshall-Smith syndrome	602535	MRSHSS	164005	19p13.2
Martinez-Frias syndrome	601346	RFX6	612659	6q22.1
Martinez-Frias syndrome	601346	RFXDC1	612659	6q22.1
Martinez-Frias syndrome	601346	MTFS	612659	6q22.1
Martsolf syndrome	212720	RAB3GAP2	609275	1q41
Martsolf syndrome	212720	RAB3GAP150	609275	1q41
Martsolf syndrome	212720	p150	609275	1q41
Martsolf syndrome	212720	KIAA0839	609275	1q41
Martsolf syndrome	212720	WARBM2	609275	1q41
Mast cell disease	154800	KIT	164920	4q12
Mast cell disease	154800	PBT	164920	4q12
Mast syndrome	248900	ACP33	608181	15q22.31
Mast syndrome	248900	MAST	608181	15q22.31
Mast syndrome	248900	SPG21	608181	15q22.31
Maturity-onset diabetes of the young 6	606394	NEUROD1	601724	2q31.3
Maturity-onset diabetes of the young 6	606394	NIDDM	601724	2q31.3
Maturity-onset diabetes of the young, type 10	613370	INS	176730	11p15.5
Maturity-onset diabetes of the young, type 10	613370	MODY10	176730	11p15.5
Maturity-onset diabetes of the young, type 10	613370	IDDM2	176730	11p15.5
Maturity-onset diabetes of the young, type 11	613375	BLK	191305	8p23.1
Maturity-onset diabetes of the young, type 11	613375	MODY11	191305	8p23.1
Maturity-onset diabetes of the young, type IX	612225	PAX4	167413	7q32.1
Maturity-onset diabetes of the young, type IX	612225	MODY9	167413	7q32.1
Maturity-onset diabetes of the young, type IX	612225	KPD	167413	7q32.1
Maturity-onset diabetes of the young, type VII	610508	KLF11	603301	2p25.1
Maturity-onset diabetes of the young, type VII	610508	TIEG2	603301	2p25.1
Maturity-onset diabetes of the young, type VII	610508	FKLF1	603301	2p25.1
Maturity-onset diabetes of the young, type VII	610508	FKLF	603301	2p25.1
Maturity-onset diabetes of the young, type VII	610508	MODY7	603301	2p25.1
Maturity-onset diabetes of the young, type VIII	609812	CEL	114840	9q34.2
Maturity-onset diabetes of the young, type VIII	609812	BSSL	114840	9q34.2
Maturity-onset diabetes of the young, type VIII	609812	CELL	114840	9q34.2
Maturity-onset diabetes of the young, type VIII	609812	MODY8	114840	9q34.2
May-Hegglin anomaly	155100	MYH9	160775	22q12.3
May-Hegglin anomaly	155100	MHA	160775	22q12.3
May-Hegglin anomaly	155100	FTNS	160775	22q12.3
May-Hegglin anomaly	155100	DFNA17	160775	22q12.3
May-Hegglin anomaly	155100	BDPLT6	160775	22q12.3
McArdle disease	232600	PYGM	608455	11q13.1
McCune-Albright syndrome	174800	GNAS	139320	20q13.32
McCune-Albright syndrome	174800	GNAS1	139320	20q13.32
McCune-Albright syndrome	174800	GPSA	139320	20q13.32
McCune-Albright syndrome	174800	POH	139320	20q13.32
McCune-Albright syndrome	174800	PHP1B	139320	20q13.32
McCune-Albright syndrome	174800	PHP1A	139320	20q13.32
McCune-Albright syndrome	174800	AHO	139320	20q13.32
McCune-Albright syndrome	174800	PHP1C	139320	20q13.32
McKusick-Kaufman syndrome	236700	MKKS	604896	20p12.2
McKusick-Kaufman syndrome	236700	HMCS	604896	20p12.2
McKusick-Kaufman syndrome	236700	KMS	604896	20p12.2
McKusick-Kaufman syndrome	236700	MKS	604896	20p12.2
McKusick-Kaufman syndrome	236700	BBS6	604896	20p12.2
McLeod syndrome with or without chronic granulomatous disease	300842	XK	314850	Xp21.1
McLeod syndrome with or without chronic granulomatous disease	300842	MCLDS	314850	Xp21.1
Meacham syndrome	608978	WT1	607102	11p13
Meacham syndrome	608978	NPHS4	607102	11p13
Mean platelet volume QTL4	614644	MPVQTL4		6p21.3-p21.2
Mean platelet volume QTL5	614645	MPVQTL5		6q23.3
Mean platelet volume QTL6	614646	MPVQTL6		7q22.3
Meckel syndrome 1	249000	MKS1	609883	17q22
Meckel syndrome 1	249000	MKS	609883	17q22
Meckel syndrome 1	249000	BBS13	609883	17q22
Meckel syndrome 10	614175	B9D2	611951	19q13.2
Meckel syndrome 10	614175	MKS10	611951	19q13.2
Meckel syndrome 2	603194	TMEM216	613277	11q12.2
Meckel syndrome 2	603194	JBTS2	613277	11q12.2
Meckel syndrome 2	603194	CORS2	613277	11q12.2
Meckel syndrome 2	603194	MKS2	613277	11q12.2
Meckel syndrome 3	607361	TMEM67	609884	8q22.1
Meckel syndrome 3	607361	MKS3	609884	8q22.1
Meckel syndrome 3	607361	JBTS6	609884	8q22.1
Meckel syndrome 3	607361	NPHP11	609884	8q22.1
Meckel syndrome 4	611134	CEP290	610142	12q21.32
Meckel syndrome 4	611134	KIAA0373	610142	12q21.32
Meckel syndrome 4	611134	3H11AG	610142	12q21.32
Meckel syndrome 4	611134	JBTS5	610142	12q21.32
Meckel syndrome 4	611134	SLSN6	610142	12q21.32
Meckel syndrome 4	611134	LCA10	610142	12q21.32
Meckel syndrome 4	611134	BBS14	610142	12q21.32
Meckel syndrome 5	611561	RPGRIP1L	610937	16q12.2
Meckel syndrome 5	611561	KIAA1005	610937	16q12.2
Meckel syndrome 5	611561	JBTS7	610937	16q12.2
Meckel syndrome 5	611561	MKS5	610937	16q12.2
Meckel syndrome 6	612284	CC2D2A	612013	4p15.32
Meckel syndrome 6	612284	KIAA1345	612013	4p15.32
Meckel syndrome 6	612284	MKS6	612013	4p15.32
Meckel syndrome 7	267010	NPHP3	608002	3q22.1
Meckel syndrome 7	267010	NPH3	608002	3q22.1
Meckel syndrome 7	267010	RHPD1	608002	3q22.1
Meckel syndrome 7	267010	MKS7	608002	3q22.1
Meckel syndrome 8	613885	TCTN2	613846	12q24.31
Meckel syndrome 8	613885	TECT2	613846	12q24.31
Meckel syndrome 8	613885	MKS8	613846	12q24.31
Meckel syndrome 9	614209	B9D1	614144	17p11.2
Meckel syndrome 9	614209	MKSR1	614144	17p11.2
Meckel syndrome 9	614209	MKS9	614144	17p11.2
Meckel syndrome, type 11	615397	TMEM231	614949	16q23.1
Meckel syndrome, type 11	615397	JBTS20	614949	16q23.1
Meckel syndrome, type 11	615397	MKS11	614949	16q23.1
Meconium ileus	614665	GUCY2C	601330	12p13.1-p12.3
Meconium ileus	614665	GUC2C	601330	12p13.1-p12.3
Meconium ileus	614665	DIAR6	601330	12p13.1-p12.3
Meconium ileus	614665	MECIL	601330	12p13.1-p12.3
Medullary cystic kidney disease 1	174000	MUC1	158340	1q22
Medullary cystic kidney disease 1	174000	PUM	158340	1q22
Medullary cystic kidney disease 1	174000	MCKD1	158340	1q22
Medullary cystic kidney disease 2	603860	UMOD	191845	16p12.3
Medullary cystic kidney disease 2	603860	HNFJ1	191845	16p12.3
Medullary cystic kidney disease 2	603860	FJHN	191845	16p12.3
Medullary cystic kidney disease 2	603860	MCKD2	191845	16p12.3
Medullary cystic kidney disease 2	603860	ADMCKD2	191845	16p12.3
Medullary thyroid carcinoma	155240	RET	164761	10q11.21
Medullary thyroid carcinoma	155240	MEN2A	164761	10q11.21
Medullary thyroid carcinoma	155240	HSCR1	164761	10q11.21
Medullary thyroid carcinoma, familial	155240	NTRK1	191315	1q23.1
Medullary thyroid carcinoma, familial	155240	TRKA	191315	1q23.1
Medullary thyroid carcinoma, familial	155240	MTC	191315	1q23.1
Medulloblastoma	155255	PTCH2	603673	1p34.1
Medulloblastoma, desmoplastic	155255	SUFU	607035	10q24.32
Medulloblastoma, desmoplastic	155255	SUFUXL	607035	10q24.32
Medulloblastoma, desmoplastic	155255	SUFUH	607035	10q24.32
Meesmann corneal dystrophy	122100	KRT12	601687	17q21.2
Meesmann corneal dystrophy	122100	KRT3	148043	12q13.13
Megakaryoblastic leukemia, acute		RBM15	606077	1p13.3
Megakaryoblastic leukemia, acute		SPEN	606077	1p13.3
Megakaryoblastic leukemia, acute		OTT	606077	1p13.3
Megakaryoblastic leukemia, acute		MKL1	606078	22q13.1-q13.2
Megakaryoblastic leukemia, acute		AMKL	606078	22q13.1-q13.2
Megakaryoblastic leukemia, acute		MAL	606078	22q13.1-q13.2
Megalencephalic leukoencephalopathy with subcortical cysts 2A	613925	HEPACAM	611642	11q24.2
Megalencephalic leukoencephalopathy with subcortical cysts 2A	613925	MLC2A	611642	11q24.2
Megalencephalic leukoencephalopathy with subcortical cysts 2A	613925	MLC2B	611642	11q24.2
Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation	613926	HEPACAM	611642	11q24.2
Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation	613926	MLC2A	611642	11q24.2
Megalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation	613926	MLC2B	611642	11q24.2
Megalencephalic leukoencephalopathy with subcortical cysts	604004	MLC1	605908	22q13.33
Megalencephalic leukoencephalopathy with subcortical cysts	604004	LVM	605908	22q13.33
Megalencephalic leukoencephalopathy with subcortical cysts	604004	VL	605908	22q13.33
Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	PIK3CA	171834	3q26.32
Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	CLOVE	171834	3q26.32
Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	MCAP	171834	3q26.32
Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	MCM	171834	3q26.32
Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	MCMTC	171834	3q26.32
Megalencephaly-capillary malformation-polymicrogyria syndrome, somatic	602501	CWS5	171834	3q26.32
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome	603387	AKT3	611223	1q43-q44
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome	603387	PKBG	611223	1q43-q44
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome	603387	MPPH	611223	1q43-q44
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome	603387	PIK3R2	603157	19p13.11
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome	603387	MPPH	603157	19p13.11
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, somatic	603387	PIK3CA	171834	3q26.32
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, somatic	603387	CLOVE	171834	3q26.32
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, somatic	603387	MCAP	171834	3q26.32
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, somatic	603387	MCM	171834	3q26.32
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, somatic	603387	MCMTC	171834	3q26.32
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome, somatic	603387	CWS5	171834	3q26.32
Megaloblastic anemia due to dihydrofolate reductase deficiency	613839	DHFR	126060	5q14.1
Megaloblastic anemia-1, Finnish type	261100	CUBN	602997	10p13
Megaloblastic anemia-1, Finnish type	261100	IFCR	602997	10p13
Megaloblastic anemia-1, Finnish type	261100	MGA1	602997	10p13
Megaloblastic anemia-1, Norwegian type	261100	AMN	605799	14q32.32
Megalocornea 1, X-linked 309300		CHRDL1	300350	Xq23
Megalocornea 1, X-linked 309300		VOPT	300350	Xq23
Megalocornea 1, X-linked 309300		MGC1	300350	Xq23
Meier-Gorlin syndrome 1	224690	ORC1	601902	1p32.3
Meier-Gorlin syndrome 1	224690	ORC1L	601902	1p32.3
Meier-Gorlin syndrome 2	613800	ORC4	603056	2q22.3-q23.1
Meier-Gorlin syndrome 2	613800	ORC4L	603056	2q22.3-q23.1
Meier-Gorlin syndrome 3	613803	ORC6	607213	16q11.2
Meier-Gorlin syndrome 3	613803	ORC6L	607213	16q11.2
Meier-Gorlin syndrome 4	613804	CDT1	605525	16q24.3
Meier-Gorlin syndrome 5	613805	CDC6	602627	17q21.2
Meier-Gorlin syndrome 5	613805	CDC18L	602627	17q21.2
Melanoma and neural system tumor syndrome	155755	CDKN2A	600160	9p21.3
Melanoma and neural system tumor syndrome	155755	MTS1	600160	9p21.3
Melanoma and neural system tumor syndrome	155755	P16	600160	9p21.3
Melanoma and neural system tumor syndrome	155755	MLM	600160	9p21.3
Melanoma and neural system tumor syndrome	155755	CMM2	600160	9p21.3
Melanoma, desmoplastic neurotrophic		NF1	613113	17q11.2
Melanoma, desmoplastic neurotrophic		VRNF	613113	17q11.2
Melanoma, desmoplastic neurotrophic		WSS	613113	17q11.2
Melanoma, desmoplastic neurotrophic		NFNS	613113	17q11.2
Melanoma, malignant, somatic		BRAF	164757	7q34
Melanoma, malignant, somatic		NS7	164757	7q34
Melanoma, malignant, somatic		STK11	602216	19p13.3
Melanoma, malignant, somatic		PJS	602216	19p13.3
Melanoma, malignant, somatic		LKB1	602216	19p13.3
Meleda disease	248300	SLURP1	606119	8q24.3
Meleda disease	248300	MDM	606119	8q24.3
Melnick-Needles syndrome	309350	FLNA	300017	Xq28
Melnick-Needles syndrome	309350	FLN1	300017	Xq28
Melnick-Needles syndrome	309350	NHBP	300017	Xq28
Melnick-Needles syndrome	309350	OPD1	300017	Xq28
Melnick-Needles syndrome	309350	OPD2	300017	Xq28
Melnick-Needles syndrome	309350	FMD	300017	Xq28
Melnick-Needles syndrome	309350	MNS	300017	Xq28
Melnick-Needles syndrome	309350	CVD1	300017	Xq28
Melnick-Needles syndrome	309350	CSBS	300017	Xq28
Melorheostosis with osteopoikilosis	155950	LEMD3	607844	12q14.3
Melorheostosis with osteopoikilosis	155950	MAN1	607844	12q14.3
Membranous glomerulonephritis, antenatal		MME	120520	3q25.2
Membranous glomerulonephritis, antenatal		CD10	120520	3q25.2
Membranous glomerulonephritis, antenatal		CALLA	120520	3q25.2
Membranous glomerulonephritis, antenatal		NEP	120520	3q25.2
Meningioma	607174	MN1	156100	22q12.1
Meningioma	607174	MGCR	156100	22q12.1
Meningioma, NF2-related, somatic	607174	NF2	607379	22q12.2
Meningioma, SIS-related	607174	PDGFB	190040	22q13.1
Meningioma, SIS-related	607174	SIS	190040	22q13.1
Meningioma, SIS-related	607174	IBGC5	190040	22q13.1
Meningioma, radiation-induced		MNRI	606190	1p11
Menkes disease	309400	ATP7A	300011	Xq21.1
Menkes disease	309400	MNK	300011	Xq21.1
Menkes disease	309400	MK	300011	Xq21.1
Menkes disease	309400	OHS	300011	Xq21.1
Menkes disease	309400	SMAX3	300011	Xq21.1
Mental retardation and microcephaly with pontine and cerebellar hypoplasia	300749	CASK	300172	Xp11.4
Mental retardation and microcephaly with pontine and cerebellar hypoplasia	300749	MICPCH	300172	Xp11.4
Mental retardation and microcephaly with pontine and cerebellar hypoplasia	300749	FGS4	300172	Xp11.4
Mental retardation and microcephaly with pontine and cerebellar hypoplasia	300749	CMG	300172	Xp11.4
Mental retardation and microcephaly with pontine and cerebellar hypoplasia	300749	MRXSNA	300172	Xp11.4
Mental retardation syndrome, X-linked, Armfield type	300261	MRXSA		Xq28
Mental retardation syndrome, X-linked, Siderius type	300263	PHF8	300560	Xp11.22
Mental retardation syndrome, X-linked, Siderius type	300263	ZNF422	300560	Xp11.22
Mental retardation syndrome, X-linked, Siderius type	300263	KIAA1111	300560	Xp11.22
Mental retardation syndrome, X-linked, Siderius type	300263	MRXSSD	300560	Xp11.22
Mental retardation with language impairment and autistic features	613670	FOXP1	605515	3p13
Mental retardation with language impairment and autistic features	613670	QRF1	605515	3p13
Mental retardation, FRA12A type	136630	DIP2B	611379	12q13.12
Mental retardation, FRA12A type	136630	KIAA1463	611379	12q13.12
Mental retardation, X-linked 1	309530	IQSEC2	300522	Xp11.22
Mental retardation, X-linked 1	309530	KIAA0522	300522	Xp11.22
Mental retardation, X-linked 1	309530	MRX1	300522	Xp11.22
Mental retardation, X-linked 14	300062	MRX14		Xp11.3-q13.3
Mental retardation, X-linked 17/31, microduplication	300705	HSD17B10	300256	Xp11.22
Mental retardation, X-linked 17/31, microduplication	300705	HADH2	300256	Xp11.22
Mental retardation, X-linked 17/31, microduplication	300705	ERAB	300256	Xp11.22
Mental retardation, X-linked 17/31, microduplication	300705	MRXS10	300256	Xp11.22
Mental retardation, X-linked 17/31, microduplication	300705	MRX17	300256	Xp11.22
Mental retardation, X-linked 17/31, microduplication	300705	MRX31	300256	Xp11.22
Mental retardation, X-linked 17/31, microduplication	300705	DUPXp11.22	300256	Xp11.22
Mental retardation, X-linked 19	300844	RPS6KA3	300075	Xp22.12
Mental retardation, X-linked 19	300844	RSK2	300075	Xp22.12
Mental retardation, X-linked 19	300844	MRX19	300075	Xp22.12
Mental retardation, X-linked 2	300428	MRX2		Xp22.3
Mental retardation, X-linked 20	300047	MRX20		Xp11-q21
Mental retardation, X-linked 21/34	300143	IL1RAPL1	300206	Xp21.3-p21.2
Mental retardation, X-linked 21/34	300143	IL1R8	300206	Xp21.3-p21.2
Mental retardation, X-linked 21/34	300143	MRX21	300206	Xp21.3-p21.2
Mental retardation, X-linked 21/34	300143	MRX34	300206	Xp21.3-p21.2
Mental retardation, X-linked 23	300046	MRX23		Xq23-q24
Mental retardation, X-linked 29		MRX29	300077	Xp22.3-p21.3
Mental retardation, X-linked 29 and others	300419	ARX	300382	Xp21.3
Mental retardation, X-linked 29 and others	300419	ISSX	300382	Xp21.3
Mental retardation, X-linked 29 and others	300419	PRTS	300382	Xp21.3
Mental retardation, X-linked 29 and others	300419	MRXS1	300382	Xp21.3
Mental retardation, X-linked 29 and others	300419	MRX36	300382	Xp21.3
Mental retardation, X-linked 29 and others	300419	MRX54	300382	Xp21.3
Mental retardation, X-linked 29 and others	300419	MRX43	300382	Xp21.3
Mental retardation, X-linked 29 and others	300419	MRX87	300382	Xp21.3
Mental retardation, X-linked 29 and others	300419	MRX29	300382	Xp21.3
Mental retardation, X-linked 29 and others	300419	MRX32	300382	Xp21.3
Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type )	309541	HCFC1	300019	Xq28
Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type )	309541	HCF1	300019	Xq28
Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type )	309541	MRX3	300019	Xq28
Mental retardation, X-linked 30/47	300558	PAK3	300142	Xq23
Mental retardation, X-linked 30/47	300558	MRX30	300142	Xq23
Mental retardation, X-linked 30/47	300558	MRX47	300142	Xq23
Mental retardation, X-linked 41	300849	GDI1	300104	Xq28
Mental retardation, X-linked 41	300849	RABGD1A	300104	Xq28
Mental retardation, X-linked 41	300849	MRX41	300104	Xq28
Mental retardation, X-linked 41	300849	MRX48	300104	Xq28
Mental retardation, X-linked 42	300372	MRX42		Xq26
Mental retardation, X-linked 45	300498	ZNF81	314998	Xp11.23
Mental retardation, X-linked 45	300498	MRX45	314998	Xp11.23
Mental retardation, X-linked 46	300436	ARHGEF6	300267	Xq26.3
Mental retardation, X-linked 46	300436	MRX46	300267	Xq26.3
Mental retardation, X-linked 46	300436	COOL2	300267	Xq26.3
Mental retardation, X-linked 49	300114	MRX49		Xp22.3
Mental retardation, X-linked 50	300115	MRX50		Xp11.3-p11.21
Mental retardation, X-linked 52	300504	MRX52		Xp11.21-q22.3
Mental retardation, X-linked 53	300324	MRX53		Xq22.2-q26
Mental retardation, X-linked 58	300210	TSPAN7	300096	Xp11.4
Mental retardation, X-linked 58	300210	TM4SF2	300096	Xp11.4
Mental retardation, X-linked 58	300210	MXS1	300096	Xp11.4
Mental retardation, X-linked 58	300210	A15	300096	Xp11.4
Mental retardation, X-linked 58	300210	MRX58	300096	Xp11.4
Mental retardation, X-linked 63	300387	ACSL4	300157	Xq23
Mental retardation, X-linked 63	300387	FACL4	300157	Xq23
Mental retardation, X-linked 63	300387	ACS4	300157	Xq23
Mental retardation, X-linked 63	300387	MRX63	300157	Xq23
Mental retardation, X-linked 72	300271	RAB39B	300774	Xq28
Mental retardation, X-linked 72	300271	MRX72	300774	Xq28
Mental retardation, X-linked 77	300454	MRX77		Xq12-q21.3
Mental retardation, X-linked 78	300551	MRX78		Xp11.4-q21.1
Mental retardation, X-linked 81	300433	MRX81		Xp11.2-q12
Mental retardation, X-linked 82	300518	MRX82		Xq24-q25
Mental retardation, X-linked 84	300505	MRX84		Xp11.3-q22.3
Mental retardation, X-linked 89	300848	MRX89		Xp11.3
Mental retardation, X-linked 9	309549	FTSJ1	300499	Xp11.23
Mental retardation, X-linked 9	309549	JM23	300499	Xp11.23
Mental retardation, X-linked 9	309549	SPB1	300499	Xp11.23
Mental retardation, X-linked 9	309549	MRX44	300499	Xp11.23
Mental retardation, X-linked 9	309549	MRX9	300499	Xp11.23
Mental retardation, X-linked 90	300850	DLG3	300189	Xq13.1
Mental retardation, X-linked 90	300850	NEDLG	300189	Xq13.1
Mental retardation, X-linked 90	300850	SAP102	300189	Xq13.1
Mental retardation, X-linked 90	300850	MRX90	300189	Xq13.1
Mental retardation, X-linked 91	300577	ZDHHC15	300576	Xq13.3
Mental retardation, X-linked 91	300577	MRX91	300576	Xq13.3
Mental retardation, X-linked 92	300851	MRX92		Xp11.3
Mental retardation, X-linked 93	300659	BRWD3	300553	Xq21.1
Mental retardation, X-linked 93	300659	MRX93	300553	Xq21.1
Mental retardation, X-linked 94	300699	GRIA3	305915	Xq25
Mental retardation, X-linked 94	300699	GLUR3	305915	Xq25
Mental retardation, X-linked 94	300699	MRX94	305915	Xq25
Mental retardation, X-linked 95	300716	MRX95		Chr.X
Mental retardation, X-linked 96	300802	SYP	313475	Xp11.23
Mental retardation, X-linked 96	300802	MRXSYP	313475	Xp11.23
Mental retardation, X-linked 97	300803	ZNF711	314990	Xq21.1
Mental retardation, X-linked 97	300803	ZNF6	314990	Xq21.1
Mental retardation, X-linked 97	300803	CMPX1	314990	Xq21.1
Mental retardation, X-linked 97	300803	MRX97	314990	Xq21.1
Mental retardation, X-linked 98	300912	KIAA2022	300524	Xq13.3
Mental retardation, X-linked 98	300912	MRX98	300524	Xq13.3
Mental retardation, X-linked syndromic 10	300220	HSD17B10	300256	Xp11.22
Mental retardation, X-linked syndromic 10	300220	HADH2	300256	Xp11.22
Mental retardation, X-linked syndromic 10	300220	ERAB	300256	Xp11.22
Mental retardation, X-linked syndromic 10	300220	MRXS10	300256	Xp11.22
Mental retardation, X-linked syndromic 10	300220	MRX17	300256	Xp11.22
Mental retardation, X-linked syndromic 10	300220	MRX31	300256	Xp11.22
Mental retardation, X-linked syndromic 10	300220	DUPXp11.22	300256	Xp11.22
Mental retardation, X-linked syndromic 16	305400	FGD1	300546	Xp11.22
Mental retardation, X-linked syndromic 16	305400	FGDY	300546	Xp11.22
Mental retardation, X-linked syndromic 16	305400	AAS	300546	Xp11.22
Mental retardation, X-linked syndromic 16	305400	MRXS16	300546	Xp11.22
Mental retardation, X-linked syndromic 7	300218	MRXS7		Xp11.3-q22
Mental retardation, X-linked syndromic, Abidi type	300262	MRXSAB		Xq13.2
Mental retardation, X-linked syndromic, Christianson type	300243	SLC9A6	300231	Xq26.3
Mental retardation, X-linked syndromic, Christianson type	300243	NHE6	300231	Xq26.3
Mental retardation, X-linked syndromic, Fried type	300630	AP1S2	300629	Xp22.2
Mental retardation, X-linked syndromic, Fried type	300630	MRX59	300629	Xp22.2
Mental retardation, X-linked syndromic, Fried type	300630	MRXSF	300629	Xp22.2
Mental retardation, X-linked syndromic, Fried type	300630	MRXS21	300629	Xp22.2
Mental retardation, X-linked syndromic, Lubs type	300260	MECP2	300005	Xq28
Mental retardation, X-linked syndromic, Lubs type	300260	RTT	300005	Xq28
Mental retardation, X-linked syndromic, Lubs type	300260	PPMX	300005	Xq28
Mental retardation, X-linked syndromic, Lubs type	300260	MRX16	300005	Xq28
Mental retardation, X-linked syndromic, Lubs type	300260	MRX79	300005	Xq28
Mental retardation, X-linked syndromic, Lubs type	300260	AUTSX3	300005	Xq28
Mental retardation, X-linked syndromic, Lubs type	300260	MRXSL	300005	Xq28
Mental retardation, X-linked syndromic, Lubs type	300260	MRXS13	300005	Xq28
Mental retardation, X-linked syndromic, Lubs type	300260	MRX79	300005	Xq28
Mental retardation, X-linked syndromic, Lubs type	300260	MRX16	300005	Xq28
Mental retardation, X-linked syndromic, Nascimento-type	300860	UBE2A	312180	Xq24
Mental retardation, X-linked syndromic, Nascimento-type	300860	RAD6A	312180	Xq24
Mental retardation, X-linked syndromic, Nascimento-type	300860	MRXSN	312180	Xq24
Mental retardation, X-linked syndromic, Nascimento-type	300860	MRXS30	312180	Xq24
Mental retardation, X-linked syndromic, Raymond type	300799	ZDHHC9	300646	Xq26.1
Mental retardation, X-linked syndromic, Raymond type	300799	DHHC9	300646	Xq26.1
Mental retardation, X-linked syndromic, Raymond type	300799	MRXSZ	300646	Xq26.1
Mental retardation, X-linked syndromic, Shashi type	300238	MRXS11		Xq26-q27
Mental retardation, X-linked syndromic, Shashi type	300238	SMRXS		Xq26-q27
Mental retardation, X-linked syndromic, Turner type	300706	HUWE1	300697	Xp11.22
Mental retardation, X-linked syndromic, Turner type	300706	UREB1	300697	Xp11.22
Mental retardation, X-linked syndromic, Turner type	300706	KIAA0312	300697	Xp11.22
Mental retardation, X-linked syndromic, Turner type	300706	LASU1	300697	Xp11.22
Mental retardation, X-linked	300495	NLGN4	300427	Xp22.32-p22.31
Mental retardation, X-linked	300495	KIAA1260	300427	Xp22.32-p22.31
Mental retardation, X-linked	300495	AUTSX2	300427	Xp22.32-p22.31
Mental retardation, X-linked	300495	ASPGX2	300427	Xp22.32-p22.31
Mental retardation, X-linked, FRAXE type	309548	AFF2	300806	Xq28
Mental retardation, X-linked, FRAXE type	309548	FMR2	300806	Xq28
Mental retardation, X-linked, FRAXE type	309548	FRAXE	300806	Xq28
Mental retardation, X-linked, FRAXE type	309548	MRX2	300806	Xq28
Mental retardation, X-linked, Snyder-Robinson type	309583	SMS	300105	Xp22.11
Mental retardation, X-linked, Snyder-Robinson type	309583	SRS	300105	Xp22.11
Mental retardation, X-linked, Snyder-Robinson type	309583	MRSR	300105	Xp22.11
Mental retardation, X-linked, syndromic 13	300055	MECP2	300005	Xq28
Mental retardation, X-linked, syndromic 13	300055	RTT	300005	Xq28
Mental retardation, X-linked, syndromic 13	300055	PPMX	300005	Xq28
Mental retardation, X-linked, syndromic 13	300055	MRX16	300005	Xq28
Mental retardation, X-linked, syndromic 13	300055	MRX79	300005	Xq28
Mental retardation, X-linked, syndromic 13	300055	AUTSX3	300005	Xq28
Mental retardation, X-linked, syndromic 13	300055	MRXSL	300005	Xq28
Mental retardation, X-linked, syndromic 13	300055	MRXS13	300005	Xq28
Mental retardation, X-linked, syndromic 13	300055	MRX79	300005	Xq28
Mental retardation, X-linked, syndromic 13	300055	MRX16	300005	Xq28
Mental retardation, X-linked, syndromic 14	300676	UPF3B	300298	Xq24
Mental retardation, X-linked, syndromic 14	300676	RENT3B	300298	Xq24
Mental retardation, X-linked, syndromic 14	300676	MRXS14	300298	Xq24
Mental retardation, X-linked, syndromic 15 (Cabezas type)	300354	CUL4B	300304	Xq24
Mental retardation, X-linked, syndromic 15 (Cabezas type)	300354	MRXSC	300304	Xq24
Mental retardation, X-linked, syndromic 15 (Cabezas type)	300354	MRXHF2	300304	Xq24
Mental retardation, X-linked, syndromic 15 (Cabezas type)	300354	SFM2	300304	Xq24
Mental retardation, X-linked, syndromic 15 (Cabezas type)	300354	MRXS15	300304	Xq24
Mental retardation, X-linked, syndromic 17	300858	MRXS17		Xp21.1-p11.23
Mental retardation, X-linked, syndromic 32	300886	CLIC2	300138	Xq28
Mental retardation, X-linked, syndromic 32	300886	XAP121	300138	Xq28
Mental retardation, X-linked, syndromic 32	300886	MRXS32	300138	Xq28
Mental retardation, X-linked, syndromic 9	300709	MRXS9		Xq12-q21.31
Mental retardation, X-linked, syndromic, Chudley-Schwartz type,	300861	MRXSCS		Xq21.33-q23
Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	KDM5C	314690	Xp11.22
Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	JARID1C	314690	Xp11.22
Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	SMCX	314690	Xp11.22
Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	DXS1272E	314690	Xp11.22
Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	XE169	314690	Xp11.22
Mental retardation, X-linked, syndromic, Claes-Jensen type	300534	MRXSCJ	314690	Xp11.22
Mental retardation, X-linked, syndromic, Martin-Probst type	300519	RAB40AL	300405	Xq22.1
Mental retardation, X-linked, syndromic, Martin-Probst type	300519	RLGP	300405	Xq22.1
Mental retardation, X-linked, syndromic, Martin-Probst type	300519	MRXSMP	300405	Xq22.1
Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance	300486	OPHN1	300127	Xq12
Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance	300486	MRX60	300127	Xq12
Mental retardation, X-linked, with isolated growth hormone deficiency	300123	SOX3	313430	Xq27.1
Mental retardation, X-linked, with isolated growth hormone deficiency	300123	MRGH	313430	Xq27.1
Mental retardation, X-linked, with short stature	300360	MRSS		Xq24
Mental retardation, anterior maxillary protrusion, and strabismus	613671	SOBP	613667	6q21
Mental retardation, anterior maxillary protrusion, and strabismus	613671	JXC1	613667	6q21
Mental retardation, anterior maxillary protrusion, and strabismus	613671	MRAMS	613667	6q21
Mental retardation, autosomal dominant 1	156200	MBD5	611472	2q23.1
Mental retardation, autosomal dominant 1	156200	KIAA1461	611472	2q23.1
Mental retardation, autosomal dominant 1	156200	MRD1	611472	2q23.1
Mental retardation, autosomal dominant 10	614256	CACNG2	602911	22q12.3
Mental retardation, autosomal dominant 10	614256	MRD10	602911	22q12.3
Mental retardation, autosomal dominant 11	614257	EPB41L1	602879	20q11.23
Mental retardation, autosomal dominant 11	614257	MRD11	602879	20q11.23
Mental retardation, autosomal dominant 12	614562	ARID1B	614556	6q25.3
Mental retardation, autosomal dominant 12	614562	BAF250B	614556	6q25.3
Mental retardation, autosomal dominant 12	614562	KIAA1235	614556	6q25.3
Mental retardation, autosomal dominant 12	614562	MRD12	614556	6q25.3
Mental retardation, autosomal dominant 13	614563	DYNC1H1	600112	14q32.31
Mental retardation, autosomal dominant 13	614563	DNCL	600112	14q32.31
Mental retardation, autosomal dominant 13	614563	DNECL	600112	14q32.31
Mental retardation, autosomal dominant 13	614563	CMT20	600112	14q32.31
Mental retardation, autosomal dominant 13	614563	MRD13	600112	14q32.31
Mental retardation, autosomal dominant 13	614563	SMALED1	600112	14q32.31
Mental retardation, autosomal dominant 14	614607	ARID1A	603024	1p36.11
Mental retardation, autosomal dominant 14	614607	C1orf4	603024	1p36.11
Mental retardation, autosomal dominant 14	614607	B120	603024	1p36.11
Mental retardation, autosomal dominant 14	614607	SMARCF1	603024	1p36.11
Mental retardation, autosomal dominant 14	614607	MRD14	603024	1p36.11
Mental retardation, autosomal dominant 15	614608	SMARCB1	601607	22q11.23
Mental retardation, autosomal dominant 15	614608	SNF5	601607	22q11.23
Mental retardation, autosomal dominant 15	614608	INI1	601607	22q11.23
Mental retardation, autosomal dominant 15	614608	RDT	601607	22q11.23
Mental retardation, autosomal dominant 15	614608	RTPS1	601607	22q11.23
Mental retardation, autosomal dominant 15	614608	MRD15	601607	22q11.23
Mental retardation, autosomal dominant 16	614609	SMARCA4	603254	19p13.2
Mental retardation, autosomal dominant 16	614609	BRG1	603254	19p13.2
Mental retardation, autosomal dominant 16	614609	RTPS2	603254	19p13.2
Mental retardation, autosomal dominant 16	614609	MRD16	603254	19p13.2
Mental retardation, autosomal dominant 17	615009	PACS1	607492	11q13.1-q13.2
Mental retardation, autosomal dominant 17	615009	MRD17	607492	11q13.1-q13.2
Mental retardation, autosomal dominant 18	615074	GATAD2B	614998	1q21.3
Mental retardation, autosomal dominant 18	615074	KIAA1150	614998	1q21.3
Mental retardation, autosomal dominant 18	615074	p68	614998	1q21.3
Mental retardation, autosomal dominant 18	615074	MRD18	614998	1q21.3
Mental retardation, autosomal dominant 19	615075	CTNNB1	116806	3p22.1
Mental retardation, autosomal dominant 19	615075	MRD19	116806	3p22.1
Mental retardation, autosomal dominant 2	614113	DOCK8	611432	9p24.3
Mental retardation, autosomal dominant 2	614113	MRD2	611432	9p24.3
Mental retardation, autosomal dominant 21	615502	CTCF	604167	16q22.1
Mental retardation, autosomal dominant 21	615502	MRD21	604167	16q22.1
Mental retardation, autosomal dominant 3	612580	CDH15	114019	16q24.3
Mental retardation, autosomal dominant 3	612580	CDH14	114019	16q24.3
Mental retardation, autosomal dominant 3	612580	CDH3	114019	16q24.3
Mental retardation, autosomal dominant 3	612580	MRD3	114019	16q24.3
Mental retardation, autosomal dominant 4	612581	KIRREL3	607761	11q24.2
Mental retardation, autosomal dominant 4	612581	NEPH2	607761	11q24.2
Mental retardation, autosomal dominant 4	612581	KIAA1867	607761	11q24.2
Mental retardation, autosomal dominant 4	612581	KIRRE	607761	11q24.2
Mental retardation, autosomal dominant 4	612581	MRD4	607761	11q24.2
Mental retardation, autosomal dominant 5	612621	SYNGAP1	603384	6p21.32
Mental retardation, autosomal dominant 5	612621	MRD5	603384	6p21.32
Mental retardation, autosomal dominant 6	613970	GRIN2B	138252	12p13.1
Mental retardation, autosomal dominant 6	613970	NMDAR2B	138252	12p13.1
Mental retardation, autosomal dominant 6	613970	MRD6	138252	12p13.1
Mental retardation, autosomal dominant 7	614104	DYRK1A	600855	21q22.13
Mental retardation, autosomal dominant 7	614104	MNBH	600855	21q22.13
Mental retardation, autosomal dominant 7	614104	MNB	600855	21q22.13
Mental retardation, autosomal dominant 7	614104	MRD7	600855	21q22.13
Mental retardation, autosomal dominant 8	614254	GRIN1	138249	9q34.3
Mental retardation, autosomal dominant 8	614254	NMDAR1	138249	9q34.3
Mental retardation, autosomal dominant 8	614254	MRD8	138249	9q34.3
Mental retardation, autosomal dominant 9	614255	KIF1A	601255	2q37.3
Mental retardation, autosomal dominant 9	614255	ATSV	601255	2q37.3
Mental retardation, autosomal dominant 9	614255	UNC104	601255	2q37.3
Mental retardation, autosomal dominant 9	614255	SPG30	601255	2q37.3
Mental retardation, autosomal dominant 9	614255	HSN2C	601255	2q37.3
Mental retardation, autosomal dominant 9	614255	MRD9	601255	2q37.3
Mental retardation, autosomal recessive 1	249500	PRSS12	606709	4q26
Mental retardation, autosomal recessive 1	249500	BSSP3	606709	4q26
Mental retardation, autosomal recessive 1	249500	MRT1	606709	4q26
Mental retardation, autosomal recessive 10/20	611096	MRT10		16p12.2-q12.1
Mental retardation, autosomal recessive 10/20	611096	MRT20		16p12.2-q12.1
Mental retardation, autosomal recessive 12	611090	ST3GAL3	606494	1p34.1
Mental retardation, autosomal recessive 12	611090	SIAT6	606494	1p34.1
Mental retardation, autosomal recessive 12	611090	ST3GALII	606494	1p34.1
Mental retardation, autosomal recessive 12	611090	MRT12	606494	1p34.1
Mental retardation, autosomal recessive 12	611090	EIEE15	606494	1p34.1
Mental retardation, autosomal recessive 13	613192	TRAPPC9	611966	8q24.3
Mental retardation, autosomal recessive 13	613192	NIBP	611966	8q24.3
Mental retardation, autosomal recessive 13	613192	KIAA1882	611966	8q24.3
Mental retardation, autosomal recessive 13	613192	MRT13	611966	8q24.3
Mental retardation, autosomal recessive 14	614020	TECR	610057	19p13.12
Mental retardation, autosomal recessive 14	614020	GPSN2	610057	19p13.12
Mental retardation, autosomal recessive 14	614020	TER	610057	19p13.12
Mental retardation, autosomal recessive 14	614020	SC2	610057	19p13.12
Mental retardation, autosomal recessive 14	614020	MRT14	610057	19p13.12
Mental retardation, autosomal recessive 15	614202	MAN1B1	604346	9q34.3
Mental retardation, autosomal recessive 15	614202	MRT15	604346	9q34.3
Mental retardation, autosomal recessive 16	614208	MRT16		9p23-p13.3
Mental retardation, autosomal recessive 18	614249	MED23	605042	6q23.2
Mental retardation, autosomal recessive 18	614249	MRT18	605042	6q23.2
Mental retardation, autosomal recessive 19	614343	MRT19		18p11.3
Mental retardation, autosomal recessive 2	607417	CRBN	609262	3p26.2
Mental retardation, autosomal recessive 2	607417	MRT2	609262	3p26.2
Mental retardation, autosomal recessive 23	614344	MRT23		11p13-q14.1
Mental retardation, autosomal recessive 24	614345	MRT24		6p12.2-q12
Mental retardation, autosomal recessive 25	614346	MRT25		12q13.11-q15
Mental retardation, autosomal recessive 27	614340	MRT27		15q24.1-q26.1
Mental retardation, autosomal recessive 28	614347	MRT28		6q26-q27
Mental retardation, autosomal recessive 29	614333	MRT29		4q27-q28.2
Mental retardation, autosomal recessive 3	608443	CC2D1A	610055	19p13.12
Mental retardation, autosomal recessive 3	608443	MRT3	610055	19p13.12
Mental retardation, autosomal recessive 30	614342	MRT30		6q12-q15
Mental retardation, autosomal recessive 31	614329	MRT31		4q12-q13.1
Mental retardation, autosomal recessive 32	614339	MRT32		14q32.13-q32.2
Mental retardation, autosomal recessive 33	614341	MRT33		17p13.2-p13.1
Mental retardation, autosomal recessive 34	614499	CRADD	603454	12q22
Mental retardation, autosomal recessive 34	614499	RAIDD	603454	12q22
Mental retardation, autosomal recessive 34	614499	MRT34	603454	12q22
Mental retardation, autosomal recessive 35	615162	MRT35		17q21.31-q22
Mental retardation, autosomal recessive 36	615286	ADAT3	615302	19p13.3
Mental retardation, autosomal recessive 36	615286	TAD3	615302	19p13.3
Mental retardation, autosomal recessive 36	615286	MRT36	615302	19p13.3
Mental retardation, autosomal recessive 38	615516	HERC2	605837	15q13.1
Mental retardation, autosomal recessive 38	615516	SHEP1	605837	15q13.1
Mental retardation, autosomal recessive 38	615516	MRT38	605837	15q13.1
Mental retardation, autosomal recessive 39	615541	TTI2	614426	8p12
Mental retardation, autosomal recessive 39	615541	C8orf41	614426	8p12
Mental retardation, autosomal recessive 39	615541	MRT39	614426	8p12
Mental retardation, autosomal recessive 40	615599	TAF2	604912	8q24.12
Mental retardation, autosomal recessive 40	615599	TAF2B	604912	8q24.12
Mental retardation, autosomal recessive 40	615599	TAFII150	604912	8q24.12
Mental retardation, autosomal recessive 40	615599	CIF150	604912	8q24.12
Mental retardation, autosomal recessive 40	615599	MRT40	604912	8q24.12
Mental retardation, autosomal recessive 5	611091	NSUN2	610916	5p15.31
Mental retardation, autosomal recessive 5	611091	TRM4	610916	5p15.31
Mental retardation, autosomal recessive 5	611091	SAKI	610916	5p15.31
Mental retardation, autosomal recessive 5	611091	MISU	610916	5p15.31
Mental retardation, autosomal recessive 5	611091	MRT5	610916	5p15.31
Mental retardation, autosomal recessive 7	611093	TUSC3	601385	8p22
Mental retardation, autosomal recessive 7	611093	M33	601385	8p22
Mental retardation, autosomal recessive 7	611093	D8S1992	601385	8p22
Mental retardation, autosomal recessive 7	611093	MRT7	601385	8p22
Mental retardation, autosomal recessive 7	611093	MRT22	601385	8p22
Mental retardation, autosomal recessive, 11	611097	MRT11		19q13.2-q13.3
Mental retardation, autosomal recessive, 4	611107	MRT4		1p21.1-p13.3
Mental retardation, autosomal recessive, 6	611092	GRIK2	138244	6q16.3
Mental retardation, autosomal recessive, 6	611092	GLUR6	138244	6q16.3
Mental retardation, autosomal recessive, 6	611092	MRT6	138244	6q16.3
Mental retardation, autosomal recessive, 8	611094	MRT8		10q22
Mental retardation, autosomal recessive, 9/26	611095	MRT9		14q11.2-q12
Mental retardation, autosomal recessive, 9/26	611095	MRT26		14q11.2-q12
Mental retardation, severe, with spasticity and tapetoretinal degeneration	602685	MRST		15q24
Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	613443	MEF2C	600662	5q14.3
Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	613443	C5DELq14.3	600662	5q14.3
Mental retardation, stereotypic movements, epilepsy, and/or cerebral malformations	613443	DEL5q14.3	600662	5q14.3
Mental retardation, truncal obesity, retinal dystrophy, and micropenis	610156	INPP5E	613037	9q34.3
Mental retardation, truncal obesity, retinal dystrophy, and micropenis	610156	MORMS	613037	9q34.3
Mental retardation, truncal obesity, retinal dystrophy, and micropenis	610156	JBTS1	613037	9q34.3
Mental retardation, truncal obesity, retinal dystrophy, and micropenis	610156	CORS1	613037	9q34.3
Mental retardation, with or without nystagmus	300422	CASK	300172	Xp11.4
Mental retardation, with or without nystagmus	300422	MICPCH	300172	Xp11.4
Mental retardation, with or without nystagmus	300422	FGS4	300172	Xp11.4
Mental retardation, with or without nystagmus	300422	CMG	300172	Xp11.4
Mental retardation, with or without nystagmus	300422	MRXSNA	300172	Xp11.4
Mental retardation-hypotonic facies syndrome, X-linked	309580	ATRX	300032	Xq21.1
Mental retardation-hypotonic facies syndrome, X-linked	309580	XH2	300032	Xq21.1
Mental retardation-hypotonic facies syndrome, X-linked	309580	XNP	300032	Xq21.1
Mental retardation-hypotonic facies syndrome, X-linked	309580	SHS	300032	Xq21.1
Mental retardation-hypotonic facies syndrome, X-linked	309580	SFM1	300032	Xq21.1
Mental retardation-hypotonic facies syndrome, X-linked	309580	MRXHF1	300032	Xq21.1
Mental retardation-skeletal dysplasia	309620	MRSD		Xq28
Mental retardation-skeletal dysplasia	309620	CHRS		Xq28
Mephenytoin poor metabolizer	609535	CYP2C	124020	10q23.33
Mephenytoin poor metabolizer	609535	CYP2C19	124020	10q23.33
Merkel cell carcinoma, somatic		SDHD	602690	11q23.1
Merkel cell carcinoma, somatic		PGL1	602690	11q23.1
Merkel cell carcinoma, somatic		CWS3	602690	11q23.1
Mesomelia-synostoses syndrome	600383	DEL8q13		8q13
Mesomelia-synostoses syndrome	600383	C8DELq13		8q13
Mesomelic dysplasia, Kantaputra type	156232	MMDK		2q24-q32
Mesomelic dysplasia, Kantaputra type	156232	MDK		2q24-q32
Mesothelioma, somatic	156240	WT1	607102	11p13
Mesothelioma, somatic	156240	NPHS4	607102	11p13
Metacarpal 4-5 fusion	309630	FGF16	300827	Xq21.1
Metacarpal 4-5 fusion	309630	MF4	300827	Xq21.1
Metachondromatosis	156250	PTPN11	176876	12q24.13
Metachondromatosis	156250	PTP2C	176876	12q24.13
Metachondromatosis	156250	SHP2	176876	12q24.13
Metachondromatosis	156250	NS1	176876	12q24.13
Metachromatic leukodystrophy due to SAP-b deficiency	249900	PSAP	176801	10q22.1
Metachromatic leukodystrophy due to SAP-b deficiency	249900	SAP1	176801	10q22.1
Metachromatic leukodystrophy	250100	ARSA	607574	22q13.33
Metaphyseal anadysplasia 1	602111	MMP13	600108	11q22.2
Metaphyseal anadysplasia 1	602111	CLG3	600108	11q22.2
Metaphyseal anadysplasia 1	602111	MANDP1	600108	11q22.2
Metaphyseal anadysplasia 2	613073	MMP9	120361	20q13.12
Metaphyseal anadysplasia 2	613073	CLG4B	120361	20q13.12
Metaphyseal anadysplasia 2	613073	MANDP2	120361	20q13.12
Metaphyseal chondrodysplasia, Murk Jansen type	156400	PTHR1	168468	3p21.31
Metaphyseal chondrodysplasia, Murk Jansen type	156400	PTHR	168468	3p21.31
Metaphyseal chondrodysplasia, Murk Jansen type	156400	PFE	168468	3p21.31
Metaphyseal chondrodysplasia, Schmid type	156500	COL10A1	120110	6q22.1
Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	RUNX2	600211	6p21.1
Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	CBFA1	600211	6p21.1
Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	PEBP2A1	600211	6p21.1
Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	AML3	600211	6p21.1
Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	CCD	600211	6p21.1
Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly	156510	CLCD	600211	6p21.1
Metaphyseal dysplasia without hypotrichosis	250460	RMRP	157660	9p13.3
Metaphyseal dysplasia without hypotrichosis	250460	RMRPR	157660	9p13.3
Metaphyseal dysplasia without hypotrichosis	250460	CHH	157660	9p13.3
Metastasis efficiency, modification of		SIPA1	602180	11q13.1
Metastasis efficiency, modification of		SPA1	602180	11q13.1
Metatropic dysplasia	156530	TRPV4	605427	12q24.11
Metatropic dysplasia	156530	VROAC	605427	12q24.11
Metatropic dysplasia	156530	HMSN2C	605427	12q24.11
Metatropic dysplasia	156530	CMT2C	605427	12q24.11
Metatropic dysplasia	156530	SPSMA	605427	12q24.11
Metatropic dysplasia	156530	SSQTL1	605427	12q24.11
Metatropic dysplasia	156530	SMAL	605427	12q24.11
Methemoglobinemia, type I	250800	CYB5R3	613213	22q13.2
Methemoglobinemia, type I	250800	DIA1	613213	22q13.2
Methemoglobinemia, type I	250800	B5R	613213	22q13.2
Methemoglobinemia, type II	250800	CYB5R3	613213	22q13.2
Methemoglobinemia, type II	250800	DIA1	613213	22q13.2
Methemoglobinemia, type II	250800	B5R	613213	22q13.2
Methemoglobinemia, type IV	250790	CYB5A	613218	18q22.3
Methemoglobinemia, type IV	250790	MCB5	613218	18q22.3
Methemoglobinemias, alpha-	141800	HBA1		16p13.3
Methemoglobinemias, alpha-	141800	HBH		16p13.3
Methemoglobinemias, beta-	141900	HBB		11p15.4
Methionine adenosyltransferase deficiency, autosomal recessive	250850	MAT1A	610550	10q23.1
Methionine adenosyltransferase deficiency, autosomal recessive	250850	MATA1	610550	10q23.1
Methionine adenosyltransferase deficiency, autosomal recessive	250850	SAMS1	610550	10q23.1
Methylmalonate semialdehyde dehydrogenase deficiency	614105	ALDH6A1	603178	14q24.3
Methylmalonate semialdehyde dehydrogenase deficiency	614105	MMSDH	603178	14q24.3
Methylmalonic aciduria and homocystinuria, cblC type	277400	MMACHC	609831	1p34.1
Methylmalonic aciduria and homocystinuria, cblD type	277410	C2orf25	611935	2q23.2
Methylmalonic aciduria and homocystinuria, cblD type	277410	MMADHC	611935	2q23.2
Methylmalonic aciduria and homocystinuria, cblF type	277380	LMBRD1	612625	6q13
Methylmalonic aciduria and homocystinuria, cblF type	277380	LMBD1	612625	6q13
Methylmalonic aciduria and homocystinuria, cblF type	277380	NESI	612625	6q13
Methylmalonic aciduria and homocystinuria, cblF type	277380	MAHCF	612625	6q13
Methylmalonic aciduria and homocystinuria, cblJ type	614857	ABCD4	603214	14q24.3
Methylmalonic aciduria and homocystinuria, cblJ type	614857	PXMP1L	603214	14q24.3
Methylmalonic aciduria and homocystinuria, cblJ type	614857	P79R	603214	14q24.3
Methylmalonic aciduria and homocystinuria, cblJ type	614857	PMP69	603214	14q24.3
Methylmalonic aciduria and homocystinuria, cblJ type	614857	MAHCJ	603214	14q24.3
Methylmalonic aciduria due to transcobalamin receptor defect	613646	CD320	606475	19p13.2
Methylmalonic aciduria due to transcobalamin receptor defect	613646	8D6	606475	19p13.2
Methylmalonic aciduria due to transcobalamin receptor defect	613646	8D6A	606475	19p13.2
Methylmalonic aciduria due to transcobalamin receptor defect	613646	TCBLR	606475	19p13.2
Methylmalonic aciduria, cblD type, variant 2	277410	C2orf25	611935	2q23.2
Methylmalonic aciduria, cblD type, variant 2	277410	MMADHC	611935	2q23.2
Methylmalonic aciduria, mut(0) type	251000	MUT	609058	6p12.3
Methylmalonic aciduria, mut(0) type	251000	MCM	609058	6p12.3
Methylmalonic aciduria, vitamin B12-responsive	251100	MMAA	607481	4q31.21
Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type	251110	MMAB	607568	12q24.11
Methylmalonyl-CoA epimerase deficiency	251120	MCEE	608419	2p13.3
Mevalonic aciduria	610377	MVK	251170	12q24.11
Mevalonic aciduria	610377	MVLK	251170	12q24.11
Mevalonic aciduria	610377	POROK3	251170	12q24.11
Microcephalic osteodysplastic primordial dwarfism, type I	210710	RNU4ATAC	601428	2q14.2
Microcephalic osteodysplastic primordial dwarfism, type I	210710	U4ATAC	601428	2q14.2
Microcephalic osteodysplastic primordial dwarfism, type I	210710	MOPD1	601428	2q14.2
Microcephalic osteodysplastic primordial dwarfism, type I	210710	TALS	601428	2q14.2
Microcephalic osteodysplastic primordial dwarfism, type II	210720	PCNT	605925	21q22.3
Microcephalic osteodysplastic primordial dwarfism, type II	210720	PCNT2	605925	21q22.3
Microcephalic osteodysplastic primordial dwarfism, type II	210720	KEN	605925	21q22.3
Microcephalic osteodysplastic primordial dwarfism, type II	210720	SCKL4	605925	21q22.3
Microcephalic osteodysplastic primordial dwarfism, type II	210720	MOPD2	605925	21q22.3
Microcephaly 1, primary, autosomal recessive	251200	MCPH1	607117	8p23.1
Microcephaly 10, primary, autosomal recessive	615095	ZNF335	610827	20q13.12
Microcephaly 10, primary, autosomal recessive	615095	NIF1	610827	20q13.12
Microcephaly 10, primary, autosomal recessive	615095	NIF2	610827	20q13.12
Microcephaly 10, primary, autosomal recessive	615095	MCPH10	610827	20q13.12
Microcephaly 2, primary, autosomal recessive, with or without cortical malformations	604317	WDR62	613583	19q13.12
Microcephaly 2, primary, autosomal recessive, with or without cortical malformations	604317	C19orf14	613583	19q13.12
Microcephaly 2, primary, autosomal recessive, with or without cortical malformations	604317	MCPH2	613583	19q13.12
Microcephaly 3, primary, autosomal recessive	604804	CDK5RAP2	608201	9q33.2
Microcephaly 3, primary, autosomal recessive	604804	KIAA1633	608201	9q33.2
Microcephaly 3, primary, autosomal recessive	604804	MCPH3	608201	9q33.2
Microcephaly 4, primary, autosomal recessive	604321	CASC5	609173	15q15.1
Microcephaly 4, primary, autosomal recessive	604321	AF15Q14	609173	15q15.1
Microcephaly 4, primary, autosomal recessive	604321	KIAA1570	609173	15q15.1
Microcephaly 4, primary, autosomal recessive	604321	D40	609173	15q15.1
Microcephaly 4, primary, autosomal recessive	604321	MCPH4	609173	15q15.1
Microcephaly 5, primary, autosomal recessive	608716	ASPM	605481	1q31.3
Microcephaly 5, primary, autosomal recessive	608716	MCPH5	605481	1q31.3
Microcephaly 6, primary, autosomal recessive	608393	CENPJ	609279	13q12.12
Microcephaly 6, primary, autosomal recessive	608393	CPAP	609279	13q12.12
Microcephaly 6, primary, autosomal recessive	608393	MCPH6	609279	13q12.12
Microcephaly 6, primary, autosomal recessive	608393	SCKL4	609279	13q12.12
Microcephaly 7, primary, autosomal recessive	612703	STIL	181590	1p33
Microcephaly 7, primary, autosomal recessive	612703	SIL	181590	1p33
Microcephaly 7, primary, autosomal recessive	612703	MCPH7	181590	1p33
Microcephaly 8, primary, autosomal recessive	614673	CEP135	611423	4q12
Microcephaly 8, primary, autosomal recessive	614673	KIAA0635	611423	4q12
Microcephaly 8, primary, autosomal recessive	614673	MCPH8	611423	4q12
Microcephaly 9, primary, autosomal recessive	614852	CEP152	613529	15q21.1
Microcephaly 9, primary, autosomal recessive	614852	KIAA0912	613529	15q21.1
Microcephaly 9, primary, autosomal recessive	614852	MCPH9	613529	15q21.1
Microcephaly 9, primary, autosomal recessive	614852	SCKL5	613529	15q21.1
Microcephaly and chorioretinopathy with or without mental retardation	251270	TUBGCP6	610053	22q13.33
Microcephaly and chorioretinopathy with or without mental retardation	251270	GCP6	610053	22q13.33
Microcephaly and chorioretinopathy with or without mental retardation	251270	KIAA1669	610053	22q13.33
Microcephaly and chorioretinopathy with or without mental retardation	251270	MCPHCR	610053	22q13.33
Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	152950	KIF11	148760	10q23.33
Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	152950	KNSL1	148760	10q23.33
Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation	152950	MCLMR	148760	10q23.33
Microcephaly, Amish type	607196	SLC25A19	606521	17q25.1
Microcephaly, Amish type	607196	DNC	606521	17q25.1
Microcephaly, Amish type	607196	MUP1	606521	17q25.1
Microcephaly, Amish type	607196	MCPHA	606521	17q25.1
Microcephaly, Amish type	607196	THMD3	606521	17q25.1
Microcephaly, Amish type	607196	THMD4	606521	17q25.1
Microcephaly, epilepsy, and diabetes syndrome	614231	IER3IP1	609382	18q21.1
Microcephaly, epilepsy, and diabetes syndrome	614231	MEDS	609382	18q21.1
Microcephaly, mental retardation, and distinctive facies, with cardiac and genitourinary malformations	613680	MMRFCGU		16p13.3
Microcephaly, postnatal progressive, with seizures and brain atrophy	613668	MED17	603810	11q21
Microcephaly, postnatal progressive, with seizures and brain atrophy	613668	CRSP6	603810	11q21
Microcephaly, postnatal progressive, with seizures and brain atrophy	613668	CRSP77	603810	11q21
Microcephaly, postnatal progressive, with seizures and brain atrophy	613668	TRAP80	603810	11q21
Microcephaly, postnatal progressive, with seizures and brain atrophy	613668	DRIP80	603810	11q21
Microcephaly-capillary malformation syndrome	614261	STAMBP	606247	2p13.1
Microcephaly-capillary malformation syndrome	614261	AMSH	606247	2p13.1
Microcephaly-capillary malformation syndrome	614261	MICCAP	606247	2p13.1
Microcoria, congenital	156600	MCOR		13q31-q32
Microcornea, myopic chorioretinal atrophy, and telecanthus	615458	ADAMTS18	607512	16q23.1
Microcornea, myopic chorioretinal atrophy, and telecanthus	615458	MMCAT	607512	16q23.1
Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma	193220	BEST1	607854	11q12.3
Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma	193220	VMD2	607854	11q12.3
Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma	193220	ARB	607854	11q12.3
Microcornea, rod-cone dystrophy, cataract, and posterior staphyloma	193220	RP50	607854	11q12.3
Microhydranencephaly	605013	MHAC		16p13.3-p12.1
Microphthalmia with cataract 1	156850	MCOPCT1		16p13.3
Microphthalmia with cataract 2	212550	SIX6	606326	14q23.1
Microphthalmia with cataract 2	212550	MCOPCT2	606326	14q23.1
Microphthalmia with coloboma 1	300345	MCOPCB1		Chr.X
Microphthalmia with coloboma 2	605738	MCOPCB2		15q12-q15
Microphthalmia with coloboma 3	610092	CHX10	142993	14q24.3
Microphthalmia with coloboma 3	610092	HOX10	142993	14q24.3
Microphthalmia with coloboma 3	610092	MCOP2	142993	14q24.3
Microphthalmia with coloboma 3	610092	MCOPCB3	142993	14q24.3
Microphthalmia with coloboma 5	611638	SHH	600725	7q36.3
Microphthalmia with coloboma 5	611638	HPE3	600725	7q36.3
Microphthalmia with coloboma 5	611638	HLP3	600725	7q36.3
Microphthalmia with coloboma 5	611638	SMMCI	600725	7q36.3
Microphthalmia with coloboma 5	611638	MCOPCB5	600725	7q36.3
Microphthalmia with coloboma 6	613703	GDF3	606522	12p13.31
Microphthalmia with coloboma 6	613703	KFS3	606522	12p13.31
Microphthalmia with coloboma 6	613703	MCOPCB6	606522	12p13.31
Microphthalmia with coloboma 6	613703	MCOP7	606522	12p13.31
Microphthalmia with coloboma 6, digenic	613703	GDF6	601147	8q22.1
Microphthalmia with coloboma 6, digenic	613703	MCOP4	601147	8q22.1
Microphthalmia with coloboma 6, digenic	613703	KFS1	601147	8q22.1
Microphthalmia with coloboma 6, digenic	613703	MCOPCB6	601147	8q22.1
Microphthalmia with coloboma 6, digenic	613703	LCA17	601147	8q22.1
Microphthalmia with limb anomalies	206920	SMOC1	608488	14q24.2
Microphthalmia with limb anomalies	206920	OAS	608488	14q24.2
Microphthalmia, isolated 1	251600	MCOP1		14q32
Microphthalmia, isolated 2	610093	CHX10	142993	14q24.3
Microphthalmia, isolated 2	610093	HOX10	142993	14q24.3
Microphthalmia, isolated 2	610093	MCOP2	142993	14q24.3
Microphthalmia, isolated 2	610093	MCOPCB3	142993	14q24.3
Microphthalmia, isolated 3	611038	RAX	601881	18q21.32
Microphthalmia, isolated 3	611038	RX	601881	18q21.32
Microphthalmia, isolated 3	611038	MCOP3	601881	18q21.32
Microphthalmia, isolated 4	613094	GDF6	601147	8q22.1
Microphthalmia, isolated 4	613094	MCOP4	601147	8q22.1
Microphthalmia, isolated 4	613094	KFS1	601147	8q22.1
Microphthalmia, isolated 4	613094	MCOPCB6	601147	8q22.1
Microphthalmia, isolated 4	613094	LCA17	601147	8q22.1
Microphthalmia, isolated 5	611040	MFRP	606227	11q23.3
Microphthalmia, isolated 5	611040	MCOP5	606227	11q23.3
Microphthalmia, isolated 5	611040	NNO2	606227	11q23.3
Microphthalmia, isolated 6	613517	PRSS56	613858	2q37.1
Microphthalmia, isolated 6	613517	MCOP6	613858	2q37.1
Microphthalmia, isolated 7	613704	GDF3	606522	12p13.31
Microphthalmia, isolated 7	613704	KFS3	606522	12p13.31
Microphthalmia, isolated 7	613704	MCOPCB6	606522	12p13.31
Microphthalmia, isolated 7	613704	MCOP7	606522	12p13.31
Microphthalmia, isolated 8	615113	ALDH1A3	600463	15q26.3
Microphthalmia, isolated 8	615113	ALDH6	600463	15q26.3
Microphthalmia, isolated 8	615113	MCOP8	600463	15q26.3
Microphthalmia, isolated, with coloboma 7	614497	ABCB6	605452	2q35
Microphthalmia, isolated, with coloboma 7	614497	MTABC3	605452	2q35
Microphthalmia, isolated, with coloboma 7	614497	MCOPCB7	605452	2q35
Microphthalmia, isolated, with coloboma 7	614497	LAN	605452	2q35
Microphthalmia, isolated, with coloboma 7	614497	DUH3	605452	2q35
Microphthalmia, isolated, with coloboma 8	601186	STRA6	610745	15q24.1
Microphthalmia, isolated, with coloboma 8	601186	MCOPS9	610745	15q24.1
Microphthalmia, isolated, with coloboma 8	601186	MCOPCB8	610745	15q24.1
Microphthalmia, isolated, with coloboma 9	615145	ODZ3	610083	4q34.3-q35.1
Microphthalmia, isolated, with coloboma 9	615145	TNM3	610083	4q34.3-q35.1
Microphthalmia, isolated, with coloboma 9	615145	KIAA1455	610083	4q34.3-q35.1
Microphthalmia, isolated, with coloboma 9	615145	MCOPCB9	610083	4q34.3-q35.1
Microphthalmia, syndromic 1	309800	MCOPS1		Xq27-q28
Microphthalmia, syndromic 1	309800	MAA		Xq27-q28
Microphthalmia, syndromic 1	309800	LZMS		Xq27-q28
Microphthalmia, syndromic 11	614402	VAX1	604294	10q25.3
Microphthalmia, syndromic 11	614402	MCOPS11	604294	10q25.3
Microphthalmia, syndromic 12	615524	RARB	180220	3p24.2
Microphthalmia, syndromic 12	615524	HAP	180220	3p24.2
Microphthalmia, syndromic 12	615524	MCOPS12	180220	3p24.2
Microphthalmia, syndromic 13	300915	MCOPS13		Chr.X
Microphthalmia, syndromic 2	300166	BCOR	300485	Xp11.4
Microphthalmia, syndromic 2	300166	KIAA1575	300485	Xp11.4
Microphthalmia, syndromic 2	300166	MCOPS2	300485	Xp11.4
Microphthalmia, syndromic 2	300166	MAA2	300485	Xp11.4
Microphthalmia, syndromic 2	300166	ANOP2	300485	Xp11.4
Microphthalmia, syndromic 3	206900	SOX2	184429	3q26.33
Microphthalmia, syndromic 3	206900	MCOPS3	184429	3q26.33
Microphthalmia, syndromic 5	610125	OTX2	600037	14q22.3
Microphthalmia, syndromic 5	610125	MCOPS5	600037	14q22.3
Microphthalmia, syndromic 5	610125	CPHD6	600037	14q22.3
Microphthalmia, syndromic 6	607932	BMP4	112262	14q22.2
Microphthalmia, syndromic 6	607932	BMP2B1	112262	14q22.2
Microphthalmia, syndromic 6	607932	BMP2B	112262	14q22.2
Microphthalmia, syndromic 6	607932	MCOPS6	112262	14q22.2
Microphthalmia, syndromic 6	607932	OFC11	112262	14q22.2
Microphthalmia, syndromic 7	309801	HCCS	300056	Xp22.2
Microphthalmia, syndromic 7	309801	MCOPS7	300056	Xp22.2
Microphthalmia, syndromic 8	601349	MCOPS8		6q21
Microphthalmia, syndromic 8	601349	MMEP		6q21
Microphthalmia, syndromic 9	601186	STRA6	610745	15q24.1
Microphthalmia, syndromic 9	601186	MCOPS9	610745	15q24.1
Microphthalmia, syndromic 9	601186	MCOPCB8	610745	15q24.1
Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	LTBP2	602091	14q24.3
Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	LTBP3	602091	14q24.3
Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	GLC3D	602091	14q24.3
Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	MSPKA	602091	14q24.3
Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma	251750	WMS3	602091	14q24.3
Microtia with nasolacrimal duct imperforation and eye coloboma	611863	MNDEC		4p16-p15
Microvillus inclusion disease	251850	MYO5B	606540	18q21.1
Microvillus inclusion disease	251850	KIAA1119	606540	18q21.1
Migraine with or without aura, susceptibility to	607516	MGR6		1q31
Migraine with or without aura, susceptibility to	607516	FHM3		1q31
Migraine, familial basilar	602481	ATP1A2	182340	1q23.2
Migraine, familial basilar	602481	FHM2	182340	1q23.2
Migraine, familial basilar	602481	MHP2	182340	1q23.2
Migraine, familial hemiplegic	607516	MGR6		1q31
Migraine, familial hemiplegic	607516	FHM3		1q31
Migraine, familial hemiplegic, 1	141500	CACNA1A	601011	19p13.2
Migraine, familial hemiplegic, 1	141500	CACNL1A4	601011	19p13.2
Migraine, familial hemiplegic, 1	141500	SCA6	601011	19p13.2
Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia	141500	CACNA1A	601011	19p13.2
Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia	141500	CACNL1A4	601011	19p13.2
Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia	141500	SCA6	601011	19p13.2
Migraine, familial hemiplegic, 2	602481	ATP1A2	182340	1q23.2
Migraine, familial hemiplegic, 2	602481	FHM2	182340	1q23.2
Migraine, familial hemiplegic, 2	602481	MHP2	182340	1q23.2
Migraine, familial hemiplegic, 3	609634	SCN1A	182389	2q24.3
Migraine, familial hemiplegic, 3	609634	GEFSP2	182389	2q24.3
Migraine, familial hemiplegic, 3	609634	SMEI	182389	2q24.3
Migraine, familial hemiplegic, 3	609634	FEB3A	182389	2q24.3
Migraine, familial hemiplegic, 3	609634	EIEE6	182389	2q24.3
Migraine, familial hemiplegic, 3	609634	FHM3	182389	2q24.3
Migraine, resistance to	157300	EDNRA	131243	4q31.22
Miles-Carpenter syndrome	309605	MCS		Xq13-q22
Miles-Carpenter syndrome	309605	MRXS4		Xq13-q22
Miller syndrome	263750	DHODH	126064	16q22.2
Miller syndrome	263750	URA1	126064	16q22.2
Miller syndrome	263750	POADS	126064	16q22.2
Miller-Dieker lissencephaly syndrome	247200	MDLS		17p13.3
Miller-Dieker lissencephaly syndrome	247200	MDS		17p13.3
Miller-Dieker lissencephaly syndrome	247200	MDCR		17p13.3
Miller-Dieker lissencephaly syndrome	247200	DEL17p13.3		17p13.3
Miller-Dieker lissencephaly syndrome	247200	C17DELp13.3		17p13.3
Minicore myopathy with external ophthalmoplegia	255320	RYR1	180901	19q13.2
Minicore myopathy with external ophthalmoplegia	255320	MHS	180901	19q13.2
Minicore myopathy with external ophthalmoplegia	255320	CCO	180901	19q13.2
Mirror movements 1	157600	DCC	120470	18q21.2
Mirror movements 1	157600	MRMV1	120470	18q21.2
Mirror movements 2	614508	RAD51A	179617	15q15.1
Mirror movements 2	614508	RECA	179617	15q15.1
Mirror movements 2	614508	MRMV2	179617	15q15.1
Mirror-image polydactyly	135750	MIPOL1	606850	14q13.3-q21.1
Mismatch repair cancer syndrome	276300	MLH1	120436	3p22.2
Mismatch repair cancer syndrome	276300	COCA2	120436	3p22.2
Mismatch repair cancer syndrome	276300	HNPCC2	120436	3p22.2
Mismatch repair cancer syndrome	276300	MSH2	609309	2p21
Mismatch repair cancer syndrome	276300	COCA1	609309	2p21
Mismatch repair cancer syndrome	276300	FCC1	609309	2p21
Mismatch repair cancer syndrome	276300	HNPCC1	609309	2p21
Mismatch repair cancer syndrome	276300	MSH6	600678	2p16.3
Mismatch repair cancer syndrome	276300	GTBP	600678	2p16.3
Mismatch repair cancer syndrome	276300	HNPCC5	600678	2p16.3
Mismatch repair cancer syndrome	276300	PMS2	600259	7p22.1
Mismatch repair cancer syndrome	276300	PMSL2	600259	7p22.1
Mismatch repair cancer syndrome	276300	HNPCC4	600259	7p22.1
Mitochondrial DNA depletion syndrome 1 (MNGIE type)	603041	TYMP	131222	22q13.33
Mitochondrial DNA depletion syndrome 1 (MNGIE type)	603041	ECGF1	131222	22q13.33
Mitochondrial DNA depletion syndrome 1 (MNGIE type)	603041	MNGIE	131222	22q13.33
Mitochondrial DNA depletion syndrome 1 (MNGIE type)	603041	PDECGF	131222	22q13.33
Mitochondrial DNA depletion syndrome 1 (MNGIE type)	603041	MEDPS1	131222	22q13.33
Mitochondrial DNA depletion syndrome 1 (MNGIE type)	603041	MTDPS1	131222	22q13.33
Mitochondrial DNA depletion syndrome 11	615084	MGME1	615076	20p11.23
Mitochondrial DNA depletion syndrome 11	615084	C20orf72	615076	20p11.23
Mitochondrial DNA depletion syndrome 11	615084	MTDPS11	615076	20p11.23
Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type)	615418	SLC25A4	103220	4q35.1
Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type)	615418	ANT1	103220	4q35.1
Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type)	615418	T1	103220	4q35.1
Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type)	615418	PEO3	103220	4q35.1
Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type)	615418	PEO2	103220	4q35.1
Mitochondrial DNA depletion syndrome 12 (cardiomyopathic type)	615418	MTDPS12	103220	4q35.1
Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	615471	FBXL4	605654	6q16.1
Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	615471	FBL4	605654	6q16.1
Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type)	615471	MTDPS13	605654	6q16.1
Mitochondrial DNA depletion syndrome 2 (myopathic type)	609560	TK2	188250	16q21
Mitochondrial DNA depletion syndrome 2 (myopathic type)	609560	MTDPS2	188250	16q21
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	251880	DGUOK	601465	2p13.1
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	251880	DGK	601465	2p13.1
Mitochondrial DNA depletion syndrome 3 (hepatocerebral type)	251880	MTDPS3	601465	2p13.1
Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	POLG	174763	15q26.1
Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	POLG1	174763	15q26.1
Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	POLGA	174763	15q26.1
Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	PEO	174763	15q26.1
Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	SANDO	174763	15q26.1
Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	SCAE	174763	15q26.1
Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	MTDPS4A	174763	15q26.1
Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	MTDPS4B	174763	15q26.1
Mitochondrial DNA depletion syndrome 4A (Alpers type)	203700	MIRAS	174763	15q26.1
Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	POLG	174763	15q26.1
Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	POLG1	174763	15q26.1
Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	POLGA	174763	15q26.1
Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	PEO	174763	15q26.1
Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	SANDO	174763	15q26.1
Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	SCAE	174763	15q26.1
Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	MTDPS4A	174763	15q26.1
Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	MTDPS4B	174763	15q26.1
Mitochondrial DNA depletion syndrome 4B (MNGIE type)	613662	MIRAS	174763	15q26.1
Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	612073	SUCLA2	603921	13q14.2
Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria)	612073	MTDPS5	603921	13q14.2
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	256810	MPV17	137960	2p23.3
Mitochondrial DNA depletion syndrome 6 (hepatocerebral type)	256810	MTDPS6	137960	2p23.3
Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	271245	C10orf2	606075	10q24.31
Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	271245	TWINKLE	606075	10q24.31
Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	271245	PEO1	606075	10q24.31
Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	271245	PEOA3	606075	10q24.31
Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	271245	IOSCA	606075	10q24.31
Mitochondrial DNA depletion syndrome 7 (hepatocerebral type)	271245	MTDPS7	606075	10q24.31
Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy)	612075	RRM2B	604712	8q22.3
Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy)	612075	P53R2	604712	8q22.3
Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy)	612075	PEOA5	604712	8q22.3
Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy)	612075	MTDPS8A	604712	8q22.3
Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy)	612075	MTDPS8B	604712	8q22.3
Mitochondrial DNA depletion syndrome 8B (MNGIE type)	612075	RRM2B	604712	8q22.3
Mitochondrial DNA depletion syndrome 8B (MNGIE type)	612075	P53R2	604712	8q22.3
Mitochondrial DNA depletion syndrome 8B (MNGIE type)	612075	PEOA5	604712	8q22.3
Mitochondrial DNA depletion syndrome 8B (MNGIE type)	612075	MTDPS8A	604712	8q22.3
Mitochondrial DNA depletion syndrome 8B (MNGIE type)	612075	MTDPS8B	604712	8q22.3
Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)	245400	SUCLG1	611224	2p11.2
Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)	245400	SUCLA1	611224	2p11.2
Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)	245400	MTDPS9	611224	2p11.2
Mitochondrial complex 1 deficiency	252010	NDUFAF5	612360	20p12.1
Mitochondrial complex 1 deficiency	252010	C20orf7	612360	20p12.1
Mitochondrial complex I deficiency	252010	FOXRED1	613622	11q24.2
Mitochondrial complex I deficiency	252010	NDUFA1	300078	Xq24
Mitochondrial complex I deficiency	252010	MWFE	300078	Xq24
Mitochondrial complex I deficiency	252010	NDUFA11	612638	19p13.3
Mitochondrial complex I deficiency	252010	NDUFAF1	606934	15q15.1
Mitochondrial complex I deficiency	252010	CIA30	606934	15q15.1
Mitochondrial complex I deficiency	252010	CGI65	606934	15q15.1
Mitochondrial complex I deficiency	252010	NDUFAF2	609653	5q12.1
Mitochondrial complex I deficiency	252010	NDUFA12L	609653	5q12.1
Mitochondrial complex I deficiency	252010	MMTN	609653	5q12.1
Mitochondrial complex I deficiency	252010	B17.2L	609653	5q12.1
Mitochondrial complex I deficiency	252010	NDUFAF3	612911	3p21.31
Mitochondrial complex I deficiency	252010	NDUFAF4	611776	6q16.1
Mitochondrial complex I deficiency	252010	HRPAP20	611776	6q16.1
Mitochondrial complex I deficiency	252010	C6orf66	611776	6q16.1
Mitochondrial complex I deficiency	252010	NDUFB3	603839	2q33.1
Mitochondrial complex I deficiency	252010	NDUFS1	157655	2q33.3
Mitochondrial complex I deficiency	252010	NDUFS2	602985	1q23.3
Mitochondrial complex I deficiency	252010	NDUFS3	603846	11p11.2
Mitochondrial complex I deficiency	252010	NDUFS4	602694	5q11.2
Mitochondrial complex I deficiency	252010	AQDQ	602694	5q11.2
Mitochondrial complex I deficiency	252010	NDUFV1	161015	11q13.2
Mitochondrial complex I deficiency	252010	UQOR1	161015	11q13.2
Mitochondrial complex I deficiency	252010	NDUFV2	600532	18p11.22
Mitochondrial complex I deficiency	252010	NUBPL	613621	14q12
Mitochondrial complex I deficiency	252010	IND1	613621	14q12
Mitochondrial complex II deficiency	252011	SDHAF1	612848	19q13.12
Mitochondrial complex III deficiency, nuclear type 1	124000	BCS1L	603647	2q35
Mitochondrial complex III deficiency, nuclear type 1	124000	FLNMS	603647	2q35
Mitochondrial complex III deficiency, nuclear type 1	124000	GRACILE	603647	2q35
Mitochondrial complex III deficiency, nuclear type 1	124000	BJS	603647	2q35
Mitochondrial complex III deficiency, nuclear type 1	124000	PTD	603647	2q35
Mitochondrial complex III deficiency, nuclear type 1	124000	MC3DN1	603647	2q35
Mitochondrial complex III deficiency, nuclear type 2	615157	TTC19	613814	17p12
Mitochondrial complex III deficiency, nuclear type 2	615157	MC3DN2	613814	17p12
Mitochondrial complex III deficiency, nuclear type 3	615158	UQCRB	191330	8q22.1
Mitochondrial complex III deficiency, nuclear type 3	615158	UQBP	191330	8q22.1
Mitochondrial complex III deficiency, nuclear type 3	615158	QPC	191330	8q22.1
Mitochondrial complex III deficiency, nuclear type 3	615158	MC3DN3	191330	8q22.1
Mitochondrial complex III deficiency, nuclear type 4	615159	UQCRQ	612080	5q31.1
Mitochondrial complex III deficiency, nuclear type 4	615159	QPC	612080	5q31.1
Mitochondrial complex III deficiency, nuclear type 4	615159	MC3DN4	612080	5q31.1
Mitochondrial complex III deficiency, nuclear type 5	615160	UQCRC2	191329	16p12.2
Mitochondrial complex III deficiency, nuclear type 5	615160	MC3DN5	191329	16p12.2
Mitochondrial complex III deficiency, nuclear type 6	615453	CYC1	123980	8q24.3
Mitochondrial complex III deficiency, nuclear type 6	615453	MC3DN6	123980	8q24.3
Mitochondrial complex IV deficiency	220110	COA5	613920	2q11.2
Mitochondrial complex IV deficiency	220110	C2orf64	613920	2q11.2
Mitochondrial complex IV deficiency	220110	PET191	613920	2q11.2
Mitochondrial complex IV deficiency	220110	COX14	614478	12q13.12
Mitochondrial complex IV deficiency	220110	C12orf62	614478	12q13.12
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1	604273	ATPAF2	608918	17p11.2
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1	604273	ATP12	608918	17p11.2
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1	604273	MC5DN1	608918	17p11.2
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2	614052	TMEM70	612418	8q21.11
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2	614052	MC5DN2	612418	8q21.11
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3	614053	ATP5E	606153	20q13.32
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3	614053	MC5DN3	606153	20q13.32
Mitochondrial myopathy and sideroblastic anemia 1	600462	PUS1	608109	12q24.33
Mitochondrial myopathy and sideroblastic anemia 1	600462	MLASA1	608109	12q24.33
Mitochondrial phosphate carrier deficiency	610773	SLC25A3	600370	12q23.1
Mitochondrial phosphate carrier deficiency	610773	PHC	600370	12q23.1
Mitochondrial pyruvate carrier deficiency	614741	BRP44L	614738	6q27
Mitochondrial pyruvate carrier deficiency	614741	MPC1	614738	6q27
Mitochondrial pyruvate carrier deficiency	614741	MPYCD	614738	6q27
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	POLG	174763	15q26.1
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	POLG1	174763	15q26.1
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	POLGA	174763	15q26.1
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	PEO	174763	15q26.1
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	SANDO	174763	15q26.1
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	SCAE	174763	15q26.1
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	MTDPS4A	174763	15q26.1
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	MTDPS4B	174763	15q26.1
Mitochondrial recessive ataxia syndrome (includes SANDO and SCAE)	607459	MIRAS	174763	15q26.1
Mitochondrial respiratory chain complex II deficiency	252011	SDHA	600857	5p15.33
Mitochondrial respiratory chain complex II deficiency	252011	SDH1	600857	5p15.33
Mitochondrial respiratory chain complex II deficiency	252011	SDHF	600857	5p15.33
Mitochondrial respiratory chain complex II deficiency	252011	CMD1GG	600857	5p15.33
Mitochondrial respiratory chain complex II deficiency	252011	PGL5	600857	5p15.33
Mitral valve prolapse, myxomatous 1	157700	MMVP1		16p12.1-p11.2
Mitral valve prolapse, myxomatous 1	157700	MVP		16p12.1-p11.2
Mitral valve prolapse, myxomatous 1	157700	PMV		16p12.1-p11.2
Mitral valve prolapse, myxomatous 2	607829	MMVP2		11p15.4
Mitral valve prolapse, myxomatous 3	610840	MMVP3		13q31.3-q32.1
Miyoshi muscular dystrophy 1	254130	DYSF	603009	2p13.2
Miyoshi muscular dystrophy 1	254130	LGMD2B	603009	2p13.2
Miyoshi muscular dystrophy 1	254130	MMD1	603009	2p13.2
Miyoshi muscular dystrophy 2	613318	MMD2		8q22.3
Miyoshi muscular dystrophy 3	613319	ANO5	608662	11p14.3
Miyoshi muscular dystrophy 3	613319	TMEM16E	608662	11p14.3
Miyoshi muscular dystrophy 3	613319	GDD1	608662	11p14.3
Miyoshi muscular dystrophy 3	613319	LGMD2L	608662	11p14.3
Moebius syndrome-3	604185	MBS3		10q21.3-q22.1
Mohr-Tranebjaerg syndrome	304700	TIMM8A	300356	Xq22.1
Mohr-Tranebjaerg syndrome	304700	DFN1	300356	Xq22.1
Mohr-Tranebjaerg syndrome	304700	DDP	300356	Xq22.1
Mohr-Tranebjaerg syndrome	304700	MTS	300356	Xq22.1
Mohr-Tranebjaerg syndrome	304700	DDP1	300356	Xq22.1
Molybdenum cofactor deficiency A	252150	MOCS1	603707	6p21.2
Molybdenum cofactor deficiency A	252150	MOCODA	603707	6p21.2
Molybdenum cofactor deficiency B	252160	MOCS2	603708	5q11.2
Molybdenum cofactor deficiency B	252160	MPTS	603708	5q11.2
Molybdenum cofactor deficiency B	252160	MOCODB	603708	5q11.2
Molybdenum cofactor deficiency C	615501	GPHN	603930	14q23.3
Molybdenum cofactor deficiency C	615501	GPH	603930	14q23.3
Molybdenum cofactor deficiency C	615501	KIAA1385	603930	14q23.3
Molybdenum cofactor deficiency C	615501	GEPH	603930	14q23.3
Molybdenum cofactor deficiency C	615501	MOCODC	603930	14q23.3
Monilethrix	158000	KRT81	602153	12q13.13
Monilethrix	158000	KRTHB1	602153	12q13.13
Monilethrix	158000	HB1	602153	12q13.13
Monilethrix	158000	KRT83	602765	12q13.13
Monilethrix	158000	KRTHB3	602765	12q13.13
Monilethrix	158000	HB3	602765	12q13.13
Monilethrix	158000	KRT86	601928	12q13.13
Monilethrix	158000	KRTHB6	601928	12q13.13
Monilethrix	158000	HB6	601928	12q13.13
Monocyte and dendritic cell deficiency, recessive	614894	IRF8	601565	16q24.1
Monocyte and dendritic cell deficiency, recessive	614894	ICSBP1	601565	16q24.1
Mononeuropathy of the median nerve, mild	613353	SH3TC2	608206	5q32
Mononeuropathy of the median nerve, mild	613353	KIAA1985	608206	5q32
Mononeuropathy of the median nerve, mild	613353	MNMN	608206	5q32
Morning glory disc anomaly	120430	PAX6	607108	11p13
Morning glory disc anomaly	120430	AN2	607108	11p13
Morning glory disc anomaly	120430	MGDA	607108	11p13
Mosaic variegated aneuploidy syndrome 1	257300	BUB1B	602860	15q15.1
Mosaic variegated aneuploidy syndrome 1	257300	BUBR1	602860	15q15.1
Mosaic variegated aneuploidy syndrome 1	257300	MVA1	602860	15q15.1
Mosaic variegated aneuploidy syndrome 2	614114	CEP57	607951	11q21
Mosaic variegated aneuploidy syndrome 2	614114	PIG8	607951	11q21
Mosaic variegated aneuploidy syndrome 2	614114	TSP57	607951	11q21
Mosaic variegated aneuploidy syndrome 2	614114	KIAA0092	607951	11q21
Mosaic variegated aneuploidy syndrome 2	614114	MVA2	607951	11q21
Mowat-Wilson syndrome	235730	ZEB2	605802	2q22.3
Mowat-Wilson syndrome	235730	ZFHX1B	605802	2q22.3
Mowat-Wilson syndrome	235730	SMADIP1	605802	2q22.3
Mowat-Wilson syndrome	235730	SIP1	605802	2q22.3
Moyamoya disease	252350	MYMY1		3p26-p24.2
Moyamoya disease	252350	MYMY		3p26-p24.2
Moyamoya disease 3	608796	MYMY3		8q23
Moyamoya disease 4	300845	MYMY4		Xq28
Moyamoya disease 4	300845	CXDELq38		Xq28
Moyamoya disease 5	614042	ACTA2	102620	10q23.31
Moyamoya disease 5	614042	ACTSA	102620	10q23.31
Moyamoya disease 5	614042	AAT6	102620	10q23.31
Moyamoya disease 5	614042	MYMY5	102620	10q23.31
Muckle-Wells syndrome	191900	NLRP3	606416	1q44
Muckle-Wells syndrome	191900	CIAS1	606416	1q44
Muckle-Wells syndrome	191900	FCU	606416	1q44
Muckle-Wells syndrome	191900	FCAS	606416	1q44
Muckle-Wells syndrome	191900	NALP3	606416	1q44
Muckle-Wells syndrome	191900	PYPAF1	606416	1q44
Mucoepidermoid salivary gland carcinoma		CRTC1	607536	19p13.11
Mucoepidermoid salivary gland carcinoma		MECT1	607536	19p13.11
Mucoepidermoid salivary gland carcinoma		KIAA0616	607536	19p13.11
Mucoepidermoid salivary gland carcinoma		FLJ14027	607536	19p13.11
Mucoepidermoid salivary gland carcinoma		MAML2	607537	11q21
Mucoepidermoid salivary gland carcinoma		MAM3	607537	11q21
Mucolipidosis II alpha/beta	252500	GNPTAB	607840	12q23.2
Mucolipidosis II alpha/beta	252500	GNPTA	607840	12q23.2
Mucolipidosis III alpha/beta	252600	GNPTAB	607840	12q23.2
Mucolipidosis III alpha/beta	252600	GNPTA	607840	12q23.2
Mucolipidosis III gamma	252605	GNPTAG	607838	16p13.3
Mucolipidosis IV	252650	MCOLN1	605248	19p13.2
Mucolipidosis IV	252650	ML4	605248	19p13.2
Mucopolysaccharidisis type IIIA (Sanfilippo A)	252900	SGSH	605270	17q25.3
Mucopolysaccharidisis type IIIA (Sanfilippo A)	252900	MPS3A	605270	17q25.3
Mucopolysaccharidisis type IIIA (Sanfilippo A)	252900	SFMD	605270	17q25.3
Mucopolysaccharidosis II	309900	IDS	300823	Xq28
Mucopolysaccharidosis II	309900	MPS2	300823	Xq28
Mucopolysaccharidosis II	309900	SIDS	300823	Xq28
Mucopolysaccharidosis IVA	253000	GALNS	612222	16q24.3
Mucopolysaccharidosis IVA	253000	MPS4A	612222	16q24.3
Mucopolysaccharidosis Ih	607014	IDUA	252800	4p16.3
Mucopolysaccharidosis Ih	607014	IDA	252800	4p16.3
Mucopolysaccharidosis Ih/s	607015	IDUA	252800	4p16.3
Mucopolysaccharidosis Ih/s	607015	IDA	252800	4p16.3
Mucopolysaccharidosis Is	607016	IDUA	252800	4p16.3
Mucopolysaccharidosis Is	607016	IDA	252800	4p16.3
Mucopolysaccharidosis VII	253220	GUSB	611499	7q11.21
Mucopolysaccharidosis VII	253220	MPS7	611499	7q11.21
Mucopolysaccharidosis type IIIB (Sanfilippo B)	252920	NAGLU	609701	17q21.2
Mucopolysaccharidosis type IIIB (Sanfilippo B)	252920	MPS3B	609701	17q21.2
Mucopolysaccharidosis type IIIC (Sanfilippo C)	252930	HGSNAT	610453	8p11.21
Mucopolysaccharidosis type IIIC (Sanfilippo C)	252930	TMEM76	610453	8p11.21
Mucopolysaccharidosis type IIIC (Sanfilippo C)	252930	MPS3C	610453	8p11.21
Mucopolysaccharidosis type IIID	252940	GNS	607664	12q14.3
Mucopolysaccharidosis type IIID	252940	G6S	607664	12q14.3
Mucopolysaccharidosis type IVB (Morquio)	253010	GLB1	611458	3p22.3
Mucopolysaccharidosis type IVB (Morquio)	253010	MPS4B	611458	3p22.3
Mucopolysaccharidosis type IX	601492	HYAL1	607071	3p21.31
Mucopolysaccharidosis type VI (Maroteaux-Lamy)	253200	ARSB	611542	5q14.1
Mucopolysaccharidosis type VI (Maroteaux-Lamy)	253200	MPS6	611542	5q14.1
Muenke syndrome	602849	FGFR3	134934	4p16.3
Muenke syndrome	602849	ACH	134934	4p16.3
Muir-Torre syndrome	158320	MLH1	120436	3p22.2
Muir-Torre syndrome	158320	COCA2	120436	3p22.2
Muir-Torre syndrome	158320	HNPCC2	120436	3p22.2
Muir-Torre syndrome	158320	MSH2	609309	2p21
Muir-Torre syndrome	158320	COCA1	609309	2p21
Muir-Torre syndrome	158320	FCC1	609309	2p21
Muir-Torre syndrome	158320	HNPCC1	609309	2p21
Mulibrey nanism	253250	TRIM37	605073	17q22
Mulibrey nanism	253250	MUL	605073	17q22
Mulibrey nanism	253250	KIAA0898	605073	17q22
Mullerian aplasia and hyperandrogenism	158330	WNT4	603490	1p36.12
Mullerian aplasia and hyperandrogenism	158330	SERKAL	603490	1p36.12
Multicentric carpotarsal osteolysis syndrome	166300	MAFB	608968	20q12
Multicentric carpotarsal osteolysis syndrome	166300	KRML	608968	20q12
Multicentric carpotarsal osteolysis syndrome	166300	MCTO	608968	20q12
Multicentric osteolysis, nodulosis, and arthropathy	259600	MMP2	120360	16q12.2
Multicentric osteolysis, nodulosis, and arthropathy	259600	CLG4A	120360	16q12.2
Multicentric osteolysis, nodulosis, and arthropathy	259600	MONA	120360	16q12.2
Multiple congenital anomalies-hypotonia-seizures syndrome 1	614080	PIGN	606097	18q21.33
Multiple congenital anomalies-hypotonia-seizures syndrome 1	614080	MCAHS1	606097	18q21.33
Multiple congenital anomalies-hypotonia-seizures syndrome 2	300868	PIGA	311770	Xp22.2
Multiple congenital anomalies-hypotonia-seizures syndrome 2	300868	MCAHS2	311770	Xp22.2
Multiple endocrine neoplasia 1	131100	MEN1	613733	11q13.1
Multiple endocrine neoplasia IIA	171400	RET	164761	10q11.21
Multiple endocrine neoplasia IIA	171400	MEN2A	164761	10q11.21
Multiple endocrine neoplasia IIA	171400	HSCR1	164761	10q11.21
Multiple endocrine neoplasia IIB	162300	RET	164761	10q11.21
Multiple endocrine neoplasia IIB	162300	MEN2A	164761	10q11.21
Multiple endocrine neoplasia IIB	162300	HSCR1	164761	10q11.21
Multiple endocrine neoplasia, type IV	610755	CDKN1B	600778	12p13.1
Multiple endocrine neoplasia, type IV	610755	KIP1	600778	12p13.1
Multiple endocrine neoplasia, type IV	610755	CDKN4	600778	12p13.1
Multiple endocrine neoplasia, type IV	610755	MEN4	600778	12p13.1
Multiple fibroadenomas of the breast	615554	PRLR	176761	5p13.2
Multiple fibroadenomas of the breast	615554	MFAB	176761	5p13.2
Multiple fibroadenomas of the breast	615554	HPRL	176761	5p13.2
Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects	245600	B3GAT3	606374	11q12.3
Multiple joint dislocations, short stature, craniofacial dysmorphism, and congenital heart defects	245600	GLCATI	606374	11q12.3
Multiple mitochondrial dysfunctions syndrome 1	605711	NFU1	608100	2p13.3
Multiple mitochondrial dysfunctions syndrome 1	605711	HIRIP	608100	2p13.3
Multiple mitochondrial dysfunctions syndrome 1	605711	MMDS1	608100	2p13.3
Multiple mitochondrial dysfunctions syndrome 2	614299	BOLA3	613183	2p13.1
Multiple mitochondrial dysfunctions syndrome 2	614299	MMDS2	613183	2p13.1
Multiple myeloma	254500	IRF4	601900	6p25.3
Multiple myeloma	254500	LSIRF	601900	6p25.3
Multiple pterygium syndrome, lethal type	253290	CHRNA1	100690	2q31.1
Multiple pterygium syndrome, lethal type	253290	ACHRD	100690	2q31.1
Multiple pterygium syndrome, lethal type	253290	CMS2A	100690	2q31.1
Multiple pterygium syndrome, lethal type	253290	SCCMS	100690	2q31.1
Multiple pterygium syndrome, lethal type	253290	FCCMS	100690	2q31.1
Multiple pterygium syndrome, lethal type	253290	CHRND	100720	2q37.1
Multiple pterygium syndrome, lethal type	253290	ACHRD	100720	2q37.1
Multiple pterygium syndrome, lethal type	253290	SCCMS	100720	2q37.1
Multiple pterygium syndrome, lethal type	253290	CMS2A	100720	2q37.1
Multiple pterygium syndrome, lethal type	253290	FCCMS	100720	2q37.1
Multiple pterygium syndrome, lethal type	253290	CHRNG	100730	2q37.1
Multiple pterygium syndrome, lethal type	253290	ACHRG	100730	2q37.1
Multiple sulfatase deficiency	272200	SUMF1	607939	3p26.1
Multiple sulfatase deficiency	272200	FGE	607939	3p26.1
Multiple synostoses syndrome 2	610017	GDF5	601146	20q11.22
Multiple synostoses syndrome 2	610017	CDMP1	601146	20q11.22
Multiple synostoses syndrome 2	610017	SYNS2	601146	20q11.22
Multiple synostoses syndrome 2	610017	OS5	601146	20q11.22
Multiple synostoses syndrome 2	610017	BDA1C	601146	20q11.22
Multiple synostoses syndrome 2	610017	SYM1B	601146	20q11.22
Multiple synostoses syndrome 3	612961	FGF9	600921	13q12.11
Multiple synostoses syndrome 3	612961	SYNS3	600921	13q12.11
Multiple synostosis syndrome 1	186500	NOG	602991	17q22
Multiple synostosis syndrome 1	186500	SYM1	602991	17q22
Multiple synostosis syndrome 1	186500	SYNS1	602991	17q22
Multisystemic smooth muscle dysfunction syndrome	613834	ACTA2	102620	10q23.31
Multisystemic smooth muscle dysfunction syndrome	613834	ACTSA	102620	10q23.31
Multisystemic smooth muscle dysfunction syndrome	613834	AAT6	102620	10q23.31
Multisystemic smooth muscle dysfunction syndrome	613834	MYMY5	102620	10q23.31
Mungan syndrome	611376	MGS		8q23-q24
Muscle glycogenosis	300559	PHKA1	311870	Xq13.1-q13.2
Muscle hypertrophy	614160	GDF8	601788	2q32.2
Muscle hypertrophy	614160	MSTN	601788	2q32.2
Muscle hypertrophy	614160	MSLHP	601788	2q32.2
Muscle strength quantitative trait locus 1	612083	MUSTQTL1		14q24.3
Muscular dystrophy with epidermolysis bullosa simplex	226670	PLEC1	601282	8q24.3
Muscular dystrophy with epidermolysis bullosa simplex	226670	PLEC	601282	8q24.3
Muscular dystrophy with epidermolysis bullosa simplex	226670	PLTN	601282	8q24.3
Muscular dystrophy with epidermolysis bullosa simplex	226670	EBS1	601282	8q24.3
Muscular dystrophy with epidermolysis bullosa simplex	226670	LGMD2Q	601282	8q24.3
Muscular dystrophy with rimmed vacuoles	601846	MDRV		19p13.3
Muscular dystrophy, congenital merosin-deficient	607855	LAMA2	156225	6q22.33
Muscular dystrophy, congenital merosin-deficient	607855	LAMM	156225	6q22.33
Muscular dystrophy, congenital, 1B	604801	MDC1B		1q42
Muscular dystrophy, congenital	613205	LMNA	150330	1q22
Muscular dystrophy, congenital	613205	LMN1	150330	1q22
Muscular dystrophy, congenital	613205	EMD2	150330	1q22
Muscular dystrophy, congenital	613205	FPLD2	150330	1q22
Muscular dystrophy, congenital	613205	CMD1A	150330	1q22
Muscular dystrophy, congenital	613205	HGPS	150330	1q22
Muscular dystrophy, congenital	613205	LGMD1B	150330	1q22
Muscular dystrophy, congenital, due to ITGA7 deficiency	613204	ITGA7	600536	12q13.2
Muscular dystrophy, congenital, due to partial LAMA2 deficiency	607855	LAMA2	156225	6q22.33
Muscular dystrophy, congenital, due to partial LAMA2 deficiency	607855	LAMM	156225	6q22.33
Muscular dystrophy, congenital, megaconial type	602541	CHKB	612395	22q13.33
Muscular dystrophy, congenital, megaconial type	602541	CHKL	612395	22q13.33
Muscular dystrophy, congenital, megaconial type	602541	CKEKB	612395	22q13.33
Muscular dystrophy, congenital, megaconial type	602541	EKB	612395	22q13.33
Muscular dystrophy, congenital, megaconial type	602541	MDCMC	612395	22q13.33
Muscular dystrophy, congenital, merosin-positive	609456	MDCMP		4p16.3
Muscular dystrophy, limb-girdle, type 1A	159000	MYOT	604103	5q31.2
Muscular dystrophy, limb-girdle, type 1A	159000	TTOD	604103	5q31.2
Muscular dystrophy, limb-girdle, type 1A	159000	MFM3	604103	5q31.2
Muscular dystrophy, limb-girdle, type 1B	159001	LMNA	150330	1q22
Muscular dystrophy, limb-girdle, type 1B	159001	LMN1	150330	1q22
Muscular dystrophy, limb-girdle, type 1B	159001	EMD2	150330	1q22
Muscular dystrophy, limb-girdle, type 1B	159001	FPLD2	150330	1q22
Muscular dystrophy, limb-girdle, type 1B	159001	CMD1A	150330	1q22
Muscular dystrophy, limb-girdle, type 1B	159001	HGPS	150330	1q22
Muscular dystrophy, limb-girdle, type 1B	159001	LGMD1B	150330	1q22
Muscular dystrophy, limb-girdle, type 1E	603511	DNAJB6	611332	7q36.3
Muscular dystrophy, limb-girdle, type 1E	603511	MRJ	611332	7q36.3
Muscular dystrophy, limb-girdle, type 1E	603511	DJ4	611332	7q36.3
Muscular dystrophy, limb-girdle, type 1E	603511	LGMD1E	611332	7q36.3
Muscular dystrophy, limb-girdle, type 1F	608423	LGMD1F		7q32.1-q32.2
Muscular dystrophy, limb-girdle, type 1H	613530	LGMD1H		3p25.1-p23
Muscular dystrophy, limb-girdle, type 2A	253600	CAPN3	114240	15q15.1
Muscular dystrophy, limb-girdle, type 2A	253600	CANP3	114240	15q15.1
Muscular dystrophy, limb-girdle, type 2B	253601	DYSF	603009	2p13.2
Muscular dystrophy, limb-girdle, type 2B	253601	LGMD2B	603009	2p13.2
Muscular dystrophy, limb-girdle, type 2B	253601	MMD1	603009	2p13.2
Muscular dystrophy, limb-girdle, type 2C	253700	SGCG	608896	13q12.12
Muscular dystrophy, limb-girdle, type 2C	253700	LGMD2C	608896	13q12.12
Muscular dystrophy, limb-girdle, type 2C	253700	DMDA1	608896	13q12.12
Muscular dystrophy, limb-girdle, type 2C	253700	SCG3	608896	13q12.12
Muscular dystrophy, limb-girdle, type 2D	608099	SGCA	600119	17q21.33
Muscular dystrophy, limb-girdle, type 2D	608099	ADL	600119	17q21.33
Muscular dystrophy, limb-girdle, type 2D	608099	DAG2	600119	17q21.33
Muscular dystrophy, limb-girdle, type 2D	608099	LGMD2D	600119	17q21.33
Muscular dystrophy, limb-girdle, type 2D	608099	DMDA2	600119	17q21.33
Muscular dystrophy, limb-girdle, type 2E	604286	SGCB	600900	4q12
Muscular dystrophy, limb-girdle, type 2E	604286	LGMD2E	600900	4q12
Muscular dystrophy, limb-girdle, type 2F	601287	SGCD	601411	5q33.2-q33.3
Muscular dystrophy, limb-girdle, type 2F	601287	SGD	601411	5q33.2-q33.3
Muscular dystrophy, limb-girdle, type 2F	601287	LGMD2F	601411	5q33.2-q33.3
Muscular dystrophy, limb-girdle, type 2F	601287	CMD1L	601411	5q33.2-q33.3
Muscular dystrophy, limb-girdle, type 2G	601954	TCAP	604488	17q12
Muscular dystrophy, limb-girdle, type 2G	601954	LGMD2G	604488	17q12
Muscular dystrophy, limb-girdle, type 2G	601954	CMD1N	604488	17q12
Muscular dystrophy, limb-girdle, type 2H	254110	TRIM32	602290	9q33.1
Muscular dystrophy, limb-girdle, type 2H	254110	HT2A	602290	9q33.1
Muscular dystrophy, limb-girdle, type 2H	254110	LGMD2H	602290	9q33.1
Muscular dystrophy, limb-girdle, type 2H	254110	BBS11	602290	9q33.1
Muscular dystrophy, limb-girdle, type 2J	608807	TTN	188840	2q31.2
Muscular dystrophy, limb-girdle, type 2J	608807	CMD1G	188840	2q31.2
Muscular dystrophy, limb-girdle, type 2J	608807	TMD	188840	2q31.2
Muscular dystrophy, limb-girdle, type 2J	608807	LGMD2J	188840	2q31.2
Muscular dystrophy, limb-girdle, type 2J	608807	MPRM	188840	2q31.2
Muscular dystrophy, limb-girdle, type 2J	608807	HMERF	188840	2q31.2
Muscular dystrophy, limb-girdle, type 2J	608807	EOMFC	188840	2q31.2
Muscular dystrophy, limb-girdle, type 2L	611307	ANO5	608662	11p14.3
Muscular dystrophy, limb-girdle, type 2L	611307	TMEM16E	608662	11p14.3
Muscular dystrophy, limb-girdle, type 2L	611307	GDD1	608662	11p14.3
Muscular dystrophy, limb-girdle, type 2L	611307	LGMD2L	608662	11p14.3
Muscular dystrophy, limb-girdle, type 2Q	613723	PLEC1	601282	8q24.3
Muscular dystrophy, limb-girdle, type 2Q	613723	PLEC	601282	8q24.3
Muscular dystrophy, limb-girdle, type 2Q	613723	PLTN	601282	8q24.3
Muscular dystrophy, limb-girdle, type 2Q	613723	EBS1	601282	8q24.3
Muscular dystrophy, limb-girdle, type 2Q	613723	LGMD2Q	601282	8q24.3
Muscular dystrophy, limb-girdle, type 2S	615356	TRAPPC11	614138	4q35.1
Muscular dystrophy, limb-girdle, type 2S	615356	C4orf41	614138	4q35.1
Muscular dystrophy, limb-girdle, type 2S	615356	LGMD2S	614138	4q35.1
Muscular dystrophy, limb-girdle, type IC	607801	CAV3	601253	3p25.3
Muscular dystrophy, limb-girdle, type IC	607801	LGMD1C	601253	3p25.3
Muscular dystrophy, limb-girdle, type IC	607801	LQT9	601253	3p25.3
Muscular dystrophy, rigid spine, 1	602771	SEPN1	606210	1p36.11
Muscular dystrophy, rigid spine, 1	602771	SELN	606210	1p36.11
Muscular dystrophy, rigid spine, 1	602771	RSMD1	606210	1p36.11
Muscular dystrophy, rigid spine, 1	602771	CFTD	606210	1p36.11
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	236670	POMT1	607423	9q34.13
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	236670	MDDGA1	607423	9q34.13
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	236670	MDDGB1	607423	9q34.13
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1	236670	MDDGC1	607423	9q34.13
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10	615041	TMEM5	605862	12q14.2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10	615041	MDDGA10	605862	12q14.2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13	615287	B3GNT1	605517	11q13.2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13	615287	IGNT	605517	11q13.2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13	615287	IGAT	605517	11q13.2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13	615287	MDDGA13	605517	11q13.2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	615350	GMPPB	615320	3p21.31
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	615350	KIAA1851	615320	3p21.31
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	615350	MDDGA14	615320	3p21.31
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	615350	MDDGB14	615320	3p21.31
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14	615350	MDDGC14	615320	3p21.31
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	613150	POMT2	607439	14q24.3
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	613150	MDDGA2	607439	14q24.3
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	613150	MDDGB2	607439	14q24.3
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2	613150	MDDGC2	607439	14q24.3
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	253280	POMGNT1	606822	1p34.1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	253280	MEB	606822	1p34.1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	253280	MDDGA3	606822	1p34.1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	253280	MDDGB3	606822	1p34.1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3	253280	MDDGC3	606822	1p34.1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	FKTN	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	FCMD	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	CMD1X	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	LGMD2M	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	MDDGA4	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	MDDGB4	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4	253800	MDDGC4	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	613153	FKRP	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	613153	MDC1C	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	613153	LGMD2I	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	613153	MDDGA5	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	613153	MDDGB5	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5	613153	MDDGC5	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	613154	LARGE	603590	22q12.3
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	613154	KIAA0609	603590	22q12.3
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	613154	MDC1D	603590	22q12.3
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	613154	MDDGA6	603590	22q12.3
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6	613154	MDDGB6	603590	22q12.3
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	614643	ISPD	614631	7p21.2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7	614643	MDDGA7	614631	7p21.2
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11	615181	G3GALNT2	610194	1q42.3
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11	615181	MGC39558	610194	1q42.3
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11	615181	MDDGA11	610194	1q42.3
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8	614830	GTDC2	614828	3p22.1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8	614830	C3orf39	614828	3p22.1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8	614830	AGO61	614828	3p22.1
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8	614830	MDDGA8	614828	3p22.1
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1	613155	POMT1	607423	9q34.13
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1	613155	MDDGA1	607423	9q34.13
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1	613155	MDDGB1	607423	9q34.13
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 1	613155	MDDGC1	607423	9q34.13
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14	615351	GMPPB	615320	3p21.31
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14	615351	KIAA1851	615320	3p21.31
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14	615351	MDDGA14	615320	3p21.31
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14	615351	MDDGB14	615320	3p21.31
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 14	615351	MDDGC14	615320	3p21.31
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2	613156	POMT2	607439	14q24.3
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2	613156	MDDGA2	607439	14q24.3
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2	613156	MDDGB2	607439	14q24.3
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 2	613156	MDDGC2	607439	14q24.3
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3	613151	POMGNT1	606822	1p34.1
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3	613151	MEB	606822	1p34.1
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3	613151	MDDGA3	606822	1p34.1
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3	613151	MDDGB3	606822	1p34.1
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 3	613151	MDDGC3	606822	1p34.1
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6	608840	LARGE	603590	22q12.3
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6	608840	KIAA0609	603590	22q12.3
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6	608840	MDC1D	603590	22q12.3
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6	608840	MDDGA6	603590	22q12.3
Muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6	608840	MDDGB6	603590	22q12.3
Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5	606612	FKRP	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5	606612	MDC1C	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5	606612	LGMD2I	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5	606612	MDDGA5	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5	606612	MDDGB5	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (congenital with or without mental retardation), type B, 5	606612	MDDGC5	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	FKTN	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	FCMD	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	CMD1X	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	LGMD2M	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	MDDGA4	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	MDDGB4	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4	613152	MDDGC4	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1	609308	POMT1	607423	9q34.13
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1	609308	MDDGA1	607423	9q34.13
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1	609308	MDDGB1	607423	9q34.13
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1	609308	MDDGC1	607423	9q34.13
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	615352	GMPPB	615320	3p21.31
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	615352	KIAA1851	615320	3p21.31
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	615352	MDDGA14	615320	3p21.31
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	615352	MDDGB14	615320	3p21.31
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14	615352	MDDGC14	615320	3p21.31
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	613158	POMT2	607439	14q24.3
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	613158	MDDGA2	607439	14q24.3
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	613158	MDDGB2	607439	14q24.3
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2	613158	MDDGC2	607439	14q24.3
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	613157	POMGNT1	606822	1p34.1
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	613157	MEB	606822	1p34.1
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	613157	MDDGA3	606822	1p34.1
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	613157	MDDGB3	606822	1p34.1
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3	613157	MDDGC3	606822	1p34.1
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	FKTN	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	FCMD	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	CMD1X	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	LGMD2M	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	MDDGA4	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	MDDGB4	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4	611588	MDDGC4	607440	9q31.2
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	607155	FKRP	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	607155	MDC1C	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	607155	LGMD2I	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	607155	MDDGA5	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	607155	MDDGB5	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5	607155	MDDGC5	606596	19q13.32
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	613818	DAG1	128239	3p21.31
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	613818	DAG	128239	3p21.31
Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9	613818	MDDGC9	128239	3p21.31
Myasthenia gravis with thymus hyperplasia	607085	MYAS1		6p21.3
Myasthenia gravis, neonatal transient		CHRNG	100730	2q37.1
Myasthenia gravis, neonatal transient		ACHRG	100730	2q37.1
Myasthenia, congenital, with tubular aggregates 1	610542	GFPT1	138292	2p13.3
Myasthenia, congenital, with tubular aggregates 1	610542	GFAT1	138292	2p13.3
Myasthenia, congenital, with tubular aggregates 1	610542	GFPT1L	138292	2p13.3
Myasthenia, congenital, with tubular aggregates 1	610542	MSLG	138292	2p13.3
Myasthenia, congenital, with tubular aggregates 1	610542	CMSTA1	138292	2p13.3
Myasthenia, familial infantile, 1	605809	CMS1A1		17p13
Myasthenia, familial infantile, 1	605809	FIM1		17p13
Myasthenia, limb-girdle, familial	254300	AGRN	103320	1p36.33
Myasthenia, limb-girdle, familial	254300	DOK7	610285	4p16.3
Myasthenia, limb-girdle, familial	254300	C4orf25	610285	4p16.3
Myasthenia, limb-girdle, familial	254300	CMS1B	610285	4p16.3
Myasthenic syndrome, acetazolamide-responsive	614198	SCN4A	603967	17q23.3
Myasthenic syndrome, acetazolamide-responsive	614198	HYPP	603967	17q23.3
Myasthenic syndrome, acetazolamide-responsive	614198	NAC1A	603967	17q23.3
Myasthenic syndrome, acetazolamide-responsive	614198	HOKPP2	603967	17q23.3
Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency	608931	CHRNB1	100710	17p13.1
Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency	608931	ACHRB	100710	17p13.1
Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency	608931	SCCMS	100710	17p13.1
Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency	608931	CMS2A	100710	17p13.1
Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency	608931	CMS1D	100710	17p13.1
Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency	608931	CHRNE	100725	17p13.2
Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency	608931	SCCMS	100725	17p13.2
Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency	608931	CMS2A	100725	17p13.2
Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency	608931	FCCMS	100725	17p13.2
Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency	608931	CMS1E	100725	17p13.2
Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency	608931	CMS1D	100725	17p13.2
Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency	608931	MUSK	601296	9q31.3
Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency	608931	RAPSN	601592	11p11.2
Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency	608931	CMS1D	601592	11p11.2
Myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency	608931	CMS1E	601592	11p11.2
Myasthenic syndrome, congenital, associated with episodic apnea	254210	CHAT	118490	10q11.23
Myasthenic syndrome, congenital, associated with episodic apnea	254210	CMS1A2	118490	10q11.23
Myasthenic syndrome, congenital, associated with facial dysmorphism and acetylcholine receptor deficiency	608931	RAPSN	601592	11p11.2
Myasthenic syndrome, congenital, associated with facial dysmorphism and acetylcholine receptor deficiency	608931	CMS1D	601592	11p11.2
Myasthenic syndrome, congenital, associated with facial dysmorphism and acetylcholine receptor deficiency	608931	CMS1E	601592	11p11.2
Myasthenic syndrome, congenital, with tubular aggregates 2	614750	DPAGT1	191350	11q23.3
Myasthenic syndrome, congenital, with tubular aggregates 2	614750	DPAGT2	191350	11q23.3
Myasthenic syndrome, congenital, with tubular aggregates 2	614750	DGPT	191350	11q23.3
Myasthenic syndrome, congenital, with tubular aggregates 2	614750	CDG1J	191350	11q23.3
Myasthenic syndrome, congenital, with tubular aggregates 2	614750	CMSTA2	191350	11q23.3
Myasthenic syndrome, fast-channel congenital	608930	CHRNA1	100690	2q31.1
Myasthenic syndrome, fast-channel congenital	608930	ACHRD	100690	2q31.1
Myasthenic syndrome, fast-channel congenital	608930	CMS2A	100690	2q31.1
Myasthenic syndrome, fast-channel congenital	608930	SCCMS	100690	2q31.1
Myasthenic syndrome, fast-channel congenital	608930	FCCMS	100690	2q31.1
Myasthenic syndrome, fast-channel congenital	608930	CHRND	100720	2q37.1
Myasthenic syndrome, fast-channel congenital	608930	ACHRD	100720	2q37.1
Myasthenic syndrome, fast-channel congenital	608930	SCCMS	100720	2q37.1
Myasthenic syndrome, fast-channel congenital	608930	CMS2A	100720	2q37.1
Myasthenic syndrome, fast-channel congenital	608930	FCCMS	100720	2q37.1
Myasthenic syndrome, fast-channel congenital	608930	CHRNE	100725	17p13.2
Myasthenic syndrome, fast-channel congenital	608930	SCCMS	100725	17p13.2
Myasthenic syndrome, fast-channel congenital	608930	CMS2A	100725	17p13.2
Myasthenic syndrome, fast-channel congenital	608930	FCCMS	100725	17p13.2
Myasthenic syndrome, fast-channel congenital	608930	CMS1E	100725	17p13.2
Myasthenic syndrome, fast-channel congenital	608930	CMS1D	100725	17p13.2
Myasthenic syndrome, slow-channel congenital	601462	CHRNA1	100690	2q31.1
Myasthenic syndrome, slow-channel congenital	601462	ACHRD	100690	2q31.1
Myasthenic syndrome, slow-channel congenital	601462	CMS2A	100690	2q31.1
Myasthenic syndrome, slow-channel congenital	601462	SCCMS	100690	2q31.1
Myasthenic syndrome, slow-channel congenital	601462	FCCMS	100690	2q31.1
Myasthenic syndrome, slow-channel congenital	601462	CHRNB1	100710	17p13.1
Myasthenic syndrome, slow-channel congenital	601462	ACHRB	100710	17p13.1
Myasthenic syndrome, slow-channel congenital	601462	SCCMS	100710	17p13.1
Myasthenic syndrome, slow-channel congenital	601462	CMS2A	100710	17p13.1
Myasthenic syndrome, slow-channel congenital	601462	CMS1D	100710	17p13.1
Myasthenic syndrome, slow-channel congenital	601462	CHRND	100720	2q37.1
Myasthenic syndrome, slow-channel congenital	601462	ACHRD	100720	2q37.1
Myasthenic syndrome, slow-channel congenital	601462	SCCMS	100720	2q37.1
Myasthenic syndrome, slow-channel congenital	601462	CMS2A	100720	2q37.1
Myasthenic syndrome, slow-channel congenital	601462	FCCMS	100720	2q37.1
Myasthenic syndrome, slow-channel congenital	601462	CHRNE	100725	17p13.2
Myasthenic syndrome, slow-channel congenital	601462	SCCMS	100725	17p13.2
Myasthenic syndrome, slow-channel congenital	601462	CMS2A	100725	17p13.2
Myasthenic syndrome, slow-channel congenital	601462	FCCMS	100725	17p13.2
Myasthenic syndrome, slow-channel congenital	601462	CMS1E	100725	17p13.2
Myasthenic syndrome, slow-channel congenital	601462	CMS1D	100725	17p13.2
Mycobacterial and viral infections, susceptibility to, autosomal recessive	613796	STAT1	600555	2q32.2
Mycobacterial and viral infections, susceptibility to, autosomal recessive	613796	CANDF7	600555	2q32.2
Mycobacterial infection, atypical, familial disseminated	209950	IFNGR1	107470	6q23.3
Mycobacterial infection, atypical, familial disseminated	209950	STAT1	600555	2q32.2
Mycobacterial infection, atypical, familial disseminated	209950	CANDF7	600555	2q32.2
Myelodysplasia and leukemia syndrome with monosomy 7	252270	MLSM7		7q
Myelodysplasia and leukemia syndrome with monosomy 7	252270	DEL7q		7q
Myelodysplasia and leukemia syndrome with monosomy 7	252270	C7DELq		7q
Myelodysplasia syndrome-1		MDS1	600049	3q26
Myelodysplastic syndrome		ACSL6	604443	5q31.1
Myelodysplastic syndrome		FACL6	604443	5q31.1
Myelodysplastic syndrome		ACS2	604443	5q31.1
Myelodysplastic syndrome, preleukemic		IRF1	147575	5q31.1
Myelodysplastic syndrome, preleukemic		MAR	147575	5q31.1
Myelodysplastic syndrome, somatic	614286	ASXL1	612990	20q11.21
Myelodysplastic syndrome, somatic	614286	KIAA0978	612990	20q11.21
Myelodysplastic syndrome, somatic	614286	BOPS	612990	20q11.21
Myelodysplastic syndrome, somatic	614286	MDS	612990	20q11.21
Myelodysplastic syndrome, somatic	614286	SF3B1	605590	2q33.1
Myelodysplastic syndrome, somatic	614286	SF3B155	605590	2q33.1
Myelodysplastic syndrome, somatic	614286	SAP155	605590	2q33.1
Myelodysplastic syndrome, somatic	614286	MDS	605590	2q33.1
Myelodysplastic syndrome, somatic	614286	TET2	612839	4q24
Myelodysplastic syndrome, somatic	614286	KIAA1546	612839	4q24
Myelodysplastic syndrome, somatic	614286	MDS	612839	4q24
Myelofibrosis with myeloid metaplasia, somatic	254450	MPL	159530	1p34.2
Myelofibrosis with myeloid metaplasia, somatic	254450	TPOR	159530	1p34.2
Myelofibrosis with myeloid metaplasia, somatic	254450	MPLV	159530	1p34.2
Myelofibrosis with myeloid metaplasia, somatic	254450	THCYT2	159530	1p34.2
Myelofibrosis, somatic	254450	CALR	109091	19p13.2
Myelofibrosis, somatic	254450	SSA	109091	19p13.2
Myelofibrosis, somatic	254450	JAK2	147796	9p24.1
Myelofibrosis, somatic	254450	THCYT3	147796	9p24.1
Myelofibrosis, somatic	254450	SH2B3	605093	12q24.12
Myelofibrosis, somatic	254450	LNK	605093	12q24.12
Myelogenous leukemia, acute		ACSL6	604443	5q31.1
Myelogenous leukemia, acute		FACL6	604443	5q31.1
Myelogenous leukemia, acute		ACS2	604443	5q31.1
Myelogenous leukemia, acute		IRF1	147575	5q31.1
Myelogenous leukemia, acute		MAR	147575	5q31.1
Myeloid leukemia, acute, M4/M4Eo subtype, somatic	601626	CBFB	121360	16q22.1
Myeloid leukemia, acute, M4/M4Eo subtype, somatic	601626	PEBP2B	121360	16q22.1
Myelokathexis, isolated		CXCR4	162643	2q22.1
Myelokathexis, isolated		D2S201E	162643	2q22.1
Myelokathexis, isolated		NPY3R	162643	2q22.1
Myelokathexis, isolated		WHIM	162643	2q22.1
Myeloperoxidase deficiency	254600	MPO	606989	17q22
Myeloproliferative disorder		FGFR1OP	605392	6q27
Myeloproliferative disorder		FOP	605392	6q27
Myeloproliferative disorder with eosinophilia	131440	PDGFRB	173410	5q32
Myeloproliferative disorder with eosinophilia	131440	PDGFR	173410	5q32
Myeloproliferative disorder with eosinophilia	131440	IBGC4	173410	5q32
Myeloproliferative disorder with eosinophilia	131440	IMF1	173410	5q32
Myhre syndrome	139210	MADH4	600993	18q21.2
Myhre syndrome	139210	DPC4	600993	18q21.2
Myhre syndrome	139210	SMAD4	600993	18q21.2
Myhre syndrome	139210	JIP	600993	18q21.2
Myhre syndrome	139210	MYHRS	600993	18q21.2
Myoclonic epilepsy, infantile, familial	605021	TBC1D24	613577	16p13.3
Myoclonic epilepsy, infantile, familial	605021	KIAA1171	613577	16p13.3
Myoclonic epilepsy, infantile, familial	605021	FIME	613577	16p13.3
Myoclonic epilepsy, infantile, familial	605021	EIEE16	613577	16p13.3
Myoclonic epilepsy, infantile, familial	605021	DOORS	613577	16p13.3
Myoclonic epilepsy, juvenile, 4	611364	EJM4		5q12-q14
Myoclonus, familial cortical	614937	NOL3	605235	16q22.1
Myoclonus, familial cortical	614937	NOP	605235	16q22.1
Myoclonus, familial cortical	614937	MYC	605235	16q22.1
Myoclonus, familial cortical	614937	ARC	605235	16q22.1
Myoclonus, familial cortical	614937	FCM	605235	16q22.1
Myofibromatosis, infantile, 1	228550	PDGFRB	173410	5q32
Myofibromatosis, infantile, 1	228550	PDGFR	173410	5q32
Myofibromatosis, infantile, 1	228550	IBGC4	173410	5q32
Myofibromatosis, infantile, 1	228550	IMF1	173410	5q32
Myoglobinuria, acute recurrent, autosomal recessive	268200	LPIN1	605518	2p25.1
Myokymia	121200	KCNQ2	602235	20q13.33
Myokymia	121200	EBN1	602235	20q13.33
Myokymia	121200	EIEE7	602235	20q13.33
Myokymia	121200	BFNS1	602235	20q13.33
Myopathy congenital, with fiber-type disproportion	255310	TPM3	191030	1q21.3
Myopathy congenital, with fiber-type disproportion	255310	NEM1	191030	1q21.3
Myopathy congenital, with fiber-type disproportion	255310	CFTD	191030	1q21.3
Myopathy congenital, with fiber-type disproportion	255310	CAPM1	191030	1q21.3
Myopathy due to CPT II deficiency	255110	CPT2	600650	1p32.3
Myopathy due to CPT II deficiency	255110	IIAE4	600650	1p32.3
Myopathy due to myoadenylate deaminase deficiency	615511	AMPD1	102770	1p13.2
Myopathy due to myoadenylate deaminase deficiency	615511	MMDD	102770	1p13.2
Myopathy with lactic acidosis, hereditary	255125	ISCU	611911	12q23.3
Myopathy with lactic acidosis, hereditary	255125	HML	611911	12q23.3
Myopathy, X-linked, with excessive autophagy	310440	MEAX		Xq28
Myopathy, X-linked, with excessive autophagy	310440	XMEA		Xq28
Myopathy, X-linked, with postural muscle atrophy	300696	FHL1	300163	Xq26.3
Myopathy, X-linked, with postural muscle atrophy	300696	SLIM1	300163	Xq26.3
Myopathy, X-linked, with postural muscle atrophy	300696	XMPMA	300163	Xq26.3
Myopathy, X-linked, with postural muscle atrophy	300696	KYOT	300163	Xq26.3
Myopathy, X-linked, with postural muscle atrophy	300696	FHL1A	300163	Xq26.3
Myopathy, X-linked, with postural muscle atrophy	300696	FHL1B	300163	Xq26.3
Myopathy, actin, congenital, with cores	161800	ACTA1	102610	1q42.13
Myopathy, actin, congenital, with cores	161800	ASMA	102610	1q42.13
Myopathy, actin, congenital, with cores	161800	NEM3	102610	1q42.13
Myopathy, actin, congenital, with cores	161800	CFTD1	102610	1q42.13
Myopathy, actin, congenital, with excess of thin myofilaments	161800	ACTA1	102610	1q42.13
Myopathy, actin, congenital, with excess of thin myofilaments	161800	ASMA	102610	1q42.13
Myopathy, actin, congenital, with excess of thin myofilaments	161800	NEM3	102610	1q42.13
Myopathy, actin, congenital, with excess of thin myofilaments	161800	CFTD1	102610	1q42.13
Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	614399	MEGF10	612453	5q23.2
Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	614399	KIAA1780	612453	5q23.2
Myopathy, areflexia, respiratory distress, and dysphagia, early-onset	614399	EMARDD	612453	5q23.2
Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant	614399	MEGF10	612453	5q23.2
Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant	614399	KIAA1780	612453	5q23.2
Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant	614399	EMARDD	612453	5q23.2
Myopathy, centronuclear	160150	DNM2	602378	19p13.2
Myopathy, centronuclear	160150	CMTDIB	602378	19p13.2
Myopathy, centronuclear	160150	CMTDI1	602378	19p13.2
Myopathy, centronuclear	160150	CMT2M	602378	19p13.2
Myopathy, centronuclear	160150	LCCS5	602378	19p13.2
Myopathy, centronuclear, 3	614408	MYF6	159991	12q21.31
Myopathy, centronuclear, 3	614408	CNM3	159991	12q21.31
Myopathy, centronuclear, 4	614807	CCDC78	614666	16p13.3
Myopathy, centronuclear, 4	614807	C16orf25	614666	16p13.3
Myopathy, centronuclear, 4	614807	CNM4	614666	16p13.3
Myopathy, centronuclear, autosomal recessive	255200	BIN1	601248	2q14.3
Myopathy, centronuclear, autosomal recessive	255200	AMPHL	601248	2q14.3
Myopathy, congenital, Compton-North	612540	CNTN1	600016	12q12
Myopathy, congenital, with fiber-type disproportion 1	255310	ACTA1	102610	1q42.13
Myopathy, congenital, with fiber-type disproportion 1	255310	ASMA	102610	1q42.13
Myopathy, congenital, with fiber-type disproportion 1	255310	NEM3	102610	1q42.13
Myopathy, congenital, with fiber-type disproportion 1	255310	CFTD1	102610	1q42.13
Myopathy, congenital, with fiber-type disproportion	255310	SEPN1	606210	1p36.11
Myopathy, congenital, with fiber-type disproportion	255310	SELN	606210	1p36.11
Myopathy, congenital, with fiber-type disproportion	255310	RSMD1	606210	1p36.11
Myopathy, congenital, with fiber-type disproportion	255310	CFTD	606210	1p36.11
Myopathy, congenital, with fiber-type disproportion, X-linked	300580	CFTDX		Xq13.1-q22.1
Myopathy, distal 2	606070	MATR3	164015	5q31.2
Myopathy, distal 2	606070	MPD2	164015	5q31.2
Myopathy, distal 3	610099	MPD3		8p22-q11
Myopathy, distal, 4	614065	FLNC	102565	7q32.1
Myopathy, distal, 4	614065	FLN2	102565	7q32.1
Myopathy, distal, 4	614065	ABPA	102565	7q32.1
Myopathy, distal, 4	614065	ABPL	102565	7q32.1
Myopathy, distal, 4	614065	MFM5	102565	7q32.1
Myopathy, distal, 4	614065	MPD4	102565	7q32.1
Myopathy, distal, Tateyama type	614321	CAV3	601253	3p25.3
Myopathy, distal, Tateyama type	614321	LGMD1C	601253	3p25.3
Myopathy, distal, Tateyama type	614321	LQT9	601253	3p25.3
Myopathy, distal, with anterior tibial onset	606768	DYSF	603009	2p13.2
Myopathy, distal, with anterior tibial onset	606768	LGMD2B	603009	2p13.2
Myopathy, distal, with anterior tibial onset	606768	MMD1	603009	2p13.2
Myopathy, early-onset, with fatal cardiomyopathy	611705	TTN	188840	2q31.2
Myopathy, early-onset, with fatal cardiomyopathy	611705	CMD1G	188840	2q31.2
Myopathy, early-onset, with fatal cardiomyopathy	611705	TMD	188840	2q31.2
Myopathy, early-onset, with fatal cardiomyopathy	611705	LGMD2J	188840	2q31.2
Myopathy, early-onset, with fatal cardiomyopathy	611705	MPRM	188840	2q31.2
Myopathy, early-onset, with fatal cardiomyopathy	611705	HMERF	188840	2q31.2
Myopathy, early-onset, with fatal cardiomyopathy	611705	EOMFC	188840	2q31.2
Myopathy, hyaline body	255160	MHB		3p22.2-p21.32
Myopathy, lactic acidosis, and sideroblastic anemia 2	613561	YARS2	610957	12p11.21
Myopathy, lactic acidosis, and sideroblastic anemia 2	613561	TYRRS	610957	12p11.21
Myopathy, lactic acidosis, and sideroblastic anemia 2	613561	MLASA2	610957	12p11.21
Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay	613076	GFER	600924	16p13.3
Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay	613076	ERV1	600924	16p13.3
Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay	613076	ALR	600924	16p13.3
Myopathy, myofibrillar, 1	601419	DES	125660	2q35
Myopathy, myofibrillar, 1	601419	CMD1I	125660	2q35
Myopathy, myofibrillar, 1	601419	MFM1	125660	2q35
Myopathy, myofibrillar, 1	601419	SCPNK	125660	2q35
Myopathy, myofibrillar, 1	601419	ARVD7	125660	2q35
Myopathy, myofibrillar, 1	601419	ARVC7	125660	2q35
Myopathy, myofibrillar, 1	601419	LGMD2R	125660	2q35
Myopathy, myofibrillar, 2	608810	CRYAB	123590	11q23.1
Myopathy, myofibrillar, 2	608810	CRYA2	123590	11q23.1
Myopathy, myofibrillar, 2	608810	CTPP2	123590	11q23.1
Myopathy, myofibrillar, 2	608810	CMD1II	123590	11q23.1
Myopathy, myofibrillar, 2	608810	CTRCT16	123590	11q23.1
Myopathy, myofibrillar, 2	608810	MFM2	123590	11q23.1
Myopathy, myofibrillar, 3	609200	MYOT	604103	5q31.2
Myopathy, myofibrillar, 3	609200	TTOD	604103	5q31.2
Myopathy, myofibrillar, 3	609200	MFM3	604103	5q31.2
Myopathy, myofibrillar, 4	609452	LDB3	605906	10q23.2
Myopathy, myofibrillar, 4	609452	ZASP	605906	10q23.2
Myopathy, myofibrillar, 4	609452	CYPHER	605906	10q23.2
Myopathy, myofibrillar, 4	609452	KIAA01613	605906	10q23.2
Myopathy, myofibrillar, 4	609452	CMD1C	605906	10q23.2
Myopathy, myofibrillar, 4	609452	LVNC3	605906	10q23.2
Myopathy, myofibrillar, 4	609452	MFM4	605906	10q23.2
Myopathy, myofibrillar, 5	609524	FLNC	102565	7q32.1
Myopathy, myofibrillar, 5	609524	FLN2	102565	7q32.1
Myopathy, myofibrillar, 5	609524	ABPA	102565	7q32.1
Myopathy, myofibrillar, 5	609524	ABPL	102565	7q32.1
Myopathy, myofibrillar, 5	609524	MFM5	102565	7q32.1
Myopathy, myofibrillar, 5	609524	MPD4	102565	7q32.1
Myopathy, myofibrillar, 6	612954	BAG3	603883	10q26.11
Myopathy, myofibrillar, 6	612954	MFM6	603883	10q26.11
Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related	613869	CRYAB	123590	11q23.1
Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related	613869	CRYA2	123590	11q23.1
Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related	613869	CTPP2	123590	11q23.1
Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related	613869	CMD1II	123590	11q23.1
Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related	613869	CTRCT16	123590	11q23.1
Myopathy, myofibrillar, fatal infantile hypertrophy, alpha-B crystallin-related	613869	MFM2	123590	11q23.1
Myopathy, myosin storage	608358	MYH7	160760	14q11.2
Myopathy, myosin storage	608358	CMH1	160760	14q11.2
Myopathy, myosin storage	608358	MPD1	160760	14q11.2
Myopathy, myosin storage	608358	CMD1S	160760	14q11.2
Myopathy, myosin storage	608358	SPMM	160760	14q11.2
Myopathy, myosin storage	608358	SPMD	160760	14q11.2
Myopathy, proximal, with early respiratory muscle involvement	603689	TTN	188840	2q31.2
Myopathy, proximal, with early respiratory muscle involvement	603689	CMD1G	188840	2q31.2
Myopathy, proximal, with early respiratory muscle involvement	603689	TMD	188840	2q31.2
Myopathy, proximal, with early respiratory muscle involvement	603689	LGMD2J	188840	2q31.2
Myopathy, proximal, with early respiratory muscle involvement	603689	MPRM	188840	2q31.2
Myopathy, proximal, with early respiratory muscle involvement	603689	HMERF	188840	2q31.2
Myopathy, proximal, with early respiratory muscle involvement	603689	EOMFC	188840	2q31.2
Myopathy, reducing body, X-linked, childhood-onset	300718	FHL1	300163	Xq26.3
Myopathy, reducing body, X-linked, childhood-onset	300718	SLIM1	300163	Xq26.3
Myopathy, reducing body, X-linked, childhood-onset	300718	XMPMA	300163	Xq26.3
Myopathy, reducing body, X-linked, childhood-onset	300718	KYOT	300163	Xq26.3
Myopathy, reducing body, X-linked, childhood-onset	300718	FHL1A	300163	Xq26.3
Myopathy, reducing body, X-linked, childhood-onset	300718	FHL1B	300163	Xq26.3
Myopathy, reducing body, X-linked, severe early-onset	300717	FHL1	300163	Xq26.3
Myopathy, reducing body, X-linked, severe early-onset	300717	SLIM1	300163	Xq26.3
Myopathy, reducing body, X-linked, severe early-onset	300717	XMPMA	300163	Xq26.3
Myopathy, reducing body, X-linked, severe early-onset	300717	KYOT	300163	Xq26.3
Myopathy, reducing body, X-linked, severe early-onset	300717	FHL1A	300163	Xq26.3
Myopathy, reducing body, X-linked, severe early-onset	300717	FHL1B	300163	Xq26.3
Myopathy, spheroid body	182920	MYOT	604103	5q31.2
Myopathy, spheroid body	182920	TTOD	604103	5q31.2
Myopathy, spheroid body	182920	MFM3	604103	5q31.2
Myopathy, tubular aggregate	160565	STIM1	605921	11p15.4
Myopathy, tubular aggregate	160565	TAM	605921	11p15.4
Myopathy, tubular aggregate	160565	IMD10	605921	11p15.4
Myopia 10	609259	MYP10		8p23
Myopia 11	609994	MYP11		4q22-q27
Myopia 12	609995	MYP12		2q37.1
Myopia 13	300613	MYP13		Xq23-q27.2
Myopia 14	610320	MYP14		1p36
Myopia 15	612717	MYP15		10q21.1
Myopia 16	612554	MYP16		5p15.33-p15.2
Myopia 17	608367	MYP17		7p15
Myopia 17	608367	MYP4		7p15
Myopia 18	255500	MYP18		14q22.1-q24.2
Myopia 19	613969	MYP19		5p15.1-p13.3
Myopia 20, autosomal dominant	614166	MYP20		13q12.12
Myopia 21, autosomal dominant	614167	ZNF644	614159	1p22.2
Myopia 21, autosomal dominant	614167	MYP21	614159	1p22.2
Myopia 22, autosomal dominant	615420	CCDC111	615421	4q35.1
Myopia 22, autosomal dominant	615420	MYP22	615421	4q35.1
Myopia 23, autosomal recessive	615431	LRPAP1	104225	4p16.3
Myopia 23, autosomal recessive	615431	A2MRAP	104225	4p16.3
Myopia 23, autosomal recessive	615431	MYP23	104225	4p16.3
Myopia 5	608474	MYP5		17q21-q22
Myopia 6	608908	SCO2	604272	22q13.33
Myopia 6	608908	CEMCOX1	604272	22q13.33
Myopia 6	608908	MYP6	604272	22q13.33
Myopia 7	609256	MYP7		11p13
Myopia 8	609257	MYP8		3q26
Myopia 9	609258	MYP9		4q12
Myopia, high, with cataract and vitreoretinal degeneration	614292	LEPREL1	610341	3q28
Myopia, high, with cataract and vitreoretinal degeneration	614292	P3H2	610341	3q28
Myopia, high, with cataract and vitreoretinal degeneration	614292	MCVD	610341	3q28
Myopia-1	310460	MYP1		Xq28
Myopia-2	160700	MYP2		18p11.31
Myopia-3	603221	MYP3		12q21-q23
Myopia-6	608908	MYP6		22q12
Myosclerosis, congenital	255600	COL6A2	120240	21q22.3
Myotonia congenita, atypical, acetazolamide-responsive	608390	SCN4A	603967	17q23.3
Myotonia congenita, atypical, acetazolamide-responsive	608390	HYPP	603967	17q23.3
Myotonia congenita, atypical, acetazolamide-responsive	608390	NAC1A	603967	17q23.3
Myotonia congenita, atypical, acetazolamide-responsive	608390	HOKPP2	603967	17q23.3
Myotonia congenita, dominant	160800	CLCN1	118425	7q34
Myotonia congenita, recessive	255700	CLCN1	118425	7q34
Myotonia levior, recessive		CLCN1	118425	7q34
Myotonic dystrophy 1	160900	DMPK	605377	19q13.32
Myotonic dystrophy 1	160900	DM	605377	19q13.32
Myotonic dystrophy 1	160900	DMK	605377	19q13.32
Myotonic dystrophy 2	602668	ZNF9	116955	3q21.3
Myotonic dystrophy 2	602668	CNBP1	116955	3q21.3
Myotonic dystrophy 2	602668	DM2	116955	3q21.3
Myotonic dystrophy 2	602668	PROMM	116955	3q21.3
Myotubular myopathy, X-linked	310400	MTM1	300415	Xq28
Myotubular myopathy, X-linked	310400	MTMX	300415	Xq28
Myxoid liposarcoma	613488	DDIT3	126337	12q13.3
Myxoid liposarcoma	613488	GADD153	126337	12q13.3
Myxoid liposarcoma	613488	CHOP10	126337	12q13.3
Myxoma, intracardiac	255960	PRKAR1A	188830	17q24.2
Myxoma, intracardiac	255960	TSE1	188830	17q24.2
Myxoma, intracardiac	255960	CNC1	188830	17q24.2
Myxoma, intracardiac	255960	CAR	188830	17q24.2
Myxoma, intracardiac	255960	PPNAD1	188830	17q24.2
Myxoma, intracardiac	255960	ACRDYS1	188830	17q24.2
N-acetylglutamate synthase deficiency	237310	NAGS	608300	17q21.31
N-terminal acetyltransferase deficiency	300855	NAA10	300013	Xq28
N-terminal acetyltransferase deficiency	300855	ARD1A	300013	Xq28
N-terminal acetyltransferase deficiency	300855	ARD1	300013	Xq28
N-terminal acetyltransferase deficiency	300855	TE2	300013	Xq28
N-terminal acetyltransferase deficiency	300855	NATD	300013	Xq28
N-terminal acetyltransferase deficiency	300855	MCOPS1	300013	Xq28
NOR polyagglutination syndrome	111400	A4GALT	607922	22q13.2
NOR polyagglutination syndrome	111400	P1PK	607922	22q13.2
Nablus mask-like facial syndrome	608156	NMLFS		8q22.1
Nablus mask-like facial syndrome	608156	DEL8q22.1		8q22.1
Nablus mask-like facial syndrome	608156	C8DELq22.1		8q22.1
Naegeli-Franceschetti-Jadassohn syndrome	161000	KRT14	148066	17q21.2
Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails)	614157	FZD6	603409	8q22.3
Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails)	614157	NDNC10	603409	8q22.3
Nail disorder, nonsyndromic congenital, 3, (leukonychia)	151600	PLCD1	602142	3p22.2
Nail disorder, nonsyndromic congenital, 3, (leukonychia)	151600	NDNC3	602142	3p22.2
Nail disorder, nonsyndromic congenital, 9	614149	NDNC9		17q25.1-q25.3
Nail dysplasia, isolated congenital	605779	NDIC		17p13
Nail-patella syndrome	161200	LMX1B	602575	9q33.3
Nail-patella syndrome	161200	NPS1	602575	9q33.3
Nance-Horan syndrome	302350	NHS	300457	Xp22.13
Nance-Horan syndrome	302350	CXN	300457	Xp22.13
Nance-Horan syndrome	302350	CTRCT40	300457	Xp22.13
Nanophthalmos 2	609549	MFRP	606227	11q23.3
Nanophthalmos 2	609549	MCOP5	606227	11q23.3
Nanophthalmos 2	609549	NNO2	606227	11q23.3
Nanophthalmos 3	611897	NNO3		2q11-q14
Nanophthalmos-1	600165	NNO1		11p
Narcolepsy 1	161400	HCRT	602358	17q21.2
Narcolepsy 1	161400	OX	602358	17q21.2
Narcolepsy 1	161400	NRCLP1	602358	17q21.2
Narcolepsy 2	605841	NRCLP2		4p13-q21
Narcolepsy 3	609039	NRCLP3		21q11.2
Narcolepsy 6	614223	NRCLP6		19p13.2
Narcolepsy 7	614250	MOG	159465	6p22.1
Narcolepsy 7	614250	NRCLP7	159465	6p22.1
Nasopharyngeal carcinoma	607107	TP53	191170	17p13.1
Nasopharyngeal carcinoma	607107	P53	191170	17p13.1
Nasopharyngeal carcinoma	607107	LFS1 	191170	17p13.1
Nasopharyngeal carcinoma	607107	BCC7	191170	17p13.1
Nasu-Hakola disease	221770	TREM2	605086	6p21.1
Nasu-Hakola disease	221770	TYROBP	604142	19q13.12
Nasu-Hakola disease	221770	PLOSL	604142	19q13.12
Nasu-Hakola disease	221770	DAP12	604142	19q13.12
Native American myopathy	255995	STAC3	615521	12q13.3
Native American myopathy	255995	NAM	615521	12q13.3
Natural killer cell and glucocorticoid deficiency with DNA repair defect	609981	MCM4	602638	8q11.21
Natural killer cell and glucocorticoid deficiency with DNA repair defect	609981	NKGCD	602638	8q11.21
Natural killer cell and glucocorticoid deficiency with DNA repair defect	609981	NKCD	602638	8q11.21
Naxos disease	601214	JUP	173325	17q21.2
Naxos disease	601214	DP3	173325	17q21.2
Naxos disease	601214	PDGB	173325	17q21.2
Naxos disease	601214	ARVD12	173325	17q21.2
Nemaline myopathy 1, autosomal dominant or recessive	609284	TPM3	191030	1q21.3
Nemaline myopathy 1, autosomal dominant or recessive	609284	NEM1	191030	1q21.3
Nemaline myopathy 1, autosomal dominant or recessive	609284	CFTD	191030	1q21.3
Nemaline myopathy 1, autosomal dominant or recessive	609284	CAPM1	191030	1q21.3
Nemaline myopathy 2, autosomal recessive	256030	NEB	161650	2q23.3
Nemaline myopathy 2, autosomal recessive	256030	NEM2	161650	2q23.3
Nemaline myopathy 3, autosomal dominant or recessive	161800	ACTA1	102610	1q42.13
Nemaline myopathy 3, autosomal dominant or recessive	161800	ASMA	102610	1q42.13
Nemaline myopathy 3, autosomal dominant or recessive	161800	NEM3	102610	1q42.13
Nemaline myopathy 3, autosomal dominant or recessive	161800	CFTD1	102610	1q42.13
Nemaline myopathy 4, autosomal dominant	609285	TPM2	190990	9p13.3
Nemaline myopathy 4, autosomal dominant	609285	TMSB	190990	9p13.3
Nemaline myopathy 4, autosomal dominant	609285	AMCD1	190990	9p13.3
Nemaline myopathy 4, autosomal dominant	609285	DA1	190990	9p13.3
Nemaline myopathy 4, autosomal dominant	609285	DA2B	190990	9p13.3
Nemaline myopathy 4, autosomal dominant	609285	NEM4	190990	9p13.3
Nemaline myopathy 5, Amish type	605355	TNNT1	191041	19q13.42
Nemaline myopathy 5, Amish type	605355	ANM	191041	19q13.42
Nemaline myopathy 5, Amish type	605355	NEM5	191041	19q13.42
Nemaline myopathy 6, autosomal dominant	609273	KBTBD13	613727	15q22.31
Nemaline myopathy 6, autosomal dominant	609273	NEM6	613727	15q22.31
Nemaline myopathy 7, autosomal recessive	610687	CFL2	601443	14q13.1
Nemaline myopathy 7, autosomal recessive	610687	NEM7	601443	14q13.1
Nemaline myopathy 8, autosomal recessive	615348	KLHL40	615340	3p22.1
Nemaline myopathy 8, autosomal recessive	615348	SYRP	615340	3p22.1
Nemaline myopathy 8, autosomal recessive	615348	KBTBD5	615340	3p22.1
Nemaline myopathy 8, autosomal recessive	615348	NEM8	615340	3p22.1
Nephrogenic syndrome of inappropriate antidiuresis	300539	AVPR2	300538	Xq28
Nephrogenic syndrome of inappropriate antidiuresis	300539	DIR	300538	Xq28
Nephrogenic syndrome of inappropriate antidiuresis	300539	DI1	300538	Xq28
Nephrogenic syndrome of inappropriate antidiuresis	300539	ADHR	300538	Xq28
Nephrolithiasis, type I	310468	CLCN5	300008	Xp11.23-p11.22
Nephrolithiasis, type I	310468	CLCK2	300008	Xp11.23-p11.22
Nephrolithiasis, type I	310468	NPHL2	300008	Xp11.23-p11.22
Nephrolithiasis, type I	310468	DENTS	300008	Xp11.23-p11.22
Nephrolithiasis, type I	310468	NPHL1	300008	Xp11.23-p11.22
Nephrolithiasis/osteoporosis, hypophosphatemic, 1	612286	SLC34A1	182309	5q35.3
Nephrolithiasis/osteoporosis, hypophosphatemic, 1	612286	SLC17A2	182309	5q35.3
Nephrolithiasis/osteoporosis, hypophosphatemic, 1	612286	NPT2	182309	5q35.3
Nephrolithiasis/osteoporosis, hypophosphatemic, 1	612286	NPHLOP1	182309	5q35.3
Nephrolithiasis/osteoporosis, hypophosphatemic, 1	612286	FRTS2	182309	5q35.3
Nephrolithiasis/osteoporosis, hypophosphatemic, 2	612287	SLC9A3R1	604990	17q25.1
Nephrolithiasis/osteoporosis, hypophosphatemic, 2	612287	EBP50	604990	17q25.1
Nephrolithiasis/osteoporosis, hypophosphatemic, 2	612287	NHERF1	604990	17q25.1
Nephrolithiasis/osteoporosis, hypophosphatemic, 2	612287	NPHLOP2	604990	17q25.1
Nephronophthisis 1, juvenile	256100	NPHP1	607100	2q13
Nephronophthisis 1, juvenile	256100	NPH1	607100	2q13
Nephronophthisis 1, juvenile	256100	SLSN1	607100	2q13
Nephronophthisis 1, juvenile	256100	JBTS4	607100	2q13
Nephronophthisis 11	613550	TMEM67	609884	8q22.1
Nephronophthisis 11	613550	MKS3	609884	8q22.1
Nephronophthisis 11	613550	JBTS6	609884	8q22.1
Nephronophthisis 11	613550	NPHP11	609884	8q22.1
Nephronophthisis 12	613820	TTC21B	612014	2q24.3
Nephronophthisis 12	613820	THM1	612014	2q24.3
Nephronophthisis 12	613820	NPHP12	612014	2q24.3
Nephronophthisis 12	613820	SRTD4	612014	2q24.3
Nephronophthisis 12	613820	ATD4	612014	2q24.3
Nephronophthisis 13	615377	WDR19	608151	4p14
Nephronophthisis 13	615377	SRTD5	608151	4p14
Nephronophthisis 13	615377	ATD5	608151	4p14
Nephronophthisis 13	615377	NPHP13	608151	4p14
Nephronophthisis 13	615377	CED4	608151	4p14
Nephronophthisis 14	614844	ZNF423	604557	16q12.1
Nephronophthisis 14	614844	ZFP423	604557	16q12.1
Nephronophthisis 14	614844	OAZ	604557	16q12.1
Nephronophthisis 14	614844	KIAA0760	604557	16q12.1
Nephronophthisis 14	614844	NPHP14	604557	16q12.1
Nephronophthisis 14	614844	JBTS19	604557	16q12.1
Nephronophthisis 15	614845	CEP164	614848	11q23.3
Nephronophthisis 15	614845	KIAA1052	614848	11q23.3
Nephronophthisis 16	615382	ANKS6	615370	9q22.33
Nephronophthisis 16	615382	PKDR1	615370	9q22.33
Nephronophthisis 16	615382	NPHP16	615370	9q22.33
Nephronophthisis 2, infantile	602088	INVS	243305	9q31.1
Nephronophthisis 2, infantile	602088	INV	243305	9q31.1
Nephronophthisis 2, infantile	602088	NPHP2	243305	9q31.1
Nephronophthisis 2, infantile	602088	NPH2	243305	9q31.1
Nephronophthisis 3	604387	NPHP3	608002	3q22.1
Nephronophthisis 3	604387	NPH3	608002	3q22.1
Nephronophthisis 3	604387	RHPD1	608002	3q22.1
Nephronophthisis 3	604387	MKS7	608002	3q22.1
Nephronophthisis 4	606966	NPHP4	607215	1p36.31
Nephronophthisis 4	606966	SLSN4	607215	1p36.31
Nephronophthisis 7	611498	GLIS2	608539	16p13.3
Nephronophthisis 7	611498	NPHP7	608539	16p13.3
Nephronophthisis-like nephropathy 1	613159	XPNPEP3	613553	22q13.2
Nephronophthisis-like nephropathy 1	613159	APP3	613553	22q13.2
Nephronophthisis-like nephropathy 1	613159	NPHPL1	613553	22q13.2
Nephropathy due to CFHR5 deficiency	614809	CFHR5	608593	1q31.3
Nephropathy due to CFHR5 deficiency	614809	CFHL5	608593	1q31.3
Nephropathy due to CFHR5 deficiency	614809	FHR5	608593	1q31.3
Nephropathy due to CFHR5 deficiency	614809	CFHR5D	608593	1q31.3
Nephropathy with pretibial epidermolysis bullosa and deafness	609057	CD151	602243	11p15.5
Nephropathy with pretibial epidermolysis bullosa and deafness	609057	PETA3	602243	11p15.5
Nephropathy with pretibial epidermolysis bullosa and deafness	609057	SFA1	602243	11p15.5
Nephropathy with pretibial epidermolysis bullosa and deafness	609057	MER2	602243	11p15.5
Nephropathy, progressive, with deafness	609469	NEDE		11q24
Nephropathy-hypertension	161900	RFH1		1q21
Nephropathy-hypertension	161900	AORF		1q21
Nephrotic syndrome, type 1	256300	NPHS1	602716	19q13.12
Nephrotic syndrome, type 1	256300	NPHN	602716	19q13.12
Nephrotic syndrome, type 2	600995	PDCN	604766	1q25.2
Nephrotic syndrome, type 2	600995	NPHS2	604766	1q25.2
Nephrotic syndrome, type 2	600995	SRN1	604766	1q25.2
Nephrotic syndrome, type 3	610725	PLCE1	608414	10q23.33
Nephrotic syndrome, type 3	610725	KIAA1516	608414	10q23.33
Nephrotic syndrome, type 3	610725	NPHS3	608414	10q23.33
Nephrotic syndrome, type 4	256370	WT1	607102	11p13
Nephrotic syndrome, type 4	256370	NPHS4	607102	11p13
Nephrotic syndrome, type 5, with or without ocular abnormalities	614199	LAMB2	150325	3p21.31
Nephrotic syndrome, type 5, with or without ocular abnormalities	614199	LAMS	150325	3p21.31
Nephrotic syndrome, type 5, with or without ocular abnormalities	614199	NPHS5	150325	3p21.31
Nephrotic syndrome, type 6	614196	PTPRO	600579	12p12.3
Nephrotic syndrome, type 6	614196	GLEPP1	600579	12p12.3
Nephrotic syndrome, type 6	614196	NPHS6	600579	12p12.3
Nephrotic syndrome, type 7	615008	DGKE	601440	17q22
Nephrotic syndrome, type 7	615008	NPHS7	601440	17q22
Nephrotic syndrome, type 9	615573	ADCK4	615567	19q13.2
Nephrotic syndrome, type 9	615573	NPHS9	615567	19q13.2
Nestor-Guillermo progeria syndrome	614008	BANF1	603811	11q13.1
Nestor-Guillermo progeria syndrome	614008	BAF	603811	11q13.1
Nestor-Guillermo progeria syndrome	614008	NGPS	603811	11q13.1
Netherton syndrome	256500	SPINK5	605010	5q32
Netherton syndrome	256500	LEKTI	605010	5q32
Neural tube defects	182940	FUZ	610622	19q13.33
Neural tube defects	182940	NTD	610622	19q13.33
Neural tube defects	182940	VANGL1	610132	1p13.1
Neural tube defects	182940	STBM2	610132	1p13.1
Neuroaxonal neurodegeneration, infantile, with facial dysmophism	615419	NALCN	611549	13q33.1
Neuroaxonal neurodegeneration, infantile, with facial dysmophism	615419	INNFD	611549	13q33.1
Neuroblastoma with Hirschsprung disease	613013	PMX2B	603851	4p13
Neuroblastoma with Hirschsprung disease	613013	NBPHOX	603851	4p13
Neuroblastoma with Hirschsprung disease	613013	PHOX2B	603851	4p13
Neuroblastoma with Hirschsprung disease	613013	NBLST2	603851	4p13
Neuroblastoma	256700	NME1	156490	17q21.33
Neuroblastoma	256700	NM23	156490	17q21.33
Neurodegeneration due to cerebral folate transport deficiency	613068	FOLR1	136430	11q13.4
Neurodegeneration with brain iron accululation 5	300894	WDR45	300526	Xp11.23
Neurodegeneration with brain iron accululation 5	300894	WIPI4	300526	Xp11.23
Neurodegeneration with brain iron accululation 5	300894	NBIA5	300526	Xp11.23
Neurodegeneration with brain iron accumulation 1	234200	PANK2	606157	20p13
Neurodegeneration with brain iron accumulation 1	234200	NBIA1	606157	20p13
Neurodegeneration with brain iron accumulation 1	234200	PKAN	606157	20p13
Neurodegeneration with brain iron accumulation 1	234200	HARP	606157	20p13
Neurodegeneration with brain iron accumulation 2B	610217	PLA2G6	603604	22q13.1
Neurodegeneration with brain iron accumulation 2B	610217	IPLA2	603604	22q13.1
Neurodegeneration with brain iron accumulation 2B	610217	INAD1	603604	22q13.1
Neurodegeneration with brain iron accumulation 2B	610217	NBIA2B	603604	22q13.1
Neurodegeneration with brain iron accumulation 2B	610217	NBIA2A	603604	22q13.1
Neurodegeneration with brain iron accumulation 2B	610217	PARK14	603604	22q13.1
Neurodegeneration with brain iron accumulation 3	606159	FTL	134790	19q13.33
Neurodegeneration with brain iron accumulation 3	606159	NBIA3	134790	19q13.33
Neurodegeneration with brain iron accumulation 3	606159	LFTD	134790	19q13.33
Neurodegeneration with brain iron accumulation 4	614298	C19orf12	614297	19q12
Neurodegeneration with brain iron accumulation 4	614298	NBIA4	614297	19q12
Neurodegeneration with brain iron accumulation 4	614298	SPG43	614297	19q12
Neuroepithelioma	612219	EWSR1	133450	22q12.2
Neuroepithelioma	612219	EWS	133450	22q12.2
Neurofibromatosis, familial spinal	162210	NF1	613113	17q11.2
Neurofibromatosis, familial spinal	162210	VRNF	613113	17q11.2
Neurofibromatosis, familial spinal	162210	WSS	613113	17q11.2
Neurofibromatosis, familial spinal	162210	NFNS	613113	17q11.2
Neurofibromatosis, type 1	162200	NF1	613113	17q11.2
Neurofibromatosis, type 1	162200	VRNF	613113	17q11.2
Neurofibromatosis, type 1	162200	WSS	613113	17q11.2
Neurofibromatosis, type 1	162200	NFNS	613113	17q11.2
Neurofibromatosis, type 2	101000	NF2	607379	22q12.2
Neurofibromatosis-Noonan syndrome	601321	NF1	613113	17q11.2
Neurofibromatosis-Noonan syndrome	601321	VRNF	613113	17q11.2
Neurofibromatosis-Noonan syndrome	601321	WSS	613113	17q11.2
Neurofibromatosis-Noonan syndrome	601321	NFNS	613113	17q11.2
Neurofibrosarcoma		MXI1	600020	10q25.2
Neuromuscular disease, congenital, with uniform type 1 fiber	117000	RYR1	180901	19q13.2
Neuromuscular disease, congenital, with uniform type 1 fiber	117000	MHS	180901	19q13.2
Neuromuscular disease, congenital, with uniform type 1 fiber	117000	CCO	180901	19q13.2
Neuromyotonia and axonal neuropathy, autosomal recessive	137200	HINT1	601314	5q23.3
Neuromyotonia and axonal neuropathy, autosomal recessive	137200	PRKCNH1	601314	5q23.3
Neuromyotonia and axonal neuropathy, autosomal recessive	137200	NMAN	601314	5q23.3
Neuronopathy, distal hereditary motor, type I	182960	DHMN1		7q34-q36
Neuronopathy, distal hereditary motor, type IIC	613376	HSPB3	604624	5q11.2
Neuronopathy, distal hereditary motor, type IIC	613376	HSPL27	604624	5q11.2
Neuronopathy, distal hereditary motor, type IIC	613376	HMN2C	604624	5q11.2
Neuronopathy, distal hereditary motor, type IIC	613376	DHMN2C	604624	5q11.2
Neuronopathy, distal hereditary motor, type IID	615575	FBXO38	608533	5q32
Neuronopathy, distal hereditary motor, type IID	615575	FBX38	608533	5q32
Neuronopathy, distal hereditary motor, type IID	615575	MOKA	608533	5q32
Neuronopathy, distal hereditary motor, type IID	615575	HMN2D	608533	5q32
Neuronopathy, distal hereditary motor, type VB	614751	REEP1	609139	2p11.2
Neuronopathy, distal hereditary motor, type VB	614751	C2ORF23	609139	2p11.2
Neuronopathy, distal hereditary motor, type VB	614751	SPG31	609139	2p11.2
Neuronopathy, distal hereditary motor, type VB	614751	HMN5B	609139	2p11.2
Neuronopathy, distal hereditary motor, type VI	604320	IGHMBP2	600502	11q13.3
Neuronopathy, distal hereditary motor, type VI	604320	SMUBP2	600502	11q13.3
Neuronopathy, distal hereditary motor, type VI	604320	CATF1	600502	11q13.3
Neuronopathy, distal hereditary motor, type VI	604320	SMARD1	600502	11q13.3
Neuronopathy, distal hereditary motor, type VI	604320	HMN6	600502	11q13.3
Neuronopathy, distal hereditary motor, type VIIA	158580	SLC5A7	608761	2q12.3
Neuronopathy, distal hereditary motor, type VIIA	158580	CHT1	608761	2q12.3
Neuronopathy, distal hereditary motor, type VIIA	158580	HMN7A	608761	2q12.3
Neuropathy, congenital hypomyelinating, 1	605253	EGR2	129010	10q21.3
Neuropathy, congenital hypomyelinating, 1	605253	KROX20	129010	10q21.3
Neuropathy, congenital hypomyelinating	605253	MPZ	159440	1q23.3
Neuropathy, congenital hypomyelinating	605253	CMT1B	159440	1q23.3
Neuropathy, congenital hypomyelinating	605253	CMTDID	159440	1q23.3
Neuropathy, congenital hypomyelinating	605253	CHM	159440	1q23.3
Neuropathy, congenital hypomyelinating	605253	DSS	159440	1q23.3
Neuropathy, distal hereditary motor, Jerash type	605726	HMNJ		9p21.1-p12
Neuropathy, distal hereditary motor, Jerash type	605726	MNDJ		9p21.1-p12
Neuropathy, distal hereditary motor, type IIA	158590	HSPB8	608014	12q24.23
Neuropathy, distal hereditary motor, type IIA	158590	H11	608014	12q24.23
Neuropathy, distal hereditary motor, type IIA	158590	E2IG1	608014	12q24.23
Neuropathy, distal hereditary motor, type IIA	158590	DHMN2	608014	12q24.23
Neuropathy, distal hereditary motor, type IIA	158590	CMT2L	608014	12q24.23
Neuropathy, distal hereditary motor, type IIA	158590	HMN2A	608014	12q24.23
Neuropathy, distal hereditary motor, type IIB	608634	HSPB1	602195	7q11.23
Neuropathy, distal hereditary motor, type IIB	608634	HSP27	602195	7q11.23
Neuropathy, distal hereditary motor, type IIB	608634	CMT2F	602195	7q11.23
Neuropathy, distal hereditary motor, type IIB	608634	HMN2B	602195	7q11.23
Neuropathy, distal hereditary motor, type VA	600794	BSCL2	606158	11q12.3
Neuropathy, distal hereditary motor, type VA	600794	SPG17	606158	11q12.3
Neuropathy, distal hereditary motor, type VA	600794	HMN5	606158	11q12.3
Neuropathy, distal hereditary motor, type VA	600794	GARS	600287	7p14.3
Neuropathy, distal hereditary motor, type VA	600794	SMAD1	600287	7p14.3
Neuropathy, distal hereditary motor, type VA	600794	CMT2D	600287	7p14.3
Neuropathy, distal hereditary motor, type VA	600794	HMN5	600287	7p14.3
Neuropathy, distal hereditary motor, type VIIB	607641	DCTN1	601143	2p13.1
Neuropathy, distal hereditary motor, type VIIB	607641	HMN7B	601143	2p13.1
Neuropathy, hereditary motor and sensory, Russe type	605285	HK1	142600	10q22.1
Neuropathy, hereditary motor and sensory, Russe type	605285	HKD	142600	10q22.1
Neuropathy, hereditary motor and sensory, Russe type	605285	HMSNR	142600	10q22.1
Neuropathy, hereditary sensory and autonomic, type IA	162400	SPTLC1	605712	9q22.31
Neuropathy, hereditary sensory and autonomic, type IA	162400	LBC1	605712	9q22.31
Neuropathy, hereditary sensory and autonomic, type IA	162400	SPT1	605712	9q22.31
Neuropathy, hereditary sensory and autonomic, type IA	162400	HSN1	605712	9q22.31
Neuropathy, hereditary sensory and autonomic, type IA	162400	HSAN	605712	9q22.31
Neuropathy, hereditary sensory and autonomic, type IC	613640	SPTLC2	605713	14q24.3
Neuropathy, hereditary sensory and autonomic, type IC	613640	KIAA0526	605713	14q24.3
Neuropathy, hereditary sensory and autonomic, type IC	613640	SPT2	605713	14q24.3
Neuropathy, hereditary sensory and autonomic, type IC	613640	LCB2	605713	14q24.3
Neuropathy, hereditary sensory and autonomic, type IC	613640	HSN1C	605713	14q24.3
Neuropathy, hereditary sensory and autonomic, type IC	613640	NSAN1C	605713	14q24.3
Neuropathy, hereditary sensory and autonomic, type II	201300	WNK1	605232	12p13.33
Neuropathy, hereditary sensory and autonomic, type II	201300	PRKWNK1	605232	12p13.33
Neuropathy, hereditary sensory and autonomic, type II	201300	KDP	605232	12p13.33
Neuropathy, hereditary sensory and autonomic, type II	201300	PHA2C	605232	12p13.33
Neuropathy, hereditary sensory and autonomic, type II	201300	HSAN2	605232	12p13.33
Neuropathy, hereditary sensory and autonomic, type II	201300	HSN2	605232	12p13.33
Neuropathy, hereditary sensory and autonomic, type IIB	613115	FAM134B	613114	5p15.1
Neuropathy, hereditary sensory and autonomic, type IIB	613115	HSAN2B	613114	5p15.1
Neuropathy, hereditary sensory and autonomic, type V	608654	NGFB	162030	1p13.2
Neuropathy, hereditary sensory and autonomic, type V	608654	HSAN5	162030	1p13.2
Neuropathy, hereditary sensory and autonomic, type VI	614653	DST	113810	6p12.1
Neuropathy, hereditary sensory and autonomic, type VI	614653	BPAG1	113810	6p12.1
Neuropathy, hereditary sensory and autonomic, type VI	614653	DMH	113810	6p12.1
Neuropathy, hereditary sensory and autonomic, type VI	614653	D6S1101	113810	6p12.1
Neuropathy, hereditary sensory and autonomic, type VI	614653	HSAN6	113810	6p12.1
Neuropathy, hereditary sensory and autonomic, type VI	614653	EBSB2	113810	6p12.1
Neuropathy, hereditary sensory and autonomic, type VII	615548	SCN11A	604385	3p22.2
Neuropathy, hereditary sensory and autonomic, type VII	615548	HSAN7	604385	3p22.2
Neuropathy, hereditary sensory and autonomic, type VII	615548	FEPS3	604385	3p22.2
Neuropathy, hereditary sensory, type IB	608088	HSN1B		3p24-p22
Neuropathy, hereditary sensory, type ID	613708	ATL1	606439	14q22.1
Neuropathy, hereditary sensory, type ID	613708	SPG3A	606439	14q22.1
Neuropathy, hereditary sensory, type ID	613708	HSN1D	606439	14q22.1
Neuropathy, hereditary sensory, type IE	614116	DNMT1	126375	19p13.2
Neuropathy, hereditary sensory, type IE	614116	MCMT	126375	19p13.2
Neuropathy, hereditary sensory, type IE	614116	HSN1E	126375	19p13.2
Neuropathy, hereditary sensory, type IE	614116	ADCADN	126375	19p13.2
Neuropathy, hereditary sensory, type IF	615632	ATL3	609369	11q12.3-q13.1
Neuropathy, hereditary sensory, type IF	615632	HSN1F	609369	11q12.3-q13.1
Neuropathy, hereditary sensory, type IIC	614213	KIF1A	601255	2q37.3
Neuropathy, hereditary sensory, type IIC	614213	ATSV	601255	2q37.3
Neuropathy, hereditary sensory, type IIC	614213	UNC104	601255	2q37.3
Neuropathy, hereditary sensory, type IIC	614213	SPG30	601255	2q37.3
Neuropathy, hereditary sensory, type IIC	614213	HSN2C	601255	2q37.3
Neuropathy, hereditary sensory, type IIC	614213	MRD9	601255	2q37.3
Neuropathy, hereditary sensory, with spastic paraplegia	256840	CCT5	610150	5p15.2
Neuropathy, hereditary sensory, with spastic paraplegia	256840	KIAA0098	610150	5p15.2
Neuropathy, hereditary sensory, with spastic paraplegia	256840	CCTE	610150	5p15.2
Neuropathy, inflammatory demyelinating	139393	PMP22	601097	17p12
Neuropathy, inflammatory demyelinating	139393	CMT1A	601097	17p12
Neuropathy, inflammatory demyelinating	139393	CMT1E	601097	17p12
Neuropathy, inflammatory demyelinating	139393	DSS	601097	17p12
Neuropathy, motor and sensory, Russe type	605285	NMSR		10q23.2
Neuropathy, motor and sensory, Russe type	605285	HMSNR		10q23.2
Neuropathy, paraneoplastic sensory		ELAVL4	168360	1p33
Neuropathy, paraneoplastic sensory		HUD	168360	1p33
Neuropathy, paraneoplastic sensory		PNEM	168360	1p33
Neuropathy, recurrent, with pressure palsies	162500	PMP22	601097	17p12
Neuropathy, recurrent, with pressure palsies	162500	CMT1A	601097	17p12
Neuropathy, recurrent, with pressure palsies	162500	CMT1E	601097	17p12
Neuropathy, recurrent, with pressure palsies	162500	DSS	601097	17p12
Neutral lipid storage disease with myopathy	610717	PNPLA2	609059	11p15.5
Neutral lipid storage disease with myopathy	610717	TTS2	609059	11p15.5
Neutral lipid storage disease with myopathy	610717	ATGL	609059	11p15.5
Neutropenia, alloimmune neonatal		FCGR3B	610665	1q23.3
Neutropenia, cyclic	162800	ELANE	130130	19p13.3
Neutropenia, cyclic	162800	ELA2	130130	19p13.3
Neutropenia, cyclic	162800	SCN1	130130	19p13.3
Neutropenia, neonatal alloimmune		LAG5	151450	Chr.4
Neutropenia, nonimmune chronic idiopathic, of adults	607847	GFI1	600871	1p22.1
Neutropenia, nonimmune chronic idiopathic, of adults	607847	ZNF163	600871	1p22.1
Neutropenia, nonimmune chronic idiopathic, of adults	607847	SCN2	600871	1p22.1
Neutropenia, severe congenital 1, autosomal dominant	202700	ELANE	130130	19p13.3
Neutropenia, severe congenital 1, autosomal dominant	202700	ELA2	130130	19p13.3
Neutropenia, severe congenital 1, autosomal dominant	202700	SCN1	130130	19p13.3
Neutropenia, severe congenital 2, autosomal dominant	613107	GFI1	600871	1p22.1
Neutropenia, severe congenital 2, autosomal dominant	613107	ZNF163	600871	1p22.1
Neutropenia, severe congenital 2, autosomal dominant	613107	SCN2	600871	1p22.1
Neutropenia, severe congenital 3, autosomal recessive	610738	HAX1	605998	1q21.3
Neutropenia, severe congenital 3, autosomal recessive	610738	SCN3	605998	1q21.3
Neutropenia, severe congenital 4, autosomal recessive	612541	G6PC3	611045	17q21.31
Neutropenia, severe congenital 4, autosomal recessive	612541	UGRP	611045	17q21.31
Neutropenia, severe congenital 4, autosomal recessive	612541	SCN4	611045	17q21.31
Neutropenia, severe congenital, 5, autosomal recessive	615285	VPS45A	610035	1q21.2
Neutropenia, severe congenital, 5, autosomal recessive	615285	VPS45	610035	1q21.2
Neutropenia, severe congenital, 5, autosomal recessive	615285	SCN5	610035	1q21.2
Neutropenia, severe congenital, X-linked	300299	WAS	300392	Xp11.23
Neutropenia, severe congenital, X-linked	300299	IMD2	300392	Xp11.23
Neutropenia, severe congenital, X-linked	300299	THC1	300392	Xp11.23
Neutropenia, severe congenital, X-linked	300299	SCNX	300392	Xp11.23
Neutrophil immunodeficiency syndrome	608203	RAC2	602049	22q13.1
Neutrophilia, hereditary	162830	CSF3R	138971	1p34.3
Neutrophilia, hereditary	162830	GCSFR	138971	1p34.3
Nevus, epidermal, somatic	162900	FGFR3	134934	4p16.3
Nevus, epidermal, somatic	162900	ACH	134934	4p16.3
Nevus, epidermal, somatic	162900	PIK3CA	171834	3q26.32
Nevus, epidermal, somatic	162900	CLOVE	171834	3q26.32
Nevus, epidermal, somatic	162900	MCAP	171834	3q26.32
Nevus, epidermal, somatic	162900	MCM	171834	3q26.32
Nevus, epidermal, somatic	162900	MCMTC	171834	3q26.32
Nevus, epidermal, somatic	162900	CWS5	171834	3q26.32
Newfoundland rod-cone dystrophy	607476	RLBP1	180090	15q26.1
Nicolaides-Baraitser syndrome	601358	SMARCA2	600014	9p24.3
Nicolaides-Baraitser syndrome	601358	SNF2L2	600014	9p24.3
Nicolaides-Baraitser syndrome	601358	NCBRS	600014	9p24.3
Niemann-Pick disease, type A	257200	SMPD1	607608	11p15.4
Niemann-Pick disease, type A	257200	NPD	607608	11p15.4
Niemann-Pick disease, type B	607616	SMPD1	607608	11p15.4
Niemann-Pick disease, type B	607616	NPD	607608	11p15.4
Niemann-Pick disease, type C1	257220	NPC1	607623	18q11.2
Niemann-Pick disease, type C1	257220	NPC	607623	18q11.2
Niemann-Pick disease, type D	257220	NPC1	607623	18q11.2
Niemann-Pick disease, type D	257220	NPC	607623	18q11.2
Niemann-pick disease, type C2	607625	NPC2	601015	14q24.3
Niemann-pick disease, type C2	607625	HE1	601015	14q24.3
Night blindness, congenital stationary (complete), 1A, X-linked	310500	NYX	300278	Xp11.4
Night blindness, congenital stationary (complete), 1A, X-linked	310500	CSNB1A	300278	Xp11.4
Night blindness, congenital stationary (complete), 1A, X-linked	310500	NBM1	300278	Xp11.4
Night blindness, congenital stationary (complete), 1B, autosomal recessive	257270	GRM6	604096	5q35.3
Night blindness, congenital stationary (complete), 1B, autosomal recessive	257270	MGLUR6	604096	5q35.3
Night blindness, congenital stationary (complete), 1B, autosomal recessive	257270	CSNB1B	604096	5q35.3
Night blindness, congenital stationary (complete), 1C, autosomal recessive	613216	TRPM1	603576	15q13.3
Night blindness, congenital stationary (complete), 1C, autosomal recessive	613216	MLSN1	603576	15q13.3
Night blindness, congenital stationary (complete), 1C, autosomal recessive	613216	CSNB1C	603576	15q13.3
Night blindness, congenital stationary (complete), 1D, autosomal recessive	613830	SLC24A1	603617	15q22.31
Night blindness, congenital stationary (complete), 1D, autosomal recessive	613830	NCKX1	603617	15q22.31
Night blindness, congenital stationary (complete), 1D, autosomal recessive	613830	CSNB1D	603617	15q22.31
Night blindness, congenital stationary (complete), 1E, autosomal recessive	614565	GPR179	614515	17q12
Night blindness, congenital stationary (complete), 1E, autosomal recessive	614565	GPR158L	614515	17q12
Night blindness, congenital stationary (complete), 1E, autosomal recessive	614565	GPR158L1	614515	17q12
Night blindness, congenital stationary (complete), 1E, autosomal recessive	614565	CSNB1E	614515	17q12
Night blindness, congenital stationary (complete), 1F, autosomal recessive	615058	LRIT3	615004	4q25
Night blindness, congenital stationary (complete), 1F, autosomal recessive	615058	FIGLER4	615004	4q25
Night blindness, congenital stationary (complete), 1F, autosomal recessive	615058	CSNB1F	615004	4q25
Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	CACNA1F	300110	Xp11.23
Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	CSNB2	300110	Xp11.23
Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	CORDX3	300110	Xp11.23
Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	CSNB2A	300110	Xp11.23
Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	AIED	300110	Xp11.23
Night blindness, congenital stationary (incomplete), 2A, X-linked	300071	OA2	300110	Xp11.23
Night blindness, congenital stationary (incomplete), 2B, autosomal recessive	610427	CABP4	608965	11q13.2
Night blindness, congenital stationary (incomplete), 2B, autosomal recessive	610427	CSNB2B	608965	11q13.2
Night blindness, congenital stationary, autosomal dominant 1	610445	RHO	180380	3q22.1
Night blindness, congenital stationary, autosomal dominant 1	610445	RP4	180380	3q22.1
Night blindness, congenital stationary, autosomal dominant 1	610445	OPN2	180380	3q22.1
Night blindness, congenital stationary, autosomal dominant 1	610445	CSNBAD1	180380	3q22.1
Night blindness, congenital stationary, autosomal dominant 2	163500	PDE6B	180072	4p16.3
Night blindness, congenital stationary, autosomal dominant 2	163500	PDEB	180072	4p16.3
Night blindness, congenital stationary, autosomal dominant 2	163500	RP40	180072	4p16.3
Night blindness, congenital stationary, autosomal dominant 2	163500	CSNBAD2	180072	4p16.3
Night blindness, congenital stationary, autosomal dominant 3	610444	GNAT1	139330	3p21.31
Night blindness, congenital stationary, autosomal dominant 3	610444	CSNBAD3	139330	3p21.31
Nijmegen breakage syndrome	251260	NBS1	602667	8q21.3
Nijmegen breakage syndrome	251260	NBS	602667	8q21.3
Nijmegen breakage syndrome-like disorder	613078	RAD50	604040	5q31.1
Nijmegen breakage syndrome-like disorder	613078	NBSLD	604040	5q31.1
Non-Hodgkin lymphoma, somatic	605027	CASP10	601762	2q33.1
Non-Hodgkin lymphoma, somatic	605027	MCH4	601762	2q33.1
Non-Hodgkin lymphoma, somatic	605027	ALPS2	601762	2q33.1
Nonaka myopathy	605820	GNE	603824	9p13.3
Nonaka myopathy	605820	GLCNE	603824	9p13.3
Nonaka myopathy	605820	IBM2	603824	9p13.3
Nonaka myopathy	605820	DMRV	603824	9p13.3
Nonaka myopathy	605820	NM	603824	9p13.3
Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in	211980	EGFR	131550	7p11.2
Nonsmall cell lung cancer, somatic		BRAF	164757	7q34
Nonsmall cell lung cancer, somatic		NS7	164757	7q34
Nonsmall cell lung cancer, somatic	211980	IRF1	147575	5q31.1
Nonsmall cell lung cancer, somatic	211980	MAR	147575	5q31.1
Nonsmall cell lung cancer, somatic	211980	PIK3CA	171834	3q26.32
Nonsmall cell lung cancer, somatic	211980	CLOVE	171834	3q26.32
Nonsmall cell lung cancer, somatic	211980	MCAP	171834	3q26.32
Nonsmall cell lung cancer, somatic	211980	MCM	171834	3q26.32
Nonsmall cell lung cancer, somatic	211980	MCMTC	171834	3q26.32
Nonsmall cell lung cancer, somatic	211980	CWS5	171834	3q26.32
Noonan syndrome 1	163950	PTPN11	176876	12q24.13
Noonan syndrome 1	163950	PTP2C	176876	12q24.13
Noonan syndrome 1	163950	SHP2	176876	12q24.13
Noonan syndrome 1	163950	NS1	176876	12q24.13
Noonan syndrome 3	609942	KRAS	190070	12p12.1
Noonan syndrome 3	609942	KRAS2	190070	12p12.1
Noonan syndrome 3	609942	RASK2	190070	12p12.1
Noonan syndrome 3	609942	NS	190070	12p12.1
Noonan syndrome 3	609942	CFC2	190070	12p12.1
Noonan syndrome 4	610733	SOS1	182530	2p22.1
Noonan syndrome 4	610733	GINGF	182530	2p22.1
Noonan syndrome 4	610733	GF1	182530	2p22.1
Noonan syndrome 4	610733	HGF	182530	2p22.1
Noonan syndrome 4	610733	NS4	182530	2p22.1
Noonan syndrome 5	611553	RAF1	164760	3p25.2
Noonan syndrome 5	611553	CRAF	164760	3p25.2
Noonan syndrome 5	611553	NS5	164760	3p25.2
Noonan syndrome 6	613224	NRAS	164790	1p13.2
Noonan syndrome 6	613224	ALPS4	164790	1p13.2
Noonan syndrome 6	613224	NS6	164790	1p13.2
Noonan syndrome 7	613706	BRAF	164757	7q34
Noonan syndrome 7	613706	NS7	164757	7q34
Noonan syndrome 8	615355	RIT1	609591	1q22
Noonan syndrome 8	615355	RIT	609591	1q22
Noonan syndrome 8	615355	ROC1	609591	1q22
Noonan syndrome 8	615355	NS8	609591	1q22
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	613563	CBL	165360	11q23.3
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	613563	CBL2	165360	11q23.3
Noonan syndrome-like disorder with or without juvenile myelomonocytic leukemia	613563	NSLL	165360	11q23.3
Noonan-like syndrome with loose anagen hair	607721	SHOC2	602775	10q25.2
Noonan-like syndrome with loose anagen hair	607721	SIAA0862	602775	10q25.2
Noonan-like syndrome with loose anagen hair	607721	SOC2	602775	10q25.2
Noonan-like syndrome with loose anagen hair	607721	SUR8	602775	10q25.2
Norrie disease	310600	NDP	300658	Xp11.3
Norrie disease	310600	ND	300658	Xp11.3
Norum disease	245900	LCAT	606967	16q22.1
Nystagmus 1, congenital, X-linked	310700	FRMD7	300628	Xq26.2
Nystagmus 1, congenital, X-linked	310700	NYS1	300628	Xq26.2
Nystagmus 1, congenital, X-linked	310700	XIPAN	300628	Xq26.2
Nystagmus 3, congenital	608345	NYS3		7p11.2
Nystagmus 4, congenital	193003	NYS4		13q31-q33
Nystagmus 5, congenital, X-linked	300589	NYS5		Xp11.4
Nystagmus 6, congenital, X-linked	300814	GPR143	300808	Xp22.2
Nystagmus 6, congenital, X-linked	300814	OA1	300808	Xp22.2
Nystagmus 6, congenital, X-linked	300814	NYS6	300808	Xp22.2
Nystagmus 7, congenital	614826	NYS7		1q31.3-q32.1
Nystagmus, infantile periodic alternating, X-linked	310700	FRMD7	300628	Xq26.2
Nystagmus, infantile periodic alternating, X-linked	310700	NYS1	300628	Xq26.2
Nystagmus, infantile periodic alternating, X-linked	310700	XIPAN	300628	Xq26.2
Nystagmus-2, autosomal dominant	164100	NYS2		6p12
Nystagmus-2, autosomal dominant	164100	NYSA		6p12
OI type II	166210	COL1A1	120150	17q21.33
OI type III	259420	COL1A1	120150	17q21.33
OI type IV	166220	COL1A1	120150	17q21.33
OKT4 epitope deficiency	613949	CD4	186940	12p13.31
Obesity with impaired prohormone processing	600955	PCSK1	162150	5q15
Obesity with impaired prohormone processing	600955	NEC1	162150	5q15
Obesity with impaired prohormone processing	600955	PC1	162150	5q15
Obesity with impaired prohormone processing	600955	PC3	162150	5q15
Obesity with impaired prohormone processing	600955	BMIQ12	162150	5q15
Obesity, adrenal insufficiency, and red hair due to POMC deficiency	609734	POMC	176830	2p23.3
Obesity, autosomal dominant	601665	MC4R	155541	18q21.32
Obesity, hyperphagia, and developmental delay		AKR1C2	600450	10p15.1
Obesity, hyperphagia, and developmental delay		DDH2	600450	10p15.1
Obesity, hyperphagia, and developmental delay		DD2	600450	10p15.1
Obesity, hyperphagia, and developmental delay		HAKRD	600450	10p15.1
Obesity, hyperphagia, and developmental delay		SRXY8	600450	10p15.1
Obesity, hyperphagia, and developmental delay	613886	NTRK2	600456	9q21.33
Obesity, hyperphagia, and developmental delay	613886	TRKB	600456	9q21.33
Obesity, mild, early-onset	601665	NR0B2	604630	1p36.11
Obesity, mild, early-onset	601665	SHP	604630	1p36.11
Obesity, morbid, due to leptin deficiency	614962	LEP	164160	7q32.1
Obesity, morbid, due to leptin deficiency	614962	OB	164160	7q32.1
Obesity, morbid, due to leptin deficiency	614962	LEPD	164160	7q32.1
Obesity, morbid, due to leptin receptor deficiency	614963	LEPR	601007	1p31.3
Obesity, morbid, due to leptin receptor deficiency	614963	OBR	601007	1p31.3
Obesity, morbid, due to leptin receptor deficiency	614963	LEPRD	601007	1p31.3
Obesity, severe	601665	PPARG	601487	3p25.2
Obesity, severe	601665	PPARG1	601487	3p25.2
Obesity, severe	601665	PPARG2	601487	3p25.2
Obesity, severe	601665	CIMT1	601487	3p25.2
Obesity, severe	601665	GLM1	601487	3p25.2
Obesity, severe	601665	SIM1	603128	6q16.3
Occipital horn syndrome	304150	ATP7A	300011	Xq21.1
Occipital horn syndrome	304150	MNK	300011	Xq21.1
Occipital horn syndrome	304150	MK	300011	Xq21.1
Occipital horn syndrome	304150	OHS	300011	Xq21.1
Occipital horn syndrome	304150	SMAX3	300011	Xq21.1
Occult macular dystrophy	613587	RP1L1	608581	8p23.1
Ocular albinism with sensorineural deafness		OASD	300650	Xp22.3
Ocular albinism, type I, Nettleship-Falls type	300500	GPR143	300808	Xp22.2
Ocular albinism, type I, Nettleship-Falls type	300500	OA1	300808	Xp22.2
Ocular albinism, type I, Nettleship-Falls type	300500	NYS6	300808	Xp22.2
Oculoauricular syndrome	612109	HMX1	142992	4p16.1
Oculoauricular syndrome	612109	H6	142992	4p16.1
Oculodentodigital dysplasia	164200	GJA1	121014	6q22.31
Oculodentodigital dysplasia	164200	CX43	121014	6q22.31
Oculodentodigital dysplasia	164200	ODDD	121014	6q22.31
Oculodentodigital dysplasia	164200	SDTY3	121014	6q22.31
Oculodentodigital dysplasia	164200	ODOD	121014	6q22.31
Oculodentodigital dysplasia	164200	HSS	121014	6q22.31
Oculodentodigital dysplasia	164200	AVSD3	121014	6q22.31
Oculodentodigital dysplasia	164200	HLHS1	121014	6q22.31
Oculodentodigital dysplasia	164200	CMDR	121014	6q22.31
Oculodentodigital dysplasia, autosomal recessive	257850	GJA1	121014	6q22.31
Oculodentodigital dysplasia, autosomal recessive	257850	CX43	121014	6q22.31
Oculodentodigital dysplasia, autosomal recessive	257850	ODDD	121014	6q22.31
Oculodentodigital dysplasia, autosomal recessive	257850	SDTY3	121014	6q22.31
Oculodentodigital dysplasia, autosomal recessive	257850	ODOD	121014	6q22.31
Oculodentodigital dysplasia, autosomal recessive	257850	HSS	121014	6q22.31
Oculodentodigital dysplasia, autosomal recessive	257850	AVSD3	121014	6q22.31
Oculodentodigital dysplasia, autosomal recessive	257850	HLHS1	121014	6q22.31
Oculodentodigital dysplasia, autosomal recessive	257850	CMDR	121014	6q22.31
Oculomotor apraxia, congenital, Cogan-type	257550	COMA		2q13
Oculopharyngeal muscular dystrophy	164300	PABPN1	602279	14q11.2
Oculopharyngeal muscular dystrophy	164300	PABP2	602279	14q11.2
Oculopharyngeal muscular dystrophy	164300	PAB2	602279	14q11.2
Odontohypophosphatasia	146300	ALPL	171760	1p36.12
Odontohypophosphatasia	146300	HOPS	171760	1p36.12
Odontohypophosphatasia	146300	TNSALP	171760	1p36.12
Odontoonychodermal dysplasia	257980	WNT10A	606268	2q35
Odontoonychodermal dysplasia	257980	SSPS	606268	2q35
Odontoonychodermal dysplasia	257980	STHAG4	606268	2q35
Odontoonychodermal dysplasia	257980	OODD	606268	2q35
Oguchi disease-1	258100	SAG	181031	2q37.1
Oguchi disease-1	258100	RP47	181031	2q37.1
Oguchi disease-2	613411	GRK1	180381	13q34
Oguchi disease-2	613411	RHOK	180381	13q34
Oguchi disease-2	613411	RK	180381	13q34
Ohdo syndrome, X-linked	300895	MED12	300188	Xq13.1
Ohdo syndrome, X-linked	300895	TNRC11	300188	Xq13.1
Ohdo syndrome, X-linked	300895	TRAP230	300188	Xq13.1
Ohdo syndrome, X-linked	300895	HOPA	300188	Xq13.1
Ohdo syndrome, X-linked	300895	KIAA0192	300188	Xq13.1
Ohdo syndrome, X-linked	300895	OKS	300188	Xq13.1
Ohdo syndrome, X-linked	300895	FGS1	300188	Xq13.1
Ohdo syndrome, X-linked	300895	OHDOX	300188	Xq13.1
Oligodontia-colorectal cancer syndrome	608615	AXIN2	604025	17q24.1
Oligodontia-colorectal cancer syndrome	608615	ODCRCS	604025	17q24.1
Olmsted syndrome	614594	TRPV3	607066	17p13.2
Olmsted syndrome	614594	OLMS	607066	17p13.2
Omenn syndrome	603554	DCLRE1C	605988	10p13
Omenn syndrome	603554	ARTEMIS	605988	10p13
Omenn syndrome	603554	SCIDA	605988	10p13
Omenn syndrome	603554	RAG1	179615	11p12
Omenn syndrome	603554	RAG2	179616	11p12
Omodysplasia 1	258315	GPC6	604404	13q31.3-q32.1
Omodysplasia 1	258315	OMIMD1	604404	13q31.3-q32.1
Omphalocele due to duplication of 1p31.3	164750	OPHLC		1p31.3
Omphalocele due to duplication of 1p31.3	164750	C1DUPp31.3		1p31.3
Omphalocele due to duplication of 1p31.3	164750	DUP1p31.3		1p31.3
Opitz GBBB syndrome, type I	300000	MID1	300552	Xp22.2
Opitz GBBB syndrome, type I	300000	OGS1	300552	Xp22.2
Opitz GBBB syndrome, type I	300000	BBBG1	300552	Xp22.2
Opitz GBBB syndrome, type I	300000	FXY	300552	Xp22.2
Opitz GBBB syndrome, type I	300000	OSX	300552	Xp22.2
Opitz GBBB syndrome, type II	145410	OGS2		22q11.2
Opitz GBBB syndrome, type II	145410	BBBG2		22q11.2
Opitz GBBB syndrome, type II	145410	GBBB2		22q11.2
Opitz-Kaveggia syndrome	305450	MED12	300188	Xq13.1
Opitz-Kaveggia syndrome	305450	TNRC11	300188	Xq13.1
Opitz-Kaveggia syndrome	305450	TRAP230	300188	Xq13.1
Opitz-Kaveggia syndrome	305450	HOPA	300188	Xq13.1
Opitz-Kaveggia syndrome	305450	KIAA0192	300188	Xq13.1
Opitz-Kaveggia syndrome	305450	OKS	300188	Xq13.1
Opitz-Kaveggia syndrome	305450	FGS1	300188	Xq13.1
Opitz-Kaveggia syndrome	305450	OHDOX	300188	Xq13.1
Opremazole poor metabolizer	609535	CYP2C	124020	10q23.33
Opremazole poor metabolizer	609535	CYP2C19	124020	10q23.33
Opsismodysplasia	258480	INPPL1	600829	11q13.4
Opsismodysplasia	258480	OPSMD	600829	11q13.4
Optic atrophy 1	165500	OPA1	605290	3q29
Optic atrophy 1	165500	NTG	605290	3q29
Optic atrophy 1	165500	NPG	605290	3q29
Optic atrophy 2, X-linked	311050	OPA2		Xp11.4-p11.21
Optic atrophy 3 with cataract	165300	OPA3	606580	19q13.32
Optic atrophy 3 with cataract	165300	MGA3	606580	19q13.32
Optic atrophy 5	610708	OPA5		22q12.1-q13.1
Optic atrophy 6	258500	OPA6		8q21-q22
Optic atrophy plus syndrome	125250	OPA1	605290	3q29
Optic atrophy plus syndrome	125250	NTG	605290	3q29
Optic atrophy plus syndrome	125250	NPG	605290	3q29
Optic atrophy-4	605293	OPA4		18q12.2-q12.3
Optic atrophy-7	612989	TMEM126A	612988	11q14.1
Optic atrophy-7	612989	OPA7	612988	11q14.1
Optic nerve hypoplasia and abnormalities of the central nervous system	206900	SOX2	184429	3q26.33
Optic nerve hypoplasia and abnormalities of the central nervous system	206900	MCOPS3	184429	3q26.33
Optic nerve hypoplasia	165550	PAX6	607108	11p13
Optic nerve hypoplasia	165550	AN2	607108	11p13
Optic nerve hypoplasia	165550	MGDA	607108	11p13
Oral-facial-digital syndrome 1	311200	OFD1	300170	Xp22.2
Oral-facial-digital syndrome 1	311200	CXorf5	300170	Xp22.2
Oral-facial-digital syndrome 1	311200	SGBS2	300170	Xp22.2
Oral-facial-digital syndrome 1	311200	JBTS10	300170	Xp22.2
Ornithine transcarbamylase deficiency	311250	OTC	300461	Xp11.4
Orofacial cleft 10	613705	SUMO1	601912	2q33.1
Orofacial cleft 10	613705	UBL1	601912	2q33.1
Orofacial cleft 10	613705	SMT3	601912	2q33.1
Orofacial cleft 10	613705	OFC10	601912	2q33.1
Orofacial cleft 11	600625	BMP4	112262	14q22.2
Orofacial cleft 11	600625	BMP2B1	112262	14q22.2
Orofacial cleft 11	600625	BMP2B	112262	14q22.2
Orofacial cleft 11	600625	MCOPS6	112262	14q22.2
Orofacial cleft 11	600625	OFC11	112262	14q22.2
Orofacial cleft 12	612858	OFC12		8q24.3
Orofacial cleft 13	613857	OFC13		1p33
Orofacial cleft 4	608371	OFC4		4q21-q31
Orofacial cleft 5	608874	MSX1	142983	4p16.2
Orofacial cleft 5	608874	HOX7	142983	4p16.2
Orofacial cleft 5	608874	HYD1	142983	4p16.2
Orofacial cleft 5	608874	OFC5	142983	4p16.2
Orofacial cleft 5	608874	STHAG1	142983	4p16.2
Orofacial cleft 5	608874	ECTD3	142983	4p16.2
Orofacial cleft 6	608864	IRF6	607199	1q32.2
Orofacial cleft 6	608864	VWS	607199	1q32.2
Orofacial cleft 6	608864	LPS	607199	1q32.2
Orofacial cleft 6	608864	PIT	607199	1q32.2
Orofacial cleft 6	608864	PPS1	607199	1q32.2
Orofacial cleft 6	608864	OFC6	607199	1q32.2
Orofacial cleft 7	225060	HVEC	600644	11q23.3
Orofacial cleft 7	225060	PVRL1	600644	11q23.3
Orofacial cleft 7	225060	PVRR1	600644	11q23.3
Orofacial cleft 7	225060	PRR1	600644	11q23.3
Orofacial cleft 7	225060	ED4	600644	11q23.3
Orofacial cleft 7	225060	OFC7	600644	11q23.3
Orofacial cleft 7	225060	CLPED1	600644	11q23.3
Orofacial cleft 8	129400	TP63	603273	3q28
Orofacial cleft 8	129400	TP73L	603273	3q28
Orofacial cleft 8	129400	KET	603273	3q28
Orofacial cleft 8	129400	EEC3	603273	3q28
Orofacial cleft 8	129400	SHFM4	603273	3q28
Orofacial cleft 8	129400	LMS	603273	3q28
Orofacial cleft 8	129400	RHS	603273	3q28
Orofacial cleft 8	129400	OFC8	603273	3q28
Orofacial cleft 9	610361	OFC9		13q33.1-q34
Orofacial cleft-1	119530	OFC1		6p24.3
Orofacial cleft-1	119530	CL		6p24.3
Orofacial cleft-2	602966	OFC2		2p13
Orofacial cleft-3	600757	OFC3		19q13
Orofaciodigital syndrome IV	258860	TCTN3	613847	10q24.1
Orofaciodigital syndrome IV	258860	TECT3	613847	10q24.1
Orofaciodigital syndrome IV	258860	C10orf61	613847	10q24.1
Orofaciodigital syndrome IV	258860	OFD4	613847	10q24.1
Orofaciodigital syndrome IV	258860	JBTS18	613847	10q24.1
Orofaciodigital syndrome V	174300	DDX59	615464	1q32.1
Orofaciodigital syndrome V	174300	OFD5	615464	1q32.1
Orolaryngeal cancer, multiple,		CDKN2A	600160	9p21.3
Orolaryngeal cancer, multiple,		MTS1	600160	9p21.3
Orolaryngeal cancer, multiple,		P16	600160	9p21.3
Orolaryngeal cancer, multiple,		MLM	600160	9p21.3
Orolaryngeal cancer, multiple,		CMM2	600160	9p21.3
Orotic aciduria	258900	UMPS	613891	3q21.2
Orotic aciduria	258900	OPRT	613891	3q21.2
Orthostatic hypotensive disorder of Streeten	143850	OHDS		18q
Orthostatic intolerance	604715	SLC6A2	163970	16q12.2
Orthostatic intolerance	604715	NAT1	163970	16q12.2
Orthostatic intolerance	604715	NET1	163970	16q12.2
Osseous heteroplasia, progressive	166350	GNAS	139320	20q13.32
Osseous heteroplasia, progressive	166350	GNAS1	139320	20q13.32
Osseous heteroplasia, progressive	166350	GPSA	139320	20q13.32
Osseous heteroplasia, progressive	166350	POH	139320	20q13.32
Osseous heteroplasia, progressive	166350	PHP1B	139320	20q13.32
Osseous heteroplasia, progressive	166350	PHP1A	139320	20q13.32
Osseous heteroplasia, progressive	166350	AHO	139320	20q13.32
Osseous heteroplasia, progressive	166350	PHP1C	139320	20q13.32
Ossification of posterior longitudinal ligament of spine	602475	ENPP1	173335	6q23.2
Ossification of posterior longitudinal ligament of spine	602475	PDNP1	173335	6q23.2
Ossification of posterior longitudinal ligament of spine	602475	NPPS	173335	6q23.2
Ossification of posterior longitudinal ligament of spine	602475	M6S1	173335	6q23.2
Ossification of posterior longitudinal ligament of spine	602475	PCA1	173335	6q23.2
Ossification of posterior longitudinal ligament of spine	602475	ARHR2	173335	6q23.2
Ossification of posterior longitudinal ligament of spine	602475	COLED	173335	6q23.2
Osteoarthritis with mild chondrodysplasia	604864	COL2A1	120140	12q13.11
Osteochondritis dissecans, short stature, and early-onset osteoarthritis	165800	ACAN	155760	15q26.1
Osteochondritis dissecans, short stature, and early-onset osteoarthritis	165800	AGC1	155760	15q26.1
Osteochondritis dissecans, short stature, and early-onset osteoarthritis	165800	CSPG1	155760	15q26.1
Osteochondritis dissecans, short stature, and early-onset osteoarthritis	165800	MSK16	155760	15q26.1
Osteochondritis dissecans, short stature, and early-onset osteoarthritis	165800	SEDK	155760	15q26.1
Osteogenesis imperfecta, type I	166200	COL1A1	120150	17q21.33
Osteogenesis imperfecta, type II	166210	COL1A2	120160	7q21.3
Osteogenesis imperfecta, type III	259420	COL1A2	120160	7q21.3
Osteogenesis imperfecta, type IV	166220	COL1A2	120160	7q21.3
Osteogenesis imperfecta, type IX	259440	PPIB	123841	15q22.31
Osteogenesis imperfecta, type IX	259440	CYPB	123841	15q22.31
Osteogenesis imperfecta, type IX	259440	OI9	123841	15q22.31
Osteogenesis imperfecta, type V	610967	IFITM5	614757	11p15.5
Osteogenesis imperfecta, type V	610967	OI5	614757	11p15.5
Osteogenesis imperfecta, type VI	613982	SERPINF1	172860	17p13.3
Osteogenesis imperfecta, type VI	613982	PEDF	172860	17p13.3
Osteogenesis imperfecta, type VI	613982	OI6	172860	17p13.3
Osteogenesis imperfecta, type VII	610682	CRTAP	605497	3p22.3
Osteogenesis imperfecta, type VII	610682	CASP	605497	3p22.3
Osteogenesis imperfecta, type VII	610682	OI7	605497	3p22.3
Osteogenesis imperfecta, type VIII	610915	LEPRE1	610339	1p34.2
Osteogenesis imperfecta, type VIII	610915	P3H1	610339	1p34.2
Osteogenesis imperfecta, type VIII	610915	GROS1	610339	1p34.2
Osteogenesis imperfecta, type VIII	610915	OI8	610339	1p34.2
Osteogenesis imperfecta, type X	613848	SERPINH1	600943	11q13.5
Osteogenesis imperfecta, type X	613848	SERPINH2	600943	11q13.5
Osteogenesis imperfecta, type X	613848	PPROM	600943	11q13.5
Osteogenesis imperfecta, type X	613848	CBP2	600943	11q13.5
Osteogenesis imperfecta, type X	613848	CBP1	600943	11q13.5
Osteogenesis imperfecta, type X	613848	OI10	600943	11q13.5
Osteogenesis imperfecta, type XI	610968	FKBP10	607063	17q21.2
Osteogenesis imperfecta, type XI	610968	FKBP65	607063	17q21.2
Osteogenesis imperfecta, type XI	610968	OI11	607063	17q21.2
Osteogenesis imperfecta, type XII	613849	SP7	606633	12q13.13
Osteogenesis imperfecta, type XII	613849	OSX	606633	12q13.13
Osteogenesis imperfecta, type XII	613849	OI12	606633	12q13.13
Osteogenesis imperfecta, type XIII	614856	BMP1	112264	8p21.3
Osteogenesis imperfecta, type XIII	614856	OI13	112264	8p21.3
Osteogenesis imperfecta, type XIV	615066	TMEM38B	611236	9q31.2
Osteogenesis imperfecta, type XIV	615066	TRICB	611236	9q31.2
Osteogenesis imperfecta, type XIV	615066	OI14	611236	9q31.2
Osteogenesis imperfecta, type XV	615220	WNT1	164820	12q13.12
Osteogenesis imperfecta, type XV	615220	INT1	164820	12q13.12
Osteogenesis imperfecta, type XV	615220	OI15	164820	12q13.12
Osteogenesis imperfecta, type XV	615220	BMND16	164820	12q13.12
Osteoglophonic dysplasia	166250	FGFR1	136350	8p11.23-p11.22
Osteoglophonic dysplasia	166250	FLT2	136350	8p11.23-p11.22
Osteoglophonic dysplasia	166250	OGD	136350	8p11.23-p11.22
Osteoglophonic dysplasia	166250	KAL2	136350	8p11.23-p11.22
Osteoglophonic dysplasia	166250	HH2	136350	8p11.23-p11.22
Osteoglophonic dysplasia	166250	HRTFDS	136350	8p11.23-p11.22
Osteolysis, familial expansile	174810	TNFRSF11A	603499	18q21.33
Osteolysis, familial expansile	174810	RANK	603499	18q21.33
Osteolysis, familial expansile	174810	ODFR	603499	18q21.33
Osteolysis, familial expansile	174810	OFE	603499	18q21.33
Osteolysis, familial expansile	174810	OPTB7	603499	18q21.33
Osteomalacia, tumor-induced		FGF23	605380	12p13.32
Osteomalacia, tumor-induced		ADHR	605380	12p13.32
Osteomalacia, tumor-induced		HPDR2	605380	12p13.32
Osteomalacia, tumor-induced		PHPTC	605380	12p13.32
Osteopathia striata with cranial sclerosis	300373	AMER1	300647	Xq11.2
Osteopathia striata with cranial sclerosis	300373	FAM123B	300647	Xq11.2
Osteopathia striata with cranial sclerosis	300373	WTX	300647	Xq11.2
Osteopathia striata with cranial sclerosis	300373	OSCS	300647	Xq11.2
Osteopetrosis, autosomal dominant 1	607634	LRP5	603506	11q13.2
Osteopetrosis, autosomal dominant 1	607634	BMND1	603506	11q13.2
Osteopetrosis, autosomal dominant 1	607634	LRP7	603506	11q13.2
Osteopetrosis, autosomal dominant 1	607634	LR3	603506	11q13.2
Osteopetrosis, autosomal dominant 1	607634	OPPG	603506	11q13.2
Osteopetrosis, autosomal dominant 1	607634	VBCH2	603506	11q13.2
Osteopetrosis, autosomal dominant 1	607634	OPTA1	603506	11q13.2
Osteopetrosis, autosomal dominant 1	607634	EVR4	603506	11q13.2
Osteopetrosis, autosomal dominant 2	166600	CLCN7	602727	16p13.3
Osteopetrosis, autosomal dominant 2	166600	CLC7	602727	16p13.3
Osteopetrosis, autosomal dominant 2	166600	OPTA2	602727	16p13.3
Osteopetrosis, autosomal dominant 2	166600	OPTB4	602727	16p13.3
Osteopetrosis, autosomal recessive 1	259700	TCIRG1	604592	11q13.2
Osteopetrosis, autosomal recessive 1	259700	TIRC7	604592	11q13.2
Osteopetrosis, autosomal recessive 1	259700	OC116	604592	11q13.2
Osteopetrosis, autosomal recessive 1	259700	OPTB1	604592	11q13.2
Osteopetrosis, autosomal recessive 2	259710	TNFSF11	602642	13q14.11
Osteopetrosis, autosomal recessive 2	259710	OPGL	602642	13q14.11
Osteopetrosis, autosomal recessive 2	259710	TRANCE	602642	13q14.11
Osteopetrosis, autosomal recessive 2	259710	OPTB2	602642	13q14.11
Osteopetrosis, autosomal recessive 3, with renal tubular acidosis	259730	CA2	611492	8q21.2
Osteopetrosis, autosomal recessive 4	611490	CLCN7	602727	16p13.3
Osteopetrosis, autosomal recessive 4	611490	CLC7	602727	16p13.3
Osteopetrosis, autosomal recessive 4	611490	OPTA2	602727	16p13.3
Osteopetrosis, autosomal recessive 4	611490	OPTB4	602727	16p13.3
Osteopetrosis, autosomal recessive 5	259720	OSTM1	607649	6q21
Osteopetrosis, autosomal recessive 5	259720	GL	607649	6q21
Osteopetrosis, autosomal recessive 5	259720	OPTB5	607649	6q21
Osteopetrosis, autosomal recessive 6	611497	PLEKHM1	611466	17q21.31
Osteopetrosis, autosomal recessive 6	611497	AP162	611466	17q21.31
Osteopetrosis, autosomal recessive 6	611497	KIAA0356	611466	17q21.31
Osteopetrosis, autosomal recessive 6	611497	OPTB6	611466	17q21.31
Osteopetrosis, autosomal recessive 7	612301	TNFRSF11A	603499	18q21.33
Osteopetrosis, autosomal recessive 7	612301	RANK	603499	18q21.33
Osteopetrosis, autosomal recessive 7	612301	ODFR	603499	18q21.33
Osteopetrosis, autosomal recessive 7	612301	OFE	603499	18q21.33
Osteopetrosis, autosomal recessive 7	612301	OPTB7	603499	18q21.33
Osteopetrosis, autosomal recessive 8	615085	SNX10	614780	7p15.2
Osteopetrosis, autosomal recessive 8	615085	OPTB8	614780	7p15.2
Osteopoikilosis	166700	LEMD3	607844	12q14.3
Osteopoikilosis	166700	MAN1	607844	12q14.3
Osteoporosis-pseudoglioma syndrome	259770	LRP5	603506	11q13.2
Osteoporosis-pseudoglioma syndrome	259770	BMND1	603506	11q13.2
Osteoporosis-pseudoglioma syndrome	259770	LRP7	603506	11q13.2
Osteoporosis-pseudoglioma syndrome	259770	LR3	603506	11q13.2
Osteoporosis-pseudoglioma syndrome	259770	OPPG	603506	11q13.2
Osteoporosis-pseudoglioma syndrome	259770	VBCH2	603506	11q13.2
Osteoporosis-pseudoglioma syndrome	259770	OPTA1	603506	11q13.2
Osteoporosis-pseudoglioma syndrome	259770	EVR4	603506	11q13.2
Osteosarcoma	259500	TP53	191170	17p13.1
Osteosarcoma	259500	P53	191170	17p13.1
Osteosarcoma	259500	LFS1 	191170	17p13.1
Osteosarcoma	259500	BCC7	191170	17p13.1
Osteosarcoma, somatic	259500	CHEK2	604373	22q12.1
Osteosarcoma, somatic	259500	RAD53	604373	22q12.1
Osteosarcoma, somatic	259500	CHK2	604373	22q12.1
Osteosarcoma, somatic	259500	CDS1	604373	22q12.1
Osteosarcoma, somatic	259500	LFS2	604373	22q12.1
Osteosarcoma, somatic	259500	RB1	614041	13q14.2
Osteosclerosis	144750	LRP5	603506	11q13.2
Osteosclerosis	144750	BMND1	603506	11q13.2
Osteosclerosis	144750	LRP7	603506	11q13.2
Osteosclerosis	144750	LR3	603506	11q13.2
Osteosclerosis	144750	OPPG	603506	11q13.2
Osteosclerosis	144750	VBCH2	603506	11q13.2
Osteosclerosis	144750	OPTA1	603506	11q13.2
Osteosclerosis	144750	EVR4	603506	11q13.2
Otodental dysplasia chromsome deletion syndrome	166750	OTDD		11q13
Otodental dysplasia chromsome deletion syndrome	166750	DEL11q13		11q13
Otodental dysplasia chromsome deletion syndrome	166750	C11DELq13		11q13
Otopalatodigital syndrome, type I	311300	FLNA	300017	Xq28
Otopalatodigital syndrome, type I	311300	FLN1	300017	Xq28
Otopalatodigital syndrome, type I	311300	NHBP	300017	Xq28
Otopalatodigital syndrome, type I	311300	OPD1	300017	Xq28
Otopalatodigital syndrome, type I	311300	OPD2	300017	Xq28
Otopalatodigital syndrome, type I	311300	FMD	300017	Xq28
Otopalatodigital syndrome, type I	311300	MNS	300017	Xq28
Otopalatodigital syndrome, type I	311300	CVD1	300017	Xq28
Otopalatodigital syndrome, type I	311300	CSBS	300017	Xq28
Otopalatodigital syndrome, type II	304120	FLNA	300017	Xq28
Otopalatodigital syndrome, type II	304120	FLN1	300017	Xq28
Otopalatodigital syndrome, type II	304120	NHBP	300017	Xq28
Otopalatodigital syndrome, type II	304120	OPD1	300017	Xq28
Otopalatodigital syndrome, type II	304120	OPD2	300017	Xq28
Otopalatodigital syndrome, type II	304120	FMD	300017	Xq28
Otopalatodigital syndrome, type II	304120	MNS	300017	Xq28
Otopalatodigital syndrome, type II	304120	CVD1	300017	Xq28
Otopalatodigital syndrome, type II	304120	CSBS	300017	Xq28
Otosclerosis 1	166800	OTSC1		15q26.1-qter
Otosclerosis 1	166800	OTS		15q26.1-qter
Otosclerosis 10	615589	OTSC10		1q41-q44
Otosclerosis 2	605727	OTSC2		7q34-q36
Otosclerosis 3	608244	OTSC3		6p22.3-p21.3
Otosclerosis 5	608787	OTSC5		3q22-q24
Otosclerosis 7	611572	OTSC7		6q13-q16.1
Otosclerosis 8	612096	OTSC8		9p13.1-q21.11
Otospondylomegaepiphyseal dysplasia	215150	COL11A2	120290	6p21.32
Otospondylomegaepiphyseal dysplasia	215150	STL3	120290	6p21.32
Otospondylomegaepiphyseal dysplasia	215150	DFNA13	120290	6p21.32
Otospondylomegaepiphyseal dysplasia	215150	DFNB53	120290	6p21.32
Otospondylomegaepiphyseal dysplasia	215150	FBCG2	120290	6p21.32
Otospondylomegaepiphyseal dysplasia	215150	COL2A1	120140	12q13.11
Ovalocytosis	109270	SLC4A1		17q21.31
Ovalocytosis	109270	AE1		17q21.31
Ovalocytosis	109270	EPB3		17q21.31
Ovarian cancer, somatic,		ERBB2	164870	17q12
Ovarian cancer, somatic,		NGL	164870	17q12
Ovarian cancer, somatic,		NEU	164870	17q12
Ovarian cancer, somatic,		HER2	164870	17q12
Ovarian cancer, somatic	167000	AKT1	164730	14q32.33
Ovarian cancer, somatic	167000	CWS6	164730	14q32.33
Ovarian cancer, somatic	167000	CTNNB1	116806	3p22.1
Ovarian cancer, somatic	167000	MRD19	116806	3p22.1
Ovarian cancer, somatic	167000	PIK3CA	171834	3q26.32
Ovarian cancer, somatic	167000	CLOVE	171834	3q26.32
Ovarian cancer, somatic	167000	MCAP	171834	3q26.32
Ovarian cancer, somatic	167000	MCM	171834	3q26.32
Ovarian cancer, somatic	167000	MCMTC	171834	3q26.32
Ovarian cancer, somatic	167000	CWS5	171834	3q26.32
Ovarian carcinoma		SEPT9	604061	17q25.2-q25.3
Ovarian carcinoma		MSF	604061	17q25.2-q25.3
Ovarian carcinoma		MSF1	604061	17q25.2-q25.3
Ovarian carcinoma		NAPB	604061	17q25.2-q25.3
Ovarian carcinoma		RRAS2	600098	11p15.2
Ovarian carcinoma		TC21	600098	11p15.2
Ovarian carcinoma, somatic	167000	CDH1	192090	16q22.1
Ovarian carcinoma, somatic	167000	UVO	192090	16q22.1
Ovarian carcinoma, somatic	167000	LCAM	192090	16q22.1
Ovarian carcinoma, somatic	167000	ECAD	192090	16q22.1
Ovarian dysgenesis 1	233300	FSHR	136435	2p16.3
Ovarian dysgenesis 1	233300	ODG1	136435	2p16.3
Ovarian dysgenesis 2	300510	BMP15	300247	Xp11.22
Ovarian dysgenesis 2	300510	GDF9B	300247	Xp11.22
Ovarian dysgenesis 2	300510	ODG2	300247	Xp11.22
Ovarian dysgenesis 2	300510	POF4	300247	Xp11.22
Ovarian dysgenesis 3	614324	PSMC3IP	608665	17q21.2
Ovarian dysgenesis 3	614324	TBPIP	608665	17q21.2
Ovarian dysgenesis 3	614324	GT198	608665	17q21.2
Ovarian dysgenesis 3	614324	HOP2	608665	17q21.2
Ovarian dysgenesis 3	614324	ODG3	608665	17q21.2
Ovarian hyperstimulation syndrome	608115	FSHR	136435	2p16.3
Ovarian hyperstimulation syndrome	608115	ODG1	136435	2p16.3
Ovarian response to FSH stimulation	276400	FSHR	136435	2p16.3
Ovarian response to FSH stimulation	276400	ODG1	136435	2p16.3
Ovarioleukodystrophy	603896	EIF2B2	606454	14q24.3
Ovarioleukodystrophy	603896	EIF2B4	606687	2p23.3
Ovarioleukodystrophy	603896	EIF2B5	603945	3q27.1
Ovarioleukodystrophy	603896	LVWM	603945	3q27.1
Ovarioleukodystrophy	603896	CACH	603945	3q27.1
Ovarioleukodystrophy	603896	CLE	603945	3q27.1
PCWH syndrome	609136	SOX10	602229	22q13.1
PCWH syndrome	609136	WS4	602229	22q13.1
PCWH syndrome	609136	WS4C	602229	22q13.1
PCWH syndrome	609136	PCWH	602229	22q13.1
PEPCK deficiency, mitochondrial	261650	PCK2	614095	14q11.2
PEPCK deficiency, mitochondrial	261650	PEPCK2	614095	14q11.2
PTEN hamartoma tumor syndrome	601728	PTEN		10q23.31
PTEN hamartoma tumor syndrome	601728	MMAC1		10q23.31
PTEN hamartoma tumor syndrome	601728	GLM2		10q23.31
PTEN hamartoma tumor syndrome	601728	CWS1		10q23.31
Pachyonychia congenita, Jackson-Lawler type	167210	KRT17	148069	17q21.2
Pachyonychia congenita, Jackson-Lawler type	167210	PC2	148069	17q21.2
Pachyonychia congenita, Jackson-Lawler type	167210	PCHC1	148069	17q21.2
Pachyonychia congenita, Jackson-Lawler type	167210	KRT6B	148042	12q13.13
Pachyonychia congenita, Jackson-Lawler type	167210	PC2	148042	12q13.13
Pachyonychia congenita, Jadassohn-Lewandowsky type	167200	KRT16	148067	17q21.2
Pachyonychia congenita, Jadassohn-Lewandowsky type	167200	FNEPPK	148067	17q21.2
Pachyonychia congenita, Jadassohn-Lewandowsky type	167200	KRT6A	148041	12q13.13
Paget disease of bone	602080	PDB4	606263	5q31
Paget disease of bone	602080	SQSTM1	601530	5q35.3
Paget disease of bone	602080	P62	601530	5q35.3
Paget disease of bone	602080	PDB3	601530	5q35.3
Paget disease of bone	602080	TNFRSF11A	603499	18q21.33
Paget disease of bone	602080	RANK	603499	18q21.33
Paget disease of bone	602080	ODFR	603499	18q21.33
Paget disease of bone	602080	OFE	603499	18q21.33
Paget disease of bone	602080	OPTB7	603499	18q21.33
Paget disease, juvenile	239000	TNFRSF11B	602643	8q24.12
Paget disease, juvenile	239000	OPG	602643	8q24.12
Paget disease, juvenile	239000	OCIF	602643	8q24.12
Pallister-Hall syndrome	146510	GLI3	165240	7p14.1
Pallister-Hall syndrome	146510	PAPA	165240	7p14.1
Pallister-Hall syndrome	146510	PAPB	165240	7p14.1
Pallister-Killian syndrome	601803	PKS		12p
Palmoplantar hyperkeratosis and true hermaphroditism	610644	RSPO1	609595	1p34.3
Palmoplantar hyperkeratosis and true hermaphroditism	610644	FLJ40906	609595	1p34.3
Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal	610644	RSPO1	609595	1p34.3
Palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal	610644	FLJ40906	609595	1p34.3
Palmoplantar keratoderma, Bothnia type	600231	PPKB		12q11-q13
Palmoplantar keratoderma, Bothnian type	600231	AQP5	600442	12q13.12
Palmoplantar keratoderma, Bothnian type	600231	PPKB	600442	12q13.12
Palmoplantar keratoderma, Nagashima type	615598	SERPINB7	603357	18q21.33
Palmoplantar keratoderma, Nagashima type	615598	MEGSIN	603357	18q21.33
Palmoplantar keratoderma, Nagashima type	615598	PPKN	603357	18q21.33
Palmoplantar keratoderma, epidermolytic	144200	KRT1	139350	12q13.13
Palmoplantar keratoderma, epidermolytic	144200	EPPK	139350	12q13.13
Palmoplantar keratoderma, epidermolytic	144200	NEPPK	139350	12q13.13
Palmoplantar keratoderma, epidermolytic	144200	EHK	139350	12q13.13
Palmoplantar keratoderma, epidermolytic	144200	KRT9	607606	17q21.2
Palmoplantar keratoderma, epidermolytic	144200	EPPK	607606	17q21.2
Palmoplantar keratoderma, nonepidermolytic	600962	KRT1	139350	12q13.13
Palmoplantar keratoderma, nonepidermolytic	600962	EPPK	139350	12q13.13
Palmoplantar keratoderma, nonepidermolytic	600962	NEPPK	139350	12q13.13
Palmoplantar keratoderma, nonepidermolytic	600962	EHK	139350	12q13.13
Palmoplantar keratoderma, nonepidermolytic, focal	613000	KRT16	148067	17q21.2
Palmoplantar keratoderma, nonepidermolytic, focal	613000	FNEPPK	148067	17q21.2
Panbronchiolitis, diffuse	604809	PBLT		6p21.3
Pancreatic agenesis and congenital heart defects	600001	GATA6	601656	18q11.2
Pancreatic agenesis and congenital heart defects	600001	AVSD5	601656	18q11.2
Pancreatic agenesis and congenital heart defects	600001	ASD9	601656	18q11.2
Pancreatic agenesis and congenital heart defects	600001	AVSD5	601656	18q11.2
Pancreatic agenesis and congenital heart defects	600001	PACHD	601656	18q11.2
Pancreatic agenesis	260370	IPF1	600733	13q12.2
Pancreatic agenesis	260370	MODY4	600733	13q12.2
Pancreatic cancer	260350	STK11	602216	19p13.3
Pancreatic cancer	260350	PJS	602216	19p13.3
Pancreatic cancer	260350	LKB1	602216	19p13.3
Pancreatic cancer	260350	TP53	191170	17p13.1
Pancreatic cancer	260350	P53	191170	17p13.1
Pancreatic cancer	260350	LFS1 	191170	17p13.1
Pancreatic cancer	260350	BCC7	191170	17p13.1
Pancreatic cancer	613347	BRCA2	600185	13q13.1
Pancreatic cancer	613347	FANCD1	600185	13q13.1
Pancreatic cancer	613347	BROVCA2	600185	13q13.1
Pancreatic cancer	613347	GLM3	600185	13q13.1
Pancreatic cancer	613347	PNCA2	600185	13q13.1
Pancreatic cancer, somatic		ACVR1B	601300	12q13.13
Pancreatic cancer, somatic		ACVRLK4	601300	12q13.13
Pancreatic cancer, somatic		ALK4	601300	12q13.13
Pancreatic cancer, somatic	260350	MADH4	600993	18q21.2
Pancreatic cancer, somatic	260350	DPC4	600993	18q21.2
Pancreatic cancer, somatic	260350	SMAD4	600993	18q21.2
Pancreatic cancer, somatic	260350	JIP	600993	18q21.2
Pancreatic cancer, somatic	260350	MYHRS	600993	18q21.2
Pancreatic cancer/melanoma syndrome	606719	CDKN2A	600160	9p21.3
Pancreatic cancer/melanoma syndrome	606719	MTS1	600160	9p21.3
Pancreatic cancer/melanoma syndrome	606719	P16	600160	9p21.3
Pancreatic cancer/melanoma syndrome	606719	MLM	600160	9p21.3
Pancreatic cancer/melanoma syndrome	606719	CMM2	600160	9p21.3
Pancreatic carcinoma, somatic		RBBP8	604124	18q11.2
Pancreatic carcinoma, somatic		RIM	604124	18q11.2
Pancreatic carcinoma, somatic		SCKL2	604124	18q11.2
Pancreatic carcinoma, somatic		JWDS	604124	18q11.2
Pancreatic carcinoma, somatic	260350	KRAS	190070	12p12.1
Pancreatic carcinoma, somatic	260350	KRAS2	190070	12p12.1
Pancreatic carcinoma, somatic	260350	RASK2	190070	12p12.1
Pancreatic carcinoma, somatic	260350	NS	190070	12p12.1
Pancreatic carcinoma, somatic	260350	CFC2	190070	12p12.1
Pancreatic lipase deficiency	614338	PNLIP	246600	10q25.3
Pancreatic lipase deficiency	614338	PNLIPD	246600	10q25.3
Pancreatitis, hereditary	167800	PRSS1	276000	7q34
Pancreatitis, hereditary	167800	TRY1	276000	7q34
Pancreatitis, hereditary	167800	SPINK1	167790	5q32
Pancreatitis, hereditary	167800	PSTI	167790	5q32
Pancreatitis, hereditary	167800	PCTT	167790	5q32
Pancreatitis, hereditary	167800	TATI	167790	5q32
Pancreatitis, hereditary	167800	TCP	167790	5q32
Panhypopituitarism, X-linked	312000	SOX3	313430	Xq27.1
Panhypopituitarism, X-linked	312000	MRGH	313430	Xq27.1
Panic disorder 2	607853	PAND2		9q31
Panic disorder 3	609985	PAND3		4q31-q34
Panic disorder syndrome 1	167870	PAND1		13q22-q32
Papillon-Lefevre syndrome	245000	CTSC	602365	11q14.2
Papillon-Lefevre syndrome	245000	CPPI	602365	11q14.2
Papillon-Lefevre syndrome	245000	PALS	602365	11q14.2
Papillon-Lefevre syndrome	245000	PLS	602365	11q14.2
Papillon-Lefevre syndrome	245000	HMS	602365	11q14.2
Papillon-Lefevre syndrome	245000	PDON1	602365	11q14.2
Papillon-Lefevre syndrome	245000	JPD	602365	11q14.2
Papillorenal syndrome	120330	PAX2	167409	10q24.31
Papillorenal syndrome	120330	PAPRS	167409	10q24.31
Paraganglioma and gastric stromal sarcoma	606864	SDHB	185470	1p36.13
Paraganglioma and gastric stromal sarcoma	606864	SDH2	185470	1p36.13
Paraganglioma and gastric stromal sarcoma	606864	SDHIP	185470	1p36.13
Paraganglioma and gastric stromal sarcoma	606864	PGL4	185470	1p36.13
Paraganglioma and gastric stromal sarcoma	606864	CWS2	185470	1p36.13
Paraganglioma and gastric stromal sarcoma	606864	SDHC	602413	1q23.3
Paraganglioma and gastric stromal sarcoma	606864	PGL3	602413	1q23.3
Paraganglioma and gastric stromal sarcoma	606864	SDHD	602690	11q23.1
Paraganglioma and gastric stromal sarcoma	606864	PGL1	602690	11q23.1
Paraganglioma and gastric stromal sarcoma	606864	CWS3	602690	11q23.1
Paragangliomas 1, with or without deafness	168000	SDHD	602690	11q23.1
Paragangliomas 1, with or without deafness	168000	PGL1	602690	11q23.1
Paragangliomas 1, with or without deafness	168000	CWS3	602690	11q23.1
Paragangliomas 2	601650	SDHAF2	613019	11q12.2
Paragangliomas 2	601650	SDH5	613019	11q12.2
Paragangliomas 2	601650	PGL2	613019	11q12.2
Paragangliomas 3	605373	SDHC	602413	1q23.3
Paragangliomas 3	605373	PGL3	602413	1q23.3
Paragangliomas 4	115310	SDHB	185470	1p36.13
Paragangliomas 4	115310	SDH2	185470	1p36.13
Paragangliomas 4	115310	SDHIP	185470	1p36.13
Paragangliomas 4	115310	PGL4	185470	1p36.13
Paragangliomas 4	115310	CWS2	185470	1p36.13
Paragangliomas 5	614165	SDHA	600857	5p15.33
Paragangliomas 5	614165	SDH1	600857	5p15.33
Paragangliomas 5	614165	SDHF	600857	5p15.33
Paragangliomas 5	614165	CMD1GG	600857	5p15.33
Paragangliomas 5	614165	PGL5	600857	5p15.33
Paramyotonia congenita	168300	SCN4A	603967	17q23.3
Paramyotonia congenita	168300	HYPP	603967	17q23.3
Paramyotonia congenita	168300	NAC1A	603967	17q23.3
Paramyotonia congenita	168300	HOKPP2	603967	17q23.3
Parasomnia, sleepwalking type	613938	PSMNSW		20q12-q13.12
Parastremmatic dwarfism	168400	TRPV4	605427	12q24.11
Parastremmatic dwarfism	168400	VROAC	605427	12q24.11
Parastremmatic dwarfism	168400	HMSN2C	605427	12q24.11
Parastremmatic dwarfism	168400	CMT2C	605427	12q24.11
Parastremmatic dwarfism	168400	SPSMA	605427	12q24.11
Parastremmatic dwarfism	168400	SSQTL1	605427	12q24.11
Parastremmatic dwarfism	168400	SMAL	605427	12q24.11
Parathyroid adenoma with cystic changes	145001	HRPT2	607393	1q31.2
Parathyroid adenoma with cystic changes	145001	C1orf28	607393	1q31.2
Parathyroid adenoma, somatic		MEN1	613733	11q13.1
Parathyroid carcinoma	608266	HRPT2	607393	1q31.2
Parathyroid carcinoma	608266	C1orf28	607393	1q31.2
Parietal foramina 1	168500	MSX2	123101	5q35.2
Parietal foramina 1	168500	CRS2	123101	5q35.2
Parietal foramina 1	168500	HOX8	123101	5q35.2
Parietal foramina 2	609597	ALX4	605420	11p11.2
Parietal foramina 2	609597	PFM2	605420	11p11.2
Parietal foramina 2	609597	FPP	605420	11p11.2
Parietal foramina 2	609597	FND2	605420	11p11.2
Parietal foramina 2	609597	CRS5	605420	11p11.2
Parietal foramina with cleidocranial dysplasia	168550	MSX2	123101	5q35.2
Parietal foramina with cleidocranial dysplasia	168550	CRS2	123101	5q35.2
Parietal foramina with cleidocranial dysplasia	168550	HOX8	123101	5q35.2
Parkes Weber syndrome	608355	RASA1	139150	5q14.3
Parkes Weber syndrome	608355	GAP	139150	5q14.3
Parkes Weber syndrome	608355	CMAVM	139150	5q14.3
Parkes Weber syndrome	608355	PKWS	139150	5q14.3
Parkinson disease 1	168601	SNCA	163890	4q22.1
Parkinson disease 1	168601	NACP	163890	4q22.1
Parkinson disease 1	168601	PARK1	163890	4q22.1
Parkinson disease 1	168601	PARK4	163890	4q22.1
Parkinson disease 10	606852	PARK10		1p32
Parkinson disease 10	606852	AAOPD		1p32
Parkinson disease 11	607688	GIGYF2	612003	2q37.1
Parkinson disease 11	607688	KIAA0642	612003	2q37.1
Parkinson disease 11	607688	PARK11	612003	2q37.1
Parkinson disease 12	300557	PARK12		Xq21-q25
Parkinson disease 13	610297	HTRA2	606441	2p13.1
Parkinson disease 13	610297	OMI	606441	2p13.1
Parkinson disease 13	610297	PARK13	606441	2p13.1
Parkinson disease 13	610297	PRSS25	606441	2p13.1
Parkinson disease 14	612953	PLA2G6	603604	22q13.1
Parkinson disease 14	612953	IPLA2	603604	22q13.1
Parkinson disease 14	612953	INAD1	603604	22q13.1
Parkinson disease 14	612953	NBIA2B	603604	22q13.1
Parkinson disease 14	612953	NBIA2A	603604	22q13.1
Parkinson disease 14	612953	PARK14	603604	22q13.1
Parkinson disease 15, autosomal recessive	260300	FBXO7	605648	22q12.3
Parkinson disease 15, autosomal recessive	260300	FBX7	605648	22q12.3
Parkinson disease 15, autosomal recessive	260300	FBX	605648	22q12.3
Parkinson disease 15, autosomal recessive	260300	PKPS	605648	22q12.3
Parkinson disease 15, autosomal recessive	260300	PARK15	605648	22q12.3
Parkinson disease 17	614203	VPS35	601501	16q11.2
Parkinson disease 17	614203	MEM3	601501	16q11.2
Parkinson disease 17	614203	PARK17	601501	16q11.2
Parkinson disease 18	614251	EIF4G1	600495	3q27.1
Parkinson disease 18	614251	EIF4G	600495	3q27.1
Parkinson disease 18	614251	PARK18	600495	3q27.1
Parkinson disease 19, juvenile-onset	615528	DNAJC6	608375	1p31.3
Parkinson disease 19, juvenile-onset	615528	DJC6	608375	1p31.3
Parkinson disease 19, juvenile-onset	615528	KIAA0473	608375	1p31.3
Parkinson disease 19, juvenile-onset	615528	PARK19	608375	1p31.3
Parkinson disease 20, early-onset	615530	SYNJ1	604297	21q22.11
Parkinson disease 20, early-onset	615530	PARK20	604297	21q22.11
Parkinson disease 3	602404	PARK3		2p13
Parkinson disease 4	605543	SNCA	163890	4q22.1
Parkinson disease 4	605543	NACP	163890	4q22.1
Parkinson disease 4	605543	PARK1	163890	4q22.1
Parkinson disease 4	605543	PARK4	163890	4q22.1
Parkinson disease 6, early onset	605909	PINK1	608309	1p36.12
Parkinson disease 6, early onset	605909	PARK6	608309	1p36.12
Parkinson disease 7, autosomal recessive early-onset	606324	DJ1	602533	1p36.23
Parkinson disease 7, autosomal recessive early-onset	606324	PARK7	602533	1p36.23
Parkinson disease 8	607060	LRRK2	609007	12q12
Parkinson disease 8	607060	PARK8	609007	12q12
Parkinson disease, juvenile, type 2	600116	PRKN	602544	6q26
Parkinson disease, juvenile, type 2	600116	PARK2	602544	6q26
Parkinson disease, juvenile, type 2	600116	PDJ	602544	6q26
Parkinson disease, juvenile, type 2	600116	LPRS2	602544	6q26
Parkinsonism-dystonia, infantile	613135	SLC6A3	126455	5p15.33
Parkinsonism-dystonia, infantile	613135	DAT1	126455	5p15.33
Parkinsonism-dystonia, infantile	613135	PKDYS	126455	5p15.33
Paroxysmal extreme pain disorder	167400	SCN9A	603415	2q24.3
Paroxysmal extreme pain disorder	167400	NENA	603415	2q24.3
Paroxysmal extreme pain disorder	167400	PN1	603415	2q24.3
Paroxysmal extreme pain disorder	167400	FEB3B	603415	2q24.3
Paroxysmal extreme pain disorder	167400	GEFSP7	603415	2q24.3
Paroxysmal extreme pain disorder	167400	SFNP	603415	2q24.3
Paroxysmal nocturnal hemoglobinuria, somatic	300818	PIGA	311770	Xp22.2
Paroxysmal nocturnal hemoglobinuria, somatic	300818	MCAHS2	311770	Xp22.2
Paroxysmal nonkinesigenic dyskinesia 2	611147	PNKD2		2q31
Paroxysmal nonkinesigenic dyskinesia	118800	MR1	609023	2q35
Paroxysmal nonkinesigenic dyskinesia	118800	TAHCCP2	609023	2q35
Paroxysmal nonkinesigenic dyskinesia	118800	KIPP1184	609023	2q35
Paroxysmal nonkinesigenic dyskinesia	118800	BRP17	609023	2q35
Paroxysmal nonkinesigenic dyskinesia	118800	PNKD	609023	2q35
Paroxysmal nonkinesigenic dyskinesia	118800	FPD1	609023	2q35
Paroxysmal nonkinesigenic dyskinesia	118800	PDC	609023	2q35
Paroxysmal nonkinesigenic dyskinesia	118800	DYT8	609023	2q35
Partington syndrome	309510	ARX	300382	Xp21.3
Partington syndrome	309510	ISSX	300382	Xp21.3
Partington syndrome	309510	PRTS	300382	Xp21.3
Partington syndrome	309510	MRXS1	300382	Xp21.3
Partington syndrome	309510	MRX36	300382	Xp21.3
Partington syndrome	309510	MRX54	300382	Xp21.3
Partington syndrome	309510	MRX43	300382	Xp21.3
Partington syndrome	309510	MRX87	300382	Xp21.3
Partington syndrome	309510	MRX29	300382	Xp21.3
Partington syndrome	309510	MRX32	300382	Xp21.3
Patella aplasia or hypoplasia	168860	PTLAH		17q21-q22
Patella aplasia or hypoplasia	168860	FPAH		17q21-q22
Peeling skin syndrome	270300	CDSN	602593	6p21.33
Peeling skin syndrome	270300	HTSS1	602593	6p21.33
Peeling skin syndrome	270300	PSS	602593	6p21.33
Peeling skin syndrome, acral type	609796	TGM5	603805	15q15.2
Peeling skin syndrome, acral type	609796	TGX	603805	15q15.2
Pelger-Huet anomaly	169400	LBR	600024	1q42.12
Pelger-Huet anomaly	169400	PHA	600024	1q42.12
Pelizaeus-Merzbacher disease	312080	PLP1	300401	Xq22.2
Pelizaeus-Merzbacher disease	312080	PMD	300401	Xq22.2
Pelizaeus-Merzbacher disease	312080	HLD1	300401	Xq22.2
Pelizaeus-Merzbacher disease	312080	SPG2	300401	Xq22.2
Pelviureteric junction obstruction	143400	PUJO		6p
Pendred syndrome	274600	SLC26A4	605646	7q22.3
Pendred syndrome	274600	PDS	605646	7q22.3
Pendred syndrome	274600	DFNB4	605646	7q22.3
Pendred syndrome	274600	EVA	605646	7q22.3
Pendred syndrome	274600	TDH2B	605646	7q22.3
Pentosuria	260800	DCXR	608347	17q25.3
Pentosuria	260800	P34H	608347	17q25.3
Periodic fever, familial	142680	TNFRSF1A	191190	12p13.31
Periodic fever, familial	142680	TNFR1	191190	12p13.31
Periodic fever, familial	142680	TNFAR	191190	12p13.31
Periodic fever, familial	142680	FPF	191190	12p13.31
Periodic fever, familial	142680	MS5	191190	12p13.31
Periodic fever, menstrual cycle dependent	614674	HTR1A	109760	5q12.3
Periodic fever, menstrual cycle dependent	614674	ADRB2RL1	109760	5q12.3
Periodic fever, menstrual cycle dependent	614674	PFMCD	109760	5q12.3
Periodontitis 1, juvenile	170650	CTSC	602365	11q14.2
Periodontitis 1, juvenile	170650	CPPI	602365	11q14.2
Periodontitis 1, juvenile	170650	PALS	602365	11q14.2
Periodontitis 1, juvenile	170650	PLS	602365	11q14.2
Periodontitis 1, juvenile	170650	HMS	602365	11q14.2
Periodontitis 1, juvenile	170650	PDON1	602365	11q14.2
Periodontitis 1, juvenile	170650	JPD	602365	11q14.2
Periodontitis, aggressive, 2	608526	PDON2		1q25
Peripheral arterial occlusive disease 1	606787	PAOD1		1p31
Peripheral neuropathy, myopathy, hoarseness, and hearing loss	614369	MYH14	608568	19q13.33
Peripheral neuropathy, myopathy, hoarseness, and hearing loss	614369	KIAA2034	608568	19q13.33
Peripheral neuropathy, myopathy, hoarseness, and hearing loss	614369	DFNA4A	608568	19q13.33
Peripheral neuropathy, myopathy, hoarseness, and hearing loss	614369	PNMHH	608568	19q13.33
Periventricular heterotopia with microcephaly	608097	ARFGEF2	605371	20q13.13
Periventricular heterotopia with microcephaly	608097	BIG2	605371	20q13.13
Periventricular heterotopia with microcephaly	608097	PVNH2	605371	20q13.13
Periventricular nodular heterotopia 3	608098	PVNH3		5p15.1
Periventricular nodular heterotopia 5	612881	PVNH5		5q14.3-q15
Perlman syndrome	267000	DIS3L2	614184	2q37.1
Perlman syndrome	267000	PRLMNS	614184	2q37.1
Peroxisomal acyl-CoA oxidase deficiency	264470	ACOX1	609751	17q25.1
Peroxisomal acyl-CoA oxidase deficiency	264470	ACOX	609751	17q25.1
Peroxisomal acyl-CoA oxidase deficiency	264470	SCOX	609751	17q25.1
Peroxisome biogenesis disorder 10A (Zellweger)	614882	PEX3	603164	6q24.2
Peroxisome biogenesis disorder 10A (Zellweger)	614882	PBD10A	603164	6q24.2
Peroxisome biogenesis disorder 11A (Zellweger)	614883	PEX13	601789	2p16.1
Peroxisome biogenesis disorder 11A (Zellweger)	614883	ZWS	601789	2p16.1
Peroxisome biogenesis disorder 11A (Zellweger)	614883	NALD	601789	2p16.1
Peroxisome biogenesis disorder 11A (Zellweger)	614883	PBD11A	601789	2p16.1
Peroxisome biogenesis disorder 11A (Zellweger)	614883	PBD11B	601789	2p16.1
Peroxisome biogenesis disorder 11B	614885	PEX13	601789	2p16.1
Peroxisome biogenesis disorder 11B	614885	ZWS	601789	2p16.1
Peroxisome biogenesis disorder 11B	614885	NALD	601789	2p16.1
Peroxisome biogenesis disorder 11B	614885	PBD11A	601789	2p16.1
Peroxisome biogenesis disorder 11B	614885	PBD11B	601789	2p16.1
Peroxisome biogenesis disorder 12A (Zellweger)	614886	PEX19	600279	1q23.2
Peroxisome biogenesis disorder 12A (Zellweger)	614886	PXF	600279	1q23.2
Peroxisome biogenesis disorder 12A (Zellweger)	614886	HK33	600279	1q23.2
Peroxisome biogenesis disorder 12A (Zellweger)	614886	D1S2223E	600279	1q23.2
Peroxisome biogenesis disorder 12A (Zellweger)	614886	PBD12A	600279	1q23.2
Peroxisome biogenesis disorder 13A (Zellweger)	614887	PEX14	601791	1p36.22
Peroxisome biogenesis disorder 13A (Zellweger)	614887	PBD13A	601791	1p36.22
Peroxisome biogenesis disorder 14B	614920	PEX11B	603867	1q21.1
Peroxisome biogenesis disorder 14B	614920	PEX14B	603867	1q21.1
Peroxisome biogenesis disorder 1A (Zellweger)	214100	PEX1	602136	7q21.2
Peroxisome biogenesis disorder 1A (Zellweger)	214100	ZWS1	602136	7q21.2
Peroxisome biogenesis disorder 1A (Zellweger)	214100	PBD1A	602136	7q21.2
Peroxisome biogenesis disorder 1A (Zellweger)	214100	PBD1B	602136	7q21.2
Peroxisome biogenesis disorder 1B (NALD/IRD)	601539	PEX1	602136	7q21.2
Peroxisome biogenesis disorder 1B (NALD/IRD)	601539	ZWS1	602136	7q21.2
Peroxisome biogenesis disorder 1B (NALD/IRD)	601539	PBD1A	602136	7q21.2
Peroxisome biogenesis disorder 1B (NALD/IRD)	601539	PBD1B	602136	7q21.2
Peroxisome biogenesis disorder 2A (Zellweger)	214110	PEX5	600414	12p13.31
Peroxisome biogenesis disorder 2A (Zellweger)	214110	PXR1	600414	12p13.31
Peroxisome biogenesis disorder 2A (Zellweger)	214110	PTS1R	600414	12p13.31
Peroxisome biogenesis disorder 2A (Zellweger)	214110	PBD2A	600414	12p13.31
Peroxisome biogenesis disorder 2A (Zellweger)	214110	PBD2B	600414	12p13.31
Peroxisome biogenesis disorder 2B	202370	PEX5	600414	12p13.31
Peroxisome biogenesis disorder 2B	202370	PXR1	600414	12p13.31
Peroxisome biogenesis disorder 2B	202370	PTS1R	600414	12p13.31
Peroxisome biogenesis disorder 2B	202370	PBD2A	600414	12p13.31
Peroxisome biogenesis disorder 2B	202370	PBD2B	600414	12p13.31
Peroxisome biogenesis disorder 3A (Zellweger)	614859	PEX12	601758	17q12
Peroxisome biogenesis disorder 3A (Zellweger)	614859	PBD3A	601758	17q12
Peroxisome biogenesis disorder 3B	266510	PEX12	601758	17q12
Peroxisome biogenesis disorder 3B	266510	PBD3A	601758	17q12
Peroxisome biogenesis disorder 4A (Zellweger)	614862	PEX6	601498	6p21.1
Peroxisome biogenesis disorder 4A (Zellweger)	614862	PXAAA1	601498	6p21.1
Peroxisome biogenesis disorder 4A (Zellweger)	614862	PAF2	601498	6p21.1
Peroxisome biogenesis disorder 4A (Zellweger)	614862	PBD4A	601498	6p21.1
Peroxisome biogenesis disorder 4A (Zellweger)	614862	PDB4B	601498	6p21.1
Peroxisome biogenesis disorder 4B	614863	PEX6	601498	6p21.1
Peroxisome biogenesis disorder 4B	614863	PXAAA1	601498	6p21.1
Peroxisome biogenesis disorder 4B	614863	PAF2	601498	6p21.1
Peroxisome biogenesis disorder 4B	614863	PBD4A	601498	6p21.1
Peroxisome biogenesis disorder 4B	614863	PDB4B	601498	6p21.1
Peroxisome biogenesis disorder 5A (Zellweger)	614866	PXMP3	170993	8q21.11
Peroxisome biogenesis disorder 5A (Zellweger)	614866	PAF1	170993	8q21.11
Peroxisome biogenesis disorder 5A (Zellweger)	614866	PMP35	170993	8q21.11
Peroxisome biogenesis disorder 5A (Zellweger)	614866	PEX2	170993	8q21.11
Peroxisome biogenesis disorder 5A (Zellweger)	614866	PBD5A	170993	8q21.11
Peroxisome biogenesis disorder 5A (Zellweger)	614866	PBD5B	170993	8q21.11
Peroxisome biogenesis disorder 5B	614867	PXMP3	170993	8q21.11
Peroxisome biogenesis disorder 5B	614867	PAF1	170993	8q21.11
Peroxisome biogenesis disorder 5B	614867	PMP35	170993	8q21.11
Peroxisome biogenesis disorder 5B	614867	PEX2	170993	8q21.11
Peroxisome biogenesis disorder 5B	614867	PBD5A	170993	8q21.11
Peroxisome biogenesis disorder 5B	614867	PBD5B	170993	8q21.11
Peroxisome biogenesis disorder 6A (Zellweger)	614870	PEX10	602859	1p36.32
Peroxisome biogenesis disorder 6A (Zellweger)	614870	NALD	602859	1p36.32
Peroxisome biogenesis disorder 6A (Zellweger)	614870	PBD6A	602859	1p36.32
Peroxisome biogenesis disorder 6A (Zellweger)	614870	PBD6B	602859	1p36.32
Peroxisome biogenesis disorder 6B	614871	PEX10	602859	1p36.32
Peroxisome biogenesis disorder 6B	614871	NALD	602859	1p36.32
Peroxisome biogenesis disorder 6B	614871	PBD6A	602859	1p36.32
Peroxisome biogenesis disorder 6B	614871	PBD6B	602859	1p36.32
Peroxisome biogenesis disorder 7A (Zellweger)	614872	PEX26	608666	22q11.21
Peroxisome biogenesis disorder 7A (Zellweger)	614872	PBD7A	608666	22q11.21
Peroxisome biogenesis disorder 7A (Zellweger)	614872	PBD7B	608666	22q11.21
Peroxisome biogenesis disorder 7B	614873	PEX26	608666	22q11.21
Peroxisome biogenesis disorder 7B	614873	PBD7A	608666	22q11.21
Peroxisome biogenesis disorder 7B	614873	PBD7B	608666	22q11.21
Peroxisome biogenesis disorder 8A, (Zellweger)	614876	PEX16	603360	11p11.2
Peroxisome biogenesis disorder 8A, (Zellweger)	614876	PBD8A	603360	11p11.2
Peroxisome biogenesis disorder 8A, (Zellweger)	614876	PBD8B	603360	11p11.2
Peroxisome biogenesis disorder 8B	614877	PEX16	603360	11p11.2
Peroxisome biogenesis disorder 8B	614877	PBD8A	603360	11p11.2
Peroxisome biogenesis disorder 8B	614877	PBD8B	603360	11p11.2
Peroxisome biogenesis disorder 9B	614879	PEX7	601757	6q23.3
Peroxisome biogenesis disorder 9B	614879	RCDP1	601757	6q23.3
Peroxisome biogenesis disorder 9B	614879	PBD9B	601757	6q23.3
Perrault syndrome 1	233400	HSD17B4	601860	5q23.1
Perrault syndrome 1	233400	PRLTS1	601860	5q23.1
Perrault syndrome 2	614926	HARS2	600783	5q31.3
Perrault syndrome 2	614926	HARSL	600783	5q31.3
Perrault syndrome 2	614926	HARSR	600783	5q31.3
Perrault syndrome 2	614926	HO3	600783	5q31.3
Perrault syndrome 2	614926	PRLTS2	600783	5q31.3
Perrault syndrome 3	614129	CLPP	601119	19p13.3
Perrault syndrome 3	614129	PRLTS3	601119	19p13.3
Perrault syndrome 4	615300	LARS2	604544	3p21.31
Perrault syndrome 4	615300	PRLTS4	604544	3p21.31
Perry syndrome	168605	DCTN1	601143	2p13.1
Perry syndrome	168605	HMN7B	601143	2p13.1
Persistent Mullerian duct syndrome, type I	261550	AMH	600957	19p13.3
Persistent Mullerian duct syndrome, type I	261550	MIF	600957	19p13.3
Persistent Mullerian duct syndrome, type II	261550	AMHR2	600956	12q13.13
Persistent Mullerian duct syndrome, type II	261550	AMHR	600956	12q13.13
Persistent polyclonal B-cell lymphocytosis	606445	CARD11	607210	7p22.2
Persistent polyclonal B-cell lymphocytosis	606445	CARMA1	607210	7p22.2
Persistent polyclonal B-cell lymphocytosis	606445	BIMP3	607210	7p22.2
Persistent polyclonal B-cell lymphocytosis	606445	PPBL	607210	7p22.2
Persistent polyclonal B-cell lymphocytosis	606445	BENTA	607210	7p22.2
Persistent polyclonal B-cell lymphocytosis	606445	IMD11	607210	7p22.2
Persistent truncus arteriosus	217095	GATA6	601656	18q11.2
Persistent truncus arteriosus	217095	AVSD5	601656	18q11.2
Persistent truncus arteriosus	217095	ASD9	601656	18q11.2
Persistent truncus arteriosus	217095	AVSD5	601656	18q11.2
Persistent truncus arteriosus	217095	PACHD	601656	18q11.2
Persistent truncus arteriosus	217095	NKX2-6	611770	8p21.2
Persistent truncus arteriosus	217095	CSX2	611770	8p21.2
Peters anomaly	604229	CYP1B1	601771	2p22.2
Peters anomaly	604229	GLC3A	601771	2p22.2
Peters anomaly	604229	PAX6	607108	11p13
Peters anomaly	604229	AN2	607108	11p13
Peters anomaly	604229	MGDA	607108	11p13
Peters anomaly	604229	PITX2	601542	4q25
Peters anomaly	604229	IDG2	601542	4q25
Peters anomaly	604229	RIEG1	601542	4q25
Peters anomaly	604229	RGS	601542	4q25
Peters anomaly	604229	IGDS2	601542	4q25
Peters-plus syndrome	261540	B3GALTL	610308	13q12.3
Peters-plus syndrome	261540	B3GTL	610308	13q12.3
Peters-plus syndrome	261540	B3GLCT	610308	13q12.3
Pettigrew syndrome	304340	PGS		Xq25-q27
Pettigrew syndrome	304340	MRXS5		Xq25-q27
Peutz-Jeghers syndrome	175200	STK11	602216	19p13.3
Peutz-Jeghers syndrome	175200	PJS	602216	19p13.3
Peutz-Jeghers syndrome	175200	LKB1	602216	19p13.3
Pfeiffer syndrome	101600	FGFR1	136350	8p11.23-p11.22
Pfeiffer syndrome	101600	FLT2	136350	8p11.23-p11.22
Pfeiffer syndrome	101600	OGD	136350	8p11.23-p11.22
Pfeiffer syndrome	101600	KAL2	136350	8p11.23-p11.22
Pfeiffer syndrome	101600	HH2	136350	8p11.23-p11.22
Pfeiffer syndrome	101600	HRTFDS	136350	8p11.23-p11.22
Pfeiffer syndrome	101600	FGFR2	176943	10q26.13
Pfeiffer syndrome	101600	BEK	176943	10q26.13
Pfeiffer syndrome	101600	CFD1	176943	10q26.13
Pfeiffer syndrome	101600	JWS	176943	10q26.13
Pfeiffer syndrome	101600	TK14	176943	10q26.13
Pfeiffer syndrome	101600	BBDS	176943	10q26.13
Phelan-McDermid syndrome	606232	SHANK3	606230	22q13.33
Phelan-McDermid syndrome	606232	PSAP2	606230	22q13.33
Phelan-McDermid syndrome	606232	PROSAP2	606230	22q13.33
Phelan-McDermid syndrome	606232	KIAA1650	606230	22q13.33
Phelan-McDermid syndrome	606232	DEL22q13.3	606230	22q13.33
Phelan-McDermid syndrome	606232	SCZD15	606230	22q13.33
Phenylketonuria	261600	PAH	612349	12q23.2
Phenylketonuria	261600	PKU1	612349	12q23.2
Pheochromocytoma	171300	KIF1B	605995	1p36.22
Pheochromocytoma	171300	CMT2A	605995	1p36.22
Pheochromocytoma	171300	CMT2A1	605995	1p36.22
Pheochromocytoma	171300	NBLST1	605995	1p36.22
Pheochromocytoma	171300	RET	164761	10q11.21
Pheochromocytoma	171300	MEN2A	164761	10q11.21
Pheochromocytoma	171300	HSCR1	164761	10q11.21
Pheochromocytoma	171300	SDHB	185470	1p36.13
Pheochromocytoma	171300	SDH2	185470	1p36.13
Pheochromocytoma	171300	SDHIP	185470	1p36.13
Pheochromocytoma	171300	PGL4	185470	1p36.13
Pheochromocytoma	171300	CWS2	185470	1p36.13
Pheochromocytoma	171300	SDHD	602690	11q23.1
Pheochromocytoma	171300	PGL1	602690	11q23.1
Pheochromocytoma	171300	CWS3	602690	11q23.1
Pheochromocytoma	171300	VHL	608537	3p25.3
Phobia, specific	608251	PHOBS		Chr.14
Phosphoglycerate dehydrogenase deficiency	601815	PHGDH	606879	1p12
Phosphoglycerate kinase 1 deficiency	300653	PGK1	311800	Xq21.1
Phosphoglycerate kinase 1 deficiency	300653	PGKA	311800	Xq21.1
Phospholipase A2, group IV A, deficiency of	600522	PLA2G4A		1q31.1
Phospholipase A2, group IV A, deficiency of	600522	PLA2G4		1q31.1
Phosphoribosylpyrophosphate synthetase superactivity	300661	PRPS1	311850	Xq22.3
Phosphoribosylpyrophosphate synthetase superactivity	300661	CMTX5	311850	Xq22.3
Phosphoribosylpyrophosphate synthetase superactivity	300661	DFNX1	311850	Xq22.3
Phosphoribosylpyrophosphate synthetase superactivity	300661	DFN2	311850	Xq22.3
Phosphorylase kinase deficiency of liver and muscle, autosomal recessive	261750	PHKB	172490	16q12.1
Phosphoserine aminotransferase deficiency	610992	PSAT1	610936	9q21.2
Phosphoserine aminotransferase deficiency	610992	PSAT	610936	9q21.2
Phosphoserine aminotransferase deficiency	610992	EPIP	610936	9q21.2
Phosphoserine phosphatase deficiency	614023	PSP	172480	7p11.2
Phosphoserine phosphatase deficiency	614023	PSPHD	172480	7p11.2
Photoparoxysmal response 1	132100	PPR1		6p21.1
Photoparoxysmal response 2	609572	PPR2		13q31.3
Photoparoxysmal response 3	609573	PPR3		7q32
Pick disease	172700	MAPT	157140	17q21.31
Pick disease	172700	MTBT1	157140	17q21.31
Pick disease	172700	DDPAC	157140	17q21.31
Pick disease	172700	MSTD	157140	17q21.31
Pick disease	172700	PSEN1	104311	14q24.2
Pick disease	172700	AD3	104311	14q24.2
Piebaldism	172800	KIT	164920	4q12
Piebaldism	172800	PBT	164920	4q12
Piebaldism	172800	SNAI2	602150	8q11.21
Piebaldism	172800	SLUG	602150	8q11.21
Piebaldism	172800	WS2D	602150	8q11.21
Pierre Robin syndrome	261800	PRBNS		17q24.3-q25.1
Pierson syndrome	609049	LAMB2	150325	3p21.31
Pierson syndrome	609049	LAMS	150325	3p21.31
Pierson syndrome	609049	NPHS5	150325	3p21.31
Pigment disorder, reticulate	301220	PDR		Xp22-p21
Pigment dispersion syndrome	600510	GPDS1		7q35-q36
Pigment dispersion syndrome	600510	PDS1		7q35-q36
Pigmented nodular adrenocortical disease, primary, 1	610489	PRKAR1A	188830	17q24.2
Pigmented nodular adrenocortical disease, primary, 1	610489	TSE1	188830	17q24.2
Pigmented nodular adrenocortical disease, primary, 1	610489	CNC1	188830	17q24.2
Pigmented nodular adrenocortical disease, primary, 1	610489	CAR	188830	17q24.2
Pigmented nodular adrenocortical disease, primary, 1	610489	PPNAD1	188830	17q24.2
Pigmented nodular adrenocortical disease, primary, 1	610489	ACRDYS1	188830	17q24.2
Pigmented nodular adrenocortical disease, primary, 2	610475	PDE11A	604961	2q31.2
Pigmented nodular adrenocortical disease, primary, 2	610475	PDE11A1	604961	2q31.2
Pigmented nodular adrenocortical disease, primary, 2	610475	PDE11A2	604961	2q31.2
Pigmented nodular adrenocortical disease, primary, 2	610475	PDE11A3	604961	2q31.2
Pigmented nodular adrenocortical disease, primary, 2	610475	PPNAD2	604961	2q31.2
Pigmented nodular adrenocortical disease, primary, 3	614190	PDE8B	603390	5q13.3
Pigmented nodular adrenocortical disease, primary, 3	614190	PPNAD3	603390	5q13.3
Pigmented nodular adrenocortical disease, primary, 3	614190	ADSD	603390	5q13.3
Pigmented paravenous chorioretinal atrophy	172870	CRB1	604210	1q31.3
Pigmented paravenous chorioretinal atrophy	172870	RP12	604210	1q31.3
Pigmented paravenous chorioretinal atrophy	172870	LCA8	604210	1q31.3
Pilomatricoma, somatic	132600	CTNNB1	116806	3p22.1
Pilomatricoma, somatic	132600	MRD19	116806	3p22.1
Pitt-Hopkins like syndrome 1	610042	CNTNAP2	604569	7q35-q36
Pitt-Hopkins like syndrome 1	610042	CASPR2	604569	7q35-q36
Pitt-Hopkins like syndrome 1	610042	NRXN4	604569	7q35-q36
Pitt-Hopkins like syndrome 1	610042	CDFE	604569	7q35-q36
Pitt-Hopkins like syndrome 1	610042	AUTS15	604569	7q35-q36
Pitt-Hopkins like syndrome 1	610042	PTHSL1	604569	7q35-q36
Pitt-Hopkins syndrome	610954	TCF4	602272	18q21.2
Pitt-Hopkins syndrome	610954	SEF2	602272	18q21.2
Pitt-Hopkins syndrome	610954	ITF2	602272	18q21.2
Pitt-Hopkins syndrome	610954	PTHS	602272	18q21.2
Pitt-Hopkins-like syndrome 2	614325	NRXN1	600565	2p16.3
Pitt-Hopkins-like syndrome 2	614325	PTHSL2	600565	2p16.3
Pitt-Hopkins-like syndrome 2	614325	SCZD17	600565	2p16.3
Pituitary ACTH-secreting adenoma		GNAI2	139360	3p21.31
Pituitary ACTH-secreting adenoma		GNAI2B	139360	3p21.31
Pituitary ACTH-secreting adenoma		GIP	139360	3p21.31
Pituitary adenoma, ACTH-secreting	219090	AIP	605555	11q13.2
Pituitary adenoma, ACTH-secreting	219090	XAP2	605555	11q13.2
Pituitary adenoma, ACTH-secreting	219090	ARA9	605555	11q13.2
Pituitary adenoma, growth hormone-secreting	102200	AIP	605555	11q13.2
Pituitary adenoma, growth hormone-secreting	102200	XAP2	605555	11q13.2
Pituitary adenoma, growth hormone-secreting	102200	ARA9	605555	11q13.2
Pituitary adenoma, prolactin-secreting	600634	AIP	605555	11q13.2
Pituitary adenoma, prolactin-secreting	600634	XAP2	605555	11q13.2
Pituitary adenoma, prolactin-secreting	600634	ARA9	605555	11q13.2
Pituitary hormone deficiency, combined, 1	613038	POU1F1	173110	3p11.2
Pituitary hormone deficiency, combined, 1	613038	PIT1	173110	3p11.2
Pituitary hormone deficiency, combined, 1	613038	CPHD1	173110	3p11.2
Pituitary hormone deficiency, combined, 2	262600	PROP1	601538	5q35.3
Pituitary hormone deficiency, combined, 2	262600	CPHD2	601538	5q35.3
Pituitary hormone deficiency, combined, 3	221750	LHX3	600577	9q34.3
Pituitary hormone deficiency, combined, 3	221750	CPHD3	600577	9q34.3
Pituitary hormone deficiency, combined, 4	262700	LHX4	602146	1q25.2
Pituitary hormone deficiency, combined, 4	262700	CPHD4	602146	1q25.2
Pituitary hormone deficiency, combined, 5	182230	HESX1	601802	3p14.3
Pituitary hormone deficiency, combined, 5	182230	RPX	601802	3p14.3
Pituitary hormone deficiency, combined, 5	182230	CPHD5	601802	3p14.3
Pituitary hormone deficiency, combined, 6	613986	OTX2	600037	14q22.3
Pituitary hormone deficiency, combined, 6	613986	MCOPS5	600037	14q22.3
Pituitary hormone deficiency, combined, 6	613986	CPHD6	600037	14q22.3
Pituitary tumor, invasive		PRKCA	176960	17q24.2
Pituitary tumor, invasive		PKCA	176960	17q24.2
Pityriasis rubra pilaris	173200	CARD14	607211	17q25.3
Pityriasis rubra pilaris	173200	CARMA2	607211	17q25.3
Pityriasis rubra pilaris	173200	BIMP2	607211	17q25.3
Pityriasis rubra pilaris	173200	PSORS2	607211	17q25.3
Pityriasis rubra pilaris	173200	PSS1	607211	17q25.3
Pityriasis rubra pilaris	173200	PRP	607211	17q25.3
Plasma fibronectin deficiency	614101	FN1	135600	2q35
Plasma fibronectin deficiency	614101	FN	135600	2q35
Plasma fibronectin deficiency	614101	LETS	135600	2q35
Plasma fibronectin deficiency	614101	FNZ	135600	2q35
Plasma fibronectin deficiency	614101	GFND2	135600	2q35
Plasminogen Tochigi disease		PLG	173350	6q26
Plasminogen activator inhibitor-1 deficiency	613329	PAI1	173360	7q22.1
Plasminogen activator inhibitor-1 deficiency	613329	PLANH1	173360	7q22.1
Plasminogen activator inhibitor-1 deficiency	613329	SERPINE1	173360	7q22.1
Plasminogen deficiency, types I and II		PLG	173350	6q26
Platelet PLC beta-2 deficiency		PLCB2	604114	15q15.1
Platelet disorder, familial, with associated myeloid malignancy	601399	RUNX1	151385	21q22.12
Platelet disorder, familial, with associated myeloid malignancy	601399	CBFA2	151385	21q22.12
Platelet disorder, familial, with associated myeloid malignancy	601399	AML1	151385	21q22.12
Platelet glycoprotein IV deficiency	608404	CD36	173510	7q21.11
Platelet glycoprotein IV deficiency	608404	CHDS7	173510	7q21.11
Platelet glycoprotein IV deficiency	608404	BDPLT10	173510	7q21.11
Platelet-activating factor acetylhydrolase deficiency	614278	PLA2G7	601690	6p12.3
Platelet-activating factor acetylhydrolase deficiency	614278	PAFAH	601690	6p12.3
Platelet-activating factor acetylhydrolase deficiency	614278	PAFAD	601690	6p12.3
Platyspondylic skeletal dysplasia, Torrance type	151210	COL2A1	120140	12q13.11
Pleuropulmonary blastoma	601200	DICER1	606241	14q32.13
Pleuropulmonary blastoma	601200	HERNA	606241	14q32.13
Pleuropulmonary blastoma	601200	KIAA0928	606241	14q32.13
Pleuropulmonary blastoma	601200	MNG1	606241	14q32.13
Pleuropulmonary blastoma	601200	RMSE2	606241	14q32.13
Pneumothorax, primary spontaneous	173600	FLCN	607273	17p11.2
Pneumothorax, primary spontaneous	173600	BHD	607273	17p11.2
Poikiloderma with neutropenia	604173	C16orf57	613276	16q21
Poikiloderma with neutropenia	604173	PN	613276	16q21
Polycystic kidney and hepatic disease	263200	FCYT	606702	6p12.3-p12.2
Polycystic kidney and hepatic disease	263200	PKHD1	606702	6p12.3-p12.2
Polycystic kidney and hepatic disease	263200	ARPKD	606702	6p12.3-p12.2
Polycystic kidney disease 2	613095	PKD2	173910	4q22.1
Polycystic kidney disease, adult type I	173900	PKD1	601313	16p13.3
Polycystic kidney disease, infantile severe, with tuberous sclerosis	600273	PKDTS		16p13.3
Polycystic liver disease	174050	PRKCSH	177060	19p13.2
Polycystic liver disease	174050	G19P1	177060	19p13.2
Polycystic liver disease	174050	PCLD	177060	19p13.2
Polycystic liver disease	174050	SEC63	608648	6q21
Polycystic ovary syndrome 1	184700	PCOS1		19p13.2
Polycystic ovary syndrome 1	184700	PCO1		19p13.2
Polycystic ovary syndrome 1	184700	PCO		19p13.2
Polycythemia vera	263300	JAK2	147796	9p24.1
Polycythemia vera	263300	THCYT3	147796	9p24.1
Polydactyly, postaxial, type A3	607324	PAPA3		19p13.2-p13.1
Polydactyly, postaxial, type A4	608562	PAPA4		7q22
Polydactyly, postaxial, type A5	263450	PAPA5		13q13.3-q21
Polydactyly, postaxial, types A1 and B	174200	GLI3	165240	7p14.1
Polydactyly, postaxial, types A1 and B	174200	PAPA	165240	7p14.1
Polydactyly, postaxial, types A1 and B	174200	PAPB	165240	7p14.1
Polydactyly, preaxial type II	174500	LMBR1	605522	7q36.3
Polydactyly, preaxial type II	174500	ACHP	605522	7q36.3
Polydactyly, preaxial type II	174500	C7orf2	605522	7q36.3
Polydactyly, preaxial type II	174500	PPD2	605522	7q36.3
Polydactyly, preaxial, type IV	174700	GLI3	165240	7p14.1
Polydactyly, preaxial, type IV	174700	PAPA	165240	7p14.1
Polydactyly, preaxial, type IV	174700	PAPB	165240	7p14.1
Polyglucosan body disease, adult form	263570	GBE1	607839	3p12.2
Polyglucosan body disease, adult form	263570	GSD4	607839	3p12.2
Polyglucosan body disease, adult form	263570	APBD	607839	3p12.2
Polyhydramnios, megalencephaly, and symptomatic epilepsy	611087	STRADA	608626	17q23.3
Polyhydramnios, megalencephaly, and symptomatic epilepsy	611087	STRAD	608626	17q23.3
Polyhydramnios, megalencephaly, and symptomatic epilepsy	611087	LYK5	608626	17q23.3
Polymicrogyria with optic nerve hypoplasia	613180	TUBA8	605742	22q11.21
Polymicrogyria with optic nerve hypoplasia	613180	TUBAL2	605742	22q11.21
Polymicrogyria with seizures	614833	RTTN	610436	18q22.2
Polymicrogyria with seizures	614833	PMGYS	610436	18q22.2
Polymicrogyria, bilateral frontoparietal	606854	GPR56	604110	16q21
Polymicrogyria, bilateral frontoparietal	606854	TM7XN1	604110	16q21
Polymicrogyria, bilateral frontoparietal	606854	BFPP	604110	16q21
Polymicrogyria, bilateral occipital	612691	BOP		6q16.3-q22.1
Polymicrogyria, bilateral perisylvian	300388	BPP		Xq27.2-q28
Polymicrogyria, bilateral perisylvian	300388	PMGX		Xq27.2-q28
Polymicrogyria, bilateral perisylvian	300388	CBPS		Xq27.2-q28
Polymicrogyria, symmetric or asymmetric	610031	TUBB2B	612850	6p25.2
Polymicrogyria, symmetric or asymmetric	610031	PMGYSA	612850	6p25.2
Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	612674	ABHD12	613599	20p11.21
Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract	612674	PHARC	613599	20p11.21
Polyposis syndrome, hereditary mixed, 2	610069	BMPR1A	601299	10q23.2
Polyposis syndrome, hereditary mixed, 2	610069	ACVRLK3	601299	10q23.2
Polyposis syndrome, hereditary mixed, 2	610069	ALK3	601299	10q23.2
Polyposis syndrome, mixed hereditary 1	601228	HMPS1		15q15.3-q22.1
Polyposis syndrome, mixed hereditary 1	601228	CRAC1		15q15.3-q22.1
Polyposis syndrome, mixed hereditary 1	601228	CRCS4		15q15.3-q22.1
Polyposis syndrome, mixed hereditary 1	601228	DUP15q		15q15.3-q22.1
Polyposis syndrome, mixed hereditary 1	601228	C15DUPq		15q15.3-q22.1
Polyposis, juvenile intestinal	174900	BMPR1A	601299	10q23.2
Polyposis, juvenile intestinal	174900	ACVRLK3	601299	10q23.2
Polyposis, juvenile intestinal	174900	ALK3	601299	10q23.2
Polyposis, juvenile intestinal	174900	MADH4	600993	18q21.2
Polyposis, juvenile intestinal	174900	DPC4	600993	18q21.2
Polyposis, juvenile intestinal	174900	SMAD4	600993	18q21.2
Polyposis, juvenile intestinal	174900	JIP	600993	18q21.2
Polyposis, juvenile intestinal	174900	MYHRS	600993	18q21.2
Pontocerebellar hypoplasia type 1A	607596	VRK1	602168	14q32.2
Pontocerebellar hypoplasia type 1A	607596	PCH1A	602168	14q32.2
Pontocerebellar hypoplasia type 2A	277470	TSEN54	608755	17q25.1
Pontocerebellar hypoplasia type 2A	277470	SEN54	608755	17q25.1
Pontocerebellar hypoplasia type 2A	277470	PCH2A	608755	17q25.1
Pontocerebellar hypoplasia type 2A	277470	PCH4	608755	17q25.1
Pontocerebellar hypoplasia type 2B	612389	TSEN2	608753	3p25.2
Pontocerebellar hypoplasia type 2B	612389	SEN2	608753	3p25.2
Pontocerebellar hypoplasia type 2B	612389	PCH2B	608753	3p25.2
Pontocerebellar hypoplasia type 2C	612390	TSEN34	608754	19q13.42
Pontocerebellar hypoplasia type 2C	612390	PCH2C	608754	19q13.42
Pontocerebellar hypoplasia type 2C	612390	LENG5	608754	19q13.42
Pontocerebellar hypoplasia type 2C	612390	SEN34	608754	19q13.42
Pontocerebellar hypoplasia type 2D	613811	SEPSECS	613009	4p15.2
Pontocerebellar hypoplasia type 2D	613811	SLA	613009	4p15.2
Pontocerebellar hypoplasia type 2D	613811	LP	613009	4p15.2
Pontocerebellar hypoplasia type 2D	613811	PCH2D	613009	4p15.2
Pontocerebellar hypoplasia type 4	225753	TSEN54	608755	17q25.1
Pontocerebellar hypoplasia type 4	225753	SEN54	608755	17q25.1
Pontocerebellar hypoplasia type 4	225753	PCH2A	608755	17q25.1
Pontocerebellar hypoplasia type 4	225753	PCH4	608755	17q25.1
Pontocerebellar hypoplasia, type 1B	614678	EXOSC3	606489	9p13.2
Pontocerebellar hypoplasia, type 1B	614678	RRP40	606489	9p13.2
Pontocerebellar hypoplasia, type 1B	614678	PCH1B	606489	9p13.2
Pontocerebellar hypoplasia, type 3	608027	PCH3		7q11-q21
Pontocerebellar hypoplasia, type 3	608027	CLAM		7q11-q21
Pontocerebellar hypoplasia, type 6	611523	RARS2	611524	6q15
Pontocerebellar hypoplasia, type 6	611523	RARSL	611524	6q15
Pontocerebellar hypoplasia, type 6	611523	PCH6	611524	6q15
Pontocerebellar hypoplasia, type 8	614961	CHMP1A	164010	16q24.3
Pontocerebellar hypoplasia, type 8	614961	PCOLN3	164010	16q24.3
Pontocerebellar hypoplasia, type 8	614961	PRSM1	164010	16q24.3
Pontocerebellar hypoplasia, type 8	614961	PCH8	164010	16q24.3
Popliteal pterygium syndrome 1	119500	IRF6	607199	1q32.2
Popliteal pterygium syndrome 1	119500	VWS	607199	1q32.2
Popliteal pterygium syndrome 1	119500	LPS	607199	1q32.2
Popliteal pterygium syndrome 1	119500	PIT	607199	1q32.2
Popliteal pterygium syndrome 1	119500	PPS1	607199	1q32.2
Popliteal pterygium syndrome 1	119500	OFC6	607199	1q32.2
Popliteal pterygium syndrome 2, lethal type	263650	RIPK4	605706	21q22.3
Popliteal pterygium syndrome 2, lethal type	263650	NKRD3	605706	21q22.3
Popliteal pterygium syndrome 2, lethal type	263650	DIK	605706	21q22.3
Popliteal pterygium syndrome 2, lethal type	263650	PPS2	605706	21q22.3
Porencephaly 1	175780	COL4A1	120130	13q34
Porencephaly 1	175780	POREN1	120130	13q34
Porencephaly 1	175780	HANAC	120130	13q34
Porencephaly 1	175780	ICH	120130	13q34
Porencephaly 2	614483	COL4A2	120090	13q34
Porencephaly 2	614483	POREN2	120090	13q34
Porencephaly 2	614483	ICH	120090	13q34
Porokeratosis 2, palmar, plantar, and disseminated	175850	POROK2		12q24.1-q24.2
Porokeratosis 2, palmar, plantar, and disseminated	175850	PPPD1		12q24.1-q24.2
Porokeratosis 3, disseminated superficial actinic	175900	MVK	251170	12q24.11
Porokeratosis 3, disseminated superficial actinic	175900	MVLK	251170	12q24.11
Porokeratosis 3, disseminated superficial actinic	175900	POROK3	251170	12q24.11
Porokeratosis 4, disseminated superficial actinic	607728	POROK4		15q25.1-q26.1
Porokeratosis 4, disseminated superficial actinic	607728	DSAP2		15q25.1-q26.1
Porokeratosis 5, disseminated superficial actinic	612293	POROK5		1p31.3-p31.1
Porokeratosis 5, disseminated superficial actinic	612293	DSAP3		1p31.3-p31.1
Porokeratosis 6	612353	POROK6		18p11.3
Porokeratosis 6	612353	DSAP4		18p11.3
Porokeratosis 7	614714	POROK7		16q24.1-q24.3
Porokeratosis, disseminated superficial actinic, 1	175900	SART3	611684	12q23.3
Porokeratosis, disseminated superficial actinic, 1	175900	P100	611684	12q23.3
Porokeratosis, disseminated superficial actinic, 1	175900	KIAA0156	611684	12q23.3
Porokeratosis, disseminated superficial actinic, 1	175900	TIP110	611684	12q23.3
Porokeratosis, disseminated superficial actinic, 1	175900	DSAP1	611684	12q23.3
Porphyria cutanea tarda	176100	UROD	613521	1p34.1
Porphyria variegata	176200	PPOX	600923	1q23.3
Porphyria, acute hepatic	612740	ALAD	125270	9q32
Porphyria, acute hepatic	612740	ALADH	125270	9q32
Porphyria, acute hepatic	612740	PBGS	125270	9q32
Porphyria, acute intermittent	176000	HMBS	609806	11q23.3
Porphyria, acute intermittent	176000	PBGD	609806	11q23.3
Porphyria, acute intermittent	176000	UPS	609806	11q23.3
Porphyria, acute intermittent, nonerythroid variant	176000	HMBS	609806	11q23.3
Porphyria, acute intermittent, nonerythroid variant	176000	PBGD	609806	11q23.3
Porphyria, acute intermittent, nonerythroid variant	176000	UPS	609806	11q23.3
Porphyria, congenital erythropoietic	263700	UROS	606938	10q26.1-q26.2
Porphyria, hepatoerythropoietic	176100	UROD	613521	1p34.1
Postaxial polydactyly, type A2	602085	PAPA2		13q21-q32
Potocki-Lupski syndrome	610883	PTLS		17p11.2
Potocki-Shaffer syndrome	601224	PSS		11p11.2
Prader-Willi syndrome	176270	NDN	602117	15q11.2
Prader-Willi syndrome	176270	SNRPN	182279	15q11.2
Prader-Willi-like syndrome	615547	MAGEL2	605283	15q11.2
Prader-Willi-like syndrome	615547	NDNL1	605283	15q11.2
Prader-Willi-like syndrome	615547	PWLS	605283	15q11.2
Preauricular tag, isolated, autosomal dominant, 1	610420	PAURT1		14q11.2-q12
Precocious puberty, central, 1	176400	KISS1R	604161	19p13.3
Precocious puberty, central, 1	176400	GPR54 	604161	19p13.3
Precocious puberty, central, 1	176400	HH8	604161	19p13.3
Precocious puberty, central, 1	176400	CPPB1	604161	19p13.3
Precocious puberty, central, 2	615346	MKRN3	603856	15q11.2
Precocious puberty, central, 2	615346	ZFP127	603856	15q11.2
Precocious puberty, central, 2	615346	ZNF127	603856	15q11.2
Precocious puberty, central, 2	615346	CPPB2	603856	15q11.2
Precocious puberty, male	176410	LHCGR	152790	2p16.3
Precocious puberty, male	176410	LHR	152790	2p16.3
Precocious puberty, male	176410	LCGR	152790	2p16.3
Preeclampsia/eclampsia 1	189800	PEE1		2p13
Preeclampsia/eclampsia 1	189800	PREG1		2p13
Preeclampsia/eclampsia 2	609402	PEE2		2p25
Preeclampsia/eclampsia 3	609403	PEE3		9p13
Preeclampsia/eclampsia 4	609404	STOX1	609397	10q21.3-q22.1
Preeclampsia/eclampsia 4	609404	PEE4	609397	10q21.3-q22.1
Preeclampsia/eclampsia 5	614595	CORIN	605236	4p12
Preeclampsia/eclampsia 5	614595	CRN	605236	4p12
Preeclampsia/eclampsia 5	614595	TMPRSS10	605236	4p12
Preeclampsia/eclampsia 5	614595	ATC2	605236	4p12
Preeclampsia/eclampsia 5	614595	PEE5	605236	4p12
Premature ovarian failure 1	311360	FMR1	309550	Xq27.3
Premature ovarian failure 1	311360	FRAXA	309550	Xq27.3
Premature ovarian failure 1	311360	POF1	309550	Xq27.3
Premature ovarian failure 2B	300604	FLJ22792	300603	Xq21.1-q21.2
Premature ovarian failure 2B	300604	POF1B	300603	Xq21.1-q21.2
Premature ovarian failure 2B	300604	POF2B	300603	Xq21.1-q21.2
Premature ovarian failure 3	608996	FOXL2	605597	3q22.3
Premature ovarian failure 3	608996	BPES	605597	3q22.3
Premature ovarian failure 3	608996	BPES1	605597	3q22.3
Premature ovarian failure 3	608996	PFRK	605597	3q22.3
Premature ovarian failure 3	608996	POF3	605597	3q22.3
Premature ovarian failure 4	300510	BMP15	300247	Xp11.22
Premature ovarian failure 4	300510	GDF9B	300247	Xp11.22
Premature ovarian failure 4	300510	ODG2	300247	Xp11.22
Premature ovarian failure 4	300510	POF4	300247	Xp11.22
Premature ovarian failure 5	611548	NOBOX	610934	7q35
Premature ovarian failure 5	611548	POF5	610934	7q35
Premature ovarian failure 6	612310	FIGLA	608697	2p13.3
Premature ovarian failure 6	612310	POF6	608697	2p13.3
Premature ovarian failure 7	612964	NR5A1	184757	9q33.3
Premature ovarian failure 7	612964	FTZF1	184757	9q33.3
Premature ovarian failure 7	612964	FTZ1	184757	9q33.3
Premature ovarian failure 7	612964	SF1	184757	9q33.3
Premature ovarian failure 7	612964	AD4BP	184757	9q33.3
Premature ovarian failure 7	612964	POF7	184757	9q33.3
Premature ovarian failure 7	612964	SRXY3	184757	9q33.3
Premature ovarian failure 7	612964	SPGF8	184757	9q33.3
Premature ovarian failure	300511	DIAPH2	300108	Xq21.33
Premature ovarian failure	300511	DIA	300108	Xq21.33
Premature ovarian failure	300511	POF2	300108	Xq21.33
Prieto syndrome	309610	PRS		Xp11-q21
Prieto syndrome	309610	MRXS2		Xp11-q21
Primary aldosteronism, seizures, and neurologic abnormalities	615474	CACNA1D	114206	3p21.1
Primary aldosteronism, seizures, and neurologic abnormalities	615474	CACNL1A2	114206	3p21.1
Primary aldosteronism, seizures, and neurologic abnormalities	615474	CCHL1A2	114206	3p21.1
Primary aldosteronism, seizures, and neurologic abnormalities	615474	SANDD	114206	3p21.1
Primary aldosteronism, seizures, and neurologic abnormalities	615474	PASNA	114206	3p21.1
Primary lateral sclerosis, adult, 1	611637	PLSA1		4p16
Primary lateral sclerosis, adult, 1	611637	PLSA		4p16
Primary lateral sclerosis, juvenile	606353	ALS2	606352	2q33.1
Primary lateral sclerosis, juvenile	606353	ALSJ	606352	2q33.1
Primary lateral sclerosis, juvenile	606353	PLSJ	606352	2q33.1
Primary lateral sclerosis, juvenile	606353	IAHSP	606352	2q33.1
Prion disease with protracted course	606688	PRNP	176640	20p13
Prion disease with protracted course	606688	PRIP	176640	20p13
Prion disease with protracted course	606688	KURU	176640	20p13
Prion disease with protracted course	606688	CJD	176640	20p13
Progressive external ophthalmoplegia with mitochondrial DNA deletions 3	609283	SLC25A4	103220	4q35.1
Progressive external ophthalmoplegia with mitochondrial DNA deletions 3	609283	ANT1	103220	4q35.1
Progressive external ophthalmoplegia with mitochondrial DNA deletions 3	609283	T1	103220	4q35.1
Progressive external ophthalmoplegia with mitochondrial DNA deletions 3	609283	PEO3	103220	4q35.1
Progressive external ophthalmoplegia with mitochondrial DNA deletions 3	609283	PEO2	103220	4q35.1
Progressive external ophthalmoplegia with mitochondrial DNA deletions 3	609283	MTDPS12	103220	4q35.1
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	610131	POLG2	604983	17q23.3
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	610131	POLGB	604983	17q23.3
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4	610131	PEOA4	604983	17q23.3
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5	613077	RRM2B	604712	8q22.3
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5	613077	P53R2	604712	8q22.3
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5	613077	PEOA5	604712	8q22.3
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5	613077	MTDPS8A	604712	8q22.3
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5	613077	MTDPS8B	604712	8q22.3
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 6	615156	DNA2	601810	10q21.3
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 6	615156	DNA2L	601810	10q21.3
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 6	615156	KIAA0083	601810	10q21.3
Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 6	615156	PEOA6	601810	10q21.3
Progressive external ophthalmoplegia, autosomal dominant	157640	POLG	174763	15q26.1
Progressive external ophthalmoplegia, autosomal dominant	157640	POLG1	174763	15q26.1
Progressive external ophthalmoplegia, autosomal dominant	157640	POLGA	174763	15q26.1
Progressive external ophthalmoplegia, autosomal dominant	157640	PEO	174763	15q26.1
Progressive external ophthalmoplegia, autosomal dominant	157640	SANDO	174763	15q26.1
Progressive external ophthalmoplegia, autosomal dominant	157640	SCAE	174763	15q26.1
Progressive external ophthalmoplegia, autosomal dominant	157640	MTDPS4A	174763	15q26.1
Progressive external ophthalmoplegia, autosomal dominant	157640	MTDPS4B	174763	15q26.1
Progressive external ophthalmoplegia, autosomal dominant	157640	MIRAS	174763	15q26.1
Progressive external ophthalmoplegia, autosomal dominant, 3	609286	C10orf2	606075	10q24.31
Progressive external ophthalmoplegia, autosomal dominant, 3	609286	TWINKLE	606075	10q24.31
Progressive external ophthalmoplegia, autosomal dominant, 3	609286	PEO1	606075	10q24.31
Progressive external ophthalmoplegia, autosomal dominant, 3	609286	PEOA3	606075	10q24.31
Progressive external ophthalmoplegia, autosomal dominant, 3	609286	IOSCA	606075	10q24.31
Progressive external ophthalmoplegia, autosomal dominant, 3	609286	MTDPS7	606075	10q24.31
Progressive external ophthalmoplegia, autosomal recessive	258450	POLG	174763	15q26.1
Progressive external ophthalmoplegia, autosomal recessive	258450	POLG1	174763	15q26.1
Progressive external ophthalmoplegia, autosomal recessive	258450	POLGA	174763	15q26.1
Progressive external ophthalmoplegia, autosomal recessive	258450	PEO	174763	15q26.1
Progressive external ophthalmoplegia, autosomal recessive	258450	SANDO	174763	15q26.1
Progressive external ophthalmoplegia, autosomal recessive	258450	SCAE	174763	15q26.1
Progressive external ophthalmoplegia, autosomal recessive	258450	MTDPS4A	174763	15q26.1
Progressive external ophthalmoplegia, autosomal recessive	258450	MTDPS4B	174763	15q26.1
Progressive external ophthalmoplegia, autosomal recessive	258450	MIRAS	174763	15q26.1
Progressive familial heart block, type IB	604559	TRPM4	606936	19q13.33
Progressive familial heart block, type IB	604559	PFHB1B	606936	19q13.33
Proguanil poor metabolizer	609535	CYP2C	124020	10q23.33
Proguanil poor metabolizer	609535	CYP2C19	124020	10q23.33
Prolidase deficiency	170100	PEPD	613230	19q13.11
Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome	225790	FLVCR2	610865	14q24.3
Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome	225790	C14orf58	610865	14q24.3
Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome	225790	CCT	610865	14q24.3
Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome	225790	PVHH	610865	14q24.3
Proliferative vasculopathy and hydraencephaly-hydrocephaly syndrome	225790	EPV	610865	14q24.3
Prolonged bleeding time, brachydactyly and mental retardation		GNAS	139320	20q13.32
Prolonged bleeding time, brachydactyly and mental retardation		GNAS1	139320	20q13.32
Prolonged bleeding time, brachydactyly and mental retardation		GPSA	139320	20q13.32
Prolonged bleeding time, brachydactyly and mental retardation		POH	139320	20q13.32
Prolonged bleeding time, brachydactyly and mental retardation		PHP1B	139320	20q13.32
Prolonged bleeding time, brachydactyly and mental retardation		PHP1A	139320	20q13.32
Prolonged bleeding time, brachydactyly and mental retardation		AHO	139320	20q13.32
Prolonged bleeding time, brachydactyly and mental retardation		PHP1C	139320	20q13.32
Prolonged bleeding time, brachydactyly, and mental retardation		GNAS	139320	20q13.32
Prolonged bleeding time, brachydactyly, and mental retardation		GNAS1	139320	20q13.32
Prolonged bleeding time, brachydactyly, and mental retardation		GPSA	139320	20q13.32
Prolonged bleeding time, brachydactyly, and mental retardation		POH	139320	20q13.32
Prolonged bleeding time, brachydactyly, and mental retardation		PHP1B	139320	20q13.32
Prolonged bleeding time, brachydactyly, and mental retardation		PHP1A	139320	20q13.32
Prolonged bleeding time, brachydactyly, and mental retardation		AHO	139320	20q13.32
Prolonged bleeding time, brachydactyly, and mental retardation		PHP1C	139320	20q13.32
Properdin deficiency, X-linked	312060	PFC	300383	Xp11.23
Properdin deficiency, X-linked	312060	PFD	300383	Xp11.23
Propionicacidemia	606054	PCCA	232000	13q32.3
Propionicacidemia	606054	PCCB	232050	3q22.3
Prostate adenocarcinoma		ST12	601188	10pter-q11
Prostate adenocarcinoma		PAC1	601188	10pter-q11
Prostate cancer 1	601518	RNASEL	180435	1q25.3
Prostate cancer 1	601518	RNS4	180435	1q25.3
Prostate cancer 1	601518	PRCA1	180435	1q25.3
Prostate cancer 1	601518	HPC1	180435	1q25.3
Prostate cancer	176807	BRCA2	600185	13q13.1
Prostate cancer	176807	FANCD1	600185	13q13.1
Prostate cancer	176807	BROVCA2	600185	13q13.1
Prostate cancer	176807	GLM3	600185	13q13.1
Prostate cancer	176807	PNCA2	600185	13q13.1
Prostate cancer, hereditary	176807	MSR1	153622	8p22
Prostate cancer, hereditary	176807	SCARA1	153622	8p22
Prostate cancer, hereditary	176807	SRA	153622	8p22
Prostate cancer, progression and metastasis of	603688	EPHB2	600997	1p36.12
Prostate cancer, progression and metastasis of	603688	EPHT3	600997	1p36.12
Prostate cancer, progression and metastasis of	603688	DRT	600997	1p36.12
Prostate cancer, progression and metastasis of	603688	ERK	600997	1p36.12
Prostate cancer, progression and metastasis of	603688	PCBC	600997	1p36.12
Prostate cancer, progression and metastasis of	603688	CAPB	600997	1p36.12
Prostate cancer, somatic	176807	KLF6	602053	10p15.1
Prostate cancer, somatic	176807	COPEB	602053	10p15.1
Prostate cancer, somatic	176807	BCD1	602053	10p15.1
Prostate cancer, somatic	176807	ZF9	602053	10p15.1
Prostate cancer, somatic	176807	MAD1L1	602686	7p22.3
Prostate cancer, somatic	176807	TXBP181	602686	7p22.3
Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990	CLCN5	300008	Xp11.23-p11.22
Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990	CLCK2	300008	Xp11.23-p11.22
Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990	NPHL2	300008	Xp11.23-p11.22
Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990	DENTS	300008	Xp11.23-p11.22
Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis	308990	NPHL1	300008	Xp11.23-p11.22
Proteus syndrome, somatic	176920	AKT1	164730	14q32.33
Proteus syndrome, somatic	176920	CWS6	164730	14q32.33
Protoporphyria, erythropoietic, X-linked	300752	ALAS2	301300	Xp11.21
Protoporphyria, erythropoietic, X-linked	300752	ANH1	301300	Xp11.21
Protoporphyria, erythropoietic, X-linked	300752	ASB	301300	Xp11.21
Protoporphyria, erythropoietic, X-linked	300752	XLEPP	301300	Xp11.21
Protoporphyria, erythropoietic, X-linked	300752	XLSA	301300	Xp11.21
Protoporphyria, erythropoietic, X-linked	300752	ANH1	301300	Xp11.21
Protoporphyria, erythropoietic, autosomal recessive	177000	FECH	612386	18q21.31
Protoporphyria, erythropoietic, autosomal recessive	177000	FCE	612386	18q21.31
Proud syndrome	300004	ARX	300382	Xp21.3
Proud syndrome	300004	ISSX	300382	Xp21.3
Proud syndrome	300004	PRTS	300382	Xp21.3
Proud syndrome	300004	MRXS1	300382	Xp21.3
Proud syndrome	300004	MRX36	300382	Xp21.3
Proud syndrome	300004	MRX54	300382	Xp21.3
Proud syndrome	300004	MRX43	300382	Xp21.3
Proud syndrome	300004	MRX87	300382	Xp21.3
Proud syndrome	300004	MRX29	300382	Xp21.3
Proud syndrome	300004	MRX32	300382	Xp21.3
Pseudoachondroplasia	177170	COMP	600310	19p13.11
Pseudoachondroplasia	177170	EDM1	600310	19p13.11
Pseudoachondroplasia	177170	MED	600310	19p13.11
Pseudoachondroplasia	177170	PSACH	600310	19p13.11
Pseudohermaphroditism, male, with gynecomastia	264300	HSD17B3	605573	9q22.32
Pseudohermaphroditism, male, with gynecomastia	264300	EDH17B3	605573	9q22.32
Pseudohyperkalemia, familial, 2, due to red cell leak	609153	PSHK2		2q35-q36
Pseudohypoaldosteronism type I, autosomal dominant	177735	NR3C2	600983	4q31.23
Pseudohypoaldosteronism type I, autosomal dominant	177735	MLR	600983	4q31.23
Pseudohypoaldosteronism type I, autosomal dominant	177735	MCR	600983	4q31.23
Pseudohypoaldosteronism, type I	264350	SCNN1A	600228	12p13.31
Pseudohypoaldosteronism, type I	264350	BESC2	600228	12p13.31
Pseudohypoaldosteronism, type I	264350	SCNN1B	600760	16p12.2
Pseudohypoaldosteronism, type I	264350	BESC1	600760	16p12.2
Pseudohypoaldosteronism, type I	264350	SCNN1G	600761	16p12.2
Pseudohypoaldosteronism, type I	264350	PHA1	600761	16p12.2
Pseudohypoaldosteronism, type I	264350	BESC3	600761	16p12.2
Pseudohypoaldosteronism, type IIA	145260	PHA2A		1q31-q42
Pseudohypoaldosteronism, type IIA	145260	PHA2		1q31-q42
Pseudohypoaldosteronism, type IIB	614491	WNK4	601844	17q21.31
Pseudohypoaldosteronism, type IIB	614491	PRKWNK4	601844	17q21.31
Pseudohypoaldosteronism, type IIB	614491	PHA2B	601844	17q21.31
Pseudohypoaldosteronism, type IIC	614492	WNK1	605232	12p13.33
Pseudohypoaldosteronism, type IIC	614492	PRKWNK1	605232	12p13.33
Pseudohypoaldosteronism, type IIC	614492	KDP	605232	12p13.33
Pseudohypoaldosteronism, type IIC	614492	PHA2C	605232	12p13.33
Pseudohypoaldosteronism, type IIC	614492	HSAN2	605232	12p13.33
Pseudohypoaldosteronism, type IIC	614492	HSN2	605232	12p13.33
Pseudohypoaldosteronism, type IID	614495	KLHL3	605775	5q31.2
Pseudohypoaldosteronism, type IID	614495	PHA2D	605775	5q31.2
Pseudohypoaldosteronism, type IIE	614496	CUL3	603136	2q36.2
Pseudohypoaldosteronism, type IIE	614496	PHA2E	603136	2q36.2
Pseudohypoparathyroidism Ia	103580	GNAS	139320	20q13.32
Pseudohypoparathyroidism Ia	103580	GNAS1	139320	20q13.32
Pseudohypoparathyroidism Ia	103580	GPSA	139320	20q13.32
Pseudohypoparathyroidism Ia	103580	POH	139320	20q13.32
Pseudohypoparathyroidism Ia	103580	PHP1B	139320	20q13.32
Pseudohypoparathyroidism Ia	103580	PHP1A	139320	20q13.32
Pseudohypoparathyroidism Ia	103580	AHO	139320	20q13.32
Pseudohypoparathyroidism Ia	103580	PHP1C	139320	20q13.32
Pseudohypoparathyroidism Ib	603233	GNAS	139320	20q13.32
Pseudohypoparathyroidism Ib	603233	GNAS1	139320	20q13.32
Pseudohypoparathyroidism Ib	603233	GPSA	139320	20q13.32
Pseudohypoparathyroidism Ib	603233	POH	139320	20q13.32
Pseudohypoparathyroidism Ib	603233	PHP1B	139320	20q13.32
Pseudohypoparathyroidism Ib	603233	PHP1A	139320	20q13.32
Pseudohypoparathyroidism Ib	603233	AHO	139320	20q13.32
Pseudohypoparathyroidism Ib	603233	PHP1C	139320	20q13.32
Pseudohypoparathyroidism Ic	612462	GNAS	139320	20q13.32
Pseudohypoparathyroidism Ic	612462	GNAS1	139320	20q13.32
Pseudohypoparathyroidism Ic	612462	GPSA	139320	20q13.32
Pseudohypoparathyroidism Ic	612462	POH	139320	20q13.32
Pseudohypoparathyroidism Ic	612462	PHP1B	139320	20q13.32
Pseudohypoparathyroidism Ic	612462	PHP1A	139320	20q13.32
Pseudohypoparathyroidism Ic	612462	AHO	139320	20q13.32
Pseudohypoparathyroidism Ic	612462	PHP1C	139320	20q13.32
Pseudohypoparathyroidism, type IB	603233	GNASAS1	610540	20q13.32
Pseudohypoparathyroidism, type IB	603233	GNASAS	610540	20q13.32
Pseudohypoparathyroidism, type IB	603233	SANG	610540	20q13.32
Pseudohypoparathyroidism, type IB	603233	NESPAS	610540	20q13.32
Pseudohypoparathyroidism, type IB	603233	STX16	603666	20q13.32
Pseudohypoparathyroidism, type IB	603233	SYN16	603666	20q13.32
Pseudopseudohypoparathyroidism	612463	GNAS	139320	20q13.32
Pseudopseudohypoparathyroidism	612463	GNAS1	139320	20q13.32
Pseudopseudohypoparathyroidism	612463	GPSA	139320	20q13.32
Pseudopseudohypoparathyroidism	612463	POH	139320	20q13.32
Pseudopseudohypoparathyroidism	612463	PHP1B	139320	20q13.32
Pseudopseudohypoparathyroidism	612463	PHP1A	139320	20q13.32
Pseudopseudohypoparathyroidism	612463	AHO	139320	20q13.32
Pseudopseudohypoparathyroidism	612463	PHP1C	139320	20q13.32
Pseudovaginal perineoscrotal hypospadias	264600	SRD5A2	607306	2p23.1
Pseudoxanthoma elasticum	264800	ABCC6	603234	16p13.11
Pseudoxanthoma elasticum	264800	ARA	603234	16p13.11
Pseudoxanthoma elasticum	264800	ABC34	603234	16p13.11
Pseudoxanthoma elasticum	264800	MLP1	603234	16p13.11
Pseudoxanthoma elasticum	264800	PXE	603234	16p13.11
Pseudoxanthoma elasticum	264800	GACI2	603234	16p13.11
Pseudoxanthoma elasticum, forme fruste	177850	ABCC6	603234	16p13.11
Pseudoxanthoma elasticum, forme fruste	177850	ARA	603234	16p13.11
Pseudoxanthoma elasticum, forme fruste	177850	ABC34	603234	16p13.11
Pseudoxanthoma elasticum, forme fruste	177850	MLP1	603234	16p13.11
Pseudoxanthoma elasticum, forme fruste	177850	PXE	603234	16p13.11
Pseudoxanthoma elasticum, forme fruste	177850	GACI2	603234	16p13.11
Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency	610842	GGCX	137167	2p11.2
Psoriasis, generalized pustular	614204	IL36RN	605507	2q13
Psoriasis, generalized pustular	614204	IL1F5	605507	2q13
Psoriasis, generalized pustular	614204	FIL1D	605507	2q13
Psoriasis, generalized pustular	614204	IL1HY1	605507	2q13
Psoriasis, generalized pustular	614204	IL1RP3	605507	2q13
Psoriasis, generalized pustular	614204	PSORP	605507	2q13
Psychomotor retardation, epilepsy, and craniofacial dysmorphism	614501	SNIP1	608241	1p34.3
Psychomotor retardation, epilepsy, and craniofacial dysmorphism	614501	PMRED	608241	1p34.3
Ptosis, hereditary congenital 2	300245	PTOS2		Xq24-q27.1
Ptosis, hereditary congenital 2	300245	PTOSX		Xq24-q27.1
Ptosis, hereditary congenital, 1	178300	PTOS1		1p34.1-p32
Pulmonary alveolar microlithiasis	265100	SLC34A2	604217	4p15.2
Pulmonary disease, chronic obstructive, severe early-onset	606963	COPD		2q
Pulmonary fibrosis, idiopathic	178500	SFTPA2	178642	10q22.3
Pulmonary fibrosis, idiopathic	178500	SPA2	178642	10q22.3
Pulmonary fibrosis, idiopathic	178500	COLEC5	178642	10q22.3
Pulmonary hypertension, familial primary, 1, with or without HHT	178600	BMPR2	600799	2q33.1-q33.2
Pulmonary hypertension, familial primary, 1, with or without HHT	178600	PPH1	600799	2q33.1-q33.2
Pulmonary hypertension, familial primary, 1, with or without HHT	178600	POVD1	600799	2q33.1-q33.2
Pulmonary hypertension, primary, 2	615342	MADH9	603295	13q13.3
Pulmonary hypertension, primary, 2	615342	SMAD9	603295	13q13.3
Pulmonary hypertension, primary, 2	615342	MADH6	603295	13q13.3
Pulmonary hypertension, primary, 2	615342	PPH2	603295	13q13.3
Pulmonary hypertension, primary, 3	615343	CAV1	601047	7q31.2
Pulmonary hypertension, primary, 3	615343	BSCL3	601047	7q31.2
Pulmonary hypertension, primary, 3	615343	CGL3	601047	7q31.2
Pulmonary hypertension, primary, 3	615343	PPH3	601047	7q31.2
Pulmonary hypertension, primary, 4	615344	KCNK3	603220	2p23.3
Pulmonary hypertension, primary, 4	615344	TASK	603220	2p23.3
Pulmonary hypertension, primary, 4	615344	PPH4	603220	2p23.3
Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated	178600	BMPR2	600799	2q33.1-q33.2
Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated	178600	PPH1	600799	2q33.1-q33.2
Pulmonary hypertension, primary, fenfluramine or dexfenfluramine-associated	178600	POVD1	600799	2q33.1-q33.2
Pulmonary venoocclusive disease 1	265450	BMPR2	600799	2q33.1-q33.2
Pulmonary venoocclusive disease 1	265450	PPH1	600799	2q33.1-q33.2
Pulmonary venoocclusive disease 1	265450	POVD1	600799	2q33.1-q33.2
Pulmonary venoocclusive disease 2	234810	EIF2AK4	609280	15q15.1
Pulmonary venoocclusive disease 2	234810	GCN2	609280	15q15.1
Pulmonary venoocclusive disease 2	234810	KIAA1338	609280	15q15.1
Pulmonary venoocclusive disease 2	234810	PVOD2	609280	15q15.1
Purpura, posttransfusion	173470	ITGB3		17q21.32
Purpura, posttransfusion	173470	GP3A		17q21.32
Purpura, posttransfusion	173470	GT		17q21.32
Purpura, posttransfusion	173470	BDPLT2		17q21.32
Purpura, posttransfusion	173470	BDPLT16		17q21.32
Pycnodysostosis	265800	CTSK	601105	1q21.3
Pyloric stenosis, infantile hypertrophic 1	179010	IHPS1		12q
Pyloric stenosis, infantile hypertrophic 1	179010	IHPS		12q
Pyloric stenosis, infantile hypertrophic, 2	610260	IHPS2		16p13-p12
Pyloric stenosis, infantile hypertrophic, 3	612017	IHPS3		11q14-q22
Pyloric stenosis, infantile hypertrophic, 4	300711	IHPS4		Xq23
Pyloric stenosis, infantile hypertrophic, 5	612525	IHPS5		16q24.3
Pyogenic bacterial infections, recurrent, due to MYD88 deficiency	612260	MYD88	602170	3p22.2
Pyogenic bacterial infections, recurrent, due to MYD88 deficiency	612260	MYD88D	602170	3p22.2
Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	604416	PSTPIP1	606347	15q24.3
Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	604416	PSTPIP	606347	15q24.3
Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	604416	CD2BP1	606347	15q24.3
Pyogenic sterile arthritis, pyoderma gangrenosum, and acne	604416	PAPAS	606347	15q24.3
Pyridoxamine 5'-phosphate oxidase deficiency	610090	PNPO	603287	17q21.32
Pyropoikilocytosis	266140	SPTA1	182860	1q23.1
Pyropoikilocytosis	266140	EL2	182860	1q23.1
Pyropoikilocytosis	266140	SPH3	182860	1q23.1
Pyropoikilocytosis	266140	HS3	182860	1q23.1
Pyropoikilocytosis	266140	HPP	182860	1q23.1
Pyruvate carboxylase deficiency	266150	PC	608786	11q13.2
Pyruvate dehydrogenase E1-alpha deficiency	312170	PDHA1	300502	Xp22.12
Pyruvate dehydrogenase E1-alpha deficiency	312170	PHE1A	300502	Xp22.12
Pyruvate dehydrogenase E1-beta deficiency	614111	PDHB	179060	3p14.3
Pyruvate dehydrogenase E1-beta deficiency	614111	PDHBD	179060	3p14.3
Pyruvate dehydrogenase E2 deficiency	245348	DLAT	608770	11q23.1
Pyruvate dehydrogenase E2 deficiency	245348	PDCE2	608770	11q23.1
Pyruvate dehydrogenase lipoic acid synthetase deficiency	614462	LIAS	607031	4p14
Pyruvate dehydrogenase lipoic acid synthetase deficiency	614462	PDHLD	607031	4p14
Pyruvate dehydrogenase phosphatase deficiency	608782	PDP1	605993	8q22.1
Pyruvate dehydrogenase phosphatase deficiency	608782	PPM2C	605993	8q22.1
Pyruvate dehydrogenase phosphatase deficiency	608782	PDP1	605993	8q22.1
Pyruvate dehydrogenase phosphatase deficiency	608782	PDPC	605993	8q22.1
Pyruvate kinase deficiency	266200	PKLR	609712	1q22
Pyruvate kinase deficiency	266200	PK1	609712	1q22
Quebec platelet disorder	601709	PLAU	191840	10q22.2
Quebec platelet disorder	601709	URK	191840	10q22.2
Quebec platelet disorder	601709	QPD	191840	10q22.2
Quebec platelet disorder	601709	BDPLT5	191840	10q22.2
RAPADILINO syndrome	266280	RECQL4	603780	8q24.3
RAPADILINO syndrome	266280	RTS	603780	8q24.3
RAPADILINO syndrome	266280	RECQ4	603780	8q24.3
REtinitis pigmentosa 62	614181	MAK	154235	6p24.2
REtinitis pigmentosa 62	614181	RP62	154235	6p24.2
RIDDLE syndrome	611943	RNF168	612688	3q29
Rabson-Mendenhall syndrome	262190	INSR	147670	19p13.2
Rabson-Mendenhall syndrome	262190	HHF5	147670	19p13.2
Radial ray deficiency	300378	RRDX		Xq24-q25
Radiation sensitivity/chromosome instability syndrome, autosomal dominant		RSCIS	605463	14q11.2
Radioulnar synostosis with amegakaryocytic thrombocytopenia	605432	HOXA11	142958	7p15.2
Radioulnar synostosis with amegakaryocytic thrombocytopenia	605432	HOX1I	142958	7p15.2
Raine syndrome	259775	FAM20C	611061	7p22.3
Raine syndrome	259775	DMP4	611061	7p22.3
Rajab syndrome	613658	RJBS		2q36.2
Rapp-Hodgkin syndrome	129400	TP63	603273	3q28
Rapp-Hodgkin syndrome	129400	TP73L	603273	3q28
Rapp-Hodgkin syndrome	129400	KET	603273	3q28
Rapp-Hodgkin syndrome	129400	EEC3	603273	3q28
Rapp-Hodgkin syndrome	129400	SHFM4	603273	3q28
Rapp-Hodgkin syndrome	129400	LMS	603273	3q28
Rapp-Hodgkin syndrome	129400	RHS	603273	3q28
Rapp-Hodgkin syndrome	129400	OFC8	603273	3q28
Recombination rate QTL 1	612042	RNF212	612041	4p16.3
Recombination rate QTL 1	612042	ZHP3	612041	4p16.3
Refsum disease	266500	PHYH	602026	10p13
Refsum disease	266500	PAHX	602026	10p13
Refsum disease, adult, with increased pipecolicacidemia		RDPA	600964	10pter-p11.2
Renal adysplasia	191830	UPK3A	611559	22q13.31
Renal adysplasia	191830	UPK3	611559	22q13.31
Renal adysplasia	191830	UPIII	611559	22q13.31
Renal agenesis	191830	RET	164761	10q11.21
Renal agenesis	191830	MEN2A	164761	10q11.21
Renal agenesis	191830	HSCR1	164761	10q11.21
Renal carcinoma, chromophobe, somatic	144700	FLCN	607273	17p11.2
Renal carcinoma, chromophobe, somatic	144700	BHD	607273	17p11.2
Renal cell carcinoma	144700	DIRC2	602773	3q21.1
Renal cell carcinoma	144700	RCC4	602773	3q21.1
Renal cell carcinoma	144700	HNF1A	142410	12q24.31
Renal cell carcinoma	144700	TCF1	142410	12q24.31
Renal cell carcinoma	144700	MODY3	142410	12q24.31
Renal cell carcinoma	144700	IDDM20	142410	12q24.31
Renal cell carcinoma	144700	RNF139	603046	8q24.13
Renal cell carcinoma	144700	TRC8	603046	8q24.13
Renal cell carcinoma	144700	RCA1	603046	8q24.13
Renal cell carcinoma, clear cell, somatic	144700	OGG1	601982	3p25.3
Renal cell carcinoma, papillary, 1	300854	TFE3	314310	Xp11.23
Renal cell carcinoma, papillary, 1	300854	RCCX1	314310	Xp11.23
Renal cell carcinoma, papillary, 1, familial and somatic	605074	MET	164860	7q31.2
Renal cell carcinoma, papillary, 3		RCCP3	605075	17q21.32
Renal cell carcinoma, papillary	605074	PRCC	179755	1q23.1
Renal cell carcinoma, papillary	605074	RCCP1	179755	1q23.1
Renal cell carcinoma, somatic	144700	VHL	608537	3p25.3
Renal cysts and diabetes syndrome	137920	HNF1B	189907	17q12
Renal cysts and diabetes syndrome	137920	TCF2	189907	17q12
Renal cysts and diabetes syndrome	137920	HNF2	189907	17q12
Renal cysts and diabetes syndrome	137920	MODY5	189907	17q12
Renal cysts and diabetes syndrome	137920	FJHN	189907	17q12
Renal cysts and diabetes syndrome	137920	HPC11	189907	17q12
Renal glucosuria	233100	SLC5A2	182381	16p11.2
Renal glucosuria	233100	SGLT2	182381	16p11.2
Renal hypodysplasia, nonsyndromic, 1	610805	RHDNS1		1p33-p32
Renal hypoplasia, isolated	191830	PAX2	167409	10q24.31
Renal hypoplasia, isolated	191830	PAPRS	167409	10q24.31
Renal tubular acidosis with deafness	267300	ATP6B1	192132	2p13.3
Renal tubular acidosis with deafness	267300	VPP3	192132	2p13.3
Renal tubular acidosis, distal, AD	179800	SLC4A1	109270	17q21.31
Renal tubular acidosis, distal, AD	179800	AE1	109270	17q21.31
Renal tubular acidosis, distal, AD	179800	EPB3	109270	17q21.31
Renal tubular acidosis, distal, AR	611590	SLC4A1	109270	17q21.31
Renal tubular acidosis, distal, AR	611590	AE1	109270	17q21.31
Renal tubular acidosis, distal, AR	611590	EPB3	109270	17q21.31
Renal tubular acidosis, distal, autosomal recessive	602722	ATP6V0A4	605239	7q34
Renal tubular acidosis, distal, autosomal recessive	602722	ATP6N1B	605239	7q34
Renal tubular acidosis, distal, autosomal recessive	602722	VPP2	605239	7q34
Renal tubular acidosis, distal, autosomal recessive	602722	RTA1C	605239	7q34
Renal tubular acidosis, distal, autosomal recessive	602722	RTADR	605239	7q34
Renal tubular acidosis, proximal, with ocular abnormalities	604278	SLC4A4	603345	4q13.3
Renal tubular acidosis, proximal, with ocular abnormalities	604278	NBC1	603345	4q13.3
Renal tubular acidosis, proximal, with ocular abnormalities	604278	KNBC	603345	4q13.3
Renal tubular acidosis, proximal, with ocular abnormalities	604278	SLC4A5	603345	4q13.3
Renal tubular dysgenesis	267430	ACE	106180	17q23.3
Renal tubular dysgenesis	267430	DCP1	106180	17q23.3
Renal tubular dysgenesis	267430	ACE1	106180	17q23.3
Renal tubular dysgenesis	267430	MVCD3	106180	17q23.3
Renal tubular dysgenesis	267430	ICH	106180	17q23.3
Renal tubular dysgenesis	267430	AGT	106150	1q42.2
Renal tubular dysgenesis	267430	SERPINA8	106150	1q42.2
Renal tubular dysgenesis	267430	AGTR1	106165	3q24
Renal tubular dysgenesis	267430	AGTR1A	106165	3q24
Renal tubular dysgenesis	267430	AT2R1	106165	3q24
Renal tubular dysgenesis	267430	REN	179820	1q32.1
Renal tubular dysgenesis	267430	HNFJ2	179820	1q32.1
Renal-hepatic-pancreatic dysplasia 1	208540	NPHP3	608002	3q22.1
Renal-hepatic-pancreatic dysplasia 1	208540	NPH3	608002	3q22.1
Renal-hepatic-pancreatic dysplasia 1	208540	RHPD1	608002	3q22.1
Renal-hepatic-pancreatic dysplasia 1	208540	MKS7	608002	3q22.1
Renpenning syndrome	309500	PQBP1	300463	Xp11.23
Renpenning syndrome	309500	NPW38	300463	Xp11.23
Renpenning syndrome	309500	SHS	300463	Xp11.23
Renpenning syndrome	309500	MRX55	300463	Xp11.23
Renpenning syndrome	309500	MRXS3	300463	Xp11.23
Renpenning syndrome	309500	RENS1	300463	Xp11.23
Renpenning syndrome	309500	MRXS8	300463	Xp11.23
Restless legs syndrome, susceptibility to, 8	615197	RLS8		5q31
Restrictive dermopathy, lethal	275210	LMNA	150330	1q22
Restrictive dermopathy, lethal	275210	LMN1	150330	1q22
Restrictive dermopathy, lethal	275210	EMD2	150330	1q22
Restrictive dermopathy, lethal	275210	FPLD2	150330	1q22
Restrictive dermopathy, lethal	275210	CMD1A	150330	1q22
Restrictive dermopathy, lethal	275210	HGPS	150330	1q22
Restrictive dermopathy, lethal	275210	LGMD1B	150330	1q22
Restrictive dermopathy, lethal	275210	ZMPSTE24	606480	1p34.2
Restrictive dermopathy, lethal	275210	FACE1	606480	1p34.2
Restrictive dermopathy, lethal	275210	STE24	606480	1p34.2
Restrictive dermopathy, lethal	275210	MADB	606480	1p34.2
Reticular dysgenesis	267500	AK2	103020	1p35.1
Reticulate acropigmentation of Kitamura	615537	ADAM10	602192	15q21.3
Reticulate acropigmentation of Kitamura	615537	MADM	602192	15q21.3
Reticulate acropigmentation of Kitamura	615537	RAK	602192	15q21.3
Reticulate acropigmentation of Kitamura	615537	AD18	602192	15q21.3
Retinal arterial macroaneurysm with supravalvular pulmonic stenosis	614224	IGFBP7	602867	4q12
Retinal arterial macroaneurysm with supravalvular pulmonic stenosis	614224	MAC25	602867	4q12
Retinal arterial macroaneurysm with supravalvular pulmonic stenosis	614224	RAMSVPS	602867	4q12
Retinal cone dystrophy 3	610024	PDE6H	601190	12p12.3
Retinal cone dystrophy 3	610024	RCD3	601190	12p12.3
Retinal cone dystrophy 3	610024	ACHM6	601190	12p12.3
Retinal cone dystrophy 3B	610356	KCNV2	607604	9p24.2
Retinal cone dystrophy 3B	610356	KV11.1	607604	9p24.2
Retinal cone dystrophy 3B	610356	RCD3B	607604	9p24.2
Retinal cone dystrophy 4	610478	CACNA2D4	608171	12p13.33
Retinal cone dystrophy 4	610478	RCD4	608171	12p13.33
Retinal degeneration, autosomal recessive, clumped pigment type	162080	NRL		14q11.2
Retinal degeneration, autosomal recessive, clumped pigment type	162080	D14S46E		14q11.2
Retinal degeneration, autosomal recessive, clumped pigment type	162080	RP27		14q11.2
Retinal degeneration, late-onset, autosomal dominant	605670	C1QTNF5	608752	11q23.3
Retinal degeneration, late-onset, autosomal dominant	605670	CTRP5	608752	11q23.3
Retinal degeneration, late-onset, autosomal dominant	605670	LORD	608752	11q23.3
Retinal dystrophy, early-onset severe	248200	ABCA4	601691	1p22.1
Retinal dystrophy, early-onset severe	248200	ABCR	601691	1p22.1
Retinal dystrophy, early-onset severe	248200	STGD1	601691	1p22.1
Retinal dystrophy, early-onset severe	248200	FFM	601691	1p22.1
Retinal dystrophy, early-onset severe	248200	RP19	601691	1p22.1
Retinal dystrophy, early-onset severe	248200	CORD3	601691	1p22.1
Retinal dystrophy, early-onset severe	248200	ARMD2	601691	1p22.1
Retinal dystrophy, early-onset severe	613341	LRAT	604863	4q32.1
Retinal dystrophy, early-onset severe	613341	LCA14	604863	4q32.1
Retinal dystrophy, early-onset, and pituitary dysfunction	610125	OTX2	600037	14q22.3
Retinal dystrophy, early-onset, and pituitary dysfunction	610125	MCOPS5	600037	14q22.3
Retinal dystrophy, early-onset, and pituitary dysfunction	610125	CPHD6	600037	14q22.3
Retinal nonattachment, nonsyndromic congenital	221900	RNANC		10q21
Retinal nonattachment, nonsyndromic congenital	221900	NCRNA		10q21
Retinitis pigmentosa 1	180100	RP1	603937	8q12.1
Retinitis pigmentosa 1	180100	ORP1	603937	8q12.1
Retinitis pigmentosa 10	180105	IMPDH1	146690	7q32.1
Retinitis pigmentosa 10	180105	RP10	146690	7q32.1
Retinitis pigmentosa 10	180105	LCA11	146690	7q32.1
Retinitis pigmentosa 11	600138	PRPF31	606419	19q13.42
Retinitis pigmentosa 11	600138	PRP31	606419	19q13.42
Retinitis pigmentosa 11	600138	RP11	606419	19q13.42
Retinitis pigmentosa 13	600059	PRPF8	607300	17p13.3
Retinitis pigmentosa 13	600059	PRPC8	607300	17p13.3
Retinitis pigmentosa 13	600059	RP13	607300	17p13.3
Retinitis pigmentosa 14	600132	TULP1	602280	6p21.31
Retinitis pigmentosa 14	600132	RP14	602280	6p21.31
Retinitis pigmentosa 14	600132	LCA15	602280	6p21.31
Retinitis pigmentosa 17	600852	CA4	114760	17q23.1
Retinitis pigmentosa 17	600852	RP17	114760	17q23.1
Retinitis pigmentosa 18	601414	HPRP3	607301	1q21.2-q21.3
Retinitis pigmentosa 18	601414	RP18	607301	1q21.2-q21.3
Retinitis pigmentosa 19	601718	ABCA4	601691	1p22.1
Retinitis pigmentosa 19	601718	ABCR	601691	1p22.1
Retinitis pigmentosa 19	601718	STGD1	601691	1p22.1
Retinitis pigmentosa 19	601718	FFM	601691	1p22.1
Retinitis pigmentosa 19	601718	RP19	601691	1p22.1
Retinitis pigmentosa 19	601718	CORD3	601691	1p22.1
Retinitis pigmentosa 19	601718	ARMD2	601691	1p22.1
Retinitis pigmentosa 2	312600	RP2	300757	Xp11.23
Retinitis pigmentosa 20	613794	RPE65	180069	1p31.3-p31.2
Retinitis pigmentosa 20	613794	RP20	180069	1p31.3-p31.2
Retinitis pigmentosa 20	613794	LCA2	180069	1p31.3-p31.2
Retinitis pigmentosa 22	602594	RP22		16p12.3-p12.1
Retinitis pigmentosa 23	300424	RP23		Xp22
Retinitis pigmentosa 24	300155	RP24		Xq26-q27
Retinitis pigmentosa 25	602772	EYS	612424	6q12
Retinitis pigmentosa 25	602772	RP25	612424	6q12
Retinitis pigmentosa 26	608380	CERKL	608381	2q31.3
Retinitis pigmentosa 26	608380	RP26	608381	2q31.3
Retinitis pigmentosa 27	613750	NRL	162080	14q11.2
Retinitis pigmentosa 27	613750	D14S46E	162080	14q11.2
Retinitis pigmentosa 27	613750	RP27	162080	14q11.2
Retinitis pigmentosa 28	606068	FAM161A	613596	2p15
Retinitis pigmentosa 28	606068	RP28	613596	2p15
Retinitis pigmentosa 29	612165	RP29		4q32-q34
Retinitis pigmentosa 3	300029	RPGR	312610	Xp11.4
Retinitis pigmentosa 3	300029	RP3	312610	Xp11.4
Retinitis pigmentosa 3	300029	CRD	312610	Xp11.4
Retinitis pigmentosa 3	300029	RP15	312610	Xp11.4
Retinitis pigmentosa 3	300029	COD1	312610	Xp11.4
Retinitis pigmentosa 3	300029	CORDX1	312610	Xp11.4
Retinitis pigmentosa 30	607921	FSCN2	607643	17q25.3
Retinitis pigmentosa 30	607921	RFSN	607643	17q25.3
Retinitis pigmentosa 30	607921	RP30	607643	17q25.3
Retinitis pigmentosa 31	609923	TOPORS	609507	9p21.1
Retinitis pigmentosa 31	609923	P53BP3	609507	9p21.1
Retinitis pigmentosa 31	609923	LUN	609507	9p21.1
Retinitis pigmentosa 31	609923	RP31	609507	9p21.1
Retinitis pigmentosa 32	609913	RP32		1p21.3-p13.3
Retinitis pigmentosa 33	610359	SNRNP200	601664	2q11.2
Retinitis pigmentosa 33	610359	ASCC3L1	601664	2q11.2
Retinitis pigmentosa 33	610359	KIAA0788	601664	2q11.2
Retinitis pigmentosa 33	610359	RP33	601664	2q11.2
Retinitis pigmentosa 34	300605	RP34		Xq28
Retinitis pigmentosa 35	610282	SEMA4A	607292	1q22
Retinitis pigmentosa 35	610282	SEMB	607292	1q22
Retinitis pigmentosa 35	610282	RP35	607292	1q22
Retinitis pigmentosa 35	610282	CORD10	607292	1q22
Retinitis pigmentosa 36	610599	PRCD	610598	17q25.1
Retinitis pigmentosa 36	610599	RP36	610598	17q25.1
Retinitis pigmentosa 37	611131	NR2E3	604485	15q23
Retinitis pigmentosa 37	611131	PNR	604485	15q23
Retinitis pigmentosa 37	611131	ESCS	604485	15q23
Retinitis pigmentosa 37	611131	RP37	604485	15q23
Retinitis pigmentosa 38	613862	MERTK	604705	2q13
Retinitis pigmentosa 38	613862	RP38	604705	2q13
Retinitis pigmentosa 39	613809	USH2A	608400	1q41
Retinitis pigmentosa 39	613809	RP39	608400	1q41
Retinitis pigmentosa 4, autosomal dominant or recessive	613731	RHO	180380	3q22.1
Retinitis pigmentosa 4, autosomal dominant or recessive	613731	RP4	180380	3q22.1
Retinitis pigmentosa 4, autosomal dominant or recessive	613731	OPN2	180380	3q22.1
Retinitis pigmentosa 4, autosomal dominant or recessive	613731	CSNBAD1	180380	3q22.1
Retinitis pigmentosa 41	612095	PROM1	604365	4p15.32
Retinitis pigmentosa 41	612095	PROML1	604365	4p15.32
Retinitis pigmentosa 41	612095	AC133	604365	4p15.32
Retinitis pigmentosa 41	612095	RP41	604365	4p15.32
Retinitis pigmentosa 41	612095	CORD12	604365	4p15.32
Retinitis pigmentosa 41	612095	CD133	604365	4p15.32
Retinitis pigmentosa 41	612095	MCDR2	604365	4p15.32
Retinitis pigmentosa 41	612095	STGD4	604365	4p15.32
Retinitis pigmentosa 42	612943	KLHL7	611119	7p15.3
Retinitis pigmentosa 42	612943	RP42	611119	7p15.3
Retinitis pigmentosa 43	613810	PDE6A	180071	5q32
Retinitis pigmentosa 43	613810	PDEA	180071	5q32
Retinitis pigmentosa 43	613810	RP43	180071	5q32
Retinitis pigmentosa 44	613769	RGR	600342	10q23.1
Retinitis pigmentosa 44	613769	RP44	600342	10q23.1
Retinitis pigmentosa 45	613767	CNGB1	600724	16q21
Retinitis pigmentosa 45	613767	CNCG3L	600724	16q21
Retinitis pigmentosa 45	613767	CNCG2	600724	16q21
Retinitis pigmentosa 45	613767	RP45	600724	16q21
Retinitis pigmentosa 46	612572	IDH3B	604526	20p13
Retinitis pigmentosa 46	612572	RP46	604526	20p13
Retinitis pigmentosa 47	613758	SAG	181031	2q37.1
Retinitis pigmentosa 47	613758	RP47	181031	2q37.1
Retinitis pigmentosa 48	613827	GUCA1B	602275	6p21.1
Retinitis pigmentosa 48	613827	GCAP2	602275	6p21.1
Retinitis pigmentosa 48	613827	GUCA2	602275	6p21.1
Retinitis pigmentosa 48	613827	RP48	602275	6p21.1
Retinitis pigmentosa 49	613756	CNGA1	123825	4p12
Retinitis pigmentosa 49	613756	CNCG1	123825	4p12
Retinitis pigmentosa 49	613756	RP49	123825	4p12
Retinitis pigmentosa 51	613464	TTC8	608132	14q31.3
Retinitis pigmentosa 51	613464	BBS8	608132	14q31.3
Retinitis pigmentosa 51	613464	RP51	608132	14q31.3
Retinitis pigmentosa 54	613428	C2orf71	613425	2p23.2
Retinitis pigmentosa 55	613575	ARL6	608845	3q11.2
Retinitis pigmentosa 55	613575	BBS3	608845	3q11.2
Retinitis pigmentosa 55	613575	RP55	608845	3q11.2
Retinitis pigmentosa 56	613581	IMPG2	607056	3q12.3
Retinitis pigmentosa 56	613581	IPM200	607056	3q12.3
Retinitis pigmentosa 56	613581	RP56	607056	3q12.3
Retinitis pigmentosa 57	613582	PDE6G	180073	17q25.3
Retinitis pigmentosa 57	613582	PDEG	180073	17q25.3
Retinitis pigmentosa 57	613582	RP57	180073	17q25.3
Retinitis pigmentosa 58	613617	ZNF513	613598	2p23.3
Retinitis pigmentosa 58	613617	RP58	613598	2p23.3
Retinitis pigmentosa 59	613861	DHDDS	608172	1p36.11
Retinitis pigmentosa 59	613861	HDS	608172	1p36.11
Retinitis pigmentosa 59	613861	RP59	608172	1p36.11
Retinitis pigmentosa 60	613983	PRPF6	613979	20q13.33
Retinitis pigmentosa 60	613983	PRP6	613979	20q13.33
Retinitis pigmentosa 60	613983	ANT1	613979	20q13.33
Retinitis pigmentosa 60	613983	TOM	613979	20q13.33
Retinitis pigmentosa 60	613983	C20orf14	613979	20q13.33
Retinitis pigmentosa 61	614180	CLRN1	606397	3q25.1
Retinitis pigmentosa 61	614180	USH3A	606397	3q25.1
Retinitis pigmentosa 61	614180	USH3	606397	3q25.1
Retinitis pigmentosa 61	614180	RP61	606397	3q25.1
Retinitis pigmentosa 63	614494	RP63		6q23
Retinitis pigmentosa 64	614500	C8orf37	614477	8q22.1
Retinitis pigmentosa 64	614500	CORD16	614477	8q22.1
Retinitis pigmentosa 64	614500	RP64	614477	8q22.1
Retinitis pigmentosa 65	613660	CDHR1	609502	10q23.1
Retinitis pigmentosa 65	613660	PCDH21	609502	10q23.1
Retinitis pigmentosa 65	613660	PRCAD	609502	10q23.1
Retinitis pigmentosa 65	613660	CORD15	609502	10q23.1
Retinitis pigmentosa 65	613660	RP65	609502	10q23.1
Retinitis pigmentosa 7	608133	PRPH2	179605	6p21.1
Retinitis pigmentosa 7	608133	DS	179605	6p21.1
Retinitis pigmentosa 7	608133	RP7	179605	6p21.1
Retinitis pigmentosa 7	608133	PRPH	179605	6p21.1
Retinitis pigmentosa 7	608133	AVMD	179605	6p21.1
Retinitis pigmentosa 7	608133	AOFMD	179605	6p21.1
Retinitis pigmentosa 7	608133	CACD2	179605	6p21.1
Retinitis pigmentosa 7, digenic	608133	ROM1	180721	11q12.3
Retinitis pigmentosa 7, digenic	608133	ROSP1	180721	11q12.3
Retinitis pigmentosa 7, digenic	608133	RP7	180721	11q12.3
Retinitis pigmentosa 9	180104	RP9	607331	7p14.3
Retinitis pigmentosa with or without situs inversus	615434	ARL2BP	615407	16q13
Retinitis pigmentosa with or without situs inversus	615434	BART	615407	16q13
Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	RPGR	312610	Xp11.4
Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	RP3	312610	Xp11.4
Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	CRD	312610	Xp11.4
Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	RP15	312610	Xp11.4
Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	COD1	312610	Xp11.4
Retinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness	300455	CORDX1	312610	Xp11.4
Retinitis pigmentosa, Y-linked	400004	RPY		Chr.Y
Retinitis pigmentosa, concentric	613194	BEST1	607854	11q12.3
Retinitis pigmentosa, concentric	613194	VMD2	607854	11q12.3
Retinitis pigmentosa, concentric	613194	ARB	607854	11q12.3
Retinitis pigmentosa, concentric	613194	RP50	607854	11q12.3
Retinitis pigmentosa, digenic	608133	PRPH2	179605	6p21.1
Retinitis pigmentosa, digenic	608133	DS	179605	6p21.1
Retinitis pigmentosa, digenic	608133	RP7	179605	6p21.1
Retinitis pigmentosa, digenic	608133	PRPH	179605	6p21.1
Retinitis pigmentosa, digenic	608133	AVMD	179605	6p21.1
Retinitis pigmentosa, digenic	608133	AOFMD	179605	6p21.1
Retinitis pigmentosa, digenic	608133	CACD2	179605	6p21.1
Retinitis pigmentosa, juvenile	604393	AIPL1	604392	17p13.2
Retinitis pigmentosa, juvenile	604393	LCA4	604392	17p13.2
Retinitis pigmentosa, juvenile	613341	LRAT	604863	4q32.1
Retinitis pigmentosa, juvenile	613341	LCA14	604863	4q32.1
Retinitis pigmentosa, juvenile, autosomal recessive	604232	SPATA7	609868	14q31.3
Retinitis pigmentosa, juvenile, autosomal recessive	604232	HSD3	609868	14q31.3
Retinitis pigmentosa, juvenile, autosomal recessive	604232	LCA3	609868	14q31.3
Retinitis pigmentosa-12, autosomal recessive	600105	CRB1	604210	1q31.3
Retinitis pigmentosa-12, autosomal recessive	600105	RP12	604210	1q31.3
Retinitis pigmentosa-12, autosomal recessive	600105	LCA8	604210	1q31.3
Retinitis pigmentosa-40	613801	PDE6B	180072	4p16.3
Retinitis pigmentosa-40	613801	PDEB	180072	4p16.3
Retinitis pigmentosa-40	613801	RP40	180072	4p16.3
Retinitis pigmentosa-40	613801	CSNBAD2	180072	4p16.3
Retinitis pigmentosa-50	613194	BEST1	607854	11q12.3
Retinitis pigmentosa-50	613194	VMD2	607854	11q12.3
Retinitis pigmentosa-50	613194	ARB	607854	11q12.3
Retinitis pigmentosa-50	613194	RP50	607854	11q12.3
Retinitis punctata albescens	136880	PRPH2	179605	6p21.1
Retinitis punctata albescens	136880	DS	179605	6p21.1
Retinitis punctata albescens	136880	RP7	179605	6p21.1
Retinitis punctata albescens	136880	PRPH	179605	6p21.1
Retinitis punctata albescens	136880	AVMD	179605	6p21.1
Retinitis punctata albescens	136880	AOFMD	179605	6p21.1
Retinitis punctata albescens	136880	CACD2	179605	6p21.1
Retinitis punctata albescens	136880	RHO	180380	3q22.1
Retinitis punctata albescens	136880	RP4	180380	3q22.1
Retinitis punctata albescens	136880	OPN2	180380	3q22.1
Retinitis punctata albescens	136880	CSNBAD1	180380	3q22.1
Retinitis punctata albescens	136880	RLBP1	180090	15q26.1
Retinoblastoma	180200	RB1	614041	13q14.2
Retinoblastoma, trilateral	180200	RB1	614041	13q14.2
Retinol dystrophy, iris coloboma, and comedogenic acne syndrome	615147	RBP4	180250	10q23.33
Retinol dystrophy, iris coloboma, and comedogenic acne syndrome	615147	RDCCAS	180250	10q23.33
Retinopathy of prematurity	133780	FZD4	604579	11q14.2
Retinopathy of prematurity	133780	EVR1	604579	11q14.2
Retinoschisis	312700	RS1	300839	Xp22.13
Retinoschisis	312700	XLRS1	300839	Xp22.13
Rett syndrome	312750	MECP2	300005	Xq28
Rett syndrome	312750	RTT	300005	Xq28
Rett syndrome	312750	PPMX	300005	Xq28
Rett syndrome	312750	MRX16	300005	Xq28
Rett syndrome	312750	MRX79	300005	Xq28
Rett syndrome	312750	AUTSX3	300005	Xq28
Rett syndrome	312750	MRXSL	300005	Xq28
Rett syndrome	312750	MRXS13	300005	Xq28
Rett syndrome	312750	MRX79	300005	Xq28
Rett syndrome	312750	MRX16	300005	Xq28
Rett syndrome, congenital variant	613454	FOXG1	164874	14q12
Rett syndrome, congenital variant	613454	FOXG1B	164874	14q12
Rett syndrome, congenital variant	613454	FKHL1	164874	14q12
Rett syndrome, congenital variant	613454	FKH2	164874	14q12
Rett syndrome, congenital variant	613454	QIN	164874	14q12
Rett syndrome, congenital variant	613454	BF1	164874	14q12
Rett syndrome, preserved speech variant	312750	MECP2	300005	Xq28
Rett syndrome, preserved speech variant	312750	RTT	300005	Xq28
Rett syndrome, preserved speech variant	312750	PPMX	300005	Xq28
Rett syndrome, preserved speech variant	312750	MRX16	300005	Xq28
Rett syndrome, preserved speech variant	312750	MRX79	300005	Xq28
Rett syndrome, preserved speech variant	312750	AUTSX3	300005	Xq28
Rett syndrome, preserved speech variant	312750	MRXSL	300005	Xq28
Rett syndrome, preserved speech variant	312750	MRXS13	300005	Xq28
Rett syndrome, preserved speech variant	312750	MRX79	300005	Xq28
Rett syndrome, preserved speech variant	312750	MRX16	300005	Xq28
Revesz syndrome	268130	TINF2	604319	14q12
Revesz syndrome	268130	TIN2	604319	14q12
Revesz syndrome	268130	DKCA3	604319	14q12
Reynolds syndrome	613471	LBR	600024	1q42.12
Reynolds syndrome	613471	PHA	600024	1q42.12
Rh-mod syndrome		RHAG	180297	6p12.3
Rh-mod syndrome		RH50A	180297	6p12.3
Rh-null disease, amorph type	111700	RHCE		1p36.11
Rhabdoid predisposition syndrome 1	609322	SMARCB1	601607	22q11.23
Rhabdoid predisposition syndrome 1	609322	SNF5	601607	22q11.23
Rhabdoid predisposition syndrome 1	609322	INI1	601607	22q11.23
Rhabdoid predisposition syndrome 1	609322	RDT	601607	22q11.23
Rhabdoid predisposition syndrome 1	609322	RTPS1	601607	22q11.23
Rhabdoid predisposition syndrome 1	609322	MRD15	601607	22q11.23
Rhabdoid tumor predisposition syndrome 2	613325	SMARCA4	603254	19p13.2
Rhabdoid tumor predisposition syndrome 2	613325	BRG1	603254	19p13.2
Rhabdoid tumor predisposition syndrome 2	613325	RTPS2	603254	19p13.2
Rhabdoid tumor predisposition syndrome 2	613325	MRD16	603254	19p13.2
Rhabdoid tumors, somatic	609322	SMARCB1	601607	22q11.23
Rhabdoid tumors, somatic	609322	SNF5	601607	22q11.23
Rhabdoid tumors, somatic	609322	INI1	601607	22q11.23
Rhabdoid tumors, somatic	609322	RDT	601607	22q11.23
Rhabdoid tumors, somatic	609322	RTPS1	601607	22q11.23
Rhabdoid tumors, somatic	609322	MRD15	601607	22q11.23
Rhabdomyolysis, cerivastatin-induced	601129	CYP2C8		10q23.33
Rhabdomyosarcoma 2, alveolar	268220	PAX3	606597	2q36.1
Rhabdomyosarcoma 2, alveolar	268220	WS1	606597	2q36.1
Rhabdomyosarcoma 2, alveolar	268220	HUP2	606597	2q36.1
Rhabdomyosarcoma 2, alveolar	268220	CDHS	606597	2q36.1
Rhabdomyosarcoma 2, alveolar	268220	WS3	606597	2q36.1
Rhabdomyosarcoma 2, alveolar	268220	PAX7	167410	1p36.13
Rhabdomyosarcoma 2, alveolar	268220	RMS2	167410	1p36.13
Rhabdomyosarcoma, alveolar	268220	FOXO1A	136533	13q14.11
Rhabdomyosarcoma, alveolar	268220	FKHR	136533	13q14.11
Rhabdomyosarcoma, embryonal, 2	180295	DICER1	606241	14q32.13
Rhabdomyosarcoma, embryonal, 2	180295	HERNA	606241	14q32.13
Rhabdomyosarcoma, embryonal, 2	180295	KIAA0928	606241	14q32.13
Rhabdomyosarcoma, embryonal, 2	180295	MNG1	606241	14q32.13
Rhabdomyosarcoma, embryonal, 2	180295	RMSE2	606241	14q32.13
Rhabdomyosarcoma, somatic	268210	SLC22A1L	602631	11p15.4
Rhabdomyosarcoma, somatic	268210	BWSCR1A	602631	11p15.4
Rhabdomyosarcoma, somatic	268210	IMPT1	602631	11p15.4
Rhizomelic chondrodysplasia punctata, type 1	215100	PEX7	601757	6q23.3
Rhizomelic chondrodysplasia punctata, type 1	215100	RCDP1	601757	6q23.3
Rhizomelic chondrodysplasia punctata, type 1	215100	PBD9B	601757	6q23.3
Rhizomelic chondrodysplasia punctata, type 3	600121	AGPS	603051	2q31.2
Rhizomelic chondrodysplasia punctata, type 3	600121	ADHAPS	603051	2q31.2
Riboflavin deficiency	615026	SLC52A1	607883	17p13.2
Riboflavin deficiency	615026	GPR172B	607883	17p13.2
Riboflavin deficiency	615026	GPCR42	607883	17p13.2
Riboflavin deficiency	615026	PAR2	607883	17p13.2
Riboflavin deficiency	615026	FLJ10060	607883	17p13.2
Riboflavin deficiency	615026	RBFVD	607883	17p13.2
Ribose 5-phosphate isomerase deficiency	608611	RPIA	180430	2p11.2
Ribose 5-phosphate isomerase deficiency	608611	RPI	180430	2p11.2
Rickets due to defect in vitamin D 25-hydroxylation	600081	CYP2R1	608713	11p15.2
Rickets, vitamin D-resistant, type IIA	277440	VDR	601769	12q13.11
Rieger or Axenfeld anomalies	602482	FOXC1	601090	6p25.3
Rieger or Axenfeld anomalies	602482	FKHL7	601090	6p25.3
Rieger or Axenfeld anomalies	602482	FREAC3	601090	6p25.3
Rieger or Axenfeld anomalies	602482	IRID1	601090	6p25.3
Rieger or Axenfeld anomalies	602482	RIEG3	601090	6p25.3
Rieger syndrome, type 2	601499	RIEG2		13q14
Rieger syndrome, type 2	601499	RGS2		13q14
Right atrial isomerism	208530	GDF1	602880	19p13.11
Right atrial isomerism	208530	DTGA3	602880	19p13.11
Right atrial isomerism	208530	DORV	602880	19p13.11
Right atrial isomerism	208530	RAI	602880	19p13.11
Rigidity and multifocal seizure syndrome, lethal neonatal	614498	BRAT1	614506	7p22.3
Rigidity and multifocal seizure syndrome, lethal neonatal	614498	BAAT1	614506	7p22.3
Rigidity and multifocal seizure syndrome, lethal neonatal	614498	C7orf27	614506	7p22.3
Rigidity and multifocal seizure syndrome, lethal neonatal	614498	RMFSL	614506	7p22.3
Ring dermoid of cornea	180550	PITX2	601542	4q25
Ring dermoid of cornea	180550	IDG2	601542	4q25
Ring dermoid of cornea	180550	RIEG1	601542	4q25
Ring dermoid of cornea	180550	RGS	601542	4q25
Ring dermoid of cornea	180550	IGDS2	601542	4q25
Rippling muscle disease	606072	CAV3	601253	3p25.3
Rippling muscle disease	606072	LGMD1C	601253	3p25.3
Rippling muscle disease	606072	LQT9	601253	3p25.3
Rippling muscle disease-1	600332	RMD1		1q41
Ritscher-Schinzel syndrome	220210	KIAA0196	610657	8q24.13
Ritscher-Schinzel syndrome	220210	SPG8	610657	8q24.13
Ritscher-Schinzel syndrome	220210	RTSC	610657	8q24.13
Roberts syndrome	268300	ESCO2	609353	8p21.1
Robinow syndrome, autosomal dominant	180700	WNT5A	164975	3p14.3
Robinow syndrome, autosomal recessive	268310	ROR2	602337	9q22.31
Robinow syndrome, autosomal recessive	268310	BDB1	602337	9q22.31
Robinow syndrome, autosomal recessive	268310	BDB	602337	9q22.31
Robinow syndrome, autosomal recessive	268310	NTRKR2	602337	9q22.31
Robinow-Sorauf syndrome	180750	TWIST1	601622	7p21.1
Robinow-Sorauf syndrome	180750	ACS3	601622	7p21.1
Robinow-Sorauf syndrome	180750	SCS	601622	7p21.1
Robinow-Sorauf syndrome	180750	CRS1	601622	7p21.1
Roifman syndrome	300258	RFMN		Chr.X
Rolandic epilepsy, mental retardation, and speech dyspraxia	300643	SRPX2	300642	Xq22.1
Rolandic epilepsy, mental retardation, and speech dyspraxia	300643	SRPUL	300642	Xq22.1
Rolandic epilepsy, mental retardation, and speech dyspraxia	300643	RESDX	300642	Xq22.1
Rothmund-Thomson syndrome	268400	RECQL4	603780	8q24.3
Rothmund-Thomson syndrome	268400	RTS	603780	8q24.3
Rothmund-Thomson syndrome	268400	RECQ4	603780	8q24.3
Roussy-Levy syndrome	180800	MPZ	159440	1q23.3
Roussy-Levy syndrome	180800	CMT1B	159440	1q23.3
Roussy-Levy syndrome	180800	CMTDID	159440	1q23.3
Roussy-Levy syndrome	180800	CHM	159440	1q23.3
Roussy-Levy syndrome	180800	DSS	159440	1q23.3
Roussy-Levy syndrome	180800	PMP22	601097	17p12
Roussy-Levy syndrome	180800	CMT1A	601097	17p12
Roussy-Levy syndrome	180800	CMT1E	601097	17p12
Roussy-Levy syndrome	180800	DSS	601097	17p12
Rubinstein-Taybi syndrome 2	613684	EP300	602700	22q13.2
Rubinstein-Taybi syndrome 2	613684	RSTS2	602700	22q13.2
Rubinstein-Taybi syndrome	180849	CREBBP	600140	16p13.3
Rubinstein-Taybi syndrome	180849	CBP	600140	16p13.3
Rubinstein-Taybi syndrome	180849	RSTS	600140	16p13.3
SARS infection, protection against		CLEC4M	605872	19p13.2
SARS infection, protection against		CD209L	605872	19p13.2
SARS infection, protection against		LSIGN	605872	19p13.2
SARS infection, protection against		DCSIGNR	605872	19p13.2
SBBYSS syndrome	603736	KAT6B	605880	10q22.2
SBBYSS syndrome	603736	MYST4	605880	10q22.2
SBBYSS syndrome	603736	MORF	605880	10q22.2
SBBYSS syndrome	603736	GTPTS	605880	10q22.2
SC phocomelia syndrome	269000	ESCO2	609353	8p21.1
SCID due to LCK deficiency		LCK	153390	1p35.1
SCID, autosomal recessive, T-negative/B-positive type	600802	JAK3	600173	19p13.11
SCID, autosomal recessive, T-negative/B-positive type	600802	JAKL	600173	19p13.11
SED congenita	183900	COL2A1	120140	12q13.11
SED, Maroteaux type	184095	TRPV4	605427	12q24.11
SED, Maroteaux type	184095	VROAC	605427	12q24.11
SED, Maroteaux type	184095	HMSN2C	605427	12q24.11
SED, Maroteaux type	184095	CMT2C	605427	12q24.11
SED, Maroteaux type	184095	SPSMA	605427	12q24.11
SED, Maroteaux type	184095	SSQTL1	605427	12q24.11
SED, Maroteaux type	184095	SMAL	605427	12q24.11
SED, Namaqualand type	120140	COL2A1		12q13.11
SERKAL syndrome	611812	WNT4	603490	1p36.12
SERKAL syndrome	611812	SERKAL	603490	1p36.12
SESAME syndrome	612780	KCNJ10	602208	1q23.2
SESAME syndrome	612780	SESAME	602208	1q23.2
SFM syndrome, somatic mosaic	163200	KRAS	190070	12p12.1
SFM syndrome, somatic mosaic	163200	KRAS2	190070	12p12.1
SFM syndrome, somatic mosaic	163200	RASK2	190070	12p12.1
SFM syndrome, somatic mosaic	163200	NS	190070	12p12.1
SFM syndrome, somatic mosaic	163200	CFC2	190070	12p12.1
SHORT syndrome	269880	PIK3R1	171833	5q13.1
SHORT syndrome	269880	GRB1	171833	5q13.1
SHORT syndrome	269880	AGM7	171833	5q13.1
SHORT syndrome	269880	SHORT	171833	5q13.1
SMED Strudwick type	184250	COL2A1	120140	12q13.11
STAR syndrome	300707	FAM58A	300708	Xq28
STAR syndrome	300707	STAR	300708	Xq28
Saccharopinuria	268700	AASS	605113	7q31.32
Saethre-Chotzen syndrome with eyelid anomalies	101400	TWIST1	601622	7p21.1
Saethre-Chotzen syndrome with eyelid anomalies	101400	ACS3	601622	7p21.1
Saethre-Chotzen syndrome with eyelid anomalies	101400	SCS	601622	7p21.1
Saethre-Chotzen syndrome with eyelid anomalies	101400	CRS1	601622	7p21.1
Saethre-Chotzen syndrome	101400	FGFR2	176943	10q26.13
Saethre-Chotzen syndrome	101400	BEK	176943	10q26.13
Saethre-Chotzen syndrome	101400	CFD1	176943	10q26.13
Saethre-Chotzen syndrome	101400	JWS	176943	10q26.13
Saethre-Chotzen syndrome	101400	TK14	176943	10q26.13
Saethre-Chotzen syndrome	101400	BBDS	176943	10q26.13
Saethre-Chotzen syndrome	101400	TWIST1	601622	7p21.1
Saethre-Chotzen syndrome	101400	ACS3	601622	7p21.1
Saethre-Chotzen syndrome	101400	SCS	601622	7p21.1
Saethre-Chotzen syndrome	101400	CRS1	601622	7p21.1
Salla disease	604369	SLC17A5	604322	6q13
Salla disease	604369	SIASD	604322	6q13
Salla disease	604369	SLD	604322	6q13
Sandhoff disease, infantile, juvenile, and adult forms	268800	HEXB	606873	5q13.3
Sarcoidosis, early-onset	609464	NOD2	605956	16q12.1
Sarcoidosis, early-onset	609464	CARD15	605956	16q12.1
Sarcoidosis, early-onset	609464	IBD1	605956	16q12.1
Sarcoidosis, early-onset	609464	CD	605956	16q12.1
Sarcoidosis, early-onset	609464	ACUG	605956	16q12.1
Sarcoidosis, early-onset	609464	PSORAS1	605956	16q12.1
Sarcoma, synovial		SS18	600192	18q11.2
Sarcoma, synovial		SSXT	600192	18q11.2
Sarcoma, synovial		SYT	600192	18q11.2
Scalp-ear-nipple syndrome	181270	KCTD1	613420	18q11.2
Scalp-ear-nipple syndrome	181270	SENS	613420	18q11.2
Scaphocephaly and Axenfeld-Rieger anomaly		FGFR2	176943	10q26.13
Scaphocephaly and Axenfeld-Rieger anomaly		BEK	176943	10q26.13
Scaphocephaly and Axenfeld-Rieger anomaly		CFD1	176943	10q26.13
Scaphocephaly and Axenfeld-Rieger anomaly		JWS	176943	10q26.13
Scaphocephaly and Axenfeld-Rieger anomaly		TK14	176943	10q26.13
Scaphocephaly and Axenfeld-Rieger anomaly		BBDS	176943	10q26.13
Scaphocephaly, maxillary retrusion, and mental retardation	609579	FGFR2	176943	10q26.13
Scaphocephaly, maxillary retrusion, and mental retardation	609579	BEK	176943	10q26.13
Scaphocephaly, maxillary retrusion, and mental retardation	609579	CFD1	176943	10q26.13
Scaphocephaly, maxillary retrusion, and mental retardation	609579	JWS	176943	10q26.13
Scaphocephaly, maxillary retrusion, and mental retardation	609579	TK14	176943	10q26.13
Scaphocephaly, maxillary retrusion, and mental retardation	609579	BBDS	176943	10q26.13
Scapuloperoneal myopathy, X-linked dominant	300695	FHL1	300163	Xq26.3
Scapuloperoneal myopathy, X-linked dominant	300695	SLIM1	300163	Xq26.3
Scapuloperoneal myopathy, X-linked dominant	300695	XMPMA	300163	Xq26.3
Scapuloperoneal myopathy, X-linked dominant	300695	KYOT	300163	Xq26.3
Scapuloperoneal myopathy, X-linked dominant	300695	FHL1A	300163	Xq26.3
Scapuloperoneal myopathy, X-linked dominant	300695	FHL1B	300163	Xq26.3
Scapuloperoneal spinal muscular atrophy	181405	TRPV4	605427	12q24.11
Scapuloperoneal spinal muscular atrophy	181405	VROAC	605427	12q24.11
Scapuloperoneal spinal muscular atrophy	181405	HMSN2C	605427	12q24.11
Scapuloperoneal spinal muscular atrophy	181405	CMT2C	605427	12q24.11
Scapuloperoneal spinal muscular atrophy	181405	SPSMA	605427	12q24.11
Scapuloperoneal spinal muscular atrophy	181405	SSQTL1	605427	12q24.11
Scapuloperoneal spinal muscular atrophy	181405	SMAL	605427	12q24.11
Scapuloperoneal syndrome, myopathic type	181430	MYH7	160760	14q11.2
Scapuloperoneal syndrome, myopathic type	181430	CMH1	160760	14q11.2
Scapuloperoneal syndrome, myopathic type	181430	MPD1	160760	14q11.2
Scapuloperoneal syndrome, myopathic type	181430	CMD1S	160760	14q11.2
Scapuloperoneal syndrome, myopathic type	181430	SPMM	160760	14q11.2
Scapuloperoneal syndrome, myopathic type	181430	SPMD	160760	14q11.2
Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	DES	125660	2q35
Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	CMD1I	125660	2q35
Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	MFM1	125660	2q35
Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	SCPNK	125660	2q35
Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	ARVD7	125660	2q35
Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	ARVC7	125660	2q35
Scapuloperoneal syndrome, neurogenic, Kaeser type	181400	LGMD2R	125660	2q35
Schimke immunoosseous dysplasia	242900	SMARCAL1	606622	2q35
Schimke immunoosseous dysplasia	242900	HARP	606622	2q35
Schimke immunoosseous dysplasia	242900	SIOD	606622	2q35
Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic	163200	HRAS	190020	11p15.5
Schindler disease, type I	609241	NAGA	104170	22q13.2
Schindler disease, type III	609241	NAGA	104170	22q13.2
Schinzel-Giedion midface retraction syndrome	269150	SETBP1	611060	18q12.3
Schinzel-Giedion midface retraction syndrome	269150	KIAA0437	611060	18q12.3
Schinzel-Giedion midface retraction syndrome	269150	SEB	611060	18q12.3
Schizencephaly	269160	EMX2	600035	10q26.11
Schizencephaly	269160	SHH	600725	7q36.3
Schizencephaly	269160	HPE3	600725	7q36.3
Schizencephaly	269160	HLP3	600725	7q36.3
Schizencephaly	269160	SMMCI	600725	7q36.3
Schizencephaly	269160	MCOPCB5	600725	7q36.3
Schizensephaly	269160	SIX3	603714	2p21
Schizensephaly	269160	HPE2	603714	2p21
Schizophrenia 16	613959	SCZD16		7q36.3
Schizophrenia 16	613959	C16DUPq36.3		7q36.3
Schizophrenia 16	613959	DUP7q36.3		7q36.3
Schizophrenia	181500	DISC2	606271	1q42.2
Schizophrenia, neurophysiologic defect in		CHRNA7	118511	15q13.3
Schneckenbecken dysplasia	269250	SLC35D1	610804	1p31.3
Schneckenbecken dysplasia	269250	UGTREL7	610804	1p31.3
Schneckenbecken dysplasia	269250	KIAA0260	610804	1p31.3
Schopf-Schulz-Passarge syndrome	224750	WNT10A	606268	2q35
Schopf-Schulz-Passarge syndrome	224750	SSPS	606268	2q35
Schopf-Schulz-Passarge syndrome	224750	STHAG4	606268	2q35
Schopf-Schulz-Passarge syndrome	224750	OODD	606268	2q35
Schwannomatosis	162091	NF2	607379	22q12.2
Schwartz-Jampel syndrome, type 1	255800	HSPG2	142461	1p36.12
Schwartz-Jampel syndrome, type 1	255800	PLC	142461	1p36.12
Schwartz-Jampel syndrome, type 1	255800	SJS	142461	1p36.12
Schwartz-Jampel syndrome, type 1	255800	SJA	142461	1p36.12
Schwartz-Jampel syndrome, type 1	255800	SJS1	142461	1p36.12
Sclerosteosis 2	614305	LRP4	604270	11p11.2
Sclerosteosis 2	614305	MEGF7	604270	11p11.2
Sclerosteosis 2	614305	CLSS	604270	11p11.2
Sclerosteosis 2	614305	SOST2	604270	11p11.2
Sclerosteosis	269500	SOST	605740	17q21.31
Sclerosteosis	269500	VBCH	605740	17q21.31
Sclerosteosis	269500	CDD	605740	17q21.31
Scoliosis, idiopathic 1	181800	IS1		19p13.3
Scoliosis, idiopathic 1	181800	AIS		19p13.3
Scoliosis, idiopathic 2	607354	IS2		17p11.2
Scoliosis, idiopathic 2	607354	AIS2		17p11.2
Scott syndrome	262890	ANO6	608663	12q12
Scott syndrome	262890	TMEM16F	608663	12q12
Scott syndrome	262890	SCTS	608663	12q12
Scott syndrome	262890	BDPLT7	608663	12q12
Scurvy		GULOP	240400	8p21.1
Scurvy		GULO	240400	8p21.1
Sea-blue histiocyte disease	269600	APOE	107741	19q13.32
Sea-blue histiocyte disease	269600	AD2	107741	19q13.32
Sea-blue histiocyte disease	269600	LPG	107741	19q13.32
Sea-blue histiocyte disease	269600	LDLCQ5	107741	19q13.32
Sebaceous tumors, somatic	153245	LEF1		4q25
Sebastian syndrome	605249	MYH9	160775	22q12.3
Sebastian syndrome	605249	MHA	160775	22q12.3
Sebastian syndrome	605249	FTNS	160775	22q12.3
Sebastian syndrome	605249	DFNA17	160775	22q12.3
Sebastian syndrome	605249	BDPLT6	160775	22q12.3
Seborrhea-like dermatitis with psoriasiform elements	610227	ZNF750	610226	17q25.3
Seborrhea-like dermatitis with psoriasiform elements	610227	FLJ13841	610226	17q25.3
Seckel syndrome 1	210600	ATR	601215	3q23
Seckel syndrome 1	210600	FRP1	601215	3q23
Seckel syndrome 1	210600	SCKL1	601215	3q23
Seckel syndrome 1	210600	FCTCS	601215	3q23
Seckel syndrome 2	606744	RBBP8	604124	18q11.2
Seckel syndrome 2	606744	RIM	604124	18q11.2
Seckel syndrome 2	606744	SCKL2	604124	18q11.2
Seckel syndrome 2	606744	JWDS	604124	18q11.2
Seckel syndrome 3	608664	SCKL3		14q21-q22
Seckel syndrome 4	613676	CENPJ	609279	13q12.12
Seckel syndrome 4	613676	CPAP	609279	13q12.12
Seckel syndrome 4	613676	MCPH6	609279	13q12.12
Seckel syndrome 4	613676	SCKL4	609279	13q12.12
Seckel syndrome 5	613823	CEP152	613529	15q21.1
Seckel syndrome 5	613823	KIAA0912	613529	15q21.1
Seckel syndrome 5	613823	MCPH9	613529	15q21.1
Seckel syndrome 5	613823	SCKL5	613529	15q21.1
Seckel syndrome 6	614728	CEP63	614724	3q22.2
Seckel syndrome 7	614851	NIN	608684	14q22.1
Seckel syndrome 7	614851	KIAA1565	608684	14q22.1
Seckel syndrome 7	614851	SCKL7	608684	14q22.1
Segawa syndrome, recessive	605407	TH	191290	11p15.5
Segawa syndrome, recessive	605407	TYH	191290	11p15.5
Seizures, benign familial infantile, 1	601764	BFIS1		19q
Seizures, benign familial infantile, 1	601764	BFIC1		19q
Seizures, benign familial infantile, 2	605751	PRRT2	614386	16p11.2
Seizures, benign familial infantile, 2	605751	PKC	614386	16p11.2
Seizures, benign familial infantile, 2	605751	DYT10	614386	16p11.2
Seizures, benign familial infantile, 2	605751	EKD1	614386	16p11.2
Seizures, benign familial infantile, 2	605751	BFIS2	614386	16p11.2
Seizures, benign familial infantile, 2	605751	BFIC2	614386	16p11.2
Seizures, benign familial infantile, 2	605751	ICCA	614386	16p11.2
Seizures, benign familial infantile, 3	607745	SCN2A	182390	2q24.3
Seizures, benign familial infantile, 3	607745	SCN2A1	182390	2q24.3
Seizures, benign familial infantile, 3	607745	BFIC3	182390	2q24.3
Seizures, benign familial infantile, 3	607745	EIEE11	182390	2q24.3
Seizures, benign familial infantile, 3	607745	BFIS3	182390	2q24.3
Seizures, benign familial infantile, 3	607745	BFNIS	182390	2q24.3
Seizures, benign familial infantile, 4	612627	BFIS4		1p36.12-p35.1
Seizures, benign familial infantile, 4	612627	BFIC4		1p36.12-p35.1
Seizures, benign neonatal, 1	121200	KCNQ2	602235	20q13.33
Seizures, benign neonatal, 1	121200	EBN1	602235	20q13.33
Seizures, benign neonatal, 1	121200	EIEE7	602235	20q13.33
Seizures, benign neonatal, 1	121200	BFNS1	602235	20q13.33
Seizures, benign neonatal, type 2	121201	KCNQ3	602232	8q24.22
Seizures, benign neonatal, type 2	121201	EBN2	602232	8q24.22
Seizures, benign neonatal, type 2	121201	BFNC2	602232	8q24.22
Selective T-cell defect	269840	ZAP70	176947	2q11.2
Selective T-cell defect	269840	SRK	176947	2q11.2
Selective T-cell defect	269840	STD	176947	2q11.2
Selective T-cell defect	269840	STCD	176947	2q11.2
Sengers syndrome	212350	AGK	610345	7q34
Sengers syndrome	212350	MULK	610345	7q34
Sengers syndrome	212350	MTDPS10	610345	7q34
Sengers syndrome	212350	CATC5	610345	7q34
Sengers syndrome	212350	CTRCT38	610345	7q34
Senior-Loken syndrome 3	606995	SLSN3		3q22
Senior-Loken syndrome 4	606996	NPHP4	607215	1p36.31
Senior-Loken syndrome 4	606996	SLSN4	607215	1p36.31
Senior-Loken syndrome 5	609254	IQCB1	609237	3q13.33
Senior-Loken syndrome 5	609254	NPHP5	609237	3q13.33
Senior-Loken syndrome 5	609254	KIAA0036	609237	3q13.33
Senior-Loken syndrome 6	610189	CEP290	610142	12q21.32
Senior-Loken syndrome 6	610189	KIAA0373	610142	12q21.32
Senior-Loken syndrome 6	610189	3H11AG	610142	12q21.32
Senior-Loken syndrome 6	610189	JBTS5	610142	12q21.32
Senior-Loken syndrome 6	610189	SLSN6	610142	12q21.32
Senior-Loken syndrome 6	610189	LCA10	610142	12q21.32
Senior-Loken syndrome 6	610189	BBS14	610142	12q21.32
Senior-Loken syndrome 7	613615	SDCCAG8	613524	1q43
Senior-Loken syndrome 7	613615	CCCAP SLSN7	613524	1q43
Senior-Loken syndrome-1	266900	NPHP1	607100	2q13
Senior-Loken syndrome-1	266900	NPH1	607100	2q13
Senior-Loken syndrome-1	266900	SLSN1	607100	2q13
Senior-Loken syndrome-1	266900	JBTS4	607100	2q13
Sensorineural deafness with mild renal dysfunction	602522	BSND	606412	1p32.3
Septooptic dysplasia	182230	HESX1	601802	3p14.3
Septooptic dysplasia	182230	RPX	601802	3p14.3
Septooptic dysplasia	182230	CPHD5	601802	3p14.3
Severe combined immunodeficiency due to ADA deficiency	102700	ADA	608958	20q13.12
Severe combined immunodeficiency due to IL2 deficiency		IL2	147680	4q27
Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	611291	NHEJ1	611290	2q35
Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation	611291	XLF	611290	2q35
Severe combined immunodeficiency with sensitivity to ionizing radiation	602450	LIG4	601837	13q33.3
Severe combined immunodeficiency, Athabascan type	602450	DCLRE1C	605988	10p13
Severe combined immunodeficiency, Athabascan type	602450	ARTEMIS	605988	10p13
Severe combined immunodeficiency, Athabascan type	602450	SCIDA	605988	10p13
Severe combined immunodeficiency, B cell-negative	601457	RAG1	179615	11p12
Severe combined immunodeficiency, B cell-negative	601457	RAG2	179616	11p12
Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive	608971	PTPRC	151460	1q31.3-q32.1
Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive	608971	CD45	151460	1q31.3-q32.1
Severe combined immunodeficiency, T cell-negative, B-cell/natural killer-cell positive	608971	LCA	151460	1q31.3-q32.1
Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type	608971	IL7R	146661	5p13.2
Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type	608971	IL7RA	146661	5p13.2
Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type	608971	CD127	146661	5p13.2
Severe combined immunodeficiency, X-linked	300400	IL2RG	308380	Xq13.1
Severe combined immunodeficiency, X-linked	300400	SCIDX1	308380	Xq13.1
Severe combined immunodeficiency, X-linked	300400	SCIDX	308380	Xq13.1
Severe combined immunodeficiency, X-linked	300400	IMD4	308380	Xq13.1
Shaheen syndrome	615328	COG6	606977	13q14.11
Shaheen syndrome	615328	COD2	606977	13q14.11
Shaheen syndrome	615328	KIAA1134	606977	13q14.11
Shaheen syndrome	615328	CDG2L	606977	13q14.11
Shaheen syndrome	615328	SHNS	606977	13q14.11
Short QT syndrome 1	609620	KCNH2	152427	7q36.1
Short QT syndrome 1	609620	LQT2	152427	7q36.1
Short QT syndrome 1	609620	HERG	152427	7q36.1
Short QT syndrome 1	609620	SQT1	152427	7q36.1
Short QT syndrome 2	609621	KCNQ1	607542	11p15.5-p15.4
Short QT syndrome 2	609621	KCNA9	607542	11p15.5-p15.4
Short QT syndrome 2	609621	LQT1	607542	11p15.5-p15.4
Short QT syndrome 2	609621	KVLQT1	607542	11p15.5-p15.4
Short QT syndrome 2	609621	ATFB3	607542	11p15.5-p15.4
Short QT syndrome 2	609621	SQT2	607542	11p15.5-p15.4
Short QT syndrome 3	609622	KCNJ2	600681	17q24.3
Short QT syndrome 3	609622	HHIRK1	600681	17q24.3
Short QT syndrome 3	609622	KIR2.1	600681	17q24.3
Short QT syndrome 3	609622	IRK1	600681	17q24.3
Short QT syndrome 3	609622	LQT7	600681	17q24.3
Short QT syndrome 3	609622	SQT3	600681	17q24.3
Short QT syndrome 3	609622	ATFB9	600681	17q24.3
Short stature	604271	GHR	600946	5p13-p12
Short stature	604271	GHSR	601898	3q26.31
Short stature, idiopathic familial	300582	SHOX	312865	Xp22.33
Short stature, idiopathic familial	300582	GCFX	312865	Xp22.33
Short stature, idiopathic familial	300582	SS	312865	Xp22.33
Short stature, idiopathic familial	300582	PHOG	312865	Xp22.33
Short stature, idiopathic familial	300582	SHOXY	400020	Yp11.32
Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	614813	POC1A	614783	3p21.2
Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	614813	PIX2	614783	3p21.2
Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis	614813	SOFT	614783	3p21.2
Short stature, optic nerve atrophy, and Pelger-Huet anomaly	614800	NBAS	608025	2p24.3
Short stature, optic nerve atrophy, and Pelger-Huet anomaly	614800	NAG	608025	2p24.3
Short stature, optic nerve atrophy, and Pelger-Huet anomaly	614800	SOPH	608025	2p24.3
Short-rib thoracic dysplasia 1 with or without polydactyly	208500	SRTD1		15q13
Short-rib thoracic dysplasia 1 with or without polydactyly	208500	ATD1		15q13
Short-rib thoracic dysplasia 10 with or without polydactyly	615630	IFT172	607386	2p23.3
Short-rib thoracic dysplasia 10 with or without polydactyly	615630	SLB	607386	2p23.3
Short-rib thoracic dysplasia 10 with or without polydactyly	615630	KIAA1179	607386	2p23.3
Short-rib thoracic dysplasia 10 with or without polydactyly	615630	SRTD10	607386	2p23.3
Short-rib thoracic dysplasia 11 with or without polydactyly	615633	WDR34	613363	9q34.11
Short-rib thoracic dysplasia 11 with or without polydactyly	615633	SRTD11	613363	9q34.11
Short-rib thoracic dysplasia 2 with or without polydactyly	611263	IFT80	611177	3q25.33
Short-rib thoracic dysplasia 2 with or without polydactyly	611263	KIAA1374	611177	3q25.33
Short-rib thoracic dysplasia 2 with or without polydactyly	611263	WDR56	611177	3q25.33
Short-rib thoracic dysplasia 2 with or without polydactyly	611263	SRTD2	611177	3q25.33
Short-rib thoracic dysplasia 2 with or without polydactyly	611263	ATD2	611177	3q25.33
Short-rib thoracic dysplasia 3 with or without polydactyly	613091	DYNC2H1	603297	11q22.3
Short-rib thoracic dysplasia 3 with or without polydactyly	613091	DNCH2	603297	11q22.3
Short-rib thoracic dysplasia 3 with or without polydactyly	613091	DHC2	603297	11q22.3
Short-rib thoracic dysplasia 3 with or without polydactyly	613091	ATD3	603297	11q22.3
Short-rib thoracic dysplasia 3 with or without polydactyly	613091	SRPS2B	603297	11q22.3
Short-rib thoracic dysplasia 3 with or without polydactyly	613091	SRTD3	603297	11q22.3
Short-rib thoracic dysplasia 4 with or without polydactyly	613819	TTC21B	612014	2q24.3
Short-rib thoracic dysplasia 4 with or without polydactyly	613819	THM1	612014	2q24.3
Short-rib thoracic dysplasia 4 with or without polydactyly	613819	NPHP12	612014	2q24.3
Short-rib thoracic dysplasia 4 with or without polydactyly	613819	SRTD4	612014	2q24.3
Short-rib thoracic dysplasia 4 with or without polydactyly	613819	ATD4	612014	2q24.3
Short-rib thoracic dysplasia 5 with or without polydactyly	614376	WDR19	608151	4p14
Short-rib thoracic dysplasia 5 with or without polydactyly	614376	SRTD5	608151	4p14
Short-rib thoracic dysplasia 5 with or without polydactyly	614376	ATD5	608151	4p14
Short-rib thoracic dysplasia 5 with or without polydactyly	614376	NPHP13	608151	4p14
Short-rib thoracic dysplasia 5 with or without polydactyly	614376	CED4	608151	4p14
Short-rib thoracic dysplasia 6 with or without polydactyly	263520	NEK1	604588	4q33
Short-rib thoracic dysplasia 6 with or without polydactyly	263520	SRTD6	604588	4q33
Short-rib thoracic dysplasia 6 with or without polydactyly	263520	SRPS2A	604588	4q33
Short-rib thoracic dysplasia 7 with or without polydactyly	614091	WDR35	613602	2p24.1
Short-rib thoracic dysplasia 7 with or without polydactyly	614091	NAOFEN	613602	2p24.1
Short-rib thoracic dysplasia 7 with or without polydactyly	614091	KIAA1336	613602	2p24.1
Short-rib thoracic dysplasia 7 with or without polydactyly	614091	CED2	613602	2p24.1
Short-rib thoracic dysplasia 7 with or without polydactyly	614091	SRTD7	613602	2p24.1
Short-rib thoracic dysplasia 8 with or without polydactyly	615503	WDR60	615462	7q36.3
Short-rib thoracic dysplasia 8 with or without polydactyly	615503	SRTD8	615462	7q36.3
Short-rib thoracic dysplasia 8 with or without polydactyly	615503	SRPS6	615462	7q36.3
Short-rib thoracic dysplasia 9 with or without polydactyly	266920	IFT140	614620	16p13.3
Short-rib thoracic dysplasia 9 with or without polydactyly	266920	KIAA0590	614620	16p13.3
Short-rib thoracic dysplasia 9 with or without polydactyly	266920	SRTD9	614620	16p13.3
Short-rib thoracic dysplasia 9 with or without polydactyly	266920	MZSDS	614620	16p13.3
Shprintzen-Goldberg syndrome	182212	SKI	164780	1p36.33
Shprintzen-Goldberg syndrome	182212	SGS	164780	1p36.33
Shwachman-Bodian-Diamond syndrome	260400	SBDS	607444	7q11.21
Shwachman-Bodian-Diamond syndrome	260400	SDS	607444	7q11.21
Sialic acid storage disorder, infantile	269920	SLC17A5	604322	6q13
Sialic acid storage disorder, infantile	269920	SIASD	604322	6q13
Sialic acid storage disorder, infantile	269920	SLD	604322	6q13
Sialidosis, type I	256550	NEU1	608272	6p21.33
Sialidosis, type I	256550	NEU	608272	6p21.33
Sialidosis, type I	256550	SIAL1	608272	6p21.33
Sialidosis, type II	256550	NEU1	608272	6p21.33
Sialidosis, type II	256550	NEU	608272	6p21.33
Sialidosis, type II	256550	SIAL1	608272	6p21.33
Sialuria	269921	GNE	603824	9p13.3
Sialuria	269921	GLCNE	603824	9p13.3
Sialuria	269921	IBM2	603824	9p13.3
Sialuria	269921	DMRV	603824	9p13.3
Sialuria	269921	NM	603824	9p13.3
Sick sinus syndrome 1	608567	SCN5A	600163	3p22.2
Sick sinus syndrome 1	608567	LQT3	600163	3p22.2
Sick sinus syndrome 1	608567	VF1	600163	3p22.2
Sick sinus syndrome 1	608567	HB1	600163	3p22.2
Sick sinus syndrome 1	608567	SSS1	600163	3p22.2
Sick sinus syndrome 1	608567	CMD1E	600163	3p22.2
Sick sinus syndrome 1	608567	CDCD2	600163	3p22.2
Sick sinus syndrome 2	163800	HCN4	605206	15q24.1
Sick sinus syndrome 2	163800	SSS2	605206	15q24.1
Sickle cell anemia	603903	HBB	141900	11p15.4
Silver spastic paraplegia syndrome	270685	BSCL2	606158	11q12.3
Silver spastic paraplegia syndrome	270685	SPG17	606158	11q12.3
Silver spastic paraplegia syndrome	270685	HMN5	606158	11q12.3
Silver-Russell syndrome	180860	SRS		7p11.2
Silver-Russell syndrome	180860	RSS		7p11.2
Silver-Russell syndrome	180860	H19	103280	11p15.5
Silver-Russell syndrome	180860	D11S813E	103280	11p15.5
Silver-Russell syndrome	180860	ASM1	103280	11p15.5
Silver-Russell syndrome	180860	BWS	103280	11p15.5
Silver-Russell syndrome	180860	WT2	103280	11p15.5
Simpson-Golabi-Behmel syndrome, type 1	312870	GPC3	300037	Xq26.2
Simpson-Golabi-Behmel syndrome, type 1	312870	SDYS	300037	Xq26.2
Simpson-Golabi-Behmel syndrome, type 1	312870	SGBS1	300037	Xq26.2
Simpson-Golabi-Behmel syndrome, type 2	300209	OFD1	300170	Xp22.2
Simpson-Golabi-Behmel syndrome, type 2	300209	CXorf5	300170	Xp22.2
Simpson-Golabi-Behmel syndrome, type 2	300209	SGBS2	300170	Xp22.2
Simpson-Golabi-Behmel syndrome, type 2	300209	JBTS10	300170	Xp22.2
Single median maxillary central incisor	147250	SHH	600725	7q36.3
Single median maxillary central incisor	147250	HPE3	600725	7q36.3
Single median maxillary central incisor	147250	HLP3	600725	7q36.3
Single median maxillary central incisor	147250	SMMCI	600725	7q36.3
Single median maxillary central incisor	147250	MCOPCB5	600725	7q36.3
Sinoatrial node dysfunction and deafness	614896	CACNA1D	114206	3p21.1
Sinoatrial node dysfunction and deafness	614896	CACNL1A2	114206	3p21.1
Sinoatrial node dysfunction and deafness	614896	CCHL1A2	114206	3p21.1
Sinoatrial node dysfunction and deafness	614896	SANDD	114206	3p21.1
Sinoatrial node dysfunction and deafness	614896	PASNA	114206	3p21.1
Sitosterolemia	210250	ABCG5	605459	2p21
Sitosterolemia	210250	ABCG8	605460	2p21
Sitosterolemia	210250	GBD4	605460	2p21
Sjogren-Larsson syndrome	270200	ALDH3A2	609523	17p11.2
Sjogren-Larsson syndrome	270200	ALDH10	609523	17p11.2
Sjogren-Larsson syndrome	270200	SLS	609523	17p11.2
Sjogren-Larsson syndrome	270200	FALDH	609523	17p11.2
Skeletal defects, genital hypoplasia, and mental retardation	612447	ZBTB16	176797	11q23.2
Skeletal defects, genital hypoplasia, and mental retardation	612447	ZNF145	176797	11q23.2
Skeletal defects, genital hypoplasia, and mental retardation	612447	PLZF	176797	11q23.2
Skin fragility-woolly hair syndrome	607655	DSP	125647	6p24.3
Skin fragility-woolly hair syndrome	607655	KPPS2	125647	6p24.3
Skin fragility-woolly hair syndrome	607655	PPKS2	125647	6p24.3
Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)	612271	TYRP1	115501	9p23
Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)	612271	CAS2	115501	9p23
Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)	612271	GP75	115501	9p23
Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)	612271	SHEP11	115501	9p23
Slowed nerve conduction velocity, AD	608236	ARHGEF10	608136	8p23.3
Slowed nerve conduction velocity, AD	608236	KIAA0294	608136	8p23.3
Small cell cancer of the lung, somatic	182280	RB1	614041	13q14.2
Small fiber neuropathy	133020	SCN9A	603415	2q24.3
Small fiber neuropathy	133020	NENA	603415	2q24.3
Small fiber neuropathy	133020	PN1	603415	2q24.3
Small fiber neuropathy	133020	FEB3B	603415	2q24.3
Small fiber neuropathy	133020	GEFSP7	603415	2q24.3
Small fiber neuropathy	133020	SFNP	603415	2q24.3
Small patella syndrome	147891	TBX4	601719	17q23.2
Small-cell cancer of lung	182280	SCLC1		3p23-p21
Smith-Lemli-Opitz syndrome	270400	DHCR7	602858	11q13.4
Smith-Lemli-Opitz syndrome	270400	SLOS	602858	11q13.4
Smith-Magenis syndrome	182290	RAI1	607642	17p11.2
Smith-Magenis syndrome	182290	SMCR	607642	17p11.2
Smith-Magenis syndrome	182290	SMS	607642	17p11.2
Smith-McCort dysplasia 2	615222	RAB33B	605950	4q31.1
Smith-McCort dysplasia 2	615222	SMC2	605950	4q31.1
Smith-McCort dysplasia	607326	DYM	607461	18q21.1
Smith-McCort dysplasia	607326	FLJ90130	607461	18q21.1
Smith-McCort dysplasia	607326	DMC	607461	18q21.1
Smith-McCort dysplasia	607326	SMC	607461	18q21.1
Snowflake vitreoretinal degeneration	193230	KCNJ13	603208	2q37.1
Snowflake vitreoretinal degeneration	193230	SVD	603208	2q37.1
Snowflake vitreoretinal degeneration	193230	LCA16	603208	2q37.1
Somatostatin analog, resistance to	102200	SSTR5	182455	16p13.3
Sorsby fundus dystrophy	136900	TIMP3	188826	22q12.3
Sorsby fundus dystrophy	136900	SFD	188826	22q12.3
Sotos syndrome 1	117550	NSD1	606681	5q35.2-q35.3
Sotos syndrome 1	117550	ARA267	606681	5q35.2-q35.3
Sotos syndrome 1	117550	STO	606681	5q35.2-q35.3
Sotos syndrome 1	117550	SOTOS1	606681	5q35.2-q35.3
Sotos syndrome 2	614753	NFIX	164005	19p13.2
Sotos syndrome 2	614753	NF1A	164005	19p13.2
Sotos syndrome 2	614753	SOTOS2	164005	19p13.2
Sotos syndrome 2	614753	MRSHSS	164005	19p13.2
Spastic ataxia 1, autosomal dominant	108600	SPAX1		12p13
Spastic ataxia 2, autosomal recessive	611302	KIF1C	603060	17p13.2
Spastic ataxia 2, autosomal recessive	611302	LTXS1	603060	17p13.2
Spastic ataxia 2, autosomal recessive	611302	KIAA0706	603060	17p13.2
Spastic ataxia 2, autosomal recessive	611302	SPAX2	603060	17p13.2
Spastic ataxia 3, autosomal recessive	611390	MARS2	609728	2q33.1
Spastic ataxia 3, autosomal recessive	611390	SPAX3	609728	2q33.1
Spastic ataxia, Charlevoix-Saguenay type	270550	SACS	604490	13q12.12
Spastic ataxia, Charlevoix-Saguenay type	270550	ARSACS	604490	13q12.12
Spastic paralysis, infantile onset ascending	607225	ALS2	606352	2q33.1
Spastic paralysis, infantile onset ascending	607225	ALSJ	606352	2q33.1
Spastic paralysis, infantile onset ascending	607225	PLSJ	606352	2q33.1
Spastic paralysis, infantile onset ascending	607225	IAHSP	606352	2q33.1
Spastic paraplegia 10, autosomal dominant	604187	KIF5A	602821	12q13.3
Spastic paraplegia 10, autosomal dominant	604187	NKHC	602821	12q13.3
Spastic paraplegia 10, autosomal dominant	604187	SPG10	602821	12q13.3
Spastic paraplegia 11, autosomal recessive	604360	SPG11	610844	15q21.1
Spastic paraplegia 11, autosomal recessive	604360	KIAA1840	610844	15q21.1
Spastic paraplegia 11, autosomal recessive	604360	FLJ21439	610844	15q21.1
Spastic paraplegia 12, autosomal dominant	604805	RTN2	603183	19q13.32
Spastic paraplegia 12, autosomal dominant	604805	NSPL1	603183	19q13.32
Spastic paraplegia 12, autosomal dominant	604805	SPG12	603183	19q13.32
Spastic paraplegia 13, autosomal dominant	605280	HSPD1	118190	2q33.1
Spastic paraplegia 13, autosomal dominant	605280	SPG13	118190	2q33.1
Spastic paraplegia 13, autosomal dominant	605280	HSP60	118190	2q33.1
Spastic paraplegia 13, autosomal dominant	605280	HLD4	118190	2q33.1
Spastic paraplegia 14, autosomal recessive	605229	SPG14		3q27-q28
Spastic paraplegia 15, autosomal recessive	270700	ZFYVE26	612012	14q24.1
Spastic paraplegia 15, autosomal recessive	270700	KIAA0321	612012	14q24.1
Spastic paraplegia 15, autosomal recessive	270700	SPG15	612012	14q24.1
Spastic paraplegia 16, X-linked, complicated	300266	SPG16		Xq11.2
Spastic paraplegia 18, autosomal recessive	611225	ERLIN2	611605	8p11.23
Spastic paraplegia 18, autosomal recessive	611225	SPFH2	611605	8p11.23
Spastic paraplegia 18, autosomal recessive	611225	C8orf2	611605	8p11.23
Spastic paraplegia 18, autosomal recessive	611225	SPG18	611605	8p11.23
Spastic paraplegia 19, autosomal dominant	607152	SPG19		9q
Spastic paraplegia 2, X-linked	312920	PLP1	300401	Xq22.2
Spastic paraplegia 2, X-linked	312920	PMD	300401	Xq22.2
Spastic paraplegia 2, X-linked	312920	HLD1	300401	Xq22.2
Spastic paraplegia 2, X-linked	312920	SPG2	300401	Xq22.2
Spastic paraplegia 24, autosomal recessive	607584	SPG24		13q14
Spastic paraplegia 25, autosomal recessive	608220	SPG25		6q23-q24.1
Spastic paraplegia 26, autosomal recessive	609195	SPG26		12p11.1-q14
Spastic paraplegia 26, autosomal recessive	609195	B4GALNT1	601873	12q13.3
Spastic paraplegia 26, autosomal recessive	609195	GALGT	601873	12q13.3
Spastic paraplegia 26, autosomal recessive	609195	GALNACT	601873	12q13.3
Spastic paraplegia 26, autosomal recessive	609195	SPG26	601873	12q13.3
Spastic paraplegia 27, autosomal recessive	609041	SPG27		10q22.1-q24.1
Spastic paraplegia 28, autosomal recessive	609340	DDHD1	614603	14q22.1
Spastic paraplegia 28, autosomal recessive	609340	PAPLA1	614603	14q22.1
Spastic paraplegia 28, autosomal recessive	609340	KIAA1705	614603	14q22.1
Spastic paraplegia 28, autosomal recessive	609340	SPG28	614603	14q22.1
Spastic paraplegia 29, autosomal dominant	609727	SPG29		1p31.1-p21.1
Spastic paraplegia 30, autosomal recessive	610357	KIF1A	601255	2q37.3
Spastic paraplegia 30, autosomal recessive	610357	ATSV	601255	2q37.3
Spastic paraplegia 30, autosomal recessive	610357	UNC104	601255	2q37.3
Spastic paraplegia 30, autosomal recessive	610357	SPG30	601255	2q37.3
Spastic paraplegia 30, autosomal recessive	610357	HSN2C	601255	2q37.3
Spastic paraplegia 30, autosomal recessive	610357	MRD9	601255	2q37.3
Spastic paraplegia 31, autosomal dominant	610250	REEP1	609139	2p11.2
Spastic paraplegia 31, autosomal dominant	610250	C2ORF23	609139	2p11.2
Spastic paraplegia 31, autosomal dominant	610250	SPG31	609139	2p11.2
Spastic paraplegia 31, autosomal dominant	610250	HMN5B	609139	2p11.2
Spastic paraplegia 32, autosomal recessive	611252	SPG32		14q12-q21
Spastic paraplegia 33, autosomal dominant	610244	ZFYVE27	610243	10q24.2
Spastic paraplegia 33, autosomal dominant	610244	SPG33	610243	10q24.2
Spastic paraplegia 34, X-linked	300750	SPG34		Xq24-q25
Spastic paraplegia 35, autosomal recessive	612319	FA2H	611026	16q23.1
Spastic paraplegia 35, autosomal recessive	612319	FAAH	611026	16q23.1
Spastic paraplegia 35, autosomal recessive	612319	FAXDC1	611026	16q23.1
Spastic paraplegia 35, autosomal recessive	612319	FAH1	611026	16q23.1
Spastic paraplegia 35, autosomal recessive	612319	SCS7	611026	16q23.1
Spastic paraplegia 35, autosomal recessive	612319	SPG35	611026	16q23.1
Spastic paraplegia 36, autosomal dominant	613096	SPG36		12q23-q24
Spastic paraplegia 37, autosomal dominant	611945	SPG37		8p21.1-q13.3
Spastic paraplegia 38, autosomal dominant	612335	SPG38		4p16-p15
Spastic paraplegia 39, autosomal recessive	612020	PNPLA6	603197	19p13.2
Spastic paraplegia 39, autosomal recessive	612020	NTE	603197	19p13.2
Spastic paraplegia 39, autosomal recessive	612020	SPG39	603197	19p13.2
Spastic paraplegia 39, autosomal recessive	612020	NTEMND	603197	19p13.2
Spastic paraplegia 3A, autosomal dominant	182600	ATL1	606439	14q22.1
Spastic paraplegia 3A, autosomal dominant	182600	SPG3A	606439	14q22.1
Spastic paraplegia 3A, autosomal dominant	182600	HSN1D	606439	14q22.1
Spastic paraplegia 4, autosomal dominant	182601	SPAST	604277	2p22.3
Spastic paraplegia 4, autosomal dominant	182601	SPG4	604277	2p22.3
Spastic paraplegia 42, autosomal dominant	612539	SLC33A1	603690	3q25.31
Spastic paraplegia 42, autosomal dominant	612539	ACATN	603690	3q25.31
Spastic paraplegia 42, autosomal dominant	612539	AT1	603690	3q25.31
Spastic paraplegia 42, autosomal dominant	612539	SPG42	603690	3q25.31
Spastic paraplegia 42, autosomal dominant	612539	CCHLND	603690	3q25.31
Spastic paraplegia 44, autosomal recessive	613206	GJC2	608803	1q42.13
Spastic paraplegia 44, autosomal recessive	613206	GJA12	608803	1q42.13
Spastic paraplegia 44, autosomal recessive	613206	CX47	608803	1q42.13
Spastic paraplegia 44, autosomal recessive	613206	PMLDAR	608803	1q42.13
Spastic paraplegia 44, autosomal recessive	613206	HLD2	608803	1q42.13
Spastic paraplegia 44, autosomal recessive	613206	SPG44	608803	1q42.13
Spastic paraplegia 44, autosomal recessive	613206	LMPH1C	608803	1q42.13
Spastic paraplegia 45, autosomal recessive	613162	SPG45		10q24.3-q25.1
Spastic paraplegia 46, autosomal recessive	614409	GBA2	609471	9p13.3
Spastic paraplegia 46, autosomal recessive	614409	KIAA1605	609471	9p13.3
Spastic paraplegia 46, autosomal recessive	614409	SPG46	609471	9p13.3
Spastic paraplegia 47, autosomal recessive	614066	AP4B1	607245	1p13.2
Spastic paraplegia 47, autosomal recessive	614066	SPG47	607245	1p13.2
Spastic paraplegia 47, autosomal recessive	614066	CPSQ5	607245	1p13.2
Spastic paraplegia 48, autosomal recessive	613647	AP5Z1	613653	7p22.1
Spastic paraplegia 48, autosomal recessive	613647	KIAA0415	613653	7p22.1
Spastic paraplegia 48, autosomal recessive	613647	SPG48	613653	7p22.1
Spastic paraplegia 49, autosomal recessive	615031	TECPR2	615000	14q32.31
Spastic paraplegia 49, autosomal recessive	615031	KIAA0329	615000	14q32.31
Spastic paraplegia 49, autosomal recessive	615031	SPG49	615000	14q32.31
Spastic paraplegia 50, autosomal recessive	612936	AP4M1	602296	7q22.1
Spastic paraplegia 50, autosomal recessive	612936	SPG50	602296	7q22.1
Spastic paraplegia 50, autosomal recessive	612936	CPSQ3	602296	7q22.1
Spastic paraplegia 51, autosomal recessive	613744	AP4E1	607244	15q21.2
Spastic paraplegia 51, autosomal recessive	613744	SPG51	607244	15q21.2
Spastic paraplegia 51, autosomal recessive	613744	CPSQ4	607244	15q21.2
Spastic paraplegia 52, autosomal recessive	614067	AP4S1	607243	14q12
Spastic paraplegia 52, autosomal recessive	614067	CPSQ6	607243	14q12
Spastic paraplegia 52, autosomal recessive	614067	SPG52	607243	14q12
Spastic paraplegia 53, autosomal recessive	614898	VPS37A	609927	8p22
Spastic paraplegia 53, autosomal recessive	614898	HCRP1	609927	8p22
Spastic paraplegia 53, autosomal recessive	614898	SPG53	609927	8p22
Spastic paraplegia 54, autosomal recessive	615033	DDHD2	615003	8p11.23
Spastic paraplegia 54, autosomal recessive	615033	KIAA0725	615003	8p11.23
Spastic paraplegia 54, autosomal recessive	615033	SPG54	615003	8p11.23
Spastic paraplegia 55, autosomal recessive	615035	C12orf65	613541	12q24.31
Spastic paraplegia 55, autosomal recessive	615035	COXPD7	613541	12q24.31
Spastic paraplegia 55, autosomal recessive	615035	SPG55	613541	12q24.31
Spastic paraplegia 56, autosomal recessive	615030	CYP2U1	610670	4q25
Spastic paraplegia 56, autosomal recessive	615030	SPG56	610670	4q25
Spastic paraplegia 5A, autosomal recessive	270800	CYP7B1	603711	8q12.3
Spastic paraplegia 5A, autosomal recessive	270800	CBAS3	603711	8q12.3
Spastic paraplegia 5A, autosomal recessive	270800	SPG5A	603711	8q12.3
Spastic paraplegia 6, autosomal dominant	600363	NIPA1	608145	15q11.2
Spastic paraplegia 6, autosomal dominant	600363	SPG6	608145	15q11.2
Spastic paraplegia 7, autosomal recessive	607259	PGN	602783	16q24.3
Spastic paraplegia 7, autosomal recessive	607259	SPG7	602783	16q24.3
Spastic paraplegia 7, autosomal recessive	607259	CMAR	602783	16q24.3
Spastic paraplegia 7, autosomal recessive	607259	CAR	602783	16q24.3
Spastic paraplegia 8, autosomal dominant	603563	KIAA0196	610657	8q24.13
Spastic paraplegia 8, autosomal dominant	603563	SPG8	610657	8q24.13
Spastic paraplegia 8, autosomal dominant	603563	RTSC	610657	8q24.13
Spastic paraplegia 9, autosomal dominant	601162	SPG9		10q23.3-q24.1
Spastic paraplegia, optic atrophy, and neuropathy	609541	SPOAN		11q13
Specific granule deficiency	245480	CEBPE	600749	14q11.2
Specific granule deficiency	245480	CRP1	600749	14q11.2
Specific language impairment QTL, 1	606711	SLI1		16q
Specific language impairment QTL, 2	606712	SLI2		19q
Specific language impairment QTL, 3	607134	SLI3		13q21
Speech-language disorder-1	602081	FOXP2	605317	7q31.1
Speech-language disorder-1	602081	SPCH1	605317	7q31.1
Speech-language disorder-1	602081	TNRC10	605317	7q31.1
Speech-language disorder-1	602081	CAGH44	605317	7q31.1
Spermatocytic seminoma, somatic	273300	FGFR3	134934	4p16.3
Spermatocytic seminoma, somatic	273300	ACH	134934	4p16.3
Spermatogenic failure 10	614822	SEPT12	611562	16p13.3
Spermatogenic failure 10	614822	SPGF10	611562	16p13.3
Spermatogenic failure 11	615081	KLHL10	608778	17q21.2
Spermatogenic failure 11	615081	SPGF11	608778	17q21.2
Spermatogenic failure 12	615413	NANOS1	608226	10q26.11
Spermatogenic failure 12	615413	NOS1	608226	10q26.11
Spermatogenic failure 12	615413	SPGF12	608226	10q26.11
Spermatogenic failure 2	108420	SPGF2		Chr.1
Spermatogenic failure 2	108420	ASG		Chr.1
Spermatogenic failure 3	606766	SLC26A8	608480	6p21.31
Spermatogenic failure 3	606766	TAT1	608480	6p21.31
Spermatogenic failure 3	606766	SPGF3	608480	6p21.31
Spermatogenic failure 4	270960	SYCP3	604759	12q23.2
Spermatogenic failure 4	270960	SCP3	604759	12q23.2
Spermatogenic failure 4	270960	COR1	604759	12q23.2
Spermatogenic failure 4	270960	SPGF4	604759	12q23.2
Spermatogenic failure 5	243060	STK13	603495	19q13.43
Spermatogenic failure 5	243060	AIE2	603495	19q13.43
Spermatogenic failure 5	243060	SPGF5	603495	19q13.43
Spermatogenic failure 6	102530	SPATA16	609856	3q26.31
Spermatogenic failure 6	102530	SPGF6	609856	3q26.31
Spermatogenic failure 7	612997	CATSPER1	606389	11q13.1
Spermatogenic failure 7	612997	CATSPER	606389	11q13.1
Spermatogenic failure 7	612997	SPGF7	606389	11q13.1
Spermatogenic failure 8	613957	NR5A1	184757	9q33.3
Spermatogenic failure 8	613957	FTZF1	184757	9q33.3
Spermatogenic failure 8	613957	FTZ1	184757	9q33.3
Spermatogenic failure 8	613957	SF1	184757	9q33.3
Spermatogenic failure 8	613957	AD4BP	184757	9q33.3
Spermatogenic failure 8	613957	POF7	184757	9q33.3
Spermatogenic failure 8	613957	SRXY3	184757	9q33.3
Spermatogenic failure 8	613957	SPGF8	184757	9q33.3
Spermatogenic failure 9	613958	DPY19L2	613893	12q14.2
Spermatogenic failure 9	613958	SPGF9	613893	12q14.2
Spermatogenic failure, X-linked, 2		SPGFX2	309120	Chr.X
Spermatogenic failure, Y-linked, 1	400042	DELYq11		Yq11
Spermatogenic failure, Y-linked, 1	400042	CYDELq11		Yq11
Spermatogenic failure, Y-linked, 1	400042	SPGFY1		Yq11
Spermatogenic failure, Y-linked, 2	415000	USP9Y	400005	Yq11.21
Spermatogenic failure, Y-linked, 2	415000	DFFRY	400005	Yq11.21
Spermatogenic failure, Y-linked, 2	415000	SPGFY2	400005	Yq11.21
Spherocytosis, hereditary, type 5	612690	EPB42	177070	15q15.2
Spherocytosis, hereditary, type 5	612690	SPH5	177070	15q15.2
Spherocytosis, type 1	182900	ANK1	612641	8p11.21
Spherocytosis, type 1	182900	SPH2	612641	8p11.21
Spherocytosis, type 2	182870	SPTB		14q23.3
Spherocytosis, type 2	182870	SPH2		14q23.3
Spherocytosis, type 2	182870	EL3		14q23.3
Spherocytosis, type 2	182870	HS2		14q23.3
Spherocytosis, type 3	270970	SPTA1	182860	1q23.1
Spherocytosis, type 3	270970	EL2	182860	1q23.1
Spherocytosis, type 3	270970	SPH3	182860	1q23.1
Spherocytosis, type 3	270970	HS3	182860	1q23.1
Spherocytosis, type 3	270970	HPP	182860	1q23.1
Spherocytosis, type 4	612653	SLC4A1	109270	17q21.31
Spherocytosis, type 4	612653	AE1	109270	17q21.31
Spherocytosis, type 4	612653	EPB3	109270	17q21.31
Spiegler-Brooke syndrome	605041	SBS		16q12-q13
Spinal and bulbar muscular atrophy of Kennedy	313200	AR	313700	Xq12
Spinal and bulbar muscular atrophy of Kennedy	313200	DHTR	313700	Xq12
Spinal and bulbar muscular atrophy of Kennedy	313200	TFM	313700	Xq12
Spinal and bulbar muscular atrophy of Kennedy	313200	SBMA	313700	Xq12
Spinal and bulbar muscular atrophy of Kennedy	313200	KD	313700	Xq12
Spinal and bulbar muscular atrophy of Kennedy	313200	SMAX1	313700	Xq12
Spinal and bulbar muscular atrophy of Kennedy	313200	HYSP1	313700	Xq12
Spinal muscular atrophy with progressive myoclonic epilepsy	159950	ASAH1	613468	8p22
Spinal muscular atrophy with progressive myoclonic epilepsy	159950	AC	613468	8p22
Spinal muscular atrophy with progressive myoclonic epilepsy	159950	SMAPME	613468	8p22
Spinal muscular atrophy, Jokela type	615048	SMAJ		22q11.2-q13.2
Spinal muscular atrophy, X-linked 2, infantile	301830	UBA1	314370	Xp11.23
Spinal muscular atrophy, X-linked 2, infantile	301830	UBE1	314370	Xp11.23
Spinal muscular atrophy, X-linked 2, infantile	301830	GXP1	314370	Xp11.23
Spinal muscular atrophy, X-linked 2, infantile	301830	A1ST	314370	Xp11.23
Spinal muscular atrophy, X-linked 2, infantile	301830	SMAX2	314370	Xp11.23
Spinal muscular atrophy, X-linked 2, infantile	301830	AMCX1	314370	Xp11.23
Spinal muscular atrophy, chronic distal, autosomal recessive	607088	SMAR		11q13
Spinal muscular atrophy, distal, X-linked 3	300489	ATP7A	300011	Xq21.1
Spinal muscular atrophy, distal, X-linked 3	300489	MNK	300011	Xq21.1
Spinal muscular atrophy, distal, X-linked 3	300489	MK	300011	Xq21.1
Spinal muscular atrophy, distal, X-linked 3	300489	OHS	300011	Xq21.1
Spinal muscular atrophy, distal, X-linked 3	300489	SMAX3	300011	Xq21.1
Spinal muscular atrophy, distal, autosomal recessive, 4	611067	PLEKHG5	611101	1p36.31
Spinal muscular atrophy, distal, autosomal recessive, 4	611067	KIAA0720	611101	1p36.31
Spinal muscular atrophy, distal, autosomal recessive, 4	611067	DSMA4	611101	1p36.31
Spinal muscular atrophy, distal, autosomal recessive, 4	611067	CMTRIC	611101	1p36.31
Spinal muscular atrophy, distal, autosomal recessive, 5	614881	DNAJB2	604139	2q35
Spinal muscular atrophy, distal, autosomal recessive, 5	614881	HSJ1	604139	2q35
Spinal muscular atrophy, distal, autosomal recessive, 5	614881	HSPF3	604139	2q35
Spinal muscular atrophy, distal, autosomal recessive, 5	614881	DSMA5	604139	2q35
Spinal muscular atrophy, distal, congenital nonprogressive	600175	TRPV4	605427	12q24.11
Spinal muscular atrophy, distal, congenital nonprogressive	600175	VROAC	605427	12q24.11
Spinal muscular atrophy, distal, congenital nonprogressive	600175	HMSN2C	605427	12q24.11
Spinal muscular atrophy, distal, congenital nonprogressive	600175	CMT2C	605427	12q24.11
Spinal muscular atrophy, distal, congenital nonprogressive	600175	SPSMA	605427	12q24.11
Spinal muscular atrophy, distal, congenital nonprogressive	600175	SSQTL1	605427	12q24.11
Spinal muscular atrophy, distal, congenital nonprogressive	600175	SMAL	605427	12q24.11
Spinal muscular atrophy, late-onset, Finkel type	182980	VAPB	605704	20q13.32
Spinal muscular atrophy, late-onset, Finkel type	182980	VAPC	605704	20q13.32
Spinal muscular atrophy, late-onset, Finkel type	182980	ALS8	605704	20q13.32
Spinal muscular atrophy, lower extremity-predominant, 2, AD	615290	BICD2	609797	9q22.31
Spinal muscular atrophy, lower extremity-predominant, 2, AD	615290	KIAA0699	609797	9q22.31
Spinal muscular atrophy, lower extremity-predominant, 2, AD	615290	SMALED2	609797	9q22.31
Spinal muscular atrophy, lower extremity-predominant, AD	158600	DYNC1H1	600112	14q32.31
Spinal muscular atrophy, lower extremity-predominant, AD	158600	DNCL	600112	14q32.31
Spinal muscular atrophy, lower extremity-predominant, AD	158600	DNECL	600112	14q32.31
Spinal muscular atrophy, lower extremity-predominant, AD	158600	CMT20	600112	14q32.31
Spinal muscular atrophy, lower extremity-predominant, AD	158600	MRD13	600112	14q32.31
Spinal muscular atrophy, lower extremity-predominant, AD	158600	SMALED1	600112	14q32.31
Spinal muscular atrophy-1	253300	SMN1	600354	5q13.2
Spinal muscular atrophy-1	253300	SMA1	600354	5q13.2
Spinal muscular atrophy-1	253300	SMA2	600354	5q13.2
Spinal muscular atrophy-1	253300	SMA3	600354	5q13.2
Spinal muscular atrophy-1	253300	SMA4	600354	5q13.2
Spinal muscular atrophy-2	253550	SMN1	600354	5q13.2
Spinal muscular atrophy-2	253550	SMA1	600354	5q13.2
Spinal muscular atrophy-2	253550	SMA2	600354	5q13.2
Spinal muscular atrophy-2	253550	SMA3	600354	5q13.2
Spinal muscular atrophy-2	253550	SMA4	600354	5q13.2
Spinal muscular atrophy-3	253400	SMN1	600354	5q13.2
Spinal muscular atrophy-3	253400	SMA1	600354	5q13.2
Spinal muscular atrophy-3	253400	SMA2	600354	5q13.2
Spinal muscular atrophy-3	253400	SMA3	600354	5q13.2
Spinal muscular atrophy-3	253400	SMA4	600354	5q13.2
Spinal muscular atrophy-4	271150	SMN1	600354	5q13.2
Spinal muscular atrophy-4	271150	SMA1	600354	5q13.2
Spinal muscular atrophy-4	271150	SMA2	600354	5q13.2
Spinal muscular atrophy-4	271150	SMA3	600354	5q13.2
Spinal muscular atrophy-4	271150	SMA4	600354	5q13.2
Spinocerebellar ataxia 1	164400	ATXN1	601556	6p22.3
Spinocerebellar ataxia 1	164400	ATX1	601556	6p22.3
Spinocerebellar ataxia 1	164400	SCA1	601556	6p22.3
Spinocerebellar ataxia 10	603516	ATXN10	611150	22q13.31
Spinocerebellar ataxia 10	603516	SCA10	611150	22q13.31
Spinocerebellar ataxia 11	604432	TTBK2	611695	15q15.2
Spinocerebellar ataxia 11	604432	SCA11	611695	15q15.2
Spinocerebellar ataxia 12	604326	PPP2R2B	604325	5q32
Spinocerebellar ataxia 13	605259	KCNC3	176264	19q13.33
Spinocerebellar ataxia 13	605259	SCA13	176264	19q13.33
Spinocerebellar ataxia 14	605361	PRKCG	176980	19q13.42
Spinocerebellar ataxia 14	605361	PKCC	176980	19q13.42
Spinocerebellar ataxia 14	605361	PKCG	176980	19q13.42
Spinocerebellar ataxia 14	605361	SCA14	176980	19q13.42
Spinocerebellar ataxia 15	606658	ITPR1	147265	3p26.1
Spinocerebellar ataxia 15	606658	SCA15	147265	3p26.1
Spinocerebellar ataxia 15	606658	SCA16	147265	3p26.1
Spinocerebellar ataxia 15	606658	SCA29	147265	3p26.1
Spinocerebellar ataxia 17	607136	TBP	600075	6q27
Spinocerebellar ataxia 17	607136	SCA17	600075	6q27
Spinocerebellar ataxia 17	607136	HDL4	600075	6q27
Spinocerebellar ataxia 18	607458	SCA18		7q22-q32
Spinocerebellar ataxia 18	607458	SMNA		7q22-q32
Spinocerebellar ataxia 19	607346	KCND3	605411	1p13.2
Spinocerebellar ataxia 19	607346	KCND3S	605411	1p13.2
Spinocerebellar ataxia 19	607346	KCND3L	605411	1p13.2
Spinocerebellar ataxia 19	607346	SCA19	605411	1p13.2
Spinocerebellar ataxia 19	607346	SCA22	605411	1p13.2
Spinocerebellar ataxia 2	183090	ATXN2	601517	12q24.12
Spinocerebellar ataxia 2	183090	ATX2	601517	12q24.12
Spinocerebellar ataxia 2	183090	SCA2	601517	12q24.12
Spinocerebellar ataxia 2	183090	ASL13	601517	12q24.12
Spinocerebellar ataxia 20	608687	SCA20		11q12
Spinocerebellar ataxia 20	608687	DUP11q12		11q12
Spinocerebellar ataxia 20	608687	C11DUPq12		11q12
Spinocerebellar ataxia 21	607454	SCA21		7p21.3-p15.1
Spinocerebellar ataxia 23	610245	PDYN	131340	20p13
Spinocerebellar ataxia 23	610245	SCA23	131340	20p13
Spinocerebellar ataxia 25	608703	SCA25		2p21-p13
Spinocerebellar ataxia 27	609307	FGF14	601515	13q33.1
Spinocerebellar ataxia 27	609307	FHF4	601515	13q33.1
Spinocerebellar ataxia 27	609307	SCA27	601515	13q33.1
Spinocerebellar ataxia 28	610246	AFG3L2	604581	18p11.21
Spinocerebellar ataxia 28	610246	SCA28	604581	18p11.21
Spinocerebellar ataxia 28	610246	SPAX5	604581	18p11.21
Spinocerebellar ataxia 29, congenital nonprogressive	117360	ITPR1	147265	3p26.1
Spinocerebellar ataxia 29, congenital nonprogressive	117360	SCA15	147265	3p26.1
Spinocerebellar ataxia 29, congenital nonprogressive	117360	SCA16	147265	3p26.1
Spinocerebellar ataxia 29, congenital nonprogressive	117360	SCA29	147265	3p26.1
Spinocerebellar ataxia 31	117210	BEAN	612051	16q21
Spinocerebellar ataxia 31	117210	SCA31	612051	16q21
Spinocerebellar ataxia 32	613909	SCA32		7q32-q33
Spinocerebellar ataxia 34	133190	SCA34		6p12.3-q16.2
Spinocerebellar ataxia 35	613908	TGM6	613900	20p13
Spinocerebellar ataxia 35	613908	TG6	613900	20p13
Spinocerebellar ataxia 35	613908	TGY	613900	20p13
Spinocerebellar ataxia 35	613908	SCA35	613900	20p13
Spinocerebellar ataxia 36	614153	NOP56	614154	20p13
Spinocerebellar ataxia 36	614153	SCA36	614154	20p13
Spinocerebellar ataxia 4	600223	SCA4		16q22.1
Spinocerebellar ataxia 5	600224	SPTBN2	604985	11q13.2
Spinocerebellar ataxia 5	600224	SCA5	604985	11q13.2
Spinocerebellar ataxia 5	600224	SCAR14	604985	11q13.2
Spinocerebellar ataxia 6	183086	CACNA1A	601011	19p13.2
Spinocerebellar ataxia 6	183086	CACNL1A4	601011	19p13.2
Spinocerebellar ataxia 6	183086	SCA6	601011	19p13.2
Spinocerebellar ataxia 7	164500	ATXN7	607640	3p14.1
Spinocerebellar ataxia 7	164500	SCA7	607640	3p14.1
Spinocerebellar ataxia 7	164500	OPCA3	607640	3p14.1
Spinocerebellar ataxia 8	608768	ATXN8OS	603680	13q21.33
Spinocerebellar ataxia 8	608768	SCA8	603680	13q21.33
Spinocerebellar ataxia 8	608768	KLHL1AS	603680	13q21.33
Spinocerebellar ataxia 8	608768	ATXN8	613289	13q21
Spinocerebellar ataxia, X-linked 1	302500	SCAX1		Xp11.21-q21.3
Spinocerebellar ataxia, X-linked 1	302500	CLA2		Xp11.21-q21.3
Spinocerebellar ataxia, X-linked 1	302500	OPCA		Xp11.21-q21.3
Spinocerebellar ataxia, X-linked 5	300703	SCAX5		Xq25-q27.1
Spinocerebellar ataxia, autosomal recessive 10	613728	ANO10	613726	3p22.1
Spinocerebellar ataxia, autosomal recessive 10	613728	TMEM16K	613726	3p22.1
Spinocerebellar ataxia, autosomal recessive 10	613728	SCAR10	613726	3p22.1
Spinocerebellar ataxia, autosomal recessive 11	614229	SYT14	610949	1q32.2
Spinocerebellar ataxia, autosomal recessive 11	614229	SCAR11	610949	1q32.2
Spinocerebellar ataxia, autosomal recessive 12	614322	SCAR12		16q21-q23
Spinocerebellar ataxia, autosomal recessive 13	614831	GRM1	604473	6q24.3
Spinocerebellar ataxia, autosomal recessive 13	614831	MGLUR1	604473	6q24.3
Spinocerebellar ataxia, autosomal recessive 13	614831	GRM1A	604473	6q24.3
Spinocerebellar ataxia, autosomal recessive 13	614831	SCAR13	604473	6q24.3
Spinocerebellar ataxia, autosomal recessive 14	615386	SPTBN2	604985	11q13.2
Spinocerebellar ataxia, autosomal recessive 14	615386	SCA5	604985	11q13.2
Spinocerebellar ataxia, autosomal recessive 14	615386	SCAR14	604985	11q13.2
Spinocerebellar ataxia, autosomal recessive 2	213200	SCAR2		9q34-qter
Spinocerebellar ataxia, autosomal recessive 2	213200	CPD3		9q34-qter
Spinocerebellar ataxia, autosomal recessive 3	271250	SCAR3		6p23-p21
Spinocerebellar ataxia, autosomal recessive 3	271250	SCABD		6p23-p21
Spinocerebellar ataxia, autosomal recessive 4	607317	SCAR4		1p36
Spinocerebellar ataxia, autosomal recessive 4	607317	SCASI		1p36
Spinocerebellar ataxia, autosomal recessive 5	606937	ZNF592	613624	15q25.3
Spinocerebellar ataxia, autosomal recessive 5	606937	KIAA0211	613624	15q25.3
Spinocerebellar ataxia, autosomal recessive 5	606937	SCAR5	613624	15q25.3
Spinocerebellar ataxia, autosomal recessive 5	606937	CAMOS	613624	15q25.3
Spinocerebellar ataxia, autosomal recessive 6	608029	SCAR6		20q11-q13
Spinocerebellar ataxia, autosomal recessive 6	608029	CLA3		20q11-q13
Spinocerebellar ataxia, autosomal recessive 7	609270	TPP1	607998	11p15.4
Spinocerebellar ataxia, autosomal recessive 7	609270	CLN2	607998	11p15.4
Spinocerebellar ataxia, autosomal recessive 7	609270	SCAR7	607998	11p15.4
Spinocerebellar ataxia, autosomal recessive 8	610743	SYNE1	608441	6q25.1-q25.2
Spinocerebellar ataxia, autosomal recessive 8	610743	KIAA0796	608441	6q25.1-q25.2
Spinocerebellar ataxia, autosomal recessive 8	610743	KIAA1756	608441	6q25.1-q25.2
Spinocerebellar ataxia, autosomal recessive 8	610743	KIAA1262	608441	6q25.1-q25.2
Spinocerebellar ataxia, autosomal recessive 8	610743	SCAR8	608441	6q25.1-q25.2
Spinocerebellar ataxia, autosomal recessive 8	610743	EDMD4	608441	6q25.1-q25.2
Spinocerebellar ataxia, autosomal recessive with axonal neuropathy	607250	TDP1	607198	14q32.11
Split hand/foot malformation 1	183600	SHFM1		7q21.2-q21.3
Split hand/foot malformation 1	183600	SHFD1		7q21.2-q21.3
Split hand/foot malformation 1	183600	SHSF1		7q21.2-q21.3
Split hand/foot malformation 2	313350	SHFM2		Xq26
Split hand/foot malformation 2	313350	SHFD2		Xq26
Split-hand/foot malformation 3, gene duplication syndrome	246560	SHFM3		10q24
Split-hand/foot malformation 3, gene duplication syndrome	246560	SHSF3		10q24
Split-hand/foot malformation 3, gene duplication syndrome	246560	DUP10q24		10q24
Split-hand/foot malformation 3, gene duplication syndrome	246560	C10DUPq24		10q24
Split-hand/foot malformation 4	605289	TP63	603273	3q28
Split-hand/foot malformation 4	605289	TP73L	603273	3q28
Split-hand/foot malformation 4	605289	KET	603273	3q28
Split-hand/foot malformation 4	605289	EEC3	603273	3q28
Split-hand/foot malformation 4	605289	SHFM4	603273	3q28
Split-hand/foot malformation 4	605289	LMS	603273	3q28
Split-hand/foot malformation 4	605289	RHS	603273	3q28
Split-hand/foot malformation 4	605289	OFC8	603273	3q28
Split-hand/foot malformation 5	606708	SHFM5		2q31
Split-hand/foot malformation 6	225300	WNT10B	601906	12q13.12
Split-hand/foot malformation 6	225300	SHFM6	601906	12q13.12
Split-hand/foot malformation with long bone deficiency 1	119100	SHFL1		1q42.2-q43
Split-hand/foot malformation with long bone deficiency 1	119100	SHFLD		1q42.2-q43
Split-hand/foot malformation with long bone deficiency 2	610685	SHFLD2		6q14.1
Split-hand/foot malformation with long bone deficiency 3	612576	SHFLD3		17p13.3-p13.1
Spondylo-megaepiphyseal-metaphyseal dysplasia	613330	NKX3-2	602183	4p15.33
Spondylo-megaepiphyseal-metaphyseal dysplasia	613330	BAPX1	602183	4p15.33
Spondylo-megaepiphyseal-metaphyseal dysplasia	613330	SMMD	602183	4p15.33
Spondylocarpotarsal synostosis syndrome	272460	FLNB	603381	3p14.3
Spondylocarpotarsal synostosis syndrome	272460	SCT	603381	3p14.3
Spondylocarpotarsal synostosis syndrome	272460	AOI	603381	3p14.3
Spondylocarpotarsal synostosis syndrome	272460	LRS1	603381	3p14.3
Spondylocheirodysplasia, Ehlers-Danlos syndrome-like	612350	SLC39A13	608735	11p11.2
Spondylocostal dysostosis 1, autosomal recessive	277300	DLL3	602768	19q13.2
Spondylocostal dysostosis 1, autosomal recessive	277300	SCDO1	602768	19q13.2
Spondylocostal dysostosis 2, autosomal recessive	608681	MESP2	605195	15q26.1
Spondylocostal dysostosis 2, autosomal recessive	608681	SCDO2	605195	15q26.1
Spondylocostal dysostosis 3, autosomal recessive	609813	LFNG	602576	7p22.3
Spondylocostal dysostosis 3, autosomal recessive	609813	SCDO3	602576	7p22.3
Spondylocostal dysostosis 4, autosomal recessive	613686	HES7	608059	17p13.1
Spondylocostal dysostosis 4, autosomal recessive	613686	SCDO4	608059	17p13.1
Spondyloenchondrodysplasia with immune dysregulation	607944	ACP5	171640	19p13.2
Spondyloenchondrodysplasia with immune dysregulation	607944	SPENCDI	171640	19p13.2
Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	271640	B3GALT6	615291	1p36.33
Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	271640	SEMDJL1	615291	1p36.33
Spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures	271640	EDSP2	615291	1p36.33
Spondyloepimetaphyseal dysplasia with joint laxity, type 2	603546	KIF22	603213	16p11.2
Spondyloepimetaphyseal dysplasia with joint laxity, type 2	603546	KNSL4	603213	16p11.2
Spondyloepimetaphyseal dysplasia with joint laxity, type 2	603546	KID	603213	16p11.2
Spondyloepimetaphyseal dysplasia with joint laxity, type 2	603546	OBP	603213	16p11.2
Spondyloepimetaphyseal dysplasia with joint laxity, type 2	603546	SEMDJL2	603213	16p11.2
Spondyloepimetaphyseal dysplasia	608728	MATN3	602109	2p24.1
Spondyloepimetaphyseal dysplasia	608728	EDM5	602109	2p24.1
Spondyloepimetaphyseal dysplasia	608728	HOA	602109	2p24.1
Spondyloepimetaphyseal dysplasia	608728	OS2	602109	2p24.1
Spondyloepimetaphyseal dysplasia, Missouri type	602111	MMP13	600108	11q22.2
Spondyloepimetaphyseal dysplasia, Missouri type	602111	CLG3	600108	11q22.2
Spondyloepimetaphyseal dysplasia, Missouri type	602111	MANDP1	600108	11q22.2
Spondyloepimetaphyseal dysplasia, aggrecan type	612813	ACAN	155760	15q26.1
Spondyloepimetaphyseal dysplasia, aggrecan type	612813	AGC1	155760	15q26.1
Spondyloepimetaphyseal dysplasia, aggrecan type	612813	CSPG1	155760	15q26.1
Spondyloepimetaphyseal dysplasia, aggrecan type	612813	MSK16	155760	15q26.1
Spondyloepimetaphyseal dysplasia, aggrecan type	612813	SEDK	155760	15q26.1
Spondyloepiphyseal dysplasia tarda with progressive arthropathy	208230	WISP3	603400	6q21
Spondyloepiphyseal dysplasia tarda with progressive arthropathy	208230	PPAC	603400	6q21
Spondyloepiphyseal dysplasia tarda with progressive arthropathy	208230	PPD	603400	6q21
Spondyloepiphyseal dysplasia tarda	313400	TRAPPC2	300202	Xp22.2
Spondyloepiphyseal dysplasia tarda	313400	SEDL	300202	Xp22.2
Spondyloepiphyseal dysplasia tarda	313400	SEDT	300202	Xp22.2
Spondyloepiphyseal dysplasia with congenital joint dislocations	143095	CHST3	603799	10q22.1
Spondyloepiphyseal dysplasia with congenital joint dislocations	143095	C6ST	603799	10q22.1
Spondyloepiphyseal dysplasia with congenital joint dislocations	143095	C6ST1	603799	10q22.1
Spondyloepiphyseal dysplasia with congenital joint dislocations	143095	HSD	603799	10q22.1
Spondyloepiphyseal dysplasia, Kimberley type	608361	ACAN	155760	15q26.1
Spondyloepiphyseal dysplasia, Kimberley type	608361	AGC1	155760	15q26.1
Spondyloepiphyseal dysplasia, Kimberley type	608361	CSPG1	155760	15q26.1
Spondyloepiphyseal dysplasia, Kimberley type	608361	MSK16	155760	15q26.1
Spondyloepiphyseal dysplasia, Kimberley type	608361	SEDK	155760	15q26.1
Spondylometaepiphyseal dysplasia, short limb-hand type	271665	DDR2	191311	1q23.3
Spondylometaepiphyseal dysplasia, short limb-hand type	271665	NTRKR3	191311	1q23.3
Spondylometaepiphyseal dysplasia, short limb-hand type	271665	TKT	191311	1q23.3
Spondylometaphyseal dysplasia, Kozlowski type	184252	TRPV4	605427	12q24.11
Spondylometaphyseal dysplasia, Kozlowski type	184252	VROAC	605427	12q24.11
Spondylometaphyseal dysplasia, Kozlowski type	184252	HMSN2C	605427	12q24.11
Spondylometaphyseal dysplasia, Kozlowski type	184252	CMT2C	605427	12q24.11
Spondylometaphyseal dysplasia, Kozlowski type	184252	SPSMA	605427	12q24.11
Spondylometaphyseal dysplasia, Kozlowski type	184252	SSQTL1	605427	12q24.11
Spondylometaphyseal dysplasia, Kozlowski type	184252	SMAL	605427	12q24.11
Spondyloperipheral dysplasia	271700	COL2A1	120140	12q13.11
Squamous cell carcinoma, burn scar-related, somatic		TNFRSF6	134637	10q23.31
Squamous cell carcinoma, burn scar-related, somatic		APT1	134637	10q23.31
Squamous cell carcinoma, burn scar-related, somatic		FAS	134637	10q23.31
Squamous cell carcinoma, burn scar-related, somatic		CD95	134637	10q23.31
Squamous cell carcinoma, burn scar-related, somatic		ALPS1A	134637	10q23.31
Squamous cell carcinoma, head and neck	275355	TNFRSF10B	603612	8p21.3
Squamous cell carcinoma, head and neck	275355	DR5	603612	8p21.3
Squamous cell carcinoma, head and neck	275355	TRAILR2	603612	8p21.3
Squamous cell carcinoma, head and neck, somatic	275355	ING1	601566	13q34
Squamous cell carcinoma, head and neck, somatic	275355	PTEN	601728	10q23.31
Squamous cell carcinoma, head and neck, somatic	275355	MMAC1	601728	10q23.31
Squamous cell carcinoma, head and neck, somatic	275355	GLM2	601728	10q23.31
Squamous cell carcinoma, head and neck, somatic	275355	CWS1	601728	10q23.31
Stapes ankylosis with broad thumb and toes	184460	NOG	602991	17q22
Stapes ankylosis with broad thumb and toes	184460	SYM1	602991	17q22
Stapes ankylosis with broad thumb and toes	184460	SYNS1	602991	17q22
Stargardt disease 1	248200	ABCA4	601691	1p22.1
Stargardt disease 1	248200	ABCR	601691	1p22.1
Stargardt disease 1	248200	STGD1	601691	1p22.1
Stargardt disease 1	248200	FFM	601691	1p22.1
Stargardt disease 1	248200	RP19	601691	1p22.1
Stargardt disease 1	248200	CORD3	601691	1p22.1
Stargardt disease 1	248200	ARMD2	601691	1p22.1
Stargardt disease 3	600110	ELOVL4	605512	6q14.1
Stargardt disease 3	600110	ADMD	605512	6q14.1
Stargardt disease 3	600110	STGD2	605512	6q14.1
Stargardt disease 3	600110	STGD3	605512	6q14.1
Stargardt disease 3	600110	ISQMR	605512	6q14.1
Stargardt disease 4	603786	STGD4		4p
Stargardt disease 4	603786	PROM1	604365	4p15.32
Stargardt disease 4	603786	PROML1	604365	4p15.32
Stargardt disease 4	603786	AC133	604365	4p15.32
Stargardt disease 4	603786	RP41	604365	4p15.32
Stargardt disease 4	603786	CORD12	604365	4p15.32
Stargardt disease 4	603786	CD133	604365	4p15.32
Stargardt disease 4	603786	MCDR2	604365	4p15.32
Stargardt disease 4	603786	STGD4	604365	4p15.32
Steatocystoma multiplex	184500	KRT17	148069	17q21.2
Steatocystoma multiplex	184500	PC2	148069	17q21.2
Steatocystoma multiplex	184500	PCHC1	148069	17q21.2
Stickler sydrome, type I, nonsyndromic ocular	609508	COL2A1	120140	12q13.11
Stickler syndrome, type I	108300	COL2A1	120140	12q13.11
Stickler syndrome, type II	604841	COL11A1	120280	1p21.1
Stickler syndrome, type II	604841	STL2	120280	1p21.1
Stickler syndrome, type III	184840	COL11A2	120290	6p21.32
Stickler syndrome, type III	184840	STL3	120290	6p21.32
Stickler syndrome, type III	184840	DFNA13	120290	6p21.32
Stickler syndrome, type III	184840	DFNB53	120290	6p21.32
Stickler syndrome, type III	184840	FBCG2	120290	6p21.32
Stickler syndrome, type IV	614134	COL9A1	120210	6q13
Stickler syndrome, type IV	614134	EDM6	120210	6q13
Stickler syndrome, type IV	614134	STL4	120210	6q13
Stickler syndrome, type V	614284	COL9A2	120260	1p34.2
Stickler syndrome, type V	614284	EDM2	120260	1p34.2
Stickler syndrome, type V	614284	STL5	120260	1p34.2
Stiff skin syndrome	184900	FBN1	134797	15q21.1
Stiff skin syndrome	184900	MFS1	134797	15q21.1
Stiff skin syndrome	184900	WMS2	134797	15q21.1
Stiff skin syndrome	184900	SSKS	134797	15q21.1
Stiff skin syndrome	184900	GPHYSD2	134797	15q21.1
Stiff skin syndrome	184900	ACMICD	134797	15q21.1
Stiff skin syndrome	184900	ECTOL1	134797	15q21.1
Stocco dos Santos X-linked mental retardation syndrome	300434	SHROOM4	300579	Xp11.22
Stocco dos Santos X-linked mental retardation syndrome	300434	KIAA1202	300579	Xp11.22
Stocco dos Santos X-linked mental retardation syndrome	300434	SDSX	300579	Xp11.22
Striatal degeneration, autosomal dominant	609161	PDE8B	603390	5q13.3
Striatal degeneration, autosomal dominant	609161	PPNAD3	603390	5q13.3
Striatal degeneration, autosomal dominant	609161	ADSD	603390	5q13.3
Striatonigral degeneration, infantile	271930	NUP62	605815	19q13.33
Striatonigral degeneration, infantile	271930	SNDI	605815	19q13.33
Striatonigral degeneration, infantile	271930	IBSN	605815	19q13.33
Sturge-Weber syndrome, somatic, mosaic	185300	GNAQ	600998	9q21.2
Sturge-Weber syndrome, somatic, mosaic	185300	SWS	600998	9q21.2
Sturge-Weber syndrome, somatic, mosaic	185300	CMC1	600998	9q21.2
Stuttering, familial persistent 1	184450	STUT1		18p11.3-p11.2
Stuttering, familial persistent 2	609261	STUT2		12q24.1
Stuttering, familial persistent, 3	614655	STUT3		3q13.2-q13.33
Stuttering, familial persistent, 4	614668	STUT4		16q12.1-q23.1
Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	601559	LIFR	151443	5p13.1
Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	601559	STWS	151443	5p13.1
Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	601559	SWS	151443	5p13.1
Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome	601559	SJS2	151443	5p13.1
Subcortical laminal heteropia, X-linked	300067	DCX	300121	Xq23
Subcortical laminal heteropia, X-linked	300067	DBCN	300121	Xq23
Subcortical laminal heteropia, X-linked	300067	LISX	300121	Xq23
Subcortical laminar heterotopia	607432	PAFAH1B1	601545	17p13.3
Subcortical laminar heterotopia	607432	LIS1	601545	17p13.3
Succinic semialdehyde dehydrogenase deficiency	271980	ALDH5A1	610045	6p22.3
Succinic semialdehyde dehydrogenase deficiency	271980	SSADH	610045	6p22.3
Succinyl CoA:3-oxoacid CoA transferase deficiency	245050	OXCT1	601424	5p13.1
Succinyl CoA:3-oxoacid CoA transferase deficiency	245050	OXCT	601424	5p13.1
Succinyl CoA:3-oxoacid CoA transferase deficiency	245050	SCOT	601424	5p13.1
Sucrase-isomaltase deficiency, congenital	222900	SI	609845	3q26.1
Sudden infant death with dysgenesis of the testes syndrome	608800	TSPYL1	604714	6q22.1
Sudden infant death with dysgenesis of the testes syndrome	608800	TSPYL	604714	6q22.1
Sudden infant death with dysgenesis of the testes syndrome	608800	SIDDT	604714	6q22.1
Sulfite oxidase deficiency	272300	SUOX	606887	12q13.2
Supernumerary der(22)t(8-22) syndrome	613700	DER22t8-22		22q11.2
Supranuclear palsy, progressive atypical	260540	MAPT	157140	17q21.31
Supranuclear palsy, progressive atypical	260540	MTBT1	157140	17q21.31
Supranuclear palsy, progressive atypical	260540	DDPAC	157140	17q21.31
Supranuclear palsy, progressive atypical	260540	MSTD	157140	17q21.31
Supranuclear palsy, progressive, 2	609454	PSNP2		1q31.1
Supranuclear palsy, progressive, 3	610898	PSNP3		11p12-p11
Supranuclear palsy, progressive	601104	MAPT	157140	17q21.31
Supranuclear palsy, progressive	601104	MTBT1	157140	17q21.31
Supranuclear palsy, progressive	601104	DDPAC	157140	17q21.31
Supranuclear palsy, progressive	601104	MSTD	157140	17q21.31
Supravalvar aortic stenosis	185500	ELN	130160	7q11.23
Surfactant metabolism dysfunction, pulmonary, 1	265120	SFTPB	178640	2p11.2
Surfactant metabolism dysfunction, pulmonary, 1	265120	SFTB3	178640	2p11.2
Surfactant metabolism dysfunction, pulmonary, 1	265120	SMDP1	178640	2p11.2
Surfactant metabolism dysfunction, pulmonary, 2	610913	SFTPC	178620	8p21.3
Surfactant metabolism dysfunction, pulmonary, 2	610913	SFTP2	178620	8p21.3
Surfactant metabolism dysfunction, pulmonary, 2	610913	SMDP2	178620	8p21.3
Surfactant metabolism dysfunction, pulmonary, 3	610921	ABCA3	601615	16p13.3
Surfactant metabolism dysfunction, pulmonary, 3	610921	ABC3	601615	16p13.3
Surfactant metabolism dysfunction, pulmonary, 3	610921	SMDP3	601615	16p13.3
Surfactant metabolism dysfunction, pulmonary, 4	300770	CSF2RA	306250	Xp22.33
Surfactant metabolism dysfunction, pulmonary, 4	300770	SMDP4	306250	Xp22.33
Surfactant metabolism dysfunction, pulmonary, 5	614370	CSF2RB	138981	22q12.3
Surfactant metabolism dysfunction, pulmonary, 5	614370	SMDP5	138981	22q12.3
Sveinsson choreoretinal atrophy	108985	TEAD1	189967	11p15.3-p15.2
Sveinsson choreoretinal atrophy	108985	TCF13	189967	11p15.3-p15.2
Sveinsson choreoretinal atrophy	108985	REF1	189967	11p15.3-p15.2
Sweat chloride elevation without CF		CFTR	602421	7q31.2
Sweat chloride elevation without CF		ABCC7	602421	7q31.2
Sweat chloride elevation without CF		CF	602421	7q31.2
Sweat chloride elevation without CF		MRP7	602421	7q31.2
Symphalangism, proximal	185800	NOG	602991	17q22
Symphalangism, proximal	185800	SYM1	602991	17q22
Symphalangism, proximal	185800	SYNS1	602991	17q22
Symphalangism, proximal, 1B	615298	GDF5	601146	20q11.22
Symphalangism, proximal, 1B	615298	CDMP1	601146	20q11.22
Symphalangism, proximal, 1B	615298	SYNS2	601146	20q11.22
Symphalangism, proximal, 1B	615298	OS5	601146	20q11.22
Symphalangism, proximal, 1B	615298	BDA1C	601146	20q11.22
Symphalangism, proximal, 1B	615298	SYM1B	601146	20q11.22
Syndactyly, type 1	185900	CUP2q35		2q34-q36
Syndactyly, type 1	185900	C2DUPq35		2q34-q36
Syndactyly, type 1	185900	SDTY1		2q34-q36
Syndactyly, type 1	185900	SD1		2q34-q36
Syndactyly, type III	186100	GJA1	121014	6q22.31
Syndactyly, type III	186100	CX43	121014	6q22.31
Syndactyly, type III	186100	ODDD	121014	6q22.31
Syndactyly, type III	186100	SDTY3	121014	6q22.31
Syndactyly, type III	186100	ODOD	121014	6q22.31
Syndactyly, type III	186100	HSS	121014	6q22.31
Syndactyly, type III	186100	AVSD3	121014	6q22.31
Syndactyly, type III	186100	HLHS1	121014	6q22.31
Syndactyly, type III	186100	CMDR	121014	6q22.31
Syndactyly, type IV	186200	LMBR1	605522	7q36.3
Syndactyly, type IV	186200	ACHP	605522	7q36.3
Syndactyly, type IV	186200	C7orf2	605522	7q36.3
Syndactyly, type IV	186200	PPD2	605522	7q36.3
Syndactyly, type V	186300	HOXD13	142989	2q31.1
Syndactyly, type V	186300	HOX4I	142989	2q31.1
Syndactyly, type V	186300	SPD	142989	2q31.1
Syndactyly, type V	186300	BDSD	142989	2q31.1
Synesthesia	612759	SYNSTH		2q24.1
Synpolydactyly 3	610234	SPD3		14q11.2-q12
Synpolydactyly with foot anomalies	186000	HOXD13	142989	2q31.1
Synpolydactyly with foot anomalies	186000	HOX4I	142989	2q31.1
Synpolydactyly with foot anomalies	186000	SPD	142989	2q31.1
Synpolydactyly with foot anomalies	186000	BDSD	142989	2q31.1
Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses	608180	FBLN1	135820	22q13.31
Synpolydactyly, type II	186000	HOXD13	142989	2q31.1
Synpolydactyly, type II	186000	HOX4I	142989	2q31.1
Synpolydactyly, type II	186000	SPD	142989	2q31.1
Synpolydactyly, type II	186000	BDSD	142989	2q31.1
Systemic lupus erythematosus 16	614420	DNASE1L3	602244	3p14.3
Systemic lupus erythematosus 16	614420	SLEB16	602244	3p14.3
T-cell acute lymphoblastic leukemia	613065	BAX	600040	19q13.33
T-cell immunodeficiency, congenital alopecia, and nail dystrophy	601705	FOXN1	600838	17q11.2
T-cell immunodeficiency, congenital alopecia, and nail dystrophy	601705	WHN	600838	17q11.2
T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	614868	STK4	604965	20q13.12
T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	614868	MST1	604965	20q13.12
T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	614868	KRS2	604965	20q13.12
T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations	614868	TIIAC	604965	20q13.12
T-cell prolymphocytic leukemia, somatic		ATM	607585	11q22.3
T-cell prolymphocytic leukemia, somatic		ATA	607585	11q22.3
T-cell prolymphocytic leukemia, somatic		AT1	607585	11q22.3
TARP syndrome	311900	RBM10	300080	Xp11.23
TARP syndrome	311900	DXS8237E	300080	Xp11.23
TARP syndrome	311900	KIAA0122	300080	Xp11.23
TARP syndrome	311900	TARPS	300080	Xp11.23
Tangier disease	205400	ABCA1	600046	9q31.1
Tangier disease	205400	ABC1	600046	9q31.1
Tangier disease	205400	HDLDT1	600046	9q31.1
Tangier disease	205400	TGD	600046	9q31.1
Tarsal-carpal coalition syndrome	186570	NOG	602991	17q22
Tarsal-carpal coalition syndrome	186570	SYM1	602991	17q22
Tarsal-carpal coalition syndrome	186570	SYNS1	602991	17q22
Tauopathy and respiratory failure		MAPT	157140	17q21.31
Tauopathy and respiratory failure		MTBT1	157140	17q21.31
Tauopathy and respiratory failure		DDPAC	157140	17q21.31
Tauopathy and respiratory failure		MSTD	157140	17q21.31
Tay-Sachs disease	272800	HEXA	606869	15q23
Tay-Sachs disease	272800	TSD	606869	15q23
Telangiectasia, hereditary benign	187260	HBT		5q14
Telangiectasia, hereditary hemorrhagic, type 1	187300	ENG	131195	9q34.11
Telangiectasia, hereditary hemorrhagic, type 1	187300	END	131195	9q34.11
Telangiectasia, hereditary hemorrhagic, type 1	187300	HHT1	131195	9q34.11
Telangiectasia, hereditary hemorrhagic, type 1	187300	ORW	131195	9q34.11
Telangiectasia, hereditary hemorrhagic, type 2	600376	ACVRL1	601284	12q13.13
Telangiectasia, hereditary hemorrhagic, type 2	600376	ACVRLK1	601284	12q13.13
Telangiectasia, hereditary hemorrhagic, type 2	600376	ALK1	601284	12q13.13
Telangiectasia, hereditary hemorrhagic, type 2	600376	HHT2	601284	12q13.13
Telangiectasia, hereditary hemorrhagic, type 3	601101	HHT3		5q31.3-q32
Telangiectasia, hereditary hemorrhagic, type 3	601101	ORW3		5q31.3-q32
Telangiectasia, hereditary hemorrhagic, type 4	610655	HHT4		7p14
Telangiectasia, hereditary hemorrhagic, type 5	615506	GDF2	605120	10q11.22
Telangiectasia, hereditary hemorrhagic, type 5	615506	BMP9	605120	10q11.22
Telangiectasia, hereditary hemorrhagic, type 5	615506	HHT5	605120	10q11.22
Temtamy preaxial brachydactyly syndrome	605282	CHSY1	608183	15q26.3
Temtamy preaxial brachydactyly syndrome	605282	KIAA0990	608183	15q26.3
Temtamy preaxial brachydactyly syndrome	605282	TPBS	608183	15q26.3
Temtamy syndrome	218340	C12orf57	615140	12p13.31
Temtamy syndrome	218340	C10	615140	12p13.31
Temtamy syndrome	218340	TEMTYS	615140	12p13.31
Terminal osseous dysplasia	300244	FLNA	300017	Xq28
Terminal osseous dysplasia	300244	FLN1	300017	Xq28
Terminal osseous dysplasia	300244	NHBP	300017	Xq28
Terminal osseous dysplasia	300244	OPD1	300017	Xq28
Terminal osseous dysplasia	300244	OPD2	300017	Xq28
Terminal osseous dysplasia	300244	FMD	300017	Xq28
Terminal osseous dysplasia	300244	MNS	300017	Xq28
Terminal osseous dysplasia	300244	CVD1	300017	Xq28
Terminal osseous dysplasia	300244	CSBS	300017	Xq28
Testicular germ cell tumor	300228	TGCT1		Xq27
Testicular tumor, somatic	273300	STK11	602216	19p13.3
Testicular tumor, somatic	273300	PJS	602216	19p13.3
Testicular tumor, somatic	273300	LKB1	602216	19p13.3
Tetra-amelia, autosomal recessive	273395	WNT3	165330	17q21.31
Tetra-amelia, autosomal recessive	273395	INT4	165330	17q21.31
Tetralogy of Fallot	187500	GATA6	601656	18q11.2
Tetralogy of Fallot	187500	AVSD5	601656	18q11.2
Tetralogy of Fallot	187500	ASD9	601656	18q11.2
Tetralogy of Fallot	187500	AVSD5	601656	18q11.2
Tetralogy of Fallot	187500	PACHD	601656	18q11.2
Tetralogy of Fallot	187500	GDF1	602880	19p13.11
Tetralogy of Fallot	187500	DTGA3	602880	19p13.11
Tetralogy of Fallot	187500	DORV	602880	19p13.11
Tetralogy of Fallot	187500	RAI	602880	19p13.11
Tetralogy of Fallot	187500	JAG1	601920	20p12.2
Tetralogy of Fallot	187500	AGS	601920	20p12.2
Tetralogy of Fallot	187500	AHD	601920	20p12.2
Tetralogy of Fallot	187500	TBX1	602054	22q11.21
Tetralogy of Fallot	187500	DGS	602054	22q11.21
Tetralogy of Fallot	187500	CTHM	602054	22q11.21
Tetralogy of Fallot	187500	CAFS	602054	22q11.21
Tetralogy of Fallot	187500	TGA	602054	22q11.21
Tetralogy of Fallot	187500	DORV	602054	22q11.21
Tetralogy of Fallot	187500	VCFS	602054	22q11.21
Tetralogy of Fallot	187500	DGCR	602054	22q11.21
Tetralogy of Fallot	187500	ZFPM2	603693	8q23.1
Tetralogy of Fallot	187500	FOG2	603693	8q23.1
Tetralogy of Fallot	187500	DIH3	603693	8q23.1
Tetrasomy 18p	614290	TET18P		18p
Tetrology of Fallot	187500	NKX2-5	600584	5q35.1
Tetrology of Fallot	187500	NKX2E	600584	5q35.1
Tetrology of Fallot	187500	CSX	600584	5q35.1
Tetrology of Fallot	187500	CHNG5	600584	5q35.1
Tetrology of Fallot	187500	VSD3	600584	5q35.1
Tetrology of Fallot	187500	HLHS2	600584	5q35.1
Thalassemia due to Hb Lepore		HBD	142000	11p15.4
Thalassemia, Hispanic gamma-delta-beta	613985	LCRB	152424	11p15.5
Thalassemia, alpha-	604131	HBA2	141850	16p13.3
Thalassemia, alpha-	604131	HBH	141850	16p13.3
Thalassemia, delta-		HBD	142000	11p15.4
Thalassemia-beta, dominant inclusion-body	603902	HBB	141900	11p15.4
Thalassemias, alpha-	604131	HBA1	141800	16p13.3
Thalassemias, alpha-	604131	HBH	141800	16p13.3
Thalassemias, beta-	613985	HBB	141900	11p15.4
Thanatophoric dysplasia, type I	187600	FGFR3	134934	4p16.3
Thanatophoric dysplasia, type I	187600	ACH	134934	4p16.3
Thanatophoric dysplasia, type II	187601	FGFR3	134934	4p16.3
Thanatophoric dysplasia, type II	187601	ACH	134934	4p16.3
Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)	607483	SLC19A3	606152	2q36.3
Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)	607483	THMD2	606152	2q36.3
Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2)	607483	BBGD	606152	2q36.3
Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	SLC25A19	606521	17q25.1
Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	DNC	606521	17q25.1
Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	MUP1	606521	17q25.1
Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	MCPHA	606521	17q25.1
Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	THMD3	606521	17q25.1
Thiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type)	613710	THMD4	606521	17q25.1
Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	614458	TPK1	606370	7q35
Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type)	614458	THMD5	606370	7q35
Thiamine-responsive megaloblastic anemia syndrome	249270	SLC19A2	603941	1q24.2
Thiamine-responsive megaloblastic anemia syndrome	249270	THTR1	603941	1q24.2
Thiamine-responsive megaloblastic anemia syndrome	249270	TRMA	603941	1q24.2
Thiamine-responsive megaloblastic anemia syndrome	249270	THMD1	603941	1q24.2
Thoracoabdominal syndrome	313850	THAS		Xq25-q26.1
Thoracoabdominal syndrome	313850	TAS		Xq25-q26.1
Three M syndrome 3	614205	CCDC8	614145	19q13.32
Three M syndrome 3	614205	3M3	614145	19q13.32
Thrombocythemia 1	187950	THPO	600044	3q27.1
Thrombocythemia 1	187950	MGDF	600044	3q27.1
Thrombocythemia 1	187950	MPLLG	600044	3q27.1
Thrombocythemia 1	187950	TPO	600044	3q27.1
Thrombocythemia 1	187950	THCYT1	600044	3q27.1
Thrombocythemia 2	601977	MPL	159530	1p34.2
Thrombocythemia 2	601977	TPOR	159530	1p34.2
Thrombocythemia 2	601977	MPLV	159530	1p34.2
Thrombocythemia 2	601977	THCYT2	159530	1p34.2
Thrombocythemia 3	614521	JAK2	147796	9p24.1
Thrombocythemia 3	614521	THCYT3	147796	9p24.1
Thrombocythemia, X-linked	300331	THCYTX		Chr.X
Thrombocythemia, somatic	187950	CALR	109091	19p13.2
Thrombocythemia, somatic	187950	SSA	109091	19p13.2
Thrombocythemia, somatic	187950	SH2B3	605093	12q24.12
Thrombocythemia, somatic	187950	LNK	605093	12q24.12
Thrombocytopenia 2	188000	ANKRD26	610855	10p12.1
Thrombocytopenia 2	188000	KIAA1074	610855	10p12.1
Thrombocytopenia 2	188000	THC2	610855	10p12.1
Thrombocytopenia 4	612004	CYCS	123970	7p15.3
Thrombocytopenia 4	612004	CYC	123970	7p15.3
Thrombocytopenia 4	612004	THC4	123970	7p15.3
Thrombocytopenia with beta-thalassemia, X-linked	314050	GATA1	305371	Xp11.23
Thrombocytopenia with beta-thalassemia, X-linked	314050	GF1	305371	Xp11.23
Thrombocytopenia with beta-thalassemia, X-linked	314050	ERYF1	305371	Xp11.23
Thrombocytopenia with beta-thalassemia, X-linked	314050	NFE1	305371	Xp11.23
Thrombocytopenia with beta-thalassemia, X-linked	314050	XLTDA	305371	Xp11.23
Thrombocytopenia with beta-thalassemia, X-linked	314050	XLTT	305371	Xp11.23
Thrombocytopenia with beta-thalassemia, X-linked	314050	XLANP	305371	Xp11.23
Thrombocytopenia, X-linked	313900	WAS	300392	Xp11.23
Thrombocytopenia, X-linked	313900	IMD2	300392	Xp11.23
Thrombocytopenia, X-linked	313900	THC1	300392	Xp11.23
Thrombocytopenia, X-linked	313900	SCNX	300392	Xp11.23
Thrombocytopenia, X-linked, intermittent	313900	WAS	300392	Xp11.23
Thrombocytopenia, X-linked, intermittent	313900	IMD2	300392	Xp11.23
Thrombocytopenia, X-linked, intermittent	313900	THC1	300392	Xp11.23
Thrombocytopenia, X-linked, intermittent	313900	SCNX	300392	Xp11.23
Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	GATA1	305371	Xp11.23
Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	GF1	305371	Xp11.23
Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	ERYF1	305371	Xp11.23
Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	NFE1	305371	Xp11.23
Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	XLTDA	305371	Xp11.23
Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	XLTT	305371	Xp11.23
Thrombocytopenia, X-linked, with or without dyserythropoietic anemia	300367	XLANP	305371	Xp11.23
Thrombocytopenia, congenital amegakaryocytic	604498	MPL	159530	1p34.2
Thrombocytopenia, congenital amegakaryocytic	604498	TPOR	159530	1p34.2
Thrombocytopenia, congenital amegakaryocytic	604498	MPLV	159530	1p34.2
Thrombocytopenia, congenital amegakaryocytic	604498	THCYT2	159530	1p34.2
Thrombocytopenia, neonatal alloimmune	173470	ITGB3		17q21.32
Thrombocytopenia, neonatal alloimmune	173470	GP3A		17q21.32
Thrombocytopenia, neonatal alloimmune	173470	GT		17q21.32
Thrombocytopenia, neonatal alloimmune	173470	BDPLT2		17q21.32
Thrombocytopenia, neonatal alloimmune	173470	BDPLT16		17q21.32
Thrombocytopenia, neonatal alloimmune, BAK antigen related		ITGA2B	607759	17q21.31
Thrombocytopenia, neonatal alloimmune, BAK antigen related		GP2B	607759	17q21.31
Thrombocytopenia, neonatal alloimmune, BAK antigen related		CD41B	607759	17q21.31
Thrombocytopenia, neonatal alloimmune, BAK antigen related		GT	607759	17q21.31
Thrombocytopenia, neonatal alloimmune, BAK antigen related		BDPLT2	607759	17q21.31
Thrombocytopenia, neonatal alloimmune, BAK antigen related		BDPLT16	607759	17q21.31
Thrombocytopenia-2	188000	MASTL	608221	10p12.1
Thrombocytopenia-2	188000	FLJ14813	608221	10p12.1
Thrombocytopenia-2	188000	GWL	608221	10p12.1
Thrombocytopenia-2	188000	THC2	608221	10p12.1
Thrombocytopenia-absent radius syndrome	274000	RBM8A	605313	1q21.1
Thrombocytopenia-absent radius syndrome	274000	RBM8B	605313	1q21.1
Thrombocytopenia-absent radius syndrome	274000	TAR	605313	1q21.1
Thrombocytopenia-absent radius syndrome	274000	C1DELq21.1	605313	1q21.1
Thrombocytopenia-absent radius syndrome	274000	DEL1q21.1	605313	1q21.1
Thrombocytopenic purpura, autoimmune	188030	FCGR2C	612169	1q23.3
Thrombocytopenic purpura, autoimmune	188030	CD32C	612169	1q23.3
Thrombophilia due to HRG deficiency	613116	HRG	142640	3q27.3
Thrombophilia due to HRG deficiency	613116	THPH11	142640	3q27.3
Thrombophilia due to activated protein C resistance	188055	F5	612309	1q24.2
Thrombophilia due to activated protein C resistance	188055	THPH2	612309	1q24.2
Thrombophilia due to activated protein C resistance	188055	RPRGL1	612309	1q24.2
Thrombophilia due to antithrombin III deficiency	613118	SERPINC1	107300	1q25.1
Thrombophilia due to antithrombin III deficiency	613118	AT3	107300	1q25.1
Thrombophilia due to antithrombin III deficiency	613118	AT3D	107300	1q25.1
Thrombophilia due to antithrombin III deficiency	613118	THPH7	107300	1q25.1
Thrombophilia due to elevated HRG	613116	HRG	142640	3q27.3
Thrombophilia due to elevated HRG	613116	THPH11	142640	3q27.3
Thrombophilia due to heparin cofactor II deficiency	612356	HCF2	142360	22q11.21
Thrombophilia due to heparin cofactor II deficiency	612356	HC2	142360	22q11.21
Thrombophilia due to heparin cofactor II deficiency	612356	SERPIND1	142360	22q11.21
Thrombophilia due to heparin cofactor II deficiency	612356	THPH10	142360	22q11.21
Thrombophilia due to protein C deficiency, autosomal dominant	176860	PROC	612283	2q14.3
Thrombophilia due to protein C deficiency, autosomal dominant	176860	PC	612283	2q14.3
Thrombophilia due to protein C deficiency, autosomal dominant	176860	THPH3	612283	2q14.3
Thrombophilia due to protein C deficiency, autosomal dominant	176860	THPH4	612283	2q14.3
Thrombophilia due to protein C deficiency, autosomal recessive	612304	PROC	612283	2q14.3
Thrombophilia due to protein C deficiency, autosomal recessive	612304	PC	612283	2q14.3
Thrombophilia due to protein C deficiency, autosomal recessive	612304	THPH3	612283	2q14.3
Thrombophilia due to protein C deficiency, autosomal recessive	612304	THPH4	612283	2q14.3
Thrombophilia due to protein S deficiency, autosomal dominant	612336	PROS1	176880	3q11.1
Thrombophilia due to protein S deficiency, autosomal dominant	612336	THPH5	176880	3q11.1
Thrombophilia due to protein S deficiency, autosomal dominant	612336	THPH6	176880	3q11.1
Thrombophilia due to protein S deficiency, autosomal recessive	614514	PROS1	176880	3q11.1
Thrombophilia due to protein S deficiency, autosomal recessive	614514	THPH5	176880	3q11.1
Thrombophilia due to protein S deficiency, autosomal recessive	614514	THPH6	176880	3q11.1
Thrombophilia due to thrombin defect	188050	F2	176930	11p11.2
Thrombophilia due to thrombin defect	188050	THPH1	176930	11p11.2
Thrombophilia due to thrombin defect	188050	RPRGL2	176930	11p11.2
Thrombophilia due to thrombomodulin defect	614486	THBD	188040	20p11.21
Thrombophilia due to thrombomodulin defect	614486	THRM	188040	20p11.21
Thrombophilia due to thrombomodulin defect	614486	AHUS6	188040	20p11.21
Thrombophilia due to thrombomodulin defect	614486	THPH12	188040	20p11.21
Thrombophilia, X-linked, due to factor IX defect	300807	F9	300746	Xq27.1
Thrombophilia, X-linked, due to factor IX defect	300807	HEMB	300746	Xq27.1
Thrombophilia, X-linked, due to factor IX defect	300807	THPH8	300746	Xq27.1
Thrombophilia, dysfibrinogenemic		FGB	134830	4q31.3
Thrombophilia, dysfibrinogenemic		FGG	134850	4q31.3
Thrombophilia, dysplasminogenemic		PLG	173350	6q26
Thrombophilia, familial, due to decreased release of PLAT	612348	PLAT	173370	8p11.21
Thrombophilia, familial, due to decreased release of PLAT	612348	TPA	173370	8p11.21
Thrombosis, hyperhomocysteinemic	236200	CBS	613381	21q22.3
Thrombotic thrombocytopenic purpura, familial	274150	ADAMTS13	604134	9q34.2
Thrombotic thrombocytopenic purpura, familial	274150	VWFCP	604134	9q34.2
Thrombotic thrombocytopenic purpura, familial	274150	TTP	604134	9q34.2
Thryoid dyshormonogenesis 6	607200	DUOX2	606759	15q21.1
Thryoid dyshormonogenesis 6	607200	THOX2	606759	15q21.1
Thryoid dyshormonogenesis 6	607200	TDH6	606759	15q21.1
Thyroid adenoma, hyperfunctioning, somatic	603372	TSHR		14q31.1
Thyroid adenoma, hyperfunctioning, somatic	603372	CHNG1		14q31.1
Thyroid carcinoma with thyrotoxicosis	603372	TSHR		14q31.1
Thyroid carcinoma with thyrotoxicosis	603372	CHNG1		14q31.1
Thyroid carcinoma, follicular	188470	MINPP1	605391	10q23.2
Thyroid carcinoma, follicular	188470	HIPER1	605391	10q23.2
Thyroid carcinoma, follicular, somatic	188470	NRAS	164790	1p13.2
Thyroid carcinoma, follicular, somatic	188470	ALPS4	164790	1p13.2
Thyroid carcinoma, follicular, somatic	188470	NS6	164790	1p13.2
Thyroid carcinoma, follicular, somatic	188470	PTEN	601728	10q23.31
Thyroid carcinoma, follicular, somatic	188470	MMAC1	601728	10q23.31
Thyroid carcinoma, follicular, somatic	188470	GLM2	601728	10q23.31
Thyroid carcinoma, follicular, somatic	188470	CWS1	601728	10q23.31
Thyroid carcinoma, nonmedullary, 1	606240	NMTC1		2q21
Thyroid carcinoma, nonmedullary, with cell oxyphilia	603386	TCO		19p13.2
Thyroid carcinoma, papillary	188550	GOLGA5	606918	14q32.12
Thyroid carcinoma, papillary	188550	RFG5	606918	14q32.12
Thyroid carcinoma, papillary	188550	PTC5	606918	14q32.12
Thyroid carcinoma, papillary	188550	NCOA4	601984	10q11.23
Thyroid carcinoma, papillary	188550	ELE1	601984	10q11.23
Thyroid carcinoma, papillary	188550	PTC3	601984	10q11.23
Thyroid carcinoma, papillary	188550	PCM1	600299	8p22
Thyroid carcinoma, papillary	188550	PTC4	600299	8p22
Thyroid carcinoma, papillary	188550	TRIM24	603406	7q33-q34
Thyroid carcinoma, papillary	188550	TIF1	603406	7q33-q34
Thyroid carcinoma, papillary	188550	TIF1A	603406	7q33-q34
Thyroid carcinoma, papillary	188550	PTC6	603406	7q33-q34
Thyroid carcinoma, papillary	188550	TRIM33	605769	1p13.2
Thyroid carcinoma, papillary	188550	TIF1G	605769	1p13.2
Thyroid carcinoma, papillary	188550	RFG7	605769	1p13.2
Thyroid carcinoma, papillary	188550	PTC7	605769	1p13.2
Thyroid carcinoma, papillary, somatic	188550	PRKAR1A	188830	17q24.2
Thyroid carcinoma, papillary, somatic	188550	TSE1	188830	17q24.2
Thyroid carcinoma, papillary, somatic	188550	CNC1	188830	17q24.2
Thyroid carcinoma, papillary, somatic	188550	CAR	188830	17q24.2
Thyroid carcinoma, papillary, somatic	188550	PPNAD1	188830	17q24.2
Thyroid carcinoma, papillary, somatic	188550	ACRDYS1	188830	17q24.2
Thyroid carcinoma, papillary, with papillary renal neoplasia	605642	PTCPRN		1q21
Thyroid carcinoma, papillary, with papillary renal neoplasia	605642	PRN1		1q21
Thyroid dyshormonogenesis 1	274400	SLC5A5	601843	19p13.11
Thyroid dyshormonogenesis 1	274400	NIS	601843	19p13.11
Thyroid dyshormonogenesis 1	274400	TDH1	601843	19p13.11
Thyroid dyshormonogenesis 2A	274500	TPO	606765	2p25.3
Thyroid dyshormonogenesis 2A	274500	TPX	606765	2p25.3
Thyroid dyshormonogenesis 2A	274500	TDH2A	606765	2p25.3
Thyroid dyshormonogenesis 3	274700	TG	188450	8q24.22
Thyroid dyshormonogenesis 3	274700	AITD3	188450	8q24.22
Thyroid dyshormonogenesis 3	274700	TDH3	188450	8q24.22
Thyroid dyshormonogenesis 4	274800	IYD	612025	6q25.1
Thyroid dyshormonogenesis 4	274800	DEHAL1	612025	6q25.1
Thyroid dyshormonogenesis 4	274800	TDH4	612025	6q25.1
Thyroid dyshormonogenesis 5	274900	DUOXA2	612772	15q21.1
Thyroid dyshormonogenesis 5	274900	TDH5	612772	15q21.1
Thyroid hormone metabolism, abnormal	609698	SECISBP2	607693	9q22.2
Thyroid hormone metabolism, abnormal	609698	SBP2	607693	9q22.2
Thyroid hormone resistance	188570	THRB	190160	3p24.2
Thyroid hormone resistance	188570	ERBA2	190160	3p24.2
Thyroid hormone resistance	188570	THR1	190160	3p24.2
Thyroid hormone resistance	188570	PRTH	190160	3p24.2
Thyroid hormone resistance, autosomal recessive	274300	THRB	190160	3p24.2
Thyroid hormone resistance, autosomal recessive	274300	ERBA2	190160	3p24.2
Thyroid hormone resistance, autosomal recessive	274300	THR1	190160	3p24.2
Thyroid hormone resistance, autosomal recessive	274300	PRTH	190160	3p24.2
Thyroid hormone resistance, selective pituitary	145650	THRB	190160	3p24.2
Thyroid hormone resistance, selective pituitary	145650	ERBA2	190160	3p24.2
Thyroid hormone resistance, selective pituitary	145650	THR1	190160	3p24.2
Thyroid hormone resistance, selective pituitary	145650	PRTH	190160	3p24.2
Thyroid papillary carcinoma	188550	CCDC6	601985	10q21.2
Thyroid papillary carcinoma	188550	D10S170	601985	10q21.2
Thyroid papillary carcinoma	188550	H4	601985	10q21.2
Thyroid papillary carcinoma	188550	TST1	601985	10q21.2
Thyroid papillary carcinoma	188550	PTC	601985	10q21.2
Thyroid papillary carcinoma	188550	TPC	601985	10q21.2
Thyrotropin-releasing hormone deficiency	275120	TRH	613879	3q22.1
Thyrotropin-releasing hormone resistance, generalized	188545	TRHR		8q23.1
Thyroxine-binding globulin deficiency	314200	TBG		Xq22.3
Tibial muscular dystrophy, tardive	600334	TTN	188840	2q31.2
Tibial muscular dystrophy, tardive	600334	CMD1G	188840	2q31.2
Tibial muscular dystrophy, tardive	600334	TMD	188840	2q31.2
Tibial muscular dystrophy, tardive	600334	LGMD2J	188840	2q31.2
Tibial muscular dystrophy, tardive	600334	MPRM	188840	2q31.2
Tibial muscular dystrophy, tardive	600334	HMERF	188840	2q31.2
Tibial muscular dystrophy, tardive	600334	EOMFC	188840	2q31.2
Tietz albinism-deafness syndrome	103500	MITF	156845	3p14-p13
Tietz albinism-deafness syndrome	103500	WS2A	156845	3p14-p13
Tietz albinism-deafness syndrome	103500	CMM8	156845	3p14-p13
Timothy syndrome	601005	CACNA1C	114205	12p13.33
Timothy syndrome	601005	CACNL1A1	114205	12p13.33
Timothy syndrome	601005	CCHL1A1	114205	12p13.33
Timothy syndrome	601005	TS	114205	12p13.33
Tn polyagglutination syndrome, somatic	300622	C1GALT1C1	300611	Xq24
Tn polyagglutination syndrome, somatic	300622	COSMC	300611	Xq24
Tn polyagglutination syndrome, somatic	300622	C1GALT2	300611	Xq24
Tn polyagglutination syndrome, somatic	300622	TNPS	300611	Xq24
Toenail dystrophy, isolated	607523	COL7A1	120120	3p21.31
Tolbutamide poor metabolizer		CYP2C9	601130	10q23.33
Tooth agenesis, selective, 1, with or without orofacial cleft	106600	MSX1	142983	4p16.2
Tooth agenesis, selective, 1, with or without orofacial cleft	106600	HOX7	142983	4p16.2
Tooth agenesis, selective, 1, with or without orofacial cleft	106600	HYD1	142983	4p16.2
Tooth agenesis, selective, 1, with or without orofacial cleft	106600	OFC5	142983	4p16.2
Tooth agenesis, selective, 1, with or without orofacial cleft	106600	STHAG1	142983	4p16.2
Tooth agenesis, selective, 1, with or without orofacial cleft	106600	ECTD3	142983	4p16.2
Tooth agenesis, selective, 2	602639	STHAG2		16q12.1
Tooth agenesis, selective, 2	602639	HYD2		16q12.1
Tooth agenesis, selective, 3	604625	PAX9	167416	14q13.3
Tooth agenesis, selective, 3	604625	STHAG3	167416	14q13.3
Tooth agenesis, selective, 4	150400	WNT10A	606268	2q35
Tooth agenesis, selective, 4	150400	SSPS	606268	2q35
Tooth agenesis, selective, 4	150400	STHAG4	606268	2q35
Tooth agenesis, selective, 4	150400	OODD	606268	2q35
Tooth agenesis, selective, 5	610926	STHAG5		10q11.2-q21
Tooth agenesis, selective, 6	613097	LTBP3	602090	11q13.1
Tooth agenesis, selective, 6	613097	LTBP2	602090	11q13.1
Tooth agenesis, selective, 6	613097	STHAG6	602090	11q13.1
Tooth agenesis, selective, X-linked 1	313500	ED1	300451	Xq13.1
Tooth agenesis, selective, X-linked 1	313500	EDA	300451	Xq13.1
Tooth agenesis, selective, X-linked 1	313500	ECTD1	300451	Xq13.1
Tooth agenesis, selective, X-linked 1	313500	EDA	300451	Xq13.1
Tooth agenesis, selective, X-linked 1	313500	HED1	300451	Xq13.1
Tooth agenesis, selective, X-linked 1	313500	STHAGX1	300451	Xq13.1
Total anomalous pulmonary venous return	106700	TAPVR1		4q12
Tourette syndrome	137580	GTS		11q23
Tourette syndrome	137580	SLITRK1	609678	13q31.1
Tourette syndrome	137580	KIAA1910	609678	13q31.1
Tourette syndrome	137580	TTM	609678	13q31.1
Townes-Brocks branchiootorenal-like syndrome	107480	SALL1	602218	16q12.1
Townes-Brocks branchiootorenal-like syndrome	107480	HSAL1	602218	16q12.1
Townes-Brocks branchiootorenal-like syndrome	107480	TBS	602218	16q12.1
Townes-Brocks syndrome	107480	SALL1	602218	16q12.1
Townes-Brocks syndrome	107480	HSAL1	602218	16q12.1
Townes-Brocks syndrome	107480	TBS	602218	16q12.1
Transaldolase deficiency	606003	TALDO1	602063	11p15.5
Transcobalamin II deficiency	275350	TCN2	613441	22q12.2
Transcobalamin II deficiency	275350	TC2	613441	22q12.2
Transient bullous of the newborn	131705	COL7A1	120120	3p21.31
Transient erythroblastopenia of childhood	227050	TEC		19q13.2
Transposition of great arteries, dextro-looped 3	613854	GDF1	602880	19p13.11
Transposition of great arteries, dextro-looped 3	613854	DTGA3	602880	19p13.11
Transposition of great arteries, dextro-looped 3	613854	DORV	602880	19p13.11
Transposition of great arteries, dextro-looped 3	613854	RAI	602880	19p13.11
Transposition of the great arteries, dextro-looped 1	608808	MED13L	608771	12q24.21
Transposition of the great arteries, dextro-looped 1	608808	THRAP2	608771	12q24.21
Transposition of the great arteries, dextro-looped 1	608808	PROSIT240	608771	12q24.21
Transposition of the great arteries, dextro-looped 1	608808	TRAP240L	608771	12q24.21
Transposition of the great arteries, dextro-looped 1	608808	KIAA1025	608771	12q24.21
Transposition of the great arteries, dextro-looped 2	613853	CFC1	605194	2q21.1
Transposition of the great arteries, dextro-looped 2	613853	CRYPTIC	605194	2q21.1
Transposition of the great arteries, dextro-looped 2	613853	HTX2	605194	2q21.1
Transposition of the great arteries, dextro-looped 2	613853	DTGA2	605194	2q21.1
Treacher Collins syndrome 1	154500	TCOF1	606847	5q32
Treacher Collins syndrome 1	154500	MFD1	606847	5q32
Treacher Collins syndrome 1	154500	TCS1	606847	5q32
Treacher Collins syndrome 2	613717	POLR1D	613715	13q12.2
Treacher Collins syndrome 2	613717	RPA16	613715	13q12.2
Treacher Collins syndrome 2	613717	RPAC2	613715	13q12.2
Treacher Collins syndrome 2	613717	TCS2	613715	13q12.2
Treacher Collins syndrome 3	248390	POLR1C	610060	6p21.1
Treacher Collins syndrome 3	248390	RPA39	610060	6p21.1
Treacher Collins syndrome 3	248390	RPA40	610060	6p21.1
Treacher Collins syndrome 3	248390	RPAC1	610060	6p21.1
Treacher Collins syndrome 3	248390	RPA5	610060	6p21.1
Treacher Collins syndrome 3	248390	TCS3	610060	6p21.1
Trehalase deficiency	612119	TREH	275360	11q23.3
Tremor, hereditary essential, 2	602134	ETM2		2p25-p22
Tremor, hereditary essential, 2	602134	ETM		2p25-p22
Tremor, hereditary essential, 3	611456	ETM3		6p23
Tremor, hereditary essential, 4	614782	FUS	137070	16p11.2
Tremor, hereditary essential, 4	614782	TLS	137070	16p11.2
Tremor, hereditary essential, 4	614782	ALS6	137070	16p11.2
Tremor, hereditary essential, 4	614782	ETM4	137070	16p11.2
Trichilemmal cyst 1	609649	TRICY1		3p24-p21.2
Trichodontoosseous syndrome	190320	DLX3	600525	17q21.33
Trichodontoosseous syndrome	190320	TDO	600525	17q21.33
Trichodontoosseous syndrome	190320	AI4	600525	17q21.33
Trichoepithelioma, multiple familial, 1	601606	CYLD	605018	16q12.1
Trichoepithelioma, multiple familial, 1	601606	CDMT	605018	16q12.1
Trichoepithelioma, multiple familial, 1	601606	EAC	605018	16q12.1
Trichoepithelioma, multiple familial, 1	601606	MFT1	605018	16q12.1
Trichoepithelioma, multiple familial, 1	601606	KIAA0849	605018	16q12.1
Trichoepithelioma, multiple familial, 1	601606	BRSS	605018	16q12.1
Trichoepithelioma, multiple familial, 2	612099	MFT2		9p21
Trichoepithelioma, multiple familial, 2	612099	TEM		9p21
Trichohepatoenteric syndrome 1	222470	TTC37	614589	5q15
Trichohepatoenteric syndrome 1	222470	KIAA0372	614589	5q15
Trichohepatoenteric syndrome 2	614602	SKIV2L	600478	6p21.33
Trichohepatoenteric syndrome 2	614602	SKI2	600478	6p21.33
Trichohepatoenteric syndrome 2	614602	SKI2W	600478	6p21.33
Trichohepatoenteric syndrome 2	614602	THES2	600478	6p21.33
Trichorhinophalangeal syndrome, type I	190350	TRPS1	604386	8q23.3
Trichorhinophalangeal syndrome, type II	150230	TRPS2		8q24.11-q24.13
Trichorhinophalangeal syndrome, type II	150230	LGCR		8q24.11-q24.13
Trichorhinophalangeal syndrome, type II	150230	LGS		8q24.11-q24.13
Trichorhinophalangeal syndrome, type III	190351	TRPS1	604386	8q23.3
Trichothiodystrophy	601675	ERCC2	126340	19q13.32
Trichothiodystrophy	601675	EM9	126340	19q13.32
Trichothiodystrophy	601675	XPD	126340	19q13.32
Trichothiodystrophy	601675	COFS2	126340	19q13.32
Trichothiodystrophy	601675	ERCC3	133510	2q14.3
Trichothiodystrophy	601675	XPB	133510	2q14.3
Trichothiodystrophy, complementation group A	601675	GTF2H5	608780	6q25.3
Trichothiodystrophy, complementation group A	601675	TTDA	608780	6q25.3
Trichothiodystrophy, complementation group A	601675	TFB5	608780	6q25.3
Trichothiodystrophy, complementation group A	601675	C6orf175	608780	6q25.3
Trichothiodystrophy, nonphotosensitive 1	234050	MPLKIP	609188	7p14.1
Trichothiodystrophy, nonphotosensitive 1	234050	C7orf11	609188	7p14.1
Trichothiodystrophy, nonphotosensitive 1	234050	ABHS	609188	7p14.1
Trichothiodystrophy, nonphotosensitive 1	234050	TTDN1	609188	7p14.1
Trichotillomania	613229	SLITRK1	609678	13q31.1
Trichotillomania	613229	KIAA1910	609678	13q31.1
Trichotillomania	613229	TTM	609678	13q31.1
Trifunctional protein deficiency	609015	HADHA	600890	2p23.3
Trifunctional protein deficiency	609015	MTPA	600890	2p23.3
Trifunctional protein deficiency	609015	HADHB	143450	2p23.3
Trigonocephaly 1	190440	FGFR1	136350	8p11.23-p11.22
Trigonocephaly 1	190440	FLT2	136350	8p11.23-p11.22
Trigonocephaly 1	190440	OGD	136350	8p11.23-p11.22
Trigonocephaly 1	190440	KAL2	136350	8p11.23-p11.22
Trigonocephaly 1	190440	HH2	136350	8p11.23-p11.22
Trigonocephaly 1	190440	HRTFDS	136350	8p11.23-p11.22
Trigonocephaly 2	614485	FREM1	608944	9p22.3
Trigonocephaly 2	614485	C9orf154	608944	9p22.3
Trigonocephaly 2	614485	BNAR	608944	9p22.3
Trigonocephaly 2	614485	MOTA	608944	9p22.3
Trigonocephaly 2	614485	TRIGNO2	608944	9p22.3
Trimethylaminuria	602079	FMO3	136132	1q24.3
Trimethylaminuria	602079	TMAU	136132	1q24.3
Triphalangeal thumb, type I	174500	LMBR1	605522	7q36.3
Triphalangeal thumb, type I	174500	ACHP	605522	7q36.3
Triphalangeal thumb, type I	174500	C7orf2	605522	7q36.3
Triphalangeal thumb, type I	174500	PPD2	605522	7q36.3
Triphalangeal thumb-polysyndactyly syndrome	174500	LMBR1	605522	7q36.3
Triphalangeal thumb-polysyndactyly syndrome	174500	ACHP	605522	7q36.3
Triphalangeal thumb-polysyndactyly syndrome	174500	C7orf2	605522	7q36.3
Triphalangeal thumb-polysyndactyly syndrome	174500	PPD2	605522	7q36.3
Trismus-pseudocamptodactyly syndrome	158300	MYH8	160741	17p13.1
Tropical calcific pancreatitis	608189	SPINK1	167790	5q32
Tropical calcific pancreatitis	608189	PSTI	167790	5q32
Tropical calcific pancreatitis	608189	PCTT	167790	5q32
Tropical calcific pancreatitis	608189	TATI	167790	5q32
Tropical calcific pancreatitis	608189	TCP	167790	5q32
Troyer syndrome	275900	SPG20	607111	13q13.3
Trypsinogen deficiency	614044	PRSS1	276000	7q34
Trypsinogen deficiency	614044	TRY1	276000	7q34
Tuberous sclerosis-1	191100	TSC1	605284	9q34.13
Tuberous sclerosis-1	191100	LAM	605284	9q34.13
Tuberous sclerosis-2	613254	TSC2	191092	16p13.3
Tuberous sclerosis-2	613254	LAM	191092	16p13.3
Tukel syndrome	609428	TUKLS		21q22
Tumor predisposition syndrome	614327	BAP1	603089	3p21.1
Tumor predisposition syndrome	614327	TPDS	603089	3p21.1
Tumoral calcinosis, familial, normophosphatemic	610455	SAMD9	610456	7q21.2
Tumoral calcinosis, familial, normophosphatemic	610455	NFTC	610456	7q21.2
Tumoral calcinosis, hyperphosphatemic	211900	KL	604824	13q13.1
Tumoral calcinosis, hyperphosphatemic	211900	KLOTHO	604824	13q13.1
Tumoral calcinosis, hyperphosphatemic, familial	211900	FGF23	605380	12p13.32
Tumoral calcinosis, hyperphosphatemic, familial	211900	ADHR	605380	12p13.32
Tumoral calcinosis, hyperphosphatemic, familial	211900	HPDR2	605380	12p13.32
Tumoral calcinosis, hyperphosphatemic, familial	211900	PHPTC	605380	12p13.32
Tumoral calcinosis, hyperphosphatemic, familial	211900	GALNT3	601756	2q24.3
Tumoral calcinosis, hyperphosphatemic, familial	211900	HHS	601756	2q24.3
Tumoral calcinosis, hyperphosphatemic, familial	211900	HFTC	601756	2q24.3
Turner syndrome-associated neurocognitive phenotype	313000	VSPA		Xp22.33
Tylosis with esophageal cancer	148500	RHBDF2	614404	17q25.1
Tylosis with esophageal cancer	148500	IRHOM2	614404	17q25.1
Tylosis with esophageal cancer	148500	TOC	614404	17q25.1
Tyrosine kinase 2 deficiency	611521	TYK2	176941	19p13.2
Tyrosinemia, type I	276700	FAH	613871	15q25.1
Tyrosinemia, type II	276600	TAT	613018	16q22.2
Tyrosinemia, type III	276710	HPD	609695	12q24.31
Tyrosinemia, type Ib		GSTZ1	603758	14q24.3
Tyrosinemia, type Ib		MAAI	603758	14q24.3
UV-sensitive syndrome 1	600630	ERCC6	609413	10q11.23
UV-sensitive syndrome 1	600630	CKN2	609413	10q11.23
UV-sensitive syndrome 1	600630	COFS1	609413	10q11.23
UV-sensitive syndrome 1	600630	CSB	609413	10q11.23
UV-sensitive syndrome 1	600630	ARMD5	609413	10q11.23
UV-sensitive syndrome 1	600630	UVSS1	609413	10q11.23
UV-sensitive syndrome 2	614621	ERCC8	609412	5q12.1
UV-sensitive syndrome 2	614621	CKN1	609412	5q12.1
UV-sensitive syndrome 2	614621	CSA	609412	5q12.1
UV-sensitive syndrome 2	614621	UVSS2	609412	5q12.1
UV-sensitive syndrome 3	614640	UVSSA	614632	4p16.3
UV-sensitive syndrome 3	614640	KIAA1530	614632	4p16.3
UV-sensitive syndrome 3	614640	UVSS3	614632	4p16.3
Ullrich congenital muscular dystrophy	254090	COL6A1	120220	21q22.3
Ullrich congenital muscular dystrophy	254090	OPLL	120220	21q22.3
Ullrich congenital muscular dystrophy	254090	COL6A2	120240	21q22.3
Ullrich congenital muscular dystrophy	254090	COL6A3	120250	2q37.3
Ulna and fibula, absence of, with severe limb deficiency	276820	WNT7A	601570	3p25.1
Ulnar-mammary syndrome	181450	TBX3	601621	12q24.21
Urbach-Wiethe disease	247100	ECM1	602201	1q21.3
Urbach-Wiethe disease	247100	URBWD	602201	1q21.3
Urocanase deficiency	276880	UROC1	613012	3q21.3
Urofacial syndrome 1	236730	HPSE2	613469	10q24.2
Urofacial syndrome 1	236730	HPA2	613469	10q24.2
Urofacial syndrome 1	236730	UFS1	613469	10q24.2
Urofacial syndrome 2	615112	LRIG2	608869	1p13.2
Urofacial syndrome 2	615112	LIG2	608869	1p13.2
Urofacial syndrome 2	615112	KIAA0806	608869	1p13.2
Urofacial syndrome 2	615112	UFS2	608869	1p13.2
Urogenital adysplasia	191830	UPK3A	611559	22q13.31
Urogenital adysplasia	191830	UPK3	611559	22q13.31
Urogenital adysplasia	191830	UPIII	611559	22q13.31
Usher syndrome type 3B	614504	HARS	142810	5q31.3
Usher syndrome type 3B	614504	USH3B	142810	5q31.3
Usher syndrome, type 1B	276900	MYO7A	276903	11q13.5
Usher syndrome, type 1B	276900	USH1B	276903	11q13.5
Usher syndrome, type 1B	276900	DFNB2	276903	11q13.5
Usher syndrome, type 1B	276900	DFNA11	276903	11q13.5
Usher syndrome, type 1C	276904	USH1C	605242	11p15.1
Usher syndrome, type 1C	276904	DFNB18A	605242	11p15.1
Usher syndrome, type 1D	601067	CDH23	605516	10q22.1
Usher syndrome, type 1D	601067	USH1D	605516	10q22.1
Usher syndrome, type 1D/F digenic	601067	CDH23	605516	10q22.1
Usher syndrome, type 1D/F digenic	601067	USH1D	605516	10q22.1
Usher syndrome, type 1D/F digenic	601067	PCDH15	605514	10q21.1
Usher syndrome, type 1D/F digenic	601067	DFNB23	605514	10q21.1
Usher syndrome, type 1D/F digenic	601067	USH1F	605514	10q21.1
Usher syndrome, type 1E	602097	USH1E		21q21
Usher syndrome, type 1F	602083	PCDH15	605514	10q21.1
Usher syndrome, type 1F	602083	DFNB23	605514	10q21.1
Usher syndrome, type 1F	602083	USH1F	605514	10q21.1
Usher syndrome, type 1G	606943	SANS	607696	17q25.1
Usher syndrome, type 1G	606943	USH1G	607696	17q25.1
Usher syndrome, type 1H	612632	USH1H		15q22-q23
Usher syndrome, type 2A	276901	USH2A	608400	1q41
Usher syndrome, type 2A	276901	RP39	608400	1q41
Usher syndrome, type 2C	605472	GPR98	602851	5q14.3
Usher syndrome, type 2C	605472	MASS1	602851	5q14.3
Usher syndrome, type 2C	605472	VLGR1	602851	5q14.3
Usher syndrome, type 2C	605472	KIAA0686	602851	5q14.3
Usher syndrome, type 2C	605472	FEB4	602851	5q14.3
Usher syndrome, type 2C	605472	USH2C	602851	5q14.3
Usher syndrome, type 2C, GPR98/PDZD7 digenic	605472	GPR98	602851	5q14.3
Usher syndrome, type 2C, GPR98/PDZD7 digenic	605472	MASS1	602851	5q14.3
Usher syndrome, type 2C, GPR98/PDZD7 digenic	605472	VLGR1	602851	5q14.3
Usher syndrome, type 2C, GPR98/PDZD7 digenic	605472	KIAA0686	602851	5q14.3
Usher syndrome, type 2C, GPR98/PDZD7 digenic	605472	FEB4	602851	5q14.3
Usher syndrome, type 2C, GPR98/PDZD7 digenic	605472	USH2C	602851	5q14.3
Usher syndrome, type 2D	611383	WHRN	607928	9q32
Usher syndrome, type 2D	611383	CIP98	607928	9q32
Usher syndrome, type 2D	611383	KIAA1526	607928	9q32
Usher syndrome, type 2D	611383	DFNB31	607928	9q32
Usher syndrome, type 2D	611383	USH2D	607928	9q32
Usher syndrome, type 3A	276902	CLRN1	606397	3q25.1
Usher syndrome, type 3A	276902	USH3A	606397	3q25.1
Usher syndrome, type 3A	276902	USH3	606397	3q25.1
Usher syndrome, type 3A	276902	RP61	606397	3q25.1
Usher syndrome, type IIC, GPR98/PDZD7 digenic	605472	PDZD7	612971	10q24.31
Usher syndrome, type IJ	614869	CIB2	605564	15q25.1
Usher syndrome, type IJ	614869	KIP2	605564	15q25.1
Usher syndrome, type IK	614990	USH1K		10p11.21-q21.1
VACTERL association	192350	HOXD13	142989	2q31.1
VACTERL association	192350	HOX4I	142989	2q31.1
VACTERL association	192350	SPD	142989	2q31.1
VACTERL association	192350	BDSD	142989	2q31.1
VACTERL association, X-linked	314390	ZIC3	300265	Xq26.3
VACTERL association, X-linked	314390	HTX1	300265	Xq26.3
VACTERL association, X-linked	314390	HTX	300265	Xq26.3
VACTERL association, X-linked	314390	VACTERLX	300265	Xq26.3
VATER association with macrocephaly and ventriculomegaly	276950	PTEN	601728	10q23.31
VATER association with macrocephaly and ventriculomegaly	276950	MMAC1	601728	10q23.31
VATER association with macrocephaly and ventriculomegaly	276950	GLM2	601728	10q23.31
VATER association with macrocephaly and ventriculomegaly	276950	CWS1	601728	10q23.31
VLCAD deficiency	201475	ACADVL	609575	17p13.1
VLCAD deficiency	201475	VLCAD	609575	17p13.1
Van Buchem disease	239100	SOST	605740	17q21.31
Van Buchem disease	239100	VBCH	605740	17q21.31
Van Buchem disease	239100	CDD	605740	17q21.31
Van Maldergem syndrome 1	601390	DCHS1	603057	11p15.4
Van Maldergem syndrome 1	601390	PCDH16	603057	11p15.4
Van Maldergem syndrome 1	601390	FIB1	603057	11p15.4
Van Maldergem syndrome 1	601390	CDH19	603057	11p15.4
Van Maldergem syndrome 1	601390	VMLDS1	603057	11p15.4
Van Maldergem syndrome 2	615546	FAT4	612411	4q28.1
Van Maldergem syndrome 2	615546	VMLDS2	612411	4q28.1
Van den Ende-Gupta syndrome	600920	SCARF2	613619	22q11.21
Van den Ende-Gupta syndrome	600920	SREC2	613619	22q11.21
Van den Ende-Gupta syndrome	600920	VDEGS	613619	22q11.21
Vasculopathy, retinal, with cerebral leukodystrophy	192315	TREX1	606609	3p21.31
Vasculopathy, retinal, with cerebral leukodystrophy	192315	AGS1	606609	3p21.31
Vasculopathy, retinal, with cerebral leukodystrophy	192315	CRV	606609	3p21.31
Vasculopathy, retinal, with cerebral leukodystrophy	192315	HERNS	606609	3p21.31
Velocardiofacial syndrome	192430	TBX1	602054	22q11.21
Velocardiofacial syndrome	192430	DGS	602054	22q11.21
Velocardiofacial syndrome	192430	CTHM	602054	22q11.21
Velocardiofacial syndrome	192430	CAFS	602054	22q11.21
Velocardiofacial syndrome	192430	TGA	602054	22q11.21
Velocardiofacial syndrome	192430	DORV	602054	22q11.21
Velocardiofacial syndrome	192430	VCFS	602054	22q11.21
Velocardiofacial syndrome	192430	DGCR	602054	22q11.21
Venous malformations, multiple cutaneous and mucosal	600195	TEK	600221	9p21.2
Venous malformations, multiple cutaneous and mucosal	600195	TIE2	600221	9p21.2
Venous malformations, multiple cutaneous and mucosal	600195	VMCM	600221	9p21.2
Ventricular fibrillation, familial, 1	603829	SCN5A	600163	3p22.2
Ventricular fibrillation, familial, 1	603829	LQT3	600163	3p22.2
Ventricular fibrillation, familial, 1	603829	VF1	600163	3p22.2
Ventricular fibrillation, familial, 1	603829	HB1	600163	3p22.2
Ventricular fibrillation, familial, 1	603829	SSS1	600163	3p22.2
Ventricular fibrillation, familial, 1	603829	CMD1E	600163	3p22.2
Ventricular fibrillation, familial, 1	603829	CDCD2	600163	3p22.2
Ventricular fibrillation, paroxysmal familial, 2	612956	DPP6	126141	7q36.2
Ventricular fibrillation, paroxysmal familial, 2	612956	VF2	126141	7q36.2
Ventricular septal defect 1	614429	GATA4	600576	8p23.1
Ventricular septal defect 1	614429	ASD2	600576	8p23.1
Ventricular septal defect 1	614429	VSD1	600576	8p23.1
Ventricular septal defect 1	614429	TACHD	600576	8p23.1
Ventricular septal defect 2	614431	CITED2	602937	6q24.1
Ventricular septal defect 2	614431	MRG1	602937	6q24.1
Ventricular septal defect 2	614431	P35SRJ	602937	6q24.1
Ventricular septal defect 2	614431	VSD2	602937	6q24.1
Ventricular septal defect 2	614431	ASD8	602937	6q24.1
Ventricular septal defect 3	614432	NKX2-5	600584	5q35.1
Ventricular septal defect 3	614432	NKX2E	600584	5q35.1
Ventricular septal defect 3	614432	CSX	600584	5q35.1
Ventricular septal defect 3	614432	CHNG5	600584	5q35.1
Ventricular septal defect 3	614432	VSD3	600584	5q35.1
Ventricular septal defect 3	614432	HLHS2	600584	5q35.1
Ventricular tachycardia, catecholaminergic polymorphic, 1	604772	RYR2	180902	1q43
Ventricular tachycardia, catecholaminergic polymorphic, 1	604772	VTSIP	180902	1q43
Ventricular tachycardia, catecholaminergic polymorphic, 1	604772	ARVD2	180902	1q43
Ventricular tachycardia, catecholaminergic polymorphic, 1	604772	ARVC2	180902	1q43
Ventricular tachycardia, catecholaminergic polymorphic, 2	611938	CASQ2	114251	1p13.1
Ventricular tachycardia, catecholaminergic polymorphic, 3	614021	CPVT3		7p22-p14
Ventricular tachycardia, catecholaminergic polymorphic, 4	614916	CALM1	114180	14q32.11
Ventricular tachycardia, catecholaminergic polymorphic, 4	614916	PHKD	114180	14q32.11
Ventricular tachycardia, catecholaminergic polymorphic, 4	614916	CPVT4	114180	14q32.11
Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness	615441	TRDN	603283	6q22.31
Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness	615441	TDN	603283	6q22.31
Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness	615441	CPVT5	603283	6q22.31
Ventricular tachycardia, idiopathic	192605	GNAI2	139360	3p21.31
Ventricular tachycardia, idiopathic	192605	GNAI2B	139360	3p21.31
Ventricular tachycardia, idiopathic	192605	GIP	139360	3p21.31
Verheij syndrome	615583	PUF60	604819	8q24.3
Verheij syndrome	615583	FIR	604819	8q24.3
Verheij syndrome	615583	SIAHBP1	604819	8q24.3
Verheij syndrome	615583	VRJS	604819	8q24.3
Vertical talus, congenital	192950	HOXD10	142984	2q31.1
Vertical talus, congenital	192950	HOX4D	142984	2q31.1
Vertigo, benign recurrent, 2	613106	BRV2		22q12
Vesicoureteral reflux	193000	VUR		1p13
Vesicoureteral reflux 2	610878	ROBO2	602431	3p12.3
Vesicoureteral reflux 2	610878	SAX3	602431	3p12.3
Vesicoureteral reflux 2	610878	KIAA1568	602431	3p12.3
Vesicoureteral reflux 3	613674	SOX17	610928	8q11.23
Vesicoureteral reflux 3	613674	VUR3	610928	8q11.23
Vesicoureteral reflux 4	614317	VUR4		5q14.2
Vesicoureteral reflux 5	614318	VUR5		13q33.2
Vesicoureteral reflux 6	614319	VUR6		18q12.3
Vesicoureteral reflux 7	615390	VUR7		12p11-q13
Vestibulopathy, familial	193007	BPPV		6q
Vici syndrome	242840	EPG5	615068	18q12.3-q21.1
Vici syndrome	242840	KIAA1632	615068	18q12.3-q21.1
Vici syndrome	242840	HEEW1	615068	18q12.3-q21.1
Vici syndrome	242840	VICIS	615068	18q12.3-q21.1
Vitamin D-dependent rickets, type I	264700	CYP27B1	609506	12q14.1
Vitamin D-dependent rickets, type I	264700	VDD1	609506	12q14.1
Vitamin D-dependent rickets, type I	264700	PDDR	609506	12q14.1
Vitamin K-dependent clotting factors, combined deficiency of, 2	607473	VKORC1	608547	16p11.2
Vitamin K-dependent clotting factors, combined deficiency of, 2	607473	VKOR	608547	16p11.2
Vitamin K-dependent clotting factors, combined deficiency of, 2	607473	VKCFD2	608547	16p11.2
Vitamin K-dependent clotting factors, combined deficiency of, 2	607473	FLJ00289	608547	16p11.2
Vitamin K-dependent coagulation defect	277450	GGCX	137167	2p11.2
Vitelliform macular dystrophy, adult-onset	608161	BEST1	607854	11q12.3
Vitelliform macular dystrophy, adult-onset	608161	VMD2	607854	11q12.3
Vitelliform macular dystrophy, adult-onset	608161	ARB	607854	11q12.3
Vitelliform macular dystrophy, adult-onset	608161	RP50	607854	11q12.3
Vitreoretinochoroidopathy	193220	BEST1	607854	11q12.3
Vitreoretinochoroidopathy	193220	VMD2	607854	11q12.3
Vitreoretinochoroidopathy	193220	ARB	607854	11q12.3
Vitreoretinochoroidopathy	193220	RP50	607854	11q12.3
Vitreoretinopathy with phalangeal epiphyseal dysplasia	120140	COL2A1		12q13.11
Vitreoretinopathy, neovascular inflammatory	193235	VRNI		11q13
Vohwinkel syndrome with ichthyosis	604117	LOR	152445	1q21.3
Vohwinkel syndrome	124500	GJB2	121011	13q12.11
Vohwinkel syndrome	124500	CX26	121011	13q12.11
Vohwinkel syndrome	124500	DFNB1A	121011	13q12.11
Vohwinkel syndrome	124500	PPK	121011	13q12.11
Vohwinkel syndrome	124500	DFNA3A	121011	13q12.11
Vohwinkel syndrome	124500	KID	121011	13q12.11
Vohwinkel syndrome	124500	HID	121011	13q12.11
WAGRO syndrome	612469	WAGRO		11p13-p12
WAGRO syndrome	612469	DEL11p14p12		11p13-p12
WHIM syndrome	193670	CXCR4	162643	2q22.1
WHIM syndrome	193670	D2S201E	162643	2q22.1
WHIM syndrome	193670	NPY3R	162643	2q22.1
WHIM syndrome	193670	WHIM	162643	2q22.1
Waardenburg syndrome, type 1	193500	PAX3	606597	2q36.1
Waardenburg syndrome, type 1	193500	WS1	606597	2q36.1
Waardenburg syndrome, type 1	193500	HUP2	606597	2q36.1
Waardenburg syndrome, type 1	193500	CDHS	606597	2q36.1
Waardenburg syndrome, type 1	193500	WS3	606597	2q36.1
Waardenburg syndrome, type 2A	193510	MITF	156845	3p14-p13
Waardenburg syndrome, type 2A	193510	WS2A	156845	3p14-p13
Waardenburg syndrome, type 2A	193510	CMM8	156845	3p14-p13
Waardenburg syndrome, type 2B	600193	WS2B		1p21-p13.3
Waardenburg syndrome, type 2C	606662	WS2C		8p23
Waardenburg syndrome, type 2D	608890	SNAI2	602150	8q11.21
Waardenburg syndrome, type 2D	608890	SLUG	602150	8q11.21
Waardenburg syndrome, type 2D	608890	WS2D	602150	8q11.21
Waardenburg syndrome, type 2E, with or without neurologic involvement	611584	SOX10	602229	22q13.1
Waardenburg syndrome, type 2E, with or without neurologic involvement	611584	WS4	602229	22q13.1
Waardenburg syndrome, type 2E, with or without neurologic involvement	611584	WS4C	602229	22q13.1
Waardenburg syndrome, type 2E, with or without neurologic involvement	611584	PCWH	602229	22q13.1
Waardenburg syndrome, type 3	148820	PAX3	606597	2q36.1
Waardenburg syndrome, type 3	148820	WS1	606597	2q36.1
Waardenburg syndrome, type 3	148820	HUP2	606597	2q36.1
Waardenburg syndrome, type 3	148820	CDHS	606597	2q36.1
Waardenburg syndrome, type 3	148820	WS3	606597	2q36.1
Waardenburg syndrome, type 4A	277580	EDNRB	131244	13q22.3
Waardenburg syndrome, type 4A	277580	HSCR2	131244	13q22.3
Waardenburg syndrome, type 4A	277580	ABCDS	131244	13q22.3
Waardenburg syndrome, type 4A	277580	WS4A	131244	13q22.3
Waardenburg syndrome, type 4B	613265	EDN3	131242	20q13.32
Waardenburg syndrome, type 4B	613265	WS4B	131242	20q13.32
Waardenburg syndrome, type 4B	613265	HSCR4	131242	20q13.32
Waardenburg syndrome, type 4C	613266	SOX10	602229	22q13.1
Waardenburg syndrome, type 4C	613266	WS4	602229	22q13.1
Waardenburg syndrome, type 4C	613266	WS4C	602229	22q13.1
Waardenburg syndrome, type 4C	613266	PCWH	602229	22q13.1
Waardenburg syndrome/albinism, digenic	103470	TYR	606933	11q14.3
Waardenburg syndrome/albinism, digenic	103470	SHEP3	606933	11q14.3
Waardenburg syndrome/albinism, digenic	103470	CMM8	606933	11q14.3
Waardenburg syndrome/albinism, digenic	103470	OCA1A	606933	11q14.3
Waardenburg syndrome/albinism, digenic	103470	ATN	606933	11q14.3
Waardenburg syndrome/ocular albinism, digenic	103470	MITF	156845	3p14-p13
Waardenburg syndrome/ocular albinism, digenic	103470	WS2A	156845	3p14-p13
Waardenburg syndrome/ocular albinism, digenic	103470	CMM8	156845	3p14-p13
Wagner syndrome 1	143200	VCAN	118661	5q14.2-q14.3
Wagner syndrome 1	143200	CSPG2	118661	5q14.2-q14.3
Wagner syndrome 1	143200	WGN	118661	5q14.2-q14.3
Wagner syndrome 1	143200	WGN1	118661	5q14.2-q14.3
Wagner syndrome 1	143200	ERVR	118661	5q14.2-q14.3
Waisman parkinsonism-mental retardation syndrome	311510	WSN		Xq28
Waisman parkinsonism-mental retardation syndrome	311510	BGMR		Xq28
Warburg micro syndrome 1	600118	RAB3GAP1	602536	2q21.3
Warburg micro syndrome 1	600118	WARBM1	602536	2q21.3
Warburg micro syndrome 1	600118	P130	602536	2q21.3
Warburg micro syndrome 2	614225	RAB3GAP2	609275	1q41
Warburg micro syndrome 2	614225	RAB3GAP150	609275	1q41
Warburg micro syndrome 2	614225	p150	609275	1q41
Warburg micro syndrome 2	614225	KIAA0839	609275	1q41
Warburg micro syndrome 2	614225	WARBM2	609275	1q41
Warburg micro syndrome 3	614222	RAB18	602207	10p12.1
Warburg micro syndrome 3	614222	WARBM3	602207	10p12.1
Warfarin resistance	122700	VKORC1	608547	16p11.2
Warfarin resistance	122700	VKOR	608547	16p11.2
Warfarin resistance	122700	VKCFD2	608547	16p11.2
Warfarin resistance	122700	FLJ00289	608547	16p11.2
Warfarin sensitivity	122700	CYP2C9	601130	10q23.33
Warsaw breakage syndrome	613398	DDX11	601150	12p11.21
Warsaw breakage syndrome	613398	CHLR1	601150	12p11.21
Warsaw breakage syndrome	613398	KRG2	601150	12p11.21
Watson syndrome	193520	NF1	613113	17q11.2
Watson syndrome	193520	VRNF	613113	17q11.2
Watson syndrome	193520	WSS	613113	17q11.2
Watson syndrome	193520	NFNS	613113	17q11.2
Weaver syndrome	277590	EZH2	601573	7q36.1
Weaver syndrome	277590	EZH1	601573	7q36.1
Weaver syndrome	277590	WVS	601573	7q36.1
Wegener granulomatosis	608710	WG		6p21.3
Wegener-like granulomatosis		TAP2	170261	6p21.32
Wegener-like granulomatosis		ABCB3	170261	6p21.32
Wegener-like granulomatosis		PSF2	170261	6p21.32
Wegener-like granulomatosis		RING11	170261	6p21.32
Weill-Marchesani syndrome 1, recessive	277600	ADAMTS10	608990	19p13.2
Weill-Marchesani syndrome 1, recessive	277600	WMS1	608990	19p13.2
Weill-Marchesani syndrome 2, dominant	608328	FBN1	134797	15q21.1
Weill-Marchesani syndrome 2, dominant	608328	MFS1	134797	15q21.1
Weill-Marchesani syndrome 2, dominant	608328	WMS2	134797	15q21.1
Weill-Marchesani syndrome 2, dominant	608328	SSKS	134797	15q21.1
Weill-Marchesani syndrome 2, dominant	608328	GPHYSD2	134797	15q21.1
Weill-Marchesani syndrome 2, dominant	608328	ACMICD	134797	15q21.1
Weill-Marchesani syndrome 2, dominant	608328	ECTOL1	134797	15q21.1
Weill-Marchesani syndrome 3, recessive	614819	LTBP2	602091	14q24.3
Weill-Marchesani syndrome 3, recessive	614819	LTBP3	602091	14q24.3
Weill-Marchesani syndrome 3, recessive	614819	GLC3D	602091	14q24.3
Weill-Marchesani syndrome 3, recessive	614819	MSPKA	602091	14q24.3
Weill-Marchesani syndrome 3, recessive	614819	WMS3	602091	14q24.3
Weill-Marchesani-like syndrome	613195	ADAMTS17	607511	15q26.3
Weissenbacher-Zweymuller syndrome	277610	COL11A2	120290	6p21.32
Weissenbacher-Zweymuller syndrome	277610	STL3	120290	6p21.32
Weissenbacher-Zweymuller syndrome	277610	DFNA13	120290	6p21.32
Weissenbacher-Zweymuller syndrome	277610	DFNB53	120290	6p21.32
Weissenbacher-Zweymuller syndrome	277610	FBCG2	120290	6p21.32
Welander distal myopathy	604454	WDM		2p13
Welander distal myopathy	604454	TIA1	603518	2p13.3
Welander distal myopathy	604454	WDM	603518	2p13.3
Werner syndrome	277700	RECQL2	604611	8p12
Werner syndrome	277700	RECQ3	604611	8p12
Werner syndrome	277700	WRN	604611	8p12
Weyers acrodental dysostosis	193530	EVC	604831	4p16.2
White sponge nevus	193900	KRT13	148065	17q21.2
White sponge nevus	193900	KRT4	123940	12q13.13
White sponge nevus	193900	CYK4	123940	12q13.13
Wieacker-Wolf syndrome	314580	ZC4H2	300897	Xq11.2
Wieacker-Wolf syndrome	314580	KIAA1166	300897	Xq11.2
Wieacker-Wolf syndrome	314580	WRWF	300897	Xq11.2
Wiedemann-Steiner syndrome	605130	MLL	159555	11q23.3
Wiedemann-Steiner syndrome	605130	HRX	159555	11q23.3
Wiedemann-Steiner syndrome	605130	HTRX1	159555	11q23.3
Wiedemann-Steiner syndrome	605130	WDSTS	159555	11q23.3
Williams-Beuren syndrome	194050	WBS		7q11.23
Williams-Beuren syndrome	194050	WMS		7q11.23
Williams-Beuren syndrome	194050	WS		7q11.23
Williams-Beuren syndrome	194050	DEL7q11		7q11.23
Williams-Beuren syndrome	194050	C7DELq11		7q11.23
Wilms tumor 2	194071	H19	103280	11p15.5
Wilms tumor 2	194071	D11S813E	103280	11p15.5
Wilms tumor 2	194071	ASM1	103280	11p15.5
Wilms tumor 2	194071	BWS	103280	11p15.5
Wilms tumor 2	194071	WT2	103280	11p15.5
Wilms tumor	194070	BRCA2	600185	13q13.1
Wilms tumor	194070	FANCD1	600185	13q13.1
Wilms tumor	194070	BROVCA2	600185	13q13.1
Wilms tumor	194070	GLM3	600185	13q13.1
Wilms tumor	194070	PNCA2	600185	13q13.1
Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome	194072	DEL11p13		11p13
Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome	194072	C11DELp13		11p13
Wilms tumor, aniridia, genitourinary anomalies and mental retardation syndrome	194072	WAGR		11p13
Wilms tumor, somatic	194070	GPC3	300037	Xq26.2
Wilms tumor, somatic	194070	SDYS	300037	Xq26.2
Wilms tumor, somatic	194070	SGBS1	300037	Xq26.2
Wilms tumor, type 1	194070	WT1	607102	11p13
Wilms tumor, type 1	194070	NPHS4	607102	11p13
Wilms tumor, type 3	194090	WT3		16q
Wilms tumor, type 4	601363	WT4		17q12-q21
Wilson disease	277900	ATP7B	606882	13q14.3
Wilson disease	277900	WND	606882	13q14.3
Wilson-Turner syndrome	309585	HDAC8	300269	Xq13.1
Wilson-Turner syndrome	309585	WTS	300269	Xq13.1
Wilson-Turner syndrome	309585	MRXS6	300269	Xq13.1
Wilson-Turner syndrome	309585	CDLS5	300269	Xq13.1
Wiskott-Aldrich syndrome 2	614493	WIPF1	602357	2q31.1
Wiskott-Aldrich syndrome 2	614493	WASPIP	602357	2q31.1
Wiskott-Aldrich syndrome 2	614493	WIP	602357	2q31.1
Wiskott-Aldrich syndrome	301000	WAS	300392	Xp11.23
Wiskott-Aldrich syndrome	301000	IMD2	300392	Xp11.23
Wiskott-Aldrich syndrome	301000	THC1	300392	Xp11.23
Wiskott-Aldrich syndrome	301000	SCNX	300392	Xp11.23
Wolcott-Rallison syndrome	226980	EIF2AK3	604032	2p11.2
Wolcott-Rallison syndrome	226980	PEK	604032	2p11.2
Wolcott-Rallison syndrome	226980	PERK	604032	2p11.2
Wolcott-Rallison syndrome	226980	WRS	604032	2p11.2
Wolf-Hirschhorn syndrome	194190	WHS		4p16.3
Wolff-Parkinson-White syndrome	194200	PRKAG2	602743	7q36.1
Wolff-Parkinson-White syndrome	194200	WPWS	602743	7q36.1
Wolff-Parkinson-White syndrome	194200	CMH6	602743	7q36.1
Wolfram syndrome 2	604928	CISD2	611507	4q24
Wolfram syndrome 2	604928	WFS2	611507	4q24
Wolfram syndrome 2	604928	ZCD2	611507	4q24
Wolfram syndrome 2	604928	ERIS	611507	4q24
Wolfram syndrome	222300	WFS1	606201	4p16.1
Wolfram syndrome	222300	WFRS	606201	4p16.1
Wolfram syndrome	222300	WFS	606201	4p16.1
Wolfram syndrome	222300	DFNA6	606201	4p16.1
Wolfram syndrome	222300	DFNA14	606201	4p16.1
Wolfram syndrome	222300	DFNA38	606201	4p16.1
Wolfram syndrome	222300	WFSL	606201	4p16.1
Wolfram syndrome	222300	CTRCT41	606201	4p16.1
Wolfram-like syndrome, autosomal dominant	614296	WFS1	606201	4p16.1
Wolfram-like syndrome, autosomal dominant	614296	WFRS	606201	4p16.1
Wolfram-like syndrome, autosomal dominant	614296	WFS	606201	4p16.1
Wolfram-like syndrome, autosomal dominant	614296	DFNA6	606201	4p16.1
Wolfram-like syndrome, autosomal dominant	614296	DFNA14	606201	4p16.1
Wolfram-like syndrome, autosomal dominant	614296	DFNA38	606201	4p16.1
Wolfram-like syndrome, autosomal dominant	614296	WFSL	606201	4p16.1
Wolfram-like syndrome, autosomal dominant	614296	CTRCT41	606201	4p16.1
Wolman disease	278000	LIPA	613497	10q23.31
Wolman disease	278000	CESD	613497	10q23.31
Wood neuroimmunologic syndrome	300076	INDX		Xq26-qter
Woodhouse-Sakati syndrome	241080	DCAF17	612515	2q31.1
Woodhouse-Sakati syndrome	241080	C20orf37	612515	2q31.1
Woolly hair, autosomal dominant	194300	KRT74	608248	12q13.13
Woolly hair, autosomal dominant	194300	K6IRS4	608248	12q13.13
Woolly hair, autosomal dominant	194300	KRT6IRS4	608248	12q13.13
Woolly hair, autosomal dominant	194300	HTSS2	608248	12q13.13
Woolly hair, autosomal recessive 1, with or without hypotrichosis	278150	LPAR6	609239	13q14.2
Woolly hair, autosomal recessive 1, with or without hypotrichosis	278150	P2RY5	609239	13q14.2
Woolly hair, autosomal recessive 1, with or without hypotrichosis	278150	P2Y5	609239	13q14.2
Woolly hair, autosomal recessive 1, with or without hypotrichosis	278150	LAH3	609239	13q14.2
Woolly hair, autosomal recessive 1, with or without hypotrichosis	278150	ARWH1	609239	13q14.2
Woolly hair, autosomal recessive 2 with or without hypotrichosis	604379	LIPH	607365	3q27.2
Woolly hair, autosomal recessive 2 with or without hypotrichosis	604379	LAH2	607365	3q27.2
Woolly hair, autosomal recessive 2 with or without hypotrichosis	604379	ARWH2	607365	3q27.2
Wrinkly skin syndrome	278250	ATP6V0A2	611716	12q24.31
Wrinkly skin syndrome	278250	WSS	611716	12q24.31
Wrinkly skin syndrome	278250	ARCL2A	611716	12q24.31
X inactivation, familial skewed, 2	300179	SXI2		Xq25-q26
X-inactivation, familial skewed	300087	XIC	314670	Xq13.2
X-inactivation, familial skewed	300087	XCE	314670	Xq13.2
X-inactivation, familial skewed	300087	XIST	314670	Xq13.2
X-inactivation, familial skewed	300087	SXI1	314670	Xq13.2
XFE progeroid syndrome	610965	ERCC4	133520	16p13.12
XFE progeroid syndrome	610965	XPF	133520	16p13.12
XFE progeroid syndrome	610965	FANCQ	133520	16p13.12
Xanthinuria, type I	278300	XDH	607633	2p23.1
Xeroderma pigmentosum, group A	278700	XPA	611153	9q22.33
Xeroderma pigmentosum, group A	278700	XPAC	611153	9q22.33
Xeroderma pigmentosum, group B	610651	ERCC3	133510	2q14.3
Xeroderma pigmentosum, group B	610651	XPB	133510	2q14.3
Xeroderma pigmentosum, group C	278720	XPC	613208	3p25.1
Xeroderma pigmentosum, group C	278720	XPCC	613208	3p25.1
Xeroderma pigmentosum, group D	278730	ERCC2	126340	19q13.32
Xeroderma pigmentosum, group D	278730	EM9	126340	19q13.32
Xeroderma pigmentosum, group D	278730	XPD	126340	19q13.32
Xeroderma pigmentosum, group D	278730	COFS2	126340	19q13.32
Xeroderma pigmentosum, group E, DDB-negative subtype	278740	DDB2	600811	11p11.2
Xeroderma pigmentosum, group F	278760	ERCC4	133520	16p13.12
Xeroderma pigmentosum, group F	278760	XPF	133520	16p13.12
Xeroderma pigmentosum, group F	278760	FANCQ	133520	16p13.12
Xeroderma pigmentosum, group G	278780	ERCC5	133530	13q33.1
Xeroderma pigmentosum, group G	278780	XPG	133530	13q33.1
Xeroderma pigmentosum, group G	278780	COFS3	133530	13q33.1
Xeroderma pigmentosum, group G/Cockayne syndrome	278780	ERCC5	133530	13q33.1
Xeroderma pigmentosum, group G/Cockayne syndrome	278780	XPG	133530	13q33.1
Xeroderma pigmentosum, group G/Cockayne syndrome	278780	COFS3	133530	13q33.1
Xeroderma pigmentosum, type F/Cockayne syndrome	278760	ERCC4	133520	16p13.12
Xeroderma pigmentosum, type F/Cockayne syndrome	278760	XPF	133520	16p13.12
Xeroderma pigmentosum, type F/Cockayne syndrome	278760	FANCQ	133520	16p13.12
Xeroderma pigmentosum, variant type	278750	POLH	603968	6p21.1
Xeroderma pigmentosum, variant type	278750	XPV	603968	6p21.1
Yunis-Varon syndrome	216340	FIG4	609390	6q21
Yunis-Varon syndrome	216340	KIAA0274	609390	6q21
Yunis-Varon syndrome	216340	SAC3	609390	6q21
Yunis-Varon syndrome	216340	ALS11	609390	6q21
Yunis-Varon syndrome	216340	YVS	609390	6q21
Zinc deficiency, transient neonatal	608118	SLC30A2	609617	1p36.11
Zinc deficiency, transient neonatal	608118	ZNT2	609617	1p36.11
Zinc deficiency, transient neonatal	608118	TNZD	609617	1p36.11
Zygodactyly 1	609815	ZD1		3p21.31
[?Homosexuality, male]		HMS1	306995	Xq28
[?Homosexuality, male]		GAY1	306995	Xq28
[?Hyperproglucagonemia]		GCG	138030	2q24.2
[AFP deficiency, congenital]	104150	AFP		4q13.3
[AFP deficiency, congenital]	104150	HPAFP		4q13.3
[AMP deaminase deficiency, erythrocytic]	612874	AMPD3	102772	11p15.4
[Acetylation, slow]	243400	NAT2	612182	8p22
[Acetylation, slow]	243400	AAC2	612182	8p22
[Alpha-actinin-3 deficiency]	102574	ACTN3		11q13.2
[Analgesia from kappa-opioid receptor agonist, female-specific]	613098	MC1R	155555	16q24.3
[Analgesia from kappa-opioid receptor agonist, female-specific]	613098	SHEP2	155555	16q24.3
[Analgesia from kappa-opioid receptor agonist, female-specific]	613098	CMM5	155555	16q24.3
[Angiotensin I-converting enzyme, benign serum increase]	106180	ACE		17q23.3
[Angiotensin I-converting enzyme, benign serum increase]	106180	DCP1		17q23.3
[Angiotensin I-converting enzyme, benign serum increase]	106180	ACE1		17q23.3
[Angiotensin I-converting enzyme, benign serum increase]	106180	MVCD3		17q23.3
[Angiotensin I-converting enzyme, benign serum increase]	106180	ICH		17q23.3
[Anhaptoglobinemia]	614081	HP	140100	16q22.2
[Aquaporin-1 deficiency]		AQP1	107776	7p14.3
[Aquaporin-1 deficiency]		CHIP28	107776	7p14.3
[Aquaporin-1 deficiency]		CO	107776	7p14.3
[Axillary odor, variation in]	117800	ABCC11	607040	16q12.1
[Axillary odor, variation in]	117800	MRP8	607040	16q12.1
[Axillary odor, variation in]	117800	EWWD	607040	16q12.1
[Axillary odor, variation in]	117800	WW	607040	16q12.1
[Beta-glycopyranoside tasting]		RCBTB1	607867	13q14.2
[Beta-glycopyranoside tasting]		CLLD7	607867	13q14.2
[Beta-glycopyranoside tasting]		GLP	607867	13q14.2
[Bilirubin, serum level of, QTL1]	601816	UGT1A1	191740	2q37.1
[Bilirubin, serum level of, QTL1]	601816	UGT1	191740	2q37.1
[Bilirubin, serum level of, QTL1]	601816	GNT1	191740	2q37.1
[Bilirubin, serum level of, QTL1]	601816	BILIQTL1	191740	2q37.1
[Birbeck granule deficiency]	613393	CD207	604862	2p13.3
[Birbeck granule deficiency]	613393	LANGERIN	604862	2p13.3
[Birbeck granule deficiency]	613393	CLEC4K	604862	2p13.3
[Birth weight QTL 1]	613219	FGQTL2		7p15-p13
[Birth weight QTL 1]	613219	BWQTL1		7p15-p13
[Birth weight QTL 2]	613459	BWQTL2		3q25.3
[Birth weight QTL 3]	613460	FGQTL6		3q21
[Birth weight QTL 3]	613460	BWQTL3		3q21
[Birth weight QTL 3]	613460	PGQTL1		3q21
[Birth weight QTL4]	615192	BWQTL4		6p22.3
[Blood group Cromer]	613793	CD55	125240	1q32.2
[Blood group Cromer]	613793	DAF	125240	1q32.2
[Blood group Cromer]	613793	CROM	125240	1q32.2
[Blood group GIL]	607457	AQP3	600170	9p13.3
[Blood group, ABO system]	110300	ABO		9q34.2
[Blood group, Auberger system]	111200	LU	612773	19q13.32
[Blood group, Auberger system]	111200	AU	612773	19q13.32
[Blood group, Auberger system]	111200	BCAM	612773	19q13.32
[Blood group, Colton]	110450	AQP1	107776	7p14.3
[Blood group, Colton]	110450	CHIP28	107776	7p14.3
[Blood group, Colton]	110450	CO	107776	7p14.3
[Blood group, Diego]	110500	SLC4A1	109270	17q21.31
[Blood group, Diego]	110500	AE1	109270	17q21.31
[Blood group, Diego]	110500	EPB3	109270	17q21.31
[Blood group, Dombrock]	110600	ART4		12p12.3
[Blood group, Dombrock]	110600	DO		12p12.3
[Blood group, Dombrock]	110600	DOK1		12p12.3
[Blood group, Duffy system]	110700	DARC	613665	1q23.2
[Blood group, Duffy system]	110700	FY	613665	1q23.2
[Blood group, Duffy system]	110700	GPD	613665	1q23.2
[Blood group, Duffy system]	110700	WBCQ1	613665	1q23.2
[Blood group, Froese]	601551	SLC4A1	109270	17q21.31
[Blood group, Froese]	601551	AE1	109270	17q21.31
[Blood group, Froese]	601551	EPB3	109270	17q21.31
[Blood group, Gerbich]	110750	GYPC		2q14.3
[Blood group, Gerbich]	110750	GE		2q14.3
[Blood group, Gerbich]	110750	GPC		2q14.3
[Blood group, Ii]	110800	GCNT2	600429	6p24.3-p24.2
[Blood group, Ii]	110800	Ii	600429	6p24.3-p24.2
[Blood group, Ii]	110800	CTRCT13	600429	6p24.3-p24.2
[Blood group, Indian system]	609027	CD44	107269	11p13
[Blood group, Indian system]	609027	MDU2	107269	11p13
[Blood group, Indian system]	609027	MDU3	107269	11p13
[Blood group, Indian system]	609027	MIC4	107269	11p13
[Blood group, Indian system]	609027	IN	107269	11p13
[Blood group, John-Milton-Hagen system]	614745	SEMA7A	607961	15q24.1
[Blood group, John-Milton-Hagen system]	614745	SEMAL	607961	15q24.1
[Blood group, John-Milton-Hagen system]	614745	SEMAK1	607961	15q24.1
[Blood group, John-Milton-Hagen system]	614745	CDW108	607961	15q24.1
[Blood group, John-Milton-Hagen system]	614745	JMH	607961	15q24.1
[Blood group, Kell]	110900	KEL	613883	7q34
[Blood group, Kidd]	111000	SLC14A1	613868	18q12.3
[Blood group, Kidd]	111000	JK	613868	18q12.3
[Blood group, Kidd]	111000	UTE	613868	18q12.3
[Blood group, Kidd]	111000	UT1	613868	18q12.3
[Blood group, Knops system]	607486	CR1	120620	1q32.2
[Blood group, Knops system]	607486	C3BR	120620	1q32.2
[Blood group, Landsteiner-Wiener]	111250	ICAM4	614088	19p13.2
[Blood group, Landsteiner-Wiener]	111250	CD242	614088	19p13.2
[Blood group, Landsteiner-Wiener]	111250	LW	614088	19p13.2
[Blood group, Langereis system]	111600	ABCB6	605452	2q35
[Blood group, Langereis system]	111600	MTABC3	605452	2q35
[Blood group, Langereis system]	111600	MCOPCB7	605452	2q35
[Blood group, Langereis system]	111600	LAN	605452	2q35
[Blood group, Langereis system]	111600	DUH3	605452	2q35
[Blood group, Lewis]	111100	FUT3		19p13.3
[Blood group, Lewis]	111100	LE		19p13.3
[Blood group, Lutheran null]	247420	LU	612773	19q13.32
[Blood group, Lutheran null]	247420	AU	612773	19q13.32
[Blood group, Lutheran null]	247420	BCAM	612773	19q13.32
[Blood group, Lutheran system]	111200	LU	612773	19q13.32
[Blood group, Lutheran system]	111200	AU	612773	19q13.32
[Blood group, Lutheran system]	111200	BCAM	612773	19q13.32
[Blood group, MN]	111300	GYPA		4q31.21
[Blood group, MN]	111300	MN		4q31.21
[Blood group, MN]	111300	GPA		4q31.21
[Blood group, OK]	111380	BSG	109480	19p13.3
[Blood group, P1PK system, P(k) phenotype]	111400	B3GALT3	603094	3q26.1
[Blood group, P1PK system, P(k) phenotype]	111400	GLCT3	603094	3q26.1
[Blood group, P1PK system, P(k) phenotype]	111400	GLOB	603094	3q26.1
[Blood group, P1Pk system, P(2) phenotype]	111400	A4GALT	607922	22q13.2
[Blood group, P1Pk system, P(2) phenotype]	111400	P1PK	607922	22q13.2
[Blood group, P1Pk system, p phenotype]	111400	A4GALT	607922	22q13.2
[Blood group, P1Pk system, p phenotype]	111400	P1PK	607922	22q13.2
[Blood group, Radin]	111620	ERMAP	609017	1p34.2
[Blood group, Radin]	111620	SC	609017	1p34.2
[Blood group, Radin]	111620	RD	609017	1p34.2
[Blood group, Raph]	179620	CD151	602243	11p15.5
[Blood group, Raph]	179620	PETA3	602243	11p15.5
[Blood group, Raph]	179620	SFA1	602243	11p15.5
[Blood group, Raph]	179620	MER2	602243	11p15.5
[Blood group, Rhesus]	111690	RHCE	111700	1p36.11
[Blood group, Rodgers]	614374	C4A	120810	6p21.33
[Blood group, Rodgers]	614374	C4S	120810	6p21.33
[Blood group, Rodgers]	614374	C4AD	120810	6p21.33
[Blood group, Scianna system]	111750	ERMAP	609017	1p34.2
[Blood group, Scianna system]	111750	SC	609017	1p34.2
[Blood group, Scianna system]	111750	RD	609017	1p34.2
[Blood group, Ss]	111740	GYPB		4q31.21
[Blood group, Ss]	111740	SS		4q31.21
[Blood group, Ss]	111740	MNS		4q31.21
[Blood group, Stoltzfus system]	111800	SF		4q28-q31
[Blood group, Swann]	601550	SLC4A1	109270	17q21.31
[Blood group, Swann]	601550	AE1	109270	17q21.31
[Blood group, Swann]	601550	EPB3	109270	17q21.31
[Blood group, Vel system]	615264	SMIM1	615242	1p36.32
[Blood group, Vel system]	615264	VEL	615242	1p36.32
[Blood group, Waldner]	112010	SLC4A1	109270	17q21.31
[Blood group, Waldner]	112010	AE1	109270	17q21.31
[Blood group, Waldner]	112010	EPB3	109270	17q21.31
[Blood group, Wright]	112050	SLC4A1	109270	17q21.31
[Blood group, Wright]	112050	AE1	109270	17q21.31
[Blood group, Wright]	112050	EPB3	109270	17q21.31
[Blood group, XG system]		XG	314700	Xpter-p22.32
[Blood group, Yt system]	112100	ACHE	100740	7q22.1
[Blood group, Yt system]	112100	YT	100740	7q22.1
[Blood group, globoside system]	615021	B3GALT3	603094	3q26.1
[Blood group, globoside system]	615021	GLCT3	603094	3q26.1
[Blood group, globoside system]	615021	GLOB	603094	3q26.1
[Blood pressure regulation QTL]	145500	ATP1B1	182330	1q24.2
[Blood pressure regulation QTL]	145500	RGS5	603276	1q23.3
[Blood pressure regulation QTL]	145500	SELE	131210	1q24.2
[Blood pressure regulation QTL]	145500	ELAM1	131210	1q24.2
[Body mass index QTL 15]	612967	BMIQ15		17q23.2-q25.1
[Body mass index QTL13]	612459	BMIQ13		2q14.1
[Body mass index QTL14]	612460	BMIQ14		16q12.2
[Body mass index QTL16]	613444	BMIQ16		16p11.2
[Body mass index QTL16]	613444	DEL16p.11.2		16p11.2
[Body mass index QTL16]	613444	C16DELp11.2		16p11.2
[Body mass index QTL1]	606641	BMIQ1		7q32.3
[Body mass index QTL2]	606643	BMIQ2		13q14
[Body mass index QTL3]	607446	BMIQ3		6q23-q25
[Body mass index QTL5]	608558	BMIQ5		16p13
[Body mass index QTL6]	608559	BMIQ6		20pter-p11.2
[Bombay phenotype]	211100	FUT1		19q13.33
[Bombay phenotype]	211100	H		19q13.33
[Bombay phenotype]	211100	HH		19q13.33
[Bombay phenotype]	182100	FUT2		19q13.33
[Bombay phenotype]	182100	SE		19q13.33
[Bombay phenotype]	182100	B12QTL1		19q13.33
[Bone mineral density QTL 10]	612113	BMND10		8q24
[Bone mineral density QTL 11]	612114	BMND11		6q25
[Bone mineral density QTL 13]	612727	BMND13		16q23
[Bone mineral density QTL 14]	612728	BMND14		1p33-p32
[Bone mineral density QTL 15]	613418	MIR2861	613405	9q34.11
[Bone mineral density QTL 15]	613418	MIRN2861	613405	9q34.11
[Bone mineral density QTL 15]	613418	BMND15	613405	9q34.11
[Bone mineral density QTL 2]	605833	BMND2		1q21-q23
[Bone mineral density QTL 3]	606928	BMND3		1p36
[Bone mineral density QTL 4]	300536	BMND4		Xq27
[Bone mineral density QTL 5]	609354	BMND5		11q23
[Bone mineral density QTL 6]	609876	BMND6		21q22.13-qter
[Bone mineral density QTL 9]	612110	BMND9		13q14
[Bone mineral density variability 1]	601884	LRP5	603506	11q13.2
[Bone mineral density variability 1]	601884	BMND1	603506	11q13.2
[Bone mineral density variability 1]	601884	LRP7	603506	11q13.2
[Bone mineral density variability 1]	601884	LR3	603506	11q13.2
[Bone mineral density variability 1]	601884	OPPG	603506	11q13.2
[Bone mineral density variability 1]	601884	VBCH2	603506	11q13.2
[Bone mineral density variability 1]	601884	OPTA1	603506	11q13.2
[Bone mineral density variability 1]	601884	EVR4	603506	11q13.2
[Bone mineral density variation QTL]	166710	COL1A1	120150	17q21.33
[Bone size quantitative trait locus 3]	610649	BSZQTL3		8q24
[C-reactive protein QTL]	611920	CPROTQ		10q23-q24
[C3HEX, ability to smell]	615082	OR2J3	615016	6p22.1
[C3HEX, ability to smell]	615082	C3HEXS	615016	6p22.1
[Chitotriosidase deficiency]	614122	CHIT	600031	1q32.1
[Chitotriosidase deficiency]	614122	CHITD	600031	1q32.1
[Cholesterol level QTL 1]	604595	CLQTL1		13q
[Cholesterol level QTL 1]	604595	CLF		13q
[Cholesterol level QTL 2]	610760	CLQTL2		2p24-p22
[Cinnamon odor, pleasantness of]	611109	CINN		4q32.3
[Colostrum secretion, variation in]	117800	ABCC11	607040	16q12.1
[Colostrum secretion, variation in]	117800	MRP8	607040	16q12.1
[Colostrum secretion, variation in]	117800	EWWD	607040	16q12.1
[Colostrum secretion, variation in]	117800	WW	607040	16q12.1
[Creatine kinase, brain type, ectopic expression of]		CKBE	123270	14q32
[Dopamine-beta-hydroxylase activity levels, plasma]		DBH	609312	9q34.2
[Dysalbuminemic hyperthyroxinemia]	103600	ALB		4q13.3
[Dysalbuminemic hyperzincemia]	194470	ALB	103600	4q13.3
[Dystransthyretinemic hyperthyroxinemia]	145680	TTR	176300	18q12.1
[Dystransthyretinemic hyperthyroxinemia]	145680	PALB	176300	18q12.1
[Earwax, wet/dry]	117800	ABCC11	607040	16q12.1
[Earwax, wet/dry]	117800	MRP8	607040	16q12.1
[Earwax, wet/dry]	117800	EWWD	607040	16q12.1
[Earwax, wet/dry]	117800	WW	607040	16q12.1
[Erythrocytosis, familial, 1]	133100	EPOR	133171	19p13.2
[Ezetimibe, nonresponse to]	608010	NPC1L1		7p13
[Fasting insulin level quantitative trait locus 1]	606035	FIQTL1		6q22-q24
[Fasting plasma glucose level QTL 1]	612108	FGQTL1		2q24-q32
[Fasting plasma glucose level QTL 2]	613219	FGQTL2		7p15-p13
[Fasting plasma glucose level QTL 2]	613219	BWQTL1		7p15-p13
[Fasting plasma glucose level QTL 3]	613233	FGQTL3		11q21-q22
[Fasting plasma glucose level QTL 4]	613462	FGQTL4		7p21.2
[Fasting plasma glucose level QTL 5]	613463	GCKR	600842	2p23.3
[Fasting plasma glucose level QTL 5]	613463	GKRP	600842	2p23.3
[Fasting plasma glucose level QTL 5]	613463	FGQTL5	600842	2p23.3
[Fasting plasma glucose level QTL 6]	613460	FGQTL6		3q21
[Fasting plasma glucose level QTL 6]	613460	BWQTL3		3q21
[Fasting plasma glucose level QTL 6]	613460	PGQTL1		3q21
[Fetal hemoglobin QTL5]	142335	HBFQTL5		7q36
[Fructosuria]	229800	KHK	614058	2p23.3
[Gamma-glutamyltransferase, familial high serum]		GGT2	137181	22q11.21
[Gilbert syndrome]	143500	UGT1A1	191740	2q37.1
[Gilbert syndrome]	143500	UGT1	191740	2q37.1
[Gilbert syndrome]	143500	GNT1	191740	2q37.1
[Gilbert syndrome]	143500	BILIQTL1	191740	2q37.1
[Glutaric aciduria III]	231690	C7orf10	609187	7p14.1
[Glycerol quantitative trait locus]	614411	AQP7	602974	9p13.3
[Glycerol quantitative trait locus]	614411	GLYCQTL	602974	9p13.3
[Glyoxalase II deficiency]	614033	HAGH	138760	16p13.3
[Glyoxalase II deficiency]	614033	GLO2	138760	16p13.3
[Hair morphology 1, hair thickness]	612630	EDAR	604095	2q12.3
[Hair morphology 1, hair thickness]	612630	DL	604095	2q12.3
[Hair morphology 1, hair thickness]	612630	ED3	604095	2q12.3
[Hair morphology 1, hair thickness]	612630	EDA3	604095	2q12.3
[Hair morphology 1, hair thickness]	612630	HRM1	604095	2q12.3
[Hair morphology 1, hair thickness]	612630	ECTD10A	604095	2q12.3
[Hair morphology 1, hair thickness]	612630	ECTD10B	604095	2q12.3
[Handedness]	139900	HSR		2p12-q22
[Hematocrit/hemoglobin quantitative trait locus 1]	609319	HCHGQ1		6q23
[Hematocrit/hemoglobin quantitative trait locus 2]	609320	HCHGQ2		9q
[Hematocrit/hemoglobin quantitative trait locus 3]	613284	HCHGQ3		22q12-q13
[Hereditary persistence of alpha-fetoprotein]	104150	AFP		4q13.3
[Hereditary persistence of alpha-fetoprotein]	104150	HPAFP		4q13.3
[Hereditary persistence of fetal hemoglobin]	613566	KLF1	600599	19p13.2
[Hereditary persistence of fetal hemoglobin]	613566	EKLF	600599	19p13.2
[Hereditary persistence of fetal hemoglobin]	613566	INLU	600599	19p13.2
[Hereditary persistence of fetal hemoglobin]	613566	HBFQTL6	600599	19p13.2
[Hereditary persistence of fetal hemoglobin]	613566	CDAN4	600599	19p13.2
[Hex A pseudodeficiency]	272800	HEXA	606869	15q23
[Hex A pseudodeficiency]	272800	TSD	606869	15q23
[High density lipoprotein cholesterol level QTL 10]	143470	CETP	118470	16q13
[High density lipoprotein cholesterol level QTL 10]	143470	HDLCQ10	118470	16q13
[High density lipoprotein cholesterol level QTL 11]	609708	LPL		8p21.3
[High density lipoprotein cholesterol level QTL 11]	609708	LIPD		8p21.3
[High density lipoprotein cholesterol level QTL 11]	609708	HDLCQ11		8p21.3
[High density lipoprotein cholesterol level QTL 12]	612797	LIPC	151670	15q21.3
[High density lipoprotein cholesterol level QTL 12]	612797	HL	151670	15q21.3
[High density lipoprotein cholesterol level QTL 12]	612797	LIPH	151670	15q21.3
[High density lipoprotein cholesterol level QTL 12]	612797	HDLCQ12	151670	15q21.3
[High density lipoprotein cholesterol level QTL 1]	606613	HDLCQ1		9p
[High density lipoprotein cholesterol level QTL 2]	607053	HDLCQ2		8q23
[High density lipoprotein cholesterol level QTL 4]	610239	HDLCQ4		4q32.3
[High density lipoprotein cholesterol level QTL 5]	610761	HDLCQ5		3q24-q26
[High density lipoprotein cholesterol level QTL 8]	603570	VNN1		6q23.2
[High density lipoprotein cholesterol level QTL 8]	603570	HDLCQ8		6q23.2
[High density lipoprotein cholesterol level QTL 9]	172425	PLTP		20q13.12
[High density lipoprotein cholesterol level QTL 9]	172425	HDLCQ9		20q13.12
[High density lipoprotien cholesterol level QTL6]	610762	SCARB1	601040	12q24.31
[High density lipoprotien cholesterol level QTL6]	610762	CD36L1	601040	12q24.31
[High density lipoprotien cholesterol level QTL6]	610762	CLA1	601040	12q24.31
[High density lipoprotien cholesterol level QTL6]	610762	HDLQTL6	601040	12q24.31
[High molecular weight kininogen deficiency]	228960	KNG1	612358	3q27.3
[High molecular weight kininogen deficiency]	228960	KNG	612358	3q27.3
[Histidinemia]	235800	HAL	609457	12q23.1
[Histidinemia]	235800	HSTD	609457	12q23.1
[Hyperphenylalaninemia, non-PKU mild]	261600	PAH	612349	12q23.2
[Hyperphenylalaninemia, non-PKU mild]	261600	PKU1	612349	12q23.2
[Hyperproreninemia]		REN	179820	1q32.1
[Hyperproreninemia]		HNFJ2	179820	1q32.1
[Hypoceruloplasminemia, hereditary]	604290	CP	117700	3q24-q25
[Hypohaptoglobinemia]	614081	HP	140100	16q22.2
[IMPDH2 enzyme activity, variation in]	146691	IMPDH2		3p21.31
[IMPDH2 enzyme activity, variation in]	146691	IMPD2		3p21.31
[IgE levels QTL]	147050	PHF11	607796	13q14.2
[IgE levels QTL]	147050	NYREN34	607796	13q14.2
[IgE, elevated level of]	147050	IL21R	605383	16p12.1
[IgG receptor I, phagocytic, familial deficiency of]		FCGR1A	146760	1q21.2
[IgG receptor I, phagocytic, familial deficiency of]		IGFR1	146760	1q21.2
[IgG receptor I, phagocytic, familial deficiency of]		CD64	146760	1q21.2
[Inosine triphosphatase deficiency]	613850	ITPA	147520	20p13
[Interleukin 6, serum level of, QTL]	614752	IL6R	147880	1q21.3
[Interleukin 6, serum level of, QTL]	614752	IL6RQ	147880	1q21.3
[Interleukin 6, serum level of, QTL]	614752	IL6Q	147880	1q21.3
[Interleukin-6 receptor, soluble, serum level of, QTL]	614689	IL6R	147880	1q21.3
[Interleukin-6 receptor, soluble, serum level of, QTL]	614689	IL6RQ	147880	1q21.3
[Interleukin-6 receptor, soluble, serum level of, QTL]	614689	IL6Q	147880	1q21.3
[Junior blood group system]	614490	ABCG2	603756	4q22.1
[Junior blood group system]	614490	BCRP	603756	4q22.1
[Junior blood group system]	614490	ABCP	603756	4q22.1
[Junior blood group system]	614490	UAQTL1	603756	4q22.1
[Junior blood group system]	614490	GOUT1	603756	4q22.1
[Kallikrein, decreased urinary activity of]	147910	KLK1		19q13.33
[Kallikrein, decreased urinary activity of]	147910	KLKR		19q13.33
[Kappa light chain deficiency]	614102	IGKC	147200	2p11.2
[Kappa light chain deficiency]	614102	IGKCD	147200	2p11.2
[Kininogen deficiency]	228960	KNG1	612358	3q27.3
[Kininogen deficiency]	228960	KNG	612358	3q27.3
[LPA deficiency, congenital]	152200	LPA		6q25-q26
[Lean body mass QTL 1]	612729	LBMQTL1		8q23
[Leptin serum levels QTL1]	601694	LEPQTL1		2p21
[Leptin serum levels QTL1]	601694	LSL		2p21
[Longevity 1]	152430	LGV1		4q25
[Longevity 2]	606460	LGV2		6q21
[Low density lipoprotein cholesterol level QTL 3]	142910	HMGCR		5q13.3
[Low density lipoprotein cholesterol level QTL 3]	142910	LDLCQ3		5q13.3
[Low density lipoprotein cholesterol level QTL6]	613589	SORT1	602458	1p13.3
[Low density lipoprotein cholesterol level QTL6]	613589	NT3	602458	1p13.3
[Low density lipoprotein cholesterol level QTL6]	613589	LDLCQ6	602458	1p13.3
[Macrothrombocytopenia]		CD36	173510	7q21.11
[Macrothrombocytopenia]		CHDS7	173510	7q21.11
[Macrothrombocytopenia]		BDPLT10	173510	7q21.11
[Malaria, resistance to]	611162	SLC4A1	109270	17q21.31
[Malaria, resistance to]	611162	AE1	109270	17q21.31
[Malaria, resistance to]	611162	EPB3	109270	17q21.31
[Mean platelet volume QTL1]	612573	MPVQTL1		12q24.31
[Mean platelet volume QTL2]	612574	MPVQTL2		3p21-p13
[Mean platelet volume QTL3]	612575	MPVQTL3		17q11.2
[Memory, enhanced, QTL]	615602	WWC1	610533	5q34
[Memory, enhanced, QTL]	615602	KIBRA	610533	5q34
[Memory, enhanced, QTL]	615602	KIAA0869	610533	5q34
[Memory, enhanced, QTL]	615602	MEMRYQTL	610533	5q34
[Musical aptitude QTL 1]	612343	MUSQTL1		4q22
[Neutral endopeptidase deficiency]		MME	120520	3q25.2
[Neutral endopeptidase deficiency]		CD10	120520	3q25.2
[Neutral endopeptidase deficiency]		CALLA	120520	3q25.2
[Neutral endopeptidase deficiency]		NEP	120520	3q25.2
[Novelty seeking personality]	601696	DRD4	126452	11p15.5
[Obesity, resistance to]		PPARG	601487	3p25.2
[Obesity, resistance to]		PPARG1	601487	3p25.2
[Obesity, resistance to]		PPARG2	601487	3p25.2
[Obesity, resistance to]		CIMT1	601487	3p25.2
[Obesity, resistance to]		GLM1	601487	3p25.2
[Phenylthiocarbamide tasting]	171200	TAS2R38	607751	7q34
[Phenylthiocarbamide tasting]	171200	T2R61	607751	7q34
[Phenylthiocarbamide tasting]	171200	PTC	607751	7q34
[Phosphohydroxylysinuria]	615011	AGXT2L2	614683	5q35.3
[Phosphohydroxylysinuria]	615011	PHLU	614683	5q35.3
[Placental lactogen deficiency]		CSH1	150200	17q23.3
[Placental lactogen deficiency]		CSA	150200	17q23.3
[Placental lactogen deficiency]		PL	150200	17q23.3
[Plasma glucose, 2-hour, QTL 1]	613460	FGQTL6		3q21
[Plasma glucose, 2-hour, QTL 1]	613460	BWQTL3		3q21
[Plasma glucose, 2-hour, QTL 1]	613460	PGQTL1		3q21
[Plasma glucose, 2-hour, QTL 2]	137241	GIPR		19q13.32
[Plasma glucose, 2-hour, QTL 2]	137241	PGQTL2		19q13.32
[Polyunsaturated fatty acids plasma level QTL1]	612795	PURAQTL1		11q12-q13.1
[Premature chromatid separation trait]	176430	BUB1B	602860	15q15.1
[Premature chromatid separation trait]	176430	BUBR1	602860	15q15.1
[Premature chromatid separation trait]	176430	MVA1	602860	15q15.1
[Protein Z deficiency]	614024	PROZ	176895	13q34
[Protein Z deficiency]	614024	PZ	176895	13q34
[QT interval, variation in]	610141	QTV		1q23.3
[Respiratory rhythmicity in sleep]	609116	RRIS		10q26
[Resting heart rate]	607276	ADRB1	109630	10q25.3
[Resting heart rate]	607276	ADRB1R	109630	10q25.3
[Resting heart rate]	607276	RHR	109630	10q25.3
[Rh-negative blood type]		RHD	111680	1p36.11
[Sarcosinemia]	268900	SARDH	604455	9q34.2
[Sarcosinemia]	268900	SARD	604455	9q34.2
[Sarcosinemia]	268900	SAR	604455	9q34.2
[Sex hormone-binding blobulin circulating level QTL 1]	613498	SXGQTL1		17p13
[Short sleeper]	612975	BHLHE41	606200	12p12.1
[Short sleeper]	612975	BHLHB3	606200	12p12.1
[Short sleeper]	612975	DEC2	606200	12p12.1
[Short sleeper]	612975	SHARP1	606200	12p12.1
[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	HERC2	605837	15q13.1
[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	SHEP1	605837	15q13.1
[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	MRT38	605837	15q13.1
[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	OCA2	611409	15q12-q13
[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	P	611409	15q12-q13
[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	PED	611409	15q12-q13
[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	D15S12	611409	15q12-q13
[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	BOCA	611409	15q12-q13
[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	EYCL3	611409	15q12-q13
[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	HCL3	611409	15q12-q13
[Skin/hair/eye pigmentation 1, blond/brown hair]	227220	SHEP1	611409	15q12-q13
[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	HERC2	605837	15q13.1
[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	SHEP1	605837	15q13.1
[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	MRT38	605837	15q13.1
[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	OCA2	611409	15q12-q13
[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	P	611409	15q12-q13
[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	PED	611409	15q12-q13
[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	D15S12	611409	15q12-q13
[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	BOCA	611409	15q12-q13
[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	EYCL3	611409	15q12-q13
[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	HCL3	611409	15q12-q13
[Skin/hair/eye pigmentation 1, blue/nonblue eyes]	227220	SHEP1	611409	15q12-q13
[Skin/hair/eye pigmentation 10, blond/brown hair]	612267	TPCN2	612163	11q13.3
[Skin/hair/eye pigmentation 10, blond/brown hair]	612267	TPC2	612163	11q13.3
[Skin/hair/eye pigmentation 10, blond/brown hair]	612267	SHEP10	612163	11q13.3
[Skin/hair/eye pigmentation 11, blue/nonblue eyes]	612271	SHEP11		9p23
[Skin/hair/eye pigmentation 2, blond hair/fair skin]	266300	MC1R	155555	16q24.3
[Skin/hair/eye pigmentation 2, blond hair/fair skin]	266300	SHEP2	155555	16q24.3
[Skin/hair/eye pigmentation 2, blond hair/fair skin]	266300	CMM5	155555	16q24.3
[Skin/hair/eye pigmentation 2, red hair/fair skin]	266300	MC1R	155555	16q24.3
[Skin/hair/eye pigmentation 2, red hair/fair skin]	266300	SHEP2	155555	16q24.3
[Skin/hair/eye pigmentation 2, red hair/fair skin]	266300	CMM5	155555	16q24.3
[Skin/hair/eye pigmentation 3, blue/green eyes]	601800	TYR	606933	11q14.3
[Skin/hair/eye pigmentation 3, blue/green eyes]	601800	SHEP3	606933	11q14.3
[Skin/hair/eye pigmentation 3, blue/green eyes]	601800	CMM8	606933	11q14.3
[Skin/hair/eye pigmentation 3, blue/green eyes]	601800	OCA1A	606933	11q14.3
[Skin/hair/eye pigmentation 3, blue/green eyes]	601800	ATN	606933	11q14.3
[Skin/hair/eye pigmentation 3, light/dark/freckling skin]	601800	TYR	606933	11q14.3
[Skin/hair/eye pigmentation 3, light/dark/freckling skin]	601800	SHEP3	606933	11q14.3
[Skin/hair/eye pigmentation 3, light/dark/freckling skin]	601800	CMM8	606933	11q14.3
[Skin/hair/eye pigmentation 3, light/dark/freckling skin]	601800	OCA1A	606933	11q14.3
[Skin/hair/eye pigmentation 3, light/dark/freckling skin]	601800	ATN	606933	11q14.3
[Skin/hair/eye pigmentation 4, fair/dark skin]	113750	SLC24A5	609802	15q21.1
[Skin/hair/eye pigmentation 4, fair/dark skin]	113750	NCKX5	609802	15q21.1
[Skin/hair/eye pigmentation 4, fair/dark skin]	113750	SHEP4	609802	15q21.1
[Skin/hair/eye pigmentation 4, fair/dark skin]	113750	OCA6	609802	15q21.1
[Skin/hair/eye pigmentation 5, black/nonblack hair]	227240	SLC45A2	606202	5p13.2
[Skin/hair/eye pigmentation 5, black/nonblack hair]	227240	MATP	606202	5p13.2
[Skin/hair/eye pigmentation 5, black/nonblack hair]	227240	AIM1	606202	5p13.2
[Skin/hair/eye pigmentation 5, black/nonblack hair]	227240	SHEP5	606202	5p13.2
[Skin/hair/eye pigmentation 5, black/nonblack hair]	227240	OCA4	606202	5p13.2
[Skin/hair/eye pigmentation 5, dark/fair skin]	227240	SLC45A2	606202	5p13.2
[Skin/hair/eye pigmentation 5, dark/fair skin]	227240	MATP	606202	5p13.2
[Skin/hair/eye pigmentation 5, dark/fair skin]	227240	AIM1	606202	5p13.2
[Skin/hair/eye pigmentation 5, dark/fair skin]	227240	SHEP5	606202	5p13.2
[Skin/hair/eye pigmentation 5, dark/fair skin]	227240	OCA4	606202	5p13.2
[Skin/hair/eye pigmentation 5, dark/light eyes]	227240	SLC45A2	606202	5p13.2
[Skin/hair/eye pigmentation 5, dark/light eyes]	227240	MATP	606202	5p13.2
[Skin/hair/eye pigmentation 5, dark/light eyes]	227240	AIM1	606202	5p13.2
[Skin/hair/eye pigmentation 5, dark/light eyes]	227240	SHEP5	606202	5p13.2
[Skin/hair/eye pigmentation 5, dark/light eyes]	227240	OCA4	606202	5p13.2
[Skin/hair/eye pigmentation 6, blond/brown hair]	210750	SLC24A4	609840	14q32.12
[Skin/hair/eye pigmentation 6, blond/brown hair]	210750	NCKX4	609840	14q32.12
[Skin/hair/eye pigmentation 6, blond/brown hair]	210750	SHEP6	609840	14q32.12
[Skin/hair/eye pigmentation 6, blue/green eyes]	210750	SLC24A4	609840	14q32.12
[Skin/hair/eye pigmentation 6, blue/green eyes]	210750	NCKX4	609840	14q32.12
[Skin/hair/eye pigmentation 6, blue/green eyes]	210750	SHEP6	609840	14q32.12
[Skin/hair/eye pigmentation 7, blond/brown hair]	611664	KITLG	184745	12q21.32
[Skin/hair/eye pigmentation 7, blond/brown hair]	611664	MGF	184745	12q21.32
[Skin/hair/eye pigmentation 7, blond/brown hair]	611664	SF	184745	12q21.32
[Skin/hair/eye pigmentation 7, blond/brown hair]	611664	SCF	184745	12q21.32
[Skin/hair/eye pigmentation 7, blond/brown hair]	611664	SHEP7	184745	12q21.32
[Skin/hair/eye pigmentation 8, freckling]	611724	SHEP8		6p25.3
[Skin/hair/eye pigmentation 9, brown/nonbrown eyes]	611742	ASIP	600201	20q11.22
[Skin/hair/eye pigmentation 9, brown/nonbrown eyes]	611742	AGTIL	600201	20q11.22
[Skin/hair/eye pigmentation 9, brown/nonbrown eyes]	611742	SHEP9	600201	20q11.22
[Skin/hair/eye pigmentation 9, dark/light hair]	611742	ASIP	600201	20q11.22
[Skin/hair/eye pigmentation 9, dark/light hair]	611742	AGTIL	600201	20q11.22
[Skin/hair/eye pigmentation 9, dark/light hair]	611742	SHEP9	600201	20q11.22
[Social cognition]	300082	CGF1		Xq
[Sodium serum level QTL 1]	613508	TRPV4	605427	12q24.11
[Sodium serum level QTL 1]	613508	VROAC	605427	12q24.11
[Sodium serum level QTL 1]	613508	HMSN2C	605427	12q24.11
[Sodium serum level QTL 1]	613508	CMT2C	605427	12q24.11
[Sodium serum level QTL 1]	613508	SPSMA	605427	12q24.11
[Sodium serum level QTL 1]	613508	SSQTL1	605427	12q24.11
[Sodium serum level QTL 1]	613508	SMAL	605427	12q24.11
[Sprinting performance]	102574	ACTN3		11q13.2
[Statins, attenuated cholesterol lowering by]	142910	HMGCR		5q13.3
[Statins, attenuated cholesterol lowering by]	142910	LDLCQ3		5q13.3
[Superoxide dismutase, elevated extracellular]		SOD3	185490	4p15.2
[Telomere length, mean leukocyte]	609113	TELM		14q23.2
[Thyroid-stimulating hormone level QTL 1]	612306	TSHQTL1		5q13
[Transferrin serum level QTL2]	614193	HFE	613609	6p22.2
[Transferrin serum level QTL2]	614193	HLA-H	613609	6p22.2
[Transferrin serum level QTL2]	614193	HFE1	613609	6p22.2
[Transferrin serum level QTL2]	614193	MVCD7	613609	6p22.2
[Transferrin serum level QTL2]	614193	TFQTL2	613609	6p22.2
[Tuberculin skin test reactivity QTL]	613637	TST2		5p15
[Tuberculin skin test reactivity, absence of]	613636	TST1		11p14
[Urate oxidase deficiency]		UOX	191540	1p22
[Uric acid concentration, serum, QTL1]	138900	ABCG2	603756	4q22.1
[Uric acid concentration, serum, QTL1]	138900	BCRP	603756	4q22.1
[Uric acid concentration, serum, QTL1]	138900	ABCP	603756	4q22.1
[Uric acid concentration, serum, QTL1]	138900	UAQTL1	603756	4q22.1
[Uric acid concentration, serum, QTL1]	138900	GOUT1	603756	4q22.1
[Uric acid concentration, serum, QTL4]	612671	UAQTL4		6p21
[Uric acid concentration, serum, QTL4]	612671	GOUT4		6p21
[Uric acid concentration, serum, QTL4]	612671	SLC17A3	611034	6p22.2
[Uric acid concentration, serum, QTL4]	612671	NPT4	611034	6p22.2
[Uric acid concentration, serum, QTL5]	614746	UAQTL5		19q13
[Uric acid concentration, serum, QTL6]	614747	UAQTL6		1q21.1
[Visuospatial/perceptual abilities]	313000	VSPA		Xp22.33
[White blood cell count QTL]	611862	DARC	613665	1q23.2
[White blood cell count QTL]	611862	FY	613665	1q23.2
[White blood cell count QTL]	611862	GPD	613665	1q23.2
[White blood cell count QTL]	611862	WBCQ1	613665	1q23.2
van Buchem disease, type 2	607636	LRP5	603506	11q13.2
van Buchem disease, type 2	607636	BMND1	603506	11q13.2
van Buchem disease, type 2	607636	LRP7	603506	11q13.2
van Buchem disease, type 2	607636	LR3	603506	11q13.2
van Buchem disease, type 2	607636	OPPG	603506	11q13.2
van Buchem disease, type 2	607636	VBCH2	603506	11q13.2
van Buchem disease, type 2	607636	OPTA1	603506	11q13.2
van Buchem disease, type 2	607636	EVR4	603506	11q13.2
van der Woude syndrome 2	606713	VWS2		1p34
van der Woude syndrome	119300	IRF6	607199	1q32.2
van der Woude syndrome	119300	VWS	607199	1q32.2
van der Woude syndrome	119300	LPS	607199	1q32.2
van der Woude syndrome	119300	PIT	607199	1q32.2
van der Woude syndrome	119300	PPS1	607199	1q32.2
van der Woude syndrome	119300	OFC6	607199	1q32.2
von Hippel-Lindau syndrome	193300	VHL	608537	3p25.3
von Willebrand disease, platelet-type	177820	GP1BA	606672	17p13.2
von Willebrand disease, platelet-type	177820	BSS	606672	17p13.2
von Willebrand disease, platelet-type	177820	BDPLT1	606672	17p13.2
von Willebrand disease, platelet-type	177820	VWDP	606672	17p13.2
von Willebrand disease, platelet-type	177820	BDPLT3	606672	17p13.2
von Willebrand disease, type 1	193400	VWF	613160	12p13.31
von Willebrand disease, type 1	193400	F8VWF	613160	12p13.31
von Willebrand disease, types 2A, 2B, 2M, and 2N	613554	VWF	613160	12p13.31
von Willebrand disease, types 2A, 2B, 2M, and 2N	613554	F8VWF	613160	12p13.31
von Willibrand disease, type 3	277480	VWF	613160	12p13.31
von Willibrand disease, type 3	277480	F8VWF	613160	12p13.31
{46XY sex reversal 8, modifier of}	614279	AKR1C4	600451	10p15.1
{46XY sex reversal 8, modifier of}	614279	CHDR	600451	10p15.1
{46XY sex reversal 8, modifier of}	614279	CDR	600451	10p15.1
{46XY sex reversal 8, modifier of}	614279	HAKRA	600451	10p15.1
{46XY sex reversal 8, modifier of}	614279	DD4	600451	10p15.1
{?Allergy and asthma susceptibility}	147061	IGES		5q31.1
{?Amyloidosis, secondary, susceptibility to}		APCS	104770	1q23.2
{?Amyloidosis, secondary, susceptibility to}		SAP	104770	1q23.2
{?Bladder cancer susceptibility}	109800	TACC3	605303	4p16.3
{?Breast cancer susceptibility}	114480	NQO2	160998	6p25.2
{?Breast cancer susceptibility}	114480	NMOR2	160998	6p25.2
{?Hearing loss, cisplatin-induced, susceptibility to}	613290	CIHL		6p22.3
{?Hypertension, essential}		ACSM3	145505	16p12.3
{?Hypertension, essential}		SAH	145505	16p12.3
{?Macular degeneration, age-related}	603075	APOE	107741	19q13.32
{?Macular degeneration, age-related}	603075	AD2	107741	19q13.32
{?Macular degeneration, age-related}	603075	LPG	107741	19q13.32
{?Macular degeneration, age-related}	603075	LDLCQ5	107741	19q13.32
{?Major affective disorder 2}	309200	MAFD2		Xq28
{?Major affective disorder 2}	309200	MDX		Xq28
{?Membranous nephropathy, susceptibility to}	614692	MBNP		6p21.3
{?SLE susceptibility}		CR1	120620	1q32.2
{?SLE susceptibility}		C3BR	120620	1q32.2
{?Schizophrenia susceptibility 18}	615232	SLC1A1	133550	9p24.2
{?Schizophrenia susceptibility 18}	615232	EAAC1	133550	9p24.2
{?Schizophrenia susceptibility 18}	615232	SCZD18	133550	9p24.2
{?Schizophrenia, susceptibility to}	603013	NRG1	142445	8p12
{?Schizophrenia, susceptibility to}	603013	HGL	142445	8p12
{?Schizophrenia, susceptibility to}	603013	HRGA	142445	8p12
{?Schizophrenia, susceptibility to}	603013	ARIA	142445	8p12
{?Schizophrenia}	181500	SCZD2	603342	11q14-q21
{AIDS, delayed/rapid progression to}	609423	KIR3DL1	604946	19q13.42
{AIDS, delayed/rapid progression to}	609423	NKAT3	604946	19q13.42
{AIDS, delayed/rapid progression to}	609423	NKB1	604946	19q13.42
{AIDS, delayed/rapid progression to}	609423	AMB11	604946	19q13.42
{AIDS, delayed/rapid progression to}	609423	KIR3DS1	604946	19q13.42
{AIDS, rapid progression to}	609423	IFNG	147570	12q15
{AIDS, rapid progression to}	609423	IFG	147570	12q15
{AIDS, rapid progression to}	609423	IFI	147570	12q15
{AIDS, resistance to}	609423	CXCL12	600835	10q11.21
{AIDS, resistance to}	609423	SDF1	600835	10q11.21
{AIDS, slow progression to}	609423	CXCR1	146929	2q35
{AIDS, slow progression to}	609423	IL8RA	146929	2q35
{AIDS, slow progression to}	609423	IL4R	147781	16p12.1
{AIDS, slow progression to}	609423	IL4RA	147781	16p12.1
{Abacavir hypersensitivity, susceptibility to}	142830	HLA-B		6p21.33
{Abacavir hypersensitivity, susceptibility to}	142830	SPDA1		6p21.33
{Abruptio placentae, susceptibility to}		MTHFD	172460	14q23.3
{Abruptio placentae, susceptibility to}		MTHFC	172460	14q23.3
{Accelerated tumor formation, susceptibility to}	614401	MDM2	164785	12q15
{Accelerated tumor formation, susceptibility to}	614401	ACTFS	164785	12q15
{Adiponectin, serum level of, QTL2}	606770	ADIPQTL2		5p15.2-p14
{Adiponectin, serum level of, QTL2}	606770	CAQ5		5p15.2-p14
{Adiponectin, serum level of, QTL3}	606771	ADIPQTL3		14p11.2-q13
{Adiponectin, serum level of, QTL3}	606771	CAQ14		14p11.2-q13
{Adiponectin, serum level of, QTL4}	612629	ADIPQTL4		11q23-q24
{Adiponectin, serum level of, QTL5]	613836	ADIPQTL5		16q23.3
{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}	103720	ADH1B		4q23
{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}	103720	ADH2		4q23
{Age-related hearing impairment 1}	612448	ARHI1		8q24.13-q24.22
{Age-related hearing impairment 2}	612976	ARHI2		3p26.1-p25.1
{Age-related maculopathy, susceptibility to}	603075	PLEKHA1	607772	10q26.13
{Age-related maculopathy, susceptibility to}	603075	TAPP1	607772	10q26.13
{Albinism, oculocutaneous, type II, modifier of}	203200	MC1R	155555	16q24.3
{Albinism, oculocutaneous, type II, modifier of}	203200	SHEP2	155555	16q24.3
{Albinism, oculocutaneous, type II, modifier of}	203200	CMM5	155555	16q24.3
{Alcohol dependence, protection against}	103780	ADH1B	103720	4q23
{Alcohol dependence, protection against}	103780	ADH2	103720	4q23
{Alcohol dependence, protection against}	103780	ADH1C	103730	4q23
{Alcohol dependence, protection against}	103780	ADH3	103730	4q23
{Alcohol dependence, susceptibility to}	103780	GABRA2	137140	4p12
{Alcohol dependence, susceptibility to}	103780	HTR2A	182135	13q14.2
{Alcohol dependence, susceptibility to}	103780	RCBTB1	607867	13q14.2
{Alcohol dependence, susceptibility to}	103780	CLLD7	607867	13q14.2
{Alcohol dependence, susceptibility to}	103780	GLP	607867	13q14.2
{Alcohol dependence}	103780	TAS2R16	604867	7q31.32
{Alcohol dependence}	103780	T2R16	604867	7q31.32
{Alkaline phosphatase, plasma level of, QTL 2}	612367	ALPQTL2		1p36
{Alkaline phosphatase, plasma level of, QTL1}	171720	ALPQTL1		9q34.13
{Alkaline phosphatase, plasma level of, QTL3}	612368	ALPQTL3		6p22
{Alkaline phosphatase, plasma level of, QTL4}	612369	ALPQTL4		10q21
{Allergic rhinitis, susceptibility to}	607154	IL13	147683	5q31.1
{Allergic rhinitis, susceptibility to}	607154	ALRH	147683	5q31.1
{Allergic rhinitis, susceptibility to}	607154	BHR1	147683	5q31.1
{Alzheimer disease 12}	611073	AD12		8p12-q22
{Alzheimer disease 16}	300756	AD16		Xq21.3
{Alzheimer disease 18, susceptibility to}	615590	ADAM10	602192	15q21.3
{Alzheimer disease 18, susceptibility to}	615590	MADM	602192	15q21.3
{Alzheimer disease 18, susceptibility to}	615590	RAK	602192	15q21.3
{Alzheimer disease 18, susceptibility to}	615590	AD18	602192	15q21.3
{Alzheimer disease 9, late onset, susceptibility to}	104300	AD9	608907	19p13.2
{Alzheimer disease, late-onset, susceptibility to}	104300	NOS3	163729	7q36.1
{Alzheimer disease, late-onset, susceptibility to}	104300	PLAU	191840	10q22.2
{Alzheimer disease, late-onset, susceptibility to}	104300	URK	191840	10q22.2
{Alzheimer disease, late-onset, susceptibility to}	104300	QPD	191840	10q22.2
{Alzheimer disease, late-onset, susceptibility to}	104300	BDPLT5	191840	10q22.2
{Alzheimer disease, late-onset}	104300	APBB2	602710	4p14-p13
{Alzheimer disease, late-onset}	104300	FE65L1	602710	4p14-p13
{Alzheimer disease, pathogenesis, association with}	104300	SORL1	602005	11q24.1
{Alzheimer disease, pathogenesis, association with}	104300	LR11	602005	11q24.1
{Alzheimer disease, pathogenesis, association with}	104300	SORLA	602005	11q24.1
{Alzheimer disease, susceptibility to}	104300	A2M 	103950	12p13.31
{Alzheimer disease, susceptibility to}	104300	A2MD	103950	12p13.31
{Alzheimer disease, susceptibility to}	104300	ACE	106180	17q23.3
{Alzheimer disease, susceptibility to}	104300	DCP1	106180	17q23.3
{Alzheimer disease, susceptibility to}	104300	ACE1	106180	17q23.3
{Alzheimer disease, susceptibility to}	104300	MVCD3	106180	17q23.3
{Alzheimer disease, susceptibility to}	104300	ICH	106180	17q23.3
{Alzheimer disease, susceptibility to}	104300	BLMH	602403	17q11.2
{Alzheimer disease, susceptibility to}	104300	BMH	602403	17q11.2
{Alzheimer disease, susceptibility to}	104300	HFE	613609	6p22.2
{Alzheimer disease, susceptibility to}	104300	HLA-H	613609	6p22.2
{Alzheimer disease, susceptibility to}	104300	HFE1	613609	6p22.2
{Alzheimer disease, susceptibility to}	104300	MVCD7	613609	6p22.2
{Alzheimer disease, susceptibility to}	104300	TFQTL2	613609	6p22.2
{Alzheimer disease, susceptibility to}	104300	MPO	606989	17q22
{Alzheimer disease, susceptibility to}	104300	PACIP1	608254	7q36.2
{Alzheimer disease, susceptibility to}	104300	PAXIP1L	608254	7q36.2
{Alzheimer disease, susceptibility to}	104300	PTIP	608254	7q36.2
{Alzheimer disease-13}	611152	AD13		1q21
{Alzheimer disease-14}	611154	AD14		1q25
{Alzheimer disease-15}	611155	AD15		3q22-q24
{Amyotrophic lateral sclerosis, susceptibility to, 13}	183090	ATXN2	601517	12q24.12
{Amyotrophic lateral sclerosis, susceptibility to, 13}	183090	ATX2	601517	12q24.12
{Amyotrophic lateral sclerosis, susceptibility to, 13}	183090	SCA2	601517	12q24.12
{Amyotrophic lateral sclerosis, susceptibility to, 13}	183090	ASL13	601517	12q24.12
{Amyotrophic lateral sclerosis, susceptibility to}	105400	DCTN1	601143	2p13.1
{Amyotrophic lateral sclerosis, susceptibility to}	105400	HMN7B	601143	2p13.1
{Amyotrophic lateral sclerosis, susceptibility to}	105400	NEFH	162230	22q12.2
{Amyotrophic lateral sclerosis, susceptibility to}	105400	PRPH	170710	12q13.12
{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}	105500	TRPM7	605692	15q21.2
{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}	105500	LTRPC7	605692	15q21.2
{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}	105500	CHAK	605692	15q21.2
{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}	105500	ALSPDC	605692	15q21.2
{Aneurysm, familial abdominal 3}	611891	AAA3		9p21
{Aneurysm, intracranial berry, 10}	612587	ANIB10		8q12.1
{Aneurysm, intracranial berry, 6}	611892	ANIB6		9p21
{Aneurysm, intracranial berry, 9}	612586	ANIB9		2q33.1
{Angioedema induced by ACE inhibitors, susceptibility to}	300909	XPNPEP2	300145	Xq26.1
{Angioedema induced by ACE inhibitors, susceptibility to}	300909	AEACEI	300145	Xq26.1
{Anorexia nervosa, susceptibility to, 1}	606788	ANON1		1p
{Anorexia nervosa, susceptibility to}	606788	HTR2A	182135	13q14.2
{Anorexia nervosa, susceptibility to}	610269	BDNF	113505	11p14.1
{Anorexia nervosa, susceptibility to}	610269	BULN2	113505	11p14.1
{Anorexia nervosa, susceptibility to}	610269	ANON2	113505	11p14.1
{Anxiety-related personality traits}	607834	SLC6A4	182138	17q11.2
{Anxiety-related personality traits}	607834	HTT	182138	17q11.2
{Anxiety-related personality traits}	607834	OCD1	182138	17q11.2
{Aplastic anemia}	609135	IFNG	147570	12q15
{Aplastic anemia}	609135	IFG	147570	12q15
{Aplastic anemia}	609135	IFI	147570	12q15
{Aplastic anemia}	614743	TERC	602322	3q26.2
{Aplastic anemia}	614743	TRC3	602322	3q26.2
{Aplastic anemia}	614743	TR	602322	3q26.2
{Aplastic anemia}	614743	DKCA1	602322	3q26.2
{Aplastic anemia}	614743	PFBMFT2	602322	3q26.2
{Asperger syndrome susceptibility 1}	608638	ASPG1		3q25-q27
{Asperger syndrome susceptibility 2}	608631	ASPG2		17p13
{Asperger syndrome susceptibility 3}	608781	ASPG3		1q21-q22
{Asperger syndrome susceptibility 4}	609954	ASPG4		3p24-p21
{Asperger syndrome susceptibility, X-linked 1}	300494	NLGN3	300336	Xq13.1
{Asperger syndrome susceptibility, X-linked 1}	300494	ASPGX1	300336	Xq13.1
{Asperger syndrome susceptibility, X-linked 1}	300494	AUTSX1	300336	Xq13.1
{Asperger syndrome susceptibility, X-linked 2}	300497	NLGN4	300427	Xp22.32-p22.31
{Asperger syndrome susceptibility, X-linked 2}	300497	KIAA1260	300427	Xp22.32-p22.31
{Asperger syndrome susceptibility, X-linked 2}	300497	AUTSX2	300427	Xp22.32-p22.31
{Asperger syndrome susceptibility, X-linked 2}	300497	ASPGX2	300427	Xp22.32-p22.31
{Aspergillosis, susceptibility to}	614079	CLEC7A	606264	12p13.2
{Aspergillosis, susceptibility to}	614079	CLECSF12	606264	12p13.2
{Aspergillosis, susceptibility to}	614079	DECTIN1	606264	12p13.2
{Aspergillosis, susceptibility to}	614079	CANDF4	606264	12p13.2
{Asthma susceptibility 5}	611064	IRAK3	604459	12q14.3
{Asthma susceptibility 5}	611064	IRAKM	604459	12q14.3
{Asthma susceptibility 5}	611064	ASRT5	604459	12q14.3
{Asthma, aspirin-induced, susceptibility to}	208550	PTGER2	176804	14q22.1
{Asthma, aspirin-induced, susceptibility to}	208550	TBX21	604895	17q21.32
{Asthma, aspirin-induced, susceptibility to}	208550	TBET	604895	17q21.32
{Asthma, diminished response to antileukotriene treatment in}	600807	ALOX5	152390	10q11.21
{Asthma, nocturnal, susceptibility to}	600807	ADRB2	109690	5q32
{Asthma, protection against}	600807	MUC7	158375	4q13.3
{Asthma, susceptibility to, 1}	607277	PTGDR	604687	14q22.1
{Asthma, susceptibility to, 1}	607277	AS1	604687	14q22.1
{Asthma, susceptibility to, 1}	607277	ASRT1	604687	14q22.1
{Asthma, susceptibility to, 2}	608584	NPSR1	608595	7p14.3
{Asthma, susceptibility to, 2}	608584	GPR154	608595	7p14.3
{Asthma, susceptibility to, 2}	608584	GPRA	608595	7p14.3
{Asthma, susceptibility to, 2}	608584	VRR1	608595	7p14.3
{Asthma, susceptibility to, 2}	608584	PGR14	608595	7p14.3
{Asthma, susceptibility to, 2}	608584	ASRT2	608595	7p14.3
{Asthma, susceptibility to}	600807	HLA-G	142871	6p22.1
{Asthma, susceptibility to}	600807	CCL11	601156	17q12
{Asthma, susceptibility to}	600807	SCYA11	601156	17q12
{Asthma, susceptibility to}	600807	HNMT	605238	2q22.1
{Asthma, susceptibility to}	600807	IL12B	161561	5q33.3
{Asthma, susceptibility to}	600807	NKSF2	161561	5q33.3
{Asthma, susceptibility to}	600807	IL13	147683	5q31.1
{Asthma, susceptibility to}	600807	ALRH	147683	5q31.1
{Asthma, susceptibility to}	600807	BHR1	147683	5q31.1
{Asthma, susceptibility to}	600807	PLA2G7	601690	6p12.3
{Asthma, susceptibility to}	600807	PAFAH	601690	6p12.3
{Asthma, susceptibility to}	600807	PAFAD	601690	6p12.3
{Asthma, susceptibility to}	600807	SCGB1A1	192020	11q12.3
{Asthma, susceptibility to}	600807	UGB	192020	11q12.3
{Asthma, susceptibility to}	600807	CC10	192020	11q12.3
{Asthma, susceptibility to}	600807	CCSP	192020	11q12.3
{Asthma, susceptibility to}	600807	SCGB1A1	192020	11q12.3
{Asthma, susceptibility to}	600807	SCGB3A2	606531	5q32
{Asthma, susceptibility to}	600807	UGRP1	606531	5q32
{Asthma, susceptibility to}	600807	TNF	191160	6p21.33
{Asthma, susceptibility to}	600807	TNFA	191160	6p21.33
{Asthma-related traits, susceptibility to, 3}	609958	ASRT3		2p16
{Asthma-related traits, susceptibility to, 4}	610906	ASRT4		1p31
{Asthma-related traits, susceptibility to, 6}	611403	ASRT6		17q21
{Asthma-related traits, susceptibility to, 7}	611960	CHI3L1	601525	1q32.1
{Asthma-related traits, susceptibility to, 7}	611960	GP39	601525	1q32.1
{Asthma-related traits, susceptibility to, 7}	611960	YKL40	601525	1q32.1
{Asthma-related traits, susceptibility to, 7}	611960	ASRT7	601525	1q32.1
{Asthma-related traits, susceptibility to, 8}	613207	ASRT8		9q33
{Asthma}	600807	PHF11	607796	13q14.2
{Asthma}	600807	NYREN34	607796	13q14.2
{Atherosclerosis, susceptibility to}	108725	ATHS		19p13.3-p13.2
{Atherosclerosis, susceptibility to}	108725	ALP		19p13.3-p13.2
{Atherosclerosis, susceptibility to}		ALOX5	152390	10q11.21
{Atherosclerosis, susceptibility to}	133430	ESR1		6q25.1
{Atherosclerosis, susceptibility to}	133430	ESR		6q25.1
{Atherosclerosis, susceptibility to}	133430	ESTRR		6q25.1
{Atopy, resistance to}	147050	HAVCR1	606518	5q33.3
{Atopy, resistance to}	147050	HAVCR	606518	5q33.3
{Atopy, susceptibility to}	147050	IL4R	147781	16p12.1
{Atopy, susceptibility to}	147050	IL4RA	147781	16p12.1
{Atopy, susceptibility to}	147050	MS4A2	147138	11q12.1
{Atopy, susceptibility to}	147050	FCER1B	147138	11q12.1
{Atopy, susceptibility to}	147050	PLA2G7	601690	6p12.3
{Atopy, susceptibility to}	147050	PAFAH	601690	6p12.3
{Atopy, susceptibility to}	147050	PAFAD	601690	6p12.3
{Atopy, susceptibility to}	147050	SELP	173610	1q24.2
{Atopy, susceptibility to}	147050	GRMP	173610	1q24.2
{Atrial fibrillation, familial, 5}	611494	ATFB5		4q25
{Atrioventricular septal defect, susceptibility to, 1}	606215	AVSD1		1p31-p21
{Atrioventricular septal defect, susceptibility to, 1}	606215	AVCD		1p31-p21
{Atrioventricular septal defect, susceptibility to, 2}	606217	CRELD1	607170	3p25.3
{Atrioventricular septal defect, susceptibility to, 2}	606217	AVSD2	607170	3p25.3
{Attention deficit-hyperactivity disorder, susceptibility to, 5}	612311	ADHD5		2q21.1
{Attention deficit-hyperactivity disorder, susceptibility to, 6}	612312	ADHD6		13q12.11
{Attention deficit-hyperactivity disorder, susceptibility to, 7}	613003	TPH2	607478	12q21.1
{Attention deficit-hyperactivity disorder, susceptibility to, 7}	613003	NTPH	607478	12q21.1
{Attention deficit-hyperactivity disorder, susceptibility to, 7}	613003	ADHD7	607478	12q21.1
{Attention deficit-hyperactivity disorder, susceptibility to}	143465	DRD5	126453	4p16.1
{Attention deficit-hyperactivity disorder, susceptibility to}	143465	DRD1B	126453	4p16.1
{Attention deficit-hyperactivity disorder, susceptibility to}	143465	DRD1L2	126453	4p16.1
{Attention deficit-hyperactivity disorder}	143465	ADHD1	608903	16p13
{Attention deficit-hyperactivity disorder}	143465	ADHD2	608904	17p11
{Attention deficit-hyperactivity disorder}	143465	ADHD3	608905	6q12
{Attention deficit-hyperactivity disorder}	143465	ADHD4	608906	5p13
{Attention deficit-hyperactivity disorder}	143465	DRD4	126452	11p15.5
{Atypical mycobacteriosis, familial}	300636	IKBKG	300248	Xq28
{Atypical mycobacteriosis, familial}	300636	NEMO	300248	Xq28
{Atypical mycobacteriosis, familial}	300636	FIP3	300248	Xq28
{Atypical mycobacteriosis, familial}	300636	IP2	300248	Xq28
{Atypical mycobacteriosis, familial}	300636	IPD2	300248	Xq28
{Atypical mycobacteriosis, familial}	300636	AMCBX1	300248	Xq28
{Autism susceptibility 11}	610836	AUTS11		1q41-q42
{Autism susceptibility 12}	610838	AUTS12		21p13-q11
{Autism susceptibility 13}	610908	AUTS13		12q14.2
{Autism susceptibility 14A}	611913	DEL16p11.2		16p11.2
{Autism susceptibility 14A}	611913	C16DELp11.2		16p11.2
{Autism susceptibility 14A}	611913	AUTS14A		16p11.2
{Autism susceptibility 15}	612100	CNTNAP2	604569	7q35-q36
{Autism susceptibility 15}	612100	CASPR2	604569	7q35-q36
{Autism susceptibility 15}	612100	NRXN4	604569	7q35-q36
{Autism susceptibility 15}	612100	CDFE	604569	7q35-q36
{Autism susceptibility 15}	612100	AUTS15	604569	7q35-q36
{Autism susceptibility 15}	612100	PTHSL1	604569	7q35-q36
{Autism susceptibility 17}	613436	SHANK2	603290	11q13.3-q13.4
{Autism susceptibility 17}	613436	CORTBP1	603290	11q13.3-q13.4
{Autism susceptibility 17}	613436	AUTS17	603290	11q13.3-q13.4
{Autism susceptibility 1}	209850	AUTS1		7q22
{Autism susceptibility 3}	608049	AUTS3		13q14.2-q14.1
{Autism susceptibility 4}	608636	AUTS4		15q11
{Autism susceptibility 5}	606053	AUTS5		2q
{Autism susceptibility 6}	609378	AUTS6		17q11
{Autism susceptibility 7}	610676	AUTS7		17q21
{Autism susceptibility 8}	607373	AUTS8		3q25-q27
{Autism susceptibility, X-linked 1}	300425	NLGN3	300336	Xq13.1
{Autism susceptibility, X-linked 1}	300425	ASPGX1	300336	Xq13.1
{Autism susceptibility, X-linked 1}	300425	AUTSX1	300336	Xq13.1
{Autism susceptibility, X-linked 2}	300495	NLGN4	300427	Xp22.32-p22.31
{Autism susceptibility, X-linked 2}	300495	KIAA1260	300427	Xp22.32-p22.31
{Autism susceptibility, X-linked 2}	300495	AUTSX2	300427	Xp22.32-p22.31
{Autism susceptibility, X-linked 2}	300495	ASPGX2	300427	Xp22.32-p22.31
{Autism susceptibility, X-linked 3}	300496	MECP2	300005	Xq28
{Autism susceptibility, X-linked 3}	300496	RTT	300005	Xq28
{Autism susceptibility, X-linked 3}	300496	PPMX	300005	Xq28
{Autism susceptibility, X-linked 3}	300496	MRX16	300005	Xq28
{Autism susceptibility, X-linked 3}	300496	MRX79	300005	Xq28
{Autism susceptibility, X-linked 3}	300496	AUTSX3	300005	Xq28
{Autism susceptibility, X-linked 3}	300496	MRXSL	300005	Xq28
{Autism susceptibility, X-linked 3}	300496	MRXS13	300005	Xq28
{Autism susceptibility, X-linked 3}	300496	MRX79	300005	Xq28
{Autism susceptibility, X-linked 3}	300496	MRX16	300005	Xq28
{Autism susceptibility, X-linked 4}	300830	DELXp22.11		Xp22.11
{Autism susceptibility, X-linked 4}	300830	CXDELp22.11		Xp22.11
{Autism susceptibility, X-linked 4}	300830	AUTSX4		Xp22.11
{Autism, susceptibility to, 10}	611016	AUTS10		7q36
{Autism, susceptibility to, 14B}	614671	DUP16p11.2		16p11.2
{Autism, susceptibility to, 14B}	614671	C16DUPp11.2		16p11.2
{Autism, susceptibility to, 14B}	614671	AUTS14B		16p11.2
{Autism, susceptibility to, 18}	615032	CHD8	610528	14q11.2
{Autism, susceptibility to, 18}	615032	DUPLIN	610528	14q11.2
{Autism, susceptibility to, 18}	615032	KIAA1564	610528	14q11.2
{Autism, susceptibility to, 18}	615032	AUTS18	610528	14q11.2
{Autism, susceptibility to, 19}	615091	EIF4E	133440	4q23
{Autism, susceptibility to, 19}	615091	EIF4EL1	133440	4q23
{Autism, susceptibility to, 19}	615091	AUTS19	133440	4q23
{Autism, susceptibility to, 9}	611015	AUTS9		7q31
{Autism, susceptibility to, X-linked 5}	300847	RPL10	312173	Xq28
{Autism, susceptibility to, X-linked 5}	300847	DXS648	312173	Xq28
{Autism, susceptibility to, X-linked 5}	300847	QM	312173	Xq28
{Autism, susceptibility to, X-linked 5}	300847	AUTSX5	312173	Xq28
{Autoimmune disease, susceptibility to, 1}	607836	FOXD3	611539	1p31.3
{Autoimmune disease, susceptibility to, 1}	607836	AIS1	611539	1p31.3
{Autoimmune disease, susceptibility to, 1}	607836	VAMAS2	611539	1p31.3
{Autoimmune disease, susceptibility to, 2}	608391	AIS2		Chr.7
{Autoimmune disease, susceptibility to, 2}	608391	VAMAS3		Chr.7
{Autoimmune disease, susceptibility to, 3}	608392	AIS3		Chr.8
{Autoimmune disease, susceptibility to, 3}	608392	VAMAS4		Chr.8
{Autoimmune disease, susceptibility to, 4}	609400	AIS4		4q13-q21
{Autoimmune disease, susceptibility to, 4}	609400	VAMAS5		4q13-q21
{Autoimmune disease, susceptibility to, 5}	611598	CELIAC6		4q27
{Autoimmune disease, susceptibility to, 5}	611598	AIS5		4q27
{Autoimmune disease, susceptibility to, 6}	613551	SIAE	610079	11q24.2
{Autoimmune disease, susceptibility to, 6}	613551	AIS6	610079	11q24.2
{Autoimmune lymphoproliferative syndrome}	601859	TNFRSF6	134637	10q23.31
{Autoimmune lymphoproliferative syndrome}	601859	APT1	134637	10q23.31
{Autoimmune lymphoproliferative syndrome}	601859	FAS	134637	10q23.31
{Autoimmune lymphoproliferative syndrome}	601859	CD95	134637	10q23.31
{Autoimmune lymphoproliferative syndrome}	601859	ALPS1A	134637	10q23.31
{Autoimmune thyroid disease, susceptibility to, 1}	608173	AITD1		6p11
{Autoimmune thyroid disease, susceptibility to, 2}	608174	AITD2		5q31-q33
{Autoimmune thyroid disease, susceptibility to, 3}	608175	TG	188450	8q24.22
{Autoimmune thyroid disease, susceptibility to, 3}	608175	AITD3	188450	8q24.22
{Autoimmune thyroid disease, susceptibility to, 3}	608175	TDH3	188450	8q24.22
{Autoimmune thyroid disease, susceptibility to, 3}	608175	ZFAT1	610931	8q24.22
{Autoimmune thyroid disease, susceptibility to, 3}	608175	ZNF406	610931	8q24.22
{Autoimmune thyroid disease, susceptibility to, 3}	608175	AITD3	610931	8q24.22
{Autoimmune thyroid disease, susceptibility to, 4}	608176	AITD4		10q
{Bacteremia, protection against}	614382	TIRAP	606252	11q24.2
{Bacteremia, protection against}	614382	BACTS1	606252	11q24.2
{Bacteremia, susceptibility to}	614383	CISH	602441	3p21.2
{Bacteremia, susceptibility to}	614383	BACTS2	602441	3p21.2
{Bardet-Biedl syndrome 1, modifier of}	209900	ARL6	608845	3q11.2
{Bardet-Biedl syndrome 1, modifier of}	209900	BBS3	608845	3q11.2
{Bardet-Biedl syndrome 1, modifier of}	209900	RP55	608845	3q11.2
{Bardet-Biedl syndrome 14, modifier of}	209900	TMEM67	609884	8q22.1
{Bardet-Biedl syndrome 14, modifier of}	209900	MKS3	609884	8q22.1
{Bardet-Biedl syndrome 14, modifier of}	209900	JBTS6	609884	8q22.1
{Bardet-Biedl syndrome 14, modifier of}	209900	NPHP11	609884	8q22.1
{Bardet-Biedl syndrome, modifier of}	209900	CCDC28B	610162	1p35.1
{Bardet-Biedl syndrome, modifier of}	209900	MGC1203	610162	1p35.1
{Basal cell carcinoma 7}	614740	TP53	191170	17p13.1
{Basal cell carcinoma 7}	614740	P53	191170	17p13.1
{Basal cell carcinoma 7}	614740	LFS1 	191170	17p13.1
{Basal cell carcinoma 7}	614740	BCC7	191170	17p13.1
{Basal cell carcinoma, susceptibility to, 1}	605462	BCC1		1p36
{Basal cell carcinoma, susceptibility to, 2}	613058	BCC2		1q42
{Basal cell carcinoma, susceptibility to, 3}	613059	BCC3		5p15.33
{Basal cell carcinoma, susceptibility to, 4}	613061	BCC4		12q13
{Basal cell carcinoma, susceptibility to, 5}	613062	BCC5		9p21
{Basal cell carcinoma, susceptibility to, 6}	613063	BCC6		7q32
{Benzene toxicity, susceptibility to}	125860	NQO1		16q22.1
{Benzene toxicity, susceptibility to}	125860	DIA4		16q22.1
{Benzene toxicity, susceptibility to}	125860	NMOR1		16q22.1
{Beryllium disease, chronic, susceptibility to}		HLA-DPB1	142858	6p21.32
{Biliary cirrhosis, primary, 2}	613007	PBC2		6p21.3
{Biliary cirrhosis, primary, 3}	613008	PBC3		1p31.2
{Bladder cancer, somatic}	109800	HRAS	190020	11p15.5
{Bleeding disorder, platelet-type, 13, susceptibility to}	614009	TBXA2R	188070	19p13.3
{Bleeding disorder, platelet-type, 13, susceptibility to}	614009	BDPLT13	188070	19p13.3
{Blepharospasm, primary benign}	606798	DRD5	126453	4p16.1
{Blepharospasm, primary benign}	606798	DRD1B	126453	4p16.1
{Blepharospasm, primary benign}	606798	DRD1L2	126453	4p16.1
{Bone marrow failure, telomere-related, 1}	614742	TERT	187270	5p15.33
{Bone marrow failure, telomere-related, 1}	614742	TCS1	187270	5p15.33
{Bone marrow failure, telomere-related, 1}	614742	EST2	187270	5p15.33
{Bone marrow failure, telomere-related, 1}	614742	DKCA2	187270	5p15.33
{Bone marrow failure, telomere-related, 1}	614742	DKCB4	187270	5p15.33
{Bone marrow failure, telomere-related, 1}	614742	PFBMFT1	187270	5p15.33
{Bone marrow failure, telomere-related, 1}	614742	CMM9	187270	5p15.33
{Bone mineral density QTL 12, osteoporosis}	612560	UGT2B17	601903	4q13.2
{Bone mineral density QTL 12, osteoporosis}	612560	BMND12	601903	4q13.2
{Bone mineral density, low, susceptibility to}	615311	LGR4	606666	11p14.1
{Bone mineral density, low, susceptibility to}	615311	GPR48	606666	11p14.1
{Bone mineral density, low, susceptibility to}	615311	BNMD17	606666	11p14.1
{Bone size QTL}	609657	BSZQTL2		5q
{Bone size QTL}	609656	BSZQTL		17q23
{Breast and colorectal cancer, susceptibility to}	604373	CHEK2		22q12.1
{Breast and colorectal cancer, susceptibility to}	604373	RAD53		22q12.1
{Breast and colorectal cancer, susceptibility to}	604373	CHK2		22q12.1
{Breast and colorectal cancer, susceptibility to}	604373	CDS1		22q12.1
{Breast and colorectal cancer, susceptibility to}	604373	LFS2		22q12.1
{Breast cancer, invasive ductal}	114480	RAD54L	603615	1p34.1
{Breast cancer, invasive ductal}	114480	HR54	603615	1p34.1
{Breast cancer, invasive ductal}	114480	HRAD54	603615	1p34.1
{Breast cancer, lobular}	114480	CDH1	192090	16q22.1
{Breast cancer, lobular}	114480	UVO	192090	16q22.1
{Breast cancer, lobular}	114480	LCAM	192090	16q22.1
{Breast cancer, lobular}	114480	ECAD	192090	16q22.1
{Breast cancer, male, susceptibility to}	114480	BRCA2	600185	13q13.1
{Breast cancer, male, susceptibility to}	114480	FANCD1	600185	13q13.1
{Breast cancer, male, susceptibility to}	114480	BROVCA2	600185	13q13.1
{Breast cancer, male, susceptibility to}	114480	GLM3	600185	13q13.1
{Breast cancer, male, susceptibility to}	114480	PNCA2	600185	13q13.1
{Breast cancer, poor survival after chemotherapy for}	125860	NQO1		16q22.1
{Breast cancer, poor survival after chemotherapy for}	125860	DIA4		16q22.1
{Breast cancer, poor survival after chemotherapy for}	125860	NMOR1		16q22.1
{Breast cancer, protection against}	114480	CASP8	601763	2q33.1
{Breast cancer, protection against}	114480	MCH5	601763	2q33.1
{Breast cancer, protection against}	114480	ALPS2B	601763	2q33.1
{Breast cancer, susceptibility to}	114480	ATM	607585	11q22.3
{Breast cancer, susceptibility to}	114480	ATA	607585	11q22.3
{Breast cancer, susceptibility to}	114480	AT1	607585	11q22.3
{Breast cancer, susceptibility to}	114480	BARD1	601593	2q35
{Breast cancer, susceptibility to}	114480	CHEK2	604373	22q12.1
{Breast cancer, susceptibility to}	114480	RAD53	604373	22q12.1
{Breast cancer, susceptibility to}	114480	CHK2	604373	22q12.1
{Breast cancer, susceptibility to}	114480	CDS1	604373	22q12.1
{Breast cancer, susceptibility to}	114480	LFS2	604373	22q12.1
{Breast cancer, susceptibility to}	114480	HMMR	600936	5q34
{Breast cancer, susceptibility to}	114480	PALB2	610355	16p12.2
{Breast cancer, susceptibility to}	114480	FANCN	610355	16p12.2
{Breast cancer, susceptibility to}	114480	PNCA3	610355	16p12.2
{Breast cancer, susceptibility to}	114480	PHB	176705	17q21.33
{Breast cancer, susceptibility to}	114480	RAD51A	179617	15q15.1
{Breast cancer, susceptibility to}	114480	RECA	179617	15q15.1
{Breast cancer, susceptibility to}	114480	MRMV2	179617	15q15.1
{Breast cancer, susceptibility to}	114480	XRCC3	600675	14q32.33
{Breast cancer, susceptibility to}	114480	CMM6	600675	14q32.33
{Breast cancer}	114480	ESR1	133430	6q25.1
{Breast cancer}	114480	ESR	133430	6q25.1
{Breast cancer}	114480	ESTRR	133430	6q25.1
{Breast-ovarian cancer, familial, 1}	604370	BRCA1	113705	17q21.31
{Breast-ovarian cancer, familial, 1}	604370	PSCP	113705	17q21.31
{Breast-ovarian cancer, familial, 1}	604370	BROVCA1	113705	17q21.31
{Breast-ovarian cancer, familial, 1}	604370	PNCA4	113705	17q21.31
{Breast-ovarian cancer, familial, 2}	612555	BRCA2	600185	13q13.1
{Breast-ovarian cancer, familial, 2}	612555	FANCD1	600185	13q13.1
{Breast-ovarian cancer, familial, 2}	612555	BROVCA2	600185	13q13.1
{Breast-ovarian cancer, familial, 2}	612555	GLM3	600185	13q13.1
{Breast-ovarian cancer, familial, 2}	612555	PNCA2	600185	13q13.1
{Breast-ovarian cancer, familial, susceptibility to, 3}	613399	RAD51C	602774	17q22
{Breast-ovarian cancer, familial, susceptibility to, 3}	613399	FANCO	602774	17q22
{Breast-ovarian cancer, familial, susceptibility to, 3}	613399	BROVCA3	602774	17q22
{Breast-ovarian cancer, familial, susceptibility to, 4}	614291	RAD51L3	602954	17q12
{Breast-ovarian cancer, familial, susceptibility to, 4}	614291	RAD51D	602954	17q12
{Breast-ovarian cancer, familial, susceptibility to, 4}	614291	BROVCA4	602954	17q12
{Bronchiectasis with or without elevated sweat chloride 1, modifier of}	211400	CFTR	602421	7q31.2
{Bronchiectasis with or without elevated sweat chloride 1, modifier of}	211400	ABCC7	602421	7q31.2
{Bronchiectasis with or without elevated sweat chloride 1, modifier of}	211400	CF	602421	7q31.2
{Bronchiectasis with or without elevated sweat chloride 1, modifier of}	211400	MRP7	602421	7q31.2
{Budd-Chiari syndrome}	600880	F5	612309	1q24.2
{Budd-Chiari syndrome}	600880	THPH2	612309	1q24.2
{Budd-Chiari syndrome}	600880	RPRGL1	612309	1q24.2
{Budd-Chiari syndrome}	600880	JAK2	147796	9p24.1
{Budd-Chiari syndrome}	600880	THCYT3	147796	9p24.1
{Bulimia nervosa, age of onset of weight loss in}	607499	BDNF	113505	11p14.1
{Bulimia nervosa, age of onset of weight loss in}	607499	BULN2	113505	11p14.1
{Bulimia nervosa, age of onset of weight loss in}	607499	ANON2	113505	11p14.1
{Bulimia nervosa, susceptibility to}	607499	BULN		10p
{Buruli ulcer, susceptibility to}	610446	NRAMP1	600266	2q35
{Buruli ulcer, susceptibility to}	610446	NRAMP	600266	2q35
{Buruli ulcer, susceptibility to}	610446	SLC11A1	600266	2q35
{Calcium, serum level of}	601199	CASR		3q21.1
{Calcium, serum level of}	601199	HHC1		3q21.1
{Calcium, serum level of}	601199	PCAR1		3q21.1
{Calcium, serum level of}	601199	FIH		3q21.1
{Calcium, serum level of}	601199	EIG8		3q21.1
{Calcium, serum level of}	601199	HYPOC1		3q21.1
{Cancer progression/metastasis}		FGFR4	134935	5q35.2
{Cardiac conduction defect, susceptibility to}	115080	AKAP10	604694	17p11.2
{Carotid stenosis, susceptibility to}		HABP2	603924	10q25.3
{Carotid stenosis, susceptibility to}		PHBP	603924	10q25.3
{Carotid stenosis, susceptibility to}		HGFAL	603924	10q25.3
{Carotid stenosis, susceptibility to}		FSAP	603924	10q25.3
{Cataract 28, age-related cortical, susceptibility to}	609026	CTRCT28		6p12-q12
{Cataract 28, age-related cortical, susceptibility to}	609026	ARCC1		6p12-q12
{Celiac disease, susceptibility to, 10}	612008	CELIAC10		3q25-q26
{Celiac disease, susceptibility to, 11}	612009	CELIAC11		3q28
{Celiac disease, susceptibility to, 12}	612010	CELIAC12		6q25.3
{Celiac disease, susceptibility to, 13}	612011	CELIAC13		12q24
{Celiac disease, susceptibility to, 2}	609754	CELIAC2		5q31-q33
{Celiac disease, susceptibility to, 3}	609755	CTLA4	123890	2q33.2
{Celiac disease, susceptibility to, 3}	609755	IDDM12	123890	2q33.2
{Celiac disease, susceptibility to, 3}	609755	CELIAC3	123890	2q33.2
{Celiac disease, susceptibility to, 3}	609755	GRD4	123890	2q33.2
{Celiac disease, susceptibility to, 4}	609753	MYO9B	602129	19p13.11
{Celiac disease, susceptibility to, 4}	609753	MYR5	602129	19p13.11
{Celiac disease, susceptibility to, 4}	609753	CELIAC4	602129	19p13.11
{Celiac disease, susceptibility to, 5}	607202	CELIAC5		15q11-q13
{Celiac disease, susceptibility to, 5}	607202	GSES		15q11-q13
{Celiac disease, susceptibility to, 6}	611598	CELIAC6		4q27
{Celiac disease, susceptibility to, 6}	611598	AIS5		4q27
{Celiac disease, susceptibility to, 7}	612005	CELIAC7		1q31
{Celiac disease, susceptibility to, 8}	612006	CELIAC8		2q11-q12
{Celiac disease, susceptibility to, 9}	612007	CELIAC9		3p21
{Celiac disease, susceptibility to}	212750	HLA-DQA1	146880	6p21.32
{Celiac disease, susceptibility to}	212750	CELIAC1	146880	6p21.32
{Celiac disease, susceptibility to}	212750	HLA-DQB1	604305	6p21.32
{Celiac disease, susceptibility to}	212750	CELIAC1	604305	6p21.32
{Centronuclear myopathy, autosomal, modifier of}	160150	MTMR14	611089	3p25.3
{Centronuclear myopathy, autosomal, modifier of}	160150	C3orf29	611089	3p25.3
{Centronuclear myopathy, autosomal, modifier of}	160150	HJUMPY	611089	3p25.3
{Cerebral infarction, susceptibility to}	601367	PRKCH	605437	14q23.1
{Cerebral infarction, susceptibility to}	601367	PKCL	605437	14q23.1
{Cerebral infarction, susceptibility to}	601367	PRKCL	605437	14q23.1
{Chordoma, susceptibility to}	215400	CHDM		7q33
{Chronic infections, due to MBL deficiency}	614372	MBL2	154545	10q21.1
{Chronic infections, due to MBL deficiency}	614372	MBL	154545	10q21.1
{Chronic infections, due to MBL deficiency}	614372	MBP1	154545	10q21.1
{Chronic infections, due to MBL deficiency}	614372	MBL2D	154545	10q21.1
{Chronic infections, due to MBL deficiency}	614372	MBPD	154545	10q21.1
{Cirrhosis, noncryptogenic, susceptibility to}	215600	KRT18	148070	12q13.13
{Cirrhosis, noncryptogenic, susceptibility to}	215600	KRT8	148060	12q13.13
{Codeine sensitivity}	608902	CYP2D6	124030	22q13.2
{Codeine sensitivity}	608902	CPD6	124030	22q13.2
{Codeine sensitivity}	608902	P450DB1	124030	22q13.2
{Colchicine resistance}	120080	ABCB1	171050	7q21.12
{Colchicine resistance}	120080	PGY1	171050	7q21.12
{Colchicine resistance}	120080	MDR1	171050	7q21.12
{Colchicine resistance}	120080	IBD13	171050	7q21.12
{Colchicine resistance}	120080	CLCs	171050	7q21.12
{Colon cancer, susceptibility to}	114500	AURKA	603072	20q13.2
{Colon cancer, susceptibility to}	114500	STK15	603072	20q13.2
{Colon cancer, susceptibility to}	114500	AURORA2	603072	20q13.2
{Colon cancer, susceptibility to}	114500	BTAK	603072	20q13.2
{Colon cancer, susceptibility to}	114500	ARK1	603072	20q13.2
{Colon cancer, susceptibility to}	114500	STK6	603072	20q13.2
{Colon cancer, susceptibility to}	114500	AIK	603072	20q13.2
{Colonic adenoma recurrence, reduced risk of}	114500	ODC1	165640	2p25.1
{Colorectal cancer, susceptibility to, 10}	612591	POLD1	174761	19q13.33
{Colorectal cancer, susceptibility to, 10}	612591	CRCS10	174761	19q13.33
{Colorectal cancer, susceptibility to, 10}	612591	MDPL	174761	19q13.33
{Colorectal cancer, susceptibility to, 11}	612592	CRCS11		20p12.3
{Colorectal cancer, susceptibility to, 12}	615083	POLE1	174762	12q24.33
{Colorectal cancer, susceptibility to, 12}	615083	CRCS12	174762	12q24.33
{Colorectal cancer, susceptibility to, 12}	615083	FILS	174762	12q24.33
{Colorectal cancer, susceptibility to, 1}	608812	GALNT12	610290	9q22.33
{Colorectal cancer, susceptibility to, 1}	608812	CRCS1	610290	9q22.33
{Colorectal cancer, susceptibility to, 2}	611469	CRCS2		8q24
{Colorectal cancer, susceptibility to, 3}	612229	SMAD7	602932	18q21.1
{Colorectal cancer, susceptibility to, 3}	612229	MADH7	602932	18q21.1
{Colorectal cancer, susceptibility to, 3}	612229	CRCS3	602932	18q21.1
{Colorectal cancer, susceptibility to, 4}	601228	HMPS1		15q15.3-q22.1
{Colorectal cancer, susceptibility to, 4}	601228	CRAC1		15q15.3-q22.1
{Colorectal cancer, susceptibility to, 4}	601228	CRCS4		15q15.3-q22.1
{Colorectal cancer, susceptibility to, 4}	601228	DUP15q		15q15.3-q22.1
{Colorectal cancer, susceptibility to, 4}	601228	C15DUPq		15q15.3-q22.1
{Colorectal cancer, susceptibility to, 5}	612230	CRCS5		10p14
{Colorectal cancer, susceptibility to, 6}	612231	CRCS6		8q23
{Colorectal cancer, susceptibility to, 7}	612232	CRCS7		11q23
{Colorectal cancer, susceptibility to, 8}	612589	CRCS8		14q22.2
{Colorectal cancer, susceptibility to, 9}	612590	CRCS9		16q22.1
{Colorectal cancer, susceptibility to}	114500	CCND1	168461	11q13.3
{Colorectal cancer, susceptibility to}	114500	PRAD1	168461	11q13.3
{Colorectal cancer, susceptibility to}	114500	BCL1	168461	11q13.3
{Colorectal cancer, susceptibility to}	114500	TLR2	603028	4q31.3
{Colorectal cancer, susceptibility to}	114500	TIL4	603028	4q31.3
{Colorectal cancer, susceptibility to}	114500	TLR4	603030	9q33.1
{Colorectal cancer, susceptibility to}	114500	ARMD10	603030	9q33.1
{Colorectal cancer}	114500	PLA2G2A	172411	1p36.13
{Colorectal cancer}	114500	PLA2B	172411	1p36.13
{Colorectal cancer}	114500	PLA2L	172411	1p36.13
{Colorectal cancer}	114500	MOM1	172411	1p36.13
{Congenital anomalies of kidney and urinary tract, susceptibility to}	610805	DSTYK	612666	1q32.1
{Congenital anomalies of kidney and urinary tract, susceptibility to}	610805	KIAA0472	612666	1q32.1
{Congenital anomalies of kidney and urinary tract, susceptibility to}	610805	RIP5	612666	1q32.1
{Congenital anomalies of kidney and urinary tract, susceptibility to}	610805	DUSTYPK	612666	1q32.1
{Congenital anomalies of kidney and urinary tract, susceptibility to}	610805	CAKUT1	612666	1q32.1
{Congestive heart failure and beta-blocker response, modifier of}	104250	ADRA2C		4p16.3
{Congestive heart failure and beta-blocker response, modifier of}	104250	ADRA2L2		4p16.3
{Congestive heart failure and beta-blocker response, modifier of}	109630	ADRB1		10q25.3
{Congestive heart failure and beta-blocker response, modifier of}	109630	ADRB1R		10q25.3
{Congestive heart failure and beta-blocker response, modifier of}	109630	RHR		10q25.3
{Coronary artery disease in familial hypercholesterolemia, protection against}	143890	ABCA1	600046	9q31.1
{Coronary artery disease in familial hypercholesterolemia, protection against}	143890	ABC1	600046	9q31.1
{Coronary artery disease in familial hypercholesterolemia, protection against}	143890	HDLDT1	600046	9q31.1
{Coronary artery disease in familial hypercholesterolemia, protection against}	143890	TGD	600046	9q31.1
{Coronary artery disease, autosomal dominant, 1}	608320	MEF2A	600660	15q26.3
{Coronary artery disease, autosomal dominant, 1}	608320	ADCAD1	600660	15q26.3
{Coronary artery disease, autosomal dominant, 2}	610947	LRP6	603507	12p13.2
{Coronary artery disease, autosomal dominant, 2}	610947	ADCAD2	603507	12p13.2
{Coronary artery disease, modifier of}	158105	CCL2		17q12
{Coronary artery disease, modifier of}	158105	SCYA2		17q12
{Coronary artery disease, modifier of}	158105	MCP1		17q12
{Coronary artery disease, modifier of}	158105	MCAF		17q12
{Coronary artery disease, resistance to}	607339	CX3CR1	601470	3p22.2
{Coronary artery disease, resistance to}	607339	GPR13	601470	3p22.2
{Coronary artery disease, resistance to}	607339	V28	601470	3p22.2
{Coronary artery disease, susceptibility to}	152200	LPA		6q25-q26
{Coronary artery disease, susceptibility to}	147545	IRS1		2q36.3
{Coronary artery disease, susceptibility to}	604824	KL		13q13.1
{Coronary artery disease, susceptibility to}	604824	KLOTHO		13q13.1
{Coronary artery disease, susceptibility to}	168820	PON1		7q21.3
{Coronary artery disease, susceptibility to}	168820	PON		7q21.3
{Coronary artery disease, susceptibility to}	168820	ESA		7q21.3
{Coronary artery disease, susceptibility to}	168820	MVCD5		7q21.3
{Coronary artery disease, susceptibility to}		PON2	602447	7q21.3
{Coronary artery disease}	187270	TERT		5p15.33
{Coronary artery disease}	187270	TCS1		5p15.33
{Coronary artery disease}	187270	EST2		5p15.33
{Coronary artery disease}	187270	DKCA2		5p15.33
{Coronary artery disease}	187270	DKCB4		5p15.33
{Coronary artery disease}	187270	PFBMFT1		5p15.33
{Coronary artery disease}	187270	CMM9		5p15.33
{Coronary artery spasm 1, susceptibility to}	163729	NOS3		7q36.1
{Coronary artery spasm 2, susceptibility to	168820	PON1		7q21.3
{Coronary artery spasm 2, susceptibility to	168820	PON		7q21.3
{Coronary artery spasm 2, susceptibility to	168820	ESA		7q21.3
{Coronary artery spasm 2, susceptibility to	168820	MVCD5		7q21.3
{Coronary heart disease, susceptibility to, 2}	608316	CHDS2		2q21.1-q22
{Coronary heart disease, susceptibility to, 3}	300464	CHDS3		Xq23-q26
{Coronary heart disease, susceptibility to, 4}	608318	CHDS4		14q32
{Coronary heart disease, susceptibility to, 5}	608901	KALRN	604605	3q21.2
{Coronary heart disease, susceptibility to, 5}	608901	HAPIP	604605	3q21.2
{Coronary heart disease, susceptibility to, 5}	608901	DUO	604605	3q21.2
{Coronary heart disease, susceptibility to, 5}	608901	CHDS5	604605	3q21.2
{Coronary heart disease, susceptibility to, 6}	614466	MMP3	185250	11q22.2
{Coronary heart disease, susceptibility to, 6}	614466	STMY1	185250	11q22.2
{Coronary heart disease, susceptibility to, 6}	614466	CHDS6	185250	11q22.2
{Coronary heart disease, susceptibility to, 7}	610938	CD36	173510	7q21.11
{Coronary heart disease, susceptibility to, 7}	610938	CHDS7	173510	7q21.11
{Coronary heart disease, susceptibility to, 7}	610938	BDPLT10	173510	7q21.11
{Coronary heart disease, susceptibility to, 8}	611139	CHDS8		9p21
{Coronary heart disease, susceptibility to, 9}	612030	CHDS9		8p22
{Coronary heart disease, susceptibility to}	607339	CHDS1		16pter-p13
{Craniosynostosis 5, susceptibility to}	615529	ALX4	605420	11p11.2
{Craniosynostosis 5, susceptibility to}	615529	PFM2	605420	11p11.2
{Craniosynostosis 5, susceptibility to}	615529	FPP	605420	11p11.2
{Craniosynostosis 5, susceptibility to}	615529	FND2	605420	11p11.2
{Craniosynostosis 5, susceptibility to}	615529	CRS5	605420	11p11.2
{Creutzfeldt-Jakob disease, variant, resistance to}	123400	HLA-DQB1	604305	6p21.32
{Creutzfeldt-Jakob disease, variant, resistance to}	123400	CELIAC1	604305	6p21.32
{Crohn disease-associated growth failure}	266600	IL6	147620	7p15.3
{Crohn disease-associated growth failure}	266600	IFNB2	147620	7p15.3
{Crohn disease-associated growth failure}	266600	BSF2	147620	7p15.3
{Crohn disease-associated growth failure}	266600	HSF	147620	7p15.3
{Crohn disease-associated growth failure}	266600	HGF	147620	7p15.3
{Cystic fibrosis lung disease, modifier of}	219700	TGFB1	190180	19q13.2
{Cystic fibrosis lung disease, modifier of}	219700	DPD1	190180	19q13.2
{Cystic fibrosis lung disease, modifier of}	219700	CED	190180	19q13.2
{Deafness, autosomal recessive 12, modifier of}	601386	ATP2B2	108733	3p25.3
{Deafness, autosomal recessive 12, modifier of}	601386	PMCA2	108733	3p25.3
{Deafness, mitochondrial, modifier of}	580000	TRMU	610230	22q13.31
{Deafness, mitochondrial, modifier of}	580000	MTO2	610230	22q13.31
{Deafness, mitochondrial, modifier of}	580000	TRNT1	610230	22q13.31
{Deafness, nonsyndromic, modifier 1}	605429	DFNM1		1q24
{Debrisoquine sensitivity}	608902	CYP2D6	124030	22q13.2
{Debrisoquine sensitivity}	608902	CPD6	124030	22q13.2
{Debrisoquine sensitivity}	608902	P450DB1	124030	22q13.2
{Deep venous thrombosis, protection against}	300807	F9	300746	Xq27.1
{Deep venous thrombosis, protection against}	300807	HEMB	300746	Xq27.1
{Deep venous thrombosis, protection against}	300807	THPH8	300746	Xq27.1
{Delayed sleep phase syndrome, susceptibility to}	614163	AANAT	600950	17q25.1
{Delayed sleep phase syndrome, susceptibility to}	614163	SNAT	600950	17q25.1
{Delayed sleep phase syndrome, susceptibility to}	614163	DSPS	600950	17q25.1
{Dementia, vascular, susceptibility to}		TNF	191160	6p21.33
{Dementia, vascular, susceptibility to}		TNFA	191160	6p21.33
{Dengue fever, protection against}	614371	CD209	604672	19p13.2
{Dengue fever, protection against}	614371	CDSIGN	604672	19p13.2
{Dermatitis, atopic, susceptibility to, 1}	603165	ATOD1		3q21
{Dermatitis, atopic, susceptibility to, 2}	605803	FLG	135940	1q21.3
{Dermatitis, atopic, susceptibility to, 2}	605803	ATOD2	135940	1q21.3
{Dermatitis, atopic, susceptibility to, 3}	605804	ATOD3		20p
{Dermatitis, atopic, susceptibility to, 4}	605805	ATOD4		17q25.3
{Dermatitis, atopic, susceptibility to, 5}	605844	ATOD5		13q12-q14
{Dermatitis, atopic, susceptibility to, 6}	605845	ATOD6		5q31-q33
{Dermatitis, atopic, susceptibility to, 7}	613064	ATOD7		11q13.5
{Diabetes mellitus, insulin-dependent, 11}	601208	IDDM11		14q24.3-q31
{Diabetes mellitus, insulin-dependent, 13}	601318	IDDM13		2q34
{Diabetes mellitus, insulin-dependent, 15}	601666	IDDM15		6q21
{Diabetes mellitus, insulin-dependent, 17}	603266	IDDM17		10q25
{Diabetes mellitus, insulin-dependent, 18}	605598	IDDM18		5q31.1-q33.1
{Diabetes mellitus, insulin-dependent, 19}	610155	IDDM19		2q24.3
{Diabetes mellitus, insulin-dependent, 21}	612521	IDDM21		6q25
{Diabetes mellitus, insulin-dependent, 22}	612522	CCR5	601373	3p21.31
{Diabetes mellitus, insulin-dependent, 22}	612522	CMKBR5	601373	3p21.31
{Diabetes mellitus, insulin-dependent, 22}	612522	CCCKR5	601373	3p21.31
{Diabetes mellitus, insulin-dependent, 22}	612522	IDDM22	601373	3p21.31
{Diabetes mellitus, insulin-dependent, 23}	612622	IDDM23		4q27
{Diabetes mellitus, insulin-dependent, 24}	613006	IDDM24		10q23.31
{Diabetes mellitus, insulin-dependent, 3}	600318	IDDM3		15q26
{Diabetes mellitus, insulin-dependent, 4}	600319	IDDM4		11q13
{Diabetes mellitus, insulin-dependent, 5}	600320	SUMO4	608829	6q25.1
{Diabetes mellitus, insulin-dependent, 5}	600320	IDDM5	608829	6q25.1
{Diabetes mellitus, insulin-dependent, 6}	601941	IDDM6		18q21
{Diabetes mellitus, insulin-dependent, 7}	600321	IDDM7		2q31
{Diabetes mellitus, insulin-dependent, 8}	600883	IDDM8		6q25-q27
{Diabetes mellitus, insulin-dependent, X-linked}	300136	IDDMX		Xp11
{Diabetes mellitus, insulin-dependent, susceptibility to}	601388	CTLA4	123890	2q33.2
{Diabetes mellitus, insulin-dependent, susceptibility to}	601388	IDDM12	123890	2q33.2
{Diabetes mellitus, insulin-dependent, susceptibility to}	601388	CELIAC3	123890	2q33.2
{Diabetes mellitus, insulin-dependent, susceptibility to}	601388	GRD4	123890	2q33.2
{Diabetes mellitus, insulin-dependent-1}	222100	IDDM1		6p21.3
{Diabetes mellitus, insulin-dependent}	222100	HNF1A	142410	12q24.31
{Diabetes mellitus, insulin-dependent}	222100	TCF1	142410	12q24.31
{Diabetes mellitus, insulin-dependent}	222100	MODY3	142410	12q24.31
{Diabetes mellitus, insulin-dependent}	222100	IDDM20	142410	12q24.31
{Diabetes mellitus, non-insulin-dependent, susceptibility to}	125853	ENPP1	173335	6q23.2
{Diabetes mellitus, non-insulin-dependent, susceptibility to}	125853	PDNP1	173335	6q23.2
{Diabetes mellitus, non-insulin-dependent, susceptibility to}	125853	NPPS	173335	6q23.2
{Diabetes mellitus, non-insulin-dependent, susceptibility to}	125853	M6S1	173335	6q23.2
{Diabetes mellitus, non-insulin-dependent, susceptibility to}	125853	PCA1	173335	6q23.2
{Diabetes mellitus, non-insulin-dependent, susceptibility to}	125853	ARHR2	173335	6q23.2
{Diabetes mellitus, non-insulin-dependent, susceptibility to}	125853	COLED	173335	6q23.2
{Diabetes mellitus, noninsulin-dependent 1}	601283	CAPN10	605286	2q37.3
{Diabetes mellitus, noninsulin-dependent 1}	601283	NIDDM1	605286	2q37.3
{Diabetes mellitus, noninsulin-dependent, 2}	125853	HNF1A	142410	12q24.31
{Diabetes mellitus, noninsulin-dependent, 2}	125853	TCF1	142410	12q24.31
{Diabetes mellitus, noninsulin-dependent, 2}	125853	MODY3	142410	12q24.31
{Diabetes mellitus, noninsulin-dependent, 2}	125853	IDDM20	142410	12q24.31
{Diabetes mellitus, noninsulin-dependent, association with}	125853	WFS1	606201	4p16.1
{Diabetes mellitus, noninsulin-dependent, association with}	125853	WFRS	606201	4p16.1
{Diabetes mellitus, noninsulin-dependent, association with}	125853	WFS	606201	4p16.1
{Diabetes mellitus, noninsulin-dependent, association with}	125853	DFNA6	606201	4p16.1
{Diabetes mellitus, noninsulin-dependent, association with}	125853	DFNA14	606201	4p16.1
{Diabetes mellitus, noninsulin-dependent, association with}	125853	DFNA38	606201	4p16.1
{Diabetes mellitus, noninsulin-dependent, association with}	125853	WFSL	606201	4p16.1
{Diabetes mellitus, noninsulin-dependent, association with}	125853	CTRCT41	606201	4p16.1
{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	CDKAL1	611259	6p22.3
{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	HMGA1	600701	6p21.31
{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	HMGIY	600701	6p21.31
{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	IGF2BP2	608289	3q27.2
{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	IMP2	608289	3q27.2
{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	RETN	605565	19p13.2
{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	RSTN	605565	19p13.2
{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	FIZZ3	605565	19p13.2
{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	SLC30A8	611145	8q24.11
{Diabetes mellitus, noninsulin-dependent, susceptibility to}	125853	ZNT8	611145	8q24.11
{Diabetes mellitus, noninsulin-dependent}	125853	NIDDM3	603694	20q12-q13.1
{Diabetes mellitus, noninsulin-dependent}	125853	NIDDM4	608036	5q34-q35.2
{Diabetes mellitus, noninsulin-dependent}	125853	GCGR	138033	17q25.3
{Diabetes mellitus, noninsulin-dependent}	125853	HNF4A	600281	20q13.12
{Diabetes mellitus, noninsulin-dependent}	125853	TCF14	600281	20q13.12
{Diabetes mellitus, noninsulin-dependent}	125853	MODY1	600281	20q13.12
{Diabetes mellitus, noninsulin-dependent}	125853	IRS1	147545	2q36.3
{Diabetes mellitus, noninsulin-dependent}	125853	IRS2	600797	13q34
{Diabetes mellitus, noninsulin-dependent}	125853	LIPC	151670	15q21.3
{Diabetes mellitus, noninsulin-dependent}	125853	HL	151670	15q21.3
{Diabetes mellitus, noninsulin-dependent}	125853	LIPH	151670	15q21.3
{Diabetes mellitus, noninsulin-dependent}	125853	HDLCQ12	151670	15q21.3
{Diabetes mellitus, noninsulin-dependent}	125853	MAPK8IP1	604641	11p11.2
{Diabetes mellitus, noninsulin-dependent}	125853	IB1	604641	11p11.2
{Diabetes mellitus, noninsulin-dependent}	125853	NEUROD1	601724	2q31.3
{Diabetes mellitus, noninsulin-dependent}	125853	NIDDM	601724	2q31.3
{Diabetes mellitus, noninsulin-dependent}	125853	SLC2A4	138190	17p13.1
{Diabetes mellitus, noninsulin-dependent}	125853	GLUT4	138190	17p13.1
{Diabetes mellitus, noninsulin-dependent}	135853	SLC2A2	138160	3q26.2
{Diabetes mellitus, noninsulin-dependent}	135853	GLUT2	138160	3q26.2
{Diabetes mellitus, transient neonatal}	601410	PLAGL1	603044	6q24.2
{Diabetes mellitus, transient neonatal}	601410	ZAC	603044	6q24.2
{Diabetes mellitus, transient neonatal}	601410	LOT1	603044	6q24.2
{Diabetes mellitus, type 1, susceptibility to}	222100	OAS1	164350	12q24.13
{Diabetes mellitus, type 1, susceptibility to}	222100	OIAS	164350	12q24.13
{Diabetes mellitus, type 2, susceptibility to}	125853	KCNJ11	600937	11p15.1
{Diabetes mellitus, type 2, susceptibility to}	125853	BIR	600937	11p15.1
{Diabetes mellitus, type 2, susceptibility to}	125853	PHHI	600937	11p15.1
{Diabetes mellitus, type 2, susceptibility to}	125853	HHF2	600937	11p15.1
{Diabetes mellitus, type 2, susceptibility to}	125853	TNDM3	600937	11p15.1
{Diabetes mellitus, type 2, susceptibility to}	125853	TCF7L2	602228	10q25.2-q25.3
{Diabetes mellitus, type 2, susceptibility to}	125853	TCF4	602228	10q25.2-q25.3
{Diabetes mellitus, type 2, susceptiblity to}	125853	MTNR1B	600804	11q14.3
{Diabetes mellitus, type I, susceptibility to}	222100	FOXP3	300292	Xp11.23
{Diabetes mellitus, type I, susceptibility to}	222100	IPEX	300292	Xp11.23
{Diabetes mellitus, type I, susceptibility to}	222100	AIID	300292	Xp11.23
{Diabetes mellitus, type I, susceptibility to}	222100	XPID	300292	Xp11.23
{Diabetes mellitus, type I, susceptibility to}	222100	PIDX	300292	Xp11.23
{Diabetes mellitus, type II, susceptibility to}	125853	IPF1	600733	13q12.2
{Diabetes mellitus, type II, susceptibility to}	125853	MODY4	600733	13q12.2
{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}	601942	IL2RA	147730	10p15.1
{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}	601942	IL2R	147730	10p15.1
{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}	601942	IDDM10	147730	10p15.1
{Diabetes, susceptibility to}, 222100	125853	IL6	147620	7p15.3
{Diabetes, susceptibility to}, 222100	125853	IFNB2	147620	7p15.3
{Diabetes, susceptibility to}, 222100	125853	BSF2	147620	7p15.3
{Diabetes, susceptibility to}, 222100	125853	HSF	147620	7p15.3
{Diabetes, susceptibility to}, 222100	125853	HGF	147620	7p15.3
{Diabetes, type 1, susceptibility to}	222100	ITPR3	147267	6p21.31
{Diabetes, type 1, susceptibility to}	222100	PTPN22	600716	1p13.2
{Diabetes, type 1, susceptibility to}	222100	PEP	600716	1p13.2
{Diabetes, type 1, susceptibility to}	222100	PTPN8	600716	1p13.2
{Diabetes, type 1, susceptibility to}	222100	LYP	600716	1p13.2
{Diabetes, type 2, susceptibility to}	125853	GPD2	138430	2q24.1
{Diabetes, type 2}	125853	PPARG	601487	3p25.2
{Diabetes, type 2}	125853	PPARG1	601487	3p25.2
{Diabetes, type 2}	125853	PPARG2	601487	3p25.2
{Diabetes, type 2}	125853	CIMT1	601487	3p25.2
{Diabetes, type 2}	125853	GLM1	601487	3p25.2
{Diphtheria, susceptibility to}		HBEGF	126150	5q31.3
{Diphtheria, susceptibility to}		DTR	126150	5q31.3
{Diphtheria, susceptibility to}		DTSF	126150	5q31.3
{Diphtheria, susceptibility to}		HEGFL	126150	5q31.3
{Dravet syndrome, modifier of}	607208	SCN9A	603415	2q24.3
{Dravet syndrome, modifier of}	607208	NENA	603415	2q24.3
{Dravet syndrome, modifier of}	607208	PN1	603415	2q24.3
{Dravet syndrome, modifier of}	607208	FEB3B	603415	2q24.3
{Dravet syndrome, modifier of}	607208	GEFSP7	603415	2q24.3
{Dravet syndrome, modifier of}	607208	SFNP	603415	2q24.3
{Drug addiction, susceptibility to}	606581	FAAH	602935	1p33
{Drug-induced liver injury due to flucloxacillin}	142830	HLA-B		6p21.33
{Drug-induced liver injury due to flucloxacillin}	142830	SPDA1		6p21.33
{Dyskeratosis congenita, autosomal dominant 2}	613989	TERT	187270	5p15.33
{Dyskeratosis congenita, autosomal dominant 2}	613989	TCS1	187270	5p15.33
{Dyskeratosis congenita, autosomal dominant 2}	613989	EST2	187270	5p15.33
{Dyskeratosis congenita, autosomal dominant 2}	613989	DKCA2	187270	5p15.33
{Dyskeratosis congenita, autosomal dominant 2}	613989	DKCB4	187270	5p15.33
{Dyskeratosis congenita, autosomal dominant 2}	613989	PFBMFT1	187270	5p15.33
{Dyskeratosis congenita, autosomal dominant 2}	613989	CMM9	187270	5p15.33
{Dyskeratosis congenita, autosomal recessive 4}	613989	TERT	187270	5p15.33
{Dyskeratosis congenita, autosomal recessive 4}	613989	TCS1	187270	5p15.33
{Dyskeratosis congenita, autosomal recessive 4}	613989	EST2	187270	5p15.33
{Dyskeratosis congenita, autosomal recessive 4}	613989	DKCA2	187270	5p15.33
{Dyskeratosis congenita, autosomal recessive 4}	613989	DKCB4	187270	5p15.33
{Dyskeratosis congenita, autosomal recessive 4}	613989	PFBMFT1	187270	5p15.33
{Dyskeratosis congenita, autosomal recessive 4}	613989	CMM9	187270	5p15.33
{Dyslexia, susceptibility to, 1}	127700	DYX1C1	608706	15q21.3
{Dyslexia, susceptibility to, 1}	127700	DYXC1	608706	15q21.3
{Dyslexia, susceptibility to, 1}	127700	DYX1	608706	15q21.3
{Dyslexia, susceptibility to, 1}	127700	CILD25	608706	15q21.3
{Dyslexia, susceptibility to, 2}	600202	KIAA0319	609269	6p22.3
{Dyslexia, susceptibility to, 2}	600202	DYX2	609269	6p22.3
{Dyslexia, susceptibility to, 2}	600202	DYLX2	609269	6p22.3
{Dyslexia, susceptibility to, 2}	600202	DLX2	609269	6p22.3
{Dyslexia, susceptibility to, 3}	604254	DYX3		2p16-p15
{Dyslexia, susceptibility to, 5}	606896	DYX5		3p12-q13
{Dyslexia, susceptibility to, 6}	606616	DYX6		18p11.2
{Dyslexia, susceptibility to, 6}	606616	DYXQTL18		18p11.2
{Dyslexia, susceptibility to, 8}	608995	DYX8		1p36-p34
{Dyslexia, susceptibility to, 9}	300509	DYX9		Xq27.3
{Dystonia-1, modifier of}		DYT1	605204	9q34.11
{Dystonia-1, modifier of}		TOR1A	605204	9q34.11
{Efavirenz central nervous system toxicity, susceptibility to}	614546	CYP2B6	123930	19q13.2
{Efavirenz central nervous system toxicity, susceptibility to}	614546	CYP2B	123930	19q13.2
{Efavirenz central nervous system toxicity, susceptibility to}	614546	EFVM	123930	19q13.2
{Encephalopathy, acute, infection-induced, 3, susceptibility to}	608033	RANBP2	601181	2q12.3
{Encephalopathy, acute, infection-induced, 3, susceptibility to}	608033	NUP358	601181	2q12.3
{Encephalopathy, acute, infection-induced, 3, susceptibility to}	608033	ANE1	601181	2q12.3
{Encephalopathy, acute, infection-induced, 3, susceptibility to}	608033	IIAE3	601181	2q12.3
{Encephalopathy, acute, infection-induced, 4, susceptibility to}	614212	CPT2	600650	1p32.3
{Encephalopathy, acute, infection-induced, 4, susceptibility to}	614212	IIAE4	600650	1p32.3
{Encephalopathy, acute, infection-induced, susceptibility to, 6}	614850	TICAM1	607601	19p13.3
{Encephalopathy, acute, infection-induced, susceptibility to, 6}	614850	TRIF	607601	19p13.3
{Encephalopathy, acute, infection-induced, susceptibility to, 6}	614850	IIAE6	607601	19p13.3
{End-stage renal disease, nondiabetic, susceptibility to}	612551	APOL1	603743	22q12.3
{End-stage renal disease, nondiabetic, susceptibility to}	612551	FSGS4	603743	22q12.3
{Endometriosis, susceptibility to, 1}	131200	ENDO1		10q26
{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}	226600	MMP1	120353	11q22.2
{Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}	226600	CLG	120353	11q22.2
{Epilepsy idiopathic generalized, susceptibility to, 8}	612899	CASR	601199	3q21.1
{Epilepsy idiopathic generalized, susceptibility to, 8}	612899	HHC1	601199	3q21.1
{Epilepsy idiopathic generalized, susceptibility to, 8}	612899	PCAR1	601199	3q21.1
{Epilepsy idiopathic generalized, susceptibility to, 8}	612899	FIH	601199	3q21.1
{Epilepsy idiopathic generalized, susceptibility to, 8}	612899	EIG8	601199	3q21.1
{Epilepsy idiopathic generalized, susceptibility to, 8}	612899	HYPOC1	601199	3q21.1
{Epilepsy, childhood absence, susceptibility to, 2}	607681	GABRG2	137164	5q34
{Epilepsy, childhood absence, susceptibility to, 2}	607681	GEFSP3	137164	5q34
{Epilepsy, childhood absence, susceptibility to, 2}	607681	CAE2	137164	5q34
{Epilepsy, childhood absence, susceptibility to, 2}	607681	ECA2	137164	5q34
{Epilepsy, childhood absence, susceptibility to, 4}	611136	GABRA1	137160	5q34
{Epilepsy, childhood absence, susceptibility to, 4}	611136	EJM5	137160	5q34
{Epilepsy, childhood absence, susceptibility to, 4}	611136	ECA4	137160	5q34
{Epilepsy, childhood absence, susceptibility to, 5}	612269	GABRB3	137192	15q12
{Epilepsy, childhood absence, susceptibility to, 5}	612269	ECA5	137192	15q12
{Epilepsy, childhood absence, susceptibility to, 6}	611942	CACNA1H	607904	16p13.3
{Epilepsy, childhood absence, susceptibility to, 6}	611942	EIG6	607904	16p13.3
{Epilepsy, childhood absence, susceptibility to, 6}	611942	ECA6	607904	16p13.3
{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}	613060	GABRD	137163	1p36.33
{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}	613060	GEFSP5	137163	1p36.33
{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}	613060	EIG10	137163	1p36.33
{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}	613060	EJM7	137163	1p36.33
{Epilepsy, idiopathic generalized, 10}	613060	GABRD	137163	1p36.33
{Epilepsy, idiopathic generalized, 10}	613060	GEFSP5	137163	1p36.33
{Epilepsy, idiopathic generalized, 10}	613060	EIG10	137163	1p36.33
{Epilepsy, idiopathic generalized, 10}	613060	EJM7	137163	1p36.33
{Epilepsy, idiopathic generalized, susceptibility to, 11}	607628	CLCN2	600570	3q27.1
{Epilepsy, idiopathic generalized, susceptibility to, 11}	607628	EGMA	600570	3q27.1
{Epilepsy, idiopathic generalized, susceptibility to, 11}	607628	ECA2	600570	3q27.1
{Epilepsy, idiopathic generalized, susceptibility to, 11}	607628	EGI11	600570	3q27.1
{Epilepsy, idiopathic generalized, susceptibility to, 11}	607628	EJM8	600570	3q27.1
{Epilepsy, idiopathic generalized, susceptibility to, 1}	600669	EIG1		8q24
{Epilepsy, idiopathic generalized, susceptibility to, 2}	606972	EIG2		14q23
{Epilepsy, idiopathic generalized, susceptibility to, 3}	608762	EIG3		9q32-q33
{Epilepsy, idiopathic generalized, susceptibility to, 6}	611942	CACNA1H	607904	16p13.3
{Epilepsy, idiopathic generalized, susceptibility to, 6}	611942	EIG6	607904	16p13.3
{Epilepsy, idiopathic generalized, susceptibility to, 6}	611942	ECA6	607904	16p13.3
{Epilepsy, idiopathic generalized, susceptibility to, 7}	604827	EIG7		15q14
{Epilepsy, idiopathic generalized, susceptibility to, 7}	604827	EJM2		15q14
{Epilepsy, idiopathic generalized, susceptibility to, 9}	607682	CACNB4	601949	2q23.3
{Epilepsy, idiopathic generalized, susceptibility to, 9}	607682	EJM6	601949	2q23.3
{Epilepsy, idiopathic generalized, susceptibility to, 9}	607682	EA5	601949	2q23.3
{Epilepsy, idiopathic generalized, susceptibility to, 9}	607682	EIG9	601949	2q23.3
{Epilepsy, idiopathic generalized, susceptibility to}	600669	ME2	154270	18q21.2
{Epilepsy, idiopathic generalized, susceptibility to}	600669	ODS1	154270	18q21.2
{Epilepsy, idiopathic generalized, suscpetibility to, 12}	614847	SLC2A1	138140	1p34.2
{Epilepsy, idiopathic generalized, suscpetibility to, 12}	614847	GLUT1	138140	1p34.2
{Epilepsy, idiopathic generalized, suscpetibility to, 12}	614847	DYT18	138140	1p34.2
{Epilepsy, idiopathic generalized, suscpetibility to, 12}	614847	PED	138140	1p34.2
{Epilepsy, idiopathic generalized, suscpetibility to, 12}	614847	GLUT1DS	138140	1p34.2
{Epilepsy, idiopathic generalized, suscpetibility to, 12}	614847	EIG12	138140	1p34.2
{Epilepsy, idiopathic generalized, suscpetibility to, 12}	614847	DYT9	138140	1p34.2
{Epilepsy, juvenile absence, susceptibility to, 1}	607631	EFHC1	608815	6p12.2
{Epilepsy, juvenile absence, susceptibility to, 1}	607631	FLJ10466	608815	6p12.2
{Epilepsy, juvenile absence, susceptibility to, 1}	607631	EJM1	608815	6p12.2
{Epilepsy, juvenile absence, susceptibility to, 1}	607631	JAE	608815	6p12.2
{Epilepsy, juvenile absence, susceptibility to, 1}	607631	EJA1	608815	6p12.2
{Epilepsy, juvenile absence, susceptibility to, 2}	607628	CLCN2	600570	3q27.1
{Epilepsy, juvenile absence, susceptibility to, 2}	607628	EGMA	600570	3q27.1
{Epilepsy, juvenile absence, susceptibility to, 2}	607628	ECA2	600570	3q27.1
{Epilepsy, juvenile absence, susceptibility to, 2}	607628	EGI11	600570	3q27.1
{Epilepsy, juvenile absence, susceptibility to, 2}	607628	EJM8	600570	3q27.1
{Epilepsy, juvenile myoclonic, susceptibility to, 5}	611136	GABRA1	137160	5q34
{Epilepsy, juvenile myoclonic, susceptibility to, 5}	611136	EJM5	137160	5q34
{Epilepsy, juvenile myoclonic, susceptibility to, 5}	611136	ECA4	137160	5q34
{Epilepsy, juvenile myoclonic, susceptibility to, 6}	607682	CACNB4	601949	2q23.3
{Epilepsy, juvenile myoclonic, susceptibility to, 6}	607682	EJM6	601949	2q23.3
{Epilepsy, juvenile myoclonic, susceptibility to, 6}	607682	EA5	601949	2q23.3
{Epilepsy, juvenile myoclonic, susceptibility to, 6}	607682	EIG9	601949	2q23.3
{Epilepsy, juvenile myoclonic, susceptibility to, 8}	607628	CLCN2	600570	3q27.1
{Epilepsy, juvenile myoclonic, susceptibility to, 8}	607628	EGMA	600570	3q27.1
{Epilepsy, juvenile myoclonic, susceptibility to, 8}	607628	ECA2	600570	3q27.1
{Epilepsy, juvenile myoclonic, susceptibility to, 8}	607628	EGI11	600570	3q27.1
{Epilepsy, juvenile myoclonic, susceptibility to, 8}	607628	EJM8	600570	3q27.1
{Epilepsy, juvenile myoclonic, susceptibility to}	613060	GABRD	137163	1p36.33
{Epilepsy, juvenile myoclonic, susceptibility to}	613060	GEFSP5	137163	1p36.33
{Epilepsy, juvenile myoclonic, susceptibility to}	613060	EIG10	137163	1p36.33
{Epilepsy, juvenile myoclonic, susceptibility to}	613060	EJM7	137163	1p36.33
{Epilepsy, juvenile myoclonic, susceptiblity to, 9}	614280	EJM9		2q33-q36
{Esophageal cancer, alcohol-related, susceptibility to}	100650	ALDH2		12q24.12
{Esophagitis, eosinophilic, 1}	610247	EOE1		7q11.2
{Esophagitis, eosinophilic, 1}	610247	EE		7q11.2
{Esophagitis, eosinophilic, 2}	613412	EOE2		5q22
{Essential tremor, susceptibility to}	190300	DRD3	126451	3q13.31
{Essential tremor, susceptibility to}	190300	ETM1	126451	3q13.31
{Essential tremor, susceptibility to}	190300	FET1	126451	3q13.31
{Exfoliation syndrome, susceptibility to}	177650	LOXL1	153456	15q24.1
{Exfoliation syndrome, susceptibility to}	177650	LOXL	153456	15q24.1
{Fatty liver disease, nonalcoholic, susceptibility to, 1}	613282	NAFLD1		22q13
{Fatty liver disease, nonalcoholic, susceptibility to, 2}	613387	NAFLD2		11q23
{Fibrocalculous pancreatic diabetes, susceptibility to}	608189	SPINK1	167790	5q32
{Fibrocalculous pancreatic diabetes, susceptibility to}	608189	PSTI	167790	5q32
{Fibrocalculous pancreatic diabetes, susceptibility to}	608189	PCTT	167790	5q32
{Fibrocalculous pancreatic diabetes, susceptibility to}	608189	TATI	167790	5q32
{Fibrocalculous pancreatic diabetes, susceptibility to}	608189	TCP	167790	5q32
{Follicular lymphoma, susceptibility to, 1}	613024	FL1		6p21.33
{Gastric cancer risk after H. pylori infection}	137215	IL1B	147720	2q13
{Gastric cancer risk after H. pylori infection}	137215	IL1RN	147679	2q13
{Gastric cancer risk after H. pylori infection}	137215	MVCD4	147679	2q13
{Gastric cancer risk after H. pylori infection}	137215	DIRA	147679	2q13
{Gene expression, variation in, QTL}	608875	GEVQ1		14q32
{Gene expression, variation in, QTL}	608878	GEVQ2		20q13
{Glaucoma, normal tension, susceptibility to}	606657	OPA1	605290	3q29
{Glaucoma, normal tension, susceptibility to}	606657	NTG	605290	3q29
{Glaucoma, normal tension, susceptibility to}	606657	NPG	605290	3q29
{Glaucoma, normal tension, susceptibility to}	606657	OPTN	602432	10p13
{Glaucoma, normal tension, susceptibility to}	606657	GLC1E	602432	10p13
{Glaucoma, normal tension, susceptibility to}	606657	FIP2	602432	10p13
{Glaucoma, normal tension, susceptibility to}	606657	HYPL	602432	10p13
{Glaucoma, normal tension, susceptibility to}	606657	NRP	602432	10p13
{Glaucoma, normal tension, susceptibility to}	606657	ALS12	602432	10p13
{Glioblastoma 3}	613029	BRCA2	600185	13q13.1
{Glioblastoma 3}	613029	FANCD1	600185	13q13.1
{Glioblastoma 3}	613029	BROVCA2	600185	13q13.1
{Glioblastoma 3}	613029	GLM3	600185	13q13.1
{Glioblastoma 3}	613029	PNCA2	600185	13q13.1
{Glioma susceptibility 1}	137800	TP53	191170	17p13.1
{Glioma susceptibility 1}	137800	P53	191170	17p13.1
{Glioma susceptibility 1}	137800	LFS1 	191170	17p13.1
{Glioma susceptibility 1}	137800	BCC7	191170	17p13.1
{Glioma susceptibility 2}	613028	PTEN	601728	10q23.31
{Glioma susceptibility 2}	613028	MMAC1	601728	10q23.31
{Glioma susceptibility 2}	613028	GLM2	601728	10q23.31
{Glioma susceptibility 2}	613028	CWS1	601728	10q23.31
{Glioma susceptibility 4}	607248	GLM4		15q23-q26.3
{Glioma susceptibility 5}	613030	GLM5		9p21.3
{Glioma susceptibility 6}	613031	GLM6		20q13.33
{Glioma susceptibility 7}	613032	GLM7		8q24.21
{Glioma susceptibility 8}	613033	GLM8		5p15.33
{Glioma, susceptibility to, somatic}	137800	IDH1	147700	2q34
{Glomerulosclerosis, focal segmental, 4, susceptibility to}	612551	APOL1	603743	22q12.3
{Glomerulosclerosis, focal segmental, 4, susceptibility to}	612551	FSGS4	603743	22q12.3
{Glucocorticoid therapy, response to}	614400	GLCCI1	614283	7p21.3
{Glucocorticoid therapy, response to}	614400	TSSN1	614283	7p21.3
{Glucocorticoid therapy, response to}	614400	GCTR	614283	7p21.3
{Gout susceptibility 4}	612671	SLC17A3	611034	6p22.2
{Gout susceptibility 4}	612671	NPT4	611034	6p22.2
{Graft-versus-host disease, protection against}	614395	IL10	124092	1q32.1
{Graft-versus-host disease, protection against}	614395	CSIF	124092	1q32.1
{Graft-versus-host disease, protection against}	614395	GVHDS	124092	1q32.1
{Graves disease, susceptibility to, 1}	275000	GRD1		14q31
{Graves disease, susceptibility to, 2}	603388	GRD2		20q13.11
{Graves disease, susceptibility to, 3}	139200	GC		4q13.3
{Graves disease, susceptibility to, 3}	139200	DBP		4q13.3
{Graves disease, susceptibility to, 3}	139200	GRD3		4q13.3
{Graves disease, susceptibility to, 4}	123890	CTLA4		2q33.2
{Graves disease, susceptibility to, 4}	123890	IDDM12		2q33.2
{Graves disease, susceptibility to, 4}	123890	CELIAC3		2q33.2
{Graves disease, susceptibility to, 4}	123890	GRD4		2q33.2
{Graves disease, susceptibility to, X-linked}	300351	GRDX		Xp11
{Graves disease, susceptibility to, X-linked}	300351	GD3		Xp11
{H. pylori infection, susceptibility to}	600263	PTPRZ1	176891	7q31.32
{H. pylori infection, susceptibility to}	600263	PTP18	176891	7q31.32
{H. pylori infection, susceptibility to}	600263	IFNGR1	107470	6q23.3
{HDL response to hormone replacement, augmented}	133430	ESR1		6q25.1
{HDL response to hormone replacement, augmented}	133430	ESR		6q25.1
{HDL response to hormone replacement, augmented}	133430	ESTRR		6q25.1
{HFE hemochromatosis, modifier of}	235200	BMP2	112261	20p12.3
{HFE hemochromatosis, modifier of}	235200	BMP2A	112261	20p12.3
{HFE hemochromatosis, modifier of}	235200	BDA2	112261	20p12.3
{HIV infection, resistance to}	609423	CCL3	182283	17q12
{HIV infection, resistance to}	609423	SCYA3	182283	17q12
{HIV infection, resistance to}	609423	MIP1A	182283	17q12
{HIV infection, susceptibility/resistance to}		CCR2	601267	3p21.31
{HIV infection, susceptibility/resistance to}		CMKBR2	601267	3p21.31
{HIV infection, susceptibility/resistance to}		CCR5	601373	3p21.31
{HIV infection, susceptibility/resistance to}		CMKBR5	601373	3p21.31
{HIV infection, susceptibility/resistance to}		CCCKR5	601373	3p21.31
{HIV infection, susceptibility/resistance to}		IDDM22	601373	3p21.31
{HIV type 1, susceptibility to}	609423	CD209	604672	19p13.2
{HIV type 1, susceptibility to}	609423	CDSIGN	604672	19p13.2
{HIV-1 disease, delayed progression of}		CCL5	187011	17q12
{HIV-1 disease, delayed progression of}		SCYA5	187011	17q12
{HIV-1 disease, delayed progression of}		D17S136E	187011	17q12
{HIV-1 disease, delayed progression of}		TCP228	187011	17q12
{HIV-1 disease, rapid progression of}		CCL5	187011	17q12
{HIV-1 disease, rapid progression of}		SCYA5	187011	17q12
{HIV-1 disease, rapid progression of}		D17S136E	187011	17q12
{HIV-1 disease, rapid progression of}		TCP228	187011	17q12
{HIV-1 viremia, susceptibility to}	609423	HLA-C	142840	6p21.33
{HIV-1 viremia, susceptibility to}	609423	PSORS1	142840	6p21.33
{HIV-1, resistance to}	609423	CCL2	158105	17q12
{HIV-1, resistance to}	609423	SCYA2	158105	17q12
{HIV-1, resistance to}	609423	MCP1	158105	17q12
{HIV-1, resistance to}	609423	MCAF	158105	17q12
{HIV-1, susceptibility to}	609423	IL10	124092	1q32.1
{HIV-1, susceptibility to}	609423	CSIF	124092	1q32.1
{HIV-1, susceptibility to}	609423	GVHDS	124092	1q32.1
{HIV/AIDS, susceptibility to}	609423	CCL3L1	601395	17q12
{HIV/AIDS, susceptibility to}	609423	SCYA3L1	601395	17q12
{HIV/AIDS, susceptibility to}	609423	LD78	601395	17q12
{HIV1 infection, resistance to}	609423	TLR3	603029	4q35.1
{HIV1 infection, resistance to}	609423	IIAE2	603029	4q35.1
{HIV1, resistance to}	609423	CCL11	601156	17q12
{HIV1, resistance to}	609423	SCYA11	601156	17q12
{Hangover, susceptibility to}	610251	ALDH2	100650	12q24.12
{Hemangioma, capillary infantile, susceptibility to}	602089	ANTXR1	606410	2p13.3
{Hemangioma, capillary infantile, susceptibility to}	602089	TEM8	606410	2p13.3
{Hemangioma, capillary infantile, susceptibility to}	602089	ATR	606410	2p13.3
{Hemangioma, capillary infantile, susceptibility to}	602089	GAPO	606410	2p13.3
{Hemangioma, capillary infantile, susceptibility to}	602089	KDR	191306	4q12
{Hemolytic uremic syndrome, atypical, susceptibility to, 1}	235400	HF1	134370	1q31.3
{Hemolytic uremic syndrome, atypical, susceptibility to, 1}	235400	CFH	134370	1q31.3
{Hemolytic uremic syndrome, atypical, susceptibility to, 1}	235400	HUS	134370	1q31.3
{Hemolytic uremic syndrome, atypical, susceptibility to, 1}	235400	ARMD4	134370	1q31.3
{Hemolytic uremic syndrome, atypical, susceptibility to, 1}	235400	AHUS1	134370	1q31.3
{Hemolytic uremic syndrome, atypical, susceptibility to, 2}	612922	MCP	120920	1q32.2
{Hemolytic uremic syndrome, atypical, susceptibility to, 2}	612922	CD46	120920	1q32.2
{Hemolytic uremic syndrome, atypical, susceptibility to, 2}	612922	AHUS2	120920	1q32.2
{Hemolytic uremic syndrome, atypical, susceptibility to, 3}	612923	CFI	217030	4q25
{Hemolytic uremic syndrome, atypical, susceptibility to, 3}	612923	FI	217030	4q25
{Hemolytic uremic syndrome, atypical, susceptibility to, 3}	612923	AHUS3	217030	4q25
{Hemolytic uremic syndrome, atypical, susceptibility to, 3}	612923	ARMD13	217030	4q25
{Hemolytic uremic syndrome, atypical, susceptibility to, 4}	612924	CFB	138470	6p21.33
{Hemolytic uremic syndrome, atypical, susceptibility to, 4}	612924	BF	138470	6p21.33
{Hemolytic uremic syndrome, atypical, susceptibility to, 4}	612924	GBG	138470	6p21.33
{Hemolytic uremic syndrome, atypical, susceptibility to, 4}	612924	AHUS4	138470	6p21.33
{Hemolytic uremic syndrome, atypical, susceptibility to, 4}	612924	ARMD14	138470	6p21.33
{Hemolytic uremic syndrome, atypical, susceptibility to, 4}	612924	CFBD	138470	6p21.33
{Hemolytic uremic syndrome, atypical, susceptibility to, 5}	612925	C3	120700	19p13.3
{Hemolytic uremic syndrome, atypical, susceptibility to, 5}	612925	ARMD9	120700	19p13.3
{Hemolytic uremic syndrome, atypical, susceptibility to, 5}	612925	AHUS5	120700	19p13.3
{Hemolytic uremic syndrome, atypical, susceptibility to, 6}	612926	THBD	188040	20p11.21
{Hemolytic uremic syndrome, atypical, susceptibility to, 6}	612926	THRM	188040	20p11.21
{Hemolytic uremic syndrome, atypical, susceptibility to, 6}	612926	AHUS6	188040	20p11.21
{Hemolytic uremic syndrome, atypical, susceptibility to, 6}	612926	THPH12	188040	20p11.21
{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	CFHR1	134371	1q31.3
{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	FHR1	134371	1q31.3
{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	HFL1	134371	1q31.3
{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	CFHL1	134371	1q31.3
{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	CFHR3	605336	1q31.3
{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	FHR3	605336	1q31.3
{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	HLF4	605336	1q31.3
{Hemolytic uremic syndrome, atypical, susceptibility to}	235400	CFHL3	605336	1q31.3
{Hemorrhage, intracerebral, susceptibility to}	614519	COL4A1	120130	13q34
{Hemorrhage, intracerebral, susceptibility to}	614519	POREN1	120130	13q34
{Hemorrhage, intracerebral, susceptibility to}	614519	HANAC	120130	13q34
{Hemorrhage, intracerebral, susceptibility to}	614519	ICH	120130	13q34
{Hemorrhage, intracerebral, susceptibility to}	614519	COL4A2	120090	13q34
{Hemorrhage, intracerebral, susceptibility to}	614519	POREN2	120090	13q34
{Hemorrhage, intracerebral, susceptibility to}	614519	ICH	120090	13q34
{Hepatic fibrosis susceptibility due to Schistosoma mansoni infection}	604201	SM2		6q22-q23
{Hepatitic C virus, susceptibility to}	609532	PTPRC	151460	1q31.3-q32.1
{Hepatitic C virus, susceptibility to}	609532	CD45	151460	1q31.3-q32.1
{Hepatitic C virus, susceptibility to}	609532	LCA	151460	1q31.3-q32.1
{Hepatitis B virus infection, susceptibility to}	610424	IFNGR1	107470	6q23.3
{Hepatitis B virus, susceptibility to}	610424	CRFB4	123889	21q22.11
{Hepatitis B virus, susceptibility to}	610424	IBD25	123889	21q22.11
{Hepatitis B virus, susceptibility to}	610424	IFNAR2	602376	21q22.11
{Hepatitis C virus infection, response to therapy of}	609532	IFNL3	607402	19q13.2
{Hepatitis C virus infection, response to therapy of}	609532	IL28B	607402	19q13.2
{Hepatitis C virus, resistance to}	609532	CCR5	601373	3p21.31
{Hepatitis C virus, resistance to}	609532	CMKBR5	601373	3p21.31
{Hepatitis C virus, resistance to}	609532	CCCKR5	601373	3p21.31
{Hepatitis C virus, resistance to}	609532	IDDM22	601373	3p21.31
{Hepatitis C virus, response to therapy of}	609532	IFNG	147570	12q15
{Hepatitis C virus, response to therapy of}	609532	IFG	147570	12q15
{Hepatitis C virus, response to therapy of}	609532	IFI	147570	12q15
{Herpes simplex encephalitis, susceptibility to, 2} 613002		TLR3	603029	4q35.1
{Herpes simplex encephalitis, susceptibility to, 2} 613002		IIAE2	603029	4q35.1
{Herpes simplex encephalitis, susceptibility to, 3}	614849	TRAF3	601896	14q32.32
{Herpes simplex encephalitis, susceptibility to, 3}	614849	CD40BP	601896	14q32.32
{Herpes simplex encephalitis, susceptibility to, 3}	614849	LAP1	601896	14q32.32
{Herpes simplex encephalitis, susceptibility to, 3}	614849	CAP1	601896	14q32.32
{Herpes simplex encephalitis, susceptibility to, 3}	614849	CRAF1	601896	14q32.32
{Herpes simplex encephalitis, susceptibility to, 3}	614849	IIAE5	601896	14q32.32
{High density lipoprotein cholesterol, low serum, 3}	607687	HDLC3		16q24.1
{Hirschsprung disease, susceptibility to, 1}	142623	RET	164761	10q11.21
{Hirschsprung disease, susceptibility to, 1}	142623	MEN2A	164761	10q11.21
{Hirschsprung disease, susceptibility to, 1}	142623	HSCR1	164761	10q11.21
{Hirschsprung disease, susceptibility to, 2}	600155	EDNRB	131244	13q22.3
{Hirschsprung disease, susceptibility to, 2}	600155	HSCR2	131244	13q22.3
{Hirschsprung disease, susceptibility to, 2}	600155	ABCDS	131244	13q22.3
{Hirschsprung disease, susceptibility to, 2}	600155	WS4A	131244	13q22.3
{Hirschsprung disease, susceptibility to, 3}	613711	GDNF	600837	5p13.2
{Hirschsprung disease, susceptibility to, 3}	613711	HSCR3	600837	5p13.2
{Hirschsprung disease, susceptibility to, 4}	613712	EDN3	131242	20q13.32
{Hirschsprung disease, susceptibility to, 4}	613712	WS4B	131242	20q13.32
{Hirschsprung disease, susceptibility to, 4}	613712	HSCR4	131242	20q13.32
{Hirschsprung disease, susceptibility to, 5}	600156	HSCR5		9q31
{Hirschsprung disease, susceptibility to, 6}	606874	HSCR6		3p21
{Hirschsprung disease, susceptibility to, 7}	606875	HSCR7		19q12
{Hirschsprung disease, susceptibility to, 8}	608462	HSCR8		16q23
{Hirschsprung disease, susceptibility to, 9}	611644	HSCR9		4q31.3-q32.3
{Hodgkin disease susceptibility, pseudoautosomal}	300221	HDPA		Xpter-p22.32
{Human herpesvirus 8, susceptibility to}	614836	HHV8S		3p22
{Hyperapobetalipoproteinemia, susceptibility to}	170998	PPARA		22q13.31
{Hyperapobetalipoproteinemia, susceptibility to}	170998	PPAR		22q13.31
{Hypercalciuria, absorptive, susceptibility to}	143870	SAC	605205	1q24.2
{Hypercalciuria, absorptive, susceptibility to}	143870	HCA2	605205	1q24.2
{Hypercholesterolemia, familial, due to LDLR defect, modifier of}	143890	EPHX2	132811	8p21.2-p21.1
{Hypercholesterolemia, familial, modification of}	143890	APOA2	107670	1q23.3
{Hypercholesterolemia, familial, modification of}	143890	GHR	600946	5p13-p12
{Hypercholesterolemia, susceptibility to}	143890	GSBS	604088	7p14.3
{Hypercholesterolemia, susceptibility to}	143890	ITIH4	600564	3p21.1
{Hypercholesterolemia, susceptibility to}	143890	PK120	600564	3p21.1
{Hypercholesterolemia, susceptibility to}	143890	ITIHL1	600564	3p21.1
{Hyperlipidemia, familial combined, susceptibility to}	602491	USF1	191523	1q23.3
{Hyperlipidemia, familial combined, susceptibility to}	602491	HYPLIP1	191523	1q23.3
{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}	608579	HLA-A	142800	6p22.1
{Hypertension, diastolic, resistance to}	608622	KCNMB1	603951	5q35.1
{Hypertension, essential, salt-sensitive}	145500	ADD1	102680	4p16.3
{Hypertension, essential, susceptibility to, 1}	145500	HYT1	603918	17q
{Hypertension, essential, susceptibility to, 2}	145500	HYT2	604329	15q
{Hypertension, essential, susceptibility to, 3}	145500	HYT3	607329	2p25-p24
{Hypertension, essential, susceptibility to, 4}	145500	HYT4	608742	12p12.2-p12.1
{Hypertension, essential, susceptibility to, 5}	145500	HYT5	610261	20q11-q13
{Hypertension, essential, susceptibility to, 6}	145500	HYT6	610262	5p13-q12
{Hypertension, essential, susceptibility to, 7}	610948	HYT7		3p14.1-q12.3
{Hypertension, essential, susceptibility to, 8}	611014	HYT8		18q21.2
{Hypertension, essential, susceptibility to}	145500	AGT	106150	1q42.2
{Hypertension, essential, susceptibility to}	145500	SERPINA8	106150	1q42.2
{Hypertension, essential, susceptibility to}	145500	ECE1	600423	1p36.12
{Hypertension, essential, susceptibility to}	145500	GNB3	139130	12p13.31
{Hypertension, insulin resistance-related, susceptibility to}	125853	RETN	605565	19p13.2
{Hypertension, insulin resistance-related, susceptibility to}	125853	RSTN	605565	19p13.2
{Hypertension, insulin resistance-related, susceptibility to}	125853	FIZZ3	605565	19p13.2
{Hypertension, pregnancy-induced}	189800	NOS3	163729	7q36.1
{Hypertension, salt-sensitive essential, susceptibility to}	145500	CYP3A5	605325	7q22.1
{Hypertension, salt-sensitive essential, susceptibility to}	145500	P450PCN3	605325	7q22.1
{Hypertension, susceptibility to}	145500	NOS2A	163730	17q11.2
{Hypertension, susceptibility to}	145500	NOS2	163730	17q11.2
{Hypertension, susceptibility to}	145500	NOS3	163729	7q36.1
{Hypertriglyceridemia, susceptibility to}	145750	HTGS		15q11.2-q13.1
{Hypertriglyceridemia, susceptibility to}	145750	APOA5	606368	11q23.3
{Hypertriglyceridemia, susceptibility to}	145750	LIPI	609252	21q11.2
{Hypertriglyceridemia, susceptibility to}	145750	LPDL	609252	21q11.2
{Hypertriglyceridemia, susceptibility to}	145750	PRED5	609252	21q11.2
{Hypertriglyceridemia, susceptibility to}	145750	RP1	603937	8q12.1
{Hypertriglyceridemia, susceptibility to}	145750	ORP1	603937	8q12.1
{Hypertrypsinemia, neonatal}		CFTR	602421	7q31.2
{Hypertrypsinemia, neonatal}		ABCC7	602421	7q31.2
{Hypertrypsinemia, neonatal}		CF	602421	7q31.2
{Hypertrypsinemia, neonatal}		MRP7	602421	7q31.2
{Hypogonadotropic hypogonadism 15 with or without anosmia}	614880	HS6ST1	604846	2q14.3
{Hypogonadotropic hypogonadism 15 with or without anosmia}	614880	HS6ST	604846	2q14.3
{Hypogonadotropic hypogonadism 15 with or without anosmia}	614880	HH15	604846	2q14.3
{Hypogonadotropic hypogonadism 16 with or without anosmia}	614897	SEMA3A	603961	7q21.11
{Hypogonadotropic hypogonadism 16 with or without anosmia}	614897	SEMAD	603961	7q21.11
{Hypogonadotropic hypogonadism 16 with or without anosmia}	614897	COLL1	603961	7q21.11
{Hypogonadotropic hypogonadism 16 with or without anosmia}	614897	HH16	603961	7q21.11
{Hypospadias 4, X-linked, susceptibilty to}	300856	HYSP4		Xp11.22
{Hypothalamic hamartomas, somatic}	241800	GLI3	165240	7p14.1
{Hypothalamic hamartomas, somatic}	241800	PAPA	165240	7p14.1
{Hypothalamic hamartomas, somatic}	241800	PAPB	165240	7p14.1
{Hypothyroidism, autoimmune}	140300	CTLA4	123890	2q33.2
{Hypothyroidism, autoimmune}	140300	IDDM12	123890	2q33.2
{Hypothyroidism, autoimmune}	140300	CELIAC3	123890	2q33.2
{Hypothyroidism, autoimmune}	140300	GRD4	123890	2q33.2
{IgA nephropathy, susceptibility to, 2}	613944	IGAN2		2q36
{Inflammatory bowel disease 10}	611081	ATG16L1	610767	2q37.1
{Inflammatory bowel disease 10}	611081	APG16L	610767	2q37.1
{Inflammatory bowel disease 10}	611081	IBD10	610767	2q37.1
{Inflammatory bowel disease 11}	191390	IBD11		7q22
{Inflammatory bowel disease 12}	612241	IBD12		3p21.3
{Inflammatory bowel disease 13}	612244	ABCB1	171050	7q21.12
{Inflammatory bowel disease 13}	612244	PGY1	171050	7q21.12
{Inflammatory bowel disease 13}	612244	MDR1	171050	7q21.12
{Inflammatory bowel disease 13}	612244	IBD13	171050	7q21.12
{Inflammatory bowel disease 13}	612244	CLCs	171050	7q21.12
{Inflammatory bowel disease 14}	612245	IRF5	607218	7q32.1
{Inflammatory bowel disease 14}	612245	IBD14	607218	7q32.1
{Inflammatory bowel disease 14}	612245	SLEB10	607218	7q32.1
{Inflammatory bowel disease 15}	612255	IBD15		10q21
{Inflammatory bowel disease 16}	612259	IBD16		9q32
{Inflammatory bowel disease 17, protection against}	612261	IL23R	607562	1p31.3
{Inflammatory bowel disease 17, protection against}	612261	IBD17	607562	1p31.3
{Inflammatory bowel disease 18}	612262	IBD18		5p13.1
{Inflammatory bowel disease 1}	266600	NOD2	605956	16q12.1
{Inflammatory bowel disease 1}	266600	CARD15	605956	16q12.1
{Inflammatory bowel disease 1}	266600	IBD1	605956	16q12.1
{Inflammatory bowel disease 1}	266600	CD	605956	16q12.1
{Inflammatory bowel disease 1}	266600	ACUG	605956	16q12.1
{Inflammatory bowel disease 1}	266600	PSORAS1	605956	16q12.1
{Inflammatory bowel disease 20}	612288	IBD20		10q23-q24
{Inflammatory bowel disease 21}	612354	IBD21		18p11
{Inflammatory bowel disease 22}	612380	IBD22		17q21.2
{Inflammatory bowel disease 23}	612381	IBD23		1q32.1
{Inflammatory bowel disease 24}	612566	IBD24		20q13
{Inflammatory bowel disease 26}	612639	IBD26		12q15
{Inflammatory bowel disease 27}	612796	IBD27		13q13.3
{Inflammatory bowel disease 2}	601458	IBD2		12p13.2-q24.1
{Inflammatory bowel disease 3}	604519	IBD3		6p21.3
{Inflammatory bowel disease 4}	606675	IBD4		14q11-q12
{Inflammatory bowel disease 5}	606348	IBD5		5q31
{Inflammatory bowel disease 6}	606674	IBD6		19p13
{Inflammatory bowel disease 7}	605225	IBD7		1p36
{Inflammatory bowel disease 8}	606668	IBD8		16p
{Inflammatory bowel disease 9}	608448	IBD9		3p26
{Influenza, severe, susceptibility to}	614680	IFITM3	605579	11p15.5
{Insulin resistance, susceptibility to}	125853	PTPN1	176885	20q13.13
{Insulin resistance, susceptibility to}	125853	PTP1B	176885	20q13.13
{Intelligence QTL1}	603783	INTLQ1		4p16-q34
{Intelligence QTL3}	610295	INTLQ2		2q24.1-q31.1
{Intelligence QTL3}	610294	INTLQ3		6p25.3-p22.3
{Intervertebral disc disease, susceptibility to}	603932	COL9A2	120260	1p34.2
{Intervertebral disc disease, susceptibility to}	603932	EDM2	120260	1p34.2
{Intervertebral disc disease, susceptibility to}	603932	STL5	120260	1p34.2
{Intervertebral disc disease, susceptibility to}	603932	COL9A3	120270	20q13.33
{Intervertebral disc disease, susceptibility to}	603932	EDM3	120270	20q13.33
{Intervertebral disc disease, susceptibility to}	603932	IDD	120270	20q13.33
{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}	108010	IL6	147620	7p15.3
{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}	108010	IFNB2	147620	7p15.3
{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}	108010	BSF2	147620	7p15.3
{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}	108010	HSF	147620	7p15.3
{Intracranial hemorrhage in brain cerebrovascular malformations, susceptibility to}	108010	HGF	147620	7p15.3
{Ischemic stroke, susceptibility to}	601367	NOS3	163729	7q36.1
{Kala-azar, susceptibility to, 1}	608207	KAZA1		22q12
{Kala-azar, susceptibility to, 2}	611381	KAZA2		1p22
{Kala-azar, susceptibility to, 3}	611382	KAZA3		6q27
{Kaposi sarcoma, susceptibility to}	148000	IL6	147620	7p15.3
{Kaposi sarcoma, susceptibility to}	148000	IFNB2	147620	7p15.3
{Kaposi sarcoma, susceptibility to}	148000	BSF2	147620	7p15.3
{Kaposi sarcoma, susceptibility to}	148000	HSF	147620	7p15.3
{Kaposi sarcoma, susceptibility to}	148000	HGF	147620	7p15.3
{Kawasaki disease, susceptibility to}	611775	ITPKC	606476	19q13.2
{Kuru, susceptibility to}	245300	PRNP	176640	20p13
{Kuru, susceptibility to}	245300	PRIP	176640	20p13
{Kuru, susceptibility to}	245300	KURU	176640	20p13
{Kuru, susceptibility to}	245300	CJD	176640	20p13
{Lead poisoning, susceptibility to}	612740	ALAD	125270	9q32
{Lead poisoning, susceptibility to}	612740	ALADH	125270	9q32
{Lead poisoning, susceptibility to}	612740	PBGS	125270	9q32
{Leanness, inherited}		AGRP	602311	16q22.1
{Leanness, inherited}		ART	602311	16q22.1
{Leanness, inherited}		AGRT	602311	16q22.1
{Leber optic atrophy, susceptibility to}	308905	LOAS		Xp11
{Legionaire disease, susceptibility to}	608556	TLR5	603031	1q41
{Legionaire disease, susceptibility to}	608556	TIL3	603031	1q41
{Legionaire disease, susceptibility to}	608556	SLEB1	603031	1q41
{Legionaire disease, susceptibility to}	608556	MELIOS	603031	1q41
{Leprosy, paucibacillary type, susceptibility to}	609888	LPRS		10p13
{Leprosy, protection against}	613223	TLR1	601194	4p14
{Leprosy, protection against}	613223	TIL. LPRS5	601194	4p14
{Leprosy, susceptibility to, 4}	610988	LTA	153440	6p21.33
{Leprosy, susceptibility to, 4}	610988	TNFB	153440	6p21.33
{Leprosy, susceptibility to, 5}	613223	TLR1	601194	4p14
{Leprosy, susceptibility to, 5}	613223	TIL. LPRS5	601194	4p14
{Leprosy, susceptibility to}	246300	TLR2	603028	4q31.3
{Leprosy, susceptibility to}	246300	TIL4	603028	4q31.3
{Leprosy, susceptibility to}	607572	PRKN	602544	6q26
{Leprosy, susceptibility to}	607572	PARK2	602544	6q26
{Leprosy, susceptibility to}	607572	PDJ	602544	6q26
{Leprosy, susceptibility to}	607572	LPRS2	602544	6q26
{Leprosy, susceptiblity to, 6}	613407	LPRS6		13q14.11
{Leukemia, acute lymphoblastic, susceptibility to, 2}	613067	ALL2		7p12.2
{Leukemia, acute lymphoblastic, susceptibility to}	142981	HOXD4		2q31.1
{Leukemia, acute lymphoblastic, susceptibility to}	142981	HOX4B		2q31.1
{Leukemia, acute lymphocytic, susceptibility to, 1}	613065	ALL1		10q21
{Leukemia, acute myeloid, susceptibility to}	601626	GATA2	137295	3q21.3
{Leukemia, acute myeloid, susceptibility to}	601626	DCML	137295	3q21.3
{Leukemia, acute myeloid, susceptibility to}	601626	MONOMAC	137295	3q21.3
{Leukemia, acute myeloid}	601626	CHIC2	604332	4q12
{Leukemia, acute myeloid}	601626	BTL	604332	4q12
{Leukemia, acute myeloid}	601626	TERT	187270	5p15.33
{Leukemia, acute myeloid}	601626	TCS1	187270	5p15.33
{Leukemia, acute myeloid}	601626	EST2	187270	5p15.33
{Leukemia, acute myeloid}	601626	DKCA2	187270	5p15.33
{Leukemia, acute myeloid}	601626	DKCB4	187270	5p15.33
{Leukemia, acute myeloid}	601626	PFBMFT1	187270	5p15.33
{Leukemia, acute myeloid}	601626	CMM9	187270	5p15.33
{Leukemia, chronic lymphocytic susceptibility to, 4}	612558	CLLS4		6p25
{Leukemia, chronic lymphocytic susceptibility to, 5}	612559	CLLS5		11q24.1
{Leukemia, chronic lymphocytic, susceptibility to, 1}	609630	CLLS1		11q13.3
{Leukemia, chronic lymphocytic, susceptibility to, 2}	109543	CLLS2		13q14
{Leukemia, chronic lymphocytic, susceptibility to, 2}	109543	D13S25		13q14
{Leukemia, chronic lymphocytic, susceptibility to, 2}	109543	DBM		13q14
{Leukemia, chronic lymphocytic, susceptibility to, 3}	612557	CLLS3		9q34.1
{Leukemia, post-chemotherapy, susceptibility to}	125860	NQO1		16q22.1
{Leukemia, post-chemotherapy, susceptibility to}	125860	DIA4		16q22.1
{Leukemia, post-chemotherapy, susceptibility to}	125860	NMOR1		16q22.1
{Lewy body dementia, susceptibility to}	127750	GBA	606463	1q22
{Lipodystrophy, partial, acquired, susceptibility to}	608709	LMNB2	150341	19p13.3
{Lipodystrophy, partial, acquired, susceptibility to}	608709	LMN2	150341	19p13.3
{Long QT syndrome 1, acquired, susceptibility to}	192500	KCNQ1	607542	11p15.5-p15.4
{Long QT syndrome 1, acquired, susceptibility to}	192500	KCNA9	607542	11p15.5-p15.4
{Long QT syndrome 1, acquired, susceptibility to}	192500	LQT1	607542	11p15.5-p15.4
{Long QT syndrome 1, acquired, susceptibility to}	192500	KVLQT1	607542	11p15.5-p15.4
{Long QT syndrome 1, acquired, susceptibility to}	192500	ATFB3	607542	11p15.5-p15.4
{Long QT syndrome 1, acquired, susceptibility to}	192500	SQT2	607542	11p15.5-p15.4
{Long QT syndrome 2, acquired, susceptibility to}	613688	KCNH2	152427	7q36.1
{Long QT syndrome 2, acquired, susceptibility to}	613688	LQT2	152427	7q36.1
{Long QT syndrome 2, acquired, susceptibility to}	613688	HERG	152427	7q36.1
{Long QT syndrome 2, acquired, susceptibility to}	613688	SQT1	152427	7q36.1
{Long QT syndrome, acquired, reduced susceptibility to}	613688	ALG10	603313	12p11.1
{Long QT syndrome, acquired, reduced susceptibility to}	613688	KCR1	603313	12p11.1
{Low density lipoprotein cholesterol level QTL 1}	603776	PCSK9	607786	1p32.3
{Low density lipoprotein cholesterol level QTL 1}	603776	NARC1	607786	1p32.3
{Low density lipoprotein cholesterol level QTL 1}	603776	HCHOLA3	607786	1p32.3
{Low density lipoprotein cholesterol level QTL 1}	603776	FH3	607786	1p32.3
{Low density lipoprotein cholesterol level QTL 1}	603776	LDLCQ1	607786	1p32.3
{Low renin hypertension, susceptibility to}		CYP11B2	124080	8q24.3
{Lumbar disc degeneration}	603932	ASPN	608135	9q22.31
{Lumbar disc degeneration}	603932	PLAP1	608135	9q22.31
{Lumbar disc degeneration}	603932	OS3	608135	9q22.31
{Lumbar disc disease, susceptibility to}	603932	CILP	603489	15q22.31
{Lumbar disc herniation, susceptibility to}	603932	COL11A1	120280	1p21.1
{Lumbar disc herniation, susceptibility to}	603932	STL2	120280	1p21.1
{Lumbar disc herniation, susceptibility to}	603932	THBS2	188061	6q27
{Lung cancer susceptibility 2}	612052	CHRNA3	118503	15q25.1
{Lung cancer susceptibility 2}	612052	LNCR2	118503	15q25.1
{Lung cancer susceptibility 2}	612052	PAOD2	118503	15q25.1
{Lung cancer susceptibility 2}	612052	CHRNA5	118505	15q25.1
{Lung cancer susceptibility 2}	612052	LNCR2	118505	15q25.1
{Lung cancer susceptibility 3}	612571	LNCR3		5p15.33
{Lung cancer susceptibility 4}	612593	LNCR4		6p21.33
{Lung cancer susceptibility 5}	614210	LNCR5		3q28
{Lung cancer susceptibility}	608935	LNCR1		6q23-q25
{Lung cancer, protection against, in smokers}		MPO	606989	17q22
{Lung cancer, protection against}	211980	CASP8	601763	2q33.1
{Lung cancer, protection against}	211980	MCH5	601763	2q33.1
{Lung cancer, protection against}	211980	ALPS2B	601763	2q33.1
{Lung cancer, resistance to}	211980	CYP2A6	122720	19q13.2
{Lung cancer, resistance to}	211980	CYP2A3	122720	19q13.2
{Lung cancer, resistance to}	211980	CYP2A	122720	19q13.2
{Lung cancer, resistance to}	211980	P450C2A	122720	19q13.2
{Lung cancer, susceptibility to}	211980	ERCC6	609413	10q11.23
{Lung cancer, susceptibility to}	211980	CKN2	609413	10q11.23
{Lung cancer, susceptibility to}	211980	COFS1	609413	10q11.23
{Lung cancer, susceptibility to}	211980	CSB	609413	10q11.23
{Lung cancer, susceptibility to}	211980	ARMD5	609413	10q11.23
{Lung cancer, susceptibility to}	211980	UVSS1	609413	10q11.23
{Lung cancer, susceptibility to}	211980	TNFSF6	134638	1q24.3
{Lung cancer, susceptibility to}	211980	APT1LG1	134638	1q24.3
{Lung cancer, susceptibility to}	211980	FASL	134638	1q24.3
{Lung cancer, susceptibility to}	211980	ALPS1B	134638	1q24.3
{Lupus nephritis, susceptibility to}		FCGR2A	146790	1q23.3
{Lupus nephritis, susceptibility to}		IGFR2	146790	1q23.3
{Lupus nephritis, susceptibility to}		CD32	146790	1q23.3
{Lymphoma, follicular, somatic}	613024	BCL10	603517	1p22.3
{Macroglobulinemia, Waldenstrom, susceptibility to, 1}	153600	WM1		6p21.3
{Macroglobulinemia, Waldenstrom, susceptibility to, 2}	610430	WM2		4q
{Macular degeneration, age-related, 10}	611488	TLR4	603030	9q33.1
{Macular degeneration, age-related, 10}	611488	ARMD10	603030	9q33.1
{Macular degeneration, age-related, 12}	613784	CX3CR1	601470	3p22.2
{Macular degeneration, age-related, 12}	613784	GPR13	601470	3p22.2
{Macular degeneration, age-related, 12}	613784	V28	601470	3p22.2
{Macular degeneration, age-related, 13, susceptibility to}	615439	CFI	217030	4q25
{Macular degeneration, age-related, 13, susceptibility to}	615439	FI	217030	4q25
{Macular degeneration, age-related, 13, susceptibility to}	615439	AHUS3	217030	4q25
{Macular degeneration, age-related, 13, susceptibility to}	615439	ARMD13	217030	4q25
{Macular degeneration, age-related, 14, reduced risk of}	615489	C2	613927	6p21.33
{Macular degeneration, age-related, 14, reduced risk of}	615489	ARMD14	613927	6p21.33
{Macular degeneration, age-related, 14, reduced risk of}	615489	CFB	138470	6p21.33
{Macular degeneration, age-related, 14, reduced risk of}	615489	BF	138470	6p21.33
{Macular degeneration, age-related, 14, reduced risk of}	615489	GBG	138470	6p21.33
{Macular degeneration, age-related, 14, reduced risk of}	615489	AHUS4	138470	6p21.33
{Macular degeneration, age-related, 14, reduced risk of}	615489	ARMD14	138470	6p21.33
{Macular degeneration, age-related, 14, reduced risk of}	615489	CFBD	138470	6p21.33
{Macular degeneration, age-related, 1}	603075	HMCN1	608548	1q25.3-q31.1
{Macular degeneration, age-related, 1}	603075	FBLN6	608548	1q25.3-q31.1
{Macular degeneration, age-related, 1}	603075	FIBL6	608548	1q25.3-q31.1
{Macular degeneration, age-related, 1}	603075	ARMD1	608548	1q25.3-q31.1
{Macular degeneration, age-related, 4}	610698	HF1	134370	1q31.3
{Macular degeneration, age-related, 4}	610698	CFH	134370	1q31.3
{Macular degeneration, age-related, 4}	610698	HUS	134370	1q31.3
{Macular degeneration, age-related, 4}	610698	ARMD4	134370	1q31.3
{Macular degeneration, age-related, 4}	610698	AHUS1	134370	1q31.3
{Macular degeneration, age-related, 7}	610149	HTRA1	602194	10q26.13
{Macular degeneration, age-related, 7}	610149	PRSS11	602194	10q26.13
{Macular degeneration, age-related, 7}	610149	ARMD7	602194	10q26.13
{Macular degeneration, age-related, 7}	610149	CARASIL	602194	10q26.13
{Macular degeneration, age-related, 8}	613778	LOC387715	611313	10q26.13
{Macular degeneration, age-related, 8}	613778	ARMD8	611313	10q26.13
{Macular degeneration, age-related, 9}	611378	C3	120700	19p13.3
{Macular degeneration, age-related, 9}	611378	ARMD9	120700	19p13.3
{Macular degeneration, age-related, 9}	611378	AHUS5	120700	19p13.3
{Macular degeneration, age-related, neovascular type}	610149	HTRA1	602194	10q26.13
{Macular degeneration, age-related, neovascular type}	610149	PRSS11	602194	10q26.13
{Macular degeneration, age-related, neovascular type}	610149	ARMD7	602194	10q26.13
{Macular degeneration, age-related, neovascular type}	610149	CARASIL	602194	10q26.13
{Macular degeneration, age-related, reduced risk of}	603075	CFHR1	134371	1q31.3
{Macular degeneration, age-related, reduced risk of}	603075	FHR1	134371	1q31.3
{Macular degeneration, age-related, reduced risk of}	603075	HFL1	134371	1q31.3
{Macular degeneration, age-related, reduced risk of}	603075	CFHL1	134371	1q31.3
{Macular degeneration, age-related, reduced risk of}	603075	CFHR3	605336	1q31.3
{Macular degeneration, age-related, reduced risk of}	603075	FHR3	605336	1q31.3
{Macular degeneration, age-related, reduced risk of}	603075	HLF4	605336	1q31.3
{Macular degeneration, age-related, reduced risk of}	603075	CFHL3	605336	1q31.3
{Macular degeneration, age-related, susceptibility to 5}	613761	ERCC6	609413	10q11.23
{Macular degeneration, age-related, susceptibility to 5}	613761	CKN2	609413	10q11.23
{Macular degeneration, age-related, susceptibility to 5}	613761	COFS1	609413	10q11.23
{Macular degeneration, age-related, susceptibility to 5}	613761	CSB	609413	10q11.23
{Macular degeneration, age-related, susceptibility to 5}	613761	ARMD5	609413	10q11.23
{Macular degeneration, age-related, susceptibility to 5}	613761	UVSS1	609413	10q11.23
{Major affective disorder 1}	125480	MAFD1		18p
{Major affective disorder 1}	125480	BPAD		18p
{Major affective disorder 1}	125480	MD1		18p
{Major affective disorder 3, early onset}	609633	MAFD3		21q22.13
{Major affective disorder 3, early onset}	609633	BPEO		21q22.13
{Major affective disorder 5}	611535	MAFD5		2q22-q24
{Major affective disorder 6}	611536	MAFD6		6q23-q24
{Major affective disorder 6}	611536	BPAD		6q23-q24
{Major affective disorder-7, susceptibility to}	612371	XBP1	194355	22q12.1
{Major affective disorder-7, susceptibility to}	612371	XBP2	194355	22q12.1
{Major affective disorder-8, susceptibility to}	612357	MAFD8		10q21
{Major affective disorder-9, susceptibility to}	612372	MAFD9		12p13.3
{Major depressive disorder and accelerated response to antidepressant drug treatment}	608516	FKBP5	602623	6p21.31
{Major depressive disorder and accelerated response to antidepressant drug treatment}	608516	FKBP51	602623	6p21.31
{Major depressive disorder, response to citalopram therapy in}	608516	HTR2A	182135	13q14.2
{Malaria, cerebral, reduced risk of}	611162	CD36	173510	7q21.11
{Malaria, cerebral, reduced risk of}	611162	CHDS7	173510	7q21.11
{Malaria, cerebral, reduced risk of}	611162	BDPLT10	173510	7q21.11
{Malaria, cerebral, susceptibility to}	611162	CD36	173510	7q21.11
{Malaria, cerebral, susceptibility to}	611162	CHDS7	173510	7q21.11
{Malaria, cerebral, susceptibility to}	611162	BDPLT10	173510	7q21.11
{Malaria, cerebral, susceptibility to}	611162	ICAM1	147840	19p13.2
{Malaria, cerebral, susceptibility to}	611162	TNF	191160	6p21.33
{Malaria, cerebral, susceptibility to}	611162	TNFA	191160	6p21.33
{Malaria, intensity of infection}	248310	PFBI		5q31-q33
{Malaria, mild, susceptibility to}	609148	NCR3	611550	6p21.33
{Malaria, mild, susceptibility to}	609148	1C7	611550	6p21.33
{Malaria, mild, susceptibility to}	609148	NKP30	611550	6p21.33
{Malaria, mild, susceptibility to}	609148	CD337	611550	6p21.33
{Malaria, mild, susceptibility to}	609148	MALS	611550	6p21.33
{Malaria, protection against}	611162	TIRAP	606252	11q24.2
{Malaria, protection against}	611162	BACTS1	606252	11q24.2
{Malaria, resistance to}	611162	FCGR2B	604590	1q23.3
{Malaria, resistance to}	611162	CD32	604590	1q23.3
{Malaria, resistance to}	611162	GYPA	111300	4q31.21
{Malaria, resistance to}	611162	MN	111300	4q31.21
{Malaria, resistance to}	611162	GPA	111300	4q31.21
{Malaria, resistance to}	611162	GYPB	111740	4q31.21
{Malaria, resistance to}	611162	SS	111740	4q31.21
{Malaria, resistance to}	611162	MNS	111740	4q31.21
{Malaria, resistance to}	611162	GYPC	110750	2q14.3
{Malaria, resistance to}	611162	GE	110750	2q14.3
{Malaria, resistance to}	611162	GPC	110750	2q14.3
{Malaria, resistance to}	611162	HBB	141900	11p15.4
{Malaria, resistance to}	611162	NOS2A	163730	17q11.2
{Malaria, resistance to}	611162	NOS2	163730	17q11.2
{Malaria, severe, resistance to}	611162	CR1	120620	1q32.2
{Malaria, severe, resistance to}	611162	C3BR	120620	1q32.2
{Malaria, severe, susceptibility to}	611162	FCGR2A	146790	1q23.3
{Malaria, severe, susceptibility to}	611162	IGFR2	146790	1q23.3
{Malaria, severe, susceptibility to}	611162	CD32	146790	1q23.3
{Malaria, susceptibility to}	611162	CISH	602441	3p21.2
{Malaria, susceptibility to}	611162	BACTS2	602441	3p21.2
{Malaria, vivax, protection against}	611162	DARC	613665	1q23.2
{Malaria, vivax, protection against}	611162	FY	613665	1q23.2
{Malaria, vivax, protection against}	611162	GPD	613665	1q23.2
{Malaria, vivax, protection against}	611162	WBCQ1	613665	1q23.2
{Male germ cell tumor, somatic}, 273300,		BCL10	603517	1p22.3
{Malignant hyperthermia susceptibility 1}	145600	RYR1	180901	19q13.2
{Malignant hyperthermia susceptibility 1}	145600	MHS	180901	19q13.2
{Malignant hyperthermia susceptibility 1}	145600	CCO	180901	19q13.2
{Malignant hyperthermia susceptibility 2}	154275	MHS2		17q11.2-q24
{Malignant hyperthermia susceptibility 3}	154276	MHS3		7q21-q22
{Malignant hyperthermia susceptibility 4}	600467	MHS4		3q13.1
{Malignant hyperthermia susceptibility 5}	601887	CACNA1S	114208	1q32.1
{Malignant hyperthermia susceptibility 5}	601887	CACNL1A3	114208	1q32.1
{Malignant hyperthermia susceptibility 5}	601887	CCHL1A3	114208	1q32.1
{Malignant hyperthermia susceptibility 5}	601887	TTPP1	114208	1q32.1
{Malignant hyperthermia susceptibility 5}	601887	HOKPP1	114208	1q32.1
{Malignant hyperthermia susceptibility 6}	601888	MHS6		5p
{Malignant mesothelioma, susceptibility to}	156240	MMS		9p
{Meconium ileus in cystic fibrosis, susceptibility to}	603855	CFM1		19q13.2-q13.4
{Medulloblastoma}	155255	BRCA2	600185	13q13.1
{Medulloblastoma}	155255	FANCD1	600185	13q13.1
{Medulloblastoma}	155255	BROVCA2	600185	13q13.1
{Medulloblastoma}	155255	GLM3	600185	13q13.1
{Medulloblastoma}	155255	PNCA2	600185	13q13.1
{Melanoma, cutaneous malignant, 1}	155600	CMM		1p36
{Melanoma, cutaneous malignant, 1}	155600	MLM		1p36
{Melanoma, cutaneous malignant, 1}	155600	DNS		1p36
{Melanoma, cutaneous malignant, 2}	155601	CDKN2A	600160	9p21.3
{Melanoma, cutaneous malignant, 2}	155601	MTS1	600160	9p21.3
{Melanoma, cutaneous malignant, 2}	155601	P16	600160	9p21.3
{Melanoma, cutaneous malignant, 2}	155601	MLM	600160	9p21.3
{Melanoma, cutaneous malignant, 2}	155601	CMM2	600160	9p21.3
{Melanoma, cutaneous malignant, 3}	609048	CDK4	123829	12q14.1
{Melanoma, cutaneous malignant, 3}	609048	CMM3	123829	12q14.1
{Melanoma, cutaneous malignant, 4}	608035	CMM4		1p22
{Melanoma, cutaneous malignant, 5}	613099	MC1R	155555	16q24.3
{Melanoma, cutaneous malignant, 5}	613099	SHEP2	155555	16q24.3
{Melanoma, cutaneous malignant, 5}	613099	CMM5	155555	16q24.3
{Melanoma, cutaneous malignant, 6}	613972	XRCC3	600675	14q32.33
{Melanoma, cutaneous malignant, 6}	613972	CMM6	600675	14q32.33
{Melanoma, cutaneous malignant, 7}	612263	CMM7		20q11.2
{Melanoma, cutaneous malignant, 9}	615134	TERT	187270	5p15.33
{Melanoma, cutaneous malignant, 9}	615134	TCS1	187270	5p15.33
{Melanoma, cutaneous malignant, 9}	615134	EST2	187270	5p15.33
{Melanoma, cutaneous malignant, 9}	615134	DKCA2	187270	5p15.33
{Melanoma, cutaneous malignant, 9}	615134	DKCB4	187270	5p15.33
{Melanoma, cutaneous malignant, 9}	615134	PFBMFT1	187270	5p15.33
{Melanoma, cutaneous malignant, 9}	615134	CMM9	187270	5p15.33
{Melanoma, cutaneous malignant, susceptibility to, 8}	601800	TYR	606933	11q14.3
{Melanoma, cutaneous malignant, susceptibility to, 8}	601800	SHEP3	606933	11q14.3
{Melanoma, cutaneous malignant, susceptibility to, 8}	601800	CMM8	606933	11q14.3
{Melanoma, cutaneous malignant, susceptibility to, 8}	601800	OCA1A	606933	11q14.3
{Melanoma, cutaneous malignant, susceptibility to, 8}	601800	ATN	606933	11q14.3
{Melanoma, cutaneous malignant, susceptibility to, 8}	614456	MITF	156845	3p14-p13
{Melanoma, cutaneous malignant, susceptibility to, 8}	614456	WS2A	156845	3p14-p13
{Melanoma, cutaneous malignant, susceptibility to, 8}	614456	CMM8	156845	3p14-p13
{Melanoma, uveal, susceptibility to, 1}	606660	UVM1		3q24-q26
{Melanoma, uveal, susceptibility to, 2}	606661	UVM2		3p25.2-p25.1
{Melioidosis, susceptibilty to}	615557	TLR5	603031	1q41
{Melioidosis, susceptibilty to}	615557	TIL3	603031	1q41
{Melioidosis, susceptibilty to}	615557	SLEB1	603031	1q41
{Melioidosis, susceptibilty to}	615557	MELIOS	603031	1q41
{Memory impairment, susceptibility to}		BDNF	113505	11p14.1
{Memory impairment, susceptibility to}		BULN2	113505	11p14.1
{Memory impairment, susceptibility to}		ANON2	113505	11p14.1
{Menarche, age at, QTL2}	612882	MENAQ2		6q21
{Menarche, age at, QTL3}	612883	MENAQ3		9q31.2
{Menarche, age at, QTL}	610873	MENAQ1		22q13
{Meningioma, familial, susceptibility to}	607174	SMARCE1	603111	17q21.2
{Meningioma, familial, susceptibility to}	607174	BAF57	603111	17q21.2
{Meningioma, familial, susceptibility to}	607174	SUFU	607035	10q24.32
{Meningioma, familial, susceptibility to}	607174	SUFUXL	607035	10q24.32
{Meningioma, familial, susceptibility to}	607174	SUFUH	607035	10q24.32
{Meningioma}	607174	PTEN	601728	10q23.31
{Meningioma}	607174	MMAC1	601728	10q23.31
{Meningioma}	607174	GLM2	601728	10q23.31
{Meningioma}	607174	CWS1	601728	10q23.31
{Menopause, natural, age at, QTL1}	300488	MENOQ1		Xp21.3
{Menopause, natural, age at, QTL2}	612884	MENOQ2		19q13.4
{Menopause, natural, age at, QTL3}	612885	MENOQ3		20p12.3
{Menopause, natural, age at, QTL4}	612886	MENOQ4		5q35.2
{Mental health wellness-1}	603663	MHW1		4p
{Mental health wellness-2}		MHW2	603664	4q
{Mesothelioma, somatic}	156240	BCL10	603517	1p22.3
{Metabolic syndrome, protection against}	605552	MTP	157147	4q23
{Microvascular complications of diabetes 1}	603933	VEGF	192240	6p21.1
{Microvascular complications of diabetes 1}	603933	MVCD1	192240	6p21.1
{Microvascular complications of diabetes 2}	612623	EPO	133170	7q22.1
{Microvascular complications of diabetes 2}	612623	MVCD2	133170	7q22.1
{Microvascular complications of diabetes 3}	612624	ACE	106180	17q23.3
{Microvascular complications of diabetes 3}	612624	DCP1	106180	17q23.3
{Microvascular complications of diabetes 3}	612624	ACE1	106180	17q23.3
{Microvascular complications of diabetes 3}	612624	MVCD3	106180	17q23.3
{Microvascular complications of diabetes 3}	612624	ICH	106180	17q23.3
{Microvascular complications of diabetes 4}	612628	IL1RN	147679	2q13
{Microvascular complications of diabetes 4}	612628	MVCD4	147679	2q13
{Microvascular complications of diabetes 4}	612628	DIRA	147679	2q13
{Microvascular complications of diabetes 5}	612633	PON1	168820	7q21.3
{Microvascular complications of diabetes 5}	612633	PON	168820	7q21.3
{Microvascular complications of diabetes 5}	612633	ESA	168820	7q21.3
{Microvascular complications of diabetes 5}	612633	MVCD5	168820	7q21.3
{Microvascular complications of diabetes 6}	612634	SOD2	147460	6q25.3
{Microvascular complications of diabetes 6}	612634	MNSOD	147460	6q25.3
{Microvascular complications of diabetes 6}	612634	MVCD6	147460	6q25.3
{Microvascular complications of diabetes 7}	612635	HFE	613609	6p22.2
{Microvascular complications of diabetes 7}	612635	HLA-H	613609	6p22.2
{Microvascular complications of diabetes 7}	612635	HFE1	613609	6p22.2
{Microvascular complications of diabetes 7}	612635	MVCD7	613609	6p22.2
{Microvascular complications of diabetes 7}	612635	TFQTL2	613609	6p22.2
{Migraine with aura, susceptibility to, 7}	609179	MGR7		15q11.2-q12
{Migraine with aura, susceptibility to, 9}	609670	MGR9		11q24
{Migraine with or without aura, susceptibility to, 1}	157300	MGR1		4q24
{Migraine with or without aura, susceptibility to, 1}	157300	MA		4q24
{Migraine with or without aura, susceptibility to, 3}	607498	MGR3		6p21.1-p12.2
{Migraine with or without aura, susceptibility to, 5}	607508	MGR5		19p13
{Migraine without aura, susceptibility to, 4}	607501	MGR4		14q21.2-q22.3
{Migraine without aura, susceptibility to, 4}	607501	MGOA		14q21.2-q22.3
{Migraine without aura, susceptibility to}	157300	TNF	191160	6p21.33
{Migraine without aura, susceptibility to}	157300	TNFA	191160	6p21.33
{Migraine, familial typical, susceptibility to, 2}	300125	MGR2		Xq
{Migraine, susceptibility to, 8}	609570	MGR8		5q21
{Migraine, susceptibility to}	157300	ESR1	133430	6q25.1
{Migraine, susceptibility to}	157300	ESR	133430	6q25.1
{Migraine, susceptibility to}	157300	ESTRR	133430	6q25.1
{Migraine, with or without aura, susceptibility to, 12}	611706	MGR12		10q22-q23
{Migraine, with or without aura, susceptibility to, 13}	613656	KCNK18	613655	10q25.3
{Migraine, with or without aura, susceptibility to, 13}	613656	TRESK	613655	10q25.3
{Migraine, with or without aura, susceptibility to, 13}	613656	TRIK	613655	10q25.3
{Migraine, with or without aura, susceptibility to, 13}	613656	MGR13	613655	10q25.3
{Moyamoya disease 2, susceptibility to}	607151	RNF213	613768	17q25.3
{Moyamoya disease 2, susceptibility to}	607151	ALO17	613768	17q25.3
{Moyamoya disease 2, susceptibility to}	607151	KIAA1618	613768	17q25.3
{Moyamoya disease 2, susceptibility to}	607151	MYMY2	613768	17q25.3
{Multiple myeloma, resistance to}	254500	LIG4	601837	13q33.3
{Multiple myeloma, susceptibility to}	254500	CCND1	168461	11q13.3
{Multiple myeloma, susceptibility to}	254500	PRAD1	168461	11q13.3
{Multiple myeloma, susceptibility to}	254500	BCL1	168461	11q13.3
{Multiple sclerosis, disease progression, modifier of}	126200	PDCD1	600244	2q37.3
{Multiple sclerosis, disease progression, modifier of}	126200	SLEB2	600244	2q37.3
{Multiple sclerosis, susceptibility to, 1}	126200	HLA-DQB1	604305	6p21.32
{Multiple sclerosis, susceptibility to, 1}	126200	CELIAC1	604305	6p21.32
{Multiple sclerosis, susceptibility to, 1}	126200	HLA-DRB1	142857	6p21.32
{Multiple sclerosis, susceptibility to, 1}	126200	SS1	142857	6p21.32
{Multiple sclerosis, susceptibility to, 2}	612594	MS2		10p15.1
{Multiple sclerosis, susceptibility to, 3}	612595	MS3		5p13.2
{Multiple sclerosis, susceptibility to, 4}	612596	MS4		1p36
{Multiple sclerosis, susceptibility to, 5}	614810	TNFRSF1A	191190	12p13.31
{Multiple sclerosis, susceptibility to, 5}	614810	TNFR1	191190	12p13.31
{Multiple sclerosis, susceptibility to, 5}	614810	TNFAR	191190	12p13.31
{Multiple sclerosis, susceptibility to, 5}	614810	FPF	191190	12p13.31
{Multiple sclerosis, susceptibility to, 5}	614810	MS5	191190	12p13.31
{Multiple self-healing squamous epithelioma, susceptiblity to}	132800	TGFBR1	190181	9q22.33
{Multiple self-healing squamous epithelioma, susceptiblity to}	132800	ALK5	190181	9q22.33
{Multiple self-healing squamous epithelioma, susceptiblity to}	132800	AAT5	190181	9q22.33
{Multiple self-healing squamous epithelioma, susceptiblity to}	132800	LDS2A	190181	9q22.33
{Multiple self-healing squamous epithelioma, susceptiblity to}	132800	LDS1A	190181	9q22.33
{Multiple self-healing squamous epithelioma, susceptiblity to}	132800	MSSE	190181	9q22.33
{Multiple system atrophy, susceptibility to}	146500	COQ2	609825	4q21.23
{Multiple system atrophy, susceptibility to}	146500	COQ10D1	609825	4q21.23
{Multiple system atrophy, susceptibility to}	146500	MSA1	609825	4q21.23
{Mycobacerium tuberculosis, susceptibility, X-linked}		MTBSX	300259	Xq
{Mycobacterial and salmonella infections, susceptibility to}	209950	IL12RB1	601604	19p13.11
{Mycobacterial infection, atypical, familial disseminated}	209950	IFNGR2	147569	21q22.11
{Mycobacterial infection, atypical, familial disseminated}	209950	IFNGT1	147569	21q22.11
{Mycobacterial infection, atypical, familial disseminated}	209950	IFGR2	147569	21q22.11
{Mycobacterium tuberculosis infection, protection against}	607948	IFNGR1	107470	6q23.3
{Mycobacterium tuberculosis, protection against}	607948	IRGM	608212	5q33.1
{Mycobacterium tuberculosis, protection against}	607948	LRG47	608212	5q33.1
{Mycobacterium tuberculosis, protection against}	607948	IFI1	608212	5q33.1
{Mycobacterium tuberculosis, protection against}	607948	IBD19	608212	5q33.1
{Mycobacterium tuberculosis, protection against}	607948	MC3R	155540	20q13.2
{Mycobacterium tuberculosis, protection against}	607948	BMIQ9	155540	20q13.2
{Mycobacterium tuberculosis, susceptibility to infection by}	607948	NRAMP1	600266	2q35
{Mycobacterium tuberculosis, susceptibility to infection by}	607948	NRAMP	600266	2q35
{Mycobacterium tuberculosis, susceptibility to infection by}	607948	SLC11A1	600266	2q35
{Mycobacterium tuberculosis, susceptibility to, 2}	611046	MTBS2		8q12-q13
{Mycobacterium tuberculosis, susceptibility to, 3}	612929	MTBS3		20q13.31-q13.33
{Mycobacterium tuberculosis, susceptibility to}	607948	CCL2	158105	17q12
{Mycobacterium tuberculosis, susceptibility to}	607948	SCYA2	158105	17q12
{Mycobacterium tuberculosis, susceptibility to}	607948	MCP1	158105	17q12
{Mycobacterium tuberculosis, susceptibility to}	607948	MCAF	158105	17q12
{Mycobacterium tuberculosis, susceptibility to}	607948	CD209	604672	19p13.2
{Mycobacterium tuberculosis, susceptibility to}	607948	CDSIGN	604672	19p13.2
{Mycobacterium tuberculosis, susceptibility to}	607948	SP110	604457	2q37.1
{Mycobacterium tuberculosis, susceptibility to}	607948	IFI41	604457	2q37.1
{Mycobacterium tuberculosis, susceptibility to}	607948	IFI75	604457	2q37.1
{Mycobacterium tuberculosis, susceptibility to}	607948	VODI	604457	2q37.1
{Mycobacterium tuberculosis, susceptibility to}	607948	TLR2	603028	4q31.3
{Mycobacterium tuberculosis, susceptibility to}	607948	TIL4	603028	4q31.3
{Myelodysplastic syndrome, susceptibility to}	614286	GATA2	137295	3q21.3
{Myelodysplastic syndrome, susceptibility to}	614286	DCML	137295	3q21.3
{Myelodysplastic syndrome, susceptibility to}	614286	MONOMAC	137295	3q21.3
{Myocardial infarcation, susceptibility to}	608446	PSMA6	602855	14q13.2
{Myocardial infarcation, susceptibility to}	608446	PROS27	602855	14q13.2
{Myocardial infarcation, susceptibility to}	608446	P27K	602855	14q13.2
{Myocardial infarction susceptibility}	107741	APOE		19q13.32
{Myocardial infarction susceptibility}	107741	AD2		19q13.32
{Myocardial infarction susceptibility}	107741	LPG		19q13.32
{Myocardial infarction susceptibility}	107741	LDLCQ5		19q13.32
{Myocardial infarction, decreased susceptibility to}	608446	F7	613878	13q34
{Myocardial infarction, protection against}	608446	F13A1	134570	6p25.1
{Myocardial infarction, protection against}	608446	F13A	134570	6p25.1
{Myocardial infarction, susceptibility to, 2}	608557	MCI2		13q12
{Myocardial infarction, susceptibility to}	106180	ACE		17q23.3
{Myocardial infarction, susceptibility to}	106180	DCP1		17q23.3
{Myocardial infarction, susceptibility to}	106180	ACE1		17q23.3
{Myocardial infarction, susceptibility to}	106180	MVCD3		17q23.3
{Myocardial infarction, susceptibility to}	106180	ICH		17q23.3
{Myocardial infarction, susceptibility to}	608446	ESR1	133430	6q25.1
{Myocardial infarction, susceptibility to}	608446	ESR	133430	6q25.1
{Myocardial infarction, susceptibility to}	608446	ESTRR	133430	6q25.1
{Myocardial infarction, susceptibility to}	608446	GCLC	606857	6p12.1
{Myocardial infarction, susceptibility to}	608446	GLCLC	606857	6p12.1
{Myocardial infarction, susceptibility to}	608446	GCLM	601176	1p22.1
{Myocardial infarction, susceptibility to}	608446	GLCLR	601176	1p22.1
{Myocardial infarction, susceptibility to}	608446	ITGB3	173470	17q21.32
{Myocardial infarction, susceptibility to}	608446	GP3A	173470	17q21.32
{Myocardial infarction, susceptibility to}	608446	GT	173470	17q21.32
{Myocardial infarction, susceptibility to}	608446	BDPLT2	173470	17q21.32
{Myocardial infarction, susceptibility to}	608446	BDPLT16	173470	17q21.32
{Myocardial infarction, susceptibility to}	608446	LGALS2	150571	22q13.1
{Myocardial infarction, susceptibility to}	608446	LRP8	602600	1p32.3
{Myocardial infarction, susceptibility to}	608446	APOER2	602600	1p32.3
{Myocardial infarction, susceptibility to}	608446	MCI1	602600	1p32.3
{Myocardial infarction, susceptibility to}	608446	LTA	153440	6p21.33
{Myocardial infarction, susceptibility to}	608446	TNFB	153440	6p21.33
{Myocardial infarction, susceptibility to}	608446	MIAT	611082	22q12.1
{Myocardial infarction, susceptibility to}	608446	C22orf35	611082	22q12.1
{Myocardial infarction, susceptibility to}	608446	OLR1	602601	12p13.2
{Myocardial infarction, susceptibility to}	608446	LOX1	602601	12p13.2
{Myocardial infarction, susceptibility to}	608446	TNFSF4	603594	1q25.1
{Myocardial infarction, susceptibility to}	608446	GP34	603594	1q25.1
{Myocardial infarction, susceptibility to}	608446	OX4OL	603594	1q25.1
{Myoclonic epilepsy, juvenile, susceptibility to, 1}	254770	EFHC1	608815	6p12.2
{Myoclonic epilepsy, juvenile, susceptibility to, 1}	254770	FLJ10466	608815	6p12.2
{Myoclonic epilepsy, juvenile, susceptibility to, 1}	254770	EJM1	608815	6p12.2
{Myoclonic epilepsy, juvenile, susceptibility to, 1}	254770	JAE	608815	6p12.2
{Myoclonic epilepsy, juvenile, susceptibility to, 1}	254770	EJA1	608815	6p12.2
{Narcolepsy 4}	612417	NRCLP4		22q13
{Narcolepsy 5}	612851	NRCLP5		14q11.2
{Nasopharyngeal carcinoma 1}	607107	NPC1		4p15.1-q12
{Nasopharyngeal carcinoma 1}	607107	NPCA1		4p15.1-q12
{Nasopharyngeal carcinoma, susceptibility to, 2}	161550	NPCA2		6p21.3
{Natural teeth remaining intact}		MGP	154870	12p12.3
{Natural teeth remaining intact}		NTI	154870	12p12.3
{Nephrolithiasis, uric acid, susceptibility to}	605990	ZNF365	607818	10q21.2
{Nephrolithiasis, uric acid, susceptibility to}	605990	UAN	607818	10q21.2
{Neural tube defects, folate-sensitive, susceptibility to}	601634	MTR	156570	1q43
{Neural tube defects, folate-sensitive, susceptibility to}	601634	HMAG	156570	1q43
{Neural tube defects, folate-sensitive, susceptibility to}	601634	MTRR	602568	5p15.31
{Neural tube defects, susceptibility to}	182940	T	601397	6q27
{Neural tube defects, susceptibility to}	182940	TFT	601397	6q27
{Neural tube defects, susceptibility to}	601634	MTHFR	607093	1p36.22
{Neuroblastoma, susceptibility to, 1}	256700	KIF1B	605995	1p36.22
{Neuroblastoma, susceptibility to, 1}	256700	CMT2A	605995	1p36.22
{Neuroblastoma, susceptibility to, 1}	256700	CMT2A1	605995	1p36.22
{Neuroblastoma, susceptibility to, 1}	256700	NBLST1	605995	1p36.22
{Neuroblastoma, susceptibility to, 2}	613013	PMX2B	603851	4p13
{Neuroblastoma, susceptibility to, 2}	613013	NBPHOX	603851	4p13
{Neuroblastoma, susceptibility to, 2}	613013	PHOX2B	603851	4p13
{Neuroblastoma, susceptibility to, 2}	613013	NBLST2	603851	4p13
{Neuroblastoma, susceptibility to, 3}	613014	ALK	105590	2p23.2-p23.1
{Neuroblastoma, susceptibility to, 3}	613014	NBLST3	105590	2p23.2-p23.1
{Neuroblastoma, susceptibility to, 4}	613015	NBLST4		6p22
{Neuroblastoma, susceptibility to, 5}	613016	NBLST5		2q35
{Neuroblastoma, susceptibility to, 6}	613017	NBLST6		1q21.1
{Nevus sebaceous, somatic}	162900	HRAS	190020	11p15.5
{Nicotine addiction, protection from}	188890	CYP2A6	122720	19q13.2
{Nicotine addiction, protection from}	188890	CYP2A3	122720	19q13.2
{Nicotine addiction, protection from}	188890	CYP2A	122720	19q13.2
{Nicotine addiction, protection from}	188890	P450C2A	122720	19q13.2
{Nicotine addiction, susceptibility to}	188890	CHRNA4	118504	20q13.33
{Nicotine addiction, susceptibility to}	188890	ENFL1	118504	20q13.33
{Nicotine dependence, protection against}	188890	GPR51	607340	9q22.33
{Nicotine dependence, protection against}	188890	GABBR2	607340	9q22.33
{Nicotine dependence, protection against}	188890	SLC6A3	126455	5p15.33
{Nicotine dependence, protection against}	188890	DAT1	126455	5p15.33
{Nicotine dependence, protection against}	188890	PKDYS	126455	5p15.33
{Nicotine dependence, susceptibility to}	188890	GPR51	607340	9q22.33
{Nicotine dependence, susceptibility to}	188890	GABBR2	607340	9q22.33
{Nicotine dependence, susceptibility to}	612052	CHRNA5	118505	15q25.1
{Nicotine dependence, susceptibility to}	612052	LNCR2	118505	15q25.1
{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}	258660	GP1BA	606672	17p13.2
{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}	258660	BSS	606672	17p13.2
{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}	258660	BDPLT1	606672	17p13.2
{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}	258660	VWDP	606672	17p13.2
{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}	258660	BDPLT3	606672	17p13.2
{Nonsmall cell lung cancer, susceptibility to}	211980	EGFR	131550	7p11.2
{Nonsmall cell lung cancer}		DDX26	604331	13q14.3
{Nonsmall cell lung cancer}		DICE1	604331	13q14.3
{Nonsmall cell lung cancer}	603040	TSG11		11q23
{Norwalk virus infection, resistance to}	182100	FUT2		19q13.33
{Norwalk virus infection, resistance to}	182100	SE		19q13.33
{Norwalk virus infection, resistance to}	182100	B12QTL1		19q13.33
{Obesity, association with}	601665	SDC3	186357	1p35.2
{Obesity, association with}	601665	SYND3	186357	1p35.2
{Obesity, association with}	601665	SDCN	186357	1p35.2
{Obesity, early-onset, susceptibility to}	601665	POMC	176830	2p23.3
{Obesity, late-onset}	601665	AGRP	602311	16q22.1
{Obesity, late-onset}	601665	ART	602311	16q22.1
{Obesity, late-onset}	601665	AGRT	602311	16q22.1
{Obesity, severe, and type II diabetes}	601665	UCP3	602044	11q13.4
{Obesity, severe, susceptibility to, BMIQ9}	602025	MC3R	155540	20q13.2
{Obesity, severe, susceptibility to, BMIQ9}	602025	BMIQ9	155540	20q13.2
{Obesity, susceptibility to, BMIQ10}	607514	BMIQ10		10q
{Obesity, susceptibility to, BMIQ11}	300306	SLC6A14	300444	Xq23
{Obesity, susceptibility to, BMIQ11}	300306	OBX	300444	Xq23
{Obesity, susceptibility to, BMIQ11}	300306	BMIQ11	300444	Xq23
{Obesity, susceptibility to, BMIQ12}	612362	PCSK1	162150	5q15
{Obesity, susceptibility to, BMIQ12}	612362	NEC1	162150	5q15
{Obesity, susceptibility to, BMIQ12}	612362	PC1	162150	5q15
{Obesity, susceptibility to, BMIQ12}	612362	PC3	162150	5q15
{Obesity, susceptibility to, BMIQ12}	612362	BMIQ12	162150	5q15
{Obesity, susceptibility to, BMIQ18}	615457	MRAP2	615410	6q14.2
{Obesity, susceptibility to, BMIQ18}	615457	C6orf117	615410	6q14.2
{Obesity, susceptibility to, BMIQ18}	615457	BMIQ18	615410	6q14.2
{Obesity, susceptibility to, BMIQ4}	607447	UCP2	601693	11q13.4
{Obesity, susceptibility to, BMIQ4}	607447	BMIQ4	601693	11q13.4
{Obesity, susceptibility to, BMIQ7}	608410	BMIQ7		4p15-p14
{Obesity, susceptibility to, BMIQ8}	603188	BMIQ8		10p
{Obesity, susceptibility to}	601665	ADRB2	109690	5q32
{Obesity, susceptibility to}	601665	ADRB3	109691	8p11.23
{Obesity, susceptibility to}	601665	CART	602606	5q13.2
{Obesity, susceptibility to}	601665	ENPP1	173335	6q23.2
{Obesity, susceptibility to}	601665	PDNP1	173335	6q23.2
{Obesity, susceptibility to}	601665	NPPS	173335	6q23.2
{Obesity, susceptibility to}	601665	M6S1	173335	6q23.2
{Obesity, susceptibility to}	601665	PCA1	173335	6q23.2
{Obesity, susceptibility to}	601665	ARHR2	173335	6q23.2
{Obesity, susceptibility to}	601665	COLED	173335	6q23.2
{Obesity, susceptibility to}	601665	GHRL	605353	3p25.3
{Obesity, susceptibility to}	601665	UCP1	113730	4q31.1
{Obesity, susceptibility to}	607514	FFAR4	609044	10q23.33
{Obesity, susceptibility to}	607514	O3FAR1	609044	10q23.33
{Obesity, susceptibility to}	607514	GPR120	609044	10q23.33
{Obesity, susceptibility to}	607514	PGR4	609044	10q23.33
{Obesity, susceptibility to}	607514	BMIQ10	609044	10q23.33
{Obesity, variation in}	601665	PPARGC1B	608886	5q32
{Obesity, variation in}	601665	PGC1B	608886	5q32
{Obesity, variation in}	601665	PERC	608886	5q32
{Obesity}	601665	PYY	600781	17q21.31
{Obsessive-compulsive disorder, protection against}	164230	BDNF	113505	11p14.1
{Obsessive-compulsive disorder, protection against}	164230	BULN2	113505	11p14.1
{Obsessive-compulsive disorder, protection against}	164230	ANON2	113505	11p14.1
{Obsessive-compulsive disorder, susceptibility to}	164230	HTR2A	182135	13q14.2
{Obsessive-compulsive disorder}	164230	SLC6A4	182138	17q11.2
{Obsessive-compulsive disorder}	164230	HTT	182138	17q11.2
{Obsessive-compulsive disorder}	164230	OCD1	182138	17q11.2
{Opioid dependence, susceptibility to, 1}	610064	ODS1		Chr.17
{Opioid dependence, susceptibility to}	610064	ME2	154270	18q21.2
{Opioid dependence, susceptibility to}	610064	ODS1	154270	18q21.2
{Organophosphate poisoning, sensitivity to}	168820	PON1		7q21.3
{Organophosphate poisoning, sensitivity to}	168820	PON		7q21.3
{Organophosphate poisoning, sensitivity to}	168820	ESA		7q21.3
{Organophosphate poisoning, sensitivity to}	168820	MVCD5		7q21.3
{Ossification of the posterior longitudinal spinal ligaments}	602475	COL6A1	120220	21q22.3
{Ossification of the posterior longitudinal spinal ligaments}	602475	OPLL	120220	21q22.3
{Osteoarthritis susceptibility 1}	165720	FRZB	605083	2q32.1
{Osteoarthritis susceptibility 1}	165720	FRZB1	605083	2q32.1
{Osteoarthritis susceptibility 1}	165720	SRFP3	605083	2q32.1
{Osteoarthritis susceptibility 1}	165720	OS1	605083	2q32.1
{Osteoarthritis susceptibility 2}	140600	MATN3	602109	2p24.1
{Osteoarthritis susceptibility 2}	140600	EDM5	602109	2p24.1
{Osteoarthritis susceptibility 2}	140600	HOA	602109	2p24.1
{Osteoarthritis susceptibility 2}	140600	OS2	602109	2p24.1
{Osteoarthritis susceptibility 3}	607850	ASPN	608135	9q22.31
{Osteoarthritis susceptibility 3}	607850	PLAP1	608135	9q22.31
{Osteoarthritis susceptibility 3}	607850	OS3	608135	9q22.31
{Osteoarthritis susceptibility 4}	610839	OS4		2q33.3
{Osteoarthritis susceptibility 4}	610839	GOA1		2q33.3
{Osteoarthritis susceptibility 6}	612401	OS6		3p24.3
{Osteoarthritis-5}	612400	GDF5	601146	20q11.22
{Osteoarthritis-5}	612400	CDMP1	601146	20q11.22
{Osteoarthritis-5}	612400	SYNS2	601146	20q11.22
{Osteoarthritis-5}	612400	OS5	601146	20q11.22
{Osteoarthritis-5}	612400	BDA1C	601146	20q11.22
{Osteoarthritis-5}	612400	SYM1B	601146	20q11.22
{Osteoporosis, early-onset, susceptibility to, autosomal dominant}	615221	WNT1	164820	12q13.12
{Osteoporosis, early-onset, susceptibility to, autosomal dominant}	615221	INT1	164820	12q13.12
{Osteoporosis, early-onset, susceptibility to, autosomal dominant}	615221	OI15	164820	12q13.12
{Osteoporosis, early-onset, susceptibility to, autosomal dominant}	615221	BMND16	164820	12q13.12
{Osteoporosis, postmenopausal, susceptibility}	166710	CALCR	114131	7q21.3
{Osteoporosis, postmenopausal, susceptibility}	166710	CRT	114131	7q21.3
{Osteoporosis, postmenopausal}	166710	COL1A2	120160	7q21.3
{Osteoporosis, susceptibility to}	166710	RIL	603422	5q31.1
{Osteoporosis}	166710	BMND7	611738	20p12.3
{Osteoporosis}	166710	BMND8	611739	11p12
{Osteoporosis}	166710	COL1A1	120150	17q21.33
{Osteoporosis}	166710	LRP5	603506	11q13.2
{Osteoporosis}	166710	BMND1	603506	11q13.2
{Osteoporosis}	166710	LRP7	603506	11q13.2
{Osteoporosis}	166710	LR3	603506	11q13.2
{Osteoporosis}	166710	OPPG	603506	11q13.2
{Osteoporosis}	166710	VBCH2	603506	11q13.2
{Osteoporosis}	166710	OPTA1	603506	11q13.2
{Osteoporosis}	166710	EVR4	603506	11q13.2
{Otitis media, susceptibility to}	166760	OMS		10q26.3
{Otosclerosis 4}	611571	OTSC4		16q22.1-q23.1
{Ovarian cancer, somatic}	167000	OPCML	600632	11q25
{Ovarian cancer, susceptibility to}	607893	OVCAS1		3p25-p22
{Pancreatic cancer, susceptibility to, 1}	606856	PALLD	608092	4q32.3
{Pancreatic cancer, susceptibility to, 1}	606856	KIAA0992	608092	4q32.3
{Pancreatic cancer, susceptibility to, 1}	606856	PNCA1	608092	4q32.3
{Pancreatic cancer, susceptibility to, 3}	613348	PALB2	610355	16p12.2
{Pancreatic cancer, susceptibility to, 3}	613348	FANCN	610355	16p12.2
{Pancreatic cancer, susceptibility to, 3}	613348	PNCA3	610355	16p12.2
{Pancreatic cancer, susceptibility to, 4}	614320	BRCA1	113705	17q21.31
{Pancreatic cancer, susceptibility to, 4}	614320	PSCP	113705	17q21.31
{Pancreatic cancer, susceptibility to, 4}	614320	BROVCA1	113705	17q21.31
{Pancreatic cancer, susceptibility to, 4}	614320	PNCA4	113705	17q21.31
{Pancreatitis, chronic, protection against}	167800	PRSS2	601564	7q35
{Pancreatitis, chronic, protection against}	167800	TRY2	601564	7q35
{Pancreatitis, chronic, susceptibility to}	167800	CTRC	601405	1p36.21
{Pancreatitis, chronic, susceptibility to}	167800	CLCR	601405	1p36.21
{Pancreatitis, idiopathic}	167800	CFTR	602421	7q31.2
{Pancreatitis, idiopathic}	167800	ABCC7	602421	7q31.2
{Pancreatitis, idiopathic}	167800	CF	602421	7q31.2
{Pancreatitis, idiopathic}	167800	MRP7	602421	7q31.2
{Panic disorder, susceptibility to}	167870	COMT	116790	22q11.21
{Parkinson disease 16}	613164	PARK16		1q32
{Parkinson disease, late-onset, susceptibility to}	168600	GBA	606463	1q22
{Parkinson disease, susceptibility to}	168600	ADH1C	103730	4q23
{Parkinson disease, susceptibility to}	168600	ADH3	103730	4q23
{Parkinson disease, susceptibility to}	168600	MAPT	157140	17q21.31
{Parkinson disease, susceptibility to}	168600	MTBT1	157140	17q21.31
{Parkinson disease, susceptibility to}	168600	DDPAC	157140	17q21.31
{Parkinson disease, susceptibility to}	168600	MSTD	157140	17q21.31
{Parkinson disease, susceptibility to}	168600	TBP	600075	6q27
{Parkinson disease, susceptibility to}	168600	SCA17	600075	6q27
{Parkinson disease, susceptibility to}	168600	HDL4	600075	6q27
{Patent ductus arteriosus, susceptibility to}	607411	PDA1		12q24
{Pelvic organ prolapse, susceptibility to, 1}	176780	PVOP1		1q31
{Pelvic organ prolapse, susceptibility to, 2}	613088	PVOP2		9q21
{Pemphigoid, susceptibility to}		HLA-DRB1	142857	6p21.32
{Pemphigoid, susceptibility to}		SS1	142857	6p21.32
{Pheochromocytoma, modifier of}	171300	GDNF	600837	5p13.2
{Pheochromocytoma, modifier of}	171300	HSCR3	600837	5p13.2
{Pheochromocytoma, susceptibility to}	171300	MAX	154950	14q23.3
{Pheochromocytoma, susceptibility to}	171300	TMEM127	613403	2q11.2
{Placental abruption}	163729	NOS3		7q36.1
{Plasmodium falciparum fever episodes QTL1}	611384	PFFE1		10p15
{Pneumococcal disease, invasive, protection against}	610799	TIRAP	606252	11q24.2
{Pneumococcal disease, invasive, protection against}	610799	BACTS1	606252	11q24.2
{Podoconiosis, susceptibility to}	614590	PDCOS		6p21.3
{Porphyria cutanea tarda, susceptibility to}	176100	HFE	613609	6p22.2
{Porphyria cutanea tarda, susceptibility to}	176100	HLA-H	613609	6p22.2
{Porphyria cutanea tarda, susceptibility to}	176100	HFE1	613609	6p22.2
{Porphyria cutanea tarda, susceptibility to}	176100	MVCD7	613609	6p22.2
{Porphyria cutanea tarda, susceptibility to}	176100	TFQTL2	613609	6p22.2
{Porphyria variegata, susceptibility to}	176200	HFE	613609	6p22.2
{Porphyria variegata, susceptibility to}	176200	HLA-H	613609	6p22.2
{Porphyria variegata, susceptibility to}	176200	HFE1	613609	6p22.2
{Porphyria variegata, susceptibility to}	176200	MVCD7	613609	6p22.2
{Porphyria variegata, susceptibility to}	176200	TFQTL2	613609	6p22.2
{Pre-B-cell acute lymphoblastic leukemia}		BRCA2	600185	13q13.1
{Pre-B-cell acute lymphoblastic leukemia}		FANCD1	600185	13q13.1
{Pre-B-cell acute lymphoblastic leukemia}		BROVCA2	600185	13q13.1
{Pre-B-cell acute lymphoblastic leukemia}		GLM3	600185	13q13.1
{Pre-B-cell acute lymphoblastic leukemia}		PNCA2	600185	13q13.1
{Preeclampsia, susceptibility to}	106150	AGT		1q42.2
{Preeclampsia, susceptibility to}	106150	SERPINA8		1q42.2
{Preeclampsia, susceptibility to}	189800	EPHX1	132810	1q42.12
{Pregnancy loss, recurrent, susceptibility to, 1}	614389	F5	612309	1q24.2
{Pregnancy loss, recurrent, susceptibility to, 1}	614389	THPH2	612309	1q24.2
{Pregnancy loss, recurrent, susceptibility to, 1}	614389	RPRGL1	612309	1q24.2
{Pregnancy loss, recurrent, susceptibility to, 2}	614390	F2	176930	11p11.2
{Pregnancy loss, recurrent, susceptibility to, 2}	614390	THPH1	176930	11p11.2
{Pregnancy loss, recurrent, susceptibility to, 2}	614390	RPRGL2	176930	11p11.2
{Pregnancy loss, recurrent, susceptibility to, 3}	614391	ANXA5	131230	4q27
{Pregnancy loss, recurrent, susceptibility to, 3}	614391	ENX2	131230	4q27
{Pregnancy loss, recurrent, susceptibility to, 3}	614391	RPRGL3	131230	4q27
{Pregnancy loss, susceptibility to}		SYCP3	604759	12q23.2
{Pregnancy loss, susceptibility to}		SCP3	604759	12q23.2
{Pregnancy loss, susceptibility to}		COR1	604759	12q23.2
{Pregnancy loss, susceptibility to}		SPGF4	604759	12q23.2
{Preterm premature rupture of the membranes, susceptibility to}	610504	SERPINH1	600943	11q13.5
{Preterm premature rupture of the membranes, susceptibility to}	610504	SERPINH2	600943	11q13.5
{Preterm premature rupture of the membranes, susceptibility to}	610504	PPROM	600943	11q13.5
{Preterm premature rupture of the membranes, susceptibility to}	610504	CBP2	600943	11q13.5
{Preterm premature rupture of the membranes, susceptibility to}	610504	CBP1	600943	11q13.5
{Preterm premature rupture of the membranes, susceptibility to}	610504	OI10	600943	11q13.5
{Prostate cancer aggressiveness QTL}	176807	HPCQTL19	607592	19q
{Prostate cancer, familial, susceptibility to}	176807	CHEK2	604373	22q12.1
{Prostate cancer, familial, susceptibility to}	176807	RAD53	604373	22q12.1
{Prostate cancer, familial, susceptibility to}	176807	CHK2	604373	22q12.1
{Prostate cancer, familial, susceptibility to}	176807	CDS1	604373	22q12.1
{Prostate cancer, familial, susceptibility to}	176807	LFS2	604373	22q12.1
{Prostate cancer, hereditary, 10}	611100	HPC10		8q24
{Prostate cancer, hereditary, 11}	611955	HPC11		17q12
{Prostate cancer, hereditary, 12}	611868	EHBP1	609922	2p15
{Prostate cancer, hereditary, 12}	611868	KIAA0903	609922	2p15
{Prostate cancer, hereditary, 12}	611868	HPC12	609922	2p15
{Prostate cancer, hereditary, 13}	611928	MSMB	157145	10q11.23
{Prostate cancer, hereditary, 13}	611928	HPC13	157145	10q11.23
{Prostate cancer, hereditary, 14}	611958	HPC14		11q13
{Prostate cancer, hereditary, 15}	611959	HPC15		19q13.4
{Prostate cancer, hereditary, 2, susceptibility to}	614731	ELAC2	605367	17p12
{Prostate cancer, hereditary, 2, susceptibility to}	614731	HPC2	605367	17p12
{Prostate cancer, hereditary, 2, susceptibility to}	614731	COXPD17	605367	17p12
{Prostate cancer, hereditary, 5}	176807	HPC5	609299	3p26
{Prostate cancer, hereditary, 7}	610321	HPC7		15q12
{Prostate cancer, hereditary, 9}	610997	HPC9		17q21-q22
{Prostate cancer, hereditary, X-linked 1}	300147	HPCX1		Xq27-q28
{Prostate cancer, hereditary, X-linked 2}	300704	HPCX2		Xp11.22
{Prostate cancer, progression of}	176807	HIP1	601767	7q11.23
{Prostate cancer, somatic}	176807	PTEN	601728	10q23.31
{Prostate cancer, somatic}	176807	MMAC1	601728	10q23.31
{Prostate cancer, somatic}	176807	GLM2	601728	10q23.31
{Prostate cancer, somatic}	176807	CWS1	601728	10q23.31
{Prostate cancer, susceptibility to, 3}	176807	HPC3	608656	20q13
{Prostate cancer, susceptibility to, 4}	176807	HPC4	608658	7p11-q21
{Prostate cancer, susceptibility to}	176807	CD82	600623	11p11.2
{Prostate cancer, susceptibility to}	176807	SAR2	600623	11p11.2
{Prostate cancer, susceptibility to}	176807	KAI1	600623	11p11.2
{Prostate cancer, susceptibility to}	176807	ST6	600623	11p11.2
{Prostate cancer, susceptibility to}	176807	HPC6	609558	22q12.3
{Prostate cancer, susceptibility to}	176807	PCAP	602759	1q42.2-q43
{Prostate cancer, susceptibility to}	176807	AR	313700	Xq12
{Prostate cancer, susceptibility to}	176807	DHTR	313700	Xq12
{Prostate cancer, susceptibility to}	176807	TFM	313700	Xq12
{Prostate cancer, susceptibility to}	176807	SBMA	313700	Xq12
{Prostate cancer, susceptibility to}	176807	KD	313700	Xq12
{Prostate cancer, susceptibility to}	176807	SMAX1	313700	Xq12
{Prostate cancer, susceptibility to}	176807	HYSP1	313700	Xq12
{Prostate cancer, susceptibility to}	176807	CDH1	192090	16q22.1
{Prostate cancer, susceptibility to}	176807	UVO	192090	16q22.1
{Prostate cancer, susceptibility to}	176807	LCAM	192090	16q22.1
{Prostate cancer, susceptibility to}	176807	ECAD	192090	16q22.1
{Prostate cancer, susceptibility to}	176807	MXI1	600020	10q25.2
{Prostate cancer, susceptibility to}	176807	ZFHX3	104155	16q22.2-q22.3
{Prostate cancer, susceptibility to}	176807	ATBF1	104155	16q22.2-q22.3
{Pseudofolliculitis barbae, susceptibility to}	612318	KRT75	609025	12q13.13
{Pseudofolliculitis barbae, susceptibility to}	612318	K6HF	609025	12q13.13
{Pseudofolliculitis barbae, susceptibility to}	612318	PFB	609025	12q13.13
{Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}	219700	FCGR2A	146790	1q23.3
{Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}	219700	IGFR2	146790	1q23.3
{Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}	219700	CD32	146790	1q23.3
{Pseudoxanthoma elasticum, modifier of severity of}	264800	XYLT1	608124	16p12.3
{Pseudoxanthoma elasticum, modifier of severity of}	264800	XT1	608124	16p12.3
{Pseudoxanthoma elasticum, modifier of severity of}	264800	XYLT2	608125	17q21.33
{Pseudoxanthoma elasticum, modifier of severity of}	264800	XT2	608125	17q21.33
{Psoraisis susceptibility 9}	607857	PSORS9		4q31-q34
{Psoriasis susceptibility 10}	612410	PSORS10		18p11.23
{Psoriasis susceptibility 11}	612599	PSORS11		5q31.1-q33.1
{Psoriasis susceptibility 12}	612950	PSORS12		20q13
{Psoriasis susceptibility 13}	614070	TRAF3IP2	607043	6q21
{Psoriasis susceptibility 13}	614070	C6orf5	607043	6q21
{Psoriasis susceptibility 13}	614070	ACT1	607043	6q21
{Psoriasis susceptibility 13}	614070	CIKS	607043	6q21
{Psoriasis susceptibility 13}	614070	C6orf4	607043	6q21
{Psoriasis susceptibility 13}	614070	C6orf6	607043	6q21
{Psoriasis susceptibility 13}	614070	PSORS13	607043	6q21
{Psoriasis susceptibility 13}	614070	CANDF8	607043	6q21
{Psoriasis susceptibility 1}	177900	HLA-C	142840	6p21.33
{Psoriasis susceptibility 1}	177900	PSORS1	142840	6p21.33
{Psoriasis susceptibility 2}	602723	CARD14	607211	17q25.3
{Psoriasis susceptibility 2}	602723	CARMA2	607211	17q25.3
{Psoriasis susceptibility 2}	602723	BIMP2	607211	17q25.3
{Psoriasis susceptibility 2}	602723	PSORS2	607211	17q25.3
{Psoriasis susceptibility 2}	602723	PSS1	607211	17q25.3
{Psoriasis susceptibility 2}	602723	PRP	607211	17q25.3
{Psoriasis susceptibility 3}	601454	PSORS3		4q
{Psoriasis susceptibility 4}	603935	PSORS4		1q21
{Psoriasis susceptibility 5}	604316	PSORS5		3q21
{Psoriasis susceptibility 6}	605364	PSORS6		19p13
{Psoriasis susceptibility 7}	605606	PSORS7		1p
{Psoriasis susceptibility 8}	610707	PSORS8		16q
{Psoriasis, protection against}	605606	IL23R	607562	1p31.3
{Psoriasis, protection against}	605606	IBD17	607562	1p31.3
{Psoriatic arthritis, susceptibility to}	607507	LTA	153440	6p21.33
{Psoriatic arthritis, susceptibility to}	607507	TNFB	153440	6p21.33
{Psoriatic arthritis, susceptibility to}	607507	NOD2	605956	16q12.1
{Psoriatic arthritis, susceptibility to}	607507	CARD15	605956	16q12.1
{Psoriatic arthritis, susceptibility to}	607507	IBD1	605956	16q12.1
{Psoriatic arthritis, susceptibility to}	607507	CD	605956	16q12.1
{Psoriatic arthritis, susceptibility to}	607507	ACUG	605956	16q12.1
{Psoriatic arthritis, susceptibility to}	607507	PSORAS1	605956	16q12.1
{Pulmonary disease, chronic obstructive, susceptibility to}	606963	SERPINA1	107400	14q32.13
{Pulmonary disease, chronic obstructive, susceptibility to}	606963	PI	107400	14q32.13
{Pulmonary disease, chronic obstructive, susceptibility to}	606963	AAT	107400	14q32.13
{Pulmonary disease, chronic obstructive, susceptibility to}	606963	HMOX1	141250	22q12.3
{Pulmonary disease, chronic obstructive, susceptibility to}	606963	HMOX1D	141250	22q12.3
{Pulmonary fibrosis, idiopathic, susceptibility to}	178500	MUC5B	600770	11p15.5
{Pulmonary fibrosis, idiopathic, susceptibility to}	178500	SFTPA1	178630	10q22.3
{Pulmonary fibrosis, idiopathic, susceptibility to}	178500	SFTP1	178630	10q22.3
{Pulmonary fibrosis, idiopathic, susceptibility to}	614743	TERC	602322	3q26.2
{Pulmonary fibrosis, idiopathic, susceptibility to}	614743	TRC3	602322	3q26.2
{Pulmonary fibrosis, idiopathic, susceptibility to}	614743	TR	602322	3q26.2
{Pulmonary fibrosis, idiopathic, susceptibility to}	614743	DKCA1	602322	3q26.2
{Pulmonary fibrosis, idiopathic, susceptibility to}	614743	PFBMFT2	602322	3q26.2
{Pulmonary fibrosis, telomere-related, 1}	614742	TERT	187270	5p15.33
{Pulmonary fibrosis, telomere-related, 1}	614742	TCS1	187270	5p15.33
{Pulmonary fibrosis, telomere-related, 1}	614742	EST2	187270	5p15.33
{Pulmonary fibrosis, telomere-related, 1}	614742	DKCA2	187270	5p15.33
{Pulmonary fibrosis, telomere-related, 1}	614742	DKCB4	187270	5p15.33
{Pulmonary fibrosis, telomere-related, 1}	614742	PFBMFT1	187270	5p15.33
{Pulmonary fibrosis, telomere-related, 1}	614742	CMM9	187270	5p15.33
{Pulmonary function}	608852	PLF		6q21-q22
{Pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis, susceptibility to}	612862	CTEPH1		6p21.3
{Pulmonary hypertension, neonatal, susceptibility to}	615371	CPS1	608307	2q34
{Pulmonary hypertension, neonatal, susceptibility to}	615371	PHN	608307	2q34
{Rapid progression to AIDS from HIV1 infection}	609423	CX3CR1	601470	3p22.2
{Rapid progression to AIDS from HIV1 infection}	609423	GPR13	601470	3p22.2
{Rapid progression to AIDS from HIV1 infection}	609423	V28	601470	3p22.2
{Reduced triglycerides, susceptibility to}	605910	ANGPTL4		19p13.2
{Reduced triglycerides, susceptibility to}	605910	PGAR		19p13.2
{Reduced triglycerides, susceptibility to}	605910	HFARP		19p13.2
{Reduced triglycerides, susceptibility to}	605910	FIAF		19p13.2
{Renal cell carcinoma}	144700	HNF1B	189907	17q12
{Renal cell carcinoma}	144700	TCF2	189907	17q12
{Renal cell carcinoma}	144700	HNF2	189907	17q12
{Renal cell carcinoma}	144700	MODY5	189907	17q12
{Renal cell carcinoma}	144700	FJHN	189907	17q12
{Renal cell carcinoma}	144700	HPC11	189907	17q12
{Renal dysplasia, cystic, susceptibility to}	601331	BICC1	614295	10q21.1
{Renal dysplasia, cystic, susceptibility to}	601331	BICC	614295	10q21.1
{Renal dysplasia, cystic, susceptibility to}	601331	CYSRD	614295	10q21.1
{Resistance to malaria due to G6PD deficiency}	611162	G6PD	305900	Xq28
{Resistance to malaria due to G6PD deficiency}	611162	G6PD1	305900	Xq28
{Restless legs syndrome 1}	102300	RLS1		12q12-q21
{Restless legs syndrome 2}	608831	RLS2		14q13-q21
{Restless legs syndrome 3}	610438	RLS3		9p24-p22
{Restless legs syndrome 4}	610439	RLS4		2q33
{Restless legs syndrome 5}	611242	RLS5		20p13
{Restless legs syndrome 6}	611185	RLS6		6p21
{Restless legs syndrome 7}	612853	RLS7		2p14-p13
{Retinal disease in Usher syndrome type IIA, modifier of}	276901	PDZD7	612971	10q24.31
{Rheumatoid arthritis, progression of}	180300	IL10	124092	1q32.1
{Rheumatoid arthritis, progression of}	180300	CSIF	124092	1q32.1
{Rheumatoid arthritis, progression of}	180300	GVHDS	124092	1q32.1
{Rheumatoid arthritis, susceptibility to}	180300	RA		6q23
{Rheumatoid arthritis, susceptibility to}	180300	CD244	605554	1q23.3
{Rheumatoid arthritis, susceptibility to}	180300	NAIL	605554	1q23.3
{Rheumatoid arthritis, susceptibility to}	180300	NKR2B4	605554	1q23.3
{Rheumatoid arthritis, susceptibility to}	180300	SLAMF4	605554	1q23.3
{Rheumatoid arthritis, susceptibility to}	180300	HLA-DRB1	142857	6p21.32
{Rheumatoid arthritis, susceptibility to}	180300	SS1	142857	6p21.32
{Rheumatoid arthritis, susceptibility to}	180300	MHC2TA	600005	16p13.13
{Rheumatoid arthritis, susceptibility to}	180300	C2TA	600005	16p13.13
{Rheumatoid arthritis, susceptibility to}	180300	NFKBIL1	601022	6p21.33
{Rheumatoid arthritis, susceptibility to}	180300	PADI4	605347	1p36.13
{Rheumatoid arthritis, susceptibility to}	180300	PADI5	605347	1p36.13
{Rheumatoid arthritis, susceptibility to}	180300	PAD	605347	1p36.13
{Rheumatoid arthritis, susceptibility to}	180300	PTPN22	600716	1p13.2
{Rheumatoid arthritis, susceptibility to}	180300	PEP	600716	1p13.2
{Rheumatoid arthritis, susceptibility to}	180300	PTPN8	600716	1p13.2
{Rheumatoid arthritis, susceptibility to}	180300	LYP	600716	1p13.2
{Rheumatoid arthritis, susceptibility to}	180300	SLC22A4	604190	5q31.1
{Rheumatoid arthritis, susceptibility to}	180300	OCTN1	604190	5q31.1
{Rheumatoid arthritis, systemic juvenile, susceptibility to}	604302	MIF	153620	22q11.23
{Rheumatoid arthritis, systemic juvenile}	604302	IL6	147620	7p15.3
{Rheumatoid arthritis, systemic juvenile}	604302	IFNB2	147620	7p15.3
{Rheumatoid arthritis, systemic juvenile}	604302	BSF2	147620	7p15.3
{Rheumatoid arthritis, systemic juvenile}	604302	HSF	147620	7p15.3
{Rheumatoid arthritis, systemic juvenile}	604302	HGF	147620	7p15.3
{SARS, progression of}	106180	ACE		17q23.3
{SARS, progression of}	106180	DCP1		17q23.3
{SARS, progression of}	106180	ACE1		17q23.3
{SARS, progression of}	106180	MVCD3		17q23.3
{SARS, progression of}	106180	ICH		17q23.3
{Sarcoidosis, susceptibility to, 1}	181000	HLA-DRB1	142857	6p21.32
{Sarcoidosis, susceptibility to, 1}	181000	SS1	142857	6p21.32
{Sarcoidosis, susceptibility to, 2}	612387	BTNL2	606000	6p21.32
{Sarcoidosis, susceptibility to, 2}	612387	SS2	606000	6p21.32
{Sarcoidosis, susceptibility to, 3}	612388	SS3		10q22.3
{Schistosoma mansoni infection, susceptibility/resistance to}	181460	SM1		5q31-q33
{Schizoaffective disorder, susceptibility to}	181500	DISC1	605210	1q42.2
{Schizoaffective disorder, susceptibility to}	181500	SCZD9	605210	1q42.2
{Schizophrenia 10}	605419	SCZD10		15q15
{Schizophrenia 12}	181500	SCZD12	608543	1p36.2
{Schizophrenia 15}	613950	SHANK3	606230	22q13.33
{Schizophrenia 15}	613950	PSAP2	606230	22q13.33
{Schizophrenia 15}	613950	PROSAP2	606230	22q13.33
{Schizophrenia 15}	613950	KIAA1650	606230	22q13.33
{Schizophrenia 15}	613950	DEL22q13.3	606230	22q13.33
{Schizophrenia 15}	613950	SCZD15	606230	22q13.33
{Schizophrenia, susceptibility to, 13}	613025	SCZD13		15q13
{Schizophrenia, susceptibility to, 14}	612361	SCZD14		2q32.1
{Schizophrenia, susceptibility to, 17}	614332	NRXN1	600565	2p16.3
{Schizophrenia, susceptibility to, 17}	614332	PTHSL2	600565	2p16.3
{Schizophrenia, susceptibility to, 17}	614332	SCZD17	600565	2p16.3
{Schizophrenia, susceptibility to, 4}	600850	PRODH	606810	22q11.21
{Schizophrenia, susceptibility to, 4}	600850	PRODH2	606810	22q11.21
{Schizophrenia, susceptibility to, 4}	600850	SCZD4	606810	22q11.21
{Schizophrenia, susceptibility to}	181500	AKT1	164730	14q32.33
{Schizophrenia, susceptibility to}	181500	CWS6	164730	14q32.33
{Schizophrenia, susceptibility to}	181500	CHI3L1	601525	1q32.1
{Schizophrenia, susceptibility to}	181500	GP39	601525	1q32.1
{Schizophrenia, susceptibility to}	181500	YKL40	601525	1q32.1
{Schizophrenia, susceptibility to}	181500	ASRT7	601525	1q32.1
{Schizophrenia, susceptibility to}	181500	COMT	116790	22q11.21
{Schizophrenia, susceptibility to}	181500	DRD3	126451	3q13.31
{Schizophrenia, susceptibility to}	181500	ETM1	126451	3q13.31
{Schizophrenia, susceptibility to}	181500	FET1	126451	3q13.31
{Schizophrenia, susceptibility to}	181500	HTR2A	182135	13q14.2
{Schizophrenia, susceptibility to}	181500	MTHFR	607093	1p36.22
{Schizophrenia, susceptibility to}	181500	RTN4R	605566	22q11.21
{Schizophrenia, susceptibility to}	181500	NOGOR	605566	22q11.21
{Schizophrenia, susceptibility to}	181500	SYN2	600755	3p25.2
{Schizophrenia, susceptibility to}	604906	DISC1	605210	1q42.2
{Schizophrenia, susceptibility to}	604906	SCZD9	605210	1q42.2
{Schizophrenia}	181500	APOL2	607252	22q12.3
{Schizophrenia}	181500	APOL4	607254	22q12.3
{Schizophrenia}	181500	DAO	124050	12q24.11
{Schizophrenia}	181500	DAMOX	124050	12q24.11
{Schizophrenia}	181500	DAOA	607408	13q33.2
{Schizophrenia}	181500	G72	607408	13q33.2
{Schizophrenia}	181500	DTNBP1	607145	6p22.3
{Schizophrenia}	181500	HPS7	607145	6p22.3
{Schizophrenia}	181500	SCZD11	608078	10q22.3
{Schizophrenia}	181500	SCZD1	181510	5q23-q35
{Schizophrenia}	181500	SCZD3	600511	6p23
{Schizophrenia}	181500	SCZD5	603175	6q13-q26
{Schizophrenia}	181500	SCZD6	603013	8p21
{Schizophrenia}	181500	SCZD7	603176	13q32
{Schizophrenia}	181500	SCZD8	603206	18p
{Scoliosis, idiopathic 3}	608765	CHD7	608892	8q12.1-q12.2
{Scoliosis, idiopathic 3}	608765	IS3	608892	8q12.1-q12.2
{Scoliosis, idiopathic 3}	608765	HH5	608892	8q12.1-q12.2
{Scoliosis, idiopathic, susceptibility to, 4}	612238	IS4		9q31.2-q34.2
{Seasonal affective disorder, susceptibility to}	608516	HTR2A	182135	13q14.2
{Sepsis, susceptibility to}		CASP12	608633	11q22.3
{Sepsis, susceptibility to}		CASP12P1	608633	11q22.3
{Septic shock, susceptibility to}		TNF	191160	6p21.33
{Septic shock, susceptibility to}		TNFA	191160	6p21.33
{Sezary syndrome, somatic},		BCL10	603517	1p22.3
{Sick sinus syndrome 3}	614090	MYH6	160710	14q11.2
{Sick sinus syndrome 3}	614090	ASD3	160710	14q11.2
{Sick sinus syndrome 3}	614090	MYHCA	160710	14q11.2
{Sick sinus syndrome 3}	614090	CMD1EE	160710	14q11.2
{Sick sinus syndrome 3}	614090	CMH14	160710	14q11.2
{Sick sinus syndrome 3}	614090	SSS3	160710	14q11.2
{Smoking as a quantitative trait locus 1}	611003	SQTL1		10q22
{Smoking as a quantitative trait locus 2}	611004	SQTL2		22q12
{Specific language impairment 4}	612514	SLI4		7q35-q36
{Specific language impairment 5}	615432	TM4SF20	615404	2q36.3
{Specific language impairment 5}	615432	SLI5	615404	2q36.3
{Speech-sound disorder}	608445	SSD		3p12-q13
{Spermatogenic failure, susceptibility to}		DAZL	601486	3p24.3
{Spermatogenic failure, susceptibility to}		DAZH	601486	3p24.3
{Spermatogenic failure, susceptibility to}		SPGYLA	601486	3p24.3
{Spina bifida, folate-sensitive, susceptibility to}	601634	MTHFD	172460	14q23.3
{Spina bifida, folate-sensitive, susceptibility to}	601634	MTHFC	172460	14q23.3
{Spina bifida, susceptibility to}	182940	CCL2	158105	17q12
{Spina bifida, susceptibility to}	182940	SCYA2	158105	17q12
{Spina bifida, susceptibility to}	182940	MCP1	158105	17q12
{Spina bifida, susceptibility to}	182940	MCAF	158105	17q12
{Spinal muscular atrophy, type III, modifier of}	253400	SMN2	601627	5q13.2
{Spondyloarthropathy, susceptibility to, 1}	106300	HLA-B	142830	6p21.33
{Spondyloarthropathy, susceptibility to, 1}	106300	SPDA1	142830	6p21.33
{Spondyloarthropathy, susceptibility to, 2}	183840	SPDA2		9q31-q34
{Spondyloarthropathy, susceptibility to, 3}	613238	SPDA3		2q36.1-q36.3
{Stature QTL 10}	612221	STQTL10		3q23
{Stature QTL 11}	612223	STQTL11		7q21
{Stature QTL 12}	612224	STQTL12		4q31
{Stature QTL 13}	612226	STQTL13		4p15.3
{Stature QTL 14}	612228	STQTL14		20q11.22
{Stature QTL 15}	612578	STQTL15		8q21.13
{Stature QTL 16}	612579	STQTL16		15q22.32
{Stature QTL 17}	612737	STQTL17		7p15
{Stature QTL 18}	612892	STQTL18		6p22.1
{Stature QTL 19}	612893	STQTL19		6p21.31
{Stature QTL 1}	606255	STQTL1		6q24-q25
{Stature QTL 20}	612894	STQTL20		13q14.3
{Stature QTL 21}	613440	STQTL21		2q37.1
{Stature QTL 22}	613547	STQTL22		16q24
{Stature QTL 23}	613548	STQTL23		1p32
{Stature QTL 24}	613549	STQTL24		2p16
{Stature QTL 2}	606256	STQTL2		7q31.3
{Stature QTL 3}	606257	STQTL3		12p11.2-q14
{Stature QTL 4}	606258	STQTL4		13q32-q33
{Stature QTL 5}	608982	STQTL5		3p26
{Stature QTL 6}	300591	STQTL6		Xq24-q25
{Stature QTL 7}	609822	STQTL7		1p21
{Stature QTL 8}	610114	STQTL8		9q22
{Stature QTL 9}	611547	STQTL9		12q14.3
{Stevens-Johnson syndrome, susceptibility to}	608579	HLA-B	142830	6p21.33
{Stevens-Johnson syndrome, susceptibility to}	608579	SPDA1	142830	6p21.33
{Strabismus, susceptibility to, 1}	185100	STBMS1		7p22.1
{Stroke, hemorrhagic}	614519	ACE	106180	17q23.3
{Stroke, hemorrhagic}	614519	DCP1	106180	17q23.3
{Stroke, hemorrhagic}	614519	ACE1	106180	17q23.3
{Stroke, hemorrhagic}	614519	MVCD3	106180	17q23.3
{Stroke, hemorrhagic}	614519	ICH	106180	17q23.3
{Stroke, ischemic, susceptibility to}	601367	F2	176930	11p11.2
{Stroke, ischemic, susceptibility to}	601367	THPH1	176930	11p11.2
{Stroke, ischemic, susceptibility to}	601367	RPRGL2	176930	11p11.2
{Stroke, ischemic, susceptibility to}	601367	F5	612309	1q24.2
{Stroke, ischemic, susceptibility to}	601367	THPH2	612309	1q24.2
{Stroke, ischemic, susceptibility to}	601367	RPRGL1	612309	1q24.2
{Stroke, susceptibility to, 1}	606799	PDE4D	600129	5q11.2-q12.1
{Stroke, susceptibility to, 1}	606799	DPDE3	600129	5q11.2-q12.1
{Stroke, susceptibility to, 1}	606799	STRK1	600129	5q11.2-q12.1
{Stroke, susceptibility to, 1}	606799	ACRDYS2	600129	5q11.2-q12.1
{Stroke, susceptibility to}	601367	ALOX5AP	603700	13q12.3
{Stroke, susceptibility to}	601367	FLAP	603700	13q12.3
{Sublingual nitroglycerin, susceptibility to poor response to}	100650	ALDH2		12q24.12
{Sudden infant death syndrome, susceptibility to}	272120	SCN5A	600163	3p22.2
{Sudden infant death syndrome, susceptibility to}	272120	LQT3	600163	3p22.2
{Sudden infant death syndrome, susceptibility to}	272120	VF1	600163	3p22.2
{Sudden infant death syndrome, susceptibility to}	272120	HB1	600163	3p22.2
{Sudden infant death syndrome, susceptibility to}	272120	SSS1	600163	3p22.2
{Sudden infant death syndrome, susceptibility to}	272120	CMD1E	600163	3p22.2
{Sudden infant death syndrome, susceptibility to}	272120	CDCD2	600163	3p22.2
{Synovitis, chronic, susceptibility to}	142830	HLA-B		6p21.33
{Synovitis, chronic, susceptibility to}	142830	SPDA1		6p21.33
{Systemic lupus erthematosus, susceptibility to, 15}	300809	SLEB15		Xq28
{Systemic lupus erythematosus susceptibility to}	152700	PTPN22	600716	1p13.2
{Systemic lupus erythematosus susceptibility to}	152700	PEP	600716	1p13.2
{Systemic lupus erythematosus susceptibility to}	152700	PTPN8	600716	1p13.2
{Systemic lupus erythematosus susceptibility to}	152700	LYP	600716	1p13.2
{Systemic lupus erythematosus with hemolytic anemia}	607279	SLEH1		11q14
{Systemic lupus erythematosus with nephritis, susceptibility to, 1}	607965	SLEN1		10q22.3
{Systemic lupus erythematosus with nephritis, susceptibility to, 2}	607966	SLEN2		2q34-q35
{Systemic lupus erythematosus with nephritis, susceptibility to, 3}	607967	SLEN3		11p15.5
{Systemic lupus erythematosus, association with}	152700	BANK1	610292	4q24
{Systemic lupus erythematosus, association with}	152700	FLJ20706	610292	4q24
{Systemic lupus erythematosus, association with}	152700	BANK	610292	4q24
{Systemic lupus erythematosus, resistance to}	601744	TLR5	603031	1q41
{Systemic lupus erythematosus, resistance to}	601744	TIL3	603031	1q41
{Systemic lupus erythematosus, resistance to}	601744	SLEB1	603031	1q41
{Systemic lupus erythematosus, resistance to}	601744	MELIOS	603031	1q41
{Systemic lupus erythematosus, susceptibility to, 10}	612251	IRF5	607218	7q32.1
{Systemic lupus erythematosus, susceptibility to, 10}	612251	IBD14	607218	7q32.1
{Systemic lupus erythematosus, susceptibility to, 10}	612251	SLEB10	607218	7q32.1
{Systemic lupus erythematosus, susceptibility to, 12}	612254	SLEB12		8p23.1
{Systemic lupus erythematosus, susceptibility to, 13}	612378	SLEB13		6q23
{Systemic lupus erythematosus, susceptibility to, 14}	613145	SLEB14		1q21-q23
{Systemic lupus erythematosus, susceptibility to, 1}	601744	TLR5	603031	1q41
{Systemic lupus erythematosus, susceptibility to, 1}	601744	TIL3	603031	1q41
{Systemic lupus erythematosus, susceptibility to, 1}	601744	SLEB1	603031	1q41
{Systemic lupus erythematosus, susceptibility to, 1}	601744	MELIOS	603031	1q41
{Systemic lupus erythematosus, susceptibility to, 2}	605218	PDCD1	600244	2q37.3
{Systemic lupus erythematosus, susceptibility to, 2}	605218	SLEB2	600244	2q37.3
{Systemic lupus erythematosus, susceptibility to, 3}	605480	SLEB3		4p16-p15.2
{Systemic lupus erythematosus, susceptibility to, 4}	608437	SLEB4		12q24
{Systemic lupus erythematosus, susceptibility to, 5}	609903	SLEB5		13q32
{Systemic lupus erythematosus, susceptibility to, 7}	610065	SLEB7		20p12
{Systemic lupus erythematosus, susceptibility to, 8}	610066	SLEB8		20q13
{Systemic lupus erythematosus, susceptibility to, 9}	610927	CR2	120650	1q32.2
{Systemic lupus erythematosus, susceptibility to, 9}	610927	C3DR	120650	1q32.2
{Systemic lupus erythematosus, susceptibility to, 9}	610927	SLEB9	120650	1q32.2
{Systemic lupus erythematosus, susceptibility to, 9}	610927	CVID7	120650	1q32.2
{Systemic lupus erythematosus, susceptibility to}	152700	DNASE1	125505	16p13.3
{Systemic lupus erythematosus, susceptibility to}	152700	DNL1	125505	16p13.3
{Systemic lupus erythematosus, susceptibility to}	152700	FCGR2B	604590	1q23.3
{Systemic lupus erythematosus, susceptibility to}	152700	CD32	604590	1q23.3
{Systemic lupus erythematosus, susceptibility to}	152700	TREX1	606609	3p21.31
{Systemic lupus erythematosus, susceptibility to}	152700	AGS1	606609	3p21.31
{Systemic lupus erythematosus, susceptibility to}	152700	CRV	606609	3p21.31
{Systemic lupus erythematosus, susceptibility to}	152700	HERNS	606609	3p21.31
{Systemic lupus erythematosus, susceptitbility to, 11}	612253	STAT4	600558	2q32.2-q32.3
{Systemic lupus erythematosus, susceptitbility to, 11}	612253	SLEB11	600558	2q32.2-q32.3
{Systemic lupus erythematous, association with susceptibility to, 6}	609939	ITGAM	120980	16p11.2
{Systemic lupus erythematous, association with susceptibility to, 6}	609939	CR3A	120980	16p11.2
{Systemic lupus erythematous, association with susceptibility to, 6}	609939	CD11B	120980	16p11.2
{Systemic lupus erythematous, association with susceptibility to, 6}	609939	MAC1A	120980	16p11.2
{Systemic lupus erythematous, association with susceptibility to, 6}	609939	SLEB6	120980	16p11.2
{T-cell acute lymphoblastic leukemia}		MYB	189990	6q23.3
{TSC2 angiomyolipomas, renal, modifier of}	613254	IFNG	147570	12q15
{TSC2 angiomyolipomas, renal, modifier of}	613254	IFG	147570	12q15
{TSC2 angiomyolipomas, renal, modifier of}	613254	IFI	147570	12q15
{Thromboembolism, susceptibility to}	188050	MTHFR	607093	1p36.22
{Thrombophilia, susceptibility to, due to factor V Leiden}	188055	F5	612309	1q24.2
{Thrombophilia, susceptibility to, due to factor V Leiden}	188055	THPH2	612309	1q24.2
{Thrombophilia, susceptibility to, due to factor V Leiden}	188055	RPRGL1	612309	1q24.2
{Thyroid carcinoma, Hurthle cell}	607464	NDUFA13	609435	19p13.11
{Thyroid carcinoma, Hurthle cell}	607464	GRIM19	609435	19p13.11
{Thyroid carcinoma, follicular, somatic}	188470	HRAS	190020	11p15.5
{Thyrotoxic periodic paralysis, susceptibility to, 1}	188580	CACNA1S	114208	1q32.1
{Thyrotoxic periodic paralysis, susceptibility to, 1}	188580	CACNL1A3	114208	1q32.1
{Thyrotoxic periodic paralysis, susceptibility to, 1}	188580	CCHL1A3	114208	1q32.1
{Thyrotoxic periodic paralysis, susceptibility to, 1}	188580	TTPP1	114208	1q32.1
{Thyrotoxic periodic paralysis, susceptibility to, 1}	188580	HOKPP1	114208	1q32.1
{Thyrotoxic periodic paralysis, susceptibility to, 2}	613239	KCNJ18	613236	17p11.2
{Thyrotoxic periodic paralysis, susceptibility to, 2}	613239	KIR2.6	613236	17p11.2
{Thyrotoxic periodic paralysis, susceptibility to, 2}	613239	TTPP2	613236	17p11.2
{Toxic epidermal necrolysis, susceptibility to}	608579	HLA-B	142830	6p21.33
{Toxic epidermal necrolysis, susceptibility to}	608579	SPDA1	142830	6p21.33
{Transcription of plasminogen activator inhibitor, modulator of}		PAI1	173360	7q22.1
{Transcription of plasminogen activator inhibitor, modulator of}		PLANH1	173360	7q22.1
{Transcription of plasminogen activator inhibitor, modulator of}		SERPINE1	173360	7q22.1
{Tuberculosis, protection against}	607948	IFNG	147570	12q15
{Tuberculosis, protection against}	607948	IFG	147570	12q15
{Tuberculosis, protection against}	607948	IFI	147570	12q15
{Tuberculosis, protection against}	607948	TIRAP	606252	11q24.2
{Tuberculosis, protection against}	607948	BACTS1	606252	11q24.2
{Tuberculosis, susceptibility to}	607949	MTBS1		2q35
{Tuberculosis, susceptibility to}	607948	CISH	602441	3p21.2
{Tuberculosis, susceptibility to}	607948	BACTS2	602441	3p21.2
{Tuberculosis, susceptibility to}	607948	IFNGR1	107470	6q23.3
{UV-induced skin damage}	266300	MC1R	155555	16q24.3
{UV-induced skin damage}	266300	SHEP2	155555	16q24.3
{UV-induced skin damage}	266300	CMM5	155555	16q24.3
{Unipolar depression, susceptibility to}	608516	TPH2	607478	12q21.1
{Unipolar depression, susceptibility to}	608516	NTPH	607478	12q21.1
{Unipolar depression, susceptibility to}	608516	ADHD7	607478	12q21.1
{Uric acid concentration, serum, QTL 2}	612076	SLC2A9	606142	4p16.1
{Uric acid concentration, serum, QTL 2}	612076	GLUT9	606142	4p16.1
{Uric acid concentration, serum, QTL 2}	612076	UAQTL2	606142	4p16.1
{Vascular disease, susceptibility to}		MTHFR	607093	1p36.22
{Venoocclusive disease after bone marrow transplantation}	608307	CPS1		2q34
{Venoocclusive disease after bone marrow transplantation}	608307	PHN		2q34
{Venous thromboembolism, susceptibility to}	188050	HABP2	603924	10q25.3
{Venous thromboembolism, susceptibility to}	188050	PHBP	603924	10q25.3
{Venous thromboembolism, susceptibility to}	188050	HGFAL	603924	10q25.3
{Venous thromboembolism, susceptibility to}	188050	FSAP	603924	10q25.3
{Venous thrombosis, protection against}	188050	F13A1	134570	6p25.1
{Venous thrombosis, protection against}	188050	F13A	134570	6p25.1
{Venous thrombosis, susceptibility to}		SERPINA10	605271	14q32.13
{Venous thrombosis, susceptibility to}		ZPI	605271	14q32.13
{Viral infection, susceptibility to}		OAS1	164350	12q24.13
{Viral infection, susceptibility to}		OIAS	164350	12q24.13
{Viral infections, recurrent}		FCGR3A	146740	1q23.3
{Viral infections, recurrent}		CD16	146740	1q23.3
{Viral infections, recurrent}		IGFR3	146740	1q23.3
{Vitamin B12 plasma level QTL1}	612542	FUT2	182100	19q13.33
{Vitamin B12 plasma level QTL1}	612542	SE	182100	19q13.33
{Vitamin B12 plasma level QTL1}	612542	B12QTL1	182100	19q13.33
{Vitamin B6 plasma level QTL 1}	612957	B6QTL1		1p36.12
{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	NLRP1	606636	17p13.2
{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	NALP1	606636	17p13.2
{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	KIAA0926	606636	17p13.2
{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	DEFCAP	606636	17p13.2
{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	CARD7	606636	17p13.2
{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	SLEV1	606636	17p13.2
{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	VAMAS1	606636	17p13.2
{Vitiligo-associated multiple autoimmune disease susceptibility 1}	606579	CIDED	606636	17p13.2
{Vitiligo-associated multiple autoimmune disease susceptiblity 6}	193200	VAMAS6		6p21.3
{Warfarin sensitivity}	122700	F9	300746	Xq27.1
{Warfarin sensitivity}	122700	HEMB	300746	Xq27.1
{Warfarin sensitivity}	122700	THPH8	300746	Xq27.1
{West nile virus, susceptibility to}	610379	CCR5	601373	3p21.31
{West nile virus, susceptibility to}	610379	CMKBR5	601373	3p21.31
{West nile virus, susceptibility to}	610379	CCCKR5	601373	3p21.31
{West nile virus, susceptibility to}	610379	IDDM22	601373	3p21.31
{Wilms tumor susceptibility-5}	601583	POU6F2	609062	7p14.1
{Wilms tumor susceptibility-5}	601583	WTSL	609062	7p14.1
{Wilms tumor susceptibility-5}	601583	WT5	609062	7p14.1
{von Hippel-Lindau disease, modifier of}	193300	CCND1	168461	11q13.3
{von Hippel-Lindau disease, modifier of}	193300	PRAD1	168461	11q13.3
{von Hippel-Lindau disease, modifier of}	193300	BCL1	168461	11q13.3
